GO_ID	GO_LABEL_FULL	NUMBER_OF_GENES_IN_REFERENCE	NUMBER_OF_GENES_IN_INPUT	NUMBER_OF_GENES_EXPECTED	+/-	FOLD_ENRICHMENT	RAW_P_VALUE	FDR
GO:0090131	mesenchyme migration (GO:0090131)	5	5	.29	+	17.03	1.04E-04	2.92E-03
GO:0002651	positive regulation of tolerance induction to self antigen (GO:0002651)	1	1	.06	+	17.03	1.08E-01	5.97E-01
GO:0002649	regulation of tolerance induction to self antigen (GO:0002649)	1	1	.06	+	17.03	1.08E-01	5.97E-01
GO:0045769	negative regulation of asymmetric cell division (GO:0045769)	1	1	.06	+	17.03	1.08E-01	5.97E-01
GO:0002617	negative regulation of macrophage antigen processing and presentation (GO:0002617)	1	1	.06	+	17.03	1.08E-01	5.97E-01
GO:0002616	regulation of macrophage antigen processing and presentation (GO:0002616)	1	1	.06	+	17.03	1.08E-01	5.96E-01
GO:1903285	positive regulation of hydrogen peroxide catabolic process (GO:1903285)	1	1	.06	+	17.03	1.08E-01	5.96E-01
GO:1903284	positive regulation of glutathione peroxidase activity (GO:1903284)	1	1	.06	+	17.03	1.08E-01	5.96E-01
GO:1903280	negative regulation of calcium:sodium antiporter activity (GO:1903280)	1	1	.06	+	17.03	1.08E-01	5.96E-01
GO:0007493	endodermal cell fate determination (GO:0007493)	2	2	.12	+	17.03	1.71E-02	1.87E-01
GO:1903249	negative regulation of citrulline biosynthetic process (GO:1903249)	1	1	.06	+	17.03	1.08E-01	5.96E-01
GO:1903248	regulation of citrulline biosynthetic process (GO:1903248)	1	1	.06	+	17.03	1.08E-01	5.95E-01
GO:0021758	putamen development (GO:0021758)	1	1	.06	+	17.03	1.08E-01	5.95E-01
GO:0021757	caudate nucleus development (GO:0021757)	1	1	.06	+	17.03	1.08E-01	5.95E-01
GO:0003065	positive regulation of heart rate by epinephrine (GO:0003065)	1	1	.06	+	17.03	1.08E-01	5.95E-01
GO:0060461	right lung morphogenesis (GO:0060461)	1	1	.06	+	17.03	1.08E-01	5.94E-01
GO:0080021	response to benzoic acid (GO:0080021)	1	1	.06	+	17.03	1.08E-01	5.94E-01
GO:1902748	positive regulation of lens fiber cell differentiation (GO:1902748)	1	1	.06	+	17.03	1.08E-01	5.94E-01
GO:0071971	extracellular exosome assembly (GO:0071971)	1	1	.06	+	17.03	1.08E-01	5.94E-01
GO:0010186	positive regulation of cellular defense response (GO:0010186)	1	1	.06	+	17.03	1.08E-01	5.94E-01
GO:0010185	regulation of cellular defense response (GO:0010185)	1	1	.06	+	17.03	1.08E-01	5.93E-01
GO:0021685	cerebellar granular layer structural organization (GO:0021685)	1	1	.06	+	17.03	1.08E-01	5.93E-01
GO:0021666	rhombomere 5 formation (GO:0021666)	1	1	.06	+	17.03	1.08E-01	5.93E-01
GO:0021665	rhombomere 5 structural organization (GO:0021665)	1	1	.06	+	17.03	1.08E-01	5.93E-01
GO:0021664	rhombomere 5 morphogenesis (GO:0021664)	1	1	.06	+	17.03	1.08E-01	5.93E-01
GO:0021660	rhombomere 3 formation (GO:0021660)	1	1	.06	+	17.03	1.08E-01	5.92E-01
GO:0033624	negative regulation of integrin activation (GO:0033624)	3	3	.18	+	17.03	3.00E-03	5.05E-02
GO:0021659	rhombomere 3 structural organization (GO:0021659)	1	1	.06	+	17.03	1.08E-01	5.92E-01
GO:1903126	negative regulation of centriole-centriole cohesion (GO:1903126)	1	1	.06	+	17.03	1.08E-01	5.92E-01
GO:1903125	negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125)	1	1	.06	+	17.03	1.08E-01	5.92E-01
GO:0021629	olfactory nerve structural organization (GO:0021629)	1	1	.06	+	17.03	1.08E-01	5.92E-01
GO:2000896	amylopectin metabolic process (GO:2000896)	1	1	.06	+	17.03	1.08E-01	5.91E-01
GO:0007344	pronuclear fusion (GO:0007344)	1	1	.06	+	17.03	1.08E-01	5.91E-01
GO:0021618	hypoglossal nerve morphogenesis (GO:0021618)	1	1	.06	+	17.03	1.08E-01	5.91E-01
GO:0046086	adenosine biosynthetic process (GO:0046086)	1	1	.06	+	17.03	1.08E-01	5.91E-01
GO:0072303	positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303)	1	1	.06	+	17.03	1.08E-01	5.91E-01
GO:0071882	phospholipase C-activating adrenergic receptor signaling pathway (GO:0071882)	1	1	.06	+	17.03	1.08E-01	5.90E-01
GO:0071881	adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881)	1	1	.06	+	17.03	1.08E-01	5.90E-01
GO:0071877	regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071877)	1	1	.06	+	17.03	1.08E-01	5.90E-01
GO:2001262	positive regulation of semaphorin-plexin signaling pathway (GO:2001262)	1	1	.06	+	17.03	1.08E-01	5.90E-01
GO:0010021	amylopectin biosynthetic process (GO:0010021)	1	1	.06	+	17.03	1.08E-01	5.89E-01
GO:1903096	protein localization to meiotic spindle midzone (GO:1903096)	1	1	.06	+	17.03	1.08E-01	5.89E-01
GO:0021595	rhombomere structural organization (GO:0021595)	1	1	.06	+	17.03	1.08E-01	5.89E-01
GO:0021594	rhombomere formation (GO:0021594)	1	1	.06	+	17.03	1.08E-01	5.89E-01
GO:0021566	hypoglossal nerve development (GO:0021566)	1	1	.06	+	17.03	1.08E-01	5.89E-01
GO:0021541	ammon gyrus development (GO:0021541)	1	1	.06	+	17.03	1.08E-01	5.88E-01
GO:1903011	negative regulation of bone development (GO:1903011)	1	1	.06	+	17.03	1.08E-01	5.88E-01
GO:2000795	negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795)	1	1	.06	+	17.03	1.08E-01	5.88E-01
GO:0007225	patched ligand maturation (GO:0007225)	1	1	.06	+	17.03	1.08E-01	5.88E-01
GO:0060283	negative regulation of oocyte development (GO:0060283)	1	1	.06	+	17.03	1.08E-01	5.88E-01
GO:2000764	positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis (GO:2000764)	1	1	.06	+	17.03	1.08E-01	5.87E-01
GO:2000763	positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763)	1	1	.06	+	17.03	1.08E-01	5.87E-01
GO:2000761	positive regulation of N-terminal peptidyl-lysine acetylation (GO:2000761)	1	1	.06	+	17.03	1.08E-01	5.87E-01
GO:2000759	regulation of N-terminal peptidyl-lysine acetylation (GO:2000759)	1	1	.06	+	17.03	1.08E-01	5.87E-01
GO:0072232	metanephric proximal convoluted tubule segment 2 development (GO:0072232)	1	1	.06	+	17.03	1.08E-01	5.87E-01
GO:0072230	metanephric proximal straight tubule development (GO:0072230)	1	1	.06	+	17.03	1.08E-01	5.86E-01
GO:0072220	metanephric descending thin limb development (GO:0072220)	1	1	.06	+	17.03	1.08E-01	5.86E-01
GO:0002384	hepatic immune response (GO:0002384)	2	2	.12	+	17.03	1.71E-02	1.87E-01
GO:0002364	NK T cell lineage commitment (GO:0002364)	1	1	.06	+	17.03	1.08E-01	5.86E-01
GO:0033477	S-methylmethionine metabolic process (GO:0033477)	1	1	.06	+	17.03	1.08E-01	5.86E-01
GO:2001113	negative regulation of cellular response to hepatocyte growth factor stimulus (GO:2001113)	1	1	.06	+	17.03	1.08E-01	5.86E-01
GO:0001899	negative regulation of cytolysis by symbiont of host cells (GO:0001899)	1	1	.06	+	17.03	1.08E-01	5.85E-01
GO:0001898	regulation of cytolysis by symbiont of host cells (GO:0001898)	1	1	.06	+	17.03	1.08E-01	5.85E-01
GO:0071654	positive regulation of chemokine (C-C motif) ligand 1 production (GO:0071654)	1	1	.06	+	17.03	1.08E-01	5.85E-01
GO:0071652	regulation of chemokine (C-C motif) ligand 1 production (GO:0071652)	1	1	.06	+	17.03	1.08E-01	5.85E-01
GO:1990963	establishment of blood-retinal barrier (GO:1990963)	1	1	.06	+	17.03	1.08E-01	5.85E-01
GO:0033316	meiotic spindle assembly checkpoint signaling (GO:0033316)	1	1	.06	+	17.03	1.08E-01	5.84E-01
GO:0033301	cell cycle comprising mitosis without cytokinesis (GO:0033301)	1	1	.06	+	17.03	1.08E-01	5.84E-01
GO:0072032	proximal convoluted tubule segment 2 development (GO:0072032)	1	1	.06	+	17.03	1.08E-01	5.84E-01
GO:0032877	positive regulation of DNA endoreduplication (GO:0032877)	2	2	.12	+	17.03	1.71E-02	1.87E-01
GO:2000548	negative regulation of dendritic cell dendrite assembly (GO:2000548)	1	1	.06	+	17.03	1.08E-01	5.84E-01
GO:0072022	descending thin limb development (GO:0072022)	1	1	.06	+	17.03	1.08E-01	5.84E-01
GO:0072020	proximal straight tubule development (GO:0072020)	1	1	.06	+	17.03	1.08E-01	5.83E-01
GO:2000533	negative regulation of renal albumin absorption (GO:2000533)	1	1	.06	+	17.03	1.08E-01	5.83E-01
GO:0038154	interleukin-11-mediated signaling pathway (GO:0038154)	3	3	.18	+	17.03	3.00E-03	5.05E-02
GO:0032848	negative regulation of cellular pH reduction (GO:0032848)	1	1	.06	+	17.03	1.08E-01	5.83E-01
GO:1902319	DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319)	1	1	.06	+	17.03	1.08E-01	5.83E-01
GO:0006539	glutamate catabolic process via 2-oxoglutarate (GO:0006539)	1	1	.06	+	17.03	1.08E-01	5.83E-01
GO:1901898	negative regulation of relaxation of cardiac muscle (GO:1901898)	2	2	.12	+	17.03	1.71E-02	1.87E-01
GO:0051945	negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945)	1	1	.06	+	17.03	1.08E-01	5.82E-01
GO:1901875	positive regulation of post-translational protein modification (GO:1901875)	1	1	.06	+	17.03	1.08E-01	5.82E-01
GO:0051915	induction of synaptic plasticity by chemical substance (GO:0051915)	1	1	.06	+	17.03	1.08E-01	5.82E-01
GO:0051914	positive regulation of synaptic plasticity by chemical substance (GO:0051914)	1	1	.06	+	17.03	1.08E-01	5.82E-01
GO:0051913	regulation of synaptic plasticity by chemical substance (GO:0051913)	1	1	.06	+	17.03	1.08E-01	5.82E-01
GO:1901835	positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901835)	1	1	.06	+	17.03	1.08E-01	5.81E-01
GO:1901834	regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901834)	1	1	.06	+	17.03	1.08E-01	5.81E-01
GO:0090673	endothelial cell-matrix adhesion (GO:0090673)	1	1	.06	+	17.03	1.08E-01	5.81E-01
GO:1901826	zeaxanthin catabolic process (GO:1901826)	1	1	.06	+	17.03	1.08E-01	5.81E-01
GO:0033242	negative regulation of cellular amine catabolic process (GO:0033242)	1	1	.06	+	17.03	1.08E-01	5.81E-01
GO:0033241	regulation of cellular amine catabolic process (GO:0033241)	1	1	.06	+	17.03	1.08E-01	5.80E-01
GO:0033215	reductive iron assimilation (GO:0033215)	1	1	.06	+	17.03	1.08E-01	5.80E-01
GO:2000476	positive regulation of opioid receptor signaling pathway (GO:2000476)	1	1	.06	+	17.03	1.08E-01	5.80E-01
GO:2000469	negative regulation of peroxidase activity (GO:2000469)	1	1	.06	+	17.03	1.08E-01	5.80E-01
GO:0038097	positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097)	1	1	.06	+	17.03	1.08E-01	5.80E-01
GO:1902298	cell cycle DNA replication maintenance of fidelity (GO:1902298)	2	2	.12	+	17.03	1.71E-02	1.87E-01
GO:1902296	DNA strand elongation involved in cell cycle DNA replication (GO:1902296)	1	1	.06	+	17.03	1.08E-01	5.79E-01
GO:2000431	regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000431)	1	1	.06	+	17.03	1.08E-01	5.79E-01
GO:2000420	negative regulation of eosinophil extravasation (GO:2000420)	1	1	.06	+	17.03	1.08E-01	5.79E-01
GO:2000419	regulation of eosinophil extravasation (GO:2000419)	1	1	.06	+	17.03	1.08E-01	5.79E-01
GO:1902239	negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239)	1	1	.06	+	17.03	1.08E-01	5.79E-01
GO:1902238	regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902238)	1	1	.06	+	17.03	1.08E-01	5.78E-01
GO:1902203	negative regulation of hepatocyte growth factor receptor signaling pathway (GO:1902203)	1	1	.06	+	17.03	1.08E-01	5.78E-01
GO:1990792	cellular response to glial cell derived neurotrophic factor (GO:1990792)	2	2	.12	+	17.03	1.71E-02	1.87E-01
GO:1990790	response to glial cell derived neurotrophic factor (GO:1990790)	2	2	.12	+	17.03	1.71E-02	1.87E-01
GO:0006421	asparaginyl-tRNA aminoacylation (GO:0006421)	3	3	.18	+	17.03	3.00E-03	5.04E-02
GO:0045108	regulation of intermediate filament polymerization or depolymerization (GO:0045108)	1	1	.06	+	17.03	1.08E-01	5.78E-01
GO:0032686	negative regulation of hepatocyte growth factor production (GO:0032686)	1	1	.06	+	17.03	1.08E-01	5.78E-01
GO:2000324	positive regulation of glucocorticoid receptor signaling pathway (GO:2000324)	1	1	.06	+	17.03	1.08E-01	5.78E-01
GO:0032646	regulation of hepatocyte growth factor production (GO:0032646)	1	1	.06	+	17.03	1.08E-01	5.77E-01
GO:1902104	positive regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902104)	1	1	.06	+	17.03	1.08E-01	5.77E-01
GO:2000283	negative regulation of cellular amino acid biosynthetic process (GO:2000283)	1	1	.06	+	17.03	1.08E-01	5.77E-01
GO:0140200	adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate (GO:0140200)	1	1	.06	+	17.03	1.08E-01	5.77E-01
GO:0099642	retrograde axonal protein transport (GO:0099642)	2	2	.12	+	17.03	1.71E-02	1.87E-01
GO:0044533	positive regulation of apoptotic process in another organism (GO:0044533)	1	1	.06	+	17.03	1.08E-01	5.77E-01
GO:0044532	modulation of apoptotic process in another organism (GO:0044532)	1	1	.06	+	17.03	1.08E-01	5.76E-01
GO:1902078	positive regulation of lateral motor column neuron migration (GO:1902078)	1	1	.06	+	17.03	1.08E-01	5.76E-01
GO:1902076	regulation of lateral motor column neuron migration (GO:1902076)	1	1	.06	+	17.03	1.08E-01	5.76E-01
GO:0099607	lateral attachment of mitotic spindle microtubules to kinetochore (GO:0099607)	1	1	.06	+	17.03	1.08E-01	5.76E-01
GO:0099606	microtubule plus-end directed mitotic chromosome migration (GO:0099606)	1	1	.06	+	17.03	1.08E-01	5.76E-01
GO:0000921	septin ring assembly (GO:0000921)	1	1	.06	+	17.03	1.08E-01	5.75E-01
GO:1905935	positive regulation of cell fate determination (GO:1905935)	1	1	.06	+	17.03	1.08E-01	5.75E-01
GO:0051622	negative regulation of norepinephrine uptake (GO:0051622)	1	1	.06	+	17.03	1.08E-01	5.75E-01
GO:1901557	response to fenofibrate (GO:1901557)	1	1	.06	+	17.03	1.08E-01	5.75E-01
GO:1990505	mitotic DNA replication maintenance of fidelity (GO:1990505)	2	2	.12	+	17.03	1.71E-02	1.86E-01
GO:0140194	negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140194)	1	1	.06	+	17.03	1.08E-01	5.75E-01
GO:0140193	regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140193)	1	1	.06	+	17.03	1.08E-01	5.74E-01
GO:0090321	positive regulation of chylomicron remnant clearance (GO:0090321)	1	1	.06	+	17.03	1.08E-01	5.74E-01
GO:0090320	regulation of chylomicron remnant clearance (GO:0090320)	1	1	.06	+	17.03	1.08E-01	5.74E-01
GO:0099551	trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099551)	1	1	.06	+	17.03	1.08E-01	5.74E-01
GO:0099540	trans-synaptic signaling by neuropeptide (GO:0099540)	1	1	.06	+	17.03	1.08E-01	5.74E-01
GO:0051585	negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585)	1	1	.06	+	17.03	1.08E-01	5.74E-01
GO:0051545	negative regulation of elastin biosynthetic process (GO:0051545)	1	1	.06	+	17.03	1.08E-01	5.73E-01
GO:0051543	regulation of elastin biosynthetic process (GO:0051543)	1	1	.06	+	17.03	1.08E-01	5.73E-01
GO:1990426	mitotic recombination-dependent replication fork processing (GO:1990426)	2	2	.12	+	17.03	1.71E-02	1.86E-01
GO:0090246	convergent extension involved in somitogenesis (GO:0090246)	1	1	.06	+	17.03	1.08E-01	5.73E-01
GO:2000080	negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080)	1	1	.06	+	17.03	1.08E-01	5.73E-01
GO:0044345	stromal-epithelial cell signaling involved in prostate gland development (GO:0044345)	1	1	.06	+	17.03	1.08E-01	5.73E-01
GO:0106135	negative regulation of cardiac muscle cell contraction (GO:0106135)	1	1	.06	+	17.03	1.08E-01	5.72E-01
GO:0000741	karyogamy (GO:0000741)	1	1	.06	+	17.03	1.08E-01	5.72E-01
GO:0098990	AMPA selective glutamate receptor signaling pathway (GO:0098990)	1	1	.06	+	17.03	1.08E-01	5.72E-01
GO:0090177	establishment of planar polarity involved in neural tube closure (GO:0090177)	1	1	.06	+	17.03	1.08E-01	5.72E-01
GO:0048685	negative regulation of collateral sprouting of intact axon in response to injury (GO:0048685)	1	1	.06	+	17.03	1.08E-01	5.72E-01
GO:0048683	regulation of collateral sprouting of intact axon in response to injury (GO:0048683)	1	1	.06	+	17.03	1.08E-01	5.71E-01
GO:0090138	regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138)	1	1	.06	+	17.03	1.08E-01	5.71E-01
GO:0090126	protein-containing complex assembly involved in synapse maturation (GO:0090126)	1	1	.06	+	17.03	1.08E-01	5.71E-01
GO:0090122	cholesterol ester hydrolysis involved in cholesterol transport (GO:0090122)	1	1	.06	+	17.03	1.08E-01	5.71E-01
GO:0070512	positive regulation of histone H4-K20 methylation (GO:0070512)	1	1	.06	+	17.03	1.08E-01	5.71E-01
GO:0070510	regulation of histone H4-K20 methylation (GO:0070510)	1	1	.06	+	17.03	1.08E-01	5.70E-01
GO:0050929	induction of negative chemotaxis (GO:0050929)	1	1	.06	+	17.03	1.08E-01	5.70E-01
GO:0050924	positive regulation of negative chemotaxis (GO:0050924)	1	1	.06	+	17.03	1.08E-01	5.70E-01
GO:0048613	embryonic ectodermal digestive tract morphogenesis (GO:0048613)	1	1	.06	+	17.03	1.08E-01	5.70E-01
GO:0106028	neuron projection retraction (GO:0106028)	1	1	.06	+	17.03	1.08E-01	5.70E-01
GO:0106022	positive regulation of vesicle docking (GO:0106022)	1	1	.06	+	17.03	1.08E-01	5.69E-01
GO:1901296	negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901296)	1	1	.06	+	17.03	1.08E-01	5.69E-01
GO:1905627	regulation of serotonin biosynthetic process (GO:1905627)	1	1	.06	+	17.03	1.08E-01	5.69E-01
GO:0051322	anaphase (GO:0051322)	1	1	.06	+	17.03	1.08E-01	5.69E-01
GO:0090096	positive regulation of metanephric cap mesenchymal cell proliferation (GO:0090096)	1	1	.06	+	17.03	1.08E-01	5.69E-01
GO:0090095	regulation of metanephric cap mesenchymal cell proliferation (GO:0090095)	1	1	.06	+	17.03	1.08E-01	5.68E-01
GO:1905608	positive regulation of presynapse assembly (GO:1905608)	1	1	.06	+	17.03	1.08E-01	5.68E-01
GO:1905607	negative regulation of presynapse assembly (GO:1905607)	1	1	.06	+	17.03	1.08E-01	5.68E-01
GO:0009810	stilbene metabolic process (GO:0009810)	1	1	.06	+	17.03	1.08E-01	5.68E-01
GO:0070473	negative regulation of uterine smooth muscle contraction (GO:0070473)	1	1	.06	+	17.03	1.08E-01	5.68E-01
GO:0048567	ectodermal digestive tract morphogenesis (GO:0048567)	1	1	.06	+	17.03	1.08E-01	5.68E-01
GO:0120256	olefinic compound catabolic process (GO:0120256)	1	1	.06	+	17.03	1.08E-01	5.67E-01
GO:1900753	doxorubicin transport (GO:1900753)	1	1	.06	+	17.03	1.08E-01	5.67E-01
GO:1900731	positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:1900731)	1	1	.06	+	17.03	1.08E-01	5.67E-01
GO:1900729	regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:1900729)	1	1	.06	+	17.03	1.08E-01	5.67E-01
GO:0098786	biofilm matrix disassembly (GO:0098786)	1	1	.06	+	17.03	1.08E-01	5.67E-01
GO:0098784	biofilm matrix organization (GO:0098784)	1	1	.06	+	17.03	1.08E-01	5.66E-01
GO:0098736	negative regulation of the force of heart contraction (GO:0098736)	1	1	.06	+	17.03	1.08E-01	5.66E-01
GO:1901176	lycopene catabolic process (GO:1901176)	1	1	.06	+	17.03	1.08E-01	5.66E-01
GO:1901175	lycopene metabolic process (GO:1901175)	1	1	.06	+	17.03	1.08E-01	5.66E-01
GO:1905520	positive regulation of presynaptic active zone assembly (GO:1905520)	1	1	.06	+	17.03	1.08E-01	5.66E-01
GO:0098725	symmetric cell division (GO:0098725)	1	1	.06	+	17.03	1.08E-01	5.65E-01
GO:1990127	intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1990127)	1	1	.06	+	17.03	1.08E-01	5.65E-01
GO:1905518	regulation of presynaptic active zone assembly (GO:1905518)	1	1	.06	+	17.03	1.08E-01	5.65E-01
GO:0120181	focal adhesion disassembly (GO:0120181)	1	1	.06	+	17.03	1.08E-01	5.65E-01
GO:0120180	cell-substrate junction disassembly (GO:0120180)	1	1	.06	+	17.03	1.08E-01	5.65E-01
GO:0098694	regulation of synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0098694)	1	1	.06	+	17.03	1.08E-01	5.65E-01
GO:1905485	positive regulation of motor neuron migration (GO:1905485)	1	1	.06	+	17.03	1.08E-01	5.64E-01
GO:1905483	regulation of motor neuron migration (GO:1905483)	1	1	.06	+	17.03	1.08E-01	5.64E-01
GO:0031550	positive regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031550)	2	2	.12	+	17.03	1.71E-02	1.86E-01
GO:0070285	pigment cell development (GO:0070285)	1	1	.06	+	17.03	1.08E-01	5.64E-01
GO:1904998	negative regulation of leukocyte adhesion to arterial endothelial cell (GO:1904998)	1	1	.06	+	17.03	1.08E-01	5.64E-01
GO:0120072	positive regulation of pyloric antrum smooth muscle contraction (GO:0120072)	1	1	.06	+	17.03	1.08E-01	5.64E-01
GO:0120071	regulation of pyloric antrum smooth muscle contraction (GO:0120071)	1	1	.06	+	17.03	1.08E-01	5.63E-01
GO:1904935	positive regulation of cell proliferation in midbrain (GO:1904935)	1	1	.06	+	17.03	1.08E-01	5.63E-01
GO:0120042	negative regulation of macrophage proliferation (GO:0120042)	1	1	.06	+	17.03	1.08E-01	5.63E-01
GO:0036333	hepatocyte homeostasis (GO:0036333)	1	1	.06	+	17.03	1.08E-01	5.63E-01
GO:1904905	negative regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904905)	1	1	.06	+	17.03	1.08E-01	5.63E-01
GO:1905359	protein localization to meiotic spindle (GO:1905359)	1	1	.06	+	17.03	1.08E-01	5.62E-01
GO:1905355	spine apparatus assembly (GO:1905355)	1	1	.06	+	17.03	1.08E-01	5.62E-01
GO:1905341	negative regulation of protein localization to kinetochore (GO:1905341)	1	1	.06	+	17.03	1.08E-01	5.62E-01
GO:0051041	positive regulation of calcium-independent cell-cell adhesion (GO:0051041)	1	1	.06	+	17.03	1.08E-01	5.62E-01
GO:0031443	fast-twitch skeletal muscle fiber contraction (GO:0031443)	1	1	.06	+	17.03	1.08E-01	5.62E-01
GO:1905317	inferior endocardial cushion morphogenesis (GO:1905317)	1	1	.06	+	17.03	1.08E-01	5.62E-01
GO:0070194	synaptonemal complex disassembly (GO:0070194)	2	2	.12	+	17.03	1.71E-02	1.86E-01
GO:1904887	Wnt signalosome assembly (GO:1904887)	1	1	.06	+	17.03	1.08E-01	5.61E-01
GO:0070145	mitochondrial asparaginyl-tRNA aminoacylation (GO:0070145)	1	1	.06	+	17.03	1.08E-01	5.61E-01
GO:1900477	negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477)	1	1	.06	+	17.03	1.08E-01	5.61E-01
GO:1900450	negative regulation of glutamate receptor signaling pathway (GO:1900450)	1	1	.06	+	17.03	1.08E-01	5.61E-01
GO:0043375	CD8-positive, alpha-beta T cell lineage commitment (GO:0043375)	2	2	.12	+	17.03	1.71E-02	1.86E-01
GO:0035759	mesangial cell-matrix adhesion (GO:0035759)	2	2	.12	+	17.03	1.71E-02	1.86E-01
GO:0009444	pyruvate oxidation (GO:0009444)	1	1	.06	+	17.03	1.08E-01	5.61E-01
GO:0070091	glucagon secretion (GO:0070091)	1	1	.06	+	17.03	1.08E-01	5.60E-01
GO:1904777	negative regulation of protein localization to cell cortex (GO:1904777)	1	1	.06	+	17.03	1.08E-01	5.60E-01
GO:1904723	negative regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904723)	1	1	.06	+	17.03	1.08E-01	5.60E-01
GO:0030844	positive regulation of intermediate filament depolymerization (GO:0030844)	1	1	.06	+	17.03	1.08E-01	5.60E-01
GO:0030842	regulation of intermediate filament depolymerization (GO:0030842)	1	1	.06	+	17.03	1.08E-01	5.60E-01
GO:1904711	regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904711)	1	1	.06	+	17.03	1.08E-01	5.59E-01
GO:0061999	regulation of cardiac endothelial to mesenchymal transition (GO:0061999)	1	1	.06	+	17.03	1.08E-01	5.59E-01
GO:1905188	positive regulation of metaphase/anaphase transition of meiosis I (GO:1905188)	1	1	.06	+	17.03	1.08E-01	5.59E-01
GO:1905186	regulation of metaphase/anaphase transition of meiosis I (GO:1905186)	1	1	.06	+	17.03	1.08E-01	5.59E-01
GO:0035645	enteric smooth muscle cell differentiation (GO:0035645)	1	1	.06	+	17.03	1.08E-01	5.59E-01
GO:1905134	positive regulation of meiotic chromosome separation (GO:1905134)	1	1	.06	+	17.03	1.08E-01	5.59E-01
GO:1905116	positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905116)	1	1	.06	+	17.03	1.08E-01	5.58E-01
GO:1905115	regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905115)	1	1	.06	+	17.03	1.08E-01	5.58E-01
GO:1904631	response to glucoside (GO:1904631)	1	1	.06	+	17.03	1.08E-01	5.58E-01
GO:0061881	positive regulation of anterograde axonal transport of mitochondrion (GO:0061881)	1	1	.06	+	17.03	1.08E-01	5.58E-01
GO:0061880	regulation of anterograde axonal transport of mitochondrion (GO:0061880)	1	1	.06	+	17.03	1.08E-01	5.58E-01
GO:0061874	positive regulation of hepatic stellate cell contraction (GO:0061874)	1	1	.06	+	17.03	1.08E-01	5.57E-01
GO:0061873	regulation of hepatic stellate cell contraction (GO:0061873)	1	1	.06	+	17.03	1.08E-01	5.57E-01
GO:0061870	positive regulation of hepatic stellate cell migration (GO:0061870)	2	2	.12	+	17.03	1.71E-02	1.86E-01
GO:0000090	mitotic anaphase (GO:0000090)	1	1	.06	+	17.03	1.08E-01	5.57E-01
GO:0061869	regulation of hepatic stellate cell migration (GO:0061869)	2	2	.12	+	17.03	1.71E-02	1.86E-01
GO:1905067	negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067)	1	1	.06	+	17.03	1.08E-01	5.57E-01
GO:0035543	positive regulation of SNARE complex assembly (GO:0035543)	1	1	.06	+	17.03	1.08E-01	5.57E-01
GO:1905000	regulation of membrane repolarization during atrial cardiac muscle cell action potential (GO:1905000)	1	1	.06	+	17.03	1.08E-01	5.57E-01
GO:0042666	negative regulation of ectodermal cell fate specification (GO:0042666)	1	1	.06	+	17.03	1.08E-01	5.56E-01
GO:0042665	regulation of ectodermal cell fate specification (GO:0042665)	1	1	.06	+	17.03	1.08E-01	5.56E-01
GO:1904566	cellular response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904566)	1	1	.06	+	17.03	1.08E-01	5.56E-01
GO:1904565	response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904565)	1	1	.06	+	17.03	1.08E-01	5.56E-01
GO:1900143	positive regulation of oligodendrocyte apoptotic process (GO:1900143)	1	1	.06	+	17.03	1.08E-01	5.56E-01
GO:1900142	negative regulation of oligodendrocyte apoptotic process (GO:1900142)	1	1	.06	+	17.03	1.08E-01	5.55E-01
GO:1900141	regulation of oligodendrocyte apoptotic process (GO:1900141)	2	2	.12	+	17.03	1.71E-02	1.85E-01
GO:0015887	pantothenate transmembrane transport (GO:0015887)	1	1	.06	+	17.03	1.08E-01	5.55E-01
GO:0062175	brexanolone catabolic process (GO:0062175)	1	1	.06	+	17.03	1.08E-01	5.55E-01
GO:0062172	lutein catabolic process (GO:0062172)	1	1	.06	+	17.03	1.08E-01	5.55E-01
GO:0062170	lutein metabolic process (GO:0062170)	1	1	.06	+	17.03	1.08E-01	5.55E-01
GO:1904465	negative regulation of matrix metallopeptidase secretion (GO:1904465)	1	1	.06	+	17.03	1.08E-01	5.55E-01
GO:1904442	negative regulation of thyroid gland epithelial cell proliferation (GO:1904442)	1	1	.06	+	17.03	1.08E-01	5.54E-01
GO:1904441	regulation of thyroid gland epithelial cell proliferation (GO:1904441)	1	1	.06	+	17.03	1.08E-01	5.54E-01
GO:1900085	negative regulation of peptidyl-tyrosine autophosphorylation (GO:1900085)	1	1	.06	+	17.03	1.08E-01	5.54E-01
GO:1900082	negative regulation of arginine catabolic process (GO:1900082)	1	1	.06	+	17.03	1.08E-01	5.54E-01
GO:1900081	regulation of arginine catabolic process (GO:1900081)	1	1	.06	+	17.03	1.08E-01	5.54E-01
GO:0097601	retina blood vessel maintenance (GO:0097601)	1	1	.06	+	17.03	1.08E-01	5.53E-01
GO:1900035	negative regulation of cellular response to heat (GO:1900035)	1	1	.06	+	17.03	1.08E-01	5.53E-01
GO:0010933	positive regulation of macrophage tolerance induction (GO:0010933)	1	1	.06	+	17.03	1.08E-01	5.53E-01
GO:0010932	regulation of macrophage tolerance induction (GO:0010932)	1	1	.06	+	17.03	1.08E-01	5.53E-01
GO:0061682	seminal vesicle morphogenesis (GO:0061682)	1	1	.06	+	17.03	1.08E-01	5.53E-01
GO:0010900	negative regulation of phosphatidylcholine catabolic process (GO:0010900)	1	1	.06	+	17.03	1.08E-01	5.53E-01
GO:1903946	negative regulation of ventricular cardiac muscle cell action potential (GO:1903946)	1	1	.06	+	17.03	1.08E-01	5.52E-01
GO:0015797	mannitol transmembrane transport (GO:0015797)	1	1	.06	+	17.03	1.08E-01	5.52E-01
GO:0035364	thymine transport (GO:0035364)	1	1	.06	+	17.03	1.08E-01	5.52E-01
GO:1903914	negative regulation of fusion of virus membrane with host plasma membrane (GO:1903914)	1	1	.06	+	17.03	1.08E-01	5.52E-01
GO:1903913	regulation of fusion of virus membrane with host plasma membrane (GO:1903913)	1	1	.06	+	17.03	1.08E-01	5.52E-01
GO:1903906	regulation of plasma membrane raft polarization (GO:1903906)	1	1	.06	+	17.03	1.08E-01	5.51E-01
GO:0015724	formate transport (GO:0015724)	1	1	.06	+	17.03	1.08E-01	5.51E-01
GO:0086024	adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate (GO:0086024)	1	1	.06	+	17.03	1.08E-01	5.51E-01
GO:0150145	positive regulation of CD80 production (GO:0150145)	1	1	.06	+	17.03	1.08E-01	5.51E-01
GO:0150143	regulation of CD80 production (GO:0150143)	1	1	.06	+	17.03	1.08E-01	5.51E-01
GO:0150142	positive regulation of CD86 production (GO:0150142)	1	1	.06	+	17.03	1.08E-01	5.51E-01
GO:0150140	regulation of CD86 production (GO:0150140)	1	1	.06	+	17.03	1.08E-01	5.50E-01
GO:0008591	regulation of Wnt signaling pathway, calcium modulating pathway (GO:0008591)	1	1	.06	+	17.03	1.08E-01	5.50E-01
GO:1904343	positive regulation of colon smooth muscle contraction (GO:1904343)	1	1	.06	+	17.03	1.08E-01	5.50E-01
GO:1904341	regulation of colon smooth muscle contraction (GO:1904341)	1	1	.06	+	17.03	1.08E-01	5.50E-01
GO:0062000	positive regulation of cardiac endothelial to mesenchymal transition (GO:0062000)	1	1	.06	+	17.03	1.08E-01	5.50E-01
GO:0016132	brassinosteroid biosynthetic process (GO:0016132)	1	1	.06	+	17.03	1.08E-01	5.49E-01
GO:0016131	brassinosteroid metabolic process (GO:0016131)	1	1	.06	+	17.03	1.08E-01	5.49E-01
GO:0016129	phytosteroid biosynthetic process (GO:0016129)	1	1	.06	+	17.03	1.08E-01	5.49E-01
GO:0016128	phytosteroid metabolic process (GO:0016128)	1	1	.06	+	17.03	1.08E-01	5.49E-01
GO:0016124	xanthophyll catabolic process (GO:0016124)	1	1	.06	+	17.03	1.08E-01	5.49E-01
GO:0016118	carotenoid catabolic process (GO:0016118)	1	1	.06	+	17.03	1.08E-01	5.49E-01
GO:0016110	tetraterpenoid catabolic process (GO:0016110)	1	1	.06	+	17.03	1.08E-01	5.48E-01
GO:0061514	interleukin-34-mediated signaling pathway (GO:0061514)	1	1	.06	+	17.03	1.08E-01	5.48E-01
GO:0150072	positive regulation of arginase activity (GO:0150072)	1	1	.06	+	17.03	1.08E-01	5.48E-01
GO:0150070	regulation of arginase activity (GO:0150070)	1	1	.06	+	17.03	1.08E-01	5.48E-01
GO:1904246	negative regulation of polynucleotide adenylyltransferase activity (GO:1904246)	1	1	.06	+	17.03	1.08E-01	5.48E-01
GO:1904205	negative regulation of skeletal muscle hypertrophy (GO:1904205)	1	1	.06	+	17.03	1.08E-01	5.48E-01
GO:1903781	positive regulation of cardiac conduction (GO:1903781)	1	1	.06	+	17.03	1.08E-01	5.47E-01
GO:0060980	cell migration involved in coronary vasculogenesis (GO:0060980)	1	1	.06	+	17.03	1.08E-01	5.47E-01
GO:1904188	negative regulation of transformation of host cell by virus (GO:1904188)	1	1	.06	+	17.03	1.08E-01	5.47E-01
GO:1904187	regulation of transformation of host cell by virus (GO:1904187)	1	1	.06	+	17.03	1.08E-01	5.47E-01
GO:0097326	melanocyte adhesion (GO:0097326)	1	1	.06	+	17.03	1.08E-01	5.47E-01
GO:0008315	G2/MI transition of meiotic cell cycle (GO:0008315)	2	2	.12	+	17.03	1.71E-02	1.85E-01
GO:1903697	negative regulation of microvillus assembly (GO:1903697)	1	1	.06	+	17.03	1.08E-01	5.46E-01
GO:0061325	cell proliferation involved in outflow tract morphogenesis (GO:0061325)	2	2	.12	+	17.03	1.71E-02	1.85E-01
GO:1903634	negative regulation of leucine-tRNA ligase activity (GO:1903634)	1	1	.06	+	17.03	1.08E-01	5.46E-01
GO:1903633	regulation of leucine-tRNA ligase activity (GO:1903633)	1	1	.06	+	17.03	1.08E-01	5.46E-01
GO:1903631	negative regulation of aminoacyl-tRNA ligase activity (GO:1903631)	1	1	.06	+	17.03	1.08E-01	5.46E-01
GO:1903629	positive regulation of dUTP diphosphatase activity (GO:1903629)	1	1	.06	+	17.03	1.08E-01	5.46E-01
GO:1903627	regulation of dUTP diphosphatase activity (GO:1903627)	1	1	.06	+	17.03	1.08E-01	5.46E-01
GO:1903611	negative regulation of calcium-dependent ATPase activity (GO:1903611)	1	1	.06	+	17.03	1.08E-01	5.45E-01
GO:1903609	negative regulation of inward rectifier potassium channel activity (GO:1903609)	1	1	.06	+	17.03	1.08E-01	5.45E-01
GO:0003421	growth plate cartilage axis specification (GO:0003421)	1	1	.06	+	17.03	1.08E-01	5.45E-01
GO:1904075	positive regulation of trophectodermal cell proliferation (GO:1904075)	1	1	.06	+	17.03	1.08E-01	5.45E-01
GO:1904073	regulation of trophectodermal cell proliferation (GO:1904073)	1	1	.06	+	17.03	1.08E-01	5.45E-01
GO:1904055	negative regulation of cholangiocyte proliferation (GO:1904055)	1	1	.06	+	17.03	1.08E-01	5.45E-01
GO:1904003	negative regulation of sebum secreting cell proliferation (GO:1904003)	1	1	.06	+	17.03	1.08E-01	5.44E-01
GO:0034443	negative regulation of lipoprotein oxidation (GO:0034443)	1	1	.06	+	17.03	1.08E-01	5.44E-01
GO:0014860	neurotransmitter secretion involved in regulation of skeletal muscle contraction (GO:0014860)	1	1	.06	+	17.03	1.08E-01	5.44E-01
GO:0014843	growth factor dependent regulation of skeletal muscle satellite cell proliferation (GO:0014843)	1	1	.06	+	17.03	1.08E-01	5.44E-01
GO:0014822	detection of wounding (GO:0014822)	1	1	.06	+	17.03	1.08E-01	5.44E-01
GO:0061141	lung ciliated cell differentiation (GO:0061141)	1	1	.06	+	17.03	1.08E-01	5.43E-01
GO:0021989	olfactory cortex development (GO:0021989)	1	1	.06	+	17.03	1.08E-01	5.43E-01
GO:0021972	corticospinal neuron axon guidance through spinal cord (GO:0021972)	1	1	.06	+	17.03	1.08E-01	5.43E-01
GO:0021966	corticospinal neuron axon guidance (GO:0021966)	2	2	.12	+	17.03	1.71E-02	1.85E-01
GO:0021944	neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration (GO:0021944)	1	1	.06	+	17.03	1.08E-01	5.43E-01
GO:1903403	negative regulation of renal phosphate excretion (GO:1903403)	1	1	.06	+	17.03	1.08E-01	5.43E-01
GO:0003245	cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245)	1	1	.06	+	17.03	1.08E-01	5.43E-01
GO:1902983	DNA strand elongation involved in mitotic DNA replication (GO:1902983)	1	1	.06	+	17.03	1.08E-01	5.42E-01
GO:1902977	mitotic DNA replication preinitiation complex assembly (GO:1902977)	1	1	.06	+	17.03	1.08E-01	5.42E-01
GO:0097026	dendritic cell dendrite assembly (GO:0097026)	1	1	.06	+	17.03	1.08E-01	5.42E-01
GO:0097018	renal albumin absorption (GO:0097018)	2	2	.12	+	17.03	1.71E-02	1.85E-01
GO:0045887	positive regulation of synaptic assembly at neuromuscular junction (GO:0045887)	1	1	.06	+	17.03	1.08E-01	5.42E-01
GO:1903394	protein localization to kinetochore involved in kinetochore assembly (GO:1903394)	1	1	.06	+	17.03	1.08E-01	5.42E-01
GO:0061031	endodermal digestive tract morphogenesis (GO:0061031)	2	2	.12	+	17.03	1.71E-02	1.85E-01
GO:0045813	positive regulation of Wnt signaling pathway, calcium modulating pathway (GO:0045813)	1	1	.06	+	17.03	1.08E-01	5.42E-01
GO:0003185	sinoatrial valve morphogenesis (GO:0003185)	1	1	.06	+	17.03	1.08E-01	5.41E-01
GO:0060598	dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598)	1	1	.06	+	17.03	1.08E-01	5.41E-01
GO:0060588	negative regulation of lipoprotein lipid oxidation (GO:0060588)	1	1	.06	+	17.03	1.08E-01	5.41E-01
GO:0003142	cardiogenic plate morphogenesis (GO:0003142)	1	1	.06	+	17.03	1.08E-01	5.41E-01
GO:0046272	stilbene catabolic process (GO:0046272)	1	1	.06	+	17.03	1.08E-01	5.41E-01
GO:0003117	regulation of vasoconstriction by circulating norepinephrine (GO:0003117)	1	1	.06	+	17.03	1.08E-01	5.41E-01
GO:0003116	regulation of vasoconstriction by norepinephrine (GO:0003116)	1	1	.06	+	17.03	1.08E-01	5.40E-01
GO:1902847	regulation of neuronal signal transduction (GO:1902847)	1	1	.06	+	17.03	1.08E-01	5.40E-01
GO:0034231	islet amyloid polypeptide processing (GO:0034231)	1	1	.06	+	17.03	1.08E-01	5.40E-01
GO:1901995	positive regulation of meiotic cell cycle phase transition (GO:1901995)	4	3	.23	+	12.77	5.03E-03	7.57E-02
GO:0007057	spindle assembly involved in female meiosis I (GO:0007057)	4	3	.23	+	12.77	5.03E-03	7.57E-02
GO:0051611	regulation of serotonin uptake (GO:0051611)	4	3	.23	+	12.77	5.03E-03	7.56E-02
GO:1990086	lens fiber cell apoptotic process (GO:1990086)	4	3	.23	+	12.77	5.03E-03	7.55E-02
GO:0043137	DNA replication, removal of RNA primer (GO:0043137)	4	3	.23	+	12.77	5.03E-03	7.54E-02
GO:0060936	cardiac fibroblast cell development (GO:0060936)	4	3	.23	+	12.77	5.03E-03	7.54E-02
GO:0060935	cardiac fibroblast cell differentiation (GO:0060935)	4	3	.23	+	12.77	5.03E-03	7.53E-02
GO:0060492	lung induction (GO:0060492)	3	2	.18	+	11.35	2.75E-02	2.58E-01
GO:0071930	negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930)	3	2	.18	+	11.35	2.75E-02	2.58E-01
GO:2001260	regulation of semaphorin-plexin signaling pathway (GO:2001260)	3	2	.18	+	11.35	2.75E-02	2.57E-01
GO:0072277	metanephric glomerular capillary formation (GO:0072277)	3	2	.18	+	11.35	2.75E-02	2.57E-01
GO:0072276	metanephric glomerulus vasculature morphogenesis (GO:0072276)	3	2	.18	+	11.35	2.75E-02	2.57E-01
GO:0072275	metanephric glomerulus morphogenesis (GO:0072275)	3	2	.18	+	11.35	2.75E-02	2.57E-01
GO:0060281	regulation of oocyte development (GO:0060281)	3	2	.18	+	11.35	2.75E-02	2.57E-01
GO:0060279	positive regulation of ovulation (GO:0060279)	3	2	.18	+	11.35	2.75E-02	2.57E-01
GO:0110032	positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032)	3	2	.18	+	11.35	2.75E-02	2.56E-01
GO:0071699	olfactory placode morphogenesis (GO:0071699)	3	2	.18	+	11.35	2.75E-02	2.56E-01
GO:0071698	olfactory placode development (GO:0071698)	3	2	.18	+	11.35	2.75E-02	2.56E-01
GO:0060083	smooth muscle contraction involved in micturition (GO:0060083)	3	2	.18	+	11.35	2.75E-02	2.56E-01
GO:0032875	regulation of DNA endoreduplication (GO:0032875)	3	2	.18	+	11.35	2.75E-02	2.56E-01
GO:0060025	regulation of synaptic activity (GO:0060025)	3	2	.18	+	11.35	2.75E-02	2.56E-01
GO:0044771	meiotic cell cycle phase transition (GO:0044771)	3	2	.18	+	11.35	2.75E-02	2.56E-01
GO:0014038	regulation of Schwann cell differentiation (GO:0014038)	3	2	.18	+	11.35	2.75E-02	2.55E-01
GO:0001560	regulation of cell growth by extracellular stimulus (GO:0001560)	3	2	.18	+	11.35	2.75E-02	2.55E-01
GO:1901660	calcium ion export (GO:1901660)	3	2	.18	+	11.35	2.75E-02	2.55E-01
GO:2000297	negative regulation of synapse maturation (GO:2000297)	3	2	.18	+	11.35	2.75E-02	2.55E-01
GO:0051612	negative regulation of serotonin uptake (GO:0051612)	3	2	.18	+	11.35	2.75E-02	2.55E-01
GO:0140199	negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140199)	3	2	.18	+	11.35	2.75E-02	2.55E-01
GO:0140192	regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140192)	3	2	.18	+	11.35	2.75E-02	2.54E-01
GO:0071163	DNA replication preinitiation complex assembly (GO:0071163)	3	2	.18	+	11.35	2.75E-02	2.54E-01
GO:0051581	negative regulation of neurotransmitter uptake (GO:0051581)	3	2	.18	+	11.35	2.75E-02	2.54E-01
GO:1905879	regulation of oogenesis (GO:1905879)	3	2	.18	+	11.35	2.75E-02	2.54E-01
GO:0098912	membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912)	3	2	.18	+	11.35	2.75E-02	2.54E-01
GO:0070495	negative regulation of thrombin-activated receptor signaling pathway (GO:0070495)	3	2	.18	+	11.35	2.75E-02	2.54E-01
GO:0070494	regulation of thrombin-activated receptor signaling pathway (GO:0070494)	3	2	.18	+	11.35	2.75E-02	2.54E-01
GO:0035984	cellular response to trichostatin A (GO:0035984)	3	2	.18	+	11.35	2.75E-02	2.53E-01
GO:0035983	response to trichostatin A (GO:0035983)	3	2	.18	+	11.35	2.75E-02	2.53E-01
GO:1905463	negative regulation of DNA duplex unwinding (GO:1905463)	3	2	.18	+	11.35	2.75E-02	2.53E-01
GO:0031548	regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548)	3	2	.18	+	11.35	2.75E-02	2.53E-01
GO:0030910	olfactory placode formation (GO:0030910)	3	2	.18	+	11.35	2.75E-02	2.53E-01
GO:0046882	negative regulation of follicle-stimulating hormone secretion (GO:0046882)	3	2	.18	+	11.35	2.75E-02	2.53E-01
GO:0046878	positive regulation of saliva secretion (GO:0046878)	3	2	.18	+	11.35	2.75E-02	2.53E-01
GO:0061577	calcium ion transmembrane transport via high voltage-gated calcium channel (GO:0061577)	3	2	.18	+	11.35	2.75E-02	2.52E-01
GO:0060939	epicardium-derived cardiac fibroblast cell development (GO:0060939)	3	2	.18	+	11.35	2.75E-02	2.52E-01
GO:0060938	epicardium-derived cardiac fibroblast cell differentiation (GO:0060938)	3	2	.18	+	11.35	2.75E-02	2.52E-01
GO:0097324	melanocyte migration (GO:0097324)	3	2	.18	+	11.35	2.75E-02	2.52E-01
GO:0061364	apoptotic process involved in luteolysis (GO:0061364)	3	2	.18	+	11.35	2.75E-02	2.52E-01
GO:0061323	cell proliferation involved in heart morphogenesis (GO:0061323)	3	2	.18	+	11.35	2.75E-02	2.52E-01
GO:0034421	post-translational protein acetylation (GO:0034421)	3	2	.18	+	11.35	2.75E-02	2.51E-01
GO:0097118	neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118)	3	2	.18	+	11.35	2.75E-02	2.51E-01
GO:0060665	regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665)	3	2	.18	+	11.35	2.75E-02	2.51E-01
GO:0003220	left ventricular cardiac muscle tissue morphogenesis (GO:0003220)	3	2	.18	+	11.35	2.75E-02	2.51E-01
GO:0014707	branchiomeric skeletal muscle development (GO:0014707)	3	2	.18	+	11.35	2.75E-02	2.51E-01
GO:0051256	mitotic spindle midzone assembly (GO:0051256)	11	7	.65	+	10.84	2.94E-05	9.75E-04
GO:0000022	mitotic spindle elongation (GO:0000022)	11	7	.65	+	10.84	2.94E-05	9.73E-04
GO:0051231	spindle elongation (GO:0051231)	13	8	.76	+	10.48	9.30E-06	3.49E-04
GO:0045636	positive regulation of melanocyte differentiation (GO:0045636)	5	3	.29	+	10.22	7.72E-03	1.04E-01
GO:0001757	somite specification (GO:0001757)	5	3	.29	+	10.22	7.72E-03	1.04E-01
GO:0071504	cellular response to heparin (GO:0071504)	5	3	.29	+	10.22	7.72E-03	1.04E-01
GO:0071376	cellular response to corticotropin-releasing hormone stimulus (GO:0071376)	5	3	.29	+	10.22	7.72E-03	1.04E-01
GO:0051414	response to cortisol (GO:0051414)	5	3	.29	+	10.22	7.72E-03	1.04E-01
GO:0031547	brain-derived neurotrophic factor receptor signaling pathway (GO:0031547)	5	3	.29	+	10.22	7.72E-03	1.04E-01
GO:1904995	negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995)	5	3	.29	+	10.22	7.72E-03	1.04E-01
GO:0043435	response to corticotropin-releasing hormone (GO:0043435)	5	3	.29	+	10.22	7.72E-03	1.03E-01
GO:0070120	ciliary neurotrophic factor-mediated signaling pathway (GO:0070120)	5	3	.29	+	10.22	7.72E-03	1.03E-01
GO:1903934	positive regulation of DNA primase activity (GO:1903934)	5	3	.29	+	10.22	7.72E-03	1.03E-01
GO:1903932	regulation of DNA primase activity (GO:1903932)	5	3	.29	+	10.22	7.72E-03	1.03E-01
GO:0086029	Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029)	5	3	.29	+	10.22	7.72E-03	1.03E-01
GO:0097241	hematopoietic stem cell migration to bone marrow (GO:0097241)	5	3	.29	+	10.22	7.72E-03	1.03E-01
GO:0014834	skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834)	5	3	.29	+	10.22	7.72E-03	1.03E-01
GO:0097017	renal protein absorption (GO:0097017)	5	3	.29	+	10.22	7.72E-03	1.03E-01
GO:0000727	double-strand break repair via break-induced replication (GO:0000727)	12	7	.70	+	9.93	4.43E-05	1.41E-03
GO:0048251	elastic fiber assembly (GO:0048251)	12	7	.70	+	9.93	4.43E-05	1.40E-03
GO:0034080	CENP-A containing chromatin assembly (GO:0034080)	7	4	.41	+	9.73	2.27E-03	4.00E-02
GO:0045578	negative regulation of B cell differentiation (GO:0045578)	7	4	.41	+	9.73	2.27E-03	4.00E-02
GO:0072239	metanephric glomerulus vasculature development (GO:0072239)	7	4	.41	+	9.73	2.27E-03	3.99E-02
GO:0072126	positive regulation of glomerular mesangial cell proliferation (GO:0072126)	7	4	.41	+	9.73	2.27E-03	3.99E-02
GO:0071503	response to heparin (GO:0071503)	7	4	.41	+	9.73	2.27E-03	3.98E-02
GO:0051255	spindle midzone assembly (GO:0051255)	14	8	.82	+	9.73	1.39E-05	4.98E-04
GO:0035701	hematopoietic stem cell migration (GO:0035701)	7	4	.41	+	9.73	2.27E-03	3.98E-02
GO:0031055	chromatin remodeling at centromere (GO:0031055)	7	4	.41	+	9.73	2.27E-03	3.98E-02
GO:2000669	negative regulation of dendritic cell apoptotic process (GO:2000669)	9	5	.53	+	9.46	6.84E-04	1.47E-02
GO:1901724	positive regulation of cell proliferation involved in kidney development (GO:1901724)	9	5	.53	+	9.46	6.84E-04	1.47E-02
GO:0051383	kinetochore organization (GO:0051383)	20	11	1.17	+	9.37	4.42E-07	2.23E-05
GO:0051382	kinetochore assembly (GO:0051382)	15	8	.88	+	9.08	2.03E-05	6.98E-04
GO:0034508	centromere complex assembly (GO:0034508)	27	14	1.59	+	8.83	2.08E-08	1.28E-06
GO:0007094	mitotic spindle assembly checkpoint signaling (GO:0007094)	31	16	1.82	+	8.79	2.14E-09	1.65E-07
GO:0071174	mitotic spindle checkpoint signaling (GO:0071174)	31	16	1.82	+	8.79	2.14E-09	1.64E-07
GO:0071173	spindle assembly checkpoint signaling (GO:0071173)	31	16	1.82	+	8.79	2.14E-09	1.63E-07
GO:2000816	negative regulation of mitotic sister chromatid separation (GO:2000816)	36	18	2.11	+	8.51	3.14E-10	2.91E-08
GO:0033048	negative regulation of mitotic sister chromatid segregation (GO:0033048)	36	18	2.11	+	8.51	3.14E-10	2.89E-08
GO:0033046	negative regulation of sister chromatid segregation (GO:0033046)	36	18	2.11	+	8.51	3.14E-10	2.88E-08
GO:0032060	bleb assembly (GO:0032060)	10	5	.59	+	8.51	9.79E-04	1.98E-02
GO:0002663	positive regulation of B cell tolerance induction (GO:0002663)	2	1	.12	+	8.51	1.57E-01	7.12E-01
GO:0002661	regulation of B cell tolerance induction (GO:0002661)	2	1	.12	+	8.51	1.57E-01	7.12E-01
GO:1903282	regulation of glutathione peroxidase activity (GO:1903282)	2	1	.12	+	8.51	1.57E-01	7.11E-01
GO:1903278	positive regulation of sodium ion export across plasma membrane (GO:1903278)	4	2	.23	+	8.51	3.97E-02	3.27E-01
GO:1903276	regulation of sodium ion export across plasma membrane (GO:1903276)	4	2	.23	+	8.51	3.97E-02	3.27E-01
GO:0007497	posterior midgut development (GO:0007497)	2	1	.12	+	8.51	1.57E-01	7.11E-01
GO:1903237	negative regulation of leukocyte tethering or rolling (GO:1903237)	4	2	.23	+	8.51	3.97E-02	3.27E-01
GO:0021740	principal sensory nucleus of trigeminal nerve development (GO:0021740)	2	1	.12	+	8.51	1.57E-01	7.11E-01
GO:0021730	trigeminal sensory nucleus development (GO:0021730)	2	1	.12	+	8.51	1.57E-01	7.11E-01
GO:1903217	negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217)	2	1	.12	+	8.51	1.57E-01	7.11E-01
GO:1903216	regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216)	2	1	.12	+	8.51	1.57E-01	7.10E-01
GO:1903210	podocyte apoptotic process (GO:1903210)	2	1	.12	+	8.51	1.57E-01	7.10E-01
GO:2000982	positive regulation of inner ear receptor cell differentiation (GO:2000982)	2	1	.12	+	8.51	1.57E-01	7.10E-01
GO:0007439	ectodermal digestive tract development (GO:0007439)	2	1	.12	+	8.51	1.57E-01	7.10E-01
GO:0060486	club cell differentiation (GO:0060486)	4	2	.23	+	8.51	3.97E-02	3.27E-01
GO:0003064	regulation of heart rate by hormone (GO:0003064)	2	1	.12	+	8.51	1.57E-01	7.10E-01
GO:0003062	regulation of heart rate by chemical signal (GO:0003062)	6	3	.35	+	8.51	1.11E-02	1.38E-01
GO:0060458	right lung development (GO:0060458)	2	1	.12	+	8.51	1.57E-01	7.09E-01
GO:0060434	bronchus morphogenesis (GO:0060434)	2	1	.12	+	8.51	1.57E-01	7.09E-01
GO:0003017	lymph circulation (GO:0003017)	2	1	.12	+	8.51	1.57E-01	7.09E-01
GO:0003010	voluntary skeletal muscle contraction (GO:0003010)	2	1	.12	+	8.51	1.57E-01	7.09E-01
GO:0002554	serotonin secretion by platelet (GO:0002554)	2	1	.12	+	8.51	1.57E-01	7.09E-01
GO:0045634	regulation of melanocyte differentiation (GO:0045634)	6	3	.35	+	8.51	1.11E-02	1.38E-01
GO:0045633	positive regulation of mechanoreceptor differentiation (GO:0045633)	2	1	.12	+	8.51	1.57E-01	7.08E-01
GO:0021698	cerebellar cortex structural organization (GO:0021698)	2	1	.12	+	8.51	1.57E-01	7.08E-01
GO:0021693	cerebellar Purkinje cell layer structural organization (GO:0021693)	2	1	.12	+	8.51	1.57E-01	7.08E-01
GO:0045609	positive regulation of inner ear auditory receptor cell differentiation (GO:0045609)	2	1	.12	+	8.51	1.57E-01	7.08E-01
GO:0021658	rhombomere 3 morphogenesis (GO:0021658)	2	1	.12	+	8.51	1.57E-01	7.08E-01
GO:1903116	positive regulation of actin filament-based movement (GO:1903116)	2	1	.12	+	8.51	1.57E-01	7.07E-01
GO:2000880	positive regulation of dipeptide transport (GO:2000880)	2	1	.12	+	8.51	1.57E-01	7.07E-01
GO:2000878	positive regulation of oligopeptide transport (GO:2000878)	2	1	.12	+	8.51	1.57E-01	7.07E-01
GO:2000866	positive regulation of estradiol secretion (GO:2000866)	2	1	.12	+	8.51	1.57E-01	7.07E-01
GO:0060358	negative regulation of leucine import (GO:0060358)	2	1	.12	+	8.51	1.57E-01	7.07E-01
GO:0060357	regulation of leucine import (GO:0060357)	2	1	.12	+	8.51	1.57E-01	7.06E-01
GO:0060355	positive regulation of cell adhesion molecule production (GO:0060355)	2	1	.12	+	8.51	1.57E-01	7.06E-01
GO:0046069	cGMP catabolic process (GO:0046069)	4	2	.23	+	8.51	3.97E-02	3.26E-01
GO:0072301	regulation of metanephric glomerular mesangial cell proliferation (GO:0072301)	2	1	.12	+	8.51	1.57E-01	7.06E-01
GO:1902668	negative regulation of axon guidance (GO:1902668)	2	1	.12	+	8.51	1.57E-01	7.06E-01
GO:0046032	ADP catabolic process (GO:0046032)	2	1	.12	+	8.51	1.57E-01	7.06E-01
GO:0071846	actin filament debranching (GO:0071846)	2	1	.12	+	8.51	1.57E-01	7.05E-01
GO:0022028	tangential migration from the subventricular zone to the olfactory bulb (GO:0022028)	6	3	.35	+	8.51	1.11E-02	1.38E-01
GO:2001295	malonyl-CoA biosynthetic process (GO:2001295)	2	1	.12	+	8.51	1.57E-01	7.05E-01
GO:0002442	serotonin secretion involved in inflammatory response (GO:0002442)	2	1	.12	+	8.51	1.57E-01	7.05E-01
GO:0033567	DNA replication, Okazaki fragment processing (GO:0033567)	2	1	.12	+	8.51	1.57E-01	7.05E-01
GO:0021593	rhombomere morphogenesis (GO:0021593)	2	1	.12	+	8.51	1.57E-01	7.05E-01
GO:0019285	glycine betaine biosynthetic process from choline (GO:0019285)	2	1	.12	+	8.51	1.57E-01	7.04E-01
GO:1903056	regulation of melanosome organization (GO:1903056)	2	1	.12	+	8.51	1.57E-01	7.04E-01
GO:1903033	positive regulation of microtubule plus-end binding (GO:1903033)	2	1	.12	+	8.51	1.57E-01	7.04E-01
GO:1903031	regulation of microtubule plus-end binding (GO:1903031)	2	1	.12	+	8.51	1.57E-01	7.04E-01
GO:0001970	positive regulation of activation of membrane attack complex (GO:0001970)	2	1	.12	+	8.51	1.57E-01	7.04E-01
GO:1903016	negative regulation of exo-alpha-sialidase activity (GO:1903016)	2	1	.12	+	8.51	1.57E-01	7.03E-01
GO:0001949	sebaceous gland cell differentiation (GO:0001949)	2	1	.12	+	8.51	1.57E-01	7.03E-01
GO:2000791	negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791)	2	1	.12	+	8.51	1.57E-01	7.03E-01
GO:2000790	regulation of mesenchymal cell proliferation involved in lung development (GO:2000790)	2	1	.12	+	8.51	1.57E-01	7.03E-01
GO:0072254	metanephric glomerular mesangial cell differentiation (GO:0072254)	2	1	.12	+	8.51	1.57E-01	7.03E-01
GO:0060282	positive regulation of oocyte development (GO:0060282)	2	1	.12	+	8.51	1.57E-01	7.02E-01
GO:0060278	regulation of ovulation (GO:0060278)	4	2	.23	+	8.51	3.97E-02	3.26E-01
GO:1902595	regulation of DNA replication origin binding (GO:1902595)	2	1	.12	+	8.51	1.57E-01	7.02E-01
GO:0072229	metanephric proximal convoluted tubule development (GO:0072229)	2	1	.12	+	8.51	1.57E-01	7.02E-01
GO:2000729	positive regulation of mesenchymal cell proliferation involved in ureter development (GO:2000729)	2	1	.12	+	8.51	1.57E-01	7.02E-01
GO:0072209	metanephric mesangial cell differentiation (GO:0072209)	2	1	.12	+	8.51	1.57E-01	7.02E-01
GO:0110030	regulation of G2/MI transition of meiotic cell cycle (GO:0110030)	4	2	.23	+	8.51	3.97E-02	3.26E-01
GO:0002362	CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment (GO:0002362)	2	1	.12	+	8.51	1.57E-01	7.01E-01
GO:0002351	serotonin production involved in inflammatory response (GO:0002351)	2	1	.12	+	8.51	1.57E-01	7.01E-01
GO:2001150	positive regulation of dipeptide transmembrane transport (GO:2001150)	2	1	.12	+	8.51	1.57E-01	7.01E-01
GO:2001148	regulation of dipeptide transmembrane transport (GO:2001148)	2	1	.12	+	8.51	1.57E-01	7.01E-01
GO:2001112	regulation of cellular response to hepatocyte growth factor stimulus (GO:2001112)	2	1	.12	+	8.51	1.57E-01	7.01E-01
GO:0072198	mesenchymal cell proliferation involved in ureter development (GO:0072198)	2	1	.12	+	8.51	1.57E-01	7.00E-01
GO:0001869	negative regulation of complement activation, lectin pathway (GO:0001869)	2	1	.12	+	8.51	1.57E-01	7.00E-01
GO:0001868	regulation of complement activation, lectin pathway (GO:0001868)	2	1	.12	+	8.51	1.57E-01	7.00E-01
GO:0072160	nephron tubule epithelial cell differentiation (GO:0072160)	2	1	.12	+	8.51	1.57E-01	7.00E-01
GO:0001820	serotonin secretion (GO:0001820)	2	1	.12	+	8.51	1.57E-01	7.00E-01
GO:0072137	condensed mesenchymal cell proliferation (GO:0072137)	4	2	.23	+	8.51	3.97E-02	3.26E-01
GO:0032972	regulation of muscle filament sliding speed (GO:0032972)	2	1	.12	+	8.51	1.57E-01	6.99E-01
GO:0072110	glomerular mesangial cell proliferation (GO:0072110)	2	1	.12	+	8.51	1.57E-01	6.99E-01
GO:0072107	positive regulation of ureteric bud formation (GO:0072107)	4	2	.23	+	8.51	3.97E-02	3.26E-01
GO:0072106	regulation of ureteric bud formation (GO:0072106)	4	2	.23	+	8.51	3.97E-02	3.26E-01
GO:2000620	positive regulation of histone H4-K16 acetylation (GO:2000620)	2	1	.12	+	8.51	1.57E-01	6.99E-01
GO:0060127	prolactin secreting cell differentiation (GO:0060127)	2	1	.12	+	8.51	1.57E-01	6.99E-01
GO:1902437	positive regulation of male mating behavior (GO:1902437)	2	1	.12	+	8.51	1.57E-01	6.99E-01
GO:1902435	regulation of male mating behavior (GO:1902435)	2	1	.12	+	8.51	1.57E-01	6.98E-01
GO:0032912	negative regulation of transforming growth factor beta2 production (GO:0032912)	2	1	.12	+	8.51	1.57E-01	6.98E-01
GO:0006668	sphinganine-1-phosphate metabolic process (GO:0006668)	2	1	.12	+	8.51	1.57E-01	6.98E-01
GO:0071673	positive regulation of smooth muscle cell chemotaxis (GO:0071673)	4	2	.23	+	8.51	3.97E-02	3.25E-01
GO:0071671	regulation of smooth muscle cell chemotaxis (GO:0071671)	6	3	.35	+	8.51	1.11E-02	1.38E-01
GO:0071670	smooth muscle cell chemotaxis (GO:0071670)	2	1	.12	+	8.51	1.57E-01	6.98E-01
GO:0071657	positive regulation of granulocyte colony-stimulating factor production (GO:0071657)	4	2	.23	+	8.51	3.97E-02	3.25E-01
GO:0006601	creatine biosynthetic process (GO:0006601)	2	1	.12	+	8.51	1.57E-01	6.98E-01
GO:0007089	traversing start control point of mitotic cell cycle (GO:0007089)	4	2	.23	+	8.51	3.97E-02	3.25E-01
GO:0001781	neutrophil apoptotic process (GO:0001781)	2	1	.12	+	8.51	1.57E-01	6.97E-01
GO:0007079	mitotic chromosome movement towards spindle pole (GO:0007079)	4	2	.23	+	8.51	3.97E-02	3.25E-01
GO:0072095	regulation of branch elongation involved in ureteric bud branching (GO:0072095)	4	2	.23	+	8.51	3.97E-02	3.25E-01
GO:0007056	spindle assembly involved in female meiosis (GO:0007056)	6	3	.35	+	8.51	1.11E-02	1.38E-01
GO:0044871	negative regulation by host of viral glycoprotein metabolic process (GO:0044871)	2	1	.12	+	8.51	1.57E-01	6.97E-01
GO:0044870	modulation by host of viral glycoprotein metabolic process (GO:0044870)	2	1	.12	+	8.51	1.57E-01	6.97E-01
GO:0044869	negative regulation by host of viral exo-alpha-sialidase activity (GO:0044869)	2	1	.12	+	8.51	1.57E-01	6.97E-01
GO:0044867	modulation by host of viral catalytic activity (GO:0044867)	2	1	.12	+	8.51	1.57E-01	6.97E-01
GO:0044866	modulation by host of viral exo-alpha-sialidase activity (GO:0044866)	2	1	.12	+	8.51	1.57E-01	6.96E-01
GO:2000546	positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546)	4	2	.23	+	8.51	3.97E-02	3.24E-01
GO:0072019	proximal convoluted tubule development (GO:0072019)	2	1	.12	+	8.51	1.57E-01	6.96E-01
GO:2000536	negative regulation of entry of bacterium into host cell (GO:2000536)	2	1	.12	+	8.51	1.57E-01	6.96E-01
GO:2000532	regulation of renal albumin absorption (GO:2000532)	2	1	.12	+	8.51	1.57E-01	6.96E-01
GO:0072011	glomerular endothelium development (GO:0072011)	4	2	.23	+	8.51	3.97E-02	3.24E-01
GO:2000529	positive regulation of myeloid dendritic cell chemotaxis (GO:2000529)	2	1	.12	+	8.51	1.57E-01	6.96E-01
GO:2000527	regulation of myeloid dendritic cell chemotaxis (GO:2000527)	2	1	.12	+	8.51	1.57E-01	6.95E-01
GO:1902362	melanocyte apoptotic process (GO:1902362)	2	1	.12	+	8.51	1.57E-01	6.95E-01
GO:2000502	negative regulation of natural killer cell chemotaxis (GO:2000502)	2	1	.12	+	8.51	1.57E-01	6.95E-01
GO:0006540	glutamate decarboxylation to succinate (GO:0006540)	2	1	.12	+	8.51	1.57E-01	6.95E-01
GO:0051958	methotrexate transport (GO:0051958)	2	1	.12	+	8.51	1.57E-01	6.95E-01
GO:1901897	regulation of relaxation of cardiac muscle (GO:1901897)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:1901896	positive regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901896)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:0051946	regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051946)	4	2	.23	+	8.51	3.97E-02	3.24E-01
GO:0051941	regulation of amino acid uptake involved in synaptic transmission (GO:0051941)	4	2	.23	+	8.51	3.97E-02	3.24E-01
GO:1990839	response to endothelin (GO:1990839)	2	1	.12	+	8.51	1.57E-01	6.94E-01
GO:0071506	cellular response to mycophenolic acid (GO:0071506)	2	1	.12	+	8.51	1.57E-01	6.94E-01
GO:0071505	response to mycophenolic acid (GO:0071505)	2	1	.12	+	8.51	1.57E-01	6.94E-01
GO:1901846	positive regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901846)	2	1	.12	+	8.51	1.57E-01	6.94E-01
GO:1901843	positive regulation of high voltage-gated calcium channel activity (GO:1901843)	4	2	.23	+	8.51	3.97E-02	3.24E-01
GO:0033260	nuclear DNA replication (GO:0033260)	24	12	1.41	+	8.51	2.90E-07	1.50E-05
GO:1901825	zeaxanthin metabolic process (GO:1901825)	2	1	.12	+	8.51	1.57E-01	6.94E-01
GO:0090618	DNA clamp unloading (GO:0090618)	2	1	.12	+	8.51	1.57E-01	6.93E-01
GO:2000490	negative regulation of hepatic stellate cell activation (GO:2000490)	2	1	.12	+	8.51	1.57E-01	6.93E-01
GO:0044779	meiotic spindle checkpoint signaling (GO:0044779)	2	1	.12	+	8.51	1.57E-01	6.93E-01
GO:2000470	positive regulation of peroxidase activity (GO:2000470)	2	1	.12	+	8.51	1.57E-01	6.93E-01
GO:2000468	regulation of peroxidase activity (GO:2000468)	4	2	.23	+	8.51	3.97E-02	3.24E-01
GO:0044751	cellular response to human chorionic gonadotropin stimulus (GO:0044751)	2	1	.12	+	8.51	1.57E-01	6.93E-01
GO:2000458	regulation of astrocyte chemotaxis (GO:2000458)	2	1	.12	+	8.51	1.57E-01	6.92E-01
GO:1902283	negative regulation of primary amine oxidase activity (GO:1902283)	2	1	.12	+	8.51	1.57E-01	6.92E-01
GO:0032765	positive regulation of mast cell cytokine production (GO:0032765)	4	2	.23	+	8.51	3.97E-02	3.23E-01
GO:0032745	positive regulation of interleukin-21 production (GO:0032745)	2	1	.12	+	8.51	1.57E-01	6.92E-01
GO:2000417	negative regulation of eosinophil migration (GO:2000417)	2	1	.12	+	8.51	1.57E-01	6.92E-01
GO:0071483	cellular response to blue light (GO:0071483)	2	1	.12	+	8.51	1.57E-01	6.92E-01
GO:0014041	regulation of neuron maturation (GO:0014041)	8	4	.47	+	8.51	3.25E-03	5.33E-02
GO:0014040	positive regulation of Schwann cell differentiation (GO:0014040)	2	1	.12	+	8.51	1.57E-01	6.91E-01
GO:0006422	aspartyl-tRNA aminoacylation (GO:0006422)	2	1	.12	+	8.51	1.57E-01	6.91E-01
GO:0002032	desensitization of G protein-coupled receptor signaling pathway by arrestin (GO:0002032)	2	1	.12	+	8.51	1.57E-01	6.91E-01
GO:0071409	cellular response to cycloheximide (GO:0071409)	2	1	.12	+	8.51	1.57E-01	6.91E-01
GO:1990705	cholangiocyte proliferation (GO:1990705)	2	1	.12	+	8.51	1.57E-01	6.91E-01
GO:0070946	neutrophil-mediated killing of gram-positive bacterium (GO:0070946)	2	1	.12	+	8.51	1.57E-01	6.91E-01
GO:0032690	negative regulation of interleukin-1 alpha production (GO:0032690)	2	1	.12	+	8.51	1.57E-01	6.90E-01
GO:0032665	regulation of interleukin-21 production (GO:0032665)	2	1	.12	+	8.51	1.57E-01	6.90E-01
GO:0018352	protein-pyridoxal-5-phosphate linkage (GO:0018352)	2	1	.12	+	8.51	1.57E-01	6.90E-01
GO:0099703	induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration (GO:0099703)	4	2	.23	+	8.51	3.97E-02	3.23E-01
GO:0071387	cellular response to cortisol stimulus (GO:0071387)	2	1	.12	+	8.51	1.57E-01	6.90E-01
GO:1902102	regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102)	4	2	.23	+	8.51	3.97E-02	3.23E-01
GO:1990683	DNA double-strand break attachment to nuclear envelope (GO:1990683)	2	1	.12	+	8.51	1.57E-01	6.90E-01
GO:1990646	cellular response to prolactin (GO:1990646)	2	1	.12	+	8.51	1.57E-01	6.89E-01
GO:0033030	negative regulation of neutrophil apoptotic process (GO:0033030)	2	1	.12	+	8.51	1.57E-01	6.89E-01
GO:0044557	relaxation of smooth muscle (GO:0044557)	8	4	.47	+	8.51	3.25E-03	5.32E-02
GO:1902083	negative regulation of peptidyl-cysteine S-nitrosylation (GO:1902083)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:1902081	negative regulation of calcium ion import into sarcoplasmic reticulum (GO:1902081)	2	1	.12	+	8.51	1.57E-01	6.89E-01
GO:0071231	cellular response to folic acid (GO:0071231)	2	1	.12	+	8.51	1.57E-01	6.89E-01
GO:1905933	regulation of cell fate determination (GO:1905933)	2	1	.12	+	8.51	1.57E-01	6.89E-01
GO:0051625	epinephrine uptake (GO:0051625)	2	1	.12	+	8.51	1.57E-01	6.88E-01
GO:0051621	regulation of norepinephrine uptake (GO:0051621)	2	1	.12	+	8.51	1.57E-01	6.88E-01
GO:0099538	synaptic signaling via neuropeptide (GO:0099538)	2	1	.12	+	8.51	1.57E-01	6.88E-01
GO:0099533	positive regulation of presynaptic cytosolic calcium concentration (GO:0099533)	4	2	.23	+	8.51	3.97E-02	3.23E-01
GO:1905871	regulation of protein localization to cell leading edge (GO:1905871)	2	1	.12	+	8.51	1.57E-01	6.88E-01
GO:1990478	response to ultrasound (GO:1990478)	2	1	.12	+	8.51	1.57E-01	6.88E-01
GO:0075506	entry of viral genome into host nucleus through nuclear pore complex via importin (GO:0075506)	2	1	.12	+	8.51	1.57E-01	6.87E-01
GO:0090260	negative regulation of retinal ganglion cell axon guidance (GO:0090260)	2	1	.12	+	8.51	1.57E-01	6.87E-01
GO:2000098	negative regulation of smooth muscle cell-matrix adhesion (GO:2000098)	2	1	.12	+	8.51	1.57E-01	6.87E-01
GO:2000079	regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079)	2	1	.12	+	8.51	1.57E-01	6.87E-01
GO:2000054	negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054)	2	1	.12	+	8.51	1.57E-01	6.87E-01
GO:2000053	regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000053)	2	1	.12	+	8.51	1.57E-01	6.86E-01
GO:2000043	regulation of cardiac cell fate specification (GO:2000043)	2	1	.12	+	8.51	1.57E-01	6.86E-01
GO:2000041	negative regulation of planar cell polarity pathway involved in axis elongation (GO:2000041)	2	1	.12	+	8.51	1.57E-01	6.86E-01
GO:2000040	regulation of planar cell polarity pathway involved in axis elongation (GO:2000040)	2	1	.12	+	8.51	1.57E-01	6.86E-01
GO:1900924	negative regulation of glycine import across plasma membrane (GO:1900924)	2	1	.12	+	8.51	1.57E-01	6.86E-01
GO:1900923	regulation of glycine import across plasma membrane (GO:1900923)	2	1	.12	+	8.51	1.57E-01	6.86E-01
GO:1905775	negative regulation of DNA helicase activity (GO:1905775)	2	1	.12	+	8.51	1.57E-01	6.85E-01
GO:0051458	corticotropin secretion (GO:0051458)	2	1	.12	+	8.51	1.57E-01	6.85E-01
GO:1901390	positive regulation of transforming growth factor beta activation (GO:1901390)	2	1	.12	+	8.51	1.57E-01	6.85E-01
GO:0098910	regulation of atrial cardiac muscle cell action potential (GO:0098910)	4	2	.23	+	8.51	3.97E-02	3.23E-01
GO:1901336	lactone biosynthetic process (GO:1901336)	2	1	.12	+	8.51	1.57E-01	6.85E-01
GO:0070563	negative regulation of vitamin D receptor signaling pathway (GO:0070563)	2	1	.12	+	8.51	1.57E-01	6.85E-01
GO:0090125	cell-cell adhesion involved in synapse maturation (GO:0090125)	2	1	.12	+	8.51	1.57E-01	6.84E-01
GO:0048611	embryonic ectodermal digestive tract development (GO:0048611)	2	1	.12	+	8.51	1.57E-01	6.84E-01
GO:0050902	leukocyte adhesive activation (GO:0050902)	2	1	.12	+	8.51	1.57E-01	6.84E-01
GO:0106020	regulation of vesicle docking (GO:0106020)	2	1	.12	+	8.51	1.57E-01	6.84E-01
GO:0098886	modification of dendritic spine (GO:0098886)	2	1	.12	+	8.51	1.57E-01	6.84E-01
GO:1901295	regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295)	2	1	.12	+	8.51	1.57E-01	6.83E-01
GO:0051352	negative regulation of ligase activity (GO:0051352)	2	1	.12	+	8.51	1.57E-01	6.83E-01
GO:1901258	positive regulation of macrophage colony-stimulating factor production (GO:1901258)	4	2	.23	+	8.51	3.97E-02	3.23E-01
GO:0051309	female meiosis chromosome separation (GO:0051309)	2	1	.12	+	8.51	1.57E-01	6.83E-01
GO:0090089	regulation of dipeptide transport (GO:0090089)	2	1	.12	+	8.51	1.57E-01	6.83E-01
GO:0090088	regulation of oligopeptide transport (GO:0090088)	2	1	.12	+	8.51	1.57E-01	6.83E-01
GO:0090038	negative regulation of protein kinase C signaling (GO:0090038)	4	2	.23	+	8.51	3.97E-02	3.22E-01
GO:1990172	G protein-coupled receptor catabolic process (GO:1990172)	2	1	.12	+	8.51	1.57E-01	6.83E-01
GO:0009785	blue light signaling pathway (GO:0009785)	2	1	.12	+	8.51	1.57E-01	6.82E-01
GO:1905533	negative regulation of leucine import across plasma membrane (GO:1905533)	2	1	.12	+	8.51	1.57E-01	6.82E-01
GO:1905526	regulation of Golgi lumen acidification (GO:1905526)	2	1	.12	+	8.51	1.57E-01	6.82E-01
GO:0120169	detection of cold stimulus involved in thermoception (GO:0120169)	2	1	.12	+	8.51	1.57E-01	6.82E-01
GO:0031577	spindle checkpoint signaling (GO:0031577)	32	16	1.88	+	8.51	3.04E-09	2.27E-07
GO:1905448	positive regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905448)	4	2	.23	+	8.51	3.97E-02	3.22E-01
GO:1905447	negative regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905447)	2	1	.12	+	8.51	1.57E-01	6.82E-01
GO:1905446	regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:0051138	positive regulation of NK T cell differentiation (GO:0051138)	4	2	.23	+	8.51	3.97E-02	3.22E-01
GO:0031536	positive regulation of exit from mitosis (GO:0031536)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:0048371	lateral mesodermal cell differentiation (GO:0048371)	2	1	.12	+	8.51	1.57E-01	6.81E-01
GO:1904976	cellular response to bleomycin (GO:1904976)	2	1	.12	+	8.51	1.57E-01	6.81E-01
GO:1904975	response to bleomycin (GO:1904975)	2	1	.12	+	8.51	1.57E-01	6.81E-01
GO:0050653	chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653)	2	1	.12	+	8.51	1.57E-01	6.81E-01
GO:0036371	protein localization to T-tubule (GO:0036371)	2	1	.12	+	8.51	1.57E-01	6.81E-01
GO:1904933	regulation of cell proliferation in midbrain (GO:1904933)	2	1	.12	+	8.51	1.57E-01	6.80E-01
GO:1904904	regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:0099040	ceramide translocation (GO:0099040)	2	1	.12	+	8.51	1.57E-01	6.80E-01
GO:0036309	protein localization to M-band (GO:0036309)	2	1	.12	+	8.51	1.57E-01	6.80E-01
GO:1905342	positive regulation of protein localization to kinetochore (GO:1905342)	4	2	.23	+	8.51	3.97E-02	3.22E-01
GO:1905340	regulation of protein localization to kinetochore (GO:1905340)	4	2	.23	+	8.51	3.97E-02	3.22E-01
GO:0051040	regulation of calcium-independent cell-cell adhesion (GO:0051040)	2	1	.12	+	8.51	1.57E-01	6.80E-01
GO:0031456	glycine betaine biosynthetic process (GO:0031456)	2	1	.12	+	8.51	1.57E-01	6.80E-01
GO:0031455	glycine betaine metabolic process (GO:0031455)	2	1	.12	+	8.51	1.57E-01	6.79E-01
GO:1904879	positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904879)	2	1	.12	+	8.51	1.57E-01	6.79E-01
GO:1904849	positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849)	4	2	.23	+	8.51	3.97E-02	3.22E-01
GO:0070104	negative regulation of interleukin-6-mediated signaling pathway (GO:0070104)	2	1	.12	+	8.51	1.57E-01	6.79E-01
GO:0000279	M phase (GO:0000279)	2	1	.12	+	8.51	1.57E-01	6.79E-01
GO:0035790	platelet-derived growth factor receptor-alpha signaling pathway (GO:0035790)	2	1	.12	+	8.51	1.57E-01	6.79E-01
GO:0043381	negative regulation of memory T cell differentiation (GO:0043381)	2	1	.12	+	8.51	1.57E-01	6.79E-01
GO:0035733	hepatic stellate cell activation (GO:0035733)	2	1	.12	+	8.51	1.57E-01	6.78E-01
GO:1905243	cellular response to 3,3',5-triiodo-L-thyronine (GO:1905243)	2	1	.12	+	8.51	1.57E-01	6.78E-01
GO:1905204	negative regulation of connective tissue replacement (GO:1905204)	2	1	.12	+	8.51	1.57E-01	6.78E-01
GO:0017055	negative regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0017055)	2	1	.12	+	8.51	1.57E-01	6.78E-01
GO:1904782	negative regulation of NMDA glutamate receptor activity (GO:1904782)	2	1	.12	+	8.51	1.57E-01	6.78E-01
GO:0036145	dendritic cell homeostasis (GO:0036145)	2	1	.12	+	8.51	1.57E-01	6.77E-01
GO:1905171	positive regulation of protein localization to phagocytic vesicle (GO:1905171)	2	1	.12	+	8.51	1.57E-01	6.77E-01
GO:1905169	regulation of protein localization to phagocytic vesicle (GO:1905169)	2	1	.12	+	8.51	1.57E-01	6.77E-01
GO:1905135	biotin import across plasma membrane (GO:1905135)	2	1	.12	+	8.51	1.57E-01	6.77E-01
GO:1905132	regulation of meiotic chromosome separation (GO:1905132)	4	2	.23	+	8.51	3.97E-02	3.21E-01
GO:0048014	Tie signaling pathway (GO:0048014)	4	2	.23	+	8.51	3.97E-02	3.21E-01
GO:1904613	cellular response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904613)	2	1	.12	+	8.51	1.57E-01	6.77E-01
GO:0042701	progesterone secretion (GO:0042701)	2	1	.12	+	8.51	1.57E-01	6.77E-01
GO:1900248	negative regulation of cytoplasmic translational elongation (GO:1900248)	2	1	.12	+	8.51	1.57E-01	6.76E-01
GO:0061885	positive regulation of mini excitatory postsynaptic potential (GO:0061885)	2	1	.12	+	8.51	1.57E-01	6.76E-01
GO:0061884	regulation of mini excitatory postsynaptic potential (GO:0061884)	2	1	.12	+	8.51	1.57E-01	6.76E-01
GO:0000087	mitotic M phase (GO:0000087)	2	1	.12	+	8.51	1.57E-01	6.76E-01
GO:1905066	regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066)	2	1	.12	+	8.51	1.57E-01	6.76E-01
GO:0035505	positive regulation of myosin light chain kinase activity (GO:0035505)	2	1	.12	+	8.51	1.57E-01	6.75E-01
GO:0035504	regulation of myosin light chain kinase activity (GO:0035504)	2	1	.12	+	8.51	1.57E-01	6.75E-01
GO:0009257	10-formyltetrahydrofolate biosynthetic process (GO:0009257)	2	1	.12	+	8.51	1.57E-01	6.75E-01
GO:0031106	septin ring organization (GO:0031106)	2	1	.12	+	8.51	1.57E-01	6.75E-01
GO:1904597	negative regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904597)	2	1	.12	+	8.51	1.57E-01	6.75E-01
GO:1904596	regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904596)	2	1	.12	+	8.51	1.57E-01	6.74E-01
GO:0042663	regulation of endodermal cell fate specification (GO:0042663)	2	1	.12	+	8.51	1.57E-01	6.74E-01
GO:0042660	positive regulation of cell fate specification (GO:0042660)	2	1	.12	+	8.51	1.57E-01	6.74E-01
GO:0016321	female meiosis chromosome segregation (GO:0016321)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:0015854	guanine transport (GO:0015854)	2	1	.12	+	8.51	1.57E-01	6.74E-01
GO:0043007	maintenance of rDNA (GO:0043007)	2	1	.12	+	8.51	1.57E-01	6.74E-01
GO:0062173	brexanolone metabolic process (GO:0062173)	2	1	.12	+	8.51	1.57E-01	6.74E-01
GO:0046900	tetrahydrofolylpolyglutamate metabolic process (GO:0046900)	2	1	.12	+	8.51	1.57E-01	6.73E-01
GO:1904428	negative regulation of tubulin deacetylation (GO:1904428)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:0061643	chemorepulsion of axon (GO:0061643)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:1903966	monounsaturated fatty acid biosynthetic process (GO:1903966)	2	1	.12	+	8.51	1.57E-01	6.73E-01
GO:0035378	carbon dioxide transmembrane transport (GO:0035378)	2	1	.12	+	8.51	1.57E-01	6.73E-01
GO:1903929	primary palate development (GO:1903929)	2	1	.12	+	8.51	1.57E-01	6.73E-01
GO:1903923	positive regulation of protein processing in phagocytic vesicle (GO:1903923)	2	1	.12	+	8.51	1.57E-01	6.73E-01
GO:1903921	regulation of protein processing in phagocytic vesicle (GO:1903921)	2	1	.12	+	8.51	1.57E-01	6.72E-01
GO:0035344	hypoxanthine transport (GO:0035344)	2	1	.12	+	8.51	1.57E-01	6.72E-01
GO:0086097	phospholipase C-activating angiotensin-activated signaling pathway (GO:0086097)	2	1	.12	+	8.51	1.57E-01	6.72E-01
GO:0086092	regulation of the force of heart contraction by cardiac conduction (GO:0086092)	2	1	.12	+	8.51	1.57E-01	6.72E-01
GO:0086068	Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068)	6	3	.35	+	8.51	1.11E-02	1.37E-01
GO:0086054	bundle of His cell to Purkinje myocyte communication by electrical coupling (GO:0086054)	2	1	.12	+	8.51	1.57E-01	6.72E-01
GO:0150174	negative regulation of phosphatidylcholine metabolic process (GO:0150174)	2	1	.12	+	8.51	1.57E-01	6.72E-01
GO:0086023	adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0086023)	4	2	.23	+	8.51	3.97E-02	3.21E-01
GO:1904398	positive regulation of neuromuscular junction development (GO:1904398)	2	1	.12	+	8.51	1.57E-01	6.71E-01
GO:0042488	positive regulation of odontogenesis of dentin-containing tooth (GO:0042488)	2	1	.12	+	8.51	1.57E-01	6.71E-01
GO:1904373	response to kainic acid (GO:1904373)	2	1	.12	+	8.51	1.57E-01	6.71E-01
GO:0062035	sensory perception of cold stimulus (GO:0062035)	2	1	.12	+	8.51	1.57E-01	6.71E-01
GO:0008582	regulation of synaptic assembly at neuromuscular junction (GO:0008582)	6	3	.35	+	8.51	1.11E-02	1.36E-01
GO:0097533	cellular stress response to acid chemical (GO:0097533)	2	1	.12	+	8.51	1.57E-01	6.71E-01
GO:0097532	stress response to acid chemical (GO:0097532)	2	1	.12	+	8.51	1.57E-01	6.70E-01
GO:0042412	taurine biosynthetic process (GO:0042412)	2	1	.12	+	8.51	1.57E-01	6.70E-01
GO:1904313	response to methamphetamine hydrochloride (GO:1904313)	2	1	.12	+	8.51	1.57E-01	6.70E-01
GO:0016122	xanthophyll metabolic process (GO:0016122)	2	1	.12	+	8.51	1.57E-01	6.70E-01
GO:0016121	carotene catabolic process (GO:0016121)	2	1	.12	+	8.51	1.57E-01	6.70E-01
GO:0016119	carotene metabolic process (GO:0016119)	2	1	.12	+	8.51	1.57E-01	6.70E-01
GO:0061551	trigeminal ganglion development (GO:0061551)	4	2	.23	+	8.51	3.97E-02	3.21E-01
GO:1903862	positive regulation of oxidative phosphorylation (GO:1903862)	2	1	.12	+	8.51	1.57E-01	6.69E-01
GO:0061518	microglial cell proliferation (GO:0061518)	8	4	.47	+	8.51	3.25E-03	5.32E-02
GO:0061517	macrophage proliferation (GO:0061517)	8	4	.47	+	8.51	3.25E-03	5.31E-02
GO:0150074	positive regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150074)	2	1	.12	+	8.51	1.57E-01	6.69E-01
GO:0150073	regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150073)	2	1	.12	+	8.51	1.57E-01	6.69E-01
GO:1904291	positive regulation of mitotic DNA damage checkpoint (GO:1904291)	2	1	.12	+	8.51	1.57E-01	6.69E-01
GO:0097498	endothelial tube lumen extension (GO:0097498)	2	1	.12	+	8.51	1.57E-01	6.69E-01
GO:0046724	oxalic acid secretion (GO:0046724)	2	1	.12	+	8.51	1.57E-01	6.68E-01
GO:1904245	regulation of polynucleotide adenylyltransferase activity (GO:1904245)	2	1	.12	+	8.51	1.57E-01	6.68E-01
GO:0010767	regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010767)	2	1	.12	+	8.51	1.57E-01	6.68E-01
GO:1904204	regulation of skeletal muscle hypertrophy (GO:1904204)	2	1	.12	+	8.51	1.57E-01	6.68E-01
GO:1904200	iodide transmembrane transport (GO:1904200)	2	1	.12	+	8.51	1.57E-01	6.68E-01
GO:0010734	negative regulation of protein glutathionylation (GO:0010734)	2	1	.12	+	8.51	1.57E-01	6.68E-01
GO:0010732	regulation of protein glutathionylation (GO:0010732)	2	1	.12	+	8.51	1.57E-01	6.67E-01
GO:0010705	meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705)	2	1	.12	+	8.51	1.57E-01	6.67E-01
GO:0060979	vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)	4	2	.23	+	8.51	3.97E-02	3.21E-01
GO:0046671	negative regulation of retinal cell programmed cell death (GO:0046671)	2	1	.12	+	8.51	1.57E-01	6.67E-01
GO:0060940	epithelial to mesenchymal transition involved in cardiac fibroblast development (GO:0060940)	2	1	.12	+	8.51	1.57E-01	6.67E-01
GO:0046668	regulation of retinal cell programmed cell death (GO:0046668)	4	2	.23	+	8.51	3.97E-02	3.21E-01
GO:0060929	atrioventricular node cell fate commitment (GO:0060929)	2	1	.12	+	8.51	1.57E-01	6.67E-01
GO:1904172	positive regulation of bleb assembly (GO:1904172)	2	1	.12	+	8.51	1.57E-01	6.66E-01
GO:1904170	regulation of bleb assembly (GO:1904170)	2	1	.12	+	8.51	1.57E-01	6.66E-01
GO:0097338	response to clozapine (GO:0097338)	2	1	.12	+	8.51	1.57E-01	6.66E-01
GO:0097332	response to antipsychotic drug (GO:0097332)	2	1	.12	+	8.51	1.57E-01	6.66E-01
GO:0030221	basophil differentiation (GO:0030221)	2	1	.12	+	8.51	1.57E-01	6.66E-01
GO:0061394	regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061394)	2	1	.12	+	8.51	1.57E-01	6.66E-01
GO:0061343	cell adhesion involved in heart morphogenesis (GO:0061343)	6	3	.35	+	8.51	1.11E-02	1.36E-01
GO:0019853	L-ascorbic acid biosynthetic process (GO:0019853)	2	1	.12	+	8.51	1.57E-01	6.65E-01
GO:1903630	regulation of aminoacyl-tRNA ligase activity (GO:1903630)	2	1	.12	+	8.51	1.57E-01	6.65E-01
GO:1903610	regulation of calcium-dependent ATPase activity (GO:1903610)	2	1	.12	+	8.51	1.57E-01	6.65E-01
GO:0060857	establishment of glial blood-brain barrier (GO:0060857)	2	1	.12	+	8.51	1.57E-01	6.65E-01
GO:0003422	growth plate cartilage morphogenesis (GO:0003422)	2	1	.12	+	8.51	1.57E-01	6.65E-01
GO:0030185	nitric oxide transport (GO:0030185)	4	2	.23	+	8.51	3.97E-02	3.20E-01
GO:1904027	negative regulation of collagen fibril organization (GO:1904027)	2	1	.12	+	8.51	1.57E-01	6.64E-01
GO:1904002	regulation of sebum secreting cell proliferation (GO:1904002)	2	1	.12	+	8.51	1.57E-01	6.64E-01
GO:1903537	meiotic cell cycle process involved in oocyte maturation (GO:1903537)	2	1	.12	+	8.51	1.57E-01	6.64E-01
GO:1903515	calcium ion transport from cytosol to endoplasmic reticulum (GO:1903515)	2	1	.12	+	8.51	1.57E-01	6.64E-01
GO:0072757	cellular response to camptothecin (GO:0072757)	4	2	.23	+	8.51	3.97E-02	3.20E-01
GO:0060750	epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750)	4	2	.23	+	8.51	3.97E-02	3.20E-01
GO:0003336	corneocyte desquamation (GO:0003336)	2	1	.12	+	8.51	1.57E-01	6.64E-01
GO:0072719	cellular response to cisplatin (GO:0072719)	4	2	.23	+	8.51	3.97E-02	3.20E-01
GO:0097167	circadian regulation of translation (GO:0097167)	4	2	.23	+	8.51	3.97E-02	3.20E-01
GO:0034442	regulation of lipoprotein oxidation (GO:0034442)	2	1	.12	+	8.51	1.57E-01	6.64E-01
GO:0097156	fasciculation of motor neuron axon (GO:0097156)	2	1	.12	+	8.51	1.57E-01	6.63E-01
GO:0014852	regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852)	2	1	.12	+	8.51	1.57E-01	6.63E-01
GO:0030043	actin filament fragmentation (GO:0030043)	4	2	.23	+	8.51	3.97E-02	3.20E-01
GO:0097119	postsynaptic density protein 95 clustering (GO:0097119)	6	3	.35	+	8.51	1.11E-02	1.36E-01
GO:0097117	guanylate kinase-associated protein clustering (GO:0097117)	2	1	.12	+	8.51	1.57E-01	6.63E-01
GO:0061145	lung smooth muscle development (GO:0061145)	2	1	.12	+	8.51	1.57E-01	6.63E-01
GO:0045925	positive regulation of female receptivity (GO:0045925)	2	1	.12	+	8.51	1.57E-01	6.63E-01
GO:0061107	seminal vesicle development (GO:0061107)	2	1	.12	+	8.51	1.57E-01	6.63E-01
GO:1903402	regulation of renal phosphate excretion (GO:1903402)	2	1	.12	+	8.51	1.57E-01	6.62E-01
GO:0060689	cell differentiation involved in salivary gland development (GO:0060689)	2	1	.12	+	8.51	1.57E-01	6.62E-01
GO:0046398	UDP-glucuronate metabolic process (GO:0046398)	2	1	.12	+	8.51	1.57E-01	6.62E-01
GO:1902998	positive regulation of neurofibrillary tangle assembly (GO:1902998)	2	1	.12	+	8.51	1.57E-01	6.62E-01
GO:0046381	CMP-N-acetylneuraminate metabolic process (GO:0046381)	2	1	.12	+	8.51	1.57E-01	6.62E-01
GO:1902969	mitotic DNA replication (GO:1902969)	12	6	.70	+	8.51	3.00E-04	7.08E-03
GO:0003218	cardiac left ventricle formation (GO:0003218)	2	1	.12	+	8.51	1.57E-01	6.61E-01
GO:1902957	negative regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902957)	2	1	.12	+	8.51	1.57E-01	6.61E-01
GO:0034352	positive regulation of glial cell apoptotic process (GO:0034352)	2	1	.12	+	8.51	1.57E-01	6.61E-01
GO:1902913	positive regulation of neuroepithelial cell differentiation (GO:1902913)	2	1	.12	+	8.51	1.57E-01	6.61E-01
GO:0046305	alkanesulfonate biosynthetic process (GO:0046305)	2	1	.12	+	8.51	1.57E-01	6.61E-01
GO:0097048	dendritic cell apoptotic process (GO:0097048)	2	1	.12	+	8.51	1.57E-01	6.61E-01
GO:0014721	twitch skeletal muscle contraction (GO:0014721)	2	1	.12	+	8.51	1.57E-01	6.60E-01
GO:0008050	female courtship behavior (GO:0008050)	2	1	.12	+	8.51	1.57E-01	6.60E-01
GO:0045870	positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870)	2	1	.12	+	8.51	1.57E-01	6.60E-01
GO:0061055	myotome development (GO:0061055)	4	2	.23	+	8.51	3.97E-02	3.19E-01
GO:0061032	visceral serous pericardium development (GO:0061032)	2	1	.12	+	8.51	1.57E-01	6.60E-01
GO:0061030	epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030)	4	2	.23	+	8.51	3.97E-02	3.19E-01
GO:0061010	gall bladder development (GO:0061010)	2	1	.12	+	8.51	1.57E-01	6.60E-01
GO:1903336	negative regulation of vacuolar transport (GO:1903336)	2	1	.12	+	8.51	1.57E-01	6.60E-01
GO:0021836	chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836)	2	1	.12	+	8.51	1.57E-01	6.59E-01
GO:0021827	postnatal olfactory bulb interneuron migration (GO:0021827)	2	1	.12	+	8.51	1.57E-01	6.59E-01
GO:0021825	substrate-dependent cerebral cortex tangential migration (GO:0021825)	2	1	.12	+	8.51	1.57E-01	6.59E-01
GO:0021823	cerebral cortex tangential migration using cell-cell interactions (GO:0021823)	2	1	.12	+	8.51	1.57E-01	6.59E-01
GO:0003172	sinoatrial valve development (GO:0003172)	2	1	.12	+	8.51	1.57E-01	6.59E-01
GO:0060587	regulation of lipoprotein lipid oxidation (GO:0060587)	2	1	.12	+	8.51	1.57E-01	6.58E-01
GO:0007521	muscle cell fate determination (GO:0007521)	2	1	.12	+	8.51	1.57E-01	6.58E-01
GO:0003150	muscular septum morphogenesis (GO:0003150)	4	2	.23	+	8.51	3.97E-02	3.19E-01
GO:0072513	positive regulation of secondary heart field cardioblast proliferation (GO:0072513)	4	2	.23	+	8.51	3.97E-02	3.19E-01
GO:0060532	bronchus cartilage development (GO:0060532)	2	1	.12	+	8.51	1.57E-01	6.58E-01
GO:0046247	terpene catabolic process (GO:0046247)	2	1	.12	+	8.51	1.57E-01	6.58E-01
GO:1902823	negative regulation of late endosome to lysosome transport (GO:1902823)	2	1	.12	+	8.51	1.57E-01	6.58E-01
GO:0034230	enkephalin processing (GO:0034230)	2	1	.12	+	8.51	1.57E-01	6.58E-01
GO:0045841	negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	33	16	1.94	+	8.26	4.28E-09	3.08E-07
GO:0044786	cell cycle DNA replication (GO:0044786)	25	12	1.47	+	8.17	4.08E-07	2.06E-05
GO:0051985	negative regulation of chromosome segregation (GO:0051985)	38	18	2.23	+	8.07	6.18E-10	5.33E-08
GO:1905819	negative regulation of chromosome separation (GO:1905819)	38	18	2.23	+	8.07	6.18E-10	5.30E-08
GO:0086012	membrane depolarization during cardiac muscle cell action potential (GO:0086012)	17	8	1.00	+	8.01	4.05E-05	1.29E-03
GO:0051450	myoblast proliferation (GO:0051450)	13	6	.76	+	7.86	4.17E-04	9.46E-03
GO:1902100	negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	35	16	2.06	+	7.79	8.26E-09	5.46E-07
GO:0071313	cellular response to caffeine (GO:0071313)	11	5	.65	+	7.74	1.36E-03	2.60E-02
GO:0006268	DNA unwinding involved in DNA replication (GO:0006268)	22	10	1.29	+	7.74	5.58E-06	2.22E-04
GO:0019227	neuronal action potential propagation (GO:0019227)	9	4	.53	+	7.57	4.50E-03	6.97E-02
GO:1901993	regulation of meiotic cell cycle phase transition (GO:1901993)	9	4	.53	+	7.57	4.50E-03	6.96E-02
GO:0051988	regulation of attachment of spindle microtubules to kinetochore (GO:0051988)	18	8	1.06	+	7.57	5.57E-05	1.72E-03
GO:0090306	meiotic spindle assembly (GO:0090306)	9	4	.53	+	7.57	4.50E-03	6.95E-02
GO:0098870	action potential propagation (GO:0098870)	9	4	.53	+	7.57	4.50E-03	6.95E-02
GO:0048478	replication fork protection (GO:0048478)	9	4	.53	+	7.57	4.50E-03	6.94E-02
GO:0061072	iris morphogenesis (GO:0061072)	9	4	.53	+	7.57	4.50E-03	6.93E-02
GO:0045839	negative regulation of mitotic nuclear division (GO:0045839)	41	18	2.41	+	7.48	1.61E-09	1.29E-07
GO:2000794	regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794)	7	3	.41	+	7.30	1.52E-02	1.74E-01
GO:0060087	relaxation of vascular associated smooth muscle (GO:0060087)	7	3	.41	+	7.30	1.52E-02	1.74E-01
GO:0038001	paracrine signaling (GO:0038001)	7	3	.41	+	7.30	1.52E-02	1.74E-01
GO:0071415	cellular response to purine-containing compound (GO:0071415)	14	6	.82	+	7.30	5.68E-04	1.25E-02
GO:0090521	podocyte cell migration (GO:0090521)	7	3	.41	+	7.30	1.52E-02	1.73E-01
GO:2000322	regulation of glucocorticoid receptor signaling pathway (GO:2000322)	7	3	.41	+	7.30	1.52E-02	1.73E-01
GO:0032466	negative regulation of cytokinesis (GO:0032466)	7	3	.41	+	7.30	1.52E-02	1.73E-01
GO:0098903	regulation of membrane repolarization during action potential (GO:0098903)	7	3	.41	+	7.30	1.52E-02	1.73E-01
GO:0050942	positive regulation of pigment cell differentiation (GO:0050942)	7	3	.41	+	7.30	1.52E-02	1.73E-01
GO:0032201	telomere maintenance via semi-conservative replication (GO:0032201)	7	3	.41	+	7.30	1.52E-02	1.73E-01
GO:0043569	negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569)	7	3	.41	+	7.30	1.52E-02	1.73E-01
GO:1905150	regulation of voltage-gated sodium channel activity (GO:1905150)	7	3	.41	+	7.30	1.52E-02	1.73E-01
GO:0086027	AV node cell to bundle of His cell signaling (GO:0086027)	7	3	.41	+	7.30	1.52E-02	1.72E-01
GO:0086016	AV node cell action potential (GO:0086016)	7	3	.41	+	7.30	1.52E-02	1.72E-01
GO:1904396	regulation of neuromuscular junction development (GO:1904396)	7	3	.41	+	7.30	1.52E-02	1.72E-01
GO:0060947	cardiac vascular smooth muscle cell differentiation (GO:0060947)	7	3	.41	+	7.30	1.52E-02	1.72E-01
GO:0034699	response to luteinizing hormone (GO:0034699)	7	3	.41	+	7.30	1.52E-02	1.72E-01
GO:0023041	neuronal signal transduction (GO:0023041)	7	3	.41	+	7.30	1.52E-02	1.72E-01
GO:1903490	positive regulation of mitotic cytokinesis (GO:1903490)	7	3	.41	+	7.30	1.52E-02	1.72E-01
GO:0003253	cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253)	7	3	.41	+	7.30	1.52E-02	1.72E-01
GO:0060638	mesenchymal-epithelial cell signaling (GO:0060638)	7	3	.41	+	7.30	1.52E-02	1.71E-01
GO:1902949	positive regulation of tau-protein kinase activity (GO:1902949)	7	3	.41	+	7.30	1.52E-02	1.71E-01
GO:0071872	cellular response to epinephrine stimulus (GO:0071872)	12	5	.70	+	7.10	1.84E-03	3.39E-02
GO:0032754	positive regulation of interleukin-5 production (GO:0032754)	12	5	.70	+	7.10	1.84E-03	3.39E-02
GO:1901731	positive regulation of platelet aggregation (GO:1901731)	12	5	.70	+	7.10	1.84E-03	3.38E-02
GO:0090267	positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)	12	5	.70	+	7.10	1.84E-03	3.38E-02
GO:0090232	positive regulation of spindle checkpoint (GO:0090232)	12	5	.70	+	7.10	1.84E-03	3.38E-02
GO:0051782	negative regulation of cell division (GO:0051782)	17	7	1.00	+	7.01	2.38E-04	5.82E-03
GO:0000076	DNA replication checkpoint signaling (GO:0000076)	17	7	1.00	+	7.01	2.38E-04	5.81E-03
GO:0060426	lung vasculature development (GO:0060426)	5	2	.29	+	6.81	5.36E-02	3.97E-01
GO:0060402	calcium ion transport into cytosol (GO:0060402)	15	6	.88	+	6.81	7.59E-04	1.60E-02
GO:0071878	negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071878)	5	2	.29	+	6.81	5.36E-02	3.96E-01
GO:0006710	androgen catabolic process (GO:0006710)	5	2	.29	+	6.81	5.36E-02	3.96E-01
GO:0007195	adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195)	5	2	.29	+	6.81	5.36E-02	3.96E-01
GO:0072124	regulation of glomerular mesangial cell proliferation (GO:0072124)	10	4	.59	+	6.81	6.02E-03	8.64E-02
GO:0032966	negative regulation of collagen biosynthetic process (GO:0032966)	10	4	.59	+	6.81	6.02E-03	8.63E-02
GO:1902462	positive regulation of mesenchymal stem cell proliferation (GO:1902462)	5	2	.29	+	6.81	5.36E-02	3.96E-01
GO:1902460	regulation of mesenchymal stem cell proliferation (GO:1902460)	5	2	.29	+	6.81	5.36E-02	3.96E-01
GO:0071655	regulation of granulocyte colony-stimulating factor production (GO:0071655)	5	2	.29	+	6.81	5.36E-02	3.95E-01
GO:2001015	negative regulation of skeletal muscle cell differentiation (GO:2001015)	5	2	.29	+	6.81	5.36E-02	3.95E-01
GO:0044860	protein localization to plasma membrane raft (GO:0044860)	5	2	.29	+	6.81	5.36E-02	3.95E-01
GO:1902315	nuclear cell cycle DNA replication initiation (GO:1902315)	5	2	.29	+	6.81	5.36E-02	3.95E-01
GO:1901842	negative regulation of high voltage-gated calcium channel activity (GO:1901842)	5	2	.29	+	6.81	5.36E-02	3.95E-01
GO:0051902	negative regulation of mitochondrial depolarization (GO:0051902)	5	2	.29	+	6.81	5.36E-02	3.94E-01
GO:2000480	negative regulation of cAMP-dependent protein kinase activity (GO:2000480)	10	4	.59	+	6.81	6.02E-03	8.62E-02
GO:1902292	cell cycle DNA replication initiation (GO:1902292)	5	2	.29	+	6.81	5.36E-02	3.94E-01
GO:0002035	brain renin-angiotensin system (GO:0002035)	5	2	.29	+	6.81	5.36E-02	3.94E-01
GO:0051754	meiotic sister chromatid cohesion, centromeric (GO:0051754)	5	2	.29	+	6.81	5.36E-02	3.94E-01
GO:0000915	actomyosin contractile ring assembly (GO:0000915)	5	2	.29	+	6.81	5.36E-02	3.94E-01
GO:0000912	assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	5	2	.29	+	6.81	5.36E-02	3.94E-01
GO:1901563	response to camptothecin (GO:1901563)	5	2	.29	+	6.81	5.36E-02	3.93E-01
GO:1905821	positive regulation of chromosome condensation (GO:1905821)	5	2	.29	+	6.81	5.36E-02	3.93E-01
GO:0090244	Wnt signaling pathway involved in somitogenesis (GO:0090244)	5	2	.29	+	6.81	5.36E-02	3.93E-01
GO:0032341	aldosterone metabolic process (GO:0032341)	5	2	.29	+	6.81	5.36E-02	3.93E-01
GO:1905784	regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784)	5	2	.29	+	6.81	5.36E-02	3.93E-01
GO:0009996	negative regulation of cell fate specification (GO:0009996)	5	2	.29	+	6.81	5.36E-02	3.92E-01
GO:0032224	positive regulation of synaptic transmission, cholinergic (GO:0032224)	5	2	.29	+	6.81	5.36E-02	3.92E-01
GO:0050812	regulation of acyl-CoA biosynthetic process (GO:0050812)	5	2	.29	+	6.81	5.36E-02	3.92E-01
GO:1905563	negative regulation of vascular endothelial cell proliferation (GO:1905563)	5	2	.29	+	6.81	5.36E-02	3.92E-01
GO:0098735	positive regulation of the force of heart contraction (GO:0098735)	5	2	.29	+	6.81	5.36E-02	3.92E-01
GO:0050748	negative regulation of lipoprotein metabolic process (GO:0050748)	5	2	.29	+	6.81	5.36E-02	3.92E-01
GO:1904956	regulation of midbrain dopaminergic neuron differentiation (GO:1904956)	5	2	.29	+	6.81	5.36E-02	3.91E-01
GO:1904906	positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906)	5	2	.29	+	6.81	5.36E-02	3.91E-01
GO:0017038	protein import (GO:0017038)	5	2	.29	+	6.81	5.36E-02	3.91E-01
GO:0035624	receptor transactivation (GO:0035624)	5	2	.29	+	6.81	5.36E-02	3.91E-01
GO:0055119	relaxation of cardiac muscle (GO:0055119)	15	6	.88	+	6.81	7.59E-04	1.60E-02
GO:0055118	negative regulation of cardiac muscle contraction (GO:0055118)	5	2	.29	+	6.81	5.36E-02	3.91E-01
GO:0015853	adenine transport (GO:0015853)	5	2	.29	+	6.81	5.36E-02	3.90E-01
GO:1904447	folate import across plasma membrane (GO:1904447)	5	2	.29	+	6.81	5.36E-02	3.90E-01
GO:0035385	Roundabout signaling pathway (GO:0035385)	5	2	.29	+	6.81	5.36E-02	3.90E-01
GO:0086064	cell communication by electrical coupling involved in cardiac conduction (GO:0086064)	15	6	.88	+	6.81	7.59E-04	1.60E-02
GO:0046898	response to cycloheximide (GO:0046898)	5	2	.29	+	6.81	5.36E-02	3.90E-01
GO:0086045	membrane depolarization during AV node cell action potential (GO:0086045)	5	2	.29	+	6.81	5.36E-02	3.90E-01
GO:0061550	cranial ganglion development (GO:0061550)	5	2	.29	+	6.81	5.36E-02	3.90E-01
GO:0003402	planar cell polarity pathway involved in axis elongation (GO:0003402)	5	2	.29	+	6.81	5.36E-02	3.89E-01
GO:0042148	strand invasion (GO:0042148)	5	2	.29	+	6.81	5.36E-02	3.89E-01
GO:0061217	regulation of mesonephros development (GO:0061217)	5	2	.29	+	6.81	5.36E-02	3.89E-01
GO:0060751	branch elongation involved in mammary gland duct branching (GO:0060751)	5	2	.29	+	6.81	5.36E-02	3.89E-01
GO:0072718	response to cisplatin (GO:0072718)	5	2	.29	+	6.81	5.36E-02	3.89E-01
GO:0042045	epithelial fluid transport (GO:0042045)	10	4	.59	+	6.81	6.02E-03	8.62E-02
GO:0097116	gephyrin clustering involved in postsynaptic density assembly (GO:0097116)	5	2	.29	+	6.81	5.36E-02	3.88E-01
GO:0097114	NMDA glutamate receptor clustering (GO:0097114)	5	2	.29	+	6.81	5.36E-02	3.88E-01
GO:0061197	fungiform papilla morphogenesis (GO:0061197)	5	2	.29	+	6.81	5.36E-02	3.88E-01
GO:1903413	cellular response to bile acid (GO:1903413)	5	2	.29	+	6.81	5.36E-02	3.88E-01
GO:0003274	endocardial cushion fusion (GO:0003274)	5	2	.29	+	6.81	5.36E-02	3.88E-01
GO:0060687	regulation of branching involved in prostate gland morphogenesis (GO:0060687)	5	2	.29	+	6.81	5.36E-02	3.88E-01
GO:1902975	mitotic DNA replication initiation (GO:1902975)	5	2	.29	+	6.81	5.36E-02	3.87E-01
GO:0003211	cardiac ventricle formation (GO:0003211)	10	4	.59	+	6.81	6.02E-03	8.61E-02
GO:0097070	ductus arteriosus closure (GO:0097070)	5	2	.29	+	6.81	5.36E-02	3.87E-01
GO:0061051	positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051)	5	2	.29	+	6.81	5.36E-02	3.87E-01
GO:0060501	positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501)	5	2	.29	+	6.81	5.36E-02	3.87E-01
GO:1902809	regulation of skeletal muscle fiber differentiation (GO:1902809)	5	2	.29	+	6.81	5.36E-02	3.87E-01
GO:0051784	negative regulation of nuclear division (GO:0051784)	48	19	2.82	+	6.74	2.25E-09	1.70E-07
GO:0033047	regulation of mitotic sister chromatid segregation (GO:0033047)	56	22	3.29	+	6.69	1.38E-10	1.38E-08
GO:2000668	regulation of dendritic cell apoptotic process (GO:2000668)	13	5	.76	+	6.55	2.43E-03	4.23E-02
GO:1901841	regulation of high voltage-gated calcium channel activity (GO:1901841)	13	5	.76	+	6.55	2.43E-03	4.23E-02
GO:0051315	attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	13	5	.76	+	6.55	2.43E-03	4.23E-02
GO:0009214	cyclic nucleotide catabolic process (GO:0009214)	13	5	.76	+	6.55	2.43E-03	4.22E-02
GO:0042415	norepinephrine metabolic process (GO:0042415)	13	5	.76	+	6.55	2.43E-03	4.22E-02
GO:0003207	cardiac chamber formation (GO:0003207)	13	5	.76	+	6.55	2.43E-03	4.21E-02
GO:0072012	glomerulus vasculature development (GO:0072012)	21	8	1.23	+	6.49	1.32E-04	3.60E-03
GO:0090266	regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)	21	8	1.23	+	6.49	1.32E-04	3.60E-03
GO:0090231	regulation of spindle checkpoint (GO:0090231)	21	8	1.23	+	6.49	1.32E-04	3.59E-03
GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)	21	8	1.23	+	6.49	1.32E-04	3.58E-03
GO:1903504	regulation of mitotic spindle checkpoint (GO:1903504)	21	8	1.23	+	6.49	1.32E-04	3.58E-03
GO:0060346	bone trabecula formation (GO:0060346)	8	3	.47	+	6.39	2.01E-02	2.08E-01
GO:0072109	glomerular mesangium development (GO:0072109)	8	3	.47	+	6.39	2.01E-02	2.08E-01
GO:1902425	positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425)	8	3	.47	+	6.39	2.01E-02	2.08E-01
GO:1902423	regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423)	8	3	.47	+	6.39	2.01E-02	2.07E-01
GO:0032825	positive regulation of natural killer cell differentiation (GO:0032825)	8	3	.47	+	6.39	2.01E-02	2.07E-01
GO:1905832	positive regulation of spindle assembly (GO:1905832)	8	3	.47	+	6.39	2.01E-02	2.07E-01
GO:0050932	regulation of pigment cell differentiation (GO:0050932)	8	3	.47	+	6.39	2.01E-02	2.07E-01
GO:0051299	centrosome separation (GO:0051299)	8	3	.47	+	6.39	2.01E-02	2.07E-01
GO:0014832	urinary bladder smooth muscle contraction (GO:0014832)	8	3	.47	+	6.39	2.01E-02	2.07E-01
GO:0045988	negative regulation of striated muscle contraction (GO:0045988)	8	3	.47	+	6.39	2.01E-02	2.07E-01
GO:0061042	vascular wound healing (GO:0061042)	8	3	.47	+	6.39	2.01E-02	2.06E-01
GO:0060509	type I pneumocyte differentiation (GO:0060509)	8	3	.47	+	6.39	2.01E-02	2.06E-01
GO:0002692	negative regulation of cellular extravasation (GO:0002692)	8	3	.47	+	6.39	2.01E-02	2.06E-01
GO:0014009	glial cell proliferation (GO:0014009)	27	10	1.59	+	6.31	2.34E-05	7.88E-04
GO:2000811	negative regulation of anoikis (GO:2000811)	19	7	1.12	+	6.27	4.11E-04	9.33E-03
GO:0086010	membrane depolarization during action potential (GO:0086010)	30	11	1.76	+	6.24	9.88E-06	3.69E-04
GO:0072224	metanephric glomerulus development (GO:0072224)	11	4	.65	+	6.19	7.86E-03	1.04E-01
GO:0051987	positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987)	11	4	.65	+	6.19	7.86E-03	1.04E-01
GO:1905809	negative regulation of synapse organization (GO:1905809)	11	4	.65	+	6.19	7.86E-03	1.04E-01
GO:1904753	negative regulation of vascular associated smooth muscle cell migration (GO:1904753)	11	4	.65	+	6.19	7.86E-03	1.04E-01
GO:0086103	G protein-coupled receptor signaling pathway involved in heart process (GO:0086103)	11	4	.65	+	6.19	7.86E-03	1.04E-01
GO:0010713	negative regulation of collagen metabolic process (GO:0010713)	11	4	.65	+	6.19	7.86E-03	1.03E-01
GO:1903671	negative regulation of sprouting angiogenesis (GO:1903671)	11	4	.65	+	6.19	7.86E-03	1.03E-01
GO:1903083	protein localization to condensed chromosome (GO:1903083)	14	5	.82	+	6.08	3.15E-03	5.24E-02
GO:0001833	inner cell mass cell proliferation (GO:0001833)	14	5	.82	+	6.08	3.15E-03	5.24E-02
GO:1901722	regulation of cell proliferation involved in kidney development (GO:1901722)	14	5	.82	+	6.08	3.15E-03	5.23E-02
GO:0045019	negative regulation of nitric oxide biosynthetic process (GO:0045019)	14	5	.82	+	6.08	3.15E-03	5.23E-02
GO:1905820	positive regulation of chromosome separation (GO:1905820)	28	10	1.64	+	6.08	3.01E-05	9.93E-04
GO:0090128	regulation of synapse maturation (GO:0090128)	14	5	.82	+	6.08	3.15E-03	5.22E-02
GO:0055023	positive regulation of cardiac muscle tissue growth (GO:0055023)	28	10	1.64	+	6.08	3.01E-05	9.91E-04
GO:1904406	negative regulation of nitric oxide metabolic process (GO:1904406)	14	5	.82	+	6.08	3.15E-03	5.22E-02
GO:0034501	protein localization to kinetochore (GO:0034501)	14	5	.82	+	6.08	3.15E-03	5.21E-02
GO:0033623	regulation of integrin activation (GO:0033623)	17	6	1.00	+	6.01	1.28E-03	2.51E-02
GO:0060074	synapse maturation (GO:0060074)	17	6	1.00	+	6.01	1.28E-03	2.50E-02
GO:0060055	angiogenesis involved in wound healing (GO:0060055)	17	6	1.00	+	6.01	1.28E-03	2.50E-02
GO:0060973	cell migration involved in heart development (GO:0060973)	17	6	1.00	+	6.01	1.28E-03	2.50E-02
GO:0010644	cell communication by electrical coupling (GO:0010644)	20	7	1.17	+	5.96	5.29E-04	1.16E-02
GO:0060045	positive regulation of cardiac muscle cell proliferation (GO:0060045)	23	8	1.35	+	5.92	2.19E-04	5.45E-03
GO:0030318	melanocyte differentiation (GO:0030318)	23	8	1.35	+	5.92	2.19E-04	5.44E-03
GO:0061440	kidney vasculature development (GO:0061440)	23	8	1.35	+	5.92	2.19E-04	5.43E-03
GO:0061437	renal system vasculature development (GO:0061437)	23	8	1.35	+	5.92	2.19E-04	5.42E-03
GO:0051984	positive regulation of chromosome segregation (GO:0051984)	26	9	1.53	+	5.89	9.17E-05	2.61E-03
GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)	26	9	1.53	+	5.89	9.17E-05	2.61E-03
GO:0006270	DNA replication initiation (GO:0006270)	29	10	1.70	+	5.87	3.85E-05	1.24E-03
GO:0010880	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)	29	10	1.70	+	5.87	3.85E-05	1.23E-03
GO:0060421	positive regulation of heart growth (GO:0060421)	32	11	1.88	+	5.85	1.62E-05	5.67E-04
GO:0006957	complement activation, alternative pathway (GO:0006957)	15	5	.88	+	5.68	4.01E-03	6.34E-02
GO:0019371	cyclooxygenase pathway (GO:0019371)	9	3	.53	+	5.68	2.57E-02	2.51E-01
GO:0071871	response to epinephrine (GO:0071871)	15	5	.88	+	5.68	4.01E-03	6.33E-02
GO:0045586	regulation of gamma-delta T cell differentiation (GO:0045586)	9	3	.53	+	5.68	2.57E-02	2.51E-01
GO:0001993	regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993)	9	3	.53	+	5.68	2.57E-02	2.50E-01
GO:1903044	protein localization to membrane raft (GO:1903044)	9	3	.53	+	5.68	2.57E-02	2.50E-01
GO:0072102	glomerulus morphogenesis (GO:0072102)	9	3	.53	+	5.68	2.57E-02	2.50E-01
GO:2000553	positive regulation of T-helper 2 cell cytokine production (GO:2000553)	9	3	.53	+	5.68	2.57E-02	2.50E-01
GO:0002016	regulation of blood volume by renin-angiotensin (GO:0002016)	9	3	.53	+	5.68	2.57E-02	2.50E-01
GO:2000169	regulation of peptidyl-cysteine S-nitrosylation (GO:2000169)	9	3	.53	+	5.68	2.57E-02	2.50E-01
GO:0006198	cAMP catabolic process (GO:0006198)	9	3	.53	+	5.68	2.57E-02	2.49E-01
GO:2000104	negative regulation of DNA-templated DNA replication (GO:2000104)	15	5	.88	+	5.68	4.01E-03	6.33E-02
GO:0031915	positive regulation of synaptic plasticity (GO:0031915)	9	3	.53	+	5.68	2.57E-02	2.49E-01
GO:0090129	positive regulation of synapse maturation (GO:0090129)	9	3	.53	+	5.68	2.57E-02	2.49E-01
GO:0051014	actin filament severing (GO:0051014)	15	5	.88	+	5.68	4.01E-03	6.32E-02
GO:1905278	positive regulation of epithelial tube formation (GO:1905278)	9	3	.53	+	5.68	2.57E-02	2.49E-01
GO:1905276	regulation of epithelial tube formation (GO:1905276)	9	3	.53	+	5.68	2.57E-02	2.49E-01
GO:0048087	positive regulation of developmental pigmentation (GO:0048087)	9	3	.53	+	5.68	2.57E-02	2.49E-01
GO:0031000	response to caffeine (GO:0031000)	15	5	.88	+	5.68	4.01E-03	6.31E-02
GO:0046602	regulation of mitotic centrosome separation (GO:0046602)	9	3	.53	+	5.68	2.57E-02	2.48E-01
GO:0061309	cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309)	9	3	.53	+	5.68	2.57E-02	2.48E-01
GO:0014894	response to denervation involved in regulation of muscle adaptation (GO:0014894)	9	3	.53	+	5.68	2.57E-02	2.48E-01
GO:0014877	response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877)	9	3	.53	+	5.68	2.57E-02	2.48E-01
GO:0014866	skeletal myofibril assembly (GO:0014866)	9	3	.53	+	5.68	2.57E-02	2.48E-01
GO:0045986	negative regulation of smooth muscle contraction (GO:0045986)	15	5	.88	+	5.68	4.01E-03	6.31E-02
GO:0003214	cardiac left ventricle morphogenesis (GO:0003214)	15	5	.88	+	5.68	4.01E-03	6.30E-02
GO:0045763	negative regulation of cellular amino acid metabolic process (GO:0045763)	3	1	.18	+	5.68	2.04E-01	7.77E-01
GO:1903279	regulation of calcium:sodium antiporter activity (GO:1903279)	3	1	.18	+	5.68	2.04E-01	7.77E-01
GO:0021747	cochlear nucleus development (GO:0021747)	3	1	.18	+	5.68	2.04E-01	7.76E-01
GO:1903226	positive regulation of endodermal cell differentiation (GO:1903226)	3	1	.18	+	5.68	2.04E-01	7.76E-01
GO:0007412	axon target recognition (GO:0007412)	3	1	.18	+	5.68	2.04E-01	7.76E-01
GO:0003051	angiotensin-mediated drinking behavior (GO:0003051)	3	1	.18	+	5.68	2.04E-01	7.76E-01
GO:0060435	bronchiole development (GO:0060435)	6	2	.35	+	5.68	6.89E-02	4.59E-01
GO:0006982	response to lipid hydroperoxide (GO:0006982)	3	1	.18	+	5.68	2.04E-01	7.76E-01
GO:0060400	negative regulation of growth hormone receptor signaling pathway (GO:0060400)	3	1	.18	+	5.68	2.04E-01	7.75E-01
GO:0071931	positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931)	3	1	.18	+	5.68	2.04E-01	7.75E-01
GO:0002542	Factor XII activation (GO:0002542)	3	1	.18	+	5.68	2.04E-01	7.75E-01
GO:1903179	regulation of dopamine biosynthetic process (GO:1903179)	3	1	.18	+	5.68	2.04E-01	7.75E-01
GO:1903115	regulation of actin filament-based movement (GO:1903115)	39	13	2.29	+	5.68	3.69E-06	1.54E-04
GO:0021627	olfactory nerve morphogenesis (GO:0021627)	3	1	.18	+	5.68	2.04E-01	7.75E-01
GO:2000864	regulation of estradiol secretion (GO:2000864)	3	1	.18	+	5.68	2.04E-01	7.75E-01
GO:0060374	mast cell differentiation (GO:0060374)	3	1	.18	+	5.68	2.04E-01	7.74E-01
GO:0060318	definitive erythrocyte differentiation (GO:0060318)	3	1	.18	+	5.68	2.04E-01	7.74E-01
GO:1902645	tertiary alcohol biosynthetic process (GO:1902645)	3	1	.18	+	5.68	2.04E-01	7.74E-01
GO:0060309	elastin catabolic process (GO:0060309)	3	1	.18	+	5.68	2.04E-01	7.74E-01
GO:0006808	regulation of nitrogen utilization (GO:0006808)	3	1	.18	+	5.68	2.04E-01	7.74E-01
GO:0002434	immune complex clearance (GO:0002434)	3	1	.18	+	5.68	2.04E-01	7.73E-01
GO:0010037	response to carbon dioxide (GO:0010037)	3	1	.18	+	5.68	2.04E-01	7.73E-01
GO:0019276	UDP-N-acetylgalactosamine metabolic process (GO:0019276)	3	1	.18	+	5.68	2.04E-01	7.73E-01
GO:0021571	rhombomere 5 development (GO:0021571)	3	1	.18	+	5.68	2.04E-01	7.73E-01
GO:0001999	renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure (GO:0001999)	3	1	.18	+	5.68	2.04E-01	7.73E-01
GO:0001996	positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996)	6	2	.35	+	5.68	6.89E-02	4.59E-01
GO:0021569	rhombomere 3 development (GO:0021569)	3	1	.18	+	5.68	2.04E-01	7.72E-01
GO:0007284	spermatogonial cell division (GO:0007284)	3	1	.18	+	5.68	2.04E-01	7.72E-01
GO:0001969	regulation of activation of membrane attack complex (GO:0001969)	3	1	.18	+	5.68	2.04E-01	7.72E-01
GO:0021538	epithalamus development (GO:0021538)	3	1	.18	+	5.68	2.04E-01	7.72E-01
GO:1903015	regulation of exo-alpha-sialidase activity (GO:1903015)	3	1	.18	+	5.68	2.04E-01	7.72E-01
GO:0021502	neural fold elevation formation (GO:0021502)	3	1	.18	+	5.68	2.04E-01	7.72E-01
GO:0072237	metanephric proximal tubule development (GO:0072237)	3	1	.18	+	5.68	2.04E-01	7.71E-01
GO:0072223	metanephric glomerular mesangium development (GO:0072223)	3	1	.18	+	5.68	2.04E-01	7.71E-01
GO:0110077	vesicle-mediated intercellular transport (GO:0110077)	3	1	.18	+	5.68	2.04E-01	7.71E-01
GO:0110024	positive regulation of cardiac muscle myoblast proliferation (GO:0110024)	3	1	.18	+	5.68	2.04E-01	7.71E-01
GO:0110022	regulation of cardiac muscle myoblast proliferation (GO:0110022)	3	1	.18	+	5.68	2.04E-01	7.71E-01
GO:2001170	negative regulation of ATP biosynthetic process (GO:2001170)	3	1	.18	+	5.68	2.04E-01	7.70E-01
GO:0033484	nitric oxide homeostasis (GO:0033484)	3	1	.18	+	5.68	2.04E-01	7.70E-01
GO:0007181	transforming growth factor beta receptor complex assembly (GO:0007181)	3	1	.18	+	5.68	2.04E-01	7.70E-01
GO:0072199	regulation of mesenchymal cell proliferation involved in ureter development (GO:0072199)	3	1	.18	+	5.68	2.04E-01	7.70E-01
GO:0072193	ureter smooth muscle cell differentiation (GO:0072193)	3	1	.18	+	5.68	2.04E-01	7.70E-01
GO:0072191	ureter smooth muscle development (GO:0072191)	3	1	.18	+	5.68	2.04E-01	7.69E-01
GO:2000676	positive regulation of type B pancreatic cell apoptotic process (GO:2000676)	3	1	.18	+	5.68	2.04E-01	7.69E-01
GO:0001828	inner cell mass cellular morphogenesis (GO:0001828)	3	1	.18	+	5.68	2.04E-01	7.69E-01
GO:1902499	positive regulation of protein autoubiquitination (GO:1902499)	3	1	.18	+	5.68	2.04E-01	7.69E-01
GO:0007100	mitotic centrosome separation (GO:0007100)	6	2	.35	+	5.68	6.89E-02	4.59E-01
GO:0060160	negative regulation of dopamine receptor signaling pathway (GO:0060160)	3	1	.18	+	5.68	2.04E-01	7.69E-01
GO:2000635	negative regulation of primary miRNA processing (GO:2000635)	3	1	.18	+	5.68	2.04E-01	7.69E-01
GO:2000634	regulation of primary miRNA processing (GO:2000634)	3	1	.18	+	5.68	2.04E-01	7.68E-01
GO:0032954	regulation of cytokinetic process (GO:0032954)	3	1	.18	+	5.68	2.04E-01	7.68E-01
GO:0072104	glomerular capillary formation (GO:0072104)	6	2	.35	+	5.68	6.89E-02	4.58E-01
GO:0072103	glomerulus vasculature morphogenesis (GO:0072103)	6	2	.35	+	5.68	6.89E-02	4.58E-01
GO:0060128	corticotropin hormone secreting cell differentiation (GO:0060128)	3	1	.18	+	5.68	2.04E-01	7.68E-01
GO:0071688	striated muscle myosin thick filament assembly (GO:0071688)	3	1	.18	+	5.68	2.04E-01	7.68E-01
GO:0071672	negative regulation of smooth muscle cell chemotaxis (GO:0071672)	3	1	.18	+	5.68	2.04E-01	7.68E-01
GO:0006600	creatine metabolic process (GO:0006600)	3	1	.18	+	5.68	2.04E-01	7.67E-01
GO:1990927	calcium ion regulated lysosome exocytosis (GO:1990927)	3	1	.18	+	5.68	2.04E-01	7.67E-01
GO:0033387	putrescine biosynthetic process from ornithine (GO:0033387)	3	1	.18	+	5.68	2.04E-01	7.67E-01
GO:1990918	double-strand break repair involved in meiotic recombination (GO:1990918)	6	2	.35	+	5.68	6.89E-02	4.58E-01
GO:2001055	positive regulation of mesenchymal cell apoptotic process (GO:2001055)	3	1	.18	+	5.68	2.04E-01	7.67E-01
GO:2001016	positive regulation of skeletal muscle cell differentiation (GO:2001016)	6	2	.35	+	5.68	6.89E-02	4.58E-01
GO:0001798	positive regulation of type IIa hypersensitivity (GO:0001798)	3	1	.18	+	5.68	2.04E-01	7.67E-01
GO:0033326	cerebrospinal fluid secretion (GO:0033326)	3	1	.18	+	5.68	2.04E-01	7.67E-01
GO:0140576	ascorbate homeostasis (GO:0140576)	3	1	.18	+	5.68	2.04E-01	7.66E-01
GO:0072092	ureteric bud invasion (GO:0072092)	3	1	.18	+	5.68	2.04E-01	7.66E-01
GO:0044868	modulation by host of viral molecular function (GO:0044868)	3	1	.18	+	5.68	2.04E-01	7.66E-01
GO:0060086	circadian temperature homeostasis (GO:0060086)	3	1	.18	+	5.68	2.04E-01	7.66E-01
GO:2000547	regulation of dendritic cell dendrite assembly (GO:2000547)	3	1	.18	+	5.68	2.04E-01	7.66E-01
GO:0038172	interleukin-33-mediated signaling pathway (GO:0038172)	3	1	.18	+	5.68	2.04E-01	7.65E-01
GO:0044837	actomyosin contractile ring organization (GO:0044837)	6	2	.35	+	5.68	6.89E-02	4.58E-01
GO:0072008	glomerular mesangial cell differentiation (GO:0072008)	6	2	.35	+	5.68	6.89E-02	4.57E-01
GO:0038109	Kit signaling pathway (GO:0038109)	3	1	.18	+	5.68	2.04E-01	7.65E-01
GO:0002157	positive regulation of thyroid hormone mediated signaling pathway (GO:0002157)	3	1	.18	+	5.68	2.04E-01	7.65E-01
GO:0002154	thyroid hormone mediated signaling pathway (GO:0002154)	3	1	.18	+	5.68	2.04E-01	7.65E-01
GO:0071514	genomic imprinting (GO:0071514)	6	2	.35	+	5.68	6.89E-02	4.57E-01
GO:0045200	establishment of neuroblast polarity (GO:0045200)	3	1	.18	+	5.68	2.04E-01	7.65E-01
GO:0001661	conditioned taste aversion (GO:0001661)	3	1	.18	+	5.68	2.04E-01	7.65E-01
GO:2000481	positive regulation of cAMP-dependent protein kinase activity (GO:2000481)	6	2	.35	+	5.68	6.89E-02	4.57E-01
GO:2000474	regulation of opioid receptor signaling pathway (GO:2000474)	3	1	.18	+	5.68	2.04E-01	7.64E-01
GO:0038098	sequestering of BMP from receptor via BMP binding (GO:0038098)	3	1	.18	+	5.68	2.04E-01	7.64E-01
GO:0038091	positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091)	3	1	.18	+	5.68	2.04E-01	7.64E-01
GO:0038086	VEGF-activated platelet-derived growth factor receptor signaling pathway (GO:0038086)	3	1	.18	+	5.68	2.04E-01	7.64E-01
GO:2000446	regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446)	3	1	.18	+	5.68	2.04E-01	7.64E-01
GO:2000405	negative regulation of T cell migration (GO:2000405)	6	2	.35	+	5.68	6.89E-02	4.57E-01
GO:1902232	regulation of positive thymic T cell selection (GO:1902232)	3	1	.18	+	5.68	2.04E-01	7.63E-01
GO:0038016	insulin receptor internalization (GO:0038016)	3	1	.18	+	5.68	2.04E-01	7.63E-01
GO:0071485	cellular response to absence of light (GO:0071485)	3	1	.18	+	5.68	2.04E-01	7.63E-01
GO:0051891	positive regulation of cardioblast differentiation (GO:0051891)	6	2	.35	+	5.68	6.89E-02	4.57E-01
GO:0014043	negative regulation of neuron maturation (GO:0014043)	3	1	.18	+	5.68	2.04E-01	7.63E-01
GO:0014042	positive regulation of neuron maturation (GO:0014042)	3	1	.18	+	5.68	2.04E-01	7.63E-01
GO:0014034	neural crest cell fate commitment (GO:0014034)	6	2	.35	+	5.68	6.89E-02	4.56E-01
GO:0051866	general adaptation syndrome (GO:0051866)	3	1	.18	+	5.68	2.04E-01	7.63E-01
GO:0045196	establishment or maintenance of neuroblast polarity (GO:0045196)	3	1	.18	+	5.68	2.04E-01	7.62E-01
GO:0002025	norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002025)	3	1	.18	+	5.68	2.04E-01	7.62E-01
GO:0045162	clustering of voltage-gated sodium channels (GO:0045162)	6	2	.35	+	5.68	6.89E-02	4.56E-01
GO:0002018	renin-angiotensin regulation of aldosterone production (GO:0002018)	3	1	.18	+	5.68	2.04E-01	7.62E-01
GO:0002001	renin secretion into blood stream (GO:0002001)	3	1	.18	+	5.68	2.04E-01	7.62E-01
GO:0140367	antibacterial innate immune response (GO:0140367)	3	1	.18	+	5.68	2.04E-01	7.62E-01
GO:2000367	regulation of acrosomal vesicle exocytosis (GO:2000367)	3	1	.18	+	5.68	2.04E-01	7.61E-01
GO:2000348	regulation of CD40 signaling pathway (GO:2000348)	6	2	.35	+	5.68	6.89E-02	4.56E-01
GO:2000323	negative regulation of glucocorticoid receptor signaling pathway (GO:2000323)	6	2	.35	+	5.68	6.89E-02	4.56E-01
GO:0071373	cellular response to luteinizing hormone stimulus (GO:0071373)	6	2	.35	+	5.68	6.89E-02	4.56E-01
GO:1902103	negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103)	3	1	.18	+	5.68	2.04E-01	7.61E-01
GO:0071332	cellular response to fructose stimulus (GO:0071332)	3	1	.18	+	5.68	2.04E-01	7.61E-01
GO:1990637	response to prolactin (GO:1990637)	3	1	.18	+	5.68	2.04E-01	7.61E-01
GO:1990603	dark adaptation (GO:1990603)	3	1	.18	+	5.68	2.04E-01	7.61E-01
GO:0045023	G0 to G1 transition (GO:0045023)	3	1	.18	+	5.68	2.04E-01	7.61E-01
GO:1901624	negative regulation of lymphocyte chemotaxis (GO:1901624)	3	1	.18	+	5.68	2.04E-01	7.60E-01
GO:2000299	negative regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000299)	3	1	.18	+	5.68	2.04E-01	7.60E-01
GO:2000298	regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298)	6	2	.35	+	5.68	6.89E-02	4.55E-01
GO:2000295	regulation of hydrogen peroxide catabolic process (GO:2000295)	3	1	.18	+	5.68	2.04E-01	7.60E-01
GO:2000286	receptor internalization involved in canonical Wnt signaling pathway (GO:2000286)	3	1	.18	+	5.68	2.04E-01	7.60E-01
GO:2000282	regulation of cellular amino acid biosynthetic process (GO:2000282)	3	1	.18	+	5.68	2.04E-01	7.60E-01
GO:0071288	cellular response to mercury ion (GO:0071288)	3	1	.18	+	5.68	2.04E-01	7.59E-01
GO:0051684	maintenance of Golgi location (GO:0051684)	3	1	.18	+	5.68	2.04E-01	7.59E-01
GO:1990523	bone regeneration (GO:1990523)	3	1	.18	+	5.68	2.04E-01	7.59E-01
GO:0051615	histamine uptake (GO:0051615)	3	1	.18	+	5.68	2.04E-01	7.59E-01
GO:2000195	negative regulation of female gonad development (GO:2000195)	3	1	.18	+	5.68	2.04E-01	7.59E-01
GO:2000182	regulation of progesterone biosynthetic process (GO:2000182)	3	1	.18	+	5.68	2.04E-01	7.59E-01
GO:0032487	regulation of Rap protein signal transduction (GO:0032487)	3	1	.18	+	5.68	2.04E-01	7.58E-01
GO:0099557	trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission (GO:0099557)	3	1	.18	+	5.68	2.04E-01	7.58E-01
GO:2000124	regulation of endocannabinoid signaling pathway (GO:2000124)	3	1	.18	+	5.68	2.04E-01	7.58E-01
GO:2000111	positive regulation of macrophage apoptotic process (GO:2000111)	3	1	.18	+	5.68	2.04E-01	7.58E-01
GO:0051598	meiotic recombination checkpoint signaling (GO:0051598)	3	1	.18	+	5.68	2.04E-01	7.58E-01
GO:0043970	histone H3-K9 acetylation (GO:0043970)	3	1	.18	+	5.68	2.04E-01	7.57E-01
GO:0071139	resolution of recombination intermediates (GO:0071139)	6	2	.35	+	5.68	6.89E-02	4.55E-01
GO:1990428	miRNA transport (GO:1990428)	3	1	.18	+	5.68	2.04E-01	7.57E-01
GO:0090292	nuclear matrix anchoring at nuclear membrane (GO:0090292)	3	1	.18	+	5.68	2.04E-01	7.57E-01
GO:1990408	calcitonin gene-related peptide receptor signaling pathway (GO:1990408)	3	1	.18	+	5.68	2.04E-01	7.57E-01
GO:1990402	embryonic liver development (GO:1990402)	3	1	.18	+	5.68	2.04E-01	7.57E-01
GO:0090245	axis elongation involved in somitogenesis (GO:0090245)	3	1	.18	+	5.68	2.04E-01	7.57E-01
GO:0048755	branching morphogenesis of a nerve (GO:0048755)	6	2	.35	+	5.68	6.89E-02	4.55E-01
GO:0032342	aldosterone biosynthetic process (GO:0032342)	3	1	.18	+	5.68	2.04E-01	7.56E-01
GO:1905786	positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786)	3	1	.18	+	5.68	2.04E-01	7.56E-01
GO:1905771	negative regulation of mesodermal cell differentiation (GO:1905771)	3	1	.18	+	5.68	2.04E-01	7.56E-01
GO:0098911	regulation of ventricular cardiac muscle cell action potential (GO:0098911)	12	4	.70	+	5.68	1.00E-02	1.27E-01
GO:0098904	regulation of AV node cell action potential (GO:0098904)	3	1	.18	+	5.68	2.04E-01	7.56E-01
GO:0048669	collateral sprouting in absence of injury (GO:0048669)	3	1	.18	+	5.68	2.04E-01	7.56E-01
GO:0048625	myoblast fate commitment (GO:0048625)	6	2	.35	+	5.68	6.89E-02	4.55E-01
GO:0032238	adenosine transport (GO:0032238)	3	1	.18	+	5.68	2.04E-01	7.55E-01
GO:0051320	S phase (GO:0051320)	6	2	.35	+	5.68	6.89E-02	4.55E-01
GO:1901256	regulation of macrophage colony-stimulating factor production (GO:1901256)	6	2	.35	+	5.68	6.89E-02	4.55E-01
GO:0090075	relaxation of muscle (GO:0090075)	24	8	1.41	+	5.68	2.79E-04	6.65E-03
GO:0090042	tubulin deacetylation (GO:0090042)	3	1	.18	+	5.68	2.04E-01	7.55E-01
GO:0090027	negative regulation of monocyte chemotaxis (GO:0090027)	6	2	.35	+	5.68	6.89E-02	4.54E-01
GO:0070447	positive regulation of oligodendrocyte progenitor proliferation (GO:0070447)	3	1	.18	+	5.68	2.04E-01	7.55E-01
GO:0120253	hydrocarbon catabolic process (GO:0120253)	3	1	.18	+	5.68	2.04E-01	7.55E-01
GO:0098759	cellular response to interleukin-8 (GO:0098759)	3	1	.18	+	5.68	2.04E-01	7.55E-01
GO:0098758	response to interleukin-8 (GO:0098758)	3	1	.18	+	5.68	2.04E-01	7.55E-01
GO:1905532	regulation of leucine import across plasma membrane (GO:1905532)	3	1	.18	+	5.68	2.04E-01	7.54E-01
GO:0098728	germline stem cell asymmetric division (GO:0098728)	3	1	.18	+	5.68	2.04E-01	7.54E-01
GO:0098722	asymmetric stem cell division (GO:0098722)	3	1	.18	+	5.68	2.04E-01	7.54E-01
GO:0070345	negative regulation of fat cell proliferation (GO:0070345)	6	2	.35	+	5.68	6.89E-02	4.54E-01
GO:0070315	G1 to G0 transition involved in cell differentiation (GO:0070315)	6	2	.35	+	5.68	6.89E-02	4.54E-01
GO:0099151	regulation of postsynaptic density assembly (GO:0099151)	12	4	.70	+	5.68	1.00E-02	1.27E-01
GO:1900625	positive regulation of monocyte aggregation (GO:1900625)	3	1	.18	+	5.68	2.04E-01	7.54E-01
GO:1900623	regulation of monocyte aggregation (GO:1900623)	3	1	.18	+	5.68	2.04E-01	7.54E-01
GO:0035993	deltoid tuberosity development (GO:0035993)	3	1	.18	+	5.68	2.04E-01	7.54E-01
GO:0043578	nuclear matrix organization (GO:0043578)	3	1	.18	+	5.68	2.04E-01	7.53E-01
GO:1905462	regulation of DNA duplex unwinding (GO:1905462)	6	2	.35	+	5.68	6.89E-02	4.54E-01
GO:1905460	negative regulation of vascular associated smooth muscle cell apoptotic process (GO:1905460)	3	1	.18	+	5.68	2.04E-01	7.53E-01
GO:0051136	regulation of NK T cell differentiation (GO:0051136)	6	2	.35	+	5.68	6.89E-02	4.54E-01
GO:0009646	response to absence of light (GO:0009646)	3	1	.18	+	5.68	2.04E-01	7.53E-01
GO:0050689	negative regulation of defense response to virus by host (GO:0050689)	3	1	.18	+	5.68	2.04E-01	7.53E-01
GO:0048370	lateral mesoderm formation (GO:0048370)	3	1	.18	+	5.68	2.04E-01	7.53E-01
GO:0048369	lateral mesoderm morphogenesis (GO:0048369)	3	1	.18	+	5.68	2.04E-01	7.52E-01
GO:0070236	negative regulation of activation-induced cell death of T cells (GO:0070236)	3	1	.18	+	5.68	2.04E-01	7.52E-01
GO:1904958	positive regulation of midbrain dopaminergic neuron differentiation (GO:1904958)	3	1	.18	+	5.68	2.04E-01	7.52E-01
GO:0035880	embryonic nail plate morphogenesis (GO:0035880)	3	1	.18	+	5.68	2.04E-01	7.52E-01
GO:0098596	imitative learning (GO:0098596)	6	2	.35	+	5.68	6.89E-02	4.53E-01
GO:0035846	oviduct epithelium development (GO:0035846)	3	1	.18	+	5.68	2.04E-01	7.52E-01
GO:1905337	positive regulation of aggrephagy (GO:1905337)	3	1	.18	+	5.68	2.04E-01	7.52E-01
GO:1905335	regulation of aggrephagy (GO:1905335)	3	1	.18	+	5.68	2.04E-01	7.51E-01
GO:0035812	renal sodium excretion (GO:0035812)	3	1	.18	+	5.68	2.04E-01	7.51E-01
GO:0043420	anthranilate metabolic process (GO:0043420)	3	1	.18	+	5.68	2.04E-01	7.51E-01
GO:0098528	skeletal muscle fiber differentiation (GO:0098528)	3	1	.18	+	5.68	2.04E-01	7.51E-01
GO:0030997	regulation of centriole-centriole cohesion (GO:0030997)	3	1	.18	+	5.68	2.04E-01	7.51E-01
GO:0030950	establishment or maintenance of actin cytoskeleton polarity (GO:0030950)	3	1	.18	+	5.68	2.04E-01	7.51E-01
GO:0036216	cellular response to stem cell factor stimulus (GO:0036216)	3	1	.18	+	5.68	2.04E-01	7.50E-01
GO:0036215	response to stem cell factor (GO:0036215)	3	1	.18	+	5.68	2.04E-01	7.50E-01
GO:0035754	B cell chemotaxis (GO:0035754)	6	2	.35	+	5.68	6.89E-02	4.53E-01
GO:1905242	response to 3,3',5-triiodo-L-thyronine (GO:1905242)	3	1	.18	+	5.68	2.04E-01	7.50E-01
GO:0043318	negative regulation of cytotoxic T cell degranulation (GO:0043318)	3	1	.18	+	5.68	2.04E-01	7.50E-01
GO:0043317	regulation of cytotoxic T cell degranulation (GO:0043317)	3	1	.18	+	5.68	2.04E-01	7.50E-01
GO:0009441	glycolate metabolic process (GO:0009441)	3	1	.18	+	5.68	2.04E-01	7.49E-01
GO:1904783	positive regulation of NMDA glutamate receptor activity (GO:1904783)	6	2	.35	+	5.68	6.89E-02	4.53E-01
GO:0048170	positive regulation of long-term neuronal synaptic plasticity (GO:0048170)	6	2	.35	+	5.68	6.89E-02	4.53E-01
GO:0048133	male germ-line stem cell asymmetric division (GO:0048133)	3	1	.18	+	5.68	2.04E-01	7.49E-01
GO:1904715	negative regulation of chaperone-mediated autophagy (GO:1904715)	3	1	.18	+	5.68	2.04E-01	7.49E-01
GO:0036135	Schwann cell migration (GO:0036135)	3	1	.18	+	5.68	2.04E-01	7.49E-01
GO:0035684	helper T cell extravasation (GO:0035684)	3	1	.18	+	5.68	2.04E-01	7.49E-01
GO:1905162	regulation of phagosome maturation (GO:1905162)	3	1	.18	+	5.68	2.04E-01	7.49E-01
GO:1905133	negative regulation of meiotic chromosome separation (GO:1905133)	3	1	.18	+	5.68	2.04E-01	7.48E-01
GO:1904691	negative regulation of type B pancreatic cell proliferation (GO:1904691)	3	1	.18	+	5.68	2.04E-01	7.48E-01
GO:1904612	response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904612)	3	1	.18	+	5.68	2.04E-01	7.48E-01
GO:1900239	regulation of phenotypic switching (GO:1900239)	3	1	.18	+	5.68	2.04E-01	7.48E-01
GO:0036018	cellular response to erythropoietin (GO:0036018)	6	2	.35	+	5.68	6.89E-02	4.53E-01
GO:0000084	mitotic S phase (GO:0000084)	6	2	.35	+	5.68	6.89E-02	4.52E-01
GO:0043111	replication fork arrest (GO:0043111)	3	1	.18	+	5.68	2.04E-01	7.48E-01
GO:1904582	positive regulation of intracellular mRNA localization (GO:1904582)	3	1	.18	+	5.68	2.04E-01	7.48E-01
GO:0042662	negative regulation of mesodermal cell fate specification (GO:0042662)	3	1	.18	+	5.68	2.04E-01	7.47E-01
GO:1900195	positive regulation of oocyte maturation (GO:1900195)	3	1	.18	+	5.68	2.04E-01	7.47E-01
GO:1900168	positive regulation of glial cell-derived neurotrophic factor production (GO:1900168)	3	1	.18	+	5.68	2.04E-01	7.47E-01
GO:1900166	regulation of glial cell-derived neurotrophic factor production (GO:1900166)	3	1	.18	+	5.68	2.04E-01	7.47E-01
GO:1900148	negative regulation of Schwann cell migration (GO:1900148)	3	1	.18	+	5.68	2.04E-01	7.47E-01
GO:1900106	positive regulation of hyaluranon cable assembly (GO:1900106)	3	1	.18	+	5.68	2.04E-01	7.46E-01
GO:1900104	regulation of hyaluranon cable assembly (GO:1900104)	3	1	.18	+	5.68	2.04E-01	7.46E-01
GO:0061740	protein targeting to lysosome involved in chaperone-mediated autophagy (GO:0061740)	3	1	.18	+	5.68	2.04E-01	7.46E-01
GO:0015878	biotin transport (GO:0015878)	3	1	.18	+	5.68	2.04E-01	7.46E-01
GO:0086101	endothelin receptor signaling pathway involved in heart process (GO:0086101)	3	1	.18	+	5.68	2.04E-01	7.46E-01
GO:1900075	positive regulation of neuromuscular synaptic transmission (GO:1900075)	3	1	.18	+	5.68	2.04E-01	7.46E-01
GO:1900073	regulation of neuromuscular synaptic transmission (GO:1900073)	3	1	.18	+	5.68	2.04E-01	7.45E-01
GO:1904425	negative regulation of GTP binding (GO:1904425)	3	1	.18	+	5.68	2.04E-01	7.45E-01
GO:0008627	intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627)	3	1	.18	+	5.68	2.04E-01	7.45E-01
GO:0030505	inorganic diphosphate transport (GO:0030505)	3	1	.18	+	5.68	2.04E-01	7.45E-01
GO:1903984	positive regulation of TRAIL-activated apoptotic signaling pathway (GO:1903984)	3	1	.18	+	5.68	2.04E-01	7.45E-01
GO:1903976	negative regulation of glial cell migration (GO:1903976)	6	2	.35	+	5.68	6.89E-02	4.52E-01
GO:1903964	monounsaturated fatty acid metabolic process (GO:1903964)	3	1	.18	+	5.68	2.04E-01	7.45E-01
GO:0035377	transepithelial water transport (GO:0035377)	3	1	.18	+	5.68	2.04E-01	7.44E-01
GO:0086098	angiotensin-activated signaling pathway involved in heart process (GO:0086098)	3	1	.18	+	5.68	2.04E-01	7.44E-01
GO:0086048	membrane depolarization during bundle of His cell action potential (GO:0086048)	3	1	.18	+	5.68	2.04E-01	7.44E-01
GO:0086047	membrane depolarization during Purkinje myocyte cell action potential (GO:0086047)	3	1	.18	+	5.68	2.04E-01	7.44E-01
GO:0046881	positive regulation of follicle-stimulating hormone secretion (GO:0046881)	6	2	.35	+	5.68	6.89E-02	4.52E-01
GO:0046880	regulation of follicle-stimulating hormone secretion (GO:0046880)	6	2	.35	+	5.68	6.89E-02	4.52E-01
GO:0086019	cell-cell signaling involved in cardiac conduction (GO:0086019)	27	9	1.59	+	5.68	1.16E-04	3.22E-03
GO:0086017	Purkinje myocyte action potential (GO:0086017)	3	1	.18	+	5.68	2.04E-01	7.44E-01
GO:0086004	regulation of cardiac muscle cell contraction (GO:0086004)	33	11	1.94	+	5.68	2.06E-05	7.06E-04
GO:0042482	positive regulation of odontogenesis (GO:0042482)	6	2	.35	+	5.68	6.89E-02	4.52E-01
GO:0010899	regulation of phosphatidylcholine catabolic process (GO:0010899)	3	1	.18	+	5.68	2.04E-01	7.44E-01
GO:1904349	positive regulation of small intestine smooth muscle contraction (GO:1904349)	3	1	.18	+	5.68	2.04E-01	7.43E-01
GO:1904347	regulation of small intestine smooth muscle contraction (GO:1904347)	3	1	.18	+	5.68	2.04E-01	7.43E-01
GO:0030451	regulation of complement activation, alternative pathway (GO:0030451)	6	2	.35	+	5.68	6.89E-02	4.51E-01
GO:0016116	carotenoid metabolic process (GO:0016116)	3	1	.18	+	5.68	2.04E-01	7.43E-01
GO:0016108	tetraterpenoid metabolic process (GO:0016108)	3	1	.18	+	5.68	2.04E-01	7.43E-01
GO:0035284	brain segmentation (GO:0035284)	3	1	.18	+	5.68	2.04E-01	7.43E-01
GO:0150064	vertebrate eye-specific patterning (GO:0150064)	3	1	.18	+	5.68	2.04E-01	7.43E-01
GO:1904289	regulation of mitotic DNA damage checkpoint (GO:1904289)	3	1	.18	+	5.68	2.04E-01	7.42E-01
GO:0097477	lateral motor column neuron migration (GO:0097477)	3	1	.18	+	5.68	2.04E-01	7.42E-01
GO:1904237	positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)	3	1	.18	+	5.68	2.04E-01	7.42E-01
GO:1904235	regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)	3	1	.18	+	5.68	2.04E-01	7.42E-01
GO:0010753	positive regulation of cGMP-mediated signaling (GO:0010753)	6	2	.35	+	5.68	6.89E-02	4.51E-01
GO:0010751	negative regulation of nitric oxide mediated signal transduction (GO:0010751)	3	1	.18	+	5.68	2.04E-01	7.42E-01
GO:0097402	neuroblast migration (GO:0097402)	3	1	.18	+	5.68	2.04E-01	7.41E-01
GO:0010730	negative regulation of hydrogen peroxide biosynthetic process (GO:0010730)	3	1	.18	+	5.68	2.04E-01	7.41E-01
GO:0061470	T follicular helper cell differentiation (GO:0061470)	6	2	.35	+	5.68	6.89E-02	4.51E-01
GO:1903765	negative regulation of potassium ion export across plasma membrane (GO:1903765)	3	1	.18	+	5.68	2.04E-01	7.41E-01
GO:0060988	lipid tube assembly (GO:0060988)	3	1	.18	+	5.68	2.04E-01	7.41E-01
GO:0042297	vocal learning (GO:0042297)	6	2	.35	+	5.68	6.89E-02	4.51E-01
GO:0060927	cardiac pacemaker cell fate commitment (GO:0060927)	3	1	.18	+	5.68	2.04E-01	7.41E-01
GO:1904180	negative regulation of membrane depolarization (GO:1904180)	6	2	.35	+	5.68	6.89E-02	4.51E-01
GO:0034651	cortisol biosynthetic process (GO:0034651)	3	1	.18	+	5.68	2.04E-01	7.41E-01
GO:0097368	establishment of Sertoli cell barrier (GO:0097368)	3	1	.18	+	5.68	2.04E-01	7.40E-01
GO:0010694	positive regulation of alkaline phosphatase activity (GO:0010694)	6	2	.35	+	5.68	6.89E-02	4.51E-01
GO:0042214	terpene metabolic process (GO:0042214)	3	1	.18	+	5.68	2.04E-01	7.40E-01
GO:0030241	skeletal muscle myosin thick filament assembly (GO:0030241)	3	1	.18	+	5.68	2.04E-01	7.40E-01
GO:0030240	skeletal muscle thin filament assembly (GO:0030240)	6	2	.35	+	5.68	6.89E-02	4.50E-01
GO:0010650	positive regulation of cell communication by electrical coupling (GO:0010650)	3	1	.18	+	5.68	2.04E-01	7.40E-01
GO:0030207	chondroitin sulfate catabolic process (GO:0030207)	3	1	.18	+	5.68	2.04E-01	7.40E-01
GO:0019860	uracil metabolic process (GO:0019860)	3	1	.18	+	5.68	2.04E-01	7.40E-01
GO:1903625	negative regulation of DNA catabolic process (GO:1903625)	3	1	.18	+	5.68	2.04E-01	7.39E-01
GO:0019805	quinolinate biosynthetic process (GO:0019805)	3	1	.18	+	5.68	2.04E-01	7.39E-01
GO:0019800	peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800)	6	2	.35	+	5.68	6.89E-02	4.50E-01
GO:0003430	growth plate cartilage chondrocyte growth (GO:0003430)	3	1	.18	+	5.68	2.04E-01	7.39E-01
GO:0097278	complement-dependent cytotoxicity (GO:0097278)	3	1	.18	+	5.68	2.04E-01	7.39E-01
GO:0097274	urea homeostasis (GO:0097274)	3	1	.18	+	5.68	2.04E-01	7.39E-01
GO:1904054	regulation of cholangiocyte proliferation (GO:1904054)	3	1	.18	+	5.68	2.04E-01	7.39E-01
GO:1904017	cellular response to Thyroglobulin triiodothyronine (GO:1904017)	3	1	.18	+	5.68	2.04E-01	7.38E-01
GO:0008212	mineralocorticoid metabolic process (GO:0008212)	6	2	.35	+	5.68	6.89E-02	4.50E-01
GO:0003365	establishment of cell polarity involved in ameboidal cell migration (GO:0003365)	3	1	.18	+	5.68	2.04E-01	7.38E-01
GO:0003335	corneocyte development (GO:0003335)	3	1	.18	+	5.68	2.04E-01	7.38E-01
GO:0060748	tertiary branching involved in mammary gland duct morphogenesis (GO:0060748)	3	1	.18	+	5.68	2.04E-01	7.38E-01
GO:0060741	prostate gland stromal morphogenesis (GO:0060741)	3	1	.18	+	5.68	2.04E-01	7.38E-01
GO:0060718	chorionic trophoblast cell differentiation (GO:0060718)	6	2	.35	+	5.68	6.89E-02	4.50E-01
GO:0042078	germ-line stem cell division (GO:0042078)	3	1	.18	+	5.68	2.04E-01	7.38E-01
GO:0034447	very-low-density lipoprotein particle clearance (GO:0034447)	3	1	.18	+	5.68	2.04E-01	7.37E-01
GO:0002894	positive regulation of type II hypersensitivity (GO:0002894)	3	1	.18	+	5.68	2.04E-01	7.37E-01
GO:0097155	fasciculation of sensory neuron axon (GO:0097155)	3	1	.18	+	5.68	2.04E-01	7.37E-01
GO:0061196	fungiform papilla development (GO:0061196)	6	2	.35	+	5.68	6.89E-02	4.50E-01
GO:0045932	negative regulation of muscle contraction (GO:0045932)	24	8	1.41	+	5.68	2.79E-04	6.64E-03
GO:0021986	habenula development (GO:0021986)	3	1	.18	+	5.68	2.04E-01	7.37E-01
GO:0021965	spinal cord ventral commissure morphogenesis (GO:0021965)	3	1	.18	+	5.68	2.04E-01	7.37E-01
GO:1903416	response to glycoside (GO:1903416)	6	2	.35	+	5.68	6.89E-02	4.49E-01
GO:1903412	response to bile acid (GO:1903412)	6	2	.35	+	5.68	6.89E-02	4.49E-01
GO:0007619	courtship behavior (GO:0007619)	3	1	.18	+	5.68	2.04E-01	7.37E-01
GO:1902996	regulation of neurofibrillary tangle assembly (GO:1902996)	3	1	.18	+	5.68	2.04E-01	7.36E-01
GO:1902990	mitotic telomere maintenance via semi-conservative replication (GO:1902990)	3	1	.18	+	5.68	2.04E-01	7.36E-01
GO:0003221	right ventricular cardiac muscle tissue morphogenesis (GO:0003221)	3	1	.18	+	5.68	2.04E-01	7.36E-01
GO:1902960	negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960)	3	1	.18	+	5.68	2.04E-01	7.36E-01
GO:0097050	type B pancreatic cell apoptotic process (GO:0097050)	3	1	.18	+	5.68	2.04E-01	7.36E-01
GO:0061046	regulation of branching involved in lung morphogenesis (GO:0061046)	6	2	.35	+	5.68	6.89E-02	4.49E-01
GO:0061033	secretion by lung epithelial cell involved in lung growth (GO:0061033)	3	1	.18	+	5.68	2.04E-01	7.36E-01
GO:0021856	hypothalamic tangential migration using cell-axon interactions (GO:0021856)	6	2	.35	+	5.68	6.89E-02	4.49E-01
GO:1903335	regulation of vacuolar transport (GO:1903335)	3	1	.18	+	5.68	2.04E-01	7.35E-01
GO:0021828	gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828)	6	2	.35	+	5.68	6.89E-02	4.49E-01
GO:0003192	mitral valve formation (GO:0003192)	3	1	.18	+	5.68	2.04E-01	7.35E-01
GO:0021800	cerebral cortex tangential migration (GO:0021800)	6	2	.35	+	5.68	6.89E-02	4.48E-01
GO:0003167	atrioventricular bundle cell differentiation (GO:0003167)	3	1	.18	+	5.68	2.04E-01	7.35E-01
GO:0003166	bundle of His development (GO:0003166)	6	2	.35	+	5.68	6.89E-02	4.48E-01
GO:0007500	mesodermal cell fate determination (GO:0007500)	3	1	.18	+	5.68	2.04E-01	7.35E-01
GO:0003138	primary heart field specification (GO:0003138)	3	1	.18	+	5.68	2.04E-01	7.35E-01
GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527)	6	2	.35	+	5.68	6.89E-02	4.48E-01
GO:0060526	prostate glandular acinus morphogenesis (GO:0060526)	6	2	.35	+	5.68	6.89E-02	4.48E-01
GO:0060523	prostate epithelial cord elongation (GO:0060523)	3	1	.18	+	5.68	2.04E-01	7.35E-01
GO:0003104	positive regulation of glomerular filtration (GO:0003104)	3	1	.18	+	5.68	2.04E-01	7.34E-01
GO:0060510	type II pneumocyte differentiation (GO:0060510)	6	2	.35	+	5.68	6.89E-02	4.48E-01
GO:1902822	regulation of late endosome to lysosome transport (GO:1902822)	3	1	.18	+	5.68	2.04E-01	7.34E-01
GO:1902811	positive regulation of skeletal muscle fiber differentiation (GO:1902811)	3	1	.18	+	5.68	2.04E-01	7.34E-01
GO:0060306	regulation of membrane repolarization (GO:0060306)	34	11	2.00	+	5.51	2.59E-05	8.65E-04
GO:0044839	cell cycle G2/M phase transition (GO:0044839)	62	20	3.64	+	5.49	1.50E-08	9.38E-07
GO:0007052	mitotic spindle organization (GO:0007052)	97	31	5.70	+	5.44	2.12E-12	2.99E-10
GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)	22	7	1.29	+	5.42	8.43E-04	1.75E-02
GO:0086003	cardiac muscle cell contraction (GO:0086003)	44	14	2.58	+	5.42	2.47E-06	1.05E-04
GO:1903429	regulation of cell maturation (GO:1903429)	22	7	1.29	+	5.42	8.43E-04	1.74E-02
GO:1901978	positive regulation of cell cycle checkpoint (GO:1901978)	19	6	1.12	+	5.38	2.05E-03	3.68E-02
GO:1901970	positive regulation of mitotic sister chromatid separation (GO:1901970)	19	6	1.12	+	5.38	2.05E-03	3.67E-02
GO:2000479	regulation of cAMP-dependent protein kinase activity (GO:2000479)	19	6	1.12	+	5.38	2.05E-03	3.67E-02
GO:0001759	organ induction (GO:0001759)	16	5	.94	+	5.32	5.03E-03	7.61E-02
GO:0051447	negative regulation of meiotic cell cycle (GO:0051447)	16	5	.94	+	5.32	5.03E-03	7.60E-02
GO:0000212	meiotic spindle organization (GO:0000212)	16	5	.94	+	5.32	5.03E-03	7.59E-02
GO:1905209	positive regulation of cardiocyte differentiation (GO:1905209)	16	5	.94	+	5.32	5.03E-03	7.59E-02
GO:0010763	positive regulation of fibroblast migration (GO:0010763)	16	5	.94	+	5.32	5.03E-03	7.58E-02
GO:0010649	regulation of cell communication by electrical coupling (GO:0010649)	16	5	.94	+	5.32	5.03E-03	7.57E-02
GO:0000086	G2/M transition of mitotic cell cycle (GO:0000086)	58	18	3.41	+	5.29	1.27E-07	7.02E-06
GO:0007144	female meiosis I (GO:0007144)	13	4	.76	+	5.24	1.25E-02	1.51E-01
GO:1901894	regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894)	13	4	.76	+	5.24	1.25E-02	1.51E-01
GO:0099623	regulation of cardiac muscle cell membrane repolarization (GO:0099623)	26	8	1.53	+	5.24	4.36E-04	9.77E-03
GO:0090235	regulation of metaphase plate congression (GO:0090235)	13	4	.76	+	5.24	1.25E-02	1.51E-01
GO:1900264	positive regulation of DNA-directed DNA polymerase activity (GO:1900264)	13	4	.76	+	5.24	1.25E-02	1.50E-01
GO:1900262	regulation of DNA-directed DNA polymerase activity (GO:1900262)	13	4	.76	+	5.24	1.25E-02	1.50E-01
GO:0008608	attachment of spindle microtubules to kinetochore (GO:0008608)	26	8	1.53	+	5.24	4.36E-04	9.76E-03
GO:0035313	wound healing, spreading of epidermal cells (GO:0035313)	13	4	.76	+	5.24	1.25E-02	1.50E-01
GO:1902947	regulation of tau-protein kinase activity (GO:1902947)	13	4	.76	+	5.24	1.25E-02	1.50E-01
GO:0046058	cAMP metabolic process (GO:0046058)	23	7	1.35	+	5.18	1.05E-03	2.10E-02
GO:0033622	integrin activation (GO:0033622)	10	3	.59	+	5.11	3.20E-02	2.83E-01
GO:0021610	facial nerve morphogenesis (GO:0021610)	10	3	.59	+	5.11	3.20E-02	2.83E-01
GO:0021561	facial nerve development (GO:0021561)	10	3	.59	+	5.11	3.20E-02	2.83E-01
GO:0001867	complement activation, lectin pathway (GO:0001867)	10	3	.59	+	5.11	3.20E-02	2.83E-01
GO:1902412	regulation of mitotic cytokinesis (GO:1902412)	10	3	.59	+	5.11	3.20E-02	2.83E-01
GO:2001014	regulation of skeletal muscle cell differentiation (GO:2001014)	20	6	1.17	+	5.11	2.54E-03	4.37E-02
GO:0033314	mitotic DNA replication checkpoint signaling (GO:0033314)	10	3	.59	+	5.11	3.20E-02	2.82E-01
GO:0001553	luteinization (GO:0001553)	10	3	.59	+	5.11	3.20E-02	2.82E-01
GO:0071374	cellular response to parathyroid hormone stimulus (GO:0071374)	10	3	.59	+	5.11	3.20E-02	2.82E-01
GO:0048865	stem cell fate commitment (GO:0048865)	10	3	.59	+	5.11	3.20E-02	2.82E-01
GO:0006171	cAMP biosynthetic process (GO:0006171)	10	3	.59	+	5.11	3.20E-02	2.82E-01
GO:0043931	ossification involved in bone maturation (GO:0043931)	20	6	1.17	+	5.11	2.54E-03	4.36E-02
GO:0098976	excitatory chemical synaptic transmission (GO:0098976)	10	3	.59	+	5.11	3.20E-02	2.82E-01
GO:0009629	response to gravity (GO:0009629)	10	3	.59	+	5.11	3.20E-02	2.82E-01
GO:0000070	mitotic sister chromatid segregation (GO:0000070)	120	36	7.05	+	5.11	1.73E-13	2.95E-11
GO:0043116	negative regulation of vascular permeability (GO:0043116)	20	6	1.17	+	5.11	2.54E-03	4.36E-02
GO:0086067	AV node cell to bundle of His cell communication (GO:0086067)	10	3	.59	+	5.11	3.20E-02	2.81E-01
GO:0014870	response to muscle inactivity (GO:0014870)	10	3	.59	+	5.11	3.20E-02	2.81E-01
GO:0014848	urinary tract smooth muscle contraction (GO:0014848)	10	3	.59	+	5.11	3.20E-02	2.81E-01
GO:0097104	postsynaptic membrane assembly (GO:0097104)	10	3	.59	+	5.11	3.20E-02	2.81E-01
GO:0003266	regulation of secondary heart field cardioblast proliferation (GO:0003266)	10	3	.59	+	5.11	3.20E-02	2.81E-01
GO:0060536	cartilage morphogenesis (GO:0060536)	10	3	.59	+	5.11	3.20E-02	2.81E-01
GO:1905207	regulation of cardiocyte differentiation (GO:1905207)	27	8	1.59	+	5.05	5.37E-04	1.18E-02
GO:0048146	positive regulation of fibroblast proliferation (GO:0048146)	54	16	3.17	+	5.05	1.05E-06	4.88E-05
GO:0034112	positive regulation of homotypic cell-cell adhesion (GO:0034112)	17	5	1.00	+	5.01	6.21E-03	8.83E-02
GO:0007076	mitotic chromosome condensation (GO:0007076)	17	5	1.00	+	5.01	6.21E-03	8.82E-02
GO:0048557	embryonic digestive tract morphogenesis (GO:0048557)	17	5	1.00	+	5.01	6.21E-03	8.81E-02
GO:1904752	regulation of vascular associated smooth muscle cell migration (GO:1904752)	24	7	1.41	+	4.97	1.29E-03	2.50E-02
GO:0086002	cardiac muscle cell action potential involved in contraction (GO:0086002)	38	11	2.23	+	4.93	6.06E-05	1.86E-03
GO:1905818	regulation of chromosome separation (GO:1905818)	111	32	6.52	+	4.91	9.19E-12	1.17E-09
GO:0007088	regulation of mitotic nuclear division (GO:0007088)	118	34	6.93	+	4.91	2.10E-12	2.99E-10
GO:1902850	microtubule cytoskeleton organization involved in mitosis (GO:1902850)	129	37	7.57	+	4.88	2.52E-13	4.15E-11
GO:0010216	maintenance of DNA methylation (GO:0010216)	7	2	.41	+	4.87	8.54E-02	5.23E-01
GO:1903224	regulation of endodermal cell differentiation (GO:1903224)	7	2	.41	+	4.87	8.54E-02	5.23E-01
GO:0060463	lung lobe morphogenesis (GO:0060463)	7	2	.41	+	4.87	8.54E-02	5.23E-01
GO:0060462	lung lobe development (GO:0060462)	7	2	.41	+	4.87	8.54E-02	5.23E-01
GO:0045630	positive regulation of T-helper 2 cell differentiation (GO:0045630)	7	2	.41	+	4.87	8.54E-02	5.23E-01
GO:0072307	regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307)	7	2	.41	+	4.87	8.54E-02	5.22E-01
GO:0045588	positive regulation of gamma-delta T cell differentiation (GO:0045588)	7	2	.41	+	4.87	8.54E-02	5.22E-01
GO:0033564	anterior/posterior axon guidance (GO:0033564)	7	2	.41	+	4.87	8.54E-02	5.22E-01
GO:2000766	negative regulation of cytoplasmic translation (GO:2000766)	7	2	.41	+	4.87	8.54E-02	5.22E-01
GO:2000726	negative regulation of cardiac muscle cell differentiation (GO:2000726)	7	2	.41	+	4.87	8.54E-02	5.22E-01
GO:0002318	myeloid progenitor cell differentiation (GO:0002318)	7	2	.41	+	4.87	8.54E-02	5.21E-01
GO:0060180	female mating behavior (GO:0060180)	7	2	.41	+	4.87	8.54E-02	5.21E-01
GO:0007077	mitotic nuclear membrane disassembly (GO:0007077)	7	2	.41	+	4.87	8.54E-02	5.21E-01
GO:2000544	regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544)	7	2	.41	+	4.87	8.54E-02	5.21E-01
GO:0038165	oncostatin-M-mediated signaling pathway (GO:0038165)	7	2	.41	+	4.87	8.54E-02	5.20E-01
GO:2000535	regulation of entry of bacterium into host cell (GO:2000535)	7	2	.41	+	4.87	8.54E-02	5.20E-01
GO:0072007	mesangial cell differentiation (GO:0072007)	7	2	.41	+	4.87	8.54E-02	5.20E-01
GO:0044806	G-quadruplex DNA unwinding (GO:0044806)	7	2	.41	+	4.87	8.54E-02	5.20E-01
GO:0051964	negative regulation of synapse assembly (GO:0051964)	7	2	.41	+	4.87	8.54E-02	5.20E-01
GO:2000489	regulation of hepatic stellate cell activation (GO:2000489)	7	2	.41	+	4.87	8.54E-02	5.19E-01
GO:0032763	regulation of mast cell cytokine production (GO:0032763)	7	2	.41	+	4.87	8.54E-02	5.19E-01
GO:1902255	positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255)	7	2	.41	+	4.87	8.54E-02	5.19E-01
GO:1990791	dorsal root ganglion development (GO:1990791)	7	2	.41	+	4.87	8.54E-02	5.19E-01
GO:0014012	peripheral nervous system axon regeneration (GO:0014012)	7	2	.41	+	4.87	8.54E-02	5.19E-01
GO:0001554	luteolysis (GO:0001554)	7	2	.41	+	4.87	8.54E-02	5.18E-01
GO:0044691	tooth eruption (GO:0044691)	7	2	.41	+	4.87	8.54E-02	5.18E-01
GO:1902172	regulation of keratinocyte apoptotic process (GO:1902172)	7	2	.41	+	4.87	8.54E-02	5.18E-01
GO:2000302	positive regulation of synaptic vesicle exocytosis (GO:2000302)	7	2	.41	+	4.87	8.54E-02	5.18E-01
GO:2000270	negative regulation of fibroblast apoptotic process (GO:2000270)	7	2	.41	+	4.87	8.54E-02	5.18E-01
GO:0051694	pointed-end actin filament capping (GO:0051694)	7	2	.41	+	4.87	8.54E-02	5.17E-01
GO:1905936	regulation of germ cell proliferation (GO:1905936)	7	2	.41	+	4.87	8.54E-02	5.17E-01
GO:2000194	regulation of female gonad development (GO:2000194)	7	2	.41	+	4.87	8.54E-02	5.17E-01
GO:0032494	response to peptidoglycan (GO:0032494)	14	4	.82	+	4.87	1.54E-02	1.72E-01
GO:0032488	Cdc42 protein signal transduction (GO:0032488)	7	2	.41	+	4.87	8.54E-02	5.17E-01
GO:2000105	positive regulation of DNA-templated DNA replication (GO:2000105)	14	4	.82	+	4.87	1.54E-02	1.72E-01
GO:0099505	regulation of presynaptic membrane potential (GO:0099505)	7	2	.41	+	4.87	8.54E-02	5.17E-01
GO:0098907	regulation of SA node cell action potential (GO:0098907)	7	2	.41	+	4.87	8.54E-02	5.16E-01
GO:0032278	positive regulation of gonadotropin secretion (GO:0032278)	7	2	.41	+	4.87	8.54E-02	5.16E-01
GO:0032277	negative regulation of gonadotropin secretion (GO:0032277)	7	2	.41	+	4.87	8.54E-02	5.16E-01
GO:0032222	regulation of synaptic transmission, cholinergic (GO:0032222)	7	2	.41	+	4.87	8.54E-02	5.16E-01
GO:0098838	folate transmembrane transport (GO:0098838)	7	2	.41	+	4.87	8.54E-02	5.16E-01
GO:0051305	chromosome movement towards spindle pole (GO:0051305)	7	2	.41	+	4.87	8.54E-02	5.15E-01
GO:0050882	voluntary musculoskeletal movement (GO:0050882)	7	2	.41	+	4.87	8.54E-02	5.15E-01
GO:0043615	astrocyte cell migration (GO:0043615)	7	2	.41	+	4.87	8.54E-02	5.15E-01
GO:0099150	regulation of postsynaptic specialization assembly (GO:0099150)	14	4	.82	+	4.87	1.54E-02	1.72E-01
GO:1901098	positive regulation of autophagosome maturation (GO:1901098)	7	2	.41	+	4.87	8.54E-02	5.15E-01
GO:0051154	negative regulation of striated muscle cell differentiation (GO:0051154)	35	10	2.06	+	4.87	1.43E-04	3.81E-03
GO:1901078	negative regulation of relaxation of muscle (GO:1901078)	7	2	.41	+	4.87	8.54E-02	5.15E-01
GO:0048312	intracellular distribution of mitochondria (GO:0048312)	7	2	.41	+	4.87	8.54E-02	5.14E-01
GO:0120040	regulation of macrophage proliferation (GO:0120040)	7	2	.41	+	4.87	8.54E-02	5.14E-01
GO:0098597	observational learning (GO:0098597)	7	2	.41	+	4.87	8.54E-02	5.14E-01
GO:1904847	regulation of cell chemotaxis to fibroblast growth factor (GO:1904847)	7	2	.41	+	4.87	8.54E-02	5.14E-01
GO:0030952	establishment or maintenance of cytoskeleton polarity (GO:0030952)	7	2	.41	+	4.87	8.54E-02	5.14E-01
GO:0070100	negative regulation of chemokine-mediated signaling pathway (GO:0070100)	7	2	.41	+	4.87	8.54E-02	5.14E-01
GO:0017085	response to insecticide (GO:0017085)	7	2	.41	+	4.87	8.54E-02	5.13E-01
GO:0035630	bone mineralization involved in bone maturation (GO:0035630)	7	2	.41	+	4.87	8.54E-02	5.13E-01
GO:0036017	response to erythropoietin (GO:0036017)	7	2	.41	+	4.87	8.54E-02	5.13E-01
GO:1900193	regulation of oocyte maturation (GO:1900193)	7	2	.41	+	4.87	8.54E-02	5.13E-01
GO:0035425	autocrine signaling (GO:0035425)	7	2	.41	+	4.87	8.54E-02	5.13E-01
GO:0046958	nonassociative learning (GO:0046958)	7	2	.41	+	4.87	8.54E-02	5.12E-01
GO:0010965	regulation of mitotic sister chromatid separation (GO:0010965)	98	28	5.75	+	4.87	2.15E-10	2.05E-08
GO:1900020	positive regulation of protein kinase C activity (GO:1900020)	7	2	.41	+	4.87	8.54E-02	5.12E-01
GO:1900019	regulation of protein kinase C activity (GO:1900019)	7	2	.41	+	4.87	8.54E-02	5.12E-01
GO:0086036	regulation of cardiac muscle cell membrane potential (GO:0086036)	7	2	.41	+	4.87	8.54E-02	5.12E-01
GO:0150146	cell junction disassembly (GO:0150146)	14	4	.82	+	4.87	1.54E-02	1.72E-01
GO:0086001	cardiac muscle cell action potential (GO:0086001)	49	14	2.88	+	4.87	7.01E-06	2.73E-04
GO:0062033	positive regulation of mitotic sister chromatid segregation (GO:0062033)	7	2	.41	+	4.87	8.54E-02	5.12E-01
GO:0046813	receptor-mediated virion attachment to host cell (GO:0046813)	7	2	.41	+	4.87	8.54E-02	5.11E-01
GO:0010832	negative regulation of myotube differentiation (GO:0010832)	14	4	.82	+	4.87	1.54E-02	1.72E-01
GO:1904026	regulation of collagen fibril organization (GO:1904026)	7	2	.41	+	4.87	8.54E-02	5.11E-01
GO:0010573	vascular endothelial growth factor production (GO:0010573)	7	2	.41	+	4.87	8.54E-02	5.11E-01
GO:1903598	positive regulation of gap junction assembly (GO:1903598)	7	2	.41	+	4.87	8.54E-02	5.11E-01
GO:0060745	mammary gland branching involved in pregnancy (GO:0060745)	7	2	.41	+	4.87	8.54E-02	5.11E-01
GO:0003321	positive regulation of blood pressure by epinephrine-norepinephrine (GO:0003321)	7	2	.41	+	4.87	8.54E-02	5.10E-01
GO:0003308	negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	7	2	.41	+	4.87	8.54E-02	5.10E-01
GO:0014898	cardiac muscle hypertrophy in response to stress (GO:0014898)	14	4	.82	+	4.87	1.54E-02	1.72E-01
GO:0014887	cardiac muscle adaptation (GO:0014887)	14	4	.82	+	4.87	1.54E-02	1.72E-01
GO:0014856	skeletal muscle cell proliferation (GO:0014856)	7	2	.41	+	4.87	8.54E-02	5.10E-01
GO:0097107	postsynaptic density assembly (GO:0097107)	7	2	.41	+	4.87	8.54E-02	5.10E-01
GO:0019694	alkanesulfonate metabolic process (GO:0019694)	7	2	.41	+	4.87	8.54E-02	5.10E-01
GO:0045924	regulation of female receptivity (GO:0045924)	7	2	.41	+	4.87	8.54E-02	5.09E-01
GO:0021957	corticospinal tract morphogenesis (GO:0021957)	7	2	.41	+	4.87	8.54E-02	5.09E-01
GO:1903431	positive regulation of cell maturation (GO:1903431)	7	2	.41	+	4.87	8.54E-02	5.09E-01
GO:0003299	muscle hypertrophy in response to stress (GO:0003299)	14	4	.82	+	4.87	1.54E-02	1.72E-01
GO:0021855	hypothalamus cell migration (GO:0021855)	7	2	.41	+	4.87	8.54E-02	5.09E-01
GO:0019530	taurine metabolic process (GO:0019530)	7	2	.41	+	4.87	8.54E-02	5.09E-01
GO:0003164	His-Purkinje system development (GO:0003164)	7	2	.41	+	4.87	8.54E-02	5.08E-01
GO:0072540	T-helper 17 cell lineage commitment (GO:0072540)	7	2	.41	+	4.87	8.54E-02	5.08E-01
GO:0110110	positive regulation of animal organ morphogenesis (GO:0110110)	32	9	1.88	+	4.79	3.37E-04	7.84E-03
GO:0033045	regulation of sister chromatid segregation (GO:0033045)	107	30	6.28	+	4.77	7.25E-11	7.78E-09
GO:0071459	protein localization to chromosome, centromeric region (GO:0071459)	25	7	1.47	+	4.77	1.57E-03	2.95E-02
GO:1903779	regulation of cardiac conduction (GO:1903779)	25	7	1.47	+	4.77	1.57E-03	2.94E-02
GO:0086065	cell communication involved in cardiac conduction (GO:0086065)	43	12	2.52	+	4.75	3.82E-05	1.23E-03
GO:1902430	negative regulation of amyloid-beta formation (GO:1902430)	18	5	1.06	+	4.73	7.58E-03	1.03E-01
GO:0007019	microtubule depolymerization (GO:0007019)	18	5	1.06	+	4.73	7.58E-03	1.03E-01
GO:0051580	regulation of neurotransmitter uptake (GO:0051580)	18	5	1.06	+	4.73	7.58E-03	1.03E-01
GO:0044320	cellular response to leptin stimulus (GO:0044320)	18	5	1.06	+	4.73	7.58E-03	1.03E-01
GO:0031643	positive regulation of myelination (GO:0031643)	18	5	1.06	+	4.73	7.58E-03	1.03E-01
GO:0035886	vascular associated smooth muscle cell differentiation (GO:0035886)	18	5	1.06	+	4.73	7.58E-03	1.03E-01
GO:1903975	regulation of glial cell migration (GO:1903975)	18	5	1.06	+	4.73	7.58E-03	1.03E-01
GO:0060977	coronary vasculature morphogenesis (GO:0060977)	18	5	1.06	+	4.73	7.58E-03	1.02E-01
GO:0061337	cardiac conduction (GO:0061337)	69	19	4.05	+	4.69	2.73E-07	1.42E-05
GO:0051983	regulation of chromosome segregation (GO:0051983)	131	36	7.69	+	4.68	1.52E-12	2.19E-10
GO:0090307	mitotic spindle assembly (GO:0090307)	51	14	2.99	+	4.67	1.03E-05	3.82E-04
GO:0030239	myofibril assembly (GO:0030239)	62	17	3.64	+	4.67	1.21E-06	5.46E-05
GO:1902099	regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	95	26	5.58	+	4.66	2.04E-09	1.60E-07
GO:0071679	commissural neuron axon guidance (GO:0071679)	11	3	.65	+	4.64	3.91E-02	3.27E-01
GO:0071676	negative regulation of mononuclear cell migration (GO:0071676)	22	6	1.29	+	4.64	3.78E-03	6.04E-02
GO:0090737	telomere maintenance via telomere trimming (GO:0090737)	11	3	.65	+	4.64	3.91E-02	3.27E-01
GO:0044848	biological phase (GO:0044848)	11	3	.65	+	4.64	3.91E-02	3.27E-01
GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)	11	3	.65	+	4.64	3.91E-02	3.27E-01
GO:0090656	t-circle formation (GO:0090656)	11	3	.65	+	4.64	3.91E-02	3.26E-01
GO:0090494	dopamine uptake (GO:0090494)	11	3	.65	+	4.64	3.91E-02	3.26E-01
GO:0090493	catecholamine uptake (GO:0090493)	11	3	.65	+	4.64	3.91E-02	3.26E-01
GO:0001325	formation of extrachromosomal circular DNA (GO:0001325)	11	3	.65	+	4.64	3.91E-02	3.26E-01
GO:0044346	fibroblast apoptotic process (GO:0044346)	11	3	.65	+	4.64	3.91E-02	3.26E-01
GO:2000035	regulation of stem cell division (GO:2000035)	11	3	.65	+	4.64	3.91E-02	3.26E-01
GO:0048671	negative regulation of collateral sprouting (GO:0048671)	11	3	.65	+	4.64	3.91E-02	3.25E-01
GO:0098883	synapse pruning (GO:0098883)	11	3	.65	+	4.64	3.91E-02	3.25E-01
GO:0098763	mitotic cell cycle phase (GO:0098763)	11	3	.65	+	4.64	3.91E-02	3.25E-01
GO:0070344	regulation of fat cell proliferation (GO:0070344)	11	3	.65	+	4.64	3.91E-02	3.25E-01
GO:1904668	positive regulation of ubiquitin protein ligase activity (GO:1904668)	11	3	.65	+	4.64	3.91E-02	3.25E-01
GO:0086100	endothelin receptor signaling pathway (GO:0086100)	11	3	.65	+	4.64	3.91E-02	3.25E-01
GO:0086005	ventricular cardiac muscle cell action potential (GO:0086005)	22	6	1.29	+	4.64	3.78E-03	6.04E-02
GO:0061430	bone trabecula morphogenesis (GO:0061430)	11	3	.65	+	4.64	3.91E-02	3.24E-01
GO:0046643	regulation of gamma-delta T cell activation (GO:0046643)	11	3	.65	+	4.64	3.91E-02	3.24E-01
GO:0061299	retina vasculature morphogenesis in camera-type eye (GO:0061299)	11	3	.65	+	4.64	3.91E-02	3.24E-01
GO:0003357	noradrenergic neuron differentiation (GO:0003357)	11	3	.65	+	4.64	3.91E-02	3.24E-01
GO:0072711	cellular response to hydroxyurea (GO:0072711)	11	3	.65	+	4.64	3.91E-02	3.24E-01
GO:0022403	cell cycle phase (GO:0022403)	11	3	.65	+	4.64	3.91E-02	3.24E-01
GO:0003264	regulation of cardioblast proliferation (GO:0003264)	11	3	.65	+	4.64	3.91E-02	3.23E-01
GO:0007614	short-term memory (GO:0007614)	11	3	.65	+	4.64	3.91E-02	3.23E-01
GO:0034350	regulation of glial cell apoptotic process (GO:0034350)	11	3	.65	+	4.64	3.91E-02	3.23E-01
GO:0097012	response to granulocyte macrophage colony-stimulating factor (GO:0097012)	11	3	.65	+	4.64	3.91E-02	3.23E-01
GO:0097011	cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011)	11	3	.65	+	4.64	3.91E-02	3.23E-01
GO:0030071	regulation of mitotic metaphase/anaphase transition (GO:0030071)	92	25	5.40	+	4.63	4.68E-09	3.28E-07
GO:0055002	striated muscle cell development (GO:0055002)	63	17	3.70	+	4.60	1.46E-06	6.45E-05
GO:2000209	regulation of anoikis (GO:2000209)	26	7	1.53	+	4.58	1.90E-03	3.47E-02
GO:2001251	negative regulation of chromosome organization (GO:2001251)	82	22	4.82	+	4.57	4.71E-08	2.76E-06
GO:0009187	cyclic nucleotide metabolic process (GO:0009187)	41	11	2.41	+	4.57	1.08E-04	3.01E-03
GO:0032835	glomerulus development (GO:0032835)	56	15	3.29	+	4.56	6.45E-06	2.54E-04
GO:0033598	mammary gland epithelial cell proliferation (GO:0033598)	15	4	.88	+	4.54	1.87E-02	1.98E-01
GO:2000725	regulation of cardiac muscle cell differentiation (GO:2000725)	15	4	.88	+	4.54	1.87E-02	1.98E-01
GO:0032736	positive regulation of interleukin-13 production (GO:0032736)	15	4	.88	+	4.54	1.87E-02	1.98E-01
GO:0006271	DNA strand elongation involved in DNA replication (GO:0006271)	15	4	.88	+	4.54	1.87E-02	1.98E-01
GO:1905874	regulation of postsynaptic density organization (GO:1905874)	15	4	.88	+	4.54	1.87E-02	1.98E-01
GO:0051481	negative regulation of cytosolic calcium ion concentration (GO:0051481)	15	4	.88	+	4.54	1.87E-02	1.97E-01
GO:0048484	enteric nervous system development (GO:0048484)	15	4	.88	+	4.54	1.87E-02	1.97E-01
GO:0099171	presynaptic modulation of chemical synaptic transmission (GO:0099171)	15	4	.88	+	4.54	1.87E-02	1.97E-01
GO:0036376	sodium ion export across plasma membrane (GO:0036376)	15	4	.88	+	4.54	1.87E-02	1.97E-01
GO:1904889	regulation of excitatory synapse assembly (GO:1904889)	15	4	.88	+	4.54	1.87E-02	1.97E-01
GO:0150079	negative regulation of neuroinflammatory response (GO:0150079)	15	4	.88	+	4.54	1.87E-02	1.97E-01
GO:0150078	positive regulation of neuroinflammatory response (GO:0150078)	15	4	.88	+	4.54	1.87E-02	1.97E-01
GO:0042308	negative regulation of protein import into nucleus (GO:0042308)	15	4	.88	+	4.54	1.87E-02	1.97E-01
GO:0061469	regulation of type B pancreatic cell proliferation (GO:0061469)	15	4	.88	+	4.54	1.87E-02	1.96E-01
GO:0030174	regulation of DNA-templated DNA replication initiation (GO:0030174)	15	4	.88	+	4.54	1.87E-02	1.96E-01
GO:0050931	pigment cell differentiation (GO:0050931)	34	9	2.00	+	4.51	4.91E-04	1.09E-02
GO:0070252	actin-mediated cell contraction (GO:0070252)	68	18	3.99	+	4.51	9.11E-07	4.30E-05
GO:0000819	sister chromatid segregation (GO:0000819)	148	39	8.69	+	4.49	5.48E-13	8.77E-11
GO:0007096	regulation of exit from mitosis (GO:0007096)	19	5	1.12	+	4.48	9.15E-03	1.18E-01
GO:0060048	cardiac muscle contraction (GO:0060048)	76	20	4.46	+	4.48	2.48E-07	1.30E-05
GO:0090329	regulation of DNA-templated DNA replication (GO:0090329)	57	15	3.35	+	4.48	7.74E-06	2.98E-04
GO:0051145	smooth muscle cell differentiation (GO:0051145)	38	10	2.23	+	4.48	2.51E-04	6.09E-03
GO:0061298	retina vasculature development in camera-type eye (GO:0061298)	19	5	1.12	+	4.48	9.15E-03	1.18E-01
GO:0086091	regulation of heart rate by cardiac conduction (GO:0086091)	42	11	2.47	+	4.46	1.29E-04	3.54E-03
GO:0003081	regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081)	23	6	1.35	+	4.44	4.54E-03	7.00E-02
GO:0070977	bone maturation (GO:0070977)	23	6	1.35	+	4.44	4.54E-03	6.99E-02
GO:2000310	regulation of NMDA receptor activity (GO:2000310)	23	6	1.35	+	4.44	4.54E-03	6.98E-02
GO:0099560	synaptic membrane adhesion (GO:0099560)	23	6	1.35	+	4.44	4.54E-03	6.98E-02
GO:1902751	positive regulation of cell cycle G2/M phase transition (GO:1902751)	31	8	1.82	+	4.39	1.15E-03	2.29E-02
GO:0085029	extracellular matrix assembly (GO:0085029)	35	9	2.06	+	4.38	5.87E-04	1.28E-02
GO:0003015	heart process (GO:0003015)	109	28	6.40	+	4.37	1.65E-09	1.31E-07
GO:0046622	positive regulation of organ growth (GO:0046622)	43	11	2.52	+	4.36	1.54E-04	4.05E-03
GO:0050919	negative chemotaxis (GO:0050919)	47	12	2.76	+	4.35	7.94E-05	2.34E-03
GO:0051783	regulation of nuclear division (GO:0051783)	145	37	8.51	+	4.35	4.83E-12	6.42E-10
GO:0060218	hematopoietic stem cell differentiation (GO:0060218)	20	5	1.17	+	4.26	1.09E-02	1.36E-01
GO:0007044	cell-substrate junction assembly (GO:0007044)	40	10	2.35	+	4.26	3.57E-04	8.28E-03
GO:0043586	tongue development (GO:0043586)	20	5	1.17	+	4.26	1.09E-02	1.36E-01
GO:0048144	fibroblast proliferation (GO:0048144)	36	9	2.11	+	4.26	6.99E-04	1.50E-02
GO:0048066	developmental pigmentation (GO:0048066)	44	11	2.58	+	4.26	1.83E-04	4.71E-03
GO:0048041	focal adhesion assembly (GO:0048041)	28	7	1.64	+	4.26	2.72E-03	4.63E-02
GO:0010971	positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)	28	7	1.64	+	4.26	2.72E-03	4.62E-02
GO:0010463	mesenchymal cell proliferation (GO:0010463)	28	7	1.64	+	4.26	2.72E-03	4.62E-02
GO:0002605	negative regulation of dendritic cell antigen processing and presentation (GO:0002605)	4	1	.23	+	4.26	2.48E-01	8.53E-01
GO:1903296	positive regulation of glutamate secretion, neurotransmission (GO:1903296)	4	1	.23	+	4.26	2.48E-01	8.53E-01
GO:0045743	positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743)	8	2	.47	+	4.26	1.03E-01	5.88E-01
GO:0021773	striatal medium spiny neuron differentiation (GO:0021773)	4	1	.23	+	4.26	2.48E-01	8.53E-01
GO:0019448	L-cysteine catabolic process (GO:0019448)	4	1	.23	+	4.26	2.48E-01	8.53E-01
GO:2000969	positive regulation of AMPA receptor activity (GO:2000969)	8	2	.47	+	4.26	1.03E-01	5.87E-01
GO:0060465	pharynx development (GO:0060465)	4	1	.23	+	4.26	2.48E-01	8.53E-01
GO:0072429	response to intra-S DNA damage checkpoint signaling (GO:0072429)	4	1	.23	+	4.26	2.48E-01	8.52E-01
GO:1902746	regulation of lens fiber cell differentiation (GO:1902746)	8	2	.47	+	4.26	1.03E-01	5.87E-01
GO:0060414	aorta smooth muscle tissue morphogenesis (GO:0060414)	4	1	.23	+	4.26	2.48E-01	8.52E-01
GO:1902725	negative regulation of satellite cell differentiation (GO:1902725)	4	1	.23	+	4.26	2.48E-01	8.52E-01
GO:0002551	mast cell chemotaxis (GO:0002551)	4	1	.23	+	4.26	2.48E-01	8.52E-01
GO:0071922	regulation of cohesin loading (GO:0071922)	4	1	.23	+	4.26	2.48E-01	8.52E-01
GO:0002528	regulation of vascular permeability involved in acute inflammatory response (GO:0002528)	4	1	.23	+	4.26	2.48E-01	8.51E-01
GO:0033689	negative regulation of osteoblast proliferation (GO:0033689)	12	3	.70	+	4.26	4.70E-02	3.65E-01
GO:0033687	osteoblast proliferation (GO:0033687)	12	3	.70	+	4.26	4.70E-02	3.65E-01
GO:0021678	third ventricle development (GO:0021678)	4	1	.23	+	4.26	2.48E-01	8.51E-01
GO:1903121	regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121)	4	1	.23	+	4.26	2.48E-01	8.51E-01
GO:0033600	negative regulation of mammary gland epithelial cell proliferation (GO:0033600)	4	1	.23	+	4.26	2.48E-01	8.51E-01
GO:0072378	blood coagulation, fibrin clot formation (GO:0072378)	24	6	1.41	+	4.26	5.42E-03	8.01E-02
GO:0060385	axonogenesis involved in innervation (GO:0060385)	8	2	.47	+	4.26	1.03E-01	5.87E-01
GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371)	8	2	.47	+	4.26	1.03E-01	5.87E-01
GO:2000850	negative regulation of glucocorticoid secretion (GO:2000850)	4	1	.23	+	4.26	2.48E-01	8.51E-01
GO:2000847	negative regulation of corticosteroid hormone secretion (GO:2000847)	4	1	.23	+	4.26	2.48E-01	8.50E-01
GO:0046075	dTTP metabolic process (GO:0046075)	4	1	.23	+	4.26	2.48E-01	8.50E-01
GO:2000832	negative regulation of steroid hormone secretion (GO:2000832)	4	1	.23	+	4.26	2.48E-01	8.50E-01
GO:0060343	trabecula formation (GO:0060343)	24	6	1.41	+	4.26	5.42E-03	8.00E-02
GO:0034088	maintenance of mitotic sister chromatid cohesion (GO:0034088)	4	1	.23	+	4.26	2.48E-01	8.50E-01
GO:0034086	maintenance of sister chromatid cohesion (GO:0034086)	4	1	.23	+	4.26	2.48E-01	8.50E-01
GO:0060300	regulation of cytokine activity (GO:0060300)	4	1	.23	+	4.26	2.48E-01	8.50E-01
GO:0046016	positive regulation of transcription by glucose (GO:0046016)	4	1	.23	+	4.26	2.48E-01	8.49E-01
GO:0010044	response to aluminum ion (GO:0010044)	4	1	.23	+	4.26	2.48E-01	8.49E-01
GO:2001214	positive regulation of vasculogenesis (GO:2001214)	12	3	.70	+	4.26	4.70E-02	3.65E-01
GO:0007296	vitellogenesis (GO:0007296)	4	1	.23	+	4.26	2.48E-01	8.49E-01
GO:0019249	lactate biosynthetic process (GO:0019249)	4	1	.23	+	4.26	2.48E-01	8.49E-01
GO:0019243	methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243)	4	1	.23	+	4.26	2.48E-01	8.49E-01
GO:1903028	positive regulation of opsonization (GO:1903028)	16	4	.94	+	4.26	2.24E-02	2.25E-01
GO:0001955	blood vessel maturation (GO:0001955)	8	2	.47	+	4.26	1.03E-01	5.87E-01
GO:0007217	tachykinin receptor signaling pathway (GO:0007217)	8	2	.47	+	4.26	1.03E-01	5.86E-01
GO:2000738	positive regulation of stem cell differentiation (GO:2000738)	24	6	1.41	+	4.26	5.42E-03	8.00E-02
GO:0110091	negative regulation of hippocampal neuron apoptotic process (GO:0110091)	4	1	.23	+	4.26	2.48E-01	8.48E-01
GO:0060244	negative regulation of cell proliferation involved in contact inhibition (GO:0060244)	4	1	.23	+	4.26	2.48E-01	8.48E-01
GO:2000727	positive regulation of cardiac muscle cell differentiation (GO:2000727)	8	2	.47	+	4.26	1.03E-01	5.86E-01
GO:0060214	endocardium formation (GO:0060214)	4	1	.23	+	4.26	2.48E-01	8.48E-01
GO:0071799	cellular response to prostaglandin D stimulus (GO:0071799)	4	1	.23	+	4.26	2.48E-01	8.48E-01
GO:0071798	response to prostaglandin D (GO:0071798)	4	1	.23	+	4.26	2.48E-01	8.48E-01
GO:0002353	plasma kallikrein-kinin cascade (GO:0002353)	4	1	.23	+	4.26	2.48E-01	8.48E-01
GO:0006705	mineralocorticoid biosynthetic process (GO:0006705)	4	1	.23	+	4.26	2.48E-01	8.47E-01
GO:0002328	pro-B cell differentiation (GO:0002328)	4	1	.23	+	4.26	2.48E-01	8.47E-01
GO:0002320	lymphoid progenitor cell differentiation (GO:0002320)	12	3	.70	+	4.26	4.70E-02	3.65E-01
GO:0033490	cholesterol biosynthetic process via lathosterol (GO:0033490)	4	1	.23	+	4.26	2.48E-01	8.47E-01
GO:0002317	plasma cell differentiation (GO:0002317)	4	1	.23	+	4.26	2.48E-01	8.47E-01
GO:0033489	cholesterol biosynthetic process via desmosterol (GO:0033489)	4	1	.23	+	4.26	2.48E-01	8.47E-01
GO:0001865	NK T cell differentiation (GO:0001865)	4	1	.23	+	4.26	2.48E-01	8.46E-01
GO:0007158	neuron cell-cell adhesion (GO:0007158)	16	4	.94	+	4.26	2.24E-02	2.25E-01
GO:0032971	regulation of muscle filament sliding (GO:0032971)	4	1	.23	+	4.26	2.48E-01	8.46E-01
GO:0060157	urinary bladder development (GO:0060157)	4	1	.23	+	4.26	2.48E-01	8.46E-01
GO:2000617	positive regulation of histone H3-K9 acetylation (GO:2000617)	8	2	.47	+	4.26	1.03E-01	5.86E-01
GO:1902426	deactivation of mitotic spindle assembly checkpoint (GO:1902426)	4	1	.23	+	4.26	2.48E-01	8.46E-01
GO:0006663	platelet activating factor biosynthetic process (GO:0006663)	4	1	.23	+	4.26	2.48E-01	8.46E-01
GO:0002291	T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:0002291)	4	1	.23	+	4.26	2.48E-01	8.45E-01
GO:0002254	kinin cascade (GO:0002254)	4	1	.23	+	4.26	2.48E-01	8.45E-01
GO:1901994	negative regulation of meiotic cell cycle phase transition (GO:1901994)	4	1	.23	+	4.26	2.48E-01	8.45E-01
GO:0006603	phosphocreatine metabolic process (GO:0006603)	4	1	.23	+	4.26	2.48E-01	8.45E-01
GO:0071623	negative regulation of granulocyte chemotaxis (GO:0071623)	4	1	.23	+	4.26	2.48E-01	8.45E-01
GO:1990911	response to psychosocial stress (GO:1990911)	4	1	.23	+	4.26	2.48E-01	8.45E-01
GO:2001013	epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013)	4	1	.23	+	4.26	2.48E-01	8.44E-01
GO:0019064	fusion of virus membrane with host plasma membrane (GO:0019064)	4	1	.23	+	4.26	2.48E-01	8.44E-01
GO:0001796	regulation of type IIa hypersensitivity (GO:0001796)	4	1	.23	+	4.26	2.48E-01	8.44E-01
GO:0007091	metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	8	2	.47	+	4.26	1.03E-01	5.86E-01
GO:0001780	neutrophil homeostasis (GO:0001780)	16	4	.94	+	4.26	2.24E-02	2.24E-01
GO:0090735	DNA repair complex assembly (GO:0090735)	4	1	.23	+	4.26	2.48E-01	8.44E-01
GO:0033313	meiotic cell cycle checkpoint signaling (GO:0033313)	8	2	.47	+	4.26	1.03E-01	5.86E-01
GO:0072093	metanephric renal vesicle formation (GO:0072093)	4	1	.23	+	4.26	2.48E-01	8.44E-01
GO:2000587	negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587)	4	1	.23	+	4.26	2.48E-01	8.43E-01
GO:0044878	mitotic cytokinesis checkpoint signaling (GO:0044878)	4	1	.23	+	4.26	2.48E-01	8.43E-01
GO:0060073	micturition (GO:0060073)	8	2	.47	+	4.26	1.03E-01	5.85E-01
GO:0038162	erythropoietin-mediated signaling pathway (GO:0038162)	4	1	.23	+	4.26	2.48E-01	8.43E-01
GO:0032847	regulation of cellular pH reduction (GO:0032847)	8	2	.47	+	4.26	1.03E-01	5.85E-01
GO:0006599	phosphagen metabolic process (GO:0006599)	4	1	.23	+	4.26	2.48E-01	8.43E-01
GO:0038134	ERBB2-EGFR signaling pathway (GO:0038134)	8	2	.47	+	4.26	1.03E-01	5.85E-01
GO:0052403	negative regulation by host of symbiont catalytic activity (GO:0052403)	4	1	.23	+	4.26	2.48E-01	8.43E-01
GO:0038116	chemokine (C-C motif) ligand 21 signaling pathway (GO:0038116)	4	1	.23	+	4.26	2.48E-01	8.43E-01
GO:0006538	glutamate catabolic process (GO:0006538)	8	2	.47	+	4.26	1.03E-01	5.85E-01
GO:0006526	arginine biosynthetic process (GO:0006526)	4	1	.23	+	4.26	2.48E-01	8.42E-01
GO:1901877	negative regulation of calcium ion binding (GO:1901877)	4	1	.23	+	4.26	2.48E-01	8.42E-01
GO:1901876	regulation of calcium ion binding (GO:1901876)	4	1	.23	+	4.26	2.48E-01	8.42E-01
GO:1901860	positive regulation of mitochondrial DNA metabolic process (GO:1901860)	4	1	.23	+	4.26	2.48E-01	8.42E-01
GO:0051919	positive regulation of fibrinolysis (GO:0051919)	4	1	.23	+	4.26	2.48E-01	8.42E-01
GO:0045213	neurotransmitter receptor metabolic process (GO:0045213)	4	1	.23	+	4.26	2.48E-01	8.41E-01
GO:0140499	negative regulation of mitotic spindle assembly checkpoint signaling (GO:0140499)	4	1	.23	+	4.26	2.48E-01	8.41E-01
GO:0033212	iron import into cell (GO:0033212)	8	2	.47	+	4.26	1.03E-01	5.84E-01
GO:0044784	metaphase/anaphase transition of cell cycle (GO:0044784)	8	2	.47	+	4.26	1.03E-01	5.84E-01
GO:0032769	negative regulation of monooxygenase activity (GO:0032769)	12	3	.70	+	4.26	4.70E-02	3.65E-01
GO:2000439	positive regulation of monocyte extravasation (GO:2000439)	4	1	.23	+	4.26	2.48E-01	8.41E-01
GO:2000427	positive regulation of apoptotic cell clearance (GO:2000427)	8	2	.47	+	4.26	1.03E-01	5.84E-01
GO:0071499	cellular response to laminar fluid shear stress (GO:0071499)	8	2	.47	+	4.26	1.03E-01	5.84E-01
GO:0071493	cellular response to UV-B (GO:0071493)	8	2	.47	+	4.26	1.03E-01	5.84E-01
GO:1902202	regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202)	4	1	.23	+	4.26	2.48E-01	8.41E-01
GO:0051890	regulation of cardioblast differentiation (GO:0051890)	8	2	.47	+	4.26	1.03E-01	5.83E-01
GO:1990787	negative regulation of hh target transcription factor activity (GO:1990787)	4	1	.23	+	4.26	2.48E-01	8.41E-01
GO:0071442	positive regulation of histone H3-K14 acetylation (GO:0071442)	4	1	.23	+	4.26	2.48E-01	8.41E-01
GO:0014005	microglia development (GO:0014005)	4	1	.23	+	4.26	2.48E-01	8.40E-01
GO:0002036	regulation of L-glutamate import across plasma membrane (GO:0002036)	8	2	.47	+	4.26	1.03E-01	5.83E-01
GO:0140361	cyclic-GMP-AMP transmembrane import across plasma membrane (GO:0140361)	4	1	.23	+	4.26	2.48E-01	8.40E-01
GO:0001550	ovarian cumulus expansion (GO:0001550)	4	1	.23	+	4.26	2.48E-01	8.40E-01
GO:0044650	adhesion of symbiont to host cell (GO:0044650)	12	3	.70	+	4.26	4.70E-02	3.64E-01
GO:2000346	negative regulation of hepatocyte proliferation (GO:2000346)	4	1	.23	+	4.26	2.48E-01	8.40E-01
GO:2000342	negative regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000342)	4	1	.23	+	4.26	2.48E-01	8.40E-01
GO:1902174	positive regulation of keratinocyte apoptotic process (GO:1902174)	4	1	.23	+	4.26	2.48E-01	8.39E-01
GO:0071397	cellular response to cholesterol (GO:0071397)	16	4	.94	+	4.26	2.24E-02	2.24E-01
GO:0075732	viral penetration into host nucleus (GO:0075732)	4	1	.23	+	4.26	2.48E-01	8.39E-01
GO:1902101	positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)	16	4	.94	+	4.26	2.24E-02	2.24E-01
GO:0071314	cellular response to cocaine (GO:0071314)	8	2	.47	+	4.26	1.03E-01	5.83E-01
GO:1901671	positive regulation of superoxide dismutase activity (GO:1901671)	4	1	.23	+	4.26	2.48E-01	8.39E-01
GO:0071307	cellular response to vitamin K (GO:0071307)	4	1	.23	+	4.26	2.48E-01	8.39E-01
GO:1901632	regulation of synaptic vesicle membrane organization (GO:1901632)	8	2	.47	+	4.26	1.03E-01	5.83E-01
GO:0045003	double-strand break repair via synthesis-dependent strand annealing (GO:0045003)	8	2	.47	+	4.26	1.03E-01	5.83E-01
GO:0070836	caveola assembly (GO:0070836)	4	1	.23	+	4.26	2.48E-01	8.39E-01
GO:2000288	positive regulation of myoblast proliferation (GO:2000288)	12	3	.70	+	4.26	4.70E-02	3.64E-01
GO:2000255	negative regulation of male germ cell proliferation (GO:2000255)	4	1	.23	+	4.26	2.48E-01	8.39E-01
GO:0044546	NLRP3 inflammasome complex assembly (GO:0044546)	4	1	.23	+	4.26	2.48E-01	8.38E-01
GO:0099641	anterograde axonal protein transport (GO:0099641)	8	2	.47	+	4.26	1.03E-01	5.82E-01
GO:0099640	axo-dendritic protein transport (GO:0099640)	8	2	.47	+	4.26	1.03E-01	5.82E-01
GO:1902080	regulation of calcium ion import into sarcoplasmic reticulum (GO:1902080)	4	1	.23	+	4.26	2.48E-01	8.38E-01
GO:0006273	lagging strand elongation (GO:0006273)	4	1	.23	+	4.26	2.48E-01	8.38E-01
GO:1902020	negative regulation of cilium-dependent cell motility (GO:1902020)	4	1	.23	+	4.26	2.48E-01	8.38E-01
GO:0071279	cellular response to cobalt ion (GO:0071279)	4	1	.23	+	4.26	2.48E-01	8.38E-01
GO:0006235	dTTP biosynthetic process (GO:0006235)	4	1	.23	+	4.26	2.48E-01	8.37E-01
GO:0006231	dTMP biosynthetic process (GO:0006231)	4	1	.23	+	4.26	2.48E-01	8.37E-01
GO:0051664	nuclear pore localization (GO:0051664)	4	1	.23	+	4.26	2.48E-01	8.37E-01
GO:1905940	negative regulation of gonad development (GO:1905940)	4	1	.23	+	4.26	2.48E-01	8.37E-01
GO:1905937	negative regulation of germ cell proliferation (GO:1905937)	4	1	.23	+	4.26	2.48E-01	8.37E-01
GO:0071211	protein targeting to vacuole involved in autophagy (GO:0071211)	4	1	.23	+	4.26	2.48E-01	8.37E-01
GO:1905908	positive regulation of amyloid fibril formation (GO:1905908)	4	1	.23	+	4.26	2.48E-01	8.36E-01
GO:1901529	positive regulation of anion channel activity (GO:1901529)	4	1	.23	+	4.26	2.48E-01	8.36E-01
GO:0048852	diencephalon morphogenesis (GO:0048852)	4	1	.23	+	4.26	2.48E-01	8.36E-01
GO:0032461	positive regulation of protein oligomerization (GO:0032461)	4	1	.23	+	4.26	2.48E-01	8.36E-01
GO:0099525	presynaptic dense core vesicle exocytosis (GO:0099525)	4	1	.23	+	4.26	2.48E-01	8.36E-01
GO:0000821	regulation of arginine metabolic process (GO:0000821)	4	1	.23	+	4.26	2.48E-01	8.35E-01
GO:1990416	cellular response to brain-derived neurotrophic factor stimulus (GO:1990416)	8	2	.47	+	4.26	1.03E-01	5.82E-01
GO:0070668	positive regulation of mast cell proliferation (GO:0070668)	4	1	.23	+	4.26	2.48E-01	8.35E-01
GO:0070662	mast cell proliferation (GO:0070662)	4	1	.23	+	4.26	2.48E-01	8.35E-01
GO:0090233	negative regulation of spindle checkpoint (GO:0090233)	4	1	.23	+	4.26	2.48E-01	8.35E-01
GO:0090210	regulation of establishment of blood-brain barrier (GO:0090210)	4	1	.23	+	4.26	2.48E-01	8.35E-01
GO:2000097	regulation of smooth muscle cell-matrix adhesion (GO:2000097)	4	1	.23	+	4.26	2.48E-01	8.35E-01
GO:0070601	centromeric sister chromatid cohesion (GO:0070601)	8	2	.47	+	4.26	1.03E-01	5.82E-01
GO:2000065	negative regulation of cortisol biosynthetic process (GO:2000065)	4	1	.23	+	4.26	2.48E-01	8.34E-01
GO:0032348	negative regulation of aldosterone biosynthetic process (GO:0032348)	4	1	.23	+	4.26	2.48E-01	8.34E-01
GO:0032345	negative regulation of aldosterone metabolic process (GO:0032345)	4	1	.23	+	4.26	2.48E-01	8.34E-01
GO:0000730	DNA recombinase assembly (GO:0000730)	4	1	.23	+	4.26	2.48E-01	8.34E-01
GO:0000706	meiotic DNA double-strand break processing (GO:0000706)	4	1	.23	+	4.26	2.48E-01	8.34E-01
GO:0009957	epidermal cell fate specification (GO:0009957)	4	1	.23	+	4.26	2.48E-01	8.34E-01
GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)	8	2	.47	+	4.26	1.03E-01	5.82E-01
GO:1901321	positive regulation of heart induction (GO:1901321)	4	1	.23	+	4.26	2.48E-01	8.33E-01
GO:1901318	negative regulation of flagellated sperm motility (GO:1901318)	4	1	.23	+	4.26	2.48E-01	8.33E-01
GO:0090113	regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113)	4	1	.23	+	4.26	2.48E-01	8.33E-01
GO:0050955	thermoception (GO:0050955)	8	2	.47	+	4.26	1.03E-01	5.81E-01
GO:0050923	regulation of negative chemotaxis (GO:0050923)	4	1	.23	+	4.26	2.48E-01	8.33E-01
GO:0032286	central nervous system myelin maintenance (GO:0032286)	4	1	.23	+	4.26	2.48E-01	8.33E-01
GO:1900825	regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825)	4	1	.23	+	4.26	2.48E-01	8.32E-01
GO:0051387	negative regulation of neurotrophin TRK receptor signaling pathway (GO:0051387)	4	1	.23	+	4.26	2.48E-01	8.32E-01
GO:1905643	positive regulation of DNA methylation (GO:1905643)	4	1	.23	+	4.26	2.48E-01	8.32E-01
GO:0090082	positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082)	4	1	.23	+	4.26	2.48E-01	8.32E-01
GO:0090080	positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080)	4	1	.23	+	4.26	2.48E-01	8.32E-01
GO:0090024	negative regulation of neutrophil chemotaxis (GO:0090024)	4	1	.23	+	4.26	2.48E-01	8.32E-01
GO:0032185	septin cytoskeleton organization (GO:0032185)	4	1	.23	+	4.26	2.48E-01	8.31E-01
GO:0120222	regulation of blastocyst development (GO:0120222)	4	1	.23	+	4.26	2.48E-01	8.31E-01
GO:0044108	cellular alcohol biosynthetic process (GO:0044108)	4	1	.23	+	4.26	2.48E-01	8.31E-01
GO:0044107	cellular alcohol metabolic process (GO:0044107)	4	1	.23	+	4.26	2.48E-01	8.31E-01
GO:0031630	regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630)	8	2	.47	+	4.26	1.03E-01	5.81E-01
GO:0070346	positive regulation of fat cell proliferation (GO:0070346)	4	1	.23	+	4.26	2.48E-01	8.31E-01
GO:0036474	cell death in response to hydrogen peroxide (GO:0036474)	4	1	.23	+	4.26	2.48E-01	8.31E-01
GO:0099183	trans-synaptic signaling by BDNF, modulating synaptic transmission (GO:0099183)	4	1	.23	+	4.26	2.48E-01	8.30E-01
GO:0098698	postsynaptic specialization assembly (GO:0098698)	8	2	.47	+	4.26	1.03E-01	5.81E-01
GO:1990044	protein localization to lipid droplet (GO:1990044)	4	1	.23	+	4.26	2.48E-01	8.30E-01
GO:0035910	ascending aorta morphogenesis (GO:0035910)	4	1	.23	+	4.26	2.48E-01	8.30E-01
GO:0043503	skeletal muscle fiber adaptation (GO:0043503)	4	1	.23	+	4.26	2.48E-01	8.30E-01
GO:0031508	pericentric heterochromatin formation (GO:0031508)	4	1	.23	+	4.26	2.48E-01	8.30E-01
GO:0070278	extracellular matrix constituent secretion (GO:0070278)	4	1	.23	+	4.26	2.48E-01	8.29E-01
GO:1904997	regulation of leukocyte adhesion to arterial endothelial cell (GO:1904997)	4	1	.23	+	4.26	2.48E-01	8.29E-01
GO:1901000	regulation of response to salt stress (GO:1901000)	4	1	.23	+	4.26	2.48E-01	8.29E-01
GO:1904977	lymphatic endothelial cell migration (GO:1904977)	4	1	.23	+	4.26	2.48E-01	8.29E-01
GO:0070235	regulation of activation-induced cell death of T cells (GO:0070235)	4	1	.23	+	4.26	2.48E-01	8.29E-01
GO:1904954	canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904954)	4	1	.23	+	4.26	2.48E-01	8.29E-01
GO:0036378	calcitriol biosynthetic process from calciol (GO:0036378)	4	1	.23	+	4.26	2.48E-01	8.28E-01
GO:0036367	light adaption (GO:0036367)	4	1	.23	+	4.26	2.48E-01	8.28E-01
GO:0099039	sphingolipid translocation (GO:0099039)	4	1	.23	+	4.26	2.48E-01	8.28E-01
GO:0099011	neuronal dense core vesicle exocytosis (GO:0099011)	4	1	.23	+	4.26	2.48E-01	8.28E-01
GO:1905383	protein localization to presynapse (GO:1905383)	8	2	.47	+	4.26	1.03E-01	5.81E-01
GO:0035815	positive regulation of renal sodium excretion (GO:0035815)	12	3	.70	+	4.26	4.70E-02	3.64E-01
GO:0051001	negative regulation of nitric-oxide synthase activity (GO:0051001)	8	2	.47	+	4.26	1.03E-01	5.80E-01
GO:1904878	negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904878)	4	1	.23	+	4.26	2.48E-01	8.28E-01
GO:0048241	epinephrine transport (GO:0048241)	4	1	.23	+	4.26	2.48E-01	8.28E-01
GO:0030951	establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951)	4	1	.23	+	4.26	2.48E-01	8.27E-01
GO:1905289	regulation of CAMKK-AMPK signaling cascade (GO:1905289)	4	1	.23	+	4.26	2.48E-01	8.27E-01
GO:0043374	CD8-positive, alpha-beta T cell differentiation (GO:0043374)	8	2	.47	+	4.26	1.03E-01	5.80E-01
GO:1905246	negative regulation of aspartic-type peptidase activity (GO:1905246)	4	1	.23	+	4.26	2.48E-01	8.27E-01
GO:0035726	common myeloid progenitor cell proliferation (GO:0035726)	8	2	.47	+	4.26	1.03E-01	5.80E-01
GO:1904772	response to tetrachloromethane (GO:1904772)	4	1	.23	+	4.26	2.48E-01	8.27E-01
GO:0048165	fused antrum stage (GO:0048165)	4	1	.23	+	4.26	2.48E-01	8.27E-01
GO:0035621	ER to Golgi ceramide transport (GO:0035621)	4	1	.23	+	4.26	2.48E-01	8.26E-01
GO:1904684	negative regulation of metalloendopeptidase activity (GO:1904684)	4	1	.23	+	4.26	2.48E-01	8.26E-01
GO:0048050	post-embryonic eye morphogenesis (GO:0048050)	8	2	.47	+	4.26	1.03E-01	5.80E-01
GO:0030730	sequestering of triglyceride (GO:0030730)	4	1	.23	+	4.26	2.48E-01	8.26E-01
GO:0035585	calcium-mediated signaling using extracellular calcium source (GO:0035585)	4	1	.23	+	4.26	2.48E-01	8.26E-01
GO:0035583	sequestering of TGFbeta in extracellular matrix (GO:0035583)	4	1	.23	+	4.26	2.48E-01	8.26E-01
GO:0061820	telomeric D-loop disassembly (GO:0061820)	8	2	.47	+	4.26	1.03E-01	5.80E-01
GO:1905069	allantois development (GO:1905069)	4	1	.23	+	4.26	2.48E-01	8.26E-01
GO:1905031	regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031)	4	1	.23	+	4.26	2.48E-01	8.25E-01
GO:0009212	pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212)	4	1	.23	+	4.26	2.48E-01	8.25E-01
GO:1904580	regulation of intracellular mRNA localization (GO:1904580)	4	1	.23	+	4.26	2.48E-01	8.25E-01
GO:1900194	negative regulation of oocyte maturation (GO:1900194)	4	1	.23	+	4.26	2.48E-01	8.25E-01
GO:1900147	regulation of Schwann cell migration (GO:1900147)	4	1	.23	+	4.26	2.48E-01	8.25E-01
GO:0035493	SNARE complex assembly (GO:0035493)	12	3	.70	+	4.26	4.70E-02	3.64E-01
GO:0035481	positive regulation of Notch signaling pathway involved in heart induction (GO:0035481)	4	1	.23	+	4.26	2.48E-01	8.25E-01
GO:0035480	regulation of Notch signaling pathway involved in heart induction (GO:0035480)	4	1	.23	+	4.26	2.48E-01	8.24E-01
GO:0035441	cell migration involved in vasculogenesis (GO:0035441)	4	1	.23	+	4.26	2.48E-01	8.24E-01
GO:0015860	purine nucleoside transmembrane transport (GO:0015860)	4	1	.23	+	4.26	2.48E-01	8.24E-01
GO:0031034	myosin filament assembly (GO:0031034)	4	1	.23	+	4.26	2.48E-01	8.24E-01
GO:0031033	myosin filament organization (GO:0031033)	4	1	.23	+	4.26	2.48E-01	8.24E-01
GO:0046967	cytosol to endoplasmic reticulum transport (GO:0046967)	4	1	.23	+	4.26	2.48E-01	8.23E-01
GO:1900069	regulation of cellular hyperosmotic salinity response (GO:1900069)	4	1	.23	+	4.26	2.48E-01	8.23E-01
GO:0061684	chaperone-mediated autophagy (GO:0061684)	8	2	.47	+	4.26	1.03E-01	5.79E-01
GO:0010916	negative regulation of very-low-density lipoprotein particle clearance (GO:0010916)	4	1	.23	+	4.26	2.48E-01	8.23E-01
GO:0010915	regulation of very-low-density lipoprotein particle clearance (GO:0010915)	4	1	.23	+	4.26	2.48E-01	8.23E-01
GO:1903979	negative regulation of microglial cell activation (GO:1903979)	8	2	.47	+	4.26	1.03E-01	5.79E-01
GO:0061644	protein localization to CENP-A containing chromatin (GO:0061644)	4	1	.23	+	4.26	2.48E-01	8.23E-01
GO:0009093	cysteine catabolic process (GO:0009093)	4	1	.23	+	4.26	2.48E-01	8.23E-01
GO:0046877	regulation of saliva secretion (GO:0046877)	8	2	.47	+	4.26	1.03E-01	5.79E-01
GO:0046874	quinolinate metabolic process (GO:0046874)	4	1	.23	+	4.26	2.48E-01	8.22E-01
GO:0008592	regulation of Toll signaling pathway (GO:0008592)	4	1	.23	+	4.26	2.48E-01	8.22E-01
GO:0042426	choline catabolic process (GO:0042426)	4	1	.23	+	4.26	2.48E-01	8.22E-01
GO:0042421	norepinephrine biosynthetic process (GO:0042421)	8	2	.47	+	4.26	1.03E-01	5.79E-01
GO:0010873	positive regulation of cholesterol esterification (GO:0010873)	4	1	.23	+	4.26	2.48E-01	8.22E-01
GO:0010845	positive regulation of reciprocal meiotic recombination (GO:0010845)	4	1	.23	+	4.26	2.48E-01	8.22E-01
GO:0039663	membrane fusion involved in viral entry into host cell (GO:0039663)	4	1	.23	+	4.26	2.48E-01	8.22E-01
GO:1903867	extraembryonic membrane development (GO:1903867)	12	3	.70	+	4.26	4.70E-02	3.64E-01
GO:0035283	central nervous system segmentation (GO:0035283)	4	1	.23	+	4.26	2.48E-01	8.21E-01
GO:0061520	Langerhans cell differentiation (GO:0061520)	4	1	.23	+	4.26	2.48E-01	8.21E-01
GO:0150062	complement-mediated synapse pruning (GO:0150062)	4	1	.23	+	4.26	2.48E-01	8.21E-01
GO:0042396	phosphagen biosynthetic process (GO:0042396)	4	1	.23	+	4.26	2.48E-01	8.21E-01
GO:0097492	sympathetic neuron axon guidance (GO:0097492)	4	1	.23	+	4.26	2.48E-01	8.21E-01
GO:0097476	spinal cord motor neuron migration (GO:0097476)	4	1	.23	+	4.26	2.48E-01	8.21E-01
GO:0042368	vitamin D biosynthetic process (GO:0042368)	4	1	.23	+	4.26	2.48E-01	8.20E-01
GO:0010756	positive regulation of plasminogen activation (GO:0010756)	8	2	.47	+	4.26	1.03E-01	5.79E-01
GO:0061439	kidney vasculature morphogenesis (GO:0061439)	8	2	.47	+	4.26	1.03E-01	5.78E-01
GO:0061438	renal system vasculature morphogenesis (GO:0061438)	8	2	.47	+	4.26	1.03E-01	5.78E-01
GO:1903760	regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760)	4	1	.23	+	4.26	2.48E-01	8.20E-01
GO:0046666	retinal cell programmed cell death (GO:0046666)	4	1	.23	+	4.26	2.48E-01	8.20E-01
GO:0060932	His-Purkinje system cell differentiation (GO:0060932)	4	1	.23	+	4.26	2.48E-01	8.20E-01
GO:0060928	atrioventricular node cell development (GO:0060928)	4	1	.23	+	4.26	2.48E-01	8.20E-01
GO:0060922	atrioventricular node cell differentiation (GO:0060922)	4	1	.23	+	4.26	2.48E-01	8.19E-01
GO:0060913	cardiac cell fate determination (GO:0060913)	4	1	.23	+	4.26	2.48E-01	8.19E-01
GO:0042249	establishment of planar polarity of embryonic epithelium (GO:0042249)	4	1	.23	+	4.26	2.48E-01	8.19E-01
GO:0030214	hyaluronan catabolic process (GO:0030214)	16	4	.94	+	4.26	2.24E-02	2.24E-01
GO:0030202	heparin metabolic process (GO:0030202)	16	4	.94	+	4.26	2.24E-02	2.24E-01
GO:1903691	positive regulation of wound healing, spreading of epidermal cells (GO:1903691)	4	1	.23	+	4.26	2.48E-01	8.19E-01
GO:0061308	cardiac neural crest cell development involved in heart development (GO:0061308)	12	3	.70	+	4.26	4.70E-02	3.64E-01
GO:0061307	cardiac neural crest cell differentiation involved in heart development (GO:0061307)	12	3	.70	+	4.26	4.70E-02	3.63E-01
GO:0003400	regulation of COPII vesicle coating (GO:0003400)	4	1	.23	+	4.26	2.48E-01	8.19E-01
GO:0010593	negative regulation of lamellipodium assembly (GO:0010593)	4	1	.23	+	4.26	2.48E-01	8.19E-01
GO:1904028	positive regulation of collagen fibril organization (GO:1904028)	4	1	.23	+	4.26	2.48E-01	8.18E-01
GO:0010520	regulation of reciprocal meiotic recombination (GO:0010520)	4	1	.23	+	4.26	2.48E-01	8.18E-01
GO:0010510	regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510)	4	1	.23	+	4.26	2.48E-01	8.18E-01
GO:0003354	negative regulation of cilium movement (GO:0003354)	4	1	.23	+	4.26	2.48E-01	8.18E-01
GO:0072710	response to hydroxyurea (GO:0072710)	12	3	.70	+	4.26	4.70E-02	3.63E-01
GO:0060737	prostate gland morphogenetic growth (GO:0060737)	4	1	.23	+	4.26	2.48E-01	8.18E-01
GO:0046439	L-cysteine metabolic process (GO:0046439)	4	1	.23	+	4.26	2.48E-01	8.18E-01
GO:0034465	response to carbon monoxide (GO:0034465)	4	1	.23	+	4.26	2.48E-01	8.17E-01
GO:0002892	regulation of type II hypersensitivity (GO:0002892)	4	1	.23	+	4.26	2.48E-01	8.17E-01
GO:0014842	regulation of skeletal muscle satellite cell proliferation (GO:0014842)	12	3	.70	+	4.26	4.70E-02	3.63E-01
GO:0014827	intestine smooth muscle contraction (GO:0014827)	4	1	.23	+	4.26	2.48E-01	8.17E-01
GO:0014826	vein smooth muscle contraction (GO:0014826)	4	1	.23	+	4.26	2.48E-01	8.17E-01
GO:0030042	actin filament depolymerization (GO:0030042)	12	3	.70	+	4.26	4.70E-02	3.63E-01
GO:0014809	regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809)	4	1	.23	+	4.26	2.48E-01	8.17E-01
GO:1903430	negative regulation of cell maturation (GO:1903430)	8	2	.47	+	4.26	1.03E-01	5.78E-01
GO:0003292	cardiac septum cell differentiation (GO:0003292)	4	1	.23	+	4.26	2.48E-01	8.17E-01
GO:0060693	regulation of branching involved in salivary gland morphogenesis (GO:0060693)	8	2	.47	+	4.26	1.03E-01	5.78E-01
GO:0003273	cell migration involved in endocardial cushion formation (GO:0003273)	4	1	.23	+	4.26	2.48E-01	8.16E-01
GO:0007621	negative regulation of female receptivity (GO:0007621)	4	1	.23	+	4.26	2.48E-01	8.16E-01
GO:0003241	growth involved in heart morphogenesis (GO:0003241)	4	1	.23	+	4.26	2.48E-01	8.16E-01
GO:0003219	cardiac right ventricle formation (GO:0003219)	4	1	.23	+	4.26	2.48E-01	8.16E-01
GO:0046314	phosphocreatine biosynthetic process (GO:0046314)	4	1	.23	+	4.26	2.48E-01	8.16E-01
GO:0008065	establishment of blood-nerve barrier (GO:0008065)	4	1	.23	+	4.26	2.48E-01	8.16E-01
GO:0034309	primary alcohol biosynthetic process (GO:0034309)	4	1	.23	+	4.26	2.48E-01	8.15E-01
GO:0045898	regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898)	8	2	.47	+	4.26	1.03E-01	5.78E-01
GO:0061056	sclerotome development (GO:0061056)	4	1	.23	+	4.26	2.48E-01	8.15E-01
GO:0061050	regulation of cell growth involved in cardiac muscle cell development (GO:0061050)	16	4	.94	+	4.26	2.24E-02	2.24E-01
GO:0021888	hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888)	8	2	.47	+	4.26	1.03E-01	5.77E-01
GO:0021886	hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886)	8	2	.47	+	4.26	1.03E-01	5.77E-01
GO:0003190	atrioventricular valve formation (GO:0003190)	8	2	.47	+	4.26	1.03E-01	5.77E-01
GO:0003181	atrioventricular valve morphogenesis (GO:0003181)	24	6	1.41	+	4.26	5.42E-03	7.99E-02
GO:0007525	somatic muscle development (GO:0007525)	4	1	.23	+	4.26	2.48E-01	8.15E-01
GO:0003163	sinoatrial node development (GO:0003163)	12	3	.70	+	4.26	4.70E-02	3.63E-01
GO:0003162	atrioventricular node development (GO:0003162)	8	2	.47	+	4.26	1.03E-01	5.77E-01
GO:0060574	intestinal epithelial cell maturation (GO:0060574)	4	1	.23	+	4.26	2.48E-01	8.15E-01
GO:0003149	membranous septum morphogenesis (GO:0003149)	8	2	.47	+	4.26	1.03E-01	5.77E-01
GO:0060539	diaphragm development (GO:0060539)	8	2	.47	+	4.26	1.03E-01	5.76E-01
GO:0060502	epithelial cell proliferation involved in lung morphogenesis (GO:0060502)	4	1	.23	+	4.26	2.48E-01	8.15E-01
GO:0034242	negative regulation of syncytium formation by plasma membrane fusion (GO:0034242)	4	1	.23	+	4.26	2.48E-01	8.15E-01
GO:0060047	heart contraction (GO:0060047)	93	23	5.46	+	4.21	8.36E-08	4.73E-06
GO:1901976	regulation of cell cycle checkpoint (GO:1901976)	49	12	2.88	+	4.17	1.12E-04	3.11E-03
GO:0060071	Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	41	10	2.41	+	4.15	4.22E-04	9.56E-03
GO:0150115	cell-substrate junction organization (GO:0150115)	41	10	2.41	+	4.15	4.22E-04	9.54E-03
GO:0007051	spindle organization (GO:0007051)	160	39	9.40	+	4.15	4.28E-12	5.79E-10
GO:0071312	cellular response to alkaloid (GO:0071312)	37	9	2.17	+	4.14	8.26E-04	1.72E-02
GO:0014911	positive regulation of smooth muscle cell migration (GO:0014911)	37	9	2.17	+	4.14	8.26E-04	1.71E-02
GO:0140014	mitotic nuclear division (GO:0140014)	173	42	10.16	+	4.13	7.20E-13	1.13E-10
GO:0033137	negative regulation of peptidyl-serine phosphorylation (GO:0033137)	29	7	1.70	+	4.11	3.21E-03	5.30E-02
GO:0051497	negative regulation of stress fiber assembly (GO:0051497)	29	7	1.70	+	4.11	3.21E-03	5.29E-02
GO:0043153	entrainment of circadian clock by photoperiod (GO:0043153)	29	7	1.70	+	4.11	3.21E-03	5.29E-02
GO:0019933	cAMP-mediated signaling (GO:0019933)	29	7	1.70	+	4.11	3.21E-03	5.28E-02
GO:0014888	striated muscle adaptation (GO:0014888)	29	7	1.70	+	4.11	3.21E-03	5.28E-02
GO:0021952	central nervous system projection neuron axonogenesis (GO:0021952)	29	7	1.70	+	4.11	3.21E-03	5.27E-02
GO:0034695	response to prostaglandin E (GO:0034695)	25	6	1.47	+	4.09	6.41E-03	9.03E-02
GO:0007413	axonal fasciculation (GO:0007413)	21	5	1.23	+	4.05	1.29E-02	1.53E-01
GO:0001832	blastocyst growth (GO:0001832)	21	5	1.23	+	4.05	1.29E-02	1.53E-01
GO:0002042	cell migration involved in sprouting angiogenesis (GO:0002042)	21	5	1.23	+	4.05	1.29E-02	1.53E-01
GO:0032674	regulation of interleukin-5 production (GO:0032674)	21	5	1.23	+	4.05	1.29E-02	1.53E-01
GO:0106030	neuron projection fasciculation (GO:0106030)	21	5	1.23	+	4.05	1.29E-02	1.53E-01
GO:1902992	negative regulation of amyloid precursor protein catabolic process (GO:1902992)	21	5	1.23	+	4.05	1.29E-02	1.53E-01
GO:1902894	negative regulation of miRNA transcription (GO:1902894)	21	5	1.23	+	4.05	1.29E-02	1.53E-01
GO:1902893	regulation of miRNA transcription (GO:1902893)	63	15	3.70	+	4.05	2.14E-05	7.31E-04
GO:0044772	mitotic cell cycle phase transition (GO:0044772)	173	41	10.16	+	4.04	2.62E-12	3.66E-10
GO:0045214	sarcomere organization (GO:0045214)	38	9	2.23	+	4.03	9.72E-04	1.97E-02
GO:0051899	membrane depolarization (GO:0051899)	55	13	3.23	+	4.03	7.97E-05	2.34E-03
GO:0055021	regulation of cardiac muscle tissue growth (GO:0055021)	55	13	3.23	+	4.03	7.97E-05	2.34E-03
GO:1903236	regulation of leukocyte tethering or rolling (GO:1903236)	17	4	1.00	+	4.01	2.65E-02	2.54E-01
GO:1903206	negative regulation of hydrogen peroxide-induced cell death (GO:1903206)	17	4	1.00	+	4.01	2.65E-02	2.53E-01
GO:0046068	cGMP metabolic process (GO:0046068)	17	4	1.00	+	4.01	2.65E-02	2.53E-01
GO:0002363	alpha-beta T cell lineage commitment (GO:0002363)	17	4	1.00	+	4.01	2.65E-02	2.53E-01
GO:0072189	ureter development (GO:0072189)	17	4	1.00	+	4.01	2.65E-02	2.53E-01
GO:0007143	female meiotic nuclear division (GO:0007143)	34	8	2.00	+	4.01	1.91E-03	3.48E-02
GO:0007095	mitotic G2 DNA damage checkpoint signaling (GO:0007095)	34	8	2.00	+	4.01	1.91E-03	3.48E-02
GO:0007080	mitotic metaphase plate congression (GO:0007080)	51	12	2.99	+	4.01	1.54E-04	4.05E-03
GO:0051895	negative regulation of focal adhesion assembly (GO:0051895)	17	4	1.00	+	4.01	2.65E-02	2.53E-01
GO:0051412	response to corticosterone (GO:0051412)	17	4	1.00	+	4.01	2.65E-02	2.53E-01
GO:0070593	dendrite self-avoidance (GO:0070593)	17	4	1.00	+	4.01	2.65E-02	2.52E-01
GO:0050872	white fat cell differentiation (GO:0050872)	17	4	1.00	+	4.01	2.65E-02	2.52E-01
GO:1901032	negative regulation of response to reactive oxygen species (GO:1901032)	17	4	1.00	+	4.01	2.65E-02	2.52E-01
GO:1900006	positive regulation of dendrite development (GO:1900006)	17	4	1.00	+	4.01	2.65E-02	2.52E-01
GO:0150118	negative regulation of cell-substrate junction organization (GO:0150118)	17	4	1.00	+	4.01	2.65E-02	2.52E-01
GO:0061548	ganglion development (GO:0061548)	17	4	1.00	+	4.01	2.65E-02	2.52E-01
GO:0014829	vascular associated smooth muscle contraction (GO:0014829)	17	4	1.00	+	4.01	2.65E-02	2.52E-01
GO:0034394	protein localization to cell surface (GO:0034394)	34	8	2.00	+	4.01	1.91E-03	3.48E-02
GO:0044770	cell cycle phase transition (GO:0044770)	183	43	10.75	+	4.00	9.81E-13	1.48E-10
GO:1902895	positive regulation of miRNA transcription (GO:1902895)	47	11	2.76	+	3.99	2.99E-04	7.09E-03
GO:0006939	smooth muscle contraction (GO:0006939)	60	14	3.52	+	3.97	4.83E-05	1.52E-03
GO:0035637	multicellular organismal signaling (GO:0035637)	125	29	7.34	+	3.95	6.16E-09	4.22E-07
GO:0045741	positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)	13	3	.76	+	3.93	5.55E-02	3.98E-01
GO:0072376	protein activation cascade (GO:0072376)	26	6	1.53	+	3.93	7.52E-03	1.03E-01
GO:1902548	negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548)	13	3	.76	+	3.93	5.55E-02	3.98E-01
GO:0045475	locomotor rhythm (GO:0045475)	13	3	.76	+	3.93	5.55E-02	3.98E-01
GO:2000615	regulation of histone H3-K9 acetylation (GO:2000615)	13	3	.76	+	3.93	5.55E-02	3.98E-01
GO:2001046	positive regulation of integrin-mediated signaling pathway (GO:2001046)	13	3	.76	+	3.93	5.55E-02	3.98E-01
GO:2000551	regulation of T-helper 2 cell cytokine production (GO:2000551)	13	3	.76	+	3.93	5.55E-02	3.98E-01
GO:0038166	angiotensin-activated signaling pathway (GO:0038166)	13	3	.76	+	3.93	5.55E-02	3.97E-01
GO:0032823	regulation of natural killer cell differentiation (GO:0032823)	13	3	.76	+	3.93	5.55E-02	3.97E-01
GO:0033275	actin-myosin filament sliding (GO:0033275)	13	3	.76	+	3.93	5.55E-02	3.97E-01
GO:0002027	regulation of heart rate (GO:0002027)	104	24	6.11	+	3.93	1.34E-07	7.36E-06
GO:0002026	regulation of the force of heart contraction (GO:0002026)	26	6	1.53	+	3.93	7.52E-03	1.03E-01
GO:0070932	histone H3 deacetylation (GO:0070932)	13	3	.76	+	3.93	5.55E-02	3.97E-01
GO:0099625	ventricular cardiac muscle cell membrane repolarization (GO:0099625)	13	3	.76	+	3.93	5.55E-02	3.97E-01
GO:0044406	adhesion of symbiont to host (GO:0044406)	13	3	.76	+	3.93	5.55E-02	3.96E-01
GO:0043951	negative regulation of cAMP-mediated signaling (GO:0043951)	13	3	.76	+	3.93	5.55E-02	3.96E-01
GO:0048711	positive regulation of astrocyte differentiation (GO:0048711)	13	3	.76	+	3.93	5.55E-02	3.96E-01
GO:0051451	myoblast migration (GO:0051451)	13	3	.76	+	3.93	5.55E-02	3.96E-01
GO:0098915	membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915)	13	3	.76	+	3.93	5.55E-02	3.96E-01
GO:0098840	protein transport along microtubule (GO:0098840)	13	3	.76	+	3.93	5.55E-02	3.96E-01
GO:0099118	microtubule-based protein transport (GO:0099118)	13	3	.76	+	3.93	5.55E-02	3.95E-01
GO:0009650	UV protection (GO:0009650)	13	3	.76	+	3.93	5.55E-02	3.95E-01
GO:0035865	cellular response to potassium ion (GO:0035865)	13	3	.76	+	3.93	5.55E-02	3.95E-01
GO:1904754	positive regulation of vascular associated smooth muscle cell migration (GO:1904754)	13	3	.76	+	3.93	5.55E-02	3.95E-01
GO:0031274	positive regulation of pseudopodium assembly (GO:0031274)	13	3	.76	+	3.93	5.55E-02	3.95E-01
GO:0031272	regulation of pseudopodium assembly (GO:0031272)	13	3	.76	+	3.93	5.55E-02	3.94E-01
GO:1904666	regulation of ubiquitin protein ligase activity (GO:1904666)	26	6	1.53	+	3.93	7.52E-03	1.03E-01
GO:0016322	neuron remodeling (GO:0016322)	13	3	.76	+	3.93	5.55E-02	3.94E-01
GO:1904385	cellular response to angiotensin (GO:1904385)	26	6	1.53	+	3.93	7.52E-03	1.03E-01
GO:0010752	regulation of cGMP-mediated signaling (GO:0010752)	13	3	.76	+	3.93	5.55E-02	3.94E-01
GO:0010739	positive regulation of protein kinase A signaling (GO:0010739)	13	3	.76	+	3.93	5.55E-02	3.94E-01
GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642)	13	3	.76	+	3.93	5.55E-02	3.94E-01
GO:0010613	positive regulation of cardiac muscle hypertrophy (GO:0010613)	26	6	1.53	+	3.93	7.52E-03	1.03E-01
GO:0014912	negative regulation of smooth muscle cell migration (GO:0014912)	26	6	1.53	+	3.93	7.52E-03	1.03E-01
GO:0060707	trophoblast giant cell differentiation (GO:0060707)	13	3	.76	+	3.93	5.55E-02	3.94E-01
GO:0014854	response to inactivity (GO:0014854)	13	3	.76	+	3.93	5.55E-02	3.93E-01
GO:0007597	blood coagulation, intrinsic pathway (GO:0007597)	13	3	.76	+	3.93	5.55E-02	3.93E-01
GO:0072578	neurotransmitter-gated ion channel clustering (GO:0072578)	13	3	.76	+	3.93	5.55E-02	3.93E-01
GO:0060043	regulation of cardiac muscle cell proliferation (GO:0060043)	39	9	2.29	+	3.93	1.14E-03	2.26E-02
GO:0006936	muscle contraction (GO:0006936)	230	53	13.51	+	3.92	4.42E-15	9.24E-13
GO:0001508	action potential (GO:0001508)	100	23	5.87	+	3.92	2.56E-07	1.34E-05
GO:0051225	spindle assembly (GO:0051225)	96	22	5.64	+	3.90	4.88E-07	2.44E-05
GO:1901991	negative regulation of mitotic cell cycle phase transition (GO:1901991)	166	38	9.75	+	3.90	3.96E-11	4.46E-09
GO:0150077	regulation of neuroinflammatory response (GO:0150077)	35	8	2.06	+	3.89	2.23E-03	3.95E-02
GO:2000629	negative regulation of miRNA metabolic process (GO:2000629)	22	5	1.29	+	3.87	1.51E-02	1.74E-01
GO:0002082	regulation of oxidative phosphorylation (GO:0002082)	22	5	1.29	+	3.87	1.51E-02	1.74E-01
GO:0001556	oocyte maturation (GO:0001556)	22	5	1.29	+	3.87	1.51E-02	1.74E-01
GO:0044321	response to leptin (GO:0044321)	22	5	1.29	+	3.87	1.51E-02	1.74E-01
GO:0044062	regulation of excretion (GO:0044062)	22	5	1.29	+	3.87	1.51E-02	1.73E-01
GO:1900120	regulation of receptor binding (GO:1900120)	22	5	1.29	+	3.87	1.51E-02	1.73E-01
GO:0010738	regulation of protein kinase A signaling (GO:0010738)	22	5	1.29	+	3.87	1.51E-02	1.73E-01
GO:0003228	atrial cardiac muscle tissue development (GO:0003228)	22	5	1.29	+	3.87	1.51E-02	1.73E-01
GO:0014910	regulation of smooth muscle cell migration (GO:0014910)	66	15	3.88	+	3.87	3.41E-05	1.11E-03
GO:0003012	muscle system process (GO:0003012)	282	64	16.56	+	3.86	1.16E-17	3.87E-15
GO:0060420	regulation of heart growth (GO:0060420)	62	14	3.64	+	3.85	6.57E-05	1.98E-03
GO:0060325	face morphogenesis (GO:0060325)	31	7	1.82	+	3.85	4.41E-03	6.86E-02
GO:0010464	regulation of mesenchymal cell proliferation (GO:0010464)	31	7	1.82	+	3.85	4.41E-03	6.85E-02
GO:0051261	protein depolymerization (GO:0051261)	40	9	2.35	+	3.83	1.33E-03	2.56E-02
GO:0010863	positive regulation of phospholipase C activity (GO:0010863)	40	9	2.35	+	3.83	1.33E-03	2.55E-02
GO:0002691	regulation of cellular extravasation (GO:0002691)	40	9	2.35	+	3.83	1.33E-03	2.55E-02
GO:0002686	negative regulation of leukocyte migration (GO:0002686)	49	11	2.88	+	3.82	4.07E-04	9.25E-03
GO:0090175	regulation of establishment of planar polarity (GO:0090175)	58	13	3.41	+	3.82	1.27E-04	3.48E-03
GO:0055117	regulation of cardiac muscle contraction (GO:0055117)	76	17	4.46	+	3.81	1.25E-05	4.55E-04
GO:0008016	regulation of heart contraction (GO:0008016)	202	45	11.86	+	3.79	1.43E-12	2.07E-10
GO:0002576	platelet degranulation (GO:0002576)	9	2	.53	+	3.78	1.21E-01	5.92E-01
GO:0060353	regulation of cell adhesion molecule production (GO:0060353)	9	2	.53	+	3.78	1.21E-01	5.92E-01
GO:0060316	positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316)	9	2	.53	+	3.78	1.21E-01	5.92E-01
GO:0006863	purine nucleobase transport (GO:0006863)	9	2	.53	+	3.78	1.21E-01	5.91E-01
GO:0006837	serotonin transport (GO:0006837)	9	2	.53	+	3.78	1.21E-01	5.91E-01
GO:1903027	regulation of opsonization (GO:1903027)	18	4	1.06	+	3.78	3.10E-02	2.77E-01
GO:0021534	cell proliferation in hindbrain (GO:0021534)	9	2	.53	+	3.78	1.21E-01	5.91E-01
GO:0001956	positive regulation of neurotransmitter secretion (GO:0001956)	18	4	1.06	+	3.78	3.10E-02	2.77E-01
GO:0006776	vitamin A metabolic process (GO:0006776)	9	2	.53	+	3.78	1.21E-01	5.91E-01
GO:0007064	mitotic sister chromatid cohesion (GO:0007064)	18	4	1.06	+	3.78	3.10E-02	2.77E-01
GO:0060056	mammary gland involution (GO:0060056)	9	2	.53	+	3.78	1.21E-01	5.91E-01
GO:0002138	retinoic acid biosynthetic process (GO:0002138)	9	2	.53	+	3.78	1.21E-01	5.90E-01
GO:0033292	T-tubule organization (GO:0033292)	9	2	.53	+	3.78	1.21E-01	5.90E-01
GO:0051900	regulation of mitochondrial depolarization (GO:0051900)	18	4	1.06	+	3.78	3.10E-02	2.77E-01
GO:0038026	reelin-mediated signaling pathway (GO:0038026)	9	2	.53	+	3.78	1.21E-01	5.90E-01
GO:0002003	angiotensin maturation (GO:0002003)	9	2	.53	+	3.78	1.21E-01	5.90E-01
GO:0001547	antral ovarian follicle growth (GO:0001547)	9	2	.53	+	3.78	1.21E-01	5.90E-01
GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770)	18	4	1.06	+	3.78	3.10E-02	2.77E-01
GO:0048861	leukemia inhibitory factor signaling pathway (GO:0048861)	9	2	.53	+	3.78	1.21E-01	5.90E-01
GO:0099545	trans-synaptic signaling by trans-synaptic complex (GO:0099545)	9	2	.53	+	3.78	1.21E-01	5.89E-01
GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037)	18	4	1.06	+	3.78	3.10E-02	2.77E-01
GO:2000096	positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)	9	2	.53	+	3.78	1.21E-01	5.89E-01
GO:0006069	ethanol oxidation (GO:0006069)	9	2	.53	+	3.78	1.21E-01	5.89E-01
GO:1990314	cellular response to insulin-like growth factor stimulus (GO:1990314)	9	2	.53	+	3.78	1.21E-01	5.89E-01
GO:1901334	lactone metabolic process (GO:1901334)	9	2	.53	+	3.78	1.21E-01	5.89E-01
GO:0070562	regulation of vitamin D receptor signaling pathway (GO:0070562)	9	2	.53	+	3.78	1.21E-01	5.88E-01
GO:0090136	epithelial cell-cell adhesion (GO:0090136)	18	4	1.06	+	3.78	3.10E-02	2.76E-01
GO:0048617	embryonic foregut morphogenesis (GO:0048617)	9	2	.53	+	3.78	1.21E-01	5.88E-01
GO:0051329	mitotic interphase (GO:0051329)	9	2	.53	+	3.78	1.21E-01	5.88E-01
GO:0051325	interphase (GO:0051325)	9	2	.53	+	3.78	1.21E-01	5.88E-01
GO:0098813	nuclear chromosome segregation (GO:0098813)	234	52	13.74	+	3.78	2.80E-14	5.35E-12
GO:0048541	Peyer's patch development (GO:0048541)	9	2	.53	+	3.78	1.21E-01	5.88E-01
GO:0048537	mucosa-associated lymphoid tissue development (GO:0048537)	9	2	.53	+	3.78	1.21E-01	5.87E-01
GO:0031620	regulation of fever generation (GO:0031620)	9	2	.53	+	3.78	1.21E-01	5.87E-01
GO:0098696	regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0098696)	9	2	.53	+	3.78	1.21E-01	5.87E-01
GO:0098598	learned vocalization behavior or vocal learning (GO:0098598)	9	2	.53	+	3.78	1.21E-01	5.87E-01
GO:0035860	glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860)	9	2	.53	+	3.78	1.21E-01	5.87E-01
GO:0043369	CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)	18	4	1.06	+	3.78	3.10E-02	2.76E-01
GO:1904776	regulation of protein localization to cell cortex (GO:1904776)	9	2	.53	+	3.78	1.21E-01	5.87E-01
GO:0048012	hepatocyte growth factor receptor signaling pathway (GO:0048012)	9	2	.53	+	3.78	1.21E-01	5.86E-01
GO:1900222	negative regulation of amyloid-beta clearance (GO:1900222)	9	2	.53	+	3.78	1.21E-01	5.86E-01
GO:1900122	positive regulation of receptor binding (GO:1900122)	9	2	.53	+	3.78	1.21E-01	5.86E-01
GO:1900119	positive regulation of execution phase of apoptosis (GO:1900119)	9	2	.53	+	3.78	1.21E-01	5.86E-01
GO:0015884	folic acid transport (GO:0015884)	9	2	.53	+	3.78	1.21E-01	5.86E-01
GO:0043031	negative regulation of macrophage activation (GO:0043031)	18	4	1.06	+	3.78	3.10E-02	2.76E-01
GO:1904491	protein localization to ciliary transition zone (GO:1904491)	9	2	.53	+	3.78	1.21E-01	5.86E-01
GO:0010958	regulation of amino acid import across plasma membrane (GO:0010958)	18	4	1.06	+	3.78	3.10E-02	2.76E-01
GO:1903978	regulation of microglial cell activation (GO:1903978)	18	4	1.06	+	3.78	3.10E-02	2.76E-01
GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360)	9	2	.53	+	3.78	1.21E-01	5.85E-01
GO:0062099	negative regulation of programmed necrotic cell death (GO:0062099)	18	4	1.06	+	3.78	3.10E-02	2.76E-01
GO:0042481	regulation of odontogenesis (GO:0042481)	18	4	1.06	+	3.78	3.10E-02	2.75E-01
GO:0042416	dopamine biosynthetic process (GO:0042416)	9	2	.53	+	3.78	1.21E-01	5.85E-01
GO:1903789	regulation of amino acid transmembrane transport (GO:1903789)	18	4	1.06	+	3.78	3.10E-02	2.75E-01
GO:0060926	cardiac pacemaker cell development (GO:0060926)	9	2	.53	+	3.78	1.21E-01	5.85E-01
GO:0046645	positive regulation of gamma-delta T cell activation (GO:0046645)	9	2	.53	+	3.78	1.21E-01	5.85E-01
GO:0046601	positive regulation of centriole replication (GO:0046601)	9	2	.53	+	3.78	1.21E-01	5.85E-01
GO:0010692	regulation of alkaline phosphatase activity (GO:0010692)	9	2	.53	+	3.78	1.21E-01	5.84E-01
GO:0019852	L-ascorbic acid metabolic process (GO:0019852)	9	2	.53	+	3.78	1.21E-01	5.84E-01
GO:0003417	growth plate cartilage development (GO:0003417)	18	4	1.06	+	3.78	3.10E-02	2.75E-01
GO:0008228	opsonization (GO:0008228)	9	2	.53	+	3.78	1.21E-01	5.84E-01
GO:1903579	negative regulation of ATP metabolic process (GO:1903579)	18	4	1.06	+	3.78	3.10E-02	2.75E-01
GO:0003307	regulation of Wnt signaling pathway involved in heart development (GO:0003307)	9	2	.53	+	3.78	1.21E-01	5.84E-01
GO:0060717	chorion development (GO:0060717)	9	2	.53	+	3.78	1.21E-01	5.84E-01
GO:0014891	striated muscle atrophy (GO:0014891)	9	2	.53	+	3.78	1.21E-01	5.84E-01
GO:0002830	positive regulation of type 2 immune response (GO:0002830)	18	4	1.06	+	3.78	3.10E-02	2.75E-01
GO:0021930	cerebellar granule cell precursor proliferation (GO:0021930)	9	2	.53	+	3.78	1.21E-01	5.83E-01
GO:0021924	cell proliferation in external granule layer (GO:0021924)	9	2	.53	+	3.78	1.21E-01	5.83E-01
GO:0034351	negative regulation of glial cell apoptotic process (GO:0034351)	9	2	.53	+	3.78	1.21E-01	5.83E-01
GO:0002752	cell surface pattern recognition receptor signaling pathway (GO:0002752)	9	2	.53	+	3.78	1.21E-01	5.83E-01
GO:0085020	protein K6-linked ubiquitination (GO:0085020)	9	2	.53	+	3.78	1.21E-01	5.83E-01
GO:0045835	negative regulation of meiotic nuclear division (GO:0045835)	9	2	.53	+	3.78	1.21E-01	5.82E-01
GO:0060317	cardiac epithelial to mesenchymal transition (GO:0060317)	27	6	1.59	+	3.78	8.77E-03	1.14E-01
GO:0060314	regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)	27	6	1.59	+	3.78	8.77E-03	1.14E-01
GO:0048799	animal organ maturation (GO:0048799)	27	6	1.59	+	3.78	8.77E-03	1.14E-01
GO:0000281	mitotic cytokinesis (GO:0000281)	81	18	4.76	+	3.78	7.57E-06	2.93E-04
GO:0014742	positive regulation of muscle hypertrophy (GO:0014742)	27	6	1.59	+	3.78	8.77E-03	1.14E-01
GO:0003171	atrioventricular valve development (GO:0003171)	27	6	1.59	+	3.78	8.77E-03	1.14E-01
GO:0003156	regulation of animal organ formation (GO:0003156)	27	6	1.59	+	3.78	8.77E-03	1.14E-01
GO:0032467	positive regulation of cytokinesis (GO:0032467)	45	10	2.64	+	3.78	7.91E-04	1.66E-02
GO:0051310	metaphase plate congression (GO:0051310)	63	14	3.70	+	3.78	7.62E-05	2.25E-03
GO:0007093	mitotic cell cycle checkpoint signaling (GO:0007093)	127	28	7.46	+	3.75	2.88E-08	1.72E-06
GO:0002040	sprouting angiogenesis (GO:0002040)	59	13	3.46	+	3.75	1.47E-04	3.90E-03
GO:0051148	negative regulation of muscle cell differentiation (GO:0051148)	59	13	3.46	+	3.75	1.47E-04	3.90E-03
GO:1990776	response to angiotensin (GO:1990776)	32	7	1.88	+	3.73	5.12E-03	7.63E-02
GO:0032232	negative regulation of actin filament bundle assembly (GO:0032232)	32	7	1.88	+	3.73	5.12E-03	7.62E-02
GO:0055006	cardiac cell development (GO:0055006)	64	14	3.76	+	3.73	8.82E-05	2.53E-03
GO:0008156	negative regulation of DNA replication (GO:0008156)	32	7	1.88	+	3.73	5.12E-03	7.62E-02
GO:0044843	cell cycle G1/S phase transition (GO:0044843)	87	19	5.11	+	3.72	5.30E-06	2.13E-04
GO:0019935	cyclic-nucleotide-mediated signaling (GO:0019935)	55	12	3.23	+	3.72	2.83E-04	6.73E-03
GO:0003179	heart valve morphogenesis (GO:0003179)	55	12	3.23	+	3.72	2.83E-04	6.72E-03
GO:1903047	mitotic cell cycle process (GO:1903047)	533	116	31.30	+	3.71	7.83E-30	1.12E-26
GO:0022010	central nervous system myelination (GO:0022010)	23	5	1.35	+	3.70	1.76E-02	1.89E-01
GO:0052652	cyclic purine nucleotide metabolic process (GO:0052652)	23	5	1.35	+	3.70	1.76E-02	1.89E-01
GO:1901992	positive regulation of mitotic cell cycle phase transition (GO:1901992)	92	20	5.40	+	3.70	3.21E-06	1.36E-04
GO:0032291	axon ensheathment in central nervous system (GO:0032291)	23	5	1.35	+	3.70	1.76E-02	1.89E-01
GO:0043567	regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)	23	5	1.35	+	3.70	1.76E-02	1.88E-01
GO:0009190	cyclic nucleotide biosynthetic process (GO:0009190)	23	5	1.35	+	3.70	1.76E-02	1.88E-01
GO:0010560	positive regulation of glycoprotein biosynthetic process (GO:0010560)	23	5	1.35	+	3.70	1.76E-02	1.88E-01
GO:0045822	negative regulation of heart contraction (GO:0045822)	23	5	1.35	+	3.70	1.76E-02	1.88E-01
GO:0000075	cell cycle checkpoint signaling (GO:0000075)	157	34	9.22	+	3.69	1.45E-09	1.18E-07
GO:1903670	regulation of sprouting angiogenesis (GO:1903670)	37	8	2.17	+	3.68	3.01E-03	5.06E-02
GO:0006261	DNA-templated DNA replication (GO:0006261)	139	30	8.16	+	3.68	1.41E-08	8.91E-07
GO:0006260	DNA replication (GO:0006260)	205	44	12.04	+	3.66	7.41E-12	9.60E-10
GO:0021681	cerebellar granular layer development (GO:0021681)	14	3	.82	+	3.65	6.47E-02	4.41E-01
GO:0001991	regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991)	14	3	.82	+	3.65	6.47E-02	4.41E-01
GO:1902514	regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514)	14	3	.82	+	3.65	6.47E-02	4.41E-01
GO:0072075	metanephric mesenchyme development (GO:0072075)	14	3	.82	+	3.65	6.47E-02	4.41E-01
GO:2000402	negative regulation of lymphocyte migration (GO:2000402)	14	3	.82	+	3.65	6.47E-02	4.41E-01
GO:0002052	positive regulation of neuroblast proliferation (GO:0002052)	28	6	1.64	+	3.65	1.02E-02	1.28E-01
GO:0071107	response to parathyroid hormone (GO:0071107)	14	3	.82	+	3.65	6.47E-02	4.41E-01
GO:0048681	negative regulation of axon regeneration (GO:0048681)	14	3	.82	+	3.65	6.47E-02	4.40E-01
GO:0005513	detection of calcium ion (GO:0005513)	14	3	.82	+	3.65	6.47E-02	4.40E-01
GO:0120305	regulation of pigmentation (GO:0120305)	14	3	.82	+	3.65	6.47E-02	4.40E-01
GO:1901077	regulation of relaxation of muscle (GO:1901077)	14	3	.82	+	3.65	6.47E-02	4.40E-01
GO:0070102	interleukin-6-mediated signaling pathway (GO:0070102)	14	3	.82	+	3.65	6.47E-02	4.40E-01
GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)	14	3	.82	+	3.65	6.47E-02	4.39E-01
GO:0048070	regulation of developmental pigmentation (GO:0048070)	14	3	.82	+	3.65	6.47E-02	4.39E-01
GO:1900274	regulation of phospholipase C activity (GO:1900274)	42	9	2.47	+	3.65	1.78E-03	3.29E-02
GO:0035542	regulation of SNARE complex assembly (GO:0035542)	14	3	.82	+	3.65	6.47E-02	4.39E-01
GO:0031115	negative regulation of microtubule polymerization (GO:0031115)	14	3	.82	+	3.65	6.47E-02	4.39E-01
GO:0047484	regulation of response to osmotic stress (GO:0047484)	14	3	.82	+	3.65	6.47E-02	4.39E-01
GO:0086026	atrial cardiac muscle cell to AV node cell signaling (GO:0086026)	14	3	.82	+	3.65	6.47E-02	4.38E-01
GO:0086014	atrial cardiac muscle cell action potential (GO:0086014)	14	3	.82	+	3.65	6.47E-02	4.38E-01
GO:0019934	cGMP-mediated signaling (GO:0019934)	28	6	1.64	+	3.65	1.02E-02	1.28E-01
GO:0014812	muscle cell migration (GO:0014812)	28	6	1.64	+	3.65	1.02E-02	1.28E-01
GO:0030007	cellular potassium ion homeostasis (GO:0030007)	14	3	.82	+	3.65	6.47E-02	4.38E-01
GO:0045820	negative regulation of glycolytic process (GO:0045820)	14	3	.82	+	3.65	6.47E-02	4.38E-01
GO:0048145	regulation of fibroblast proliferation (GO:0048145)	89	19	5.23	+	3.64	7.04E-06	2.73E-04
GO:0006940	regulation of smooth muscle contraction (GO:0006940)	61	13	3.58	+	3.63	1.95E-04	4.95E-03
GO:0007059	chromosome segregation (GO:0007059)	291	62	17.09	+	3.63	4.97E-16	1.26E-13
GO:0022617	extracellular matrix disassembly (GO:0022617)	47	10	2.76	+	3.62	1.06E-03	2.12E-02
GO:0055001	muscle cell development (GO:0055001)	160	34	9.40	+	3.62	2.21E-09	1.67E-07
GO:0051968	positive regulation of synaptic transmission, glutamatergic (GO:0051968)	33	7	1.94	+	3.61	5.92E-03	8.56E-02
GO:0098801	regulation of renal system process (GO:0098801)	33	7	1.94	+	3.61	5.92E-03	8.55E-02
GO:0009648	photoperiodism (GO:0009648)	33	7	1.94	+	3.61	5.92E-03	8.54E-02
GO:0034694	response to prostaglandin (GO:0034694)	33	7	1.94	+	3.61	5.92E-03	8.53E-02
GO:0014896	muscle hypertrophy (GO:0014896)	33	7	1.94	+	3.61	5.92E-03	8.52E-02
GO:0000082	G1/S transition of mitotic cell cycle (GO:0000082)	85	18	4.99	+	3.61	1.34E-05	4.83E-04
GO:0006941	striated muscle contraction (GO:0006941)	109	23	6.40	+	3.59	9.43E-07	4.44E-05
GO:0045780	positive regulation of bone resorption (GO:0045780)	19	4	1.12	+	3.59	3.59E-02	3.06E-01
GO:0003094	glomerular filtration (GO:0003094)	19	4	1.12	+	3.59	3.59E-02	3.06E-01
GO:2000269	regulation of fibroblast apoptotic process (GO:2000269)	19	4	1.12	+	3.59	3.59E-02	3.06E-01
GO:0035813	regulation of renal sodium excretion (GO:0035813)	19	4	1.12	+	3.59	3.59E-02	3.06E-01
GO:0031290	retinal ganglion cell axon guidance (GO:0031290)	19	4	1.12	+	3.59	3.59E-02	3.06E-01
GO:0031032	actomyosin structure organization (GO:0031032)	114	24	6.69	+	3.59	5.71E-07	2.81E-05
GO:0097106	postsynaptic density organization (GO:0097106)	19	4	1.12	+	3.59	3.59E-02	3.05E-01
GO:0014743	regulation of muscle hypertrophy (GO:0014743)	57	12	3.35	+	3.59	3.75E-04	8.66E-03
GO:1901988	negative regulation of cell cycle phase transition (GO:1901988)	224	47	13.15	+	3.57	2.86E-12	3.97E-10
GO:0014003	oligodendrocyte development (GO:0014003)	43	9	2.52	+	3.56	2.05E-03	3.66E-02
GO:0010559	regulation of glycoprotein biosynthetic process (GO:0010559)	43	9	2.52	+	3.56	2.05E-03	3.66E-02
GO:0031100	animal organ regeneration (GO:0031100)	67	14	3.93	+	3.56	1.35E-04	3.62E-03
GO:0000278	mitotic cell cycle (GO:0000278)	627	131	36.82	+	3.56	4.03E-32	7.89E-29
GO:1903018	regulation of glycoprotein metabolic process (GO:1903018)	48	10	2.82	+	3.55	1.21E-03	2.39E-02
GO:0002053	positive regulation of mesenchymal cell proliferation (GO:0002053)	24	5	1.41	+	3.55	2.03E-02	2.09E-01
GO:0048483	autonomic nervous system development (GO:0048483)	48	10	2.82	+	3.55	1.21E-03	2.39E-02
GO:0042311	vasodilation (GO:0042311)	48	10	2.82	+	3.55	1.21E-03	2.38E-02
GO:0061484	hematopoietic stem cell homeostasis (GO:0061484)	24	5	1.41	+	3.55	2.03E-02	2.08E-01
GO:0003401	axis elongation (GO:0003401)	24	5	1.41	+	3.55	2.03E-02	2.08E-01
GO:0045599	negative regulation of fat cell differentiation (GO:0045599)	53	11	3.11	+	3.53	7.22E-04	1.54E-02
GO:2000630	positive regulation of miRNA metabolic process (GO:2000630)	53	11	3.11	+	3.53	7.22E-04	1.54E-02
GO:0048662	negative regulation of smooth muscle cell proliferation (GO:0048662)	53	11	3.11	+	3.53	7.22E-04	1.54E-02
GO:0010596	negative regulation of endothelial cell migration (GO:0010596)	53	11	3.11	+	3.53	7.22E-04	1.54E-02
GO:0034698	response to gonadotropin (GO:0034698)	29	6	1.70	+	3.52	1.17E-02	1.42E-01
GO:1903319	positive regulation of protein maturation (GO:1903319)	29	6	1.70	+	3.52	1.17E-02	1.42E-01
GO:0045931	positive regulation of mitotic cell cycle (GO:0045931)	121	25	7.11	+	3.52	4.53E-07	2.28E-05
GO:0045669	positive regulation of osteoblast differentiation (GO:0045669)	68	14	3.99	+	3.51	1.54E-04	4.05E-03
GO:1905606	regulation of presynapse assembly (GO:1905606)	34	7	2.00	+	3.51	6.80E-03	9.48E-02
GO:0099174	regulation of presynapse organization (GO:0099174)	34	7	2.00	+	3.51	6.80E-03	9.48E-02
GO:0009649	entrainment of circadian clock (GO:0009649)	34	7	2.00	+	3.51	6.80E-03	9.47E-02
GO:0040001	establishment of mitotic spindle localization (GO:0040001)	39	8	2.29	+	3.49	3.99E-03	6.32E-02
GO:0042551	neuron maturation (GO:0042551)	39	8	2.29	+	3.49	3.99E-03	6.31E-02
GO:0050000	chromosome localization (GO:0050000)	83	17	4.87	+	3.49	3.34E-05	1.09E-03
GO:0043114	regulation of vascular permeability (GO:0043114)	49	10	2.88	+	3.48	1.39E-03	2.65E-02
GO:0010389	regulation of G2/M transition of mitotic cell cycle (GO:0010389)	98	20	5.75	+	3.48	7.32E-06	2.83E-04
GO:0072132	mesenchyme morphogenesis (GO:0072132)	54	11	3.17	+	3.47	8.26E-04	1.72E-02
GO:0001706	endoderm formation (GO:0001706)	54	11	3.17	+	3.47	8.26E-04	1.72E-02
GO:0035914	skeletal muscle cell differentiation (GO:0035914)	54	11	3.17	+	3.47	8.26E-04	1.72E-02
GO:0010611	regulation of cardiac muscle hypertrophy (GO:0010611)	54	11	3.17	+	3.47	8.26E-04	1.72E-02
GO:1903522	regulation of blood circulation (GO:1903522)	251	51	14.74	+	3.46	9.72E-13	1.48E-10
GO:0042698	ovulation cycle (GO:0042698)	69	14	4.05	+	3.46	1.76E-04	4.55E-03
GO:2000628	regulation of miRNA metabolic process (GO:2000628)	74	15	4.35	+	3.45	1.06E-04	2.96E-03
GO:0071277	cellular response to calcium ion (GO:0071277)	89	18	5.23	+	3.44	2.30E-05	7.78E-04
GO:0032465	regulation of cytokinesis (GO:0032465)	94	19	5.52	+	3.44	1.38E-05	4.97E-04
GO:0045930	negative regulation of mitotic cell cycle (GO:0045930)	213	43	12.51	+	3.44	7.06E-11	7.68E-09
GO:0007519	skeletal muscle tissue development (GO:0007519)	134	27	7.87	+	3.43	2.46E-07	1.30E-05
GO:0006937	regulation of muscle contraction (GO:0006937)	169	34	9.92	+	3.43	7.35E-09	4.90E-07
GO:0045794	negative regulation of cell volume (GO:0045794)	5	1	.29	+	3.41	2.90E-01	9.08E-01
GO:1903294	regulation of glutamate secretion, neurotransmission (GO:1903294)	5	1	.29	+	3.41	2.90E-01	9.08E-01
GO:0021764	amygdala development (GO:0021764)	5	1	.29	+	3.41	2.90E-01	9.08E-01
GO:0003093	regulation of glomerular filtration (GO:0003093)	10	2	.59	+	3.41	1.40E-01	6.58E-01
GO:0007440	foregut morphogenesis (GO:0007440)	10	2	.59	+	3.41	1.40E-01	6.57E-01
GO:0003072	renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072)	5	1	.29	+	3.41	2.90E-01	9.08E-01
GO:0060433	bronchus development (GO:0060433)	10	2	.59	+	3.41	1.40E-01	6.57E-01
GO:0060406	positive regulation of penile erection (GO:0060406)	5	1	.29	+	3.41	2.90E-01	9.08E-01
GO:1902730	positive regulation of proteoglycan biosynthetic process (GO:1902730)	5	1	.29	+	3.41	2.90E-01	9.07E-01
GO:0046125	pyrimidine deoxyribonucleoside metabolic process (GO:0046125)	5	1	.29	+	3.41	2.90E-01	9.07E-01
GO:0046104	thymidine metabolic process (GO:0046104)	5	1	.29	+	3.41	2.90E-01	9.07E-01
GO:0034115	negative regulation of heterotypic cell-cell adhesion (GO:0034115)	10	2	.59	+	3.41	1.40E-01	6.57E-01
GO:0071932	replication fork reversal (GO:0071932)	5	1	.29	+	3.41	2.90E-01	9.07E-01
GO:0021683	cerebellar granular layer morphogenesis (GO:0021683)	10	2	.59	+	3.41	1.40E-01	6.57E-01
GO:0033602	negative regulation of dopamine secretion (GO:0033602)	5	1	.29	+	3.41	2.90E-01	9.07E-01
GO:0072377	blood coagulation, common pathway (GO:0072377)	5	1	.29	+	3.41	2.90E-01	9.07E-01
GO:0060347	heart trabecula formation (GO:0060347)	15	3	.88	+	3.41	7.45E-02	4.78E-01
GO:2000822	regulation of behavioral fear response (GO:2000822)	10	2	.59	+	3.41	1.40E-01	6.57E-01
GO:0071895	odontoblast differentiation (GO:0071895)	5	1	.29	+	3.41	2.90E-01	9.06E-01
GO:1902623	negative regulation of neutrophil migration (GO:1902623)	5	1	.29	+	3.41	2.90E-01	9.06E-01
GO:0022038	corpus callosum development (GO:0022038)	15	3	.88	+	3.41	7.45E-02	4.78E-01
GO:0071830	triglyceride-rich lipoprotein particle clearance (GO:0071830)	5	1	.29	+	3.41	2.90E-01	9.06E-01
GO:0071800	podosome assembly (GO:0071800)	5	1	.29	+	3.41	2.90E-01	9.06E-01
GO:2001241	positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)	10	2	.59	+	3.41	1.40E-01	6.56E-01
GO:1903019	negative regulation of glycoprotein metabolic process (GO:1903019)	15	3	.88	+	3.41	7.45E-02	4.78E-01
GO:0140719	constitutive heterochromatin formation (GO:0140719)	10	2	.59	+	3.41	1.40E-01	6.56E-01
GO:0002361	CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0002361)	5	1	.29	+	3.41	2.90E-01	9.06E-01
GO:0006707	cholesterol catabolic process (GO:0006707)	10	2	.59	+	3.41	1.40E-01	6.56E-01
GO:0007191	adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)	10	2	.59	+	3.41	1.40E-01	6.56E-01
GO:0007171	activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171)	20	4	1.17	+	3.41	4.12E-02	3.29E-01
GO:0007168	receptor guanylyl cyclase signaling pathway (GO:0007168)	10	2	.59	+	3.41	1.40E-01	6.56E-01
GO:0072162	metanephric mesenchymal cell differentiation (GO:0072162)	5	1	.29	+	3.41	2.90E-01	9.06E-01
GO:0072144	glomerular mesangial cell development (GO:0072144)	5	1	.29	+	3.41	2.90E-01	9.05E-01
GO:2000660	negative regulation of interleukin-1-mediated signaling pathway (GO:2000660)	5	1	.29	+	3.41	2.90E-01	9.05E-01
GO:0060161	positive regulation of dopamine receptor signaling pathway (GO:0060161)	5	1	.29	+	3.41	2.90E-01	9.05E-01
GO:0060126	somatotropin secreting cell differentiation (GO:0060126)	5	1	.29	+	3.41	2.90E-01	9.05E-01
GO:0071681	cellular response to indole-3-methanol (GO:0071681)	5	1	.29	+	3.41	2.90E-01	9.05E-01
GO:0002282	microglial cell activation involved in immune response (GO:0002282)	5	1	.29	+	3.41	2.90E-01	9.04E-01
GO:0071636	positive regulation of transforming growth factor beta production (GO:0071636)	20	4	1.17	+	3.41	4.12E-02	3.29E-01
GO:1901989	positive regulation of cell cycle phase transition (GO:1901989)	115	23	6.75	+	3.41	2.09E-06	9.04E-05
GO:1901979	regulation of inward rectifier potassium channel activity (GO:1901979)	5	1	.29	+	3.41	2.90E-01	9.04E-01
GO:2001028	positive regulation of endothelial cell chemotaxis (GO:2001028)	15	3	.88	+	3.41	7.45E-02	4.77E-01
GO:0044857	plasma membrane raft organization (GO:0044857)	10	2	.59	+	3.41	1.40E-01	6.55E-01
GO:0060068	vagina development (GO:0060068)	10	2	.59	+	3.41	1.40E-01	6.55E-01
GO:0060066	oviduct development (GO:0060066)	5	1	.29	+	3.41	2.90E-01	9.04E-01
GO:0060054	positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054)	10	2	.59	+	3.41	1.40E-01	6.55E-01
GO:0052422	modulation by host of symbiont catalytic activity (GO:0052422)	5	1	.29	+	3.41	2.90E-01	9.04E-01
GO:2000510	positive regulation of dendritic cell chemotaxis (GO:2000510)	10	2	.59	+	3.41	1.40E-01	6.55E-01
GO:0060028	convergent extension involved in axis elongation (GO:0060028)	5	1	.29	+	3.41	2.90E-01	9.04E-01
GO:0038135	ERBB2-ERBB4 signaling pathway (GO:0038135)	5	1	.29	+	3.41	2.90E-01	9.04E-01
GO:0032811	negative regulation of epinephrine secretion (GO:0032811)	5	1	.29	+	3.41	2.90E-01	9.03E-01
GO:0071593	lymphocyte aggregation (GO:0071593)	5	1	.29	+	3.41	2.90E-01	9.03E-01
GO:0002158	osteoclast proliferation (GO:0002158)	5	1	.29	+	3.41	2.90E-01	9.03E-01
GO:1901889	negative regulation of cell junction assembly (GO:1901889)	30	6	1.76	+	3.41	1.34E-02	1.57E-01
GO:0071502	cellular response to temperature stimulus (GO:0071502)	5	1	.29	+	3.41	2.90E-01	9.03E-01
GO:0090657	telomeric loop disassembly (GO:0090657)	10	2	.59	+	3.41	1.40E-01	6.55E-01
GO:0033239	negative regulation of cellular amine metabolic process (GO:0033239)	5	1	.29	+	3.41	2.90E-01	9.03E-01
GO:2000491	positive regulation of hepatic stellate cell activation (GO:2000491)	5	1	.29	+	3.41	2.90E-01	9.02E-01
GO:0044752	response to human chorionic gonadotropin (GO:0044752)	5	1	.29	+	3.41	2.90E-01	9.02E-01
GO:2000437	regulation of monocyte extravasation (GO:2000437)	5	1	.29	+	3.41	2.90E-01	9.02E-01
GO:2000425	regulation of apoptotic cell clearance (GO:2000425)	10	2	.59	+	3.41	1.40E-01	6.54E-01
GO:1902261	positive regulation of delayed rectifier potassium channel activity (GO:1902261)	5	1	.29	+	3.41	2.90E-01	9.02E-01
GO:0038031	non-canonical Wnt signaling pathway via JNK cascade (GO:0038031)	5	1	.29	+	3.41	2.90E-01	9.02E-01
GO:0038027	apolipoprotein A-I-mediated signaling pathway (GO:0038027)	5	1	.29	+	3.41	2.90E-01	9.02E-01
GO:0071498	cellular response to fluid shear stress (GO:0071498)	20	4	1.17	+	3.41	4.12E-02	3.28E-01
GO:0038007	netrin-activated signaling pathway (GO:0038007)	10	2	.59	+	3.41	1.40E-01	6.54E-01
GO:1902219	negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219)	5	1	.29	+	3.41	2.90E-01	9.01E-01
GO:0071484	cellular response to light intensity (GO:0071484)	5	1	.29	+	3.41	2.90E-01	9.01E-01
GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	80	16	4.70	+	3.41	7.22E-05	2.15E-03
GO:0014063	negative regulation of serotonin secretion (GO:0014063)	5	1	.29	+	3.41	2.90E-01	9.01E-01
GO:0014051	gamma-aminobutyric acid secretion (GO:0014051)	5	1	.29	+	3.41	2.90E-01	9.01E-01
GO:0018406	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406)	5	1	.29	+	3.41	2.90E-01	9.01E-01
GO:0014004	microglia differentiation (GO:0014004)	5	1	.29	+	3.41	2.90E-01	9.00E-01
GO:0002034	maintenance of blood vessel diameter homeostasis by renin-angiotensin (GO:0002034)	5	1	.29	+	3.41	2.90E-01	9.00E-01
GO:0002002	regulation of angiotensin levels in blood (GO:0002002)	10	2	.59	+	3.41	1.40E-01	6.54E-01
GO:0005981	regulation of glycogen catabolic process (GO:0005981)	5	1	.29	+	3.41	2.90E-01	9.00E-01
GO:0001542	ovulation from ovarian follicle (GO:0001542)	10	2	.59	+	3.41	1.40E-01	6.54E-01
GO:2000373	positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373)	5	1	.29	+	3.41	2.90E-01	9.00E-01
GO:2000371	regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371)	5	1	.29	+	3.41	2.90E-01	9.00E-01
GO:0018317	protein C-linked glycosylation via tryptophan (GO:0018317)	5	1	.29	+	3.41	2.90E-01	9.00E-01
GO:0071371	cellular response to gonadotropin stimulus (GO:0071371)	20	4	1.17	+	3.41	4.12E-02	3.28E-01
GO:0051799	negative regulation of hair follicle development (GO:0051799)	5	1	.29	+	3.41	2.90E-01	8.99E-01
GO:0006335	DNA replication-dependent chromatin assembly (GO:0006335)	10	2	.59	+	3.41	1.40E-01	6.54E-01
GO:1901668	regulation of superoxide dismutase activity (GO:1901668)	5	1	.29	+	3.41	2.90E-01	8.99E-01
GO:1901656	glycoside transport (GO:1901656)	5	1	.29	+	3.41	2.90E-01	8.99E-01
GO:0033028	myeloid cell apoptotic process (GO:0033028)	15	3	.88	+	3.41	7.45E-02	4.77E-01
GO:0090427	activation of meiosis (GO:0090427)	5	1	.29	+	3.41	2.90E-01	8.99E-01
GO:2000271	positive regulation of fibroblast apoptotic process (GO:2000271)	10	2	.59	+	3.41	1.40E-01	6.53E-01
GO:0032596	protein transport into membrane raft (GO:0032596)	5	1	.29	+	3.41	2.90E-01	8.99E-01
GO:0018211	peptidyl-tryptophan modification (GO:0018211)	5	1	.29	+	3.41	2.90E-01	8.99E-01
GO:0051660	establishment of centrosome localization (GO:0051660)	10	2	.59	+	3.41	1.40E-01	6.53E-01
GO:1901509	regulation of endothelial tube morphogenesis (GO:1901509)	5	1	.29	+	3.41	2.90E-01	8.98E-01
GO:2000172	regulation of branching morphogenesis of a nerve (GO:2000172)	5	1	.29	+	3.41	2.90E-01	8.98E-01
GO:0099566	regulation of postsynaptic cytosolic calcium ion concentration (GO:0099566)	10	2	.59	+	3.41	1.40E-01	6.53E-01
GO:0099542	trans-synaptic signaling by endocannabinoid (GO:0099542)	5	1	.29	+	3.41	2.90E-01	8.98E-01
GO:0099541	trans-synaptic signaling by lipid (GO:0099541)	5	1	.29	+	3.41	2.90E-01	8.98E-01
GO:2000118	regulation of sodium-dependent phosphate transport (GO:2000118)	5	1	.29	+	3.41	2.90E-01	8.98E-01
GO:0006196	AMP catabolic process (GO:0006196)	5	1	.29	+	3.41	2.90E-01	8.97E-01
GO:0032430	positive regulation of phospholipase A2 activity (GO:0032430)	5	1	.29	+	3.41	2.90E-01	8.97E-01
GO:0006172	ADP biosynthetic process (GO:0006172)	5	1	.29	+	3.41	2.90E-01	8.97E-01
GO:0051599	response to hydrostatic pressure (GO:0051599)	5	1	.29	+	3.41	2.90E-01	8.97E-01
GO:0051596	methylglyoxal catabolic process (GO:0051596)	5	1	.29	+	3.41	2.90E-01	8.97E-01
GO:0051593	response to folic acid (GO:0051593)	10	2	.59	+	3.41	1.40E-01	6.53E-01
GO:0018103	protein C-linked glycosylation (GO:0018103)	5	1	.29	+	3.41	2.90E-01	8.97E-01
GO:0051589	negative regulation of neurotransmitter transport (GO:0051589)	15	3	.88	+	3.41	7.45E-02	4.77E-01
GO:1905870	positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870)	5	1	.29	+	3.41	2.90E-01	8.96E-01
GO:0043932	ossification involved in bone remodeling (GO:0043932)	5	1	.29	+	3.41	2.90E-01	8.96E-01
GO:0031947	negative regulation of glucocorticoid biosynthetic process (GO:0031947)	5	1	.29	+	3.41	2.90E-01	8.96E-01
GO:0031944	negative regulation of glucocorticoid metabolic process (GO:0031944)	5	1	.29	+	3.41	2.90E-01	8.96E-01
GO:0090280	positive regulation of calcium ion import (GO:0090280)	15	3	.88	+	3.41	7.45E-02	4.77E-01
GO:0044381	glucose import in response to insulin stimulus (GO:0044381)	5	1	.29	+	3.41	2.90E-01	8.96E-01
GO:2000052	positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	15	3	.88	+	3.41	7.45E-02	4.77E-01
GO:0032379	positive regulation of intracellular lipid transport (GO:0032379)	5	1	.29	+	3.41	2.90E-01	8.96E-01
GO:1905774	regulation of DNA helicase activity (GO:1905774)	5	1	.29	+	3.41	2.90E-01	8.95E-01
GO:0006003	fructose 2,6-bisphosphate metabolic process (GO:0006003)	5	1	.29	+	3.41	2.90E-01	8.95E-01
GO:0051454	intracellular pH elevation (GO:0051454)	5	1	.29	+	3.41	2.90E-01	8.95E-01
GO:0051418	microtubule nucleation by microtubule organizing center (GO:0051418)	5	1	.29	+	3.41	2.90E-01	8.95E-01
GO:0098902	regulation of membrane depolarization during action potential (GO:0098902)	5	1	.29	+	3.41	2.90E-01	8.95E-01
GO:0098901	regulation of cardiac muscle cell action potential (GO:0098901)	30	6	1.76	+	3.41	1.34E-02	1.57E-01
GO:0070587	regulation of cell-cell adhesion involved in gastrulation (GO:0070587)	10	2	.59	+	3.41	1.40E-01	6.53E-01
GO:0070571	negative regulation of neuron projection regeneration (GO:0070571)	15	3	.88	+	3.41	7.45E-02	4.76E-01
GO:0070564	positive regulation of vitamin D receptor signaling pathway (GO:0070564)	5	1	.29	+	3.41	2.90E-01	8.94E-01
GO:0050960	detection of temperature stimulus involved in thermoception (GO:0050960)	5	1	.29	+	3.41	2.90E-01	8.94E-01
GO:0090119	vesicle-mediated cholesterol transport (GO:0090119)	5	1	.29	+	3.41	2.90E-01	8.94E-01
GO:0090116	C-5 methylation of cytosine (GO:0090116)	5	1	.29	+	3.41	2.90E-01	8.94E-01
GO:0050901	leukocyte tethering or rolling (GO:0050901)	20	4	1.17	+	3.41	4.12E-02	3.28E-01
GO:0120317	sperm mitochondrial sheath assembly (GO:0120317)	5	1	.29	+	3.41	2.90E-01	8.94E-01
GO:0051388	positive regulation of neurotrophin TRK receptor signaling pathway (GO:0051388)	5	1	.29	+	3.41	2.90E-01	8.94E-01
GO:0098868	bone growth (GO:0098868)	30	6	1.76	+	3.41	1.34E-02	1.57E-01
GO:1905653	positive regulation of artery morphogenesis (GO:1905653)	5	1	.29	+	3.41	2.90E-01	8.93E-01
GO:1905651	regulation of artery morphogenesis (GO:1905651)	5	1	.29	+	3.41	2.90E-01	8.93E-01
GO:1905605	positive regulation of blood-brain barrier permeability (GO:1905605)	5	1	.29	+	3.41	2.90E-01	8.93E-01
GO:0090081	regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081)	5	1	.29	+	3.41	2.90E-01	8.93E-01
GO:0090051	negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)	15	3	.88	+	3.41	7.45E-02	4.76E-01
GO:0070472	regulation of uterine smooth muscle contraction (GO:0070472)	10	2	.59	+	3.41	1.40E-01	6.53E-01
GO:0050873	brown fat cell differentiation (GO:0050873)	35	7	2.06	+	3.41	7.78E-03	1.03E-01
GO:0048550	negative regulation of pinocytosis (GO:0048550)	5	1	.29	+	3.41	2.90E-01	8.93E-01
GO:0050849	negative regulation of calcium-mediated signaling (GO:0050849)	20	4	1.17	+	3.41	4.12E-02	3.28E-01
GO:1905598	negative regulation of low-density lipoprotein receptor activity (GO:1905598)	5	1	.29	+	3.41	2.90E-01	8.93E-01
GO:1990166	protein localization to site of double-strand break (GO:1990166)	5	1	.29	+	3.41	2.90E-01	8.92E-01
GO:0009786	regulation of asymmetric cell division (GO:0009786)	5	1	.29	+	3.41	2.90E-01	8.92E-01
GO:0009756	carbohydrate mediated signaling (GO:0009756)	5	1	.29	+	3.41	2.90E-01	8.92E-01
GO:0098708	glucose import across plasma membrane (GO:0098708)	5	1	.29	+	3.41	2.90E-01	8.92E-01
GO:0051208	sequestering of calcium ion (GO:0051208)	5	1	.29	+	3.41	2.90E-01	8.92E-01
GO:0009713	catechol-containing compound biosynthetic process (GO:0009713)	20	4	1.17	+	3.41	4.12E-02	3.28E-01
GO:0120188	regulation of bile acid secretion (GO:0120188)	5	1	.29	+	3.41	2.90E-01	8.91E-01
GO:0099191	trans-synaptic signaling by BDNF (GO:0099191)	5	1	.29	+	3.41	2.90E-01	8.91E-01
GO:0035999	tetrahydrofolate interconversion (GO:0035999)	10	2	.59	+	3.41	1.40E-01	6.52E-01
GO:0035989	tendon development (GO:0035989)	5	1	.29	+	3.41	2.90E-01	8.91E-01
GO:0043587	tongue morphogenesis (GO:0043587)	10	2	.59	+	3.41	1.40E-01	6.52E-01
GO:0051150	regulation of smooth muscle cell differentiation (GO:0051150)	30	6	1.76	+	3.41	1.34E-02	1.57E-01
GO:0035907	dorsal aorta development (GO:0035907)	10	2	.59	+	3.41	1.40E-01	6.52E-01
GO:0035905	ascending aorta development (GO:0035905)	5	1	.29	+	3.41	2.90E-01	8.91E-01
GO:0043500	muscle adaptation (GO:0043500)	35	7	2.06	+	3.41	7.78E-03	1.03E-01
GO:0051106	positive regulation of DNA ligation (GO:0051106)	5	1	.29	+	3.41	2.90E-01	8.91E-01
GO:0070295	renal water absorption (GO:0070295)	5	1	.29	+	3.41	2.90E-01	8.91E-01
GO:0070294	renal sodium ion absorption (GO:0070294)	10	2	.59	+	3.41	1.40E-01	6.52E-01
GO:1904994	regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994)	30	6	1.76	+	3.41	1.34E-02	1.57E-01
GO:0048386	positive regulation of retinoic acid receptor signaling pathway (GO:0048386)	5	1	.29	+	3.41	2.90E-01	8.90E-01
GO:0099084	postsynaptic specialization organization (GO:0099084)	20	4	1.17	+	3.41	4.12E-02	3.28E-01
GO:0036335	intestinal stem cell homeostasis (GO:0036335)	5	1	.29	+	3.41	2.90E-01	8.90E-01
GO:0099004	calmodulin dependent kinase signaling pathway (GO:0099004)	5	1	.29	+	3.41	2.90E-01	8.90E-01
GO:0051097	negative regulation of helicase activity (GO:0051097)	5	1	.29	+	3.41	2.90E-01	8.90E-01
GO:0098535	de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535)	5	1	.29	+	3.41	2.90E-01	8.90E-01
GO:0048263	determination of dorsal identity (GO:0048263)	5	1	.29	+	3.41	2.90E-01	8.90E-01
GO:0070103	regulation of interleukin-6-mediated signaling pathway (GO:0070103)	5	1	.29	+	3.41	2.90E-01	8.89E-01
GO:0043378	positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)	5	1	.29	+	3.41	2.90E-01	8.89E-01
GO:0035767	endothelial cell chemotaxis (GO:0035767)	10	2	.59	+	3.41	1.40E-01	6.52E-01
GO:0043373	CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)	15	3	.88	+	3.41	7.45E-02	4.76E-01
GO:0043368	positive T cell selection (GO:0043368)	30	6	1.76	+	3.41	1.34E-02	1.57E-01
GO:0009446	putrescine biosynthetic process (GO:0009446)	5	1	.29	+	3.41	2.90E-01	8.89E-01
GO:0070099	regulation of chemokine-mediated signaling pathway (GO:0070099)	10	2	.59	+	3.41	1.40E-01	6.51E-01
GO:0061975	articular cartilage development (GO:0061975)	5	1	.29	+	3.41	2.90E-01	8.89E-01
GO:0035634	response to stilbenoid (GO:0035634)	5	1	.29	+	3.41	2.90E-01	8.89E-01
GO:0035633	maintenance of blood-brain barrier (GO:0035633)	35	7	2.06	+	3.41	7.78E-03	1.03E-01
GO:1904690	positive regulation of cytoplasmic translational initiation (GO:1904690)	5	1	.29	+	3.41	2.90E-01	8.89E-01
GO:0042762	regulation of sulfur metabolic process (GO:0042762)	10	2	.59	+	3.41	1.40E-01	6.51E-01
GO:0048006	antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)	5	1	.29	+	3.41	2.90E-01	8.88E-01
GO:0061888	regulation of astrocyte activation (GO:0061888)	5	1	.29	+	3.41	2.90E-01	8.88E-01
GO:0035581	sequestering of extracellular ligand from receptor (GO:0035581)	10	2	.59	+	3.41	1.40E-01	6.51E-01
GO:0035564	regulation of kidney size (GO:0035564)	5	1	.29	+	3.41	2.90E-01	8.88E-01
GO:0035509	negative regulation of myosin-light-chain-phosphatase activity (GO:0035509)	5	1	.29	+	3.41	2.90E-01	8.88E-01
GO:1905007	positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007)	5	1	.29	+	3.41	2.90E-01	8.88E-01
GO:0042695	thelarche (GO:0042695)	5	1	.29	+	3.41	2.90E-01	8.87E-01
GO:0042661	regulation of mesodermal cell fate specification (GO:0042661)	5	1	.29	+	3.41	2.90E-01	8.87E-01
GO:0097742	de novo centriole assembly (GO:0097742)	5	1	.29	+	3.41	2.90E-01	8.87E-01
GO:1904515	positive regulation of TORC2 signaling (GO:1904515)	5	1	.29	+	3.41	2.90E-01	8.87E-01
GO:1904504	positive regulation of lipophagy (GO:1904504)	5	1	.29	+	3.41	2.90E-01	8.87E-01
GO:1904502	regulation of lipophagy (GO:1904502)	5	1	.29	+	3.41	2.90E-01	8.87E-01
GO:0061727	methylglyoxal catabolic process to lactate (GO:0061727)	5	1	.29	+	3.41	2.90E-01	8.86E-01
GO:0035470	positive regulation of vascular wound healing (GO:0035470)	5	1	.29	+	3.41	2.90E-01	8.86E-01
GO:0015872	dopamine transport (GO:0015872)	15	3	.88	+	3.41	7.45E-02	4.76E-01
GO:0055024	regulation of cardiac muscle tissue development (GO:0055024)	5	1	.29	+	3.41	2.90E-01	8.86E-01
GO:0015864	pyrimidine nucleoside transport (GO:0015864)	5	1	.29	+	3.41	2.90E-01	8.86E-01
GO:0015862	uridine transport (GO:0015862)	5	1	.29	+	3.41	2.90E-01	8.86E-01
GO:0055012	ventricular cardiac muscle cell differentiation (GO:0055012)	15	3	.88	+	3.41	7.45E-02	4.76E-01
GO:0015855	pyrimidine nucleobase transport (GO:0015855)	5	1	.29	+	3.41	2.90E-01	8.86E-01
GO:0015851	nucleobase transport (GO:0015851)	10	2	.59	+	3.41	1.40E-01	6.51E-01
GO:0009181	purine ribonucleoside diphosphate catabolic process (GO:0009181)	5	1	.29	+	3.41	2.90E-01	8.85E-01
GO:0009180	purine ribonucleoside diphosphate biosynthetic process (GO:0009180)	5	1	.29	+	3.41	2.90E-01	8.85E-01
GO:0009177	pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177)	5	1	.29	+	3.41	2.90E-01	8.85E-01
GO:0009157	deoxyribonucleoside monophosphate biosynthetic process (GO:0009157)	10	2	.59	+	3.41	1.40E-01	6.51E-01
GO:0009137	purine nucleoside diphosphate catabolic process (GO:0009137)	5	1	.29	+	3.41	2.90E-01	8.85E-01
GO:0046959	habituation (GO:0046959)	5	1	.29	+	3.41	2.90E-01	8.85E-01
GO:0097688	glutamate receptor clustering (GO:0097688)	5	1	.29	+	3.41	2.90E-01	8.85E-01
GO:0097681	double-strand break repair via alternative nonhomologous end joining (GO:0097681)	5	1	.29	+	3.41	2.90E-01	8.84E-01
GO:1900084	regulation of peptidyl-tyrosine autophosphorylation (GO:1900084)	5	1	.29	+	3.41	2.90E-01	8.84E-01
GO:1903960	negative regulation of anion transmembrane transport (GO:1903960)	10	2	.59	+	3.41	1.40E-01	6.50E-01
GO:0015757	galactose transmembrane transport (GO:0015757)	5	1	.29	+	3.41	2.90E-01	8.84E-01
GO:0035329	hippo signaling (GO:0035329)	20	4	1.17	+	3.41	4.12E-02	3.27E-01
GO:0086066	atrial cardiac muscle cell to AV node cell communication (GO:0086066)	15	3	.88	+	3.41	7.45E-02	4.75E-01
GO:0086046	membrane depolarization during SA node cell action potential (GO:0086046)	5	1	.29	+	3.41	2.90E-01	8.84E-01
GO:0086043	bundle of His cell action potential (GO:0086043)	5	1	.29	+	3.41	2.90E-01	8.84E-01
GO:0086028	bundle of His cell to Purkinje myocyte signaling (GO:0086028)	5	1	.29	+	3.41	2.90E-01	8.84E-01
GO:0046865	terpenoid transport (GO:0046865)	5	1	.29	+	3.41	2.90E-01	8.83E-01
GO:0046864	isoprenoid transport (GO:0046864)	5	1	.29	+	3.41	2.90E-01	8.83E-01
GO:0042494	detection of bacterial lipoprotein (GO:0042494)	5	1	.29	+	3.41	2.90E-01	8.83E-01
GO:0062028	regulation of stress granule assembly (GO:0062028)	5	1	.29	+	3.41	2.90E-01	8.83E-01
GO:1904340	positive regulation of dopaminergic neuron differentiation (GO:1904340)	5	1	.29	+	3.41	2.90E-01	8.83E-01
GO:0042423	catecholamine biosynthetic process (GO:0042423)	20	4	1.17	+	3.41	4.12E-02	3.27E-01
GO:1904306	positive regulation of gastro-intestinal system smooth muscle contraction (GO:1904306)	5	1	.29	+	3.41	2.90E-01	8.82E-01
GO:1904304	regulation of gastro-intestinal system smooth muscle contraction (GO:1904304)	5	1	.29	+	3.41	2.90E-01	8.82E-01
GO:0097500	receptor localization to non-motile cilium (GO:0097500)	5	1	.29	+	3.41	2.90E-01	8.82E-01
GO:0016127	sterol catabolic process (GO:0016127)	10	2	.59	+	3.41	1.40E-01	6.50E-01
GO:0016102	diterpenoid biosynthetic process (GO:0016102)	10	2	.59	+	3.41	1.40E-01	6.50E-01
GO:0061523	cilium disassembly (GO:0061523)	5	1	.29	+	3.41	2.90E-01	8.82E-01
GO:0015671	oxygen transport (GO:0015671)	15	3	.88	+	3.41	7.45E-02	4.75E-01
GO:0010764	negative regulation of fibroblast migration (GO:0010764)	10	2	.59	+	3.41	1.40E-01	6.50E-01
GO:0010700	negative regulation of norepinephrine secretion (GO:0010700)	5	1	.29	+	3.41	2.90E-01	8.82E-01
GO:0035166	post-embryonic hemopoiesis (GO:0035166)	5	1	.29	+	3.41	2.90E-01	8.82E-01
GO:0035106	operant conditioning (GO:0035106)	5	1	.29	+	3.41	2.90E-01	8.81E-01
GO:0060978	angiogenesis involved in coronary vascular morphogenesis (GO:0060978)	5	1	.29	+	3.41	2.90E-01	8.81E-01
GO:0060971	embryonic heart tube left/right pattern formation (GO:0060971)	5	1	.29	+	3.41	2.90E-01	8.81E-01
GO:0060931	sinoatrial node cell development (GO:0060931)	5	1	.29	+	3.41	2.90E-01	8.81E-01
GO:0060920	cardiac pacemaker cell differentiation (GO:0060920)	10	2	.59	+	3.41	1.40E-01	6.50E-01
GO:0034650	cortisol metabolic process (GO:0034650)	5	1	.29	+	3.41	2.90E-01	8.81E-01
GO:0097350	neutrophil clearance (GO:0097350)	5	1	.29	+	3.41	2.90E-01	8.81E-01
GO:0030263	apoptotic chromosome condensation (GO:0030263)	5	1	.29	+	3.41	2.90E-01	8.80E-01
GO:0022616	DNA strand elongation (GO:0022616)	20	4	1.17	+	3.41	4.12E-02	3.27E-01
GO:0035021	negative regulation of Rac protein signal transduction (GO:0035021)	5	1	.29	+	3.41	2.90E-01	8.80E-01
GO:0003431	growth plate cartilage chondrocyte development (GO:0003431)	5	1	.29	+	3.41	2.90E-01	8.80E-01
GO:0003418	growth plate cartilage chondrocyte differentiation (GO:0003418)	10	2	.59	+	3.41	1.40E-01	6.49E-01
GO:0003415	chondrocyte hypertrophy (GO:0003415)	5	1	.29	+	3.41	2.90E-01	8.80E-01
GO:0010572	positive regulation of platelet activation (GO:0010572)	10	2	.59	+	3.41	1.40E-01	6.49E-01
GO:1904016	response to Thyroglobulin triiodothyronine (GO:1904016)	5	1	.29	+	3.41	2.90E-01	8.80E-01
GO:0014909	smooth muscle cell migration (GO:0014909)	15	3	.88	+	3.41	7.45E-02	4.75E-01
GO:0010523	negative regulation of calcium ion transport into cytosol (GO:0010523)	5	1	.29	+	3.41	2.90E-01	8.80E-01
GO:1903596	regulation of gap junction assembly (GO:1903596)	10	2	.59	+	3.41	1.40E-01	6.49E-01
GO:0060744	mammary gland branching involved in thelarche (GO:0060744)	5	1	.29	+	3.41	2.90E-01	8.79E-01
GO:0003300	cardiac muscle hypertrophy (GO:0003300)	30	6	1.76	+	3.41	1.34E-02	1.57E-01
GO:0097178	ruffle assembly (GO:0097178)	15	3	.88	+	3.41	7.45E-02	4.75E-01
GO:0097176	epoxide metabolic process (GO:0097176)	5	1	.29	+	3.41	2.90E-01	8.79E-01
GO:0014874	response to stimulus involved in regulation of muscle adaptation (GO:0014874)	15	3	.88	+	3.41	7.45E-02	4.75E-01
GO:0014857	regulation of skeletal muscle cell proliferation (GO:0014857)	15	3	.88	+	3.41	7.45E-02	4.74E-01
GO:0097113	AMPA glutamate receptor clustering (GO:0097113)	5	1	.29	+	3.41	2.90E-01	8.79E-01
GO:0097112	gamma-aminobutyric acid receptor clustering (GO:0097112)	5	1	.29	+	3.41	2.90E-01	8.79E-01
GO:0045991	carbon catabolite activation of transcription (GO:0045991)	5	1	.29	+	3.41	2.90E-01	8.79E-01
GO:0045990	carbon catabolite regulation of transcription (GO:0045990)	5	1	.29	+	3.41	2.90E-01	8.79E-01
GO:0097105	presynaptic membrane assembly (GO:0097105)	10	2	.59	+	3.41	1.40E-01	6.49E-01
GO:0061140	lung secretory cell differentiation (GO:0061140)	10	2	.59	+	3.41	1.40E-01	6.49E-01
GO:0045917	positive regulation of complement activation (GO:0045917)	5	1	.29	+	3.41	2.90E-01	8.78E-01
GO:0045900	negative regulation of translational elongation (GO:0045900)	5	1	.29	+	3.41	2.90E-01	8.78E-01
GO:0021940	positive regulation of cerebellar granule cell precursor proliferation (GO:0021940)	10	2	.59	+	3.41	1.40E-01	6.48E-01
GO:0021938	smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation (GO:0021938)	5	1	.29	+	3.41	2.90E-01	8.78E-01
GO:0021934	hindbrain tangential cell migration (GO:0021934)	5	1	.29	+	3.41	2.90E-01	8.78E-01
GO:0003289	atrial septum primum morphogenesis (GO:0003289)	5	1	.29	+	3.41	2.90E-01	8.78E-01
GO:0003284	septum primum development (GO:0003284)	5	1	.29	+	3.41	2.90E-01	8.78E-01
GO:0003278	apoptotic process involved in heart morphogenesis (GO:0003278)	5	1	.29	+	3.41	2.90E-01	8.77E-01
GO:0060662	salivary gland cavitation (GO:0060662)	5	1	.29	+	3.41	2.90E-01	8.77E-01
GO:0060633	negative regulation of transcription initiation by RNA polymerase II (GO:0060633)	5	1	.29	+	3.41	2.90E-01	8.77E-01
GO:0034382	chylomicron remnant clearance (GO:0034382)	5	1	.29	+	3.41	2.90E-01	8.77E-01
GO:1902956	regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)	5	1	.29	+	3.41	2.90E-01	8.77E-01
GO:0060623	regulation of chromosome condensation (GO:0060623)	10	2	.59	+	3.41	1.40E-01	6.48E-01
GO:0060605	tube lumen cavitation (GO:0060605)	5	1	.29	+	3.41	2.90E-01	8.77E-01
GO:0097065	anterior head development (GO:0097065)	5	1	.29	+	3.41	2.90E-01	8.76E-01
GO:1902902	negative regulation of autophagosome assembly (GO:1902902)	15	3	.88	+	3.41	7.45E-02	4.74E-01
GO:0014745	negative regulation of muscle adaptation (GO:0014745)	10	2	.59	+	3.41	1.40E-01	6.48E-01
GO:0014722	regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722)	5	1	.29	+	3.41	2.90E-01	8.76E-01
GO:0045899	positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899)	5	1	.29	+	3.41	2.90E-01	8.76E-01
GO:0045875	negative regulation of sister chromatid cohesion (GO:0045875)	5	1	.29	+	3.41	2.90E-01	8.76E-01
GO:0045842	positive regulation of mitotic metaphase/anaphase transition (GO:0045842)	15	3	.88	+	3.41	7.45E-02	4.74E-01
GO:0021873	forebrain neuroblast division (GO:0021873)	5	1	.29	+	3.41	2.90E-01	8.76E-01
GO:0021869	forebrain ventricular zone progenitor cell division (GO:0021869)	5	1	.29	+	3.41	2.90E-01	8.76E-01
GO:0061009	common bile duct development (GO:0061009)	5	1	.29	+	3.41	2.90E-01	8.75E-01
GO:0072584	caveolin-mediated endocytosis (GO:0072584)	5	1	.29	+	3.41	2.90E-01	8.75E-01
GO:0003186	tricuspid valve morphogenesis (GO:0003186)	5	1	.29	+	3.41	2.90E-01	8.75E-01
GO:0003183	mitral valve morphogenesis (GO:0003183)	10	2	.59	+	3.41	1.40E-01	6.48E-01
GO:0060591	chondroblast differentiation (GO:0060591)	5	1	.29	+	3.41	2.90E-01	8.75E-01
GO:0072539	T-helper 17 cell differentiation (GO:0072539)	10	2	.59	+	3.41	1.40E-01	6.48E-01
GO:0060525	prostate glandular acinus development (GO:0060525)	10	2	.59	+	3.41	1.40E-01	6.48E-01
GO:1902817	negative regulation of protein localization to microtubule (GO:1902817)	5	1	.29	+	3.41	2.90E-01	8.75E-01
GO:1902816	regulation of protein localization to microtubule (GO:1902816)	5	1	.29	+	3.41	2.90E-01	8.75E-01
GO:1903020	positive regulation of glycoprotein metabolic process (GO:1903020)	25	5	1.47	+	3.41	2.33E-02	2.32E-01
GO:0072010	glomerular epithelium development (GO:0072010)	25	5	1.47	+	3.41	2.33E-02	2.32E-01
GO:0044818	mitotic G2/M transition checkpoint (GO:0044818)	50	10	2.94	+	3.41	1.59E-03	2.97E-02
GO:0051446	positive regulation of meiotic cell cycle (GO:0051446)	25	5	1.47	+	3.41	2.33E-02	2.32E-01
GO:1905562	regulation of vascular endothelial cell proliferation (GO:1905562)	25	5	1.47	+	3.41	2.33E-02	2.32E-01
GO:0098703	calcium ion import across plasma membrane (GO:0098703)	25	5	1.47	+	3.41	2.33E-02	2.31E-01
GO:1901021	positive regulation of calcium ion transmembrane transporter activity (GO:1901021)	45	9	2.64	+	3.41	2.68E-03	4.58E-02
GO:1904706	negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706)	25	5	1.47	+	3.41	2.33E-02	2.31E-01
GO:0010518	positive regulation of phospholipase activity (GO:0010518)	55	11	3.23	+	3.41	9.42E-04	1.92E-02
GO:1903523	negative regulation of blood circulation (GO:1903523)	25	5	1.47	+	3.41	2.33E-02	2.31E-01
GO:0003170	heart valve development (GO:0003170)	65	13	3.82	+	3.41	3.35E-04	7.82E-03
GO:0060538	skeletal muscle organ development (GO:0060538)	146	29	8.57	+	3.38	1.17E-07	6.51E-06
GO:0010948	negative regulation of cell cycle process (GO:0010948)	272	54	15.97	+	3.38	4.64E-13	7.50E-11
GO:0051303	establishment of chromosome localization (GO:0051303)	76	15	4.46	+	3.36	1.37E-04	3.67E-03
GO:0007517	muscle organ development (GO:0007517)	304	60	17.85	+	3.36	2.88E-14	5.44E-12
GO:0048660	regulation of smooth muscle cell proliferation (GO:0048660)	142	28	8.34	+	3.36	2.19E-07	1.15E-05
GO:0014015	positive regulation of gliogenesis (GO:0014015)	66	13	3.88	+	3.35	3.81E-04	8.78E-03
GO:0010517	regulation of phospholipase activity (GO:0010517)	66	13	3.88	+	3.35	3.81E-04	8.76E-03
GO:0006584	catecholamine metabolic process (GO:0006584)	46	9	2.70	+	3.33	3.05E-03	5.11E-02
GO:0032508	DNA duplex unwinding (GO:0032508)	92	18	5.40	+	3.33	3.37E-05	1.09E-03
GO:0009712	catechol-containing compound metabolic process (GO:0009712)	46	9	2.70	+	3.33	3.05E-03	5.10E-02
GO:0051279	regulation of release of sequestered calcium ion into cytosol (GO:0051279)	82	16	4.82	+	3.32	9.32E-05	2.64E-03
GO:0034113	heterotypic cell-cell adhesion (GO:0034113)	36	7	2.11	+	3.31	8.86E-03	1.15E-01
GO:0035850	epithelial cell differentiation involved in kidney development (GO:0035850)	36	7	2.11	+	3.31	8.86E-03	1.14E-01
GO:0048008	platelet-derived growth factor receptor signaling pathway (GO:0048008)	36	7	2.11	+	3.31	8.86E-03	1.14E-01
GO:0007616	long-term memory (GO:0007616)	36	7	2.11	+	3.31	8.86E-03	1.14E-01
GO:0010927	cellular component assembly involved in morphogenesis (GO:0010927)	108	21	6.34	+	3.31	8.38E-06	3.18E-04
GO:0032392	DNA geometric change (GO:0032392)	98	19	5.75	+	3.30	2.30E-05	7.78E-04
GO:2000027	regulation of animal organ morphogenesis (GO:2000027)	129	25	7.57	+	3.30	1.27E-06	5.69E-05
GO:0010165	response to X-ray (GO:0010165)	31	6	1.82	+	3.30	1.53E-02	1.72E-01
GO:0090330	regulation of platelet aggregation (GO:0090330)	31	6	1.82	+	3.30	1.53E-02	1.72E-01
GO:0070570	regulation of neuron projection regeneration (GO:0070570)	31	6	1.82	+	3.30	1.53E-02	1.71E-01
GO:0010972	negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	62	12	3.64	+	3.30	7.24E-04	1.54E-02
GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)	31	6	1.82	+	3.30	1.53E-02	1.71E-01
GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)	31	6	1.82	+	3.30	1.53E-02	1.71E-01
GO:1903715	regulation of aerobic respiration (GO:1903715)	31	6	1.82	+	3.30	1.53E-02	1.71E-01
GO:0014897	striated muscle hypertrophy (GO:0014897)	31	6	1.82	+	3.30	1.53E-02	1.71E-01
GO:0051591	response to cAMP (GO:0051591)	93	18	5.46	+	3.30	3.82E-05	1.23E-03
GO:0001755	neural crest cell migration (GO:0001755)	57	11	3.35	+	3.29	1.22E-03	2.39E-02
GO:2000179	positive regulation of neural precursor cell proliferation (GO:2000179)	57	11	3.35	+	3.29	1.22E-03	2.38E-02
GO:0007160	cell-matrix adhesion (GO:0007160)	135	26	7.93	+	3.28	8.66E-07	4.10E-05
GO:0007157	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	52	10	3.05	+	3.27	2.05E-03	3.66E-02
GO:0038179	neurotrophin signaling pathway (GO:0038179)	26	5	1.53	+	3.27	2.66E-02	2.53E-01
GO:1990806	ligand-gated ion channel signaling pathway (GO:1990806)	26	5	1.53	+	3.27	2.66E-02	2.52E-01
GO:2000311	regulation of AMPA receptor activity (GO:2000311)	26	5	1.53	+	3.27	2.66E-02	2.52E-01
GO:0070723	response to cholesterol (GO:0070723)	26	5	1.53	+	3.27	2.66E-02	2.52E-01
GO:1901380	negative regulation of potassium ion transmembrane transport (GO:1901380)	26	5	1.53	+	3.27	2.66E-02	2.52E-01
GO:0035994	response to muscle stretch (GO:0035994)	26	5	1.53	+	3.27	2.66E-02	2.52E-01
GO:0086009	membrane repolarization (GO:0086009)	26	5	1.53	+	3.27	2.66E-02	2.52E-01
GO:0035235	ionotropic glutamate receptor signaling pathway (GO:0035235)	26	5	1.53	+	3.27	2.66E-02	2.52E-01
GO:0046716	muscle cell cellular homeostasis (GO:0046716)	26	5	1.53	+	3.27	2.66E-02	2.51E-01
GO:0007622	rhythmic behavior (GO:0007622)	26	5	1.53	+	3.27	2.66E-02	2.51E-01
GO:0000280	nuclear division (GO:0000280)	323	62	18.97	+	3.27	3.19E-14	5.81E-12
GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044)	47	9	2.76	+	3.26	3.46E-03	5.61E-02
GO:0043113	receptor clustering (GO:0043113)	47	9	2.76	+	3.26	3.46E-03	5.61E-02
GO:0003197	endocardial cushion development (GO:0003197)	47	9	2.76	+	3.26	3.46E-03	5.60E-02
GO:0051146	striated muscle cell differentiation (GO:0051146)	204	39	11.98	+	3.26	2.08E-09	1.62E-07
GO:1902749	regulation of cell cycle G2/M phase transition (GO:1902749)	110	21	6.46	+	3.25	1.07E-05	3.96E-04
GO:0090257	regulation of muscle system process (GO:0090257)	236	45	13.86	+	3.25	1.31E-10	1.32E-08
GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	21	4	1.23	+	3.24	4.70E-02	3.63E-01
GO:0072112	podocyte differentiation (GO:0072112)	21	4	1.23	+	3.24	4.70E-02	3.62E-01
GO:2001044	regulation of integrin-mediated signaling pathway (GO:2001044)	21	4	1.23	+	3.24	4.70E-02	3.62E-01
GO:0007063	regulation of sister chromatid cohesion (GO:0007063)	21	4	1.23	+	3.24	4.70E-02	3.62E-01
GO:0051769	regulation of nitric-oxide synthase biosynthetic process (GO:0051769)	21	4	1.23	+	3.24	4.70E-02	3.62E-01
GO:0048670	regulation of collateral sprouting (GO:0048670)	21	4	1.23	+	3.24	4.70E-02	3.62E-01
GO:0098743	cell aggregation (GO:0098743)	21	4	1.23	+	3.24	4.70E-02	3.62E-01
GO:1900543	negative regulation of purine nucleotide metabolic process (GO:1900543)	21	4	1.23	+	3.24	4.70E-02	3.61E-01
GO:0036315	cellular response to sterol (GO:0036315)	21	4	1.23	+	3.24	4.70E-02	3.61E-01
GO:0031111	negative regulation of microtubule polymerization or depolymerization (GO:0031111)	42	8	2.47	+	3.24	5.88E-03	8.52E-02
GO:0015669	gas transport (GO:0015669)	21	4	1.23	+	3.24	4.70E-02	3.61E-01
GO:0046688	response to copper ion (GO:0046688)	42	8	2.47	+	3.24	5.88E-03	8.51E-02
GO:0061377	mammary gland lobule development (GO:0061377)	21	4	1.23	+	3.24	4.70E-02	3.61E-01
GO:0061318	renal filtration cell differentiation (GO:0061318)	21	4	1.23	+	3.24	4.70E-02	3.61E-01
GO:0097205	renal filtration (GO:0097205)	21	4	1.23	+	3.24	4.70E-02	3.60E-01
GO:0060749	mammary gland alveolus development (GO:0060749)	21	4	1.23	+	3.24	4.70E-02	3.60E-01
GO:0061061	muscle structure development (GO:0061061)	499	95	29.30	+	3.24	5.70E-21	2.98E-18
GO:1901990	regulation of mitotic cell cycle phase transition (GO:1901990)	332	63	19.50	+	3.23	3.11E-14	5.74E-12
GO:0055013	cardiac muscle cell development (GO:0055013)	58	11	3.41	+	3.23	1.37E-03	2.62E-02
GO:0006942	regulation of striated muscle contraction (GO:0006942)	95	18	5.58	+	3.23	4.87E-05	1.53E-03
GO:0046683	response to organophosphorus (GO:0046683)	132	25	7.75	+	3.23	1.82E-06	7.96E-05
GO:0060323	head morphogenesis (GO:0060323)	37	7	2.17	+	3.22	1.00E-02	1.27E-01
GO:0048661	positive regulation of smooth muscle cell proliferation (GO:0048661)	85	16	4.99	+	3.21	1.34E-04	3.63E-03
GO:0043502	regulation of muscle adaptation (GO:0043502)	80	15	4.70	+	3.19	2.24E-04	5.49E-03
GO:0010273	detoxification of copper ion (GO:0010273)	16	3	.94	+	3.19	8.50E-02	5.24E-01
GO:0021783	preganglionic parasympathetic fiber development (GO:0021783)	16	3	.94	+	3.19	8.50E-02	5.24E-01
GO:1902750	negative regulation of cell cycle G2/M phase transition (GO:1902750)	64	12	3.76	+	3.19	9.24E-04	1.89E-02
GO:0045651	positive regulation of macrophage differentiation (GO:0045651)	16	3	.94	+	3.19	8.50E-02	5.24E-01
GO:0071391	cellular response to estrogen stimulus (GO:0071391)	16	3	.94	+	3.19	8.50E-02	5.23E-01
GO:2000291	regulation of myoblast proliferation (GO:2000291)	16	3	.94	+	3.19	8.50E-02	5.23E-01
GO:0040036	regulation of fibroblast growth factor receptor signaling pathway (GO:0040036)	32	6	1.88	+	3.19	1.73E-02	1.86E-01
GO:0090224	regulation of spindle organization (GO:0090224)	48	9	2.82	+	3.19	3.91E-03	6.22E-02
GO:2000095	regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)	16	3	.94	+	3.19	8.50E-02	5.23E-01
GO:0051445	regulation of meiotic cell cycle (GO:0051445)	64	12	3.76	+	3.19	9.24E-04	1.89E-02
GO:0048546	digestive tract morphogenesis (GO:0048546)	48	9	2.82	+	3.19	3.91E-03	6.21E-02
GO:0051282	regulation of sequestering of calcium ion (GO:0051282)	128	24	7.52	+	3.19	3.39E-06	1.42E-04
GO:1990169	stress response to copper ion (GO:1990169)	16	3	.94	+	3.19	8.50E-02	5.23E-01
GO:0035641	locomotory exploration behavior (GO:0035641)	16	3	.94	+	3.19	8.50E-02	5.23E-01
GO:0097623	potassium ion export across plasma membrane (GO:0097623)	16	3	.94	+	3.19	8.50E-02	5.22E-01
GO:0008356	asymmetric cell division (GO:0008356)	16	3	.94	+	3.19	8.50E-02	5.22E-01
GO:0022602	ovulation cycle process (GO:0022602)	48	9	2.82	+	3.19	3.91E-03	6.21E-02
GO:0014855	striated muscle cell proliferation (GO:0014855)	32	6	1.88	+	3.19	1.73E-02	1.86E-01
GO:0060602	branch elongation of an epithelium (GO:0060602)	16	3	.94	+	3.19	8.50E-02	5.22E-01
GO:0007567	parturition (GO:0007567)	16	3	.94	+	3.19	8.50E-02	5.22E-01
GO:0072520	seminiferous tubule development (GO:0072520)	16	3	.94	+	3.19	8.50E-02	5.22E-01
GO:0090068	positive regulation of cell cycle process (GO:0090068)	251	47	14.74	+	3.19	8.70E-11	9.03E-09
GO:0071103	DNA conformation change (GO:0071103)	107	20	6.28	+	3.18	2.25E-05	7.64E-04
GO:0003151	outflow tract morphogenesis (GO:0003151)	75	14	4.40	+	3.18	3.73E-04	8.62E-03
GO:0090497	mesenchymal cell migration (GO:0090497)	59	11	3.46	+	3.18	1.55E-03	2.92E-02
GO:0010232	vascular transport (GO:0010232)	86	16	5.05	+	3.17	1.51E-04	4.00E-03
GO:0045687	positive regulation of glial cell differentiation (GO:0045687)	43	8	2.52	+	3.17	6.64E-03	9.31E-02
GO:0150104	transport across blood-brain barrier (GO:0150104)	86	16	5.05	+	3.17	1.51E-04	3.99E-03
GO:0030261	chromosome condensation (GO:0030261)	43	8	2.52	+	3.17	6.64E-03	9.31E-02
GO:0003254	regulation of membrane depolarization (GO:0003254)	43	8	2.52	+	3.17	6.64E-03	9.30E-02
GO:0060415	muscle tissue morphogenesis (GO:0060415)	70	13	4.11	+	3.16	6.22E-04	1.35E-02
GO:0003208	cardiac ventricle morphogenesis (GO:0003208)	70	13	4.11	+	3.16	6.22E-04	1.35E-02
GO:0031589	cell-substrate adhesion (GO:0031589)	194	36	11.39	+	3.16	1.69E-08	1.05E-06
GO:1901019	regulation of calcium ion transmembrane transporter activity (GO:1901019)	97	18	5.70	+	3.16	6.18E-05	1.89E-03
GO:0002675	positive regulation of acute inflammatory response (GO:0002675)	27	5	1.59	+	3.15	3.01E-02	2.72E-01
GO:0051953	negative regulation of amine transport (GO:0051953)	27	5	1.59	+	3.15	3.01E-02	2.72E-01
GO:0035567	non-canonical Wnt signaling pathway (GO:0035567)	54	10	3.17	+	3.15	2.61E-03	4.47E-02
GO:0031128	developmental induction (GO:0031128)	27	5	1.59	+	3.15	3.01E-02	2.71E-01
GO:0010954	positive regulation of protein processing (GO:0010954)	27	5	1.59	+	3.15	3.01E-02	2.71E-01
GO:0003416	endochondral bone growth (GO:0003416)	27	5	1.59	+	3.15	3.01E-02	2.71E-01
GO:0051276	chromosome organization (GO:0051276)	444	82	26.07	+	3.15	1.48E-17	4.74E-15
GO:0051963	regulation of synapse assembly (GO:0051963)	103	19	6.05	+	3.14	4.19E-05	1.33E-03
GO:0035051	cardiocyte differentiation (GO:0035051)	114	21	6.69	+	3.14	1.72E-05	5.99E-04
GO:0021955	central nervous system neuron axonogenesis (GO:0021955)	38	7	2.23	+	3.14	1.13E-02	1.39E-01
GO:0014074	response to purine-containing compound (GO:0014074)	147	27	8.63	+	3.13	1.20E-06	5.44E-05
GO:0048599	oocyte development (GO:0048599)	49	9	2.88	+	3.13	4.41E-03	6.86E-02
GO:0048286	lung alveolus development (GO:0048286)	49	9	2.88	+	3.13	4.41E-03	6.86E-02
GO:0030048	actin filament-based movement (GO:0030048)	98	18	5.75	+	3.13	6.94E-05	2.08E-03
GO:0045444	fat cell differentiation (GO:0045444)	120	22	7.05	+	3.12	1.17E-05	4.28E-04
GO:0042692	muscle cell differentiation (GO:0042692)	268	49	15.74	+	3.11	7.18E-11	7.76E-09
GO:0030198	extracellular matrix organization (GO:0030198)	280	51	16.44	+	3.10	3.31E-11	3.82E-09
GO:0002604	regulation of dendritic cell antigen processing and presentation (GO:0002604)	11	2	.65	+	3.10	1.60E-01	6.65E-01
GO:0007494	midgut development (GO:0007494)	11	2	.65	+	3.10	1.60E-01	6.65E-01
GO:0060442	branching involved in prostate gland morphogenesis (GO:0060442)	11	2	.65	+	3.10	1.60E-01	6.65E-01
GO:0010171	body morphogenesis (GO:0010171)	44	8	2.58	+	3.10	7.48E-03	1.03E-01
GO:0045628	regulation of T-helper 2 cell differentiation (GO:0045628)	11	2	.65	+	3.10	1.60E-01	6.65E-01
GO:0045603	positive regulation of endothelial cell differentiation (GO:0045603)	11	2	.65	+	3.10	1.60E-01	6.65E-01
GO:0033630	positive regulation of cell adhesion mediated by integrin (GO:0033630)	22	4	1.29	+	3.10	5.32E-02	3.97E-01
GO:0033625	positive regulation of integrin activation (GO:0033625)	11	2	.65	+	3.10	1.60E-01	6.65E-01
GO:0021604	cranial nerve structural organization (GO:0021604)	11	2	.65	+	3.10	1.60E-01	6.64E-01
GO:0060379	cardiac muscle cell myoblast differentiation (GO:0060379)	11	2	.65	+	3.10	1.60E-01	6.64E-01
GO:0072311	glomerular epithelial cell differentiation (GO:0072311)	22	4	1.29	+	3.10	5.32E-02	3.97E-01
GO:0033504	floor plate development (GO:0033504)	11	2	.65	+	3.10	1.60E-01	6.64E-01
GO:0060159	regulation of dopamine receptor signaling pathway (GO:0060159)	11	2	.65	+	3.10	1.60E-01	6.64E-01
GO:0006686	sphingomyelin biosynthetic process (GO:0006686)	11	2	.65	+	3.10	1.60E-01	6.64E-01
GO:1990961	xenobiotic detoxification by transmembrane export across the plasma membrane (GO:1990961)	11	2	.65	+	3.10	1.60E-01	6.63E-01
GO:0019062	virion attachment to host cell (GO:0019062)	11	2	.65	+	3.10	1.60E-01	6.63E-01
GO:0051967	negative regulation of synaptic transmission, glutamatergic (GO:0051967)	11	2	.65	+	3.10	1.60E-01	6.63E-01
GO:0032780	negative regulation of ATP-dependent activity (GO:0032780)	22	4	1.29	+	3.10	5.32E-02	3.97E-01
GO:1902284	neuron projection extension involved in neuron projection guidance (GO:1902284)	11	2	.65	+	3.10	1.60E-01	6.63E-01
GO:0071474	cellular hyperosmotic response (GO:0071474)	11	2	.65	+	3.10	1.60E-01	6.63E-01
GO:0051838	cytolysis by host of symbiont cells (GO:0051838)	11	2	.65	+	3.10	1.60E-01	6.63E-01
GO:0032656	regulation of interleukin-13 production (GO:0032656)	22	4	1.29	+	3.10	5.32E-02	3.96E-01
GO:0071379	cellular response to prostaglandin stimulus (GO:0071379)	22	4	1.29	+	3.10	5.32E-02	3.96E-01
GO:0045059	positive thymic T cell selection (GO:0045059)	11	2	.65	+	3.10	1.60E-01	6.62E-01
GO:0051657	maintenance of organelle location (GO:0051657)	11	2	.65	+	3.10	1.60E-01	6.62E-01
GO:0048846	axon extension involved in axon guidance (GO:0048846)	11	2	.65	+	3.10	1.60E-01	6.62E-01
GO:0051574	positive regulation of histone H3-K9 methylation (GO:0051574)	11	2	.65	+	3.10	1.60E-01	6.62E-01
GO:0048745	smooth muscle tissue development (GO:0048745)	22	4	1.29	+	3.10	5.32E-02	3.96E-01
GO:0070572	positive regulation of neuron projection regeneration (GO:0070572)	11	2	.65	+	3.10	1.60E-01	6.62E-01
GO:0106072	negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106072)	11	2	.65	+	3.10	1.60E-01	6.62E-01
GO:0032288	myelin assembly (GO:0032288)	22	4	1.29	+	3.10	5.32E-02	3.96E-01
GO:0032276	regulation of gonadotropin secretion (GO:0032276)	11	2	.65	+	3.10	1.60E-01	6.61E-01
GO:0106049	regulation of cellular response to osmotic stress (GO:0106049)	11	2	.65	+	3.10	1.60E-01	6.61E-01
GO:0051307	meiotic chromosome separation (GO:0051307)	22	4	1.29	+	3.10	5.32E-02	3.96E-01
GO:0048485	sympathetic nervous system development (GO:0048485)	22	4	1.29	+	3.10	5.32E-02	3.95E-01
GO:0051152	positive regulation of smooth muscle cell differentiation (GO:0051152)	11	2	.65	+	3.10	1.60E-01	6.61E-01
GO:0051081	nuclear membrane disassembly (GO:0051081)	11	2	.65	+	3.10	1.60E-01	6.61E-01
GO:0017145	stem cell division (GO:0017145)	22	4	1.29	+	3.10	5.32E-02	3.95E-01
GO:1905208	negative regulation of cardiocyte differentiation (GO:1905208)	11	2	.65	+	3.10	1.60E-01	6.61E-01
GO:0048103	somatic stem cell division (GO:0048103)	11	2	.65	+	3.10	1.60E-01	6.61E-01
GO:0036120	cellular response to platelet-derived growth factor stimulus (GO:0036120)	22	4	1.29	+	3.10	5.32E-02	3.95E-01
GO:1900121	negative regulation of receptor binding (GO:1900121)	11	2	.65	+	3.10	1.60E-01	6.60E-01
GO:0061756	leukocyte adhesion to vascular endothelial cell (GO:0061756)	22	4	1.29	+	3.10	5.32E-02	3.95E-01
GO:0015844	monoamine transport (GO:0015844)	22	4	1.29	+	3.10	5.32E-02	3.95E-01
GO:0042487	regulation of odontogenesis of dentin-containing tooth (GO:0042487)	11	2	.65	+	3.10	1.60E-01	6.60E-01
GO:0030449	regulation of complement activation (GO:0030449)	22	4	1.29	+	3.10	5.32E-02	3.94E-01
GO:1904238	pericyte cell differentiation (GO:1904238)	11	2	.65	+	3.10	1.60E-01	6.60E-01
GO:0010749	regulation of nitric oxide mediated signal transduction (GO:0010749)	11	2	.65	+	3.10	1.60E-01	6.60E-01
GO:0030210	heparin biosynthetic process (GO:0030210)	11	2	.65	+	3.10	1.60E-01	6.60E-01
GO:0061303	cornea development in camera-type eye (GO:0061303)	11	2	.65	+	3.10	1.60E-01	6.59E-01
GO:0014889	muscle atrophy (GO:0014889)	11	2	.65	+	3.10	1.60E-01	6.59E-01
GO:0046426	negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426)	22	4	1.29	+	3.10	5.32E-02	3.94E-01
GO:0030049	muscle filament sliding (GO:0030049)	11	2	.65	+	3.10	1.60E-01	6.59E-01
GO:0014820	tonic smooth muscle contraction (GO:0014820)	11	2	.65	+	3.10	1.60E-01	6.59E-01
GO:1902959	regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959)	11	2	.65	+	3.10	1.60E-01	6.59E-01
GO:0097090	presynaptic membrane organization (GO:0097090)	11	2	.65	+	3.10	1.60E-01	6.59E-01
GO:0061052	negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052)	11	2	.65	+	3.10	1.60E-01	6.58E-01
GO:1903365	regulation of fear response (GO:1903365)	11	2	.65	+	3.10	1.60E-01	6.58E-01
GO:0003174	mitral valve development (GO:0003174)	11	2	.65	+	3.10	1.60E-01	6.58E-01
GO:0045778	positive regulation of ossification (GO:0045778)	55	10	3.23	+	3.10	2.93E-03	4.97E-02
GO:0002931	response to ischemia (GO:0002931)	55	10	3.23	+	3.10	2.93E-03	4.96E-02
GO:0003229	ventricular cardiac muscle tissue development (GO:0003229)	55	10	3.23	+	3.10	2.93E-03	4.96E-02
GO:0033198	response to ATP (GO:0033198)	33	6	1.94	+	3.10	1.95E-02	2.03E-01
GO:0070741	response to interleukin-6 (GO:0070741)	33	6	1.94	+	3.10	1.95E-02	2.03E-01
GO:0048566	embryonic digestive tract development (GO:0048566)	33	6	1.94	+	3.10	1.95E-02	2.03E-01
GO:0031114	regulation of microtubule depolymerization (GO:0031114)	33	6	1.94	+	3.10	1.95E-02	2.03E-01
GO:0061028	establishment of endothelial barrier (GO:0061028)	33	6	1.94	+	3.10	1.95E-02	2.03E-01
GO:0043062	extracellular structure organization (GO:0043062)	281	51	16.50	+	3.09	3.71E-11	4.24E-09
GO:0032231	regulation of actin filament bundle assembly (GO:0032231)	105	19	6.17	+	3.08	5.27E-05	1.64E-03
GO:1904427	positive regulation of calcium ion transmembrane transport (GO:1904427)	94	17	5.52	+	3.08	1.29E-04	3.54E-03
GO:0051153	regulation of striated muscle cell differentiation (GO:0051153)	83	15	4.87	+	3.08	3.17E-04	7.45E-03
GO:0045229	external encapsulating structure organization (GO:0045229)	283	51	16.62	+	3.07	4.64E-11	5.20E-09
GO:0046850	regulation of bone remodeling (GO:0046850)	50	9	2.94	+	3.07	4.95E-03	7.52E-02
GO:0060485	mesenchyme development (GO:0060485)	239	43	14.03	+	3.06	1.60E-09	1.29E-07
GO:0051966	regulation of synaptic transmission, glutamatergic (GO:0051966)	78	14	4.58	+	3.06	5.27E-04	1.16E-02
GO:0032570	response to progesterone (GO:0032570)	39	7	2.29	+	3.06	1.28E-02	1.52E-01
GO:0010762	regulation of fibroblast migration (GO:0010762)	39	7	2.29	+	3.06	1.28E-02	1.52E-01
GO:0060193	positive regulation of lipase activity (GO:0060193)	67	12	3.93	+	3.05	1.31E-03	2.53E-02
GO:1902305	regulation of sodium ion transmembrane transport (GO:1902305)	67	12	3.93	+	3.05	1.31E-03	2.53E-02
GO:0033688	regulation of osteoblast proliferation (GO:0033688)	28	5	1.64	+	3.04	3.39E-02	2.93E-01
GO:0001941	postsynaptic membrane organization (GO:0001941)	28	5	1.64	+	3.04	3.39E-02	2.93E-01
GO:0014072	response to isoquinoline alkaloid (GO:0014072)	28	5	1.64	+	3.04	3.39E-02	2.93E-01
GO:0090505	epiboly involved in wound healing (GO:0090505)	28	5	1.64	+	3.04	3.39E-02	2.93E-01
GO:0045005	DNA-templated DNA replication maintenance of fidelity (GO:0045005)	56	10	3.29	+	3.04	3.29E-03	5.36E-02
GO:0071280	cellular response to copper ion (GO:0071280)	28	5	1.64	+	3.04	3.39E-02	2.93E-01
GO:0044319	wound healing, spreading of cells (GO:0044319)	28	5	1.64	+	3.04	3.39E-02	2.92E-01
GO:0048679	regulation of axon regeneration (GO:0048679)	28	5	1.64	+	3.04	3.39E-02	2.92E-01
GO:0051354	negative regulation of oxidoreductase activity (GO:0051354)	28	5	1.64	+	3.04	3.39E-02	2.92E-01
GO:0031529	ruffle organization (GO:0031529)	28	5	1.64	+	3.04	3.39E-02	2.92E-01
GO:0048333	mesodermal cell differentiation (GO:0048333)	28	5	1.64	+	3.04	3.39E-02	2.92E-01
GO:0043278	response to morphine (GO:0043278)	28	5	1.64	+	3.04	3.39E-02	2.92E-01
GO:0010811	positive regulation of cell-substrate adhesion (GO:0010811)	129	23	7.57	+	3.04	1.11E-05	4.09E-04
GO:0045786	negative regulation of cell cycle (GO:0045786)	359	64	21.08	+	3.04	2.35E-13	3.92E-11
GO:0030501	positive regulation of bone mineralization (GO:0030501)	45	8	2.64	+	3.03	8.39E-03	1.10E-01
GO:0048285	organelle fission (GO:0048285)	349	62	20.49	+	3.03	6.40E-13	1.01E-10
GO:0019226	transmission of nerve impulse (GO:0019226)	62	11	3.64	+	3.02	2.19E-03	3.89E-02
GO:0003206	cardiac chamber morphogenesis (GO:0003206)	124	22	7.28	+	3.02	1.83E-05	6.33E-04
GO:0044344	cellular response to fibroblast growth factor stimulus (GO:0044344)	85	15	4.99	+	3.01	3.96E-04	9.05E-03
GO:0010224	response to UV-B (GO:0010224)	17	3	1.00	+	3.01	9.61E-02	5.61E-01
GO:0007379	segment specification (GO:0007379)	17	3	1.00	+	3.01	9.61E-02	5.60E-01
GO:2001212	regulation of vasculogenesis (GO:2001212)	17	3	1.00	+	3.01	9.61E-02	5.60E-01
GO:0001885	endothelial cell development (GO:0001885)	51	9	2.99	+	3.01	5.54E-03	8.15E-02
GO:0060070	canonical Wnt signaling pathway (GO:0060070)	102	18	5.99	+	3.01	1.09E-04	3.04E-03
GO:0051973	positive regulation of telomerase activity (GO:0051973)	34	6	2.00	+	3.01	2.19E-02	2.21E-01
GO:0051937	catecholamine transport (GO:0051937)	17	3	1.00	+	3.01	9.61E-02	5.60E-01
GO:0033194	response to hydroperoxide (GO:0033194)	17	3	1.00	+	3.01	9.61E-02	5.60E-01
GO:0071380	cellular response to prostaglandin E stimulus (GO:0071380)	17	3	1.00	+	3.01	9.61E-02	5.60E-01
GO:0006349	regulation of gene expression by genomic imprinting (GO:0006349)	17	3	1.00	+	3.01	9.61E-02	5.59E-01
GO:0048532	anatomical structure arrangement (GO:0048532)	17	3	1.00	+	3.01	9.61E-02	5.59E-01
GO:0070314	G1 to G0 transition (GO:0070314)	17	3	1.00	+	3.01	9.61E-02	5.59E-01
GO:0099068	postsynapse assembly (GO:0099068)	17	3	1.00	+	3.01	9.61E-02	5.59E-01
GO:0048245	eosinophil chemotaxis (GO:0048245)	17	3	1.00	+	3.01	9.61E-02	5.59E-01
GO:0000132	establishment of mitotic spindle orientation (GO:0000132)	34	6	2.00	+	3.01	2.19E-02	2.21E-01
GO:0043268	positive regulation of potassium ion transport (GO:0043268)	51	9	2.99	+	3.01	5.54E-03	8.14E-02
GO:0035627	ceramide transport (GO:0035627)	17	3	1.00	+	3.01	9.61E-02	5.58E-01
GO:0048009	insulin-like growth factor receptor signaling pathway (GO:0048009)	17	3	1.00	+	3.01	9.61E-02	5.58E-01
GO:0015867	ATP transport (GO:0015867)	17	3	1.00	+	3.01	9.61E-02	5.58E-01
GO:0055017	cardiac muscle tissue growth (GO:0055017)	34	6	2.00	+	3.01	2.19E-02	2.21E-01
GO:1904355	positive regulation of telomere capping (GO:1904355)	17	3	1.00	+	3.01	9.61E-02	5.58E-01
GO:0010765	positive regulation of sodium ion transport (GO:0010765)	34	6	2.00	+	3.01	2.19E-02	2.21E-01
GO:1903587	regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)	17	3	1.00	+	3.01	9.61E-02	5.58E-01
GO:0007588	excretion (GO:0007588)	17	3	1.00	+	3.01	9.61E-02	5.57E-01
GO:0060546	negative regulation of necroptotic process (GO:0060546)	17	3	1.00	+	3.01	9.61E-02	5.57E-01
GO:1901987	regulation of cell cycle phase transition (GO:1901987)	431	76	25.31	+	3.00	2.09E-15	4.76E-13
GO:0002028	regulation of sodium ion transport (GO:0002028)	91	16	5.34	+	2.99	2.67E-04	6.42E-03
GO:0071320	cellular response to cAMP (GO:0071320)	57	10	3.35	+	2.99	3.68E-03	5.90E-02
GO:0031109	microtubule polymerization or depolymerization (GO:0031109)	57	10	3.35	+	2.99	3.68E-03	5.90E-02
GO:0051301	cell division (GO:0051301)	514	90	30.18	+	2.98	7.18E-18	2.45E-15
GO:0045740	positive regulation of DNA replication (GO:0045740)	40	7	2.35	+	2.98	1.43E-02	1.66E-01
GO:1902692	regulation of neuroblast proliferation (GO:1902692)	40	7	2.35	+	2.98	1.43E-02	1.66E-01
GO:0060537	muscle tissue development (GO:0060537)	326	57	19.14	+	2.98	9.64E-12	1.22E-09
GO:0007411	axon guidance (GO:0007411)	235	41	13.80	+	2.97	8.32E-09	5.48E-07
GO:0006929	substrate-dependent cell migration (GO:0006929)	23	4	1.35	+	2.96	5.98E-02	4.16E-01
GO:0045649	regulation of macrophage differentiation (GO:0045649)	23	4	1.35	+	2.96	5.98E-02	4.15E-01
GO:0007274	neuromuscular synaptic transmission (GO:0007274)	23	4	1.35	+	2.96	5.98E-02	4.15E-01
GO:1902547	regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547)	23	4	1.35	+	2.96	5.98E-02	4.15E-01
GO:0071539	protein localization to centrosome (GO:0071539)	23	4	1.35	+	2.96	5.98E-02	4.15E-01
GO:0071295	cellular response to vitamin (GO:0071295)	23	4	1.35	+	2.96	5.98E-02	4.15E-01
GO:0051492	regulation of stress fiber assembly (GO:0051492)	92	16	5.40	+	2.96	2.97E-04	7.06E-03
GO:0051444	negative regulation of ubiquitin-protein transferase activity (GO:0051444)	23	4	1.35	+	2.96	5.98E-02	4.15E-01
GO:0030890	positive regulation of B cell proliferation (GO:0030890)	46	8	2.70	+	2.96	9.38E-03	1.20E-01
GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	115	20	6.75	+	2.96	5.53E-05	1.71E-03
GO:0035584	calcium-mediated signaling using intracellular calcium source (GO:0035584)	23	4	1.35	+	2.96	5.98E-02	4.14E-01
GO:0046823	negative regulation of nucleocytoplasmic transport (GO:0046823)	23	4	1.35	+	2.96	5.98E-02	4.14E-01
GO:0061383	trabecula morphogenesis (GO:0061383)	46	8	2.70	+	2.96	9.38E-03	1.20E-01
GO:0023019	signal transduction involved in regulation of gene expression (GO:0023019)	23	4	1.35	+	2.96	5.98E-02	4.14E-01
GO:0045980	negative regulation of nucleotide metabolic process (GO:0045980)	23	4	1.35	+	2.96	5.98E-02	4.14E-01
GO:0003272	endocardial cushion formation (GO:0003272)	23	4	1.35	+	2.96	5.98E-02	4.14E-01
GO:1902883	negative regulation of response to oxidative stress (GO:1902883)	23	4	1.35	+	2.96	5.98E-02	4.13E-01
GO:0060547	negative regulation of necrotic cell death (GO:0060547)	23	4	1.35	+	2.96	5.98E-02	4.13E-01
GO:0097485	neuron projection guidance (GO:0097485)	236	41	13.86	+	2.96	9.25E-09	6.04E-07
GO:0097306	cellular response to alcohol (GO:0097306)	98	17	5.75	+	2.95	2.00E-04	5.06E-03
GO:2000573	positive regulation of DNA biosynthetic process (GO:2000573)	75	13	4.40	+	2.95	1.09E-03	2.19E-02
GO:2000134	negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	75	13	4.40	+	2.95	1.09E-03	2.18E-02
GO:0034502	protein localization to chromosome (GO:0034502)	75	13	4.40	+	2.95	1.09E-03	2.18E-02
GO:0060324	face development (GO:0060324)	52	9	3.05	+	2.95	6.19E-03	8.83E-02
GO:0090102	cochlea development (GO:0090102)	52	9	3.05	+	2.95	6.19E-03	8.83E-02
GO:1904019	epithelial cell apoptotic process (GO:1904019)	52	9	3.05	+	2.95	6.19E-03	8.82E-02
GO:0060688	regulation of morphogenesis of a branching structure (GO:0060688)	52	9	3.05	+	2.95	6.19E-03	8.81E-02
GO:0051216	cartilage development (GO:0051216)	168	29	9.87	+	2.94	1.49E-06	6.57E-05
GO:0044057	regulation of system process (GO:0044057)	568	98	33.35	+	2.94	5.49E-19	2.21E-16
GO:0007026	negative regulation of microtubule depolymerization (GO:0007026)	29	5	1.70	+	2.94	3.80E-02	3.21E-01
GO:0090504	epiboly (GO:0090504)	29	5	1.70	+	2.94	3.80E-02	3.20E-01
GO:0051647	nucleus localization (GO:0051647)	29	5	1.70	+	2.94	3.80E-02	3.20E-01
GO:0070633	transepithelial transport (GO:0070633)	29	5	1.70	+	2.94	3.80E-02	3.20E-01
GO:0048710	regulation of astrocyte differentiation (GO:0048710)	29	5	1.70	+	2.94	3.80E-02	3.20E-01
GO:0051304	chromosome separation (GO:0051304)	29	5	1.70	+	2.94	3.80E-02	3.20E-01
GO:1903959	regulation of anion transmembrane transport (GO:1903959)	29	5	1.70	+	2.94	3.80E-02	3.20E-01
GO:0030212	hyaluronan metabolic process (GO:0030212)	29	5	1.70	+	2.94	3.80E-02	3.19E-01
GO:0034446	substrate adhesion-dependent cell spreading (GO:0034446)	58	10	3.41	+	2.94	4.10E-03	6.43E-02
GO:0071456	cellular response to hypoxia (GO:0071456)	128	22	7.52	+	2.93	2.81E-05	9.38E-04
GO:0003158	endothelium development (GO:0003158)	99	17	5.81	+	2.92	2.23E-04	5.49E-03
GO:0001974	blood vessel remodeling (GO:0001974)	35	6	2.06	+	2.92	2.45E-02	2.41E-01
GO:0043537	negative regulation of blood vessel endothelial cell migration (GO:0043537)	35	6	2.06	+	2.92	2.45E-02	2.41E-01
GO:0120033	negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	35	6	2.06	+	2.92	2.45E-02	2.41E-01
GO:0042310	vasoconstriction (GO:0042310)	35	6	2.06	+	2.92	2.45E-02	2.41E-01
GO:0021988	olfactory lobe development (GO:0021988)	35	6	2.06	+	2.92	2.45E-02	2.40E-01
GO:0014902	myotube differentiation (GO:0014902)	76	13	4.46	+	2.91	1.22E-03	2.38E-02
GO:0060412	ventricular septum morphogenesis (GO:0060412)	41	7	2.41	+	2.91	1.59E-02	1.77E-01
GO:0033627	cell adhesion mediated by integrin (GO:0033627)	41	7	2.41	+	2.91	1.59E-02	1.77E-01
GO:0051294	establishment of spindle orientation (GO:0051294)	41	7	2.41	+	2.91	1.59E-02	1.77E-01
GO:0060191	regulation of lipase activity (GO:0060191)	88	15	5.17	+	2.90	5.47E-04	1.20E-02
GO:2000273	positive regulation of signaling receptor activity (GO:2000273)	47	8	2.76	+	2.90	1.05E-02	1.31E-01
GO:2000177	regulation of neural precursor cell proliferation (GO:2000177)	94	16	5.52	+	2.90	3.68E-04	8.52E-03
GO:0031297	replication fork processing (GO:0031297)	47	8	2.76	+	2.90	1.05E-02	1.31E-01
GO:0060976	coronary vasculature development (GO:0060976)	47	8	2.76	+	2.90	1.05E-02	1.31E-01
GO:0061005	cell differentiation involved in kidney development (GO:0061005)	47	8	2.76	+	2.90	1.05E-02	1.31E-01
GO:0009994	oocyte differentiation (GO:0009994)	53	9	3.11	+	2.89	6.89E-03	9.56E-02
GO:0010543	regulation of platelet activation (GO:0010543)	53	9	3.11	+	2.89	6.89E-03	9.55E-02
GO:1904064	positive regulation of cation transmembrane transport (GO:1904064)	171	29	10.04	+	2.89	2.03E-06	8.83E-05
GO:0045428	regulation of nitric oxide biosynthetic process (GO:0045428)	59	10	3.46	+	2.89	4.57E-03	7.01E-02
GO:0055008	cardiac muscle tissue morphogenesis (GO:0055008)	59	10	3.46	+	2.89	4.57E-03	7.00E-02
GO:1904029	regulation of cyclin-dependent protein kinase activity (GO:1904029)	118	20	6.93	+	2.89	7.59E-05	2.25E-03
GO:0001570	vasculogenesis (GO:0001570)	71	12	4.17	+	2.88	2.02E-03	3.64E-02
GO:0048644	muscle organ morphogenesis (GO:0048644)	77	13	4.52	+	2.88	1.35E-03	2.59E-02
GO:0045446	endothelial cell differentiation (GO:0045446)	83	14	4.87	+	2.87	9.05E-04	1.86E-02
GO:0007346	regulation of mitotic cell cycle (GO:0007346)	493	83	28.95	+	2.87	1.06E-15	2.53E-13
GO:0110020	regulation of actomyosin structure organization (GO:0110020)	101	17	5.93	+	2.87	2.74E-04	6.58E-03
GO:0014013	regulation of gliogenesis (GO:0014013)	101	17	5.93	+	2.87	2.74E-04	6.57E-03
GO:0001525	angiogenesis (GO:0001525)	327	55	19.20	+	2.86	8.16E-11	8.59E-09
GO:0031570	DNA integrity checkpoint signaling (GO:0031570)	113	19	6.64	+	2.86	1.25E-04	3.44E-03
GO:0010639	negative regulation of organelle organization (GO:0010639)	345	58	20.26	+	2.86	2.52E-11	2.97E-09
GO:0060560	developmental growth involved in morphogenesis (GO:0060560)	131	22	7.69	+	2.86	3.83E-05	1.23E-03
GO:0051592	response to calcium ion (GO:0051592)	149	25	8.75	+	2.86	1.19E-05	4.34E-04
GO:0010976	positive regulation of neuron projection development (GO:0010976)	155	26	9.10	+	2.86	8.03E-06	3.07E-04
GO:0140694	non-membrane-bounded organelle assembly (GO:0140694)	316	53	18.56	+	2.86	1.97E-10	1.90E-08
GO:1903169	regulation of calcium ion transmembrane transport (GO:1903169)	185	31	10.86	+	2.85	1.14E-06	5.23E-05
GO:0045787	positive regulation of cell cycle (GO:0045787)	353	59	20.73	+	2.85	2.09E-11	2.52E-09
GO:0060419	heart growth (GO:0060419)	36	6	2.11	+	2.84	2.73E-02	2.57E-01
GO:0021692	cerebellar Purkinje cell layer morphogenesis (GO:0021692)	18	3	1.06	+	2.84	1.08E-01	6.01E-01
GO:0002407	dendritic cell chemotaxis (GO:0002407)	18	3	1.06	+	2.84	1.08E-01	6.01E-01
GO:0001975	response to amphetamine (GO:0001975)	30	5	1.76	+	2.84	4.24E-02	3.36E-01
GO:0001953	negative regulation of cell-matrix adhesion (GO:0001953)	36	6	2.11	+	2.84	2.73E-02	2.57E-01
GO:0007212	dopamine receptor signaling pathway (GO:0007212)	30	5	1.76	+	2.84	4.24E-02	3.35E-01
GO:0060252	positive regulation of glial cell proliferation (GO:0060252)	18	3	1.06	+	2.84	1.08E-01	6.00E-01
GO:0006684	sphingomyelin metabolic process (GO:0006684)	18	3	1.06	+	2.84	1.08E-01	6.00E-01
GO:0072074	kidney mesenchyme development (GO:0072074)	18	3	1.06	+	2.84	1.08E-01	6.00E-01
GO:0001569	branching involved in blood vessel morphogenesis (GO:0001569)	30	5	1.76	+	2.84	4.24E-02	3.35E-01
GO:0071354	cellular response to interleukin-6 (GO:0071354)	30	5	1.76	+	2.84	4.24E-02	3.35E-01
GO:0033033	negative regulation of myeloid cell apoptotic process (GO:0033033)	18	3	1.06	+	2.84	1.08E-01	6.00E-01
GO:0051653	spindle localization (GO:0051653)	60	10	3.52	+	2.84	5.07E-03	7.58E-02
GO:0071168	protein localization to chromatin (GO:0071168)	30	5	1.76	+	2.84	4.24E-02	3.35E-01
GO:0032354	response to follicle-stimulating hormone (GO:0032354)	18	3	1.06	+	2.84	1.08E-01	6.00E-01
GO:2000010	positive regulation of protein localization to cell surface (GO:2000010)	18	3	1.06	+	2.84	1.08E-01	5.99E-01
GO:0006027	glycosaminoglycan catabolic process (GO:0006027)	30	5	1.76	+	2.84	4.24E-02	3.35E-01
GO:0006026	aminoglycan catabolic process (GO:0006026)	36	6	2.11	+	2.84	2.73E-02	2.57E-01
GO:1901387	positive regulation of voltage-gated calcium channel activity (GO:1901387)	18	3	1.06	+	2.84	1.08E-01	5.99E-01
GO:1905564	positive regulation of vascular endothelial cell proliferation (GO:1905564)	18	3	1.06	+	2.84	1.08E-01	5.99E-01
GO:0048486	parasympathetic nervous system development (GO:0048486)	18	3	1.06	+	2.84	1.08E-01	5.99E-01
GO:0035909	aorta morphogenesis (GO:0035909)	30	5	1.76	+	2.84	4.24E-02	3.35E-01
GO:0035864	response to potassium ion (GO:0035864)	18	3	1.06	+	2.84	1.08E-01	5.99E-01
GO:0016486	peptide hormone processing (GO:0016486)	36	6	2.11	+	2.84	2.73E-02	2.56E-01
GO:0030728	ovulation (GO:0030728)	18	3	1.06	+	2.84	1.08E-01	5.98E-01
GO:0043149	stress fiber assembly (GO:0043149)	18	3	1.06	+	2.84	1.08E-01	5.98E-01
GO:0043117	positive regulation of vascular permeability (GO:0043117)	18	3	1.06	+	2.84	1.08E-01	5.98E-01
GO:0055003	cardiac myofibril assembly (GO:0055003)	18	3	1.06	+	2.84	1.08E-01	5.98E-01
GO:0010829	negative regulation of glucose transmembrane transport (GO:0010829)	18	3	1.06	+	2.84	1.08E-01	5.97E-01
GO:0010812	negative regulation of cell-substrate adhesion (GO:0010812)	60	10	3.52	+	2.84	5.07E-03	7.57E-02
GO:0097421	liver regeneration (GO:0097421)	30	5	1.76	+	2.84	4.24E-02	3.34E-01
GO:0014904	myotube cell development (GO:0014904)	36	6	2.11	+	2.84	2.73E-02	2.56E-01
GO:0030038	contractile actin filament bundle assembly (GO:0030038)	18	3	1.06	+	2.84	1.08E-01	5.97E-01
GO:0072677	eosinophil migration (GO:0072677)	18	3	1.06	+	2.84	1.08E-01	5.97E-01
GO:0060644	mammary gland epithelial cell differentiation (GO:0060644)	18	3	1.06	+	2.84	1.08E-01	5.97E-01
GO:0097067	cellular response to thyroid hormone stimulus (GO:0097067)	18	3	1.06	+	2.84	1.08E-01	5.97E-01
GO:0014741	negative regulation of muscle hypertrophy (GO:0014741)	30	5	1.76	+	2.84	4.24E-02	3.34E-01
GO:0002693	positive regulation of cellular extravasation (GO:0002693)	18	3	1.06	+	2.84	1.08E-01	5.96E-01
GO:0002645	positive regulation of tolerance induction (GO:0002645)	12	2	.70	+	2.84	1.80E-01	7.22E-01
GO:1903238	positive regulation of leukocyte tethering or rolling (GO:1903238)	12	2	.70	+	2.84	1.80E-01	7.21E-01
GO:0033700	phospholipid efflux (GO:0033700)	12	2	.70	+	2.84	1.80E-01	7.21E-01
GO:1903215	negative regulation of protein targeting to mitochondrion (GO:1903215)	6	1	.35	+	2.84	3.29E-01	9.71E-01
GO:1903208	negative regulation of hydrogen peroxide-induced neuron death (GO:1903208)	6	1	.35	+	2.84	3.29E-01	9.71E-01
GO:1903207	regulation of hydrogen peroxide-induced neuron death (GO:1903207)	6	1	.35	+	2.84	3.29E-01	9.71E-01
GO:2000987	positive regulation of behavioral fear response (GO:2000987)	6	1	.35	+	2.84	3.29E-01	9.71E-01
GO:0003071	renal system process involved in regulation of systemic arterial blood pressure (GO:0003071)	24	4	1.41	+	2.84	6.68E-02	4.51E-01
GO:0003057	regulation of the force of heart contraction by chemical signal (GO:0003057)	6	1	.35	+	2.84	3.29E-01	9.70E-01
GO:0060455	negative regulation of gastric acid secretion (GO:0060455)	6	1	.35	+	2.84	3.29E-01	9.70E-01
GO:0060437	lung growth (GO:0060437)	6	1	.35	+	2.84	3.29E-01	9.70E-01
GO:1902747	negative regulation of lens fiber cell differentiation (GO:1902747)	6	1	.35	+	2.84	3.29E-01	9.70E-01
GO:1902744	negative regulation of lamellipodium organization (GO:1902744)	6	1	.35	+	2.84	3.29E-01	9.70E-01
GO:0052803	imidazole-containing compound metabolic process (GO:0052803)	6	1	.35	+	2.84	3.29E-01	9.69E-01
GO:0010193	response to ozone (GO:0010193)	6	1	.35	+	2.84	3.29E-01	9.69E-01
GO:0010172	embryonic body morphogenesis (GO:0010172)	6	1	.35	+	2.84	3.29E-01	9.69E-01
GO:0045653	negative regulation of megakaryocyte differentiation (GO:0045653)	6	1	.35	+	2.84	3.29E-01	9.69E-01
GO:0021670	lateral ventricle development (GO:0021670)	12	2	.70	+	2.84	1.80E-01	7.21E-01
GO:0033631	cell-cell adhesion mediated by integrin (GO:0033631)	6	1	.35	+	2.84	3.29E-01	9.69E-01
GO:1903142	positive regulation of establishment of endothelial barrier (GO:1903142)	6	1	.35	+	2.84	3.29E-01	9.69E-01
GO:0033603	positive regulation of dopamine secretion (GO:0033603)	6	1	.35	+	2.84	3.29E-01	9.68E-01
GO:0021631	optic nerve morphogenesis (GO:0021631)	6	1	.35	+	2.84	3.29E-01	9.68E-01
GO:0072383	plus-end-directed vesicle transport along microtubule (GO:0072383)	6	1	.35	+	2.84	3.29E-01	9.68E-01
GO:2000858	regulation of aldosterone secretion (GO:2000858)	6	1	.35	+	2.84	3.29E-01	9.68E-01
GO:2000855	regulation of mineralocorticoid secretion (GO:2000855)	6	1	.35	+	2.84	3.29E-01	9.68E-01
GO:0060354	negative regulation of cell adhesion molecule production (GO:0060354)	6	1	.35	+	2.84	3.29E-01	9.67E-01
GO:2000821	regulation of grooming behavior (GO:2000821)	6	1	.35	+	2.84	3.29E-01	9.67E-01
GO:0071875	adrenergic receptor signaling pathway (GO:0071875)	24	4	1.41	+	2.84	6.68E-02	4.51E-01
GO:0002476	antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476)	6	1	.35	+	2.84	3.29E-01	9.67E-01
GO:2001293	malonyl-CoA metabolic process (GO:2001293)	6	1	.35	+	2.84	3.29E-01	9.67E-01
GO:0010040	response to iron(II) ion (GO:0010040)	6	1	.35	+	2.84	3.29E-01	9.67E-01
GO:0010032	meiotic chromosome condensation (GO:0010032)	6	1	.35	+	2.84	3.29E-01	9.67E-01
GO:0007231	osmosensory signaling pathway (GO:0007231)	6	1	.35	+	2.84	3.29E-01	9.66E-01
GO:0060290	transdifferentiation (GO:0060290)	6	1	.35	+	2.84	3.29E-01	9.66E-01
GO:0001921	positive regulation of receptor recycling (GO:0001921)	12	2	.70	+	2.84	1.80E-01	7.21E-01
GO:0072236	metanephric loop of Henle development (GO:0072236)	6	1	.35	+	2.84	3.29E-01	9.66E-01
GO:1902512	positive regulation of apoptotic DNA fragmentation (GO:1902512)	6	1	.35	+	2.84	3.29E-01	9.66E-01
GO:0002360	T cell lineage commitment (GO:0002360)	24	4	1.41	+	2.84	6.68E-02	4.51E-01
GO:0002326	B cell lineage commitment (GO:0002326)	6	1	.35	+	2.84	3.29E-01	9.66E-01
GO:0001886	endothelial cell morphogenesis (GO:0001886)	12	2	.70	+	2.84	1.80E-01	7.21E-01
GO:0007185	transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185)	6	1	.35	+	2.84	3.29E-01	9.65E-01
GO:0072143	mesangial cell development (GO:0072143)	6	1	.35	+	2.84	3.29E-01	9.65E-01
GO:1902498	regulation of protein autoubiquitination (GO:1902498)	6	1	.35	+	2.84	3.29E-01	9.65E-01
GO:2000618	regulation of histone H4-K16 acetylation (GO:2000618)	6	1	.35	+	2.84	3.29E-01	9.65E-01
GO:0060129	thyroid-stimulating hormone-secreting cell differentiation (GO:0060129)	6	1	.35	+	2.84	3.29E-01	9.65E-01
GO:0006685	sphingomyelin catabolic process (GO:0006685)	6	1	.35	+	2.84	3.29E-01	9.65E-01
GO:0032911	negative regulation of transforming growth factor beta1 production (GO:0032911)	6	1	.35	+	2.84	3.29E-01	9.64E-01
GO:0071697	ectodermal placode morphogenesis (GO:0071697)	12	2	.70	+	2.84	1.80E-01	7.21E-01
GO:0032908	regulation of transforming growth factor beta1 production (GO:0032908)	12	2	.70	+	2.84	1.80E-01	7.20E-01
GO:0071680	response to indole-3-methanol (GO:0071680)	6	1	.35	+	2.84	3.29E-01	9.64E-01
GO:0002295	T-helper cell lineage commitment (GO:0002295)	12	2	.70	+	2.84	1.80E-01	7.20E-01
GO:1990962	xenobiotic transport across blood-brain barrier (GO:1990962)	6	1	.35	+	2.84	3.29E-01	9.64E-01
GO:0071638	negative regulation of monocyte chemotactic protein-1 production (GO:0071638)	6	1	.35	+	2.84	3.29E-01	9.64E-01
GO:0045345	positive regulation of MHC class I biosynthetic process (GO:0045345)	6	1	.35	+	2.84	3.29E-01	9.64E-01
GO:0001714	endodermal cell fate specification (GO:0001714)	6	1	.35	+	2.84	3.29E-01	9.63E-01
GO:0044854	plasma membrane raft assembly (GO:0044854)	6	1	.35	+	2.84	3.29E-01	9.63E-01
GO:0038180	nerve growth factor signaling pathway (GO:0038180)	12	2	.70	+	2.84	1.80E-01	7.20E-01
GO:0072033	renal vesicle formation (GO:0072033)	6	1	.35	+	2.84	3.29E-01	9.63E-01
GO:0038146	chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146)	6	1	.35	+	2.84	3.29E-01	9.63E-01
GO:2000508	regulation of dendritic cell chemotaxis (GO:2000508)	12	2	.70	+	2.84	1.80E-01	7.20E-01
GO:0006578	amino-acid betaine biosynthetic process (GO:0006578)	6	1	.35	+	2.84	3.29E-01	9.63E-01
GO:0006561	proline biosynthetic process (GO:0006561)	6	1	.35	+	2.84	3.29E-01	9.63E-01
GO:0002155	regulation of thyroid hormone mediated signaling pathway (GO:0002155)	6	1	.35	+	2.84	3.29E-01	9.62E-01
GO:1901895	negative regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901895)	6	1	.35	+	2.84	3.29E-01	9.62E-01
GO:0051934	catecholamine uptake involved in synaptic transmission (GO:0051934)	6	1	.35	+	2.84	3.29E-01	9.62E-01
GO:1901873	regulation of post-translational protein modification (GO:1901873)	6	1	.35	+	2.84	3.29E-01	9.62E-01
GO:0033278	cell proliferation in midbrain (GO:0033278)	6	1	.35	+	2.84	3.29E-01	9.62E-01
GO:0001692	histamine metabolic process (GO:0001692)	6	1	.35	+	2.84	3.29E-01	9.62E-01
GO:0032782	bile acid secretion (GO:0032782)	6	1	.35	+	2.84	3.29E-01	9.61E-01
GO:2000416	regulation of eosinophil migration (GO:2000416)	6	1	.35	+	2.84	3.29E-01	9.61E-01
GO:0038030	non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030)	6	1	.35	+	2.84	3.29E-01	9.61E-01
GO:1902218	regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218)	6	1	.35	+	2.84	3.29E-01	9.61E-01
GO:0071481	cellular response to X-ray (GO:0071481)	12	2	.70	+	2.84	1.80E-01	7.20E-01
GO:0014066	regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	108	18	6.34	+	2.84	2.05E-04	5.14E-03
GO:0002087	regulation of respiratory gaseous exchange by nervous system process (GO:0002087)	12	2	.70	+	2.84	1.80E-01	7.19E-01
GO:0071455	cellular response to hyperoxia (GO:0071455)	6	1	.35	+	2.84	3.29E-01	9.61E-01
GO:0014031	mesenchymal cell development (GO:0014031)	6	1	.35	+	2.84	3.29E-01	9.60E-01
GO:0002069	columnar/cuboidal epithelial cell maturation (GO:0002069)	12	2	.70	+	2.84	1.80E-01	7.19E-01
GO:0071440	regulation of histone H3-K14 acetylation (GO:0071440)	6	1	.35	+	2.84	3.29E-01	9.60E-01
GO:0045161	neuronal ion channel clustering (GO:0045161)	12	2	.70	+	2.84	1.80E-01	7.19E-01
GO:1901727	positive regulation of histone deacetylase activity (GO:1901727)	6	1	.35	+	2.84	3.29E-01	9.60E-01
GO:0071393	cellular response to progesterone stimulus (GO:0071393)	6	1	.35	+	2.84	3.29E-01	9.60E-01
GO:0071372	cellular response to follicle-stimulating hormone stimulus (GO:0071372)	12	2	.70	+	2.84	1.80E-01	7.19E-01
GO:0071321	cellular response to cGMP (GO:0071321)	6	1	.35	+	2.84	3.29E-01	9.60E-01
GO:0140271	hexose import across plasma membrane (GO:0140271)	6	1	.35	+	2.84	3.29E-01	9.60E-01
GO:2000254	regulation of male germ cell proliferation (GO:2000254)	6	1	.35	+	2.84	3.29E-01	9.59E-01
GO:0032534	regulation of microvillus assembly (GO:0032534)	6	1	.35	+	2.84	3.29E-01	9.59E-01
GO:1902037	negative regulation of hematopoietic stem cell differentiation (GO:1902037)	6	1	.35	+	2.84	3.29E-01	9.59E-01
GO:0051661	maintenance of centrosome location (GO:0051661)	6	1	.35	+	2.84	3.29E-01	9.59E-01
GO:1990544	mitochondrial ATP transmembrane transport (GO:1990544)	6	1	.35	+	2.84	3.29E-01	9.59E-01
GO:0051620	norepinephrine uptake (GO:0051620)	6	1	.35	+	2.84	3.29E-01	9.58E-01
GO:1901552	positive regulation of endothelial cell development (GO:1901552)	6	1	.35	+	2.84	3.29E-01	9.58E-01
GO:1990504	dense core granule exocytosis (GO:1990504)	6	1	.35	+	2.84	3.29E-01	9.58E-01
GO:0090381	regulation of heart induction (GO:0090381)	6	1	.35	+	2.84	3.29E-01	9.58E-01
GO:1901526	positive regulation of mitophagy (GO:1901526)	6	1	.35	+	2.84	3.29E-01	9.58E-01
GO:0048866	stem cell fate specification (GO:0048866)	6	1	.35	+	2.84	3.29E-01	9.58E-01
GO:0070729	cyclic nucleotide transport (GO:0070729)	6	1	.35	+	2.84	3.29E-01	9.57E-01
GO:2000143	negative regulation of DNA-templated transcription initiation (GO:2000143)	6	1	.35	+	2.84	3.29E-01	9.57E-01
GO:0032459	regulation of protein oligomerization (GO:0032459)	6	1	.35	+	2.84	3.29E-01	9.57E-01
GO:2000121	regulation of removal of superoxide radicals (GO:2000121)	6	1	.35	+	2.84	3.29E-01	9.57E-01
GO:0099509	regulation of presynaptic cytosolic calcium ion concentration (GO:0099509)	12	2	.70	+	2.84	1.80E-01	7.19E-01
GO:0006182	cGMP biosynthetic process (GO:0006182)	12	2	.70	+	2.84	1.80E-01	7.19E-01
GO:0051597	response to methylmercury (GO:0051597)	6	1	.35	+	2.84	3.29E-01	9.57E-01
GO:0051590	positive regulation of neurotransmitter transport (GO:0051590)	24	4	1.41	+	2.84	6.68E-02	4.51E-01
GO:0051583	dopamine uptake involved in synaptic transmission (GO:0051583)	6	1	.35	+	2.84	3.29E-01	9.57E-01
GO:0051572	negative regulation of histone H3-K4 methylation (GO:0051572)	6	1	.35	+	2.84	3.29E-01	9.56E-01
GO:0031999	negative regulation of fatty acid beta-oxidation (GO:0031999)	6	1	.35	+	2.84	3.29E-01	9.56E-01
GO:1905868	regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868)	6	1	.35	+	2.84	3.29E-01	9.56E-01
GO:0031987	locomotion involved in locomotory behavior (GO:0031987)	6	1	.35	+	2.84	3.29E-01	9.56E-01
GO:0051549	positive regulation of keratinocyte migration (GO:0051549)	12	2	.70	+	2.84	1.80E-01	7.18E-01
GO:0051541	elastin metabolic process (GO:0051541)	6	1	.35	+	2.84	3.29E-01	9.56E-01
GO:1990440	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)	12	2	.70	+	2.84	1.80E-01	7.18E-01
GO:0031953	negative regulation of protein autophosphorylation (GO:0031953)	12	2	.70	+	2.84	1.80E-01	7.18E-01
GO:0090261	positive regulation of inclusion body assembly (GO:0090261)	6	1	.35	+	2.84	3.29E-01	9.55E-01
GO:0090259	regulation of retinal ganglion cell axon guidance (GO:0090259)	6	1	.35	+	2.84	3.29E-01	9.55E-01
GO:0070640	vitamin D3 metabolic process (GO:0070640)	6	1	.35	+	2.84	3.29E-01	9.55E-01
GO:0140021	mitochondrial ADP transmembrane transport (GO:0140021)	6	1	.35	+	2.84	3.29E-01	9.55E-01
GO:2000051	negative regulation of non-canonical Wnt signaling pathway (GO:2000051)	6	1	.35	+	2.84	3.29E-01	9.55E-01
GO:2000009	negative regulation of protein localization to cell surface (GO:2000009)	12	2	.70	+	2.84	1.80E-01	7.18E-01
GO:2000003	positive regulation of DNA damage checkpoint (GO:2000003)	6	1	.35	+	2.84	3.29E-01	9.55E-01
GO:0051490	negative regulation of filopodium assembly (GO:0051490)	6	1	.35	+	2.84	3.29E-01	9.54E-01
GO:0006032	chitin catabolic process (GO:0006032)	6	1	.35	+	2.84	3.29E-01	9.54E-01
GO:0006030	chitin metabolic process (GO:0006030)	6	1	.35	+	2.84	3.29E-01	9.54E-01
GO:0051480	regulation of cytosolic calcium ion concentration (GO:0051480)	54	9	3.17	+	2.84	7.66E-03	1.03E-01
GO:1905725	protein localization to microtubule end (GO:1905725)	6	1	.35	+	2.84	3.29E-01	9.54E-01
GO:0090179	planar cell polarity pathway involved in neural tube closure (GO:0090179)	12	2	.70	+	2.84	1.80E-01	7.18E-01
GO:0048668	collateral sprouting (GO:0048668)	12	2	.70	+	2.84	1.80E-01	7.17E-01
GO:0032289	central nervous system myelin formation (GO:0032289)	6	1	.35	+	2.84	3.29E-01	9.54E-01
GO:0032229	negative regulation of synaptic transmission, GABAergic (GO:0032229)	6	1	.35	+	2.84	3.29E-01	9.54E-01
GO:0051386	regulation of neurotrophin TRK receptor signaling pathway (GO:0051386)	12	2	.70	+	2.84	1.80E-01	7.17E-01
GO:1901299	negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299)	6	1	.35	+	2.84	3.29E-01	9.53E-01
GO:0051344	negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344)	6	1	.35	+	2.84	3.29E-01	9.53E-01
GO:0009838	abscission (GO:0009838)	6	1	.35	+	2.84	3.29E-01	9.53E-01
GO:0090032	negative regulation of steroid hormone biosynthetic process (GO:0090032)	6	1	.35	+	2.84	3.29E-01	9.53E-01
GO:0048563	post-embryonic animal organ morphogenesis (GO:0048563)	12	2	.70	+	2.84	1.80E-01	7.17E-01
GO:0048548	regulation of pinocytosis (GO:0048548)	12	2	.70	+	2.84	1.80E-01	7.17E-01
GO:0048512	circadian behavior (GO:0048512)	24	4	1.41	+	2.84	6.68E-02	4.50E-01
GO:1900748	positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)	6	1	.35	+	2.84	3.29E-01	9.53E-01
GO:0043697	cell dedifferentiation (GO:0043697)	6	1	.35	+	2.84	3.29E-01	9.52E-01
GO:0043696	dedifferentiation (GO:0043696)	6	1	.35	+	2.84	3.29E-01	9.52E-01
GO:0031650	regulation of heat generation (GO:0031650)	12	2	.70	+	2.84	1.80E-01	7.17E-01
GO:1905522	negative regulation of macrophage migration (GO:1905522)	12	2	.70	+	2.84	1.80E-01	7.17E-01
GO:0031641	regulation of myelination (GO:0031641)	48	8	2.82	+	2.84	1.16E-02	1.41E-01
GO:1905508	protein localization to microtubule organizing center (GO:1905508)	24	4	1.41	+	2.84	6.68E-02	4.50E-01
GO:0098704	carbohydrate import across plasma membrane (GO:0098704)	6	1	.35	+	2.84	3.29E-01	9.52E-01
GO:0070317	negative regulation of G0 to G1 transition (GO:0070317)	6	1	.35	+	2.84	3.29E-01	9.52E-01
GO:0070301	cellular response to hydrogen peroxide (GO:0070301)	66	11	3.88	+	2.84	3.37E-03	5.47E-02
GO:0032020	ISG15-protein conjugation (GO:0032020)	6	1	.35	+	2.84	3.29E-01	9.52E-01
GO:0035988	chondrocyte proliferation (GO:0035988)	12	2	.70	+	2.84	1.80E-01	7.16E-01
GO:0043570	maintenance of DNA repeat elements (GO:0043570)	6	1	.35	+	2.84	3.29E-01	9.52E-01
GO:0031584	activation of phospholipase D activity (GO:0031584)	6	1	.35	+	2.84	3.29E-01	9.51E-01
GO:0035929	steroid hormone secretion (GO:0035929)	6	1	.35	+	2.84	3.29E-01	9.51E-01
GO:0043504	mitochondrial DNA repair (GO:0043504)	6	1	.35	+	2.84	3.29E-01	9.51E-01
GO:0051105	regulation of DNA ligation (GO:0051105)	6	1	.35	+	2.84	3.29E-01	9.51E-01
GO:0009637	response to blue light (GO:0009637)	6	1	.35	+	2.84	3.29E-01	9.51E-01
GO:1904948	midbrain dopaminergic neuron differentiation (GO:1904948)	12	2	.70	+	2.84	1.80E-01	7.16E-01
GO:0070200	establishment of protein localization to telomere (GO:0070200)	6	1	.35	+	2.84	3.29E-01	9.51E-01
GO:0120041	positive regulation of macrophage proliferation (GO:0120041)	6	1	.35	+	2.84	3.29E-01	9.50E-01
GO:0043415	positive regulation of skeletal muscle tissue regeneration (GO:0043415)	6	1	.35	+	2.84	3.29E-01	9.50E-01
GO:0051005	negative regulation of lipoprotein lipase activity (GO:0051005)	6	1	.35	+	2.84	3.29E-01	9.50E-01
GO:0042997	negative regulation of Golgi to plasma membrane protein transport (GO:0042997)	6	1	.35	+	2.84	3.29E-01	9.50E-01
GO:0042976	activation of Janus kinase activity (GO:0042976)	6	1	.35	+	2.84	3.29E-01	9.50E-01
GO:0048262	determination of dorsal/ventral asymmetry (GO:0048262)	6	1	.35	+	2.84	3.29E-01	9.49E-01
GO:1904825	protein localization to microtubule plus-end (GO:1904825)	6	1	.35	+	2.84	3.29E-01	9.49E-01
GO:1900449	regulation of glutamate receptor signaling pathway (GO:1900449)	6	1	.35	+	2.84	3.29E-01	9.49E-01
GO:0030913	paranodal junction assembly (GO:0030913)	6	1	.35	+	2.84	3.29E-01	9.49E-01
GO:1905203	regulation of connective tissue replacement (GO:1905203)	6	1	.35	+	2.84	3.29E-01	9.49E-01
GO:0009449	gamma-aminobutyric acid biosynthetic process (GO:0009449)	6	1	.35	+	2.84	3.29E-01	9.49E-01
GO:1904798	positive regulation of core promoter binding (GO:1904798)	6	1	.35	+	2.84	3.29E-01	9.48E-01
GO:0048169	regulation of long-term neuronal synaptic plasticity (GO:0048169)	24	4	1.41	+	2.84	6.68E-02	4.50E-01
GO:1904751	positive regulation of protein localization to nucleolus (GO:1904751)	6	1	.35	+	2.84	3.29E-01	9.48E-01
GO:1900372	negative regulation of purine nucleotide biosynthetic process (GO:1900372)	6	1	.35	+	2.84	3.29E-01	9.48E-01
GO:0036124	histone H3-K9 trimethylation (GO:0036124)	6	1	.35	+	2.84	3.29E-01	9.48E-01
GO:0036119	response to platelet-derived growth factor (GO:0036119)	24	4	1.41	+	2.84	6.68E-02	4.50E-01
GO:0030809	negative regulation of nucleotide biosynthetic process (GO:0030809)	6	1	.35	+	2.84	3.29E-01	9.48E-01
GO:0031223	auditory behavior (GO:0031223)	12	2	.70	+	2.84	1.80E-01	7.16E-01
GO:1904688	regulation of cytoplasmic translational initiation (GO:1904688)	6	1	.35	+	2.84	3.29E-01	9.48E-01
GO:0042713	sperm ejaculation (GO:0042713)	6	1	.35	+	2.84	3.29E-01	9.47E-01
GO:0036037	CD8-positive, alpha-beta T cell activation (GO:0036037)	12	2	.70	+	2.84	1.80E-01	7.16E-01
GO:1900244	positive regulation of synaptic vesicle endocytosis (GO:1900244)	6	1	.35	+	2.84	3.29E-01	9.47E-01
GO:0036005	response to macrophage colony-stimulating factor (GO:0036005)	12	2	.70	+	2.84	1.80E-01	7.16E-01
GO:1905098	negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098)	6	1	.35	+	2.84	3.29E-01	9.47E-01
GO:0055129	L-proline biosynthetic process (GO:0055129)	6	1	.35	+	2.84	3.29E-01	9.47E-01
GO:1905065	positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065)	6	1	.35	+	2.84	3.29E-01	9.47E-01
GO:0015942	formate metabolic process (GO:0015942)	6	1	.35	+	2.84	3.29E-01	9.47E-01
GO:0009256	10-formyltetrahydrofolate metabolic process (GO:0009256)	6	1	.35	+	2.84	3.29E-01	9.46E-01
GO:1905005	regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005)	6	1	.35	+	2.84	3.29E-01	9.46E-01
GO:0009249	protein lipoylation (GO:0009249)	6	1	.35	+	2.84	3.29E-01	9.46E-01
GO:0097734	extracellular exosome biogenesis (GO:0097734)	6	1	.35	+	2.84	3.29E-01	9.46E-01
GO:1904528	positive regulation of microtubule binding (GO:1904528)	6	1	.35	+	2.84	3.29E-01	9.46E-01
GO:1900116	extracellular negative regulation of signal transduction (GO:1900116)	12	2	.70	+	2.84	1.80E-01	7.15E-01
GO:1900115	extracellular regulation of signal transduction (GO:1900115)	12	2	.70	+	2.84	1.80E-01	7.15E-01
GO:0055059	asymmetric neuroblast division (GO:0055059)	6	1	.35	+	2.84	3.29E-01	9.45E-01
GO:0035457	cellular response to interferon-alpha (GO:0035457)	12	2	.70	+	2.84	1.80E-01	7.15E-01
GO:0015874	norepinephrine transport (GO:0015874)	6	1	.35	+	2.84	3.29E-01	9.45E-01
GO:0055022	negative regulation of cardiac muscle tissue growth (GO:0055022)	24	4	1.41	+	2.84	6.68E-02	4.50E-01
GO:0055009	atrial cardiac muscle tissue morphogenesis (GO:0055009)	6	1	.35	+	2.84	3.29E-01	9.45E-01
GO:0055007	cardiac muscle cell differentiation (GO:0055007)	84	14	4.93	+	2.84	1.00E-03	2.03E-02
GO:0046985	positive regulation of hemoglobin biosynthetic process (GO:0046985)	6	1	.35	+	2.84	3.29E-01	9.45E-01
GO:0009136	purine nucleoside diphosphate biosynthetic process (GO:0009136)	6	1	.35	+	2.84	3.29E-01	9.45E-01
GO:0046951	ketone body biosynthetic process (GO:0046951)	6	1	.35	+	2.84	3.29E-01	9.45E-01
GO:1904464	regulation of matrix metallopeptidase secretion (GO:1904464)	6	1	.35	+	2.84	3.29E-01	9.44E-01
GO:0042541	hemoglobin biosynthetic process (GO:0042541)	6	1	.35	+	2.84	3.29E-01	9.44E-01
GO:0030579	ubiquitin-dependent SMAD protein catabolic process (GO:0030579)	6	1	.35	+	2.84	3.29E-01	9.44E-01
GO:0042532	negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)	12	2	.70	+	2.84	1.80E-01	7.15E-01
GO:0010986	positive regulation of lipoprotein particle clearance (GO:0010986)	6	1	.35	+	2.84	3.29E-01	9.44E-01
GO:0010936	negative regulation of macrophage cytokine production (GO:0010936)	12	2	.70	+	2.84	1.80E-01	7.15E-01
GO:0015791	polyol transmembrane transport (GO:0015791)	12	2	.70	+	2.84	1.80E-01	7.15E-01
GO:1903939	regulation of TORC2 signaling (GO:1903939)	6	1	.35	+	2.84	3.29E-01	9.44E-01
GO:1903903	regulation of establishment of T cell polarity (GO:1903903)	6	1	.35	+	2.84	3.29E-01	9.44E-01
GO:0015705	iodide transport (GO:0015705)	6	1	.35	+	2.84	3.29E-01	9.43E-01
GO:0042447	hormone catabolic process (GO:0042447)	12	2	.70	+	2.84	1.80E-01	7.14E-01
GO:1904338	regulation of dopaminergic neuron differentiation (GO:1904338)	12	2	.70	+	2.84	1.80E-01	7.14E-01
GO:0010872	regulation of cholesterol esterification (GO:0010872)	6	1	.35	+	2.84	3.29E-01	9.43E-01
GO:0015677	copper ion import (GO:0015677)	6	1	.35	+	2.84	3.29E-01	9.43E-01
GO:0030397	membrane disassembly (GO:0030397)	12	2	.70	+	2.84	1.80E-01	7.14E-01
GO:0010754	negative regulation of cGMP-mediated signaling (GO:0010754)	6	1	.35	+	2.84	3.29E-01	9.43E-01
GO:0010726	positive regulation of hydrogen peroxide metabolic process (GO:0010726)	6	1	.35	+	2.84	3.29E-01	9.43E-01
GO:0010712	regulation of collagen metabolic process (GO:0010712)	42	7	2.47	+	2.84	1.77E-02	1.89E-01
GO:1903790	guanine nucleotide transmembrane transport (GO:1903790)	6	1	.35	+	2.84	3.29E-01	9.43E-01
GO:0060956	endocardial cell differentiation (GO:0060956)	6	1	.35	+	2.84	3.29E-01	9.42E-01
GO:0060921	sinoatrial node cell differentiation (GO:0060921)	6	1	.35	+	2.84	3.29E-01	9.42E-01
GO:0010635	regulation of mitochondrial fusion (GO:0010635)	12	2	.70	+	2.84	1.80E-01	7.14E-01
GO:0060842	arterial endothelial cell differentiation (GO:0060842)	6	1	.35	+	2.84	3.29E-01	9.42E-01
GO:0042135	neurotransmitter catabolic process (GO:0042135)	12	2	.70	+	2.84	1.80E-01	7.14E-01
GO:0010571	positive regulation of nuclear cell cycle DNA replication (GO:0010571)	6	1	.35	+	2.84	3.29E-01	9.42E-01
GO:0010561	negative regulation of glycoprotein biosynthetic process (GO:0010561)	12	2	.70	+	2.84	1.80E-01	7.13E-01
GO:0060788	ectodermal placode formation (GO:0060788)	12	2	.70	+	2.84	1.80E-01	7.13E-01
GO:0060770	negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770)	6	1	.35	+	2.84	3.29E-01	9.42E-01
GO:0003348	cardiac endothelial cell differentiation (GO:0003348)	6	1	.35	+	2.84	3.29E-01	9.42E-01
GO:0097152	mesenchymal cell apoptotic process (GO:0097152)	12	2	.70	+	2.84	1.80E-01	7.13E-01
GO:0002885	positive regulation of hypersensitivity (GO:0002885)	6	1	.35	+	2.84	3.29E-01	9.41E-01
GO:0014831	gastro-intestinal system smooth muscle contraction (GO:0014831)	6	1	.35	+	2.84	3.29E-01	9.41E-01
GO:0019695	choline metabolic process (GO:0019695)	6	1	.35	+	2.84	3.29E-01	9.41E-01
GO:0021979	hypothalamus cell differentiation (GO:0021979)	12	2	.70	+	2.84	1.80E-01	7.13E-01
GO:0021960	anterior commissure morphogenesis (GO:0021960)	6	1	.35	+	2.84	3.29E-01	9.41E-01
GO:0061117	negative regulation of heart growth (GO:0061117)	24	4	1.41	+	2.84	6.68E-02	4.49E-01
GO:0021936	regulation of cerebellar granule cell precursor proliferation (GO:0021936)	12	2	.70	+	2.84	1.80E-01	7.13E-01
GO:0060677	ureteric bud elongation (GO:0060677)	6	1	.35	+	2.84	3.29E-01	9.41E-01
GO:0097084	vascular associated smooth muscle cell development (GO:0097084)	12	2	.70	+	2.84	1.80E-01	7.13E-01
GO:0034354	'de novo' NAD biosynthetic process from tryptophan (GO:0034354)	6	1	.35	+	2.84	3.29E-01	9.41E-01
GO:0008038	neuron recognition (GO:0008038)	48	8	2.82	+	2.84	1.16E-02	1.41E-01
GO:0061092	positive regulation of phospholipid translocation (GO:0061092)	6	1	.35	+	2.84	3.29E-01	9.40E-01
GO:0021891	olfactory bulb interneuron development (GO:0021891)	6	1	.35	+	2.84	3.29E-01	9.40E-01
GO:0007566	embryo implantation (GO:0007566)	42	7	2.47	+	2.84	1.77E-02	1.89E-01
GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)	12	2	.70	+	2.84	1.80E-01	7.12E-01
GO:0003175	tricuspid valve development (GO:0003175)	6	1	.35	+	2.84	3.29E-01	9.40E-01
GO:0003160	endocardium morphogenesis (GO:0003160)	6	1	.35	+	2.84	3.29E-01	9.40E-01
GO:0060575	intestinal epithelial cell differentiation (GO:0060575)	24	4	1.41	+	2.84	6.68E-02	4.49E-01
GO:0072537	fibroblast activation (GO:0072537)	6	1	.35	+	2.84	3.29E-01	9.40E-01
GO:1902807	negative regulation of cell cycle G1/S phase transition (GO:1902807)	84	14	4.93	+	2.84	1.00E-03	2.02E-02
GO:1902803	regulation of synaptic vesicle transport (GO:1902803)	6	1	.35	+	2.84	3.29E-01	9.39E-01
GO:2000243	positive regulation of reproductive process (GO:2000243)	90	15	5.28	+	2.84	6.73E-04	1.45E-02
GO:0070507	regulation of microtubule cytoskeleton organization (GO:0070507)	157	26	9.22	+	2.82	9.82E-06	3.67E-04
GO:0061640	cytoskeleton-dependent cytokinesis (GO:0061640)	109	18	6.40	+	2.81	2.26E-04	5.55E-03
GO:0042542	response to hydrogen peroxide (GO:0042542)	103	17	6.05	+	2.81	3.36E-04	7.83E-03
GO:0071774	response to fibroblast growth factor (GO:0071774)	91	15	5.34	+	2.81	7.44E-04	1.58E-02
GO:0003018	vascular process in circulatory system (GO:0003018)	267	44	15.68	+	2.81	1.09E-08	6.92E-07
GO:0003007	heart morphogenesis (GO:0003007)	249	41	14.62	+	2.80	3.49E-08	2.05E-06
GO:0060761	negative regulation of response to cytokine stimulus (GO:0060761)	79	13	4.64	+	2.80	1.66E-03	3.09E-02
GO:0045664	regulation of neuron differentiation (GO:0045664)	195	32	11.45	+	2.79	1.16E-06	5.27E-05
GO:0022402	cell cycle process (GO:0022402)	841	138	49.38	+	2.79	1.36E-24	9.28E-22
GO:0051302	regulation of cell division (GO:0051302)	189	31	11.10	+	2.79	1.70E-06	7.49E-05
GO:1904705	regulation of vascular associated smooth muscle cell proliferation (GO:1904705)	61	10	3.58	+	2.79	5.61E-03	8.21E-02
GO:0030278	regulation of ossification (GO:0030278)	122	20	7.16	+	2.79	1.14E-04	3.15E-03
GO:0048762	mesenchymal cell differentiation (GO:0048762)	171	28	10.04	+	2.79	5.48E-06	2.19E-04
GO:0051293	establishment of spindle localization (GO:0051293)	55	9	3.23	+	2.79	8.48E-03	1.11E-01
GO:0002673	regulation of acute inflammatory response (GO:0002673)	49	8	2.88	+	2.78	1.29E-02	1.53E-01
GO:0032715	negative regulation of interleukin-6 production (GO:0032715)	49	8	2.88	+	2.78	1.29E-02	1.53E-01
GO:0048675	axon extension (GO:0048675)	49	8	2.88	+	2.78	1.29E-02	1.53E-01
GO:0043457	regulation of cellular respiration (GO:0043457)	49	8	2.88	+	2.78	1.29E-02	1.53E-01
GO:0032970	regulation of actin filament-based process (GO:0032970)	405	66	23.78	+	2.78	5.16E-12	6.80E-10
GO:0045124	regulation of bone resorption (GO:0045124)	43	7	2.52	+	2.77	1.97E-02	2.04E-01
GO:0042908	xenobiotic transport (GO:0042908)	43	7	2.52	+	2.77	1.97E-02	2.04E-01
GO:2000241	regulation of reproductive process (GO:2000241)	209	34	12.27	+	2.77	6.45E-07	3.11E-05
GO:0003013	circulatory system process (GO:0003013)	498	81	29.24	+	2.77	1.56E-14	3.06E-12
GO:0001837	epithelial to mesenchymal transition (GO:0001837)	80	13	4.70	+	2.77	1.83E-03	3.38E-02
GO:0007272	ensheathment of neurons (GO:0007272)	117	19	6.87	+	2.77	1.86E-04	4.75E-03
GO:0008366	axon ensheathment (GO:0008366)	117	19	6.87	+	2.77	1.86E-04	4.75E-03
GO:0000910	cytokinesis (GO:0000910)	111	18	6.52	+	2.76	2.76E-04	6.59E-03
GO:0045685	regulation of glial cell differentiation (GO:0045685)	74	12	4.35	+	2.76	2.74E-03	4.66E-02
GO:0001990	regulation of systemic arterial blood pressure by hormone (GO:0001990)	37	6	2.17	+	2.76	3.03E-02	2.72E-01
GO:0032965	regulation of collagen biosynthetic process (GO:0032965)	37	6	2.17	+	2.76	3.03E-02	2.72E-01
GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)	37	6	2.17	+	2.76	3.03E-02	2.72E-01
GO:1900181	negative regulation of protein localization to nucleus (GO:1900181)	37	6	2.17	+	2.76	3.03E-02	2.72E-01
GO:0003203	endocardial cushion morphogenesis (GO:0003203)	37	6	2.17	+	2.76	3.03E-02	2.72E-01
GO:0140013	meiotic nuclear division (GO:0140013)	173	28	10.16	+	2.76	6.66E-06	2.60E-04
GO:0006275	regulation of DNA replication (GO:0006275)	136	22	7.99	+	2.75	6.30E-05	1.92E-03
GO:0051147	regulation of muscle cell differentiation (GO:0051147)	136	22	7.99	+	2.75	6.30E-05	1.91E-03
GO:0036294	cellular response to decreased oxygen levels (GO:0036294)	136	22	7.99	+	2.75	6.30E-05	1.91E-03
GO:0010633	negative regulation of epithelial cell migration (GO:0010633)	68	11	3.99	+	2.75	4.12E-03	6.45E-02
GO:0021602	cranial nerve morphogenesis (GO:0021602)	31	5	1.82	+	2.75	4.71E-02	3.60E-01
GO:2000463	positive regulation of excitatory postsynaptic potential (GO:2000463)	31	5	1.82	+	2.75	4.71E-02	3.60E-01
GO:0043524	negative regulation of neuron apoptotic process (GO:0043524)	155	25	9.10	+	2.75	2.14E-05	7.31E-04
GO:0036314	response to sterol (GO:0036314)	31	5	1.82	+	2.75	4.71E-02	3.60E-01
GO:0034767	positive regulation of ion transmembrane transport (GO:0034767)	186	30	10.92	+	2.75	3.36E-06	1.41E-04
GO:0090130	tissue migration (GO:0090130)	112	18	6.58	+	2.74	3.04E-04	7.17E-03
GO:0035904	aorta development (GO:0035904)	56	9	3.29	+	2.74	9.38E-03	1.20E-01
GO:0030500	regulation of bone mineralization (GO:0030500)	81	13	4.76	+	2.73	2.02E-03	3.64E-02
GO:0051928	positive regulation of calcium ion transport (GO:0051928)	131	21	7.69	+	2.73	1.03E-04	2.89E-03
GO:0001960	negative regulation of cytokine-mediated signaling pathway (GO:0001960)	75	12	4.40	+	2.72	3.03E-03	5.07E-02
GO:0001763	morphogenesis of a branching structure (GO:0001763)	175	28	10.28	+	2.72	8.06E-06	3.07E-04
GO:1903205	regulation of hydrogen peroxide-induced cell death (GO:1903205)	25	4	1.47	+	2.72	7.43E-02	4.78E-01
GO:0060487	lung epithelial cell differentiation (GO:0060487)	25	4	1.47	+	2.72	7.43E-02	4.78E-01
GO:0060479	lung cell differentiation (GO:0060479)	25	4	1.47	+	2.72	7.43E-02	4.78E-01
GO:0060038	cardiac muscle cell proliferation (GO:0060038)	25	4	1.47	+	2.72	7.43E-02	4.78E-01
GO:0045132	meiotic chromosome segregation (GO:0045132)	100	16	5.87	+	2.72	6.71E-04	1.45E-02
GO:0071294	cellular response to zinc ion (GO:0071294)	25	4	1.47	+	2.72	7.43E-02	4.78E-01
GO:0036336	dendritic cell migration (GO:0036336)	25	4	1.47	+	2.72	7.43E-02	4.77E-01
GO:1904893	negative regulation of receptor signaling pathway via STAT (GO:1904893)	25	4	1.47	+	2.72	7.43E-02	4.77E-01
GO:0046717	acid secretion (GO:0046717)	25	4	1.47	+	2.72	7.43E-02	4.77E-01
GO:0046697	decidualization (GO:0046697)	25	4	1.47	+	2.72	7.43E-02	4.77E-01
GO:0042026	protein refolding (GO:0042026)	25	4	1.47	+	2.72	7.43E-02	4.77E-01
GO:0072530	purine-containing compound transmembrane transport (GO:0072530)	25	4	1.47	+	2.72	7.43E-02	4.77E-01
GO:0003148	outflow tract septum morphogenesis (GO:0003148)	25	4	1.47	+	2.72	7.43E-02	4.76E-01
GO:0010810	regulation of cell-substrate adhesion (GO:0010810)	219	35	12.86	+	2.72	6.41E-07	3.10E-05
GO:0030336	negative regulation of cell migration (GO:0030336)	288	46	16.91	+	2.72	1.64E-08	1.02E-06
GO:0051402	neuron apoptotic process (GO:0051402)	94	15	5.52	+	2.72	9.99E-04	2.02E-02
GO:0014706	striated muscle tissue development (GO:0014706)	188	30	11.04	+	2.72	4.07E-06	1.69E-04
GO:0010564	regulation of cell cycle process (GO:0010564)	715	114	41.99	+	2.72	1.95E-19	8.25E-17
GO:0048738	cardiac muscle tissue development (GO:0048738)	182	29	10.69	+	2.71	6.00E-06	2.38E-04
GO:0008015	blood circulation (GO:0008015)	408	65	23.96	+	2.71	1.39E-11	1.71E-09
GO:0021782	glial cell development (GO:0021782)	113	18	6.64	+	2.71	3.34E-04	7.82E-03
GO:0000724	double-strand break repair via homologous recombination (GO:0000724)	113	18	6.64	+	2.71	3.34E-04	7.81E-03
GO:0048514	blood vessel morphogenesis (GO:0048514)	421	67	24.72	+	2.71	6.86E-12	8.97E-10
GO:0060236	regulation of mitotic spindle organization (GO:0060236)	44	7	2.58	+	2.71	2.17E-02	2.20E-01
GO:1901381	positive regulation of potassium ion transmembrane transport (GO:1901381)	44	7	2.58	+	2.71	2.17E-02	2.20E-01
GO:0098815	modulation of excitatory postsynaptic potential (GO:0098815)	44	7	2.58	+	2.71	2.17E-02	2.20E-01
GO:0035987	endodermal cell differentiation (GO:0035987)	44	7	2.58	+	2.71	2.17E-02	2.20E-01
GO:1900087	positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	44	7	2.58	+	2.71	2.17E-02	2.20E-01
GO:0048565	digestive tract development (GO:0048565)	132	21	7.75	+	2.71	1.13E-04	3.14E-03
GO:0033044	regulation of chromosome organization (GO:0033044)	252	40	14.80	+	2.70	1.74E-07	9.42E-06
GO:0032233	positive regulation of actin filament bundle assembly (GO:0032233)	63	10	3.70	+	2.70	6.84E-03	9.51E-02
GO:0061180	mammary gland epithelium development (GO:0061180)	63	10	3.70	+	2.70	6.84E-03	9.50E-02
GO:0002526	acute inflammatory response (GO:0002526)	82	13	4.82	+	2.70	2.22E-03	3.94E-02
GO:0048863	stem cell differentiation (GO:0048863)	183	29	10.75	+	2.70	6.59E-06	2.58E-04
GO:2000146	negative regulation of cell motility (GO:2000146)	303	48	17.79	+	2.70	8.90E-09	5.84E-07
GO:0060438	trachea development (GO:0060438)	19	3	1.12	+	2.69	1.20E-01	5.89E-01
GO:0034110	regulation of homotypic cell-cell adhesion (GO:0034110)	38	6	2.23	+	2.69	3.35E-02	2.91E-01
GO:0045616	regulation of keratinocyte differentiation (GO:0045616)	38	6	2.23	+	2.69	3.35E-02	2.91E-01
GO:0060339	negative regulation of type I interferon-mediated signaling pathway (GO:0060339)	19	3	1.12	+	2.69	1.20E-01	5.89E-01
GO:0060292	long-term synaptic depression (GO:0060292)	19	3	1.12	+	2.69	1.20E-01	5.89E-01
GO:0007193	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	76	12	4.46	+	2.69	3.33E-03	5.42E-02
GO:0071625	vocalization behavior (GO:0071625)	19	3	1.12	+	2.69	1.20E-01	5.89E-01
GO:0060039	pericardium development (GO:0060039)	19	3	1.12	+	2.69	1.20E-01	5.88E-01
GO:1901881	positive regulation of protein depolymerization (GO:1901881)	19	3	1.12	+	2.69	1.20E-01	5.88E-01
GO:0140448	signaling receptor ligand precursor processing (GO:0140448)	38	6	2.23	+	2.69	3.35E-02	2.91E-01
GO:0032717	negative regulation of interleukin-8 production (GO:0032717)	19	3	1.12	+	2.69	1.20E-01	5.88E-01
GO:0002076	osteoblast development (GO:0002076)	19	3	1.12	+	2.69	1.20E-01	5.88E-01
GO:0033189	response to vitamin A (GO:0033189)	19	3	1.12	+	2.69	1.20E-01	5.88E-01
GO:2000353	positive regulation of endothelial cell apoptotic process (GO:2000353)	19	3	1.12	+	2.69	1.20E-01	5.87E-01
GO:0140115	export across plasma membrane (GO:0140115)	57	9	3.35	+	2.69	1.03E-02	1.30E-01
GO:2000136	regulation of cell proliferation involved in heart morphogenesis (GO:2000136)	19	3	1.12	+	2.69	1.20E-01	5.87E-01
GO:2000042	negative regulation of double-strand break repair via homologous recombination (GO:2000042)	19	3	1.12	+	2.69	1.20E-01	5.87E-01
GO:0000729	DNA double-strand break processing (GO:0000729)	19	3	1.12	+	2.69	1.20E-01	5.87E-01
GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190)	19	3	1.12	+	2.69	1.20E-01	5.87E-01
GO:0098900	regulation of action potential (GO:0098900)	57	9	3.35	+	2.69	1.03E-02	1.30E-01
GO:0070509	calcium ion import (GO:0070509)	19	3	1.12	+	2.69	1.20E-01	5.86E-01
GO:0090049	regulation of cell migration involved in sprouting angiogenesis (GO:0090049)	38	6	2.23	+	2.69	3.35E-02	2.91E-01
GO:0090043	regulation of tubulin deacetylation (GO:0090043)	19	3	1.12	+	2.69	1.20E-01	5.86E-01
GO:0090036	regulation of protein kinase C signaling (GO:0090036)	19	3	1.12	+	2.69	1.20E-01	5.86E-01
GO:1900221	regulation of amyloid-beta clearance (GO:1900221)	19	3	1.12	+	2.69	1.20E-01	5.86E-01
GO:0055078	sodium ion homeostasis (GO:0055078)	38	6	2.23	+	2.69	3.35E-02	2.90E-01
GO:0061687	detoxification of inorganic compound (GO:0061687)	19	3	1.12	+	2.69	1.20E-01	5.86E-01
GO:0010761	fibroblast migration (GO:0010761)	19	3	1.12	+	2.69	1.20E-01	5.86E-01
GO:0030041	actin filament polymerization (GO:0030041)	38	6	2.23	+	2.69	3.35E-02	2.90E-01
GO:0003215	cardiac right ventricle morphogenesis (GO:0003215)	19	3	1.12	+	2.69	1.20E-01	5.85E-01
GO:0061003	positive regulation of dendritic spine morphogenesis (GO:0061003)	19	3	1.12	+	2.69	1.20E-01	5.85E-01
GO:0061138	morphogenesis of a branching epithelium (GO:0061138)	165	26	9.69	+	2.68	2.12E-05	7.25E-04
GO:0045667	regulation of osteoblast differentiation (GO:0045667)	127	20	7.46	+	2.68	1.84E-04	4.71E-03
GO:0097553	calcium ion transmembrane import into cytosol (GO:0097553)	89	14	5.23	+	2.68	1.64E-03	3.06E-02
GO:0046620	regulation of organ growth (GO:0046620)	89	14	5.23	+	2.68	1.64E-03	3.05E-02
GO:0060411	cardiac septum morphogenesis (GO:0060411)	70	11	4.11	+	2.68	5.00E-03	7.58E-02
GO:0014823	response to activity (GO:0014823)	70	11	4.11	+	2.68	5.00E-03	7.57E-02
GO:0061448	connective tissue development (GO:0061448)	223	35	13.09	+	2.67	1.30E-06	5.82E-05
GO:1903170	negative regulation of calcium ion transmembrane transport (GO:1903170)	51	8	2.99	+	2.67	1.57E-02	1.74E-01
GO:0071453	cellular response to oxygen levels (GO:0071453)	153	24	8.98	+	2.67	4.62E-05	1.46E-03
GO:0034764	positive regulation of transmembrane transport (GO:0034764)	236	37	13.86	+	2.67	6.24E-07	3.03E-05
GO:2001257	regulation of cation channel activity (GO:2001257)	185	29	10.86	+	2.67	1.26E-05	4.58E-04
GO:0007422	peripheral nervous system development (GO:0007422)	83	13	4.87	+	2.67	2.45E-03	4.23E-02
GO:0032414	positive regulation of ion transmembrane transporter activity (GO:0032414)	115	18	6.75	+	2.67	4.03E-04	9.19E-03
GO:0042552	myelination (GO:0042552)	115	18	6.75	+	2.67	4.03E-04	9.18E-03
GO:0060351	cartilage development involved in endochondral bone morphogenesis (GO:0060351)	32	5	1.88	+	2.66	5.20E-02	3.92E-01
GO:0007127	meiosis I (GO:0007127)	128	20	7.52	+	2.66	2.01E-04	5.07E-03
GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253)	32	5	1.88	+	2.66	5.20E-02	3.92E-01
GO:0040020	regulation of meiotic nuclear division (GO:0040020)	32	5	1.88	+	2.66	5.20E-02	3.92E-01
GO:1901016	regulation of potassium ion transmembrane transporter activity (GO:1901016)	64	10	3.76	+	2.66	7.53E-03	1.03E-01
GO:0008585	female gonad development (GO:0008585)	96	15	5.64	+	2.66	1.21E-03	2.38E-02
GO:1904062	regulation of cation transmembrane transport (GO:1904062)	384	60	22.55	+	2.66	1.62E-10	1.59E-08
GO:0003180	aortic valve morphogenesis (GO:0003180)	32	5	1.88	+	2.66	5.20E-02	3.92E-01
GO:0080164	regulation of nitric oxide metabolic process (GO:0080164)	64	10	3.76	+	2.66	7.53E-03	1.03E-01
GO:0007520	myoblast fusion (GO:0007520)	32	5	1.88	+	2.66	5.20E-02	3.91E-01
GO:1990138	neuron projection extension (GO:1990138)	77	12	4.52	+	2.65	3.66E-03	5.88E-02
GO:0031099	regeneration (GO:0031099)	154	24	9.04	+	2.65	5.06E-05	1.58E-03
GO:0019932	second-messenger-mediated signaling (GO:0019932)	231	36	13.56	+	2.65	9.77E-07	4.59E-05
GO:0072006	nephron development (GO:0072006)	135	21	7.93	+	2.65	1.49E-04	3.96E-03
GO:0032781	positive regulation of ATP-dependent activity (GO:0032781)	45	7	2.64	+	2.65	2.40E-02	2.37E-01
GO:1901385	regulation of voltage-gated calcium channel activity (GO:1901385)	45	7	2.64	+	2.65	2.40E-02	2.37E-01
GO:1900026	positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	45	7	2.64	+	2.65	2.40E-02	2.36E-01
GO:0008347	glial cell migration (GO:0008347)	45	7	2.64	+	2.65	2.40E-02	2.36E-01
GO:0048588	developmental cell growth (GO:0048588)	103	16	6.05	+	2.65	8.89E-04	1.83E-02
GO:0045604	regulation of epidermal cell differentiation (GO:0045604)	58	9	3.41	+	2.64	1.14E-02	1.39E-01
GO:0001954	positive regulation of cell-matrix adhesion (GO:0001954)	58	9	3.41	+	2.64	1.14E-02	1.39E-01
GO:2000649	regulation of sodium ion transmembrane transporter activity (GO:2000649)	58	9	3.41	+	2.64	1.14E-02	1.39E-01
GO:0043030	regulation of macrophage activation (GO:0043030)	58	9	3.41	+	2.64	1.14E-02	1.39E-01
GO:0030282	bone mineralization (GO:0030282)	58	9	3.41	+	2.64	1.14E-02	1.39E-01
GO:0071248	cellular response to metal ion (GO:0071248)	200	31	11.74	+	2.64	6.55E-06	2.57E-04
GO:0001952	regulation of cell-matrix adhesion (GO:0001952)	123	19	7.22	+	2.63	3.27E-04	7.66E-03
GO:1902904	negative regulation of supramolecular fiber organization (GO:1902904)	162	25	9.51	+	2.63	6.33E-05	1.91E-03
GO:0030308	negative regulation of cell growth (GO:0030308)	188	29	11.04	+	2.63	1.43E-05	5.10E-04
GO:0010259	multicellular organism aging (GO:0010259)	26	4	1.53	+	2.62	8.21E-02	5.10E-01
GO:0002638	negative regulation of immunoglobulin production (GO:0002638)	13	2	.76	+	2.62	2.01E-01	7.76E-01
GO:0003096	renal sodium ion transport (GO:0003096)	13	2	.76	+	2.62	2.01E-01	7.76E-01
GO:0033690	positive regulation of osteoblast proliferation (GO:0033690)	13	2	.76	+	2.62	2.01E-01	7.76E-01
GO:0033604	negative regulation of catecholamine secretion (GO:0033604)	13	2	.76	+	2.62	2.01E-01	7.76E-01
GO:0060394	negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)	13	2	.76	+	2.62	2.01E-01	7.75E-01
GO:0007320	insemination (GO:0007320)	13	2	.76	+	2.62	2.01E-01	7.75E-01
GO:0006855	xenobiotic transmembrane transport (GO:0006855)	13	2	.76	+	2.62	2.01E-01	7.75E-01
GO:0060213	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)	13	2	.76	+	2.62	2.01E-01	7.75E-01
GO:0006760	folic acid-containing compound metabolic process (GO:0006760)	26	4	1.53	+	2.62	8.21E-02	5.10E-01
GO:0002357	defense response to tumor cell (GO:0002357)	13	2	.76	+	2.62	2.01E-01	7.75E-01
GO:0006706	steroid catabolic process (GO:0006706)	26	4	1.53	+	2.62	8.21E-02	5.10E-01
GO:0072182	regulation of nephron tubule epithelial cell differentiation (GO:0072182)	13	2	.76	+	2.62	2.01E-01	7.75E-01
GO:0071696	ectodermal placode development (GO:0071696)	13	2	.76	+	2.62	2.01E-01	7.74E-01
GO:0071635	negative regulation of transforming growth factor beta production (GO:0071635)	13	2	.76	+	2.62	2.01E-01	7.74E-01
GO:0001711	endodermal cell fate commitment (GO:0001711)	13	2	.76	+	2.62	2.01E-01	7.74E-01
GO:0060044	negative regulation of cardiac muscle cell proliferation (GO:0060044)	13	2	.76	+	2.62	2.01E-01	7.74E-01
GO:0033262	regulation of nuclear cell cycle DNA replication (GO:0033262)	13	2	.76	+	2.62	2.01E-01	7.74E-01
GO:0038066	p38MAPK cascade (GO:0038066)	13	2	.76	+	2.62	2.01E-01	7.73E-01
GO:0033145	positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)	13	2	.76	+	2.62	2.01E-01	7.73E-01
GO:0090435	protein localization to nuclear envelope (GO:0090435)	13	2	.76	+	2.62	2.01E-01	7.73E-01
GO:0032515	negative regulation of phosphoprotein phosphatase activity (GO:0032515)	26	4	1.53	+	2.62	8.21E-02	5.10E-01
GO:0071285	cellular response to lithium ion (GO:0071285)	13	2	.76	+	2.62	2.01E-01	7.73E-01
GO:1905939	regulation of gonad development (GO:1905939)	13	2	.76	+	2.62	2.01E-01	7.73E-01
GO:0099550	trans-synaptic signaling, modulating synaptic transmission (GO:0099550)	13	2	.76	+	2.62	2.01E-01	7.72E-01
GO:0051573	negative regulation of histone H3-K9 methylation (GO:0051573)	13	2	.76	+	2.62	2.01E-01	7.72E-01
GO:0048742	regulation of skeletal muscle fiber development (GO:0048742)	13	2	.76	+	2.62	2.01E-01	7.72E-01
GO:0140042	lipid droplet formation (GO:0140042)	13	2	.76	+	2.62	2.01E-01	7.72E-01
GO:2000050	regulation of non-canonical Wnt signaling pathway (GO:2000050)	26	4	1.53	+	2.62	8.21E-02	5.10E-01
GO:2000008	regulation of protein localization to cell surface (GO:2000008)	39	6	2.29	+	2.62	3.69E-02	3.14E-01
GO:0051489	regulation of filopodium assembly (GO:0051489)	52	8	3.05	+	2.62	1.73E-02	1.86E-01
GO:0000725	recombinational repair (GO:0000725)	117	18	6.87	+	2.62	4.84E-04	1.08E-02
GO:0050995	negative regulation of lipid catabolic process (GO:0050995)	26	4	1.53	+	2.62	8.21E-02	5.09E-01
GO:0090103	cochlea morphogenesis (GO:0090103)	26	4	1.53	+	2.62	8.21E-02	5.09E-01
GO:0043650	dicarboxylic acid biosynthetic process (GO:0043650)	13	2	.76	+	2.62	2.01E-01	7.72E-01
GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)	13	2	.76	+	2.62	2.01E-01	7.71E-01
GO:0043501	skeletal muscle adaptation (GO:0043501)	13	2	.76	+	2.62	2.01E-01	7.71E-01
GO:1901020	negative regulation of calcium ion transmembrane transporter activity (GO:1901020)	39	6	2.29	+	2.62	3.69E-02	3.13E-01
GO:1905330	regulation of morphogenesis of an epithelium (GO:1905330)	65	10	3.82	+	2.62	8.26E-03	1.08E-01
GO:0035810	positive regulation of urine volume (GO:0035810)	13	2	.76	+	2.62	2.01E-01	7.71E-01
GO:1905245	regulation of aspartic-type peptidase activity (GO:1905245)	13	2	.76	+	2.62	2.01E-01	7.71E-01
GO:0030836	positive regulation of actin filament depolymerization (GO:0030836)	13	2	.76	+	2.62	2.01E-01	7.71E-01
GO:0061982	meiosis I cell cycle process (GO:0061982)	130	20	7.63	+	2.62	2.42E-04	5.87E-03
GO:1904667	negative regulation of ubiquitin protein ligase activity (GO:1904667)	13	2	.76	+	2.62	2.01E-01	7.71E-01
GO:0000002	mitochondrial genome maintenance (GO:0000002)	26	4	1.53	+	2.62	8.21E-02	5.09E-01
GO:0042659	regulation of cell fate specification (GO:0042659)	26	4	1.53	+	2.62	8.21E-02	5.09E-01
GO:0010875	positive regulation of cholesterol efflux (GO:0010875)	26	4	1.53	+	2.62	8.21E-02	5.09E-01
GO:1904322	cellular response to forskolin (GO:1904322)	13	2	.76	+	2.62	2.01E-01	7.70E-01
GO:1904321	response to forskolin (GO:1904321)	13	2	.76	+	2.62	2.01E-01	7.70E-01
GO:0015670	carbon dioxide transport (GO:0015670)	13	2	.76	+	2.62	2.01E-01	7.70E-01
GO:0010718	positive regulation of epithelial to mesenchymal transition (GO:0010718)	52	8	3.05	+	2.62	1.73E-02	1.86E-01
GO:0034638	phosphatidylcholine catabolic process (GO:0034638)	13	2	.76	+	2.62	2.01E-01	7.70E-01
GO:0010659	cardiac muscle cell apoptotic process (GO:0010659)	13	2	.76	+	2.62	2.01E-01	7.70E-01
GO:0003334	keratinocyte development (GO:0003334)	13	2	.76	+	2.62	2.01E-01	7.69E-01
GO:0010454	negative regulation of cell fate commitment (GO:0010454)	13	2	.76	+	2.62	2.01E-01	7.69E-01
GO:0061154	endothelial tube morphogenesis (GO:0061154)	13	2	.76	+	2.62	2.01E-01	7.69E-01
GO:0072698	protein localization to microtubule cytoskeleton (GO:0072698)	39	6	2.29	+	2.62	3.69E-02	3.13E-01
GO:0060670	branching involved in labyrinthine layer morphogenesis (GO:0060670)	13	2	.76	+	2.62	2.01E-01	7.69E-01
GO:0046325	negative regulation of glucose import (GO:0046325)	13	2	.76	+	2.62	2.01E-01	7.69E-01
GO:0002726	positive regulation of T cell cytokine production (GO:0002726)	26	4	1.53	+	2.62	8.21E-02	5.08E-01
GO:0061029	eyelid development in camera-type eye (GO:0061029)	13	2	.76	+	2.62	2.01E-01	7.68E-01
GO:0003188	heart valve formation (GO:0003188)	13	2	.76	+	2.62	2.01E-01	7.68E-01
GO:0007512	adult heart development (GO:0007512)	13	2	.76	+	2.62	2.01E-01	7.68E-01
GO:0003159	morphogenesis of an endothelium (GO:0003159)	13	2	.76	+	2.62	2.01E-01	7.68E-01
GO:1901379	regulation of potassium ion transmembrane transport (GO:1901379)	91	14	5.34	+	2.62	1.97E-03	3.56E-02
GO:0007409	axonogenesis (GO:0007409)	365	56	21.43	+	2.61	1.91E-09	1.50E-07
GO:0040013	negative regulation of locomotion (GO:0040013)	339	52	19.91	+	2.61	4.70E-09	3.27E-07
GO:0072073	kidney epithelium development (GO:0072073)	137	21	8.04	+	2.61	1.79E-04	4.61E-03
GO:0048754	branching morphogenesis of an epithelial tube (GO:0048754)	137	21	8.04	+	2.61	1.79E-04	4.60E-03
GO:0009308	amine metabolic process (GO:0009308)	98	15	5.75	+	2.61	1.45E-03	2.75E-02
GO:0044774	mitotic DNA integrity checkpoint signaling (GO:0044774)	85	13	4.99	+	2.60	2.94E-03	4.96E-02
GO:0001568	blood vessel development (GO:0001568)	510	78	29.95	+	2.60	7.37E-13	1.14E-10
GO:0097746	blood vessel diameter maintenance (GO:0097746)	144	22	8.46	+	2.60	2.06E-04	5.18E-03
GO:0035296	regulation of tube diameter (GO:0035296)	144	22	8.46	+	2.60	2.06E-04	5.17E-03
GO:1903046	meiotic cell cycle process (GO:1903046)	190	29	11.16	+	2.60	1.60E-05	5.58E-04
GO:0022898	regulation of transmembrane transporter activity (GO:0022898)	282	43	16.56	+	2.60	1.21E-07	6.71E-06
GO:0070997	neuron death (GO:0070997)	105	16	6.17	+	2.60	1.07E-03	2.14E-02
GO:0016049	cell growth (GO:0016049)	105	16	6.17	+	2.60	1.07E-03	2.13E-02
GO:0071241	cellular response to inorganic substance (GO:0071241)	230	35	13.51	+	2.59	1.99E-06	8.66E-05
GO:0045666	positive regulation of neuron differentiation (GO:0045666)	92	14	5.40	+	2.59	2.16E-03	3.84E-02
GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)	46	7	2.70	+	2.59	2.63E-02	2.53E-01
GO:0060021	roof of mouth development (GO:0060021)	92	14	5.40	+	2.59	2.16E-03	3.84E-02
GO:1901879	regulation of protein depolymerization (GO:1901879)	92	14	5.40	+	2.59	2.16E-03	3.84E-02
GO:0001658	branching involved in ureteric bud morphogenesis (GO:0001658)	46	7	2.70	+	2.59	2.63E-02	2.53E-01
GO:0055010	ventricular cardiac muscle tissue morphogenesis (GO:0055010)	46	7	2.70	+	2.59	2.63E-02	2.53E-01
GO:0061387	regulation of extent of cell growth (GO:0061387)	112	17	6.58	+	2.58	7.85E-04	1.65E-02
GO:0035150	regulation of tube size (GO:0035150)	145	22	8.51	+	2.58	2.15E-04	5.34E-03
GO:0021772	olfactory bulb development (GO:0021772)	33	5	1.94	+	2.58	5.73E-02	4.04E-01
GO:0045577	regulation of B cell differentiation (GO:0045577)	33	5	1.94	+	2.58	5.73E-02	4.04E-01
GO:0001935	endothelial cell proliferation (GO:0001935)	33	5	1.94	+	2.58	5.73E-02	4.04E-01
GO:0072210	metanephric nephron development (GO:0072210)	33	5	1.94	+	2.58	5.73E-02	4.03E-01
GO:0033032	regulation of myeloid cell apoptotic process (GO:0033032)	33	5	1.94	+	2.58	5.73E-02	4.03E-01
GO:0051642	centrosome localization (GO:0051642)	33	5	1.94	+	2.58	5.73E-02	4.03E-01
GO:0048841	regulation of axon extension involved in axon guidance (GO:0048841)	33	5	1.94	+	2.58	5.73E-02	4.03E-01
GO:0090022	regulation of neutrophil chemotaxis (GO:0090022)	33	5	1.94	+	2.58	5.73E-02	4.03E-01
GO:0050771	negative regulation of axonogenesis (GO:0050771)	66	10	3.88	+	2.58	9.06E-03	1.17E-01
GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)	33	5	1.94	+	2.58	5.73E-02	4.02E-01
GO:0043534	blood vessel endothelial cell migration (GO:0043534)	33	5	1.94	+	2.58	5.73E-02	4.02E-01
GO:1901031	regulation of response to reactive oxygen species (GO:1901031)	33	5	1.94	+	2.58	5.73E-02	4.02E-01
GO:0043267	negative regulation of potassium ion transport (GO:0043267)	33	5	1.94	+	2.58	5.73E-02	4.02E-01
GO:0042573	retinoic acid metabolic process (GO:0042573)	33	5	1.94	+	2.58	5.73E-02	4.02E-01
GO:0061384	heart trabecula morphogenesis (GO:0061384)	33	5	1.94	+	2.58	5.73E-02	4.02E-01
GO:0007617	mating behavior (GO:0007617)	33	5	1.94	+	2.58	5.73E-02	4.01E-01
GO:0007292	female gamete generation (GO:0007292)	152	23	8.93	+	2.58	1.51E-04	4.00E-03
GO:0021954	central nervous system neuron development (GO:0021954)	86	13	5.05	+	2.57	3.22E-03	5.27E-02
GO:0051283	negative regulation of sequestering of calcium ion (GO:0051283)	53	8	3.11	+	2.57	1.89E-02	1.98E-01
GO:0032412	regulation of ion transmembrane transporter activity (GO:0032412)	272	41	15.97	+	2.57	3.06E-07	1.57E-05
GO:2000242	negative regulation of reproductive process (GO:2000242)	73	11	4.29	+	2.57	6.59E-03	9.27E-02
GO:0010827	regulation of glucose transmembrane transport (GO:0010827)	73	11	4.29	+	2.57	6.59E-03	9.26E-02
GO:0032989	cellular component morphogenesis (GO:0032989)	604	91	35.47	+	2.57	1.92E-14	3.72E-12
GO:0051781	positive regulation of cell division (GO:0051781)	93	14	5.46	+	2.56	2.36E-03	4.13E-02
GO:0001944	vasculature development (GO:0001944)	532	80	31.24	+	2.56	1.03E-12	1.54E-10
GO:0007612	learning (GO:0007612)	153	23	8.98	+	2.56	1.58E-04	4.13E-03
GO:2001259	positive regulation of cation channel activity (GO:2001259)	80	12	4.70	+	2.55	4.81E-03	7.33E-02
GO:0019079	viral genome replication (GO:0019079)	20	3	1.17	+	2.55	1.32E-01	6.28E-01
GO:0032793	positive regulation of CREB transcription factor activity (GO:0032793)	20	3	1.17	+	2.55	1.32E-01	6.27E-01
GO:0032733	positive regulation of interleukin-10 production (GO:0032733)	40	6	2.35	+	2.55	4.05E-02	3.25E-01
GO:0001502	cartilage condensation (GO:0001502)	20	3	1.17	+	2.55	1.32E-01	6.27E-01
GO:0099622	cardiac muscle cell membrane repolarization (GO:0099622)	20	3	1.17	+	2.55	1.32E-01	6.27E-01
GO:0032332	positive regulation of chondrocyte differentiation (GO:0032332)	20	3	1.17	+	2.55	1.32E-01	6.27E-01
GO:0006067	ethanol metabolic process (GO:0006067)	20	3	1.17	+	2.55	1.32E-01	6.27E-01
GO:0051493	regulation of cytoskeleton organization (GO:0051493)	540	81	31.71	+	2.55	7.72E-13	1.19E-10
GO:0048569	post-embryonic animal organ development (GO:0048569)	20	3	1.17	+	2.55	1.32E-01	6.26E-01
GO:1900371	regulation of purine nucleotide biosynthetic process (GO:1900371)	40	6	2.35	+	2.55	4.05E-02	3.24E-01
GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)	20	3	1.17	+	2.55	1.32E-01	6.26E-01
GO:0035461	vitamin transmembrane transport (GO:0035461)	20	3	1.17	+	2.55	1.32E-01	6.26E-01
GO:0086013	membrane repolarization during cardiac muscle cell action potential (GO:0086013)	20	3	1.17	+	2.55	1.32E-01	6.26E-01
GO:0042474	middle ear morphogenesis (GO:0042474)	20	3	1.17	+	2.55	1.32E-01	6.26E-01
GO:0097501	stress response to metal ion (GO:0097501)	20	3	1.17	+	2.55	1.32E-01	6.25E-01
GO:0042069	regulation of catecholamine metabolic process (GO:0042069)	20	3	1.17	+	2.55	1.32E-01	6.25E-01
GO:0042053	regulation of dopamine metabolic process (GO:0042053)	20	3	1.17	+	2.55	1.32E-01	6.25E-01
GO:0008090	retrograde axonal transport (GO:0008090)	20	3	1.17	+	2.55	1.32E-01	6.25E-01
GO:0002689	negative regulation of leukocyte chemotaxis (GO:0002689)	20	3	1.17	+	2.55	1.32E-01	6.25E-01
GO:0046545	development of primary female sexual characteristics (GO:0046545)	100	15	5.87	+	2.55	1.73E-03	3.21E-02
GO:0000302	response to reactive oxygen species (GO:0000302)	167	25	9.81	+	2.55	8.05E-05	2.35E-03
GO:0048864	stem cell development (GO:0048864)	87	13	5.11	+	2.54	3.52E-03	5.68E-02
GO:0031110	regulation of microtubule polymerization or depolymerization (GO:0031110)	87	13	5.11	+	2.54	3.52E-03	5.67E-02
GO:1901888	regulation of cell junction assembly (GO:1901888)	201	30	11.80	+	2.54	1.48E-05	5.21E-04
GO:0006112	energy reserve metabolic process (GO:0006112)	67	10	3.93	+	2.54	9.90E-03	1.26E-01
GO:0032147	activation of protein kinase activity (GO:0032147)	141	21	8.28	+	2.54	3.47E-04	8.06E-03
GO:0060291	long-term synaptic potentiation (GO:0060291)	47	7	2.76	+	2.54	2.89E-02	2.62E-01
GO:0014033	neural crest cell differentiation (GO:0014033)	94	14	5.52	+	2.54	2.57E-03	4.42E-02
GO:0006110	regulation of glycolytic process (GO:0006110)	47	7	2.76	+	2.54	2.89E-02	2.62E-01
GO:0003205	cardiac chamber development (GO:0003205)	168	25	9.87	+	2.53	8.53E-05	2.47E-03
GO:0035239	tube morphogenesis (GO:0035239)	673	100	39.52	+	2.53	2.25E-15	4.97E-13
GO:0035265	organ growth (GO:0035265)	101	15	5.93	+	2.53	1.89E-03	3.45E-02
GO:0032956	regulation of actin cytoskeleton organization (GO:0032956)	364	54	21.37	+	2.53	7.33E-09	4.92E-07
GO:0045606	positive regulation of epidermal cell differentiation (GO:0045606)	27	4	1.59	+	2.52	9.03E-02	5.33E-01
GO:0048843	negative regulation of axon extension involved in axon guidance (GO:0048843)	27	4	1.59	+	2.52	9.03E-02	5.33E-01
GO:0051503	adenine nucleotide transport (GO:0051503)	27	4	1.59	+	2.52	9.03E-02	5.32E-01
GO:2000001	regulation of DNA damage checkpoint (GO:2000001)	27	4	1.59	+	2.52	9.03E-02	5.32E-01
GO:0050886	endocrine process (GO:0050886)	54	8	3.17	+	2.52	2.07E-02	2.12E-01
GO:0040007	growth (GO:0040007)	413	61	24.25	+	2.52	8.19E-10	6.94E-08
GO:0048589	developmental growth (GO:0048589)	413	61	24.25	+	2.52	8.19E-10	6.91E-08
GO:0051058	negative regulation of small GTPase mediated signal transduction (GO:0051058)	61	9	3.58	+	2.51	1.49E-02	1.73E-01
GO:0198738	cell-cell signaling by wnt (GO:0198738)	285	42	16.74	+	2.51	4.99E-07	2.48E-05
GO:0016055	Wnt signaling pathway (GO:0016055)	285	42	16.74	+	2.51	4.99E-07	2.47E-05
GO:0050769	positive regulation of neurogenesis (GO:0050769)	231	34	13.56	+	2.51	4.91E-06	1.98E-04
GO:0090169	regulation of spindle assembly (GO:0090169)	34	5	2.00	+	2.50	6.29E-02	4.32E-01
GO:0031670	cellular response to nutrient (GO:0031670)	34	5	2.00	+	2.50	6.29E-02	4.32E-01
GO:0043403	skeletal muscle tissue regeneration (GO:0043403)	34	5	2.00	+	2.50	6.29E-02	4.32E-01
GO:0061842	microtubule organizing center localization (GO:0061842)	34	5	2.00	+	2.50	6.29E-02	4.31E-01
GO:0035249	synaptic transmission, glutamatergic (GO:0035249)	34	5	2.00	+	2.50	6.29E-02	4.31E-01
GO:0016525	negative regulation of angiogenesis (GO:0016525)	102	15	5.99	+	2.50	3.30E-03	5.37E-02
GO:0051384	response to glucocorticoid (GO:0051384)	143	21	8.40	+	2.50	3.84E-04	8.80E-03
GO:0055123	digestive system development (GO:0055123)	143	21	8.40	+	2.50	3.84E-04	8.79E-03
GO:0021700	developmental maturation (GO:0021700)	259	38	15.21	+	2.50	2.13E-06	9.17E-05
GO:0034103	regulation of tissue remodeling (GO:0034103)	75	11	4.40	+	2.50	7.86E-03	1.04E-01
GO:0071479	cellular response to ionizing radiation (GO:0071479)	75	11	4.40	+	2.50	7.86E-03	1.04E-01
GO:0071470	cellular response to osmotic stress (GO:0071470)	41	6	2.41	+	2.49	4.43E-02	3.47E-01
GO:0033002	muscle cell proliferation (GO:0033002)	41	6	2.41	+	2.49	4.43E-02	3.47E-01
GO:1900744	regulation of p38MAPK cascade (GO:1900744)	41	6	2.41	+	2.49	4.43E-02	3.47E-01
GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	41	6	2.41	+	2.49	4.43E-02	3.47E-01
GO:0070050	neuron cellular homeostasis (GO:0070050)	41	6	2.41	+	2.49	4.43E-02	3.47E-01
GO:0030808	regulation of nucleotide biosynthetic process (GO:0030808)	41	6	2.41	+	2.49	4.43E-02	3.46E-01
GO:0042063	gliogenesis (GO:0042063)	246	36	14.45	+	2.49	4.42E-06	1.81E-04
GO:0072001	renal system development (GO:0072001)	308	45	18.09	+	2.49	2.06E-07	1.10E-05
GO:0010720	positive regulation of cell development (GO:0010720)	308	45	18.09	+	2.49	2.06E-07	1.09E-05
GO:0061564	axon development (GO:0061564)	404	59	23.72	+	2.49	3.20E-09	2.38E-07
GO:0060443	mammary gland morphogenesis (GO:0060443)	48	7	2.82	+	2.48	3.16E-02	2.79E-01
GO:0007062	sister chromatid cohesion (GO:0007062)	48	7	2.82	+	2.48	3.16E-02	2.79E-01
GO:0045926	negative regulation of growth (GO:0045926)	247	36	14.50	+	2.48	4.57E-06	1.86E-04
GO:2000181	negative regulation of blood vessel morphogenesis (GO:2000181)	103	15	6.05	+	2.48	3.41E-03	5.53E-02
GO:0051494	negative regulation of cytoskeleton organization (GO:0051494)	158	23	9.28	+	2.48	2.09E-04	5.23E-03
GO:2000107	negative regulation of leukocyte apoptotic process (GO:2000107)	55	8	3.23	+	2.48	2.26E-02	2.26E-01
GO:1901215	negative regulation of neuron death (GO:1901215)	220	32	12.92	+	2.48	1.14E-05	4.19E-04
GO:0070371	ERK1 and ERK2 cascade (GO:0070371)	55	8	3.23	+	2.48	2.26E-02	2.25E-01
GO:0043470	regulation of carbohydrate catabolic process (GO:0043470)	55	8	3.23	+	2.48	2.26E-02	2.25E-01
GO:0070169	positive regulation of biomineral tissue development (GO:0070169)	55	8	3.23	+	2.48	2.26E-02	2.25E-01
GO:0034614	cellular response to reactive oxygen species (GO:0034614)	117	17	6.87	+	2.47	1.67E-03	3.11E-02
GO:0048858	cell projection morphogenesis (GO:0048858)	489	71	28.71	+	2.47	6.70E-11	7.35E-09
GO:0060393	regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	62	9	3.64	+	2.47	1.63E-02	1.79E-01
GO:0042246	tissue regeneration (GO:0042246)	62	9	3.64	+	2.47	1.63E-02	1.79E-01
GO:0006935	chemotaxis (GO:0006935)	518	75	30.42	+	2.47	3.01E-11	3.53E-09
GO:0120039	plasma membrane bounded cell projection morphogenesis (GO:0120039)	484	70	28.42	+	2.46	1.06E-10	1.08E-08
GO:0001666	response to hypoxia (GO:0001666)	277	40	16.27	+	2.46	1.31E-06	5.86E-05
GO:0010717	regulation of epithelial to mesenchymal transition (GO:0010717)	97	14	5.70	+	2.46	5.07E-03	7.56E-02
GO:0001667	ameboidal-type cell migration (GO:0001667)	201	29	11.80	+	2.46	3.35E-05	1.09E-03
GO:0090288	negative regulation of cellular response to growth factor stimulus (GO:0090288)	104	15	6.11	+	2.46	3.54E-03	5.70E-02
GO:1901343	negative regulation of vasculature development (GO:1901343)	104	15	6.11	+	2.46	3.54E-03	5.70E-02
GO:0042330	taxis (GO:0042330)	520	75	30.53	+	2.46	3.26E-11	3.78E-09
GO:0048812	neuron projection morphogenesis (GO:0048812)	479	69	28.13	+	2.45	1.67E-10	1.63E-08
GO:0001764	neuron migration (GO:0001764)	139	20	8.16	+	2.45	6.34E-04	1.37E-02
GO:0032409	regulation of transporter activity (GO:0032409)	299	43	17.56	+	2.45	5.33E-07	2.63E-05
GO:0045759	negative regulation of action potential (GO:0045759)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0002606	positive regulation of dendritic cell antigen processing and presentation (GO:0002606)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1903288	positive regulation of potassium ion import across plasma membrane (GO:1903288)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0045719	negative regulation of glycogen biosynthetic process (GO:0045719)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0021766	hippocampus development (GO:0021766)	84	12	4.93	+	2.43	1.09E-02	1.36E-01
GO:1903243	negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0021756	striatum development (GO:0021756)	21	3	1.23	+	2.43	1.45E-01	6.69E-01
GO:0003097	renal water transport (GO:0003097)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0072423	response to DNA damage checkpoint signaling (GO:0072423)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060449	bud elongation involved in lung branching (GO:0060449)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060440	trachea formation (GO:0060440)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0072402	response to DNA integrity checkpoint signaling (GO:0072402)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1902742	apoptotic process involved in development (GO:1902742)	35	5	2.06	+	2.43	6.87E-02	4.60E-01
GO:0060405	regulation of penile erection (GO:0060405)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)	14	2	.82	+	2.43	2.22E-01	7.86E-01
GO:0034141	positive regulation of toll-like receptor 3 signaling pathway (GO:0034141)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0006953	acute-phase response (GO:0006953)	42	6	2.47	+	2.43	4.84E-02	3.69E-01
GO:0006925	inflammatory cell apoptotic process (GO:0006925)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0002548	monocyte chemotaxis (GO:0002548)	42	6	2.47	+	2.43	4.84E-02	3.69E-01
GO:0002523	leukocyte migration involved in inflammatory response (GO:0002523)	21	3	1.23	+	2.43	1.45E-01	6.69E-01
GO:0045656	negative regulation of monocyte differentiation (GO:0045656)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0045650	negative regulation of macrophage differentiation (GO:0045650)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0072396	response to cell cycle checkpoint signaling (GO:0072396)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0072386	plus-end-directed organelle transport along microtubule (GO:0072386)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060398	regulation of growth hormone receptor signaling pathway (GO:0060398)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060372	regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0046073	dTMP metabolic process (GO:0046073)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0110151	positive regulation of biomineralization (GO:0110151)	56	8	3.29	+	2.43	2.46E-02	2.42E-01
GO:0046015	regulation of transcription by glucose (GO:0046015)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0002475	antigen processing and presentation via MHC class Ib (GO:0002475)	14	2	.82	+	2.43	2.22E-01	7.86E-01
GO:0002428	antigen processing and presentation of peptide antigen via MHC class Ib (GO:0002428)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010002	cardioblast differentiation (GO:0010002)	14	2	.82	+	2.43	2.22E-01	7.86E-01
GO:0001976	nervous system process involved in regulation of systemic arterial blood pressure (GO:0001976)	14	2	.82	+	2.43	2.22E-01	7.86E-01
GO:0021546	rhombomere development (GO:0021546)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0001957	intramembranous ossification (GO:0001957)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:2000757	negative regulation of peptidyl-lysine acetylation (GO:2000757)	21	3	1.23	+	2.43	1.45E-01	6.69E-01
GO:0052651	monoacylglycerol catabolic process (GO:0052651)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0110089	regulation of hippocampal neuron apoptotic process (GO:0110089)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0072201	negative regulation of mesenchymal cell proliferation (GO:0072201)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060232	delamination (GO:0060232)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0110025	DNA strand resection involved in replication fork processing (GO:0110025)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0006704	glucocorticoid biosynthetic process (GO:0006704)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:2001171	positive regulation of ATP biosynthetic process (GO:2001171)	14	2	.82	+	2.43	2.22E-01	7.85E-01
GO:2001169	regulation of ATP biosynthetic process (GO:2001169)	21	3	1.23	+	2.43	1.45E-01	6.69E-01
GO:0007182	common-partner SMAD protein phosphorylation (GO:0007182)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0001842	neural fold formation (GO:0001842)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0001836	release of cytochrome c from mitochondria (GO:0001836)	21	3	1.23	+	2.43	1.45E-01	6.68E-01
GO:0140632	inflammasome complex assembly (GO:0140632)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0032958	inositol phosphate biosynthetic process (GO:0032958)	14	2	.82	+	2.43	2.22E-01	7.85E-01
GO:0032957	inositol trisphosphate metabolic process (GO:0032957)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060136	embryonic process involved in female pregnancy (GO:0060136)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060100	positive regulation of phagocytosis, engulfment (GO:0060100)	14	2	.82	+	2.43	2.22E-01	7.85E-01
GO:0032914	positive regulation of transforming growth factor beta1 production (GO:0032914)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0071694	maintenance of protein location in extracellular region (GO:0071694)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0006657	CDP-choline pathway (GO:0006657)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:2001026	regulation of endothelial cell chemotaxis (GO:2001026)	21	3	1.23	+	2.43	1.45E-01	6.68E-01
GO:0044849	estrous cycle (GO:0044849)	14	2	.82	+	2.43	2.22E-01	7.85E-01
GO:0072014	proximal tubule development (GO:0072014)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060027	convergent extension involved in gastrulation (GO:0060027)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0032808	lacrimal gland development (GO:0032808)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0006554	lysine catabolic process (GO:0006554)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1902307	positive regulation of sodium ion transmembrane transport (GO:1902307)	21	3	1.23	+	2.43	1.45E-01	6.68E-01
GO:0071526	semaphorin-plexin signaling pathway (GO:0071526)	42	6	2.47	+	2.43	4.84E-02	3.68E-01
GO:1901880	negative regulation of protein depolymerization (GO:1901880)	70	10	4.11	+	2.43	1.28E-02	1.53E-01
GO:1901857	positive regulation of cellular respiration (GO:1901857)	14	2	.82	+	2.43	2.22E-01	7.85E-01
GO:0032776	DNA methylation on cytosine (GO:0032776)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1902259	regulation of delayed rectifier potassium channel activity (GO:1902259)	21	3	1.23	+	2.43	1.45E-01	6.68E-01
GO:1902231	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0014062	regulation of serotonin secretion (GO:0014062)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0014060	regulation of epinephrine secretion (GO:0014060)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0014029	neural crest formation (GO:0014029)	14	2	.82	+	2.43	2.22E-01	7.85E-01
GO:0014002	astrocyte development (GO:0014002)	35	5	2.06	+	2.43	6.87E-02	4.60E-01
GO:0005979	regulation of glycogen biosynthetic process (GO:0005979)	28	4	1.64	+	2.43	9.89E-02	5.71E-01
GO:2000394	positive regulation of lamellipodium morphogenesis (GO:2000394)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0001516	prostaglandin biosynthetic process (GO:0001516)	21	3	1.23	+	2.43	1.45E-01	6.68E-01
GO:0006382	adenosine to inosine editing (GO:0006382)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0006346	DNA methylation-dependent heterochromatin formation (GO:0006346)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0051764	actin crosslink formation (GO:0051764)	14	2	.82	+	2.43	2.22E-01	7.84E-01
GO:0045066	regulatory T cell differentiation (GO:0045066)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1901642	nucleoside transmembrane transport (GO:1901642)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0033005	positive regulation of mast cell activation (GO:0033005)	21	3	1.23	+	2.43	1.45E-01	6.67E-01
GO:0032594	protein transport within lipid bilayer (GO:0032594)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0001408	guanine nucleotide transport (GO:0001408)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0032571	response to vitamin K (GO:0032571)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1902043	positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)	14	2	.82	+	2.43	2.22E-01	7.84E-01
GO:0106300	protein-DNA covalent cross-linking repair (GO:0106300)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0071286	cellular response to magnesium ion (GO:0071286)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0071267	L-methionine salvage (GO:0071267)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0071265	L-methionine biosynthetic process (GO:0071265)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0071236	cellular response to antibiotic (GO:0071236)	14	2	.82	+	2.43	2.22E-01	7.84E-01
GO:0071224	cellular response to peptidoglycan (GO:0071224)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0051610	serotonin uptake (GO:0051610)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1905907	negative regulation of amyloid fibril formation (GO:1905907)	14	2	.82	+	2.43	2.22E-01	7.84E-01
GO:0048842	positive regulation of axon extension involved in axon guidance (GO:0048842)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0040011	locomotion (GO:0040011)	539	77	31.65	+	2.43	2.19E-11	2.62E-09
GO:0051547	regulation of keratinocyte migration (GO:0051547)	14	2	.82	+	2.43	2.22E-01	7.84E-01
GO:1990414	replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0090240	positive regulation of histone H4 acetylation (GO:0090240)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0048752	semicircular canal morphogenesis (GO:0048752)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0090201	negative regulation of release of cytochrome c from mitochondria (GO:0090201)	21	3	1.23	+	2.43	1.45E-01	6.67E-01
GO:0044387	negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0048730	epidermis morphogenesis (GO:0048730)	35	5	2.06	+	2.43	6.87E-02	4.59E-01
GO:2000064	regulation of cortisol biosynthetic process (GO:2000064)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0048715	negative regulation of oligodendrocyte differentiation (GO:0048715)	14	2	.82	+	2.43	2.22E-01	7.83E-01
GO:1905770	regulation of mesodermal cell differentiation (GO:1905770)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0000722	telomere maintenance via recombination (GO:0000722)	14	2	.82	+	2.43	2.22E-01	7.83E-01
GO:0009992	cellular water homeostasis (GO:0009992)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0090178	regulation of establishment of planar polarity involved in neural tube closure (GO:0090178)	14	2	.82	+	2.43	2.22E-01	7.83E-01
GO:0090166	Golgi disassembly (GO:0090166)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0090141	positive regulation of mitochondrial fission (GO:0090141)	21	3	1.23	+	2.43	1.45E-01	6.67E-01
GO:0106070	regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070)	14	2	.82	+	2.43	2.22E-01	7.83E-01
GO:0050916	sensory perception of sweet taste (GO:0050916)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1905691	lipid droplet disassembly (GO:1905691)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0090050	positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050)	21	3	1.23	+	2.43	1.45E-01	6.67E-01
GO:0070445	regulation of oligodendrocyte progenitor proliferation (GO:0070445)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0050859	negative regulation of B cell receptor signaling pathway (GO:0050859)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0048549	positive regulation of pinocytosis (GO:0048549)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0048538	thymus development (GO:0048538)	49	7	2.88	+	2.43	3.44E-02	2.95E-01
GO:0120252	hydrocarbon metabolic process (GO:0120252)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0051298	centrosome duplication (GO:0051298)	35	5	2.06	+	2.43	6.87E-02	4.59E-01
GO:0031649	heat generation (GO:0031649)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1905517	macrophage migration (GO:1905517)	21	3	1.23	+	2.43	1.45E-01	6.67E-01
GO:0009750	response to fructose (GO:0009750)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0031622	positive regulation of fever generation (GO:0031622)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0070358	actin polymerization-dependent cell motility (GO:0070358)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0070305	response to cGMP (GO:0070305)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0043584	nose development (GO:0043584)	14	2	.82	+	2.43	2.22E-01	7.83E-01
GO:0031532	actin cytoskeleton reorganization (GO:0031532)	70	10	4.11	+	2.43	1.28E-02	1.53E-01
GO:1901029	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)	14	2	.82	+	2.43	2.22E-01	7.83E-01
GO:0009624	response to nematode (GO:0009624)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0070293	renal absorption (GO:0070293)	28	4	1.64	+	2.43	9.89E-02	5.71E-01
GO:0031509	subtelomeric heterochromatin formation (GO:0031509)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0099010	modification of postsynaptic structure (GO:0099010)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0098532	histone H3-K27 trimethylation (GO:0098532)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0051026	chiasma assembly (GO:0051026)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0042985	negative regulation of amyloid precursor protein biosynthetic process (GO:0042985)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0042984	regulation of amyloid precursor protein biosynthetic process (GO:0042984)	14	2	.82	+	2.43	2.22E-01	7.82E-01
GO:0048246	macrophage chemotaxis (GO:0048246)	14	2	.82	+	2.43	2.22E-01	7.82E-01
GO:0070106	interleukin-27-mediated signaling pathway (GO:0070106)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0043376	regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1905279	regulation of retrograde transport, endosome to Golgi (GO:1905279)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0043305	negative regulation of mast cell degranulation (GO:0043305)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0043301	negative regulation of leukocyte degranulation (GO:0043301)	14	2	.82	+	2.43	2.22E-01	7.82E-01
GO:0031338	regulation of vesicle fusion (GO:0031338)	21	3	1.23	+	2.43	1.45E-01	6.67E-01
GO:0009438	methylglyoxal metabolic process (GO:0009438)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0009415	response to water (GO:0009415)	14	2	.82	+	2.43	2.22E-01	7.82E-01
GO:1904796	regulation of core promoter binding (GO:1904796)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0030878	thyroid gland development (GO:0030878)	28	4	1.64	+	2.43	9.89E-02	5.71E-01
GO:1905155	positive regulation of membrane invagination (GO:1905155)	14	2	.82	+	2.43	2.22E-01	7.82E-01
GO:1904683	regulation of metalloendopeptidase activity (GO:1904683)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0042754	negative regulation of circadian rhythm (GO:0042754)	14	2	.82	+	2.43	2.22E-01	7.82E-01
GO:0036089	cleavage furrow formation (GO:0036089)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0048048	embryonic eye morphogenesis (GO:0048048)	35	5	2.06	+	2.43	6.87E-02	4.59E-01
GO:0036072	direct ossification (GO:0036072)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1904645	response to amyloid-beta (GO:1904645)	49	7	2.88	+	2.43	3.44E-02	2.95E-01
GO:0048007	antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0048003	antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0036016	cellular response to interleukin-3 (GO:0036016)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0036015	response to interleukin-3 (GO:0036015)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0000083	regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)	21	3	1.23	+	2.43	1.45E-01	6.66E-01
GO:1905049	negative regulation of metallopeptidase activity (GO:1905049)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0035519	protein K29-linked ubiquitination (GO:0035519)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0035507	regulation of myosin-light-chain-phosphatase activity (GO:0035507)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0043102	amino acid salvage (GO:0043102)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0009211	pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0055075	potassium ion homeostasis (GO:0055075)	35	5	2.06	+	2.43	6.87E-02	4.59E-01
GO:0055057	neuroblast division (GO:0055057)	14	2	.82	+	2.43	2.22E-01	7.81E-01
GO:0031086	nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0015868	purine ribonucleotide transport (GO:0015868)	28	4	1.64	+	2.43	9.89E-02	5.70E-01
GO:0015858	nucleoside transport (GO:0015858)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0046984	regulation of hemoglobin biosynthetic process (GO:0046984)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0009110	vitamin biosynthetic process (GO:0009110)	14	2	.82	+	2.43	2.22E-01	7.81E-01
GO:0030578	PML body organization (GO:0030578)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010996	response to auditory stimulus (GO:0010996)	28	4	1.64	+	2.43	9.89E-02	5.70E-01
GO:0010994	free ubiquitin chain polymerization (GO:0010994)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0097647	amylin receptor signaling pathway (GO:0097647)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010966	regulation of phosphate transport (GO:0010966)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010962	regulation of glucan biosynthetic process (GO:0010962)	28	4	1.64	+	2.43	9.89E-02	5.70E-01
GO:1900028	negative regulation of ruffle assembly (GO:1900028)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0035358	regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358)	14	2	.82	+	2.43	2.22E-01	7.81E-01
GO:0086069	bundle of His cell to Purkinje myocyte communication (GO:0086069)	14	2	.82	+	2.43	2.22E-01	7.81E-01
GO:0086018	SA node cell to atrial cardiac muscle cell signaling (GO:0086018)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0086015	SA node cell action potential (GO:0086015)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1904376	negative regulation of protein localization to cell periphery (GO:1904376)	28	4	1.64	+	2.43	9.89E-02	5.70E-01
GO:0016191	synaptic vesicle uncoating (GO:0016191)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010888	negative regulation of lipid storage (GO:0010888)	21	3	1.23	+	2.43	1.45E-01	6.66E-01
GO:0097531	mast cell migration (GO:0097531)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	49	7	2.88	+	2.43	3.44E-02	2.95E-01
GO:0097503	sialylation (GO:0097503)	21	3	1.23	+	2.43	1.45E-01	6.66E-01
GO:0010838	positive regulation of keratinocyte proliferation (GO:0010838)	14	2	.82	+	2.43	2.22E-01	7.81E-01
GO:0010830	regulation of myotube differentiation (GO:0010830)	42	6	2.47	+	2.43	4.84E-02	3.68E-01
GO:1903817	negative regulation of voltage-gated potassium channel activity (GO:1903817)	14	2	.82	+	2.43	2.22E-01	7.80E-01
GO:0097475	motor neuron migration (GO:0097475)	14	2	.82	+	2.43	2.22E-01	7.80E-01
GO:0042364	water-soluble vitamin biosynthetic process (GO:0042364)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0042362	fat-soluble vitamin biosynthetic process (GO:0042362)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1904251	regulation of bile acid metabolic process (GO:1904251)	14	2	.82	+	2.43	2.22E-01	7.80E-01
GO:0016082	synaptic vesicle priming (GO:0016082)	14	2	.82	+	2.43	2.22E-01	7.80E-01
GO:0010727	negative regulation of hydrogen peroxide metabolic process (GO:0010727)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010719	negative regulation of epithelial to mesenchymal transition (GO:0010719)	35	5	2.06	+	2.43	6.87E-02	4.59E-01
GO:1903764	regulation of potassium ion export across plasma membrane (GO:1903764)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1903753	negative regulation of p38MAPK cascade (GO:1903753)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1903726	negative regulation of phospholipid metabolic process (GO:1903726)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1903721	positive regulation of I-kappaB phosphorylation (GO:1903721)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0035116	embryonic hindlimb morphogenesis (GO:0035116)	28	4	1.64	+	2.43	9.89E-02	5.70E-01
GO:0046654	tetrahydrofolate biosynthetic process (GO:0046654)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060911	cardiac cell fate commitment (GO:0060911)	14	2	.82	+	2.43	2.22E-01	7.80E-01
GO:0046618	xenobiotic export from cell (GO:0046618)	14	2	.82	+	2.43	2.22E-01	7.80E-01
GO:0046600	negative regulation of centriole replication (GO:0046600)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1904141	positive regulation of microglial cell migration (GO:1904141)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0034627	'de novo' NAD biosynthetic process (GO:0034627)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0034616	response to laminar fluid shear stress (GO:0034616)	14	2	.82	+	2.43	2.22E-01	7.79E-01
GO:0010658	striated muscle cell apoptotic process (GO:0010658)	14	2	.82	+	2.43	2.22E-01	7.79E-01
GO:0030213	hyaluronan biosynthetic process (GO:0030213)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010616	negative regulation of cardiac muscle adaptation (GO:0010616)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010614	negative regulation of cardiac muscle hypertrophy (GO:0010614)	28	4	1.64	+	2.43	9.89E-02	5.69E-01
GO:1903672	positive regulation of sprouting angiogenesis (GO:1903672)	21	3	1.23	+	2.43	1.45E-01	6.66E-01
GO:0061312	BMP signaling pathway involved in heart development (GO:0061312)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1903626	positive regulation of DNA catabolic process (GO:1903626)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1903624	regulation of DNA catabolic process (GO:1903624)	14	2	.82	+	2.43	2.22E-01	7.79E-01
GO:0060856	establishment of blood-brain barrier (GO:0060856)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0046543	development of secondary female sexual characteristics (GO:0046543)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1904063	negative regulation of cation transmembrane transport (GO:1904063)	98	14	5.75	+	2.43	5.26E-03	7.80E-02
GO:0097240	chromosome attachment to the nuclear envelope (GO:0097240)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0030157	pancreatic juice secretion (GO:0030157)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010536	positive regulation of activation of Janus kinase activity (GO:0010536)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0002903	negative regulation of B cell apoptotic process (GO:0002903)	14	2	.82	+	2.43	2.22E-01	7.79E-01
GO:1903588	negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1903546	protein localization to photoreceptor outer segment (GO:1903546)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0072708	response to sorbitol (GO:0072708)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060732	positive regulation of inositol phosphate biosynthetic process (GO:0060732)	14	2	.82	+	2.43	2.22E-01	7.79E-01
GO:0046457	prostanoid biosynthetic process (GO:0046457)	21	3	1.23	+	2.43	1.45E-01	6.66E-01
GO:0003301	physiological cardiac muscle hypertrophy (GO:0003301)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060710	chorio-allantoic fusion (GO:0060710)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0030091	protein repair (GO:0030091)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0030070	insulin processing (GO:0030070)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0002826	negative regulation of T-helper 1 type immune response (GO:0002826)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0045964	positive regulation of dopamine metabolic process (GO:0045964)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0061179	negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0045916	negative regulation of complement activation (GO:0045916)	14	2	.82	+	2.43	2.22E-01	7.79E-01
GO:0045915	positive regulation of catecholamine metabolic process (GO:0045915)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0021937	cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0003298	physiological muscle hypertrophy (GO:0003298)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0072673	lamellipodium morphogenesis (GO:0072673)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0007638	mechanosensory behavior (GO:0007638)	14	2	.82	+	2.43	2.22E-01	7.78E-01
GO:0060696	regulation of phospholipid catabolic process (GO:0060696)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0060628	regulation of ER to Golgi vesicle-mediated transport (GO:0060628)	14	2	.82	+	2.43	2.22E-01	7.78E-01
GO:0034334	adherens junction maintenance (GO:0034334)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0097049	motor neuron apoptotic process (GO:0097049)	14	2	.82	+	2.43	2.22E-01	7.78E-01
GO:0034316	negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0014732	skeletal muscle atrophy (GO:0014732)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0061091	regulation of phospholipid translocation (GO:0061091)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0010332	response to gamma radiation (GO:0010332)	56	8	3.29	+	2.43	2.46E-02	2.41E-01
GO:0033864	positive regulation of NAD(P)H oxidase activity (GO:0033864)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0021894	cerebral cortex GABAergic interneuron development (GO:0021894)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0061049	cell growth involved in cardiac muscle cell development (GO:0061049)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0045821	positive regulation of glycolytic process (GO:0045821)	21	3	1.23	+	2.43	1.45E-01	6.65E-01
GO:1903367	positive regulation of fear response (GO:1903367)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0045815	epigenetic maintenance of chromatin in transcription-competent conformation (GO:0045815)	14	2	.82	+	2.43	2.22E-01	7.78E-01
GO:1903361	protein localization to basolateral plasma membrane (GO:1903361)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:1903348	positive regulation of bicellular tight junction assembly (GO:1903348)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0072575	epithelial cell proliferation involved in liver morphogenesis (GO:0072575)	7	1	.41	+	2.43	3.67E-01	1.00E00
GO:0072574	hepatocyte proliferation (GO:0072574)	7	1	.41	+	2.43	3.67E-01	9.99E-01
GO:0060576	intestinal epithelial cell development (GO:0060576)	14	2	.82	+	2.43	2.22E-01	7.78E-01
GO:0072538	T-helper 17 type immune response (GO:0072538)	14	2	.82	+	2.43	2.22E-01	7.78E-01
GO:0060534	trachea cartilage development (GO:0060534)	7	1	.41	+	2.43	3.67E-01	9.99E-01
GO:0018958	phenol-containing compound metabolic process (GO:0018958)	91	13	5.34	+	2.43	7.55E-03	1.03E-01
GO:0019229	regulation of vasoconstriction (GO:0019229)	63	9	3.70	+	2.43	1.77E-02	1.89E-01
GO:0032411	positive regulation of transporter activity (GO:0032411)	126	18	7.40	+	2.43	1.31E-03	2.54E-02
GO:1900542	regulation of purine nucleotide metabolic process (GO:1900542)	91	13	5.34	+	2.43	7.55E-03	1.03E-01
GO:0030324	lung development (GO:0030324)	182	26	10.69	+	2.43	9.84E-05	2.77E-03
GO:0003231	cardiac ventricle development (GO:0003231)	126	18	7.40	+	2.43	1.31E-03	2.54E-02
GO:0030029	actin filament-based process (GO:0030029)	611	87	35.88	+	2.42	1.41E-12	2.06E-10
GO:0045765	regulation of angiogenesis (GO:0045765)	288	41	16.91	+	2.42	1.22E-06	5.48E-05
GO:0051129	negative regulation of cellular component organization (GO:0051129)	690	98	40.52	+	2.42	4.32E-14	7.69E-12
GO:0030900	forebrain development (GO:0030900)	388	55	22.78	+	2.41	2.20E-08	1.34E-06
GO:0032990	cell part morphogenesis (GO:0032990)	508	72	29.83	+	2.41	1.40E-10	1.39E-08
GO:0001704	formation of primary germ layer (GO:0001704)	120	17	7.05	+	2.41	1.94E-03	3.51E-02
GO:0002244	hematopoietic progenitor cell differentiation (GO:0002244)	106	15	6.22	+	2.41	3.85E-03	6.15E-02
GO:0072009	nephron epithelium development (GO:0072009)	106	15	6.22	+	2.41	3.85E-03	6.14E-02
GO:0043266	regulation of potassium ion transport (GO:0043266)	106	15	6.22	+	2.41	3.85E-03	6.13E-02
GO:0001503	ossification (GO:0001503)	290	41	17.03	+	2.41	1.39E-06	6.17E-05
GO:0007049	cell cycle (GO:0007049)	1249	176	73.34	+	2.40	1.69E-24	1.10E-21
GO:0032922	circadian regulation of gene expression (GO:0032922)	71	10	4.17	+	2.40	1.39E-02	1.62E-01
GO:0048729	tissue morphogenesis (GO:0048729)	568	80	33.35	+	2.40	1.95E-11	2.37E-09
GO:1903578	regulation of ATP metabolic process (GO:1903578)	71	10	4.17	+	2.40	1.39E-02	1.62E-01
GO:0060541	respiratory system development (GO:0060541)	206	29	12.10	+	2.40	6.79E-05	2.04E-03
GO:0007266	Rho protein signal transduction (GO:0007266)	64	9	3.76	+	2.39	1.93E-02	2.01E-01
GO:0099601	regulation of neurotransmitter receptor activity (GO:0099601)	64	9	3.76	+	2.39	1.93E-02	2.01E-01
GO:0008154	actin polymerization or depolymerization (GO:0008154)	64	9	3.76	+	2.39	1.93E-02	2.01E-01
GO:0001822	kidney development (GO:0001822)	299	42	17.56	+	2.39	1.80E-06	7.86E-05
GO:1901342	regulation of vasculature development (GO:1901342)	292	41	17.15	+	2.39	1.59E-06	7.02E-05
GO:0060675	ureteric bud morphogenesis (GO:0060675)	57	8	3.35	+	2.39	2.68E-02	2.53E-01
GO:2000045	regulation of G1/S transition of mitotic cell cycle (GO:2000045)	164	23	9.63	+	2.39	3.11E-04	7.33E-03
GO:0019722	calcium-mediated signaling (GO:0019722)	157	22	9.22	+	2.39	4.26E-04	9.61E-03
GO:0035295	tube development (GO:0035295)	885	124	51.97	+	2.39	5.04E-17	1.44E-14
GO:0045744	negative regulation of G protein-coupled receptor signaling pathway (GO:0045744)	50	7	2.94	+	2.38	3.74E-02	3.17E-01
GO:0051972	regulation of telomerase activity (GO:0051972)	50	7	2.94	+	2.38	3.74E-02	3.17E-01
GO:0048247	lymphocyte chemotaxis (GO:0048247)	50	7	2.94	+	2.38	3.74E-02	3.17E-01
GO:0001823	mesonephros development (GO:0001823)	93	13	5.46	+	2.38	8.13E-03	1.07E-01
GO:1901216	positive regulation of neuron death (GO:1901216)	93	13	5.46	+	2.38	8.13E-03	1.07E-01
GO:0030323	respiratory tube development (GO:0030323)	186	26	10.92	+	2.38	1.97E-04	4.98E-03
GO:2000758	positive regulation of peptidyl-lysine acetylation (GO:2000758)	43	6	2.52	+	2.38	5.27E-02	3.96E-01
GO:0045123	cellular extravasation (GO:0045123)	43	6	2.52	+	2.38	5.27E-02	3.96E-01
GO:0045058	T cell selection (GO:0045058)	43	6	2.52	+	2.38	5.27E-02	3.95E-01
GO:2000249	regulation of actin cytoskeleton reorganization (GO:2000249)	43	6	2.52	+	2.38	5.27E-02	3.95E-01
GO:0044380	protein localization to cytoskeleton (GO:0044380)	43	6	2.52	+	2.38	5.27E-02	3.95E-01
GO:0070527	platelet aggregation (GO:0070527)	43	6	2.52	+	2.38	5.27E-02	3.95E-01
GO:0051281	positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)	43	6	2.52	+	2.38	5.27E-02	3.95E-01
GO:0051155	positive regulation of striated muscle cell differentiation (GO:0051155)	43	6	2.52	+	2.38	5.27E-02	3.94E-01
GO:0009154	purine ribonucleotide catabolic process (GO:0009154)	43	6	2.52	+	2.38	5.27E-02	3.94E-01
GO:0010828	positive regulation of glucose transmembrane transport (GO:0010828)	43	6	2.52	+	2.38	5.27E-02	3.94E-01
GO:1902991	regulation of amyloid precursor protein catabolic process (GO:1902991)	43	6	2.52	+	2.38	5.27E-02	3.94E-01
GO:0007528	neuromuscular junction development (GO:0007528)	43	6	2.52	+	2.38	5.27E-02	3.94E-01
GO:0051321	meiotic cell cycle (GO:0051321)	251	35	14.74	+	2.37	1.11E-05	4.09E-04
GO:0007613	memory (GO:0007613)	122	17	7.16	+	2.37	2.16E-03	3.83E-02
GO:0048709	oligodendrocyte differentiation (GO:0048709)	79	11	4.64	+	2.37	1.68E-02	1.84E-01
GO:0046660	female sex differentiation (GO:0046660)	115	16	6.75	+	2.37	3.02E-03	5.06E-02
GO:0046189	phenol-containing compound biosynthetic process (GO:0046189)	36	5	2.11	+	2.37	7.49E-02	4.76E-01
GO:0045601	regulation of endothelial cell differentiation (GO:0045601)	36	5	2.11	+	2.37	7.49E-02	4.75E-01
GO:1902003	regulation of amyloid-beta formation (GO:1902003)	36	5	2.11	+	2.37	7.49E-02	4.75E-01
GO:1904707	positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)	36	5	2.11	+	2.37	7.49E-02	4.75E-01
GO:0043243	positive regulation of protein-containing complex disassembly (GO:0043243)	36	5	2.11	+	2.37	7.49E-02	4.75E-01
GO:0042596	fear response (GO:0042596)	36	5	2.11	+	2.37	7.49E-02	4.75E-01
GO:0046627	negative regulation of insulin receptor signaling pathway (GO:0046627)	36	5	2.11	+	2.37	7.49E-02	4.75E-01
GO:1904037	positive regulation of epithelial cell apoptotic process (GO:1904037)	36	5	2.11	+	2.37	7.49E-02	4.74E-01
GO:1903580	positive regulation of ATP metabolic process (GO:1903580)	36	5	2.11	+	2.37	7.49E-02	4.74E-01
GO:0051588	regulation of neurotransmitter transport (GO:0051588)	108	15	6.34	+	2.37	4.24E-03	6.63E-02
GO:0048667	cell morphogenesis involved in neuron differentiation (GO:0048667)	440	61	25.84	+	2.36	8.08E-09	5.37E-07
GO:0070167	regulation of biomineral tissue development (GO:0070167)	101	14	5.93	+	2.36	5.98E-03	8.60E-02
GO:0045682	regulation of epidermis development (GO:0045682)	65	9	3.82	+	2.36	2.09E-02	2.13E-01
GO:0045143	homologous chromosome segregation (GO:0045143)	65	9	3.82	+	2.36	2.09E-02	2.13E-01
GO:0021885	forebrain cell migration (GO:0021885)	65	9	3.82	+	2.36	2.09E-02	2.13E-01
GO:0051495	positive regulation of cytoskeleton organization (GO:0051495)	195	27	11.45	+	2.36	1.50E-04	3.98E-03
GO:0071695	anatomical structure maturation (GO:0071695)	217	30	12.74	+	2.35	5.83E-05	1.80E-03
GO:0007163	establishment or maintenance of cell polarity (GO:0007163)	210	29	12.33	+	2.35	8.08E-05	2.36E-03
GO:0045576	mast cell activation (GO:0045576)	29	4	1.70	+	2.35	1.08E-01	5.40E-01
GO:0007190	activation of adenylate cyclase activity (GO:0007190)	29	4	1.70	+	2.35	1.08E-01	5.40E-01
GO:0072171	mesonephric tubule morphogenesis (GO:0072171)	58	8	3.41	+	2.35	2.90E-02	2.63E-01
GO:0060037	pharyngeal system development (GO:0060037)	29	4	1.70	+	2.35	1.08E-01	5.40E-01
GO:0033280	response to vitamin D (GO:0033280)	29	4	1.70	+	2.35	1.08E-01	5.40E-01
GO:0051897	positive regulation of protein kinase B signaling (GO:0051897)	116	16	6.81	+	2.35	3.18E-03	5.26E-02
GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)	29	4	1.70	+	2.35	1.08E-01	5.39E-01
GO:0032148	activation of protein kinase B activity (GO:0032148)	29	4	1.70	+	2.35	1.08E-01	5.39E-01
GO:1901018	positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	29	4	1.70	+	2.35	1.08E-01	5.39E-01
GO:0036293	response to decreased oxygen levels (GO:0036293)	290	40	17.03	+	2.35	4.18E-06	1.73E-04
GO:0015865	purine nucleotide transport (GO:0015865)	29	4	1.70	+	2.35	1.08E-01	5.39E-01
GO:0062098	regulation of programmed necrotic cell death (GO:0062098)	29	4	1.70	+	2.35	1.08E-01	5.39E-01
GO:0010575	positive regulation of vascular endothelial growth factor production (GO:0010575)	29	4	1.70	+	2.35	1.08E-01	5.38E-01
GO:1902808	positive regulation of cell cycle G1/S phase transition (GO:1902808)	58	8	3.41	+	2.35	2.90E-02	2.63E-01
GO:0097305	response to alcohol (GO:0097305)	254	35	14.92	+	2.35	1.34E-05	4.84E-04
GO:0070588	calcium ion transmembrane transport (GO:0070588)	196	27	11.51	+	2.35	1.57E-04	4.09E-03
GO:0045766	positive regulation of angiogenesis (GO:0045766)	167	23	9.81	+	2.35	5.92E-04	1.29E-02
GO:1904018	positive regulation of vasculature development (GO:1904018)	167	23	9.81	+	2.35	5.92E-04	1.29E-02
GO:0110053	regulation of actin filament organization (GO:0110053)	276	38	16.21	+	2.34	8.19E-06	3.12E-04
GO:0043523	regulation of neuron apoptotic process (GO:0043523)	218	30	12.80	+	2.34	6.15E-05	1.89E-03
GO:0009612	response to mechanical stimulus (GO:0009612)	218	30	12.80	+	2.34	6.15E-05	1.88E-03
GO:0043242	negative regulation of protein-containing complex disassembly (GO:0043242)	80	11	4.70	+	2.34	1.73E-02	1.86E-01
GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)	51	7	2.99	+	2.34	4.06E-02	3.25E-01
GO:0002011	morphogenesis of an epithelial sheet (GO:0002011)	51	7	2.99	+	2.34	4.06E-02	3.25E-01
GO:0051726	regulation of cell cycle (GO:0051726)	1122	154	65.88	+	2.34	2.39E-20	1.21E-17
GO:0048771	tissue remodeling (GO:0048771)	102	14	5.99	+	2.34	6.27E-03	8.87E-02
GO:0001655	urogenital system development (GO:0001655)	350	48	20.55	+	2.34	3.96E-07	2.01E-05
GO:0043462	regulation of ATP-dependent activity (GO:0043462)	73	10	4.29	+	2.33	2.50E-02	2.45E-01
GO:0030218	erythrocyte differentiation (GO:0030218)	95	13	5.58	+	2.33	8.86E-03	1.15E-01
GO:0010959	regulation of metal ion transport (GO:0010959)	410	56	24.08	+	2.33	5.25E-08	3.05E-06
GO:0072359	circulatory system development (GO:0072359)	909	124	53.38	+	2.32	2.41E-16	6.41E-14
GO:0045624	positive regulation of T-helper cell differentiation (GO:0045624)	22	3	1.29	+	2.32	1.59E-01	6.62E-01
GO:0006883	cellular sodium ion homeostasis (GO:0006883)	22	3	1.29	+	2.32	1.59E-01	6.62E-01
GO:0001657	ureteric bud development (GO:0001657)	88	12	5.17	+	2.32	1.26E-02	1.51E-01
GO:0014075	response to amine (GO:0014075)	44	6	2.58	+	2.32	5.72E-02	4.03E-01
GO:1905709	negative regulation of membrane permeability (GO:1905709)	22	3	1.29	+	2.32	1.59E-01	6.62E-01
GO:0090189	regulation of branching involved in ureteric bud morphogenesis (GO:0090189)	22	3	1.29	+	2.32	1.59E-01	6.61E-01
GO:1901017	negative regulation of potassium ion transmembrane transporter activity (GO:1901017)	22	3	1.29	+	2.32	1.59E-01	6.61E-01
GO:0035855	megakaryocyte development (GO:0035855)	22	3	1.29	+	2.32	1.59E-01	6.61E-01
GO:0086011	membrane repolarization during action potential (GO:0086011)	22	3	1.29	+	2.32	1.59E-01	6.61E-01
GO:0060713	labyrinthine layer morphogenesis (GO:0060713)	22	3	1.29	+	2.32	1.59E-01	6.61E-01
GO:0097164	ammonium ion metabolic process (GO:0097164)	22	3	1.29	+	2.32	1.59E-01	6.60E-01
GO:1902905	positive regulation of supramolecular fiber organization (GO:1902905)	176	24	10.33	+	2.32	4.47E-04	9.99E-03
GO:0002262	myeloid cell homeostasis (GO:0002262)	132	18	7.75	+	2.32	1.86E-03	3.41E-02
GO:0043467	regulation of generation of precursor metabolites and energy (GO:0043467)	132	18	7.75	+	2.32	1.86E-03	3.40E-02
GO:0051962	positive regulation of nervous system development (GO:0051962)	279	38	16.38	+	2.32	9.13E-06	3.43E-04
GO:0048511	rhythmic process (GO:0048511)	272	37	15.97	+	2.32	1.27E-05	4.60E-04
GO:0110149	regulation of biomineralization (GO:0110149)	103	14	6.05	+	2.31	6.59E-03	9.25E-02
GO:1901654	response to ketone (GO:1901654)	206	28	12.10	+	2.31	1.30E-04	3.57E-03
GO:0007492	endoderm development (GO:0007492)	81	11	4.76	+	2.31	1.80E-02	1.91E-01
GO:1903034	regulation of response to wounding (GO:1903034)	162	22	9.51	+	2.31	8.86E-04	1.82E-02
GO:0044773	mitotic DNA damage checkpoint signaling (GO:0044773)	81	11	4.76	+	2.31	1.80E-02	1.91E-01
GO:0014032	neural crest cell development (GO:0014032)	81	11	4.76	+	2.31	1.80E-02	1.91E-01
GO:1902903	regulation of supramolecular fiber organization (GO:1902903)	383	52	22.49	+	2.31	2.00E-07	1.07E-05
GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	118	16	6.93	+	2.31	3.57E-03	5.73E-02
GO:0008543	fibroblast growth factor receptor signaling pathway (GO:0008543)	59	8	3.46	+	2.31	3.14E-02	2.79E-01
GO:1902806	regulation of cell cycle G1/S phase transition (GO:1902806)	192	26	11.27	+	2.31	2.50E-04	6.05E-03
GO:0045762	positive regulation of adenylate cyclase activity (GO:0045762)	37	5	2.17	+	2.30	8.13E-02	5.08E-01
GO:0060428	lung epithelium development (GO:0060428)	37	5	2.17	+	2.30	8.13E-02	5.08E-01
GO:0021537	telencephalon development (GO:0021537)	259	35	15.21	+	2.30	2.57E-05	8.60E-04
GO:0032506	cytokinetic process (GO:0032506)	37	5	2.17	+	2.30	8.13E-02	5.08E-01
GO:0051693	actin filament capping (GO:0051693)	37	5	2.17	+	2.30	8.13E-02	5.07E-01
GO:0090218	positive regulation of lipid kinase activity (GO:0090218)	37	5	2.17	+	2.30	8.13E-02	5.07E-01
GO:0042401	cellular biogenic amine biosynthetic process (GO:0042401)	37	5	2.17	+	2.30	8.13E-02	5.07E-01
GO:0046320	regulation of fatty acid oxidation (GO:0046320)	37	5	2.17	+	2.30	8.13E-02	5.07E-01
GO:0003176	aortic valve development (GO:0003176)	37	5	2.17	+	2.30	8.13E-02	5.07E-01
GO:0070555	response to interleukin-1 (GO:0070555)	126	17	7.40	+	2.30	2.73E-03	4.64E-02
GO:0000904	cell morphogenesis involved in differentiation (GO:0000904)	556	75	32.65	+	2.30	4.69E-10	4.14E-08
GO:0042391	regulation of membrane potential (GO:0042391)	430	58	25.25	+	2.30	5.79E-08	3.34E-06
GO:0072164	mesonephric tubule development (GO:0072164)	89	12	5.23	+	2.30	1.31E-02	1.55E-01
GO:0072163	mesonephric epithelium development (GO:0072163)	89	12	5.23	+	2.30	1.31E-02	1.55E-01
GO:0006576	cellular biogenic amine metabolic process (GO:0006576)	89	12	5.23	+	2.30	1.31E-02	1.55E-01
GO:0044106	cellular amine metabolic process (GO:0044106)	89	12	5.23	+	2.30	1.31E-02	1.55E-01
GO:0034101	erythrocyte homeostasis (GO:0034101)	104	14	6.11	+	2.29	6.94E-03	9.61E-02
GO:0045597	positive regulation of cell differentiation (GO:0045597)	884	119	51.91	+	2.29	3.40E-15	7.40E-13
GO:0051209	release of sequestered calcium ion into cytosol (GO:0051209)	52	7	3.05	+	2.29	4.39E-02	3.45E-01
GO:0046638	positive regulation of alpha-beta T cell differentiation (GO:0046638)	52	7	3.05	+	2.29	4.39E-02	3.45E-01
GO:0007611	learning or memory (GO:0007611)	275	37	16.15	+	2.29	1.44E-05	5.10E-04
GO:0043270	positive regulation of ion transport (GO:0043270)	290	39	17.03	+	2.29	7.97E-06	3.05E-04
GO:0051926	negative regulation of calcium ion transport (GO:0051926)	67	9	3.93	+	2.29	3.74E-02	3.17E-01
GO:0048844	artery morphogenesis (GO:0048844)	67	9	3.93	+	2.29	3.74E-02	3.17E-01
GO:0048639	positive regulation of developmental growth (GO:0048639)	164	22	9.63	+	2.28	9.46E-04	1.92E-02
GO:0071870	cellular response to catecholamine stimulus (GO:0071870)	97	13	5.70	+	2.28	9.75E-03	1.24E-01
GO:0071868	cellular response to monoamine stimulus (GO:0071868)	97	13	5.70	+	2.28	9.75E-03	1.24E-01
GO:0006140	regulation of nucleotide metabolic process (GO:0006140)	97	13	5.70	+	2.28	9.75E-03	1.24E-01
GO:0030516	regulation of axon extension (GO:0030516)	97	13	5.70	+	2.28	9.75E-03	1.24E-01
GO:0030168	platelet activation (GO:0030168)	97	13	5.70	+	2.28	9.75E-03	1.24E-01
GO:0030010	establishment of cell polarity (GO:0030010)	127	17	7.46	+	2.28	2.90E-03	4.92E-02
GO:0030334	regulation of cell migration (GO:0030334)	929	124	54.55	+	2.27	9.74E-16	2.35E-13
GO:0030335	positive regulation of cell migration (GO:0030335)	532	71	31.24	+	2.27	2.07E-09	1.61E-07
GO:0045725	positive regulation of glycogen biosynthetic process (GO:0045725)	15	2	.88	+	2.27	2.43E-01	8.43E-01
GO:0072498	embryonic skeletal joint development (GO:0072498)	15	2	.88	+	2.27	2.43E-01	8.43E-01
GO:0046185	aldehyde catabolic process (GO:0046185)	15	2	.88	+	2.27	2.43E-01	8.43E-01
GO:0060413	atrial septum morphogenesis (GO:0060413)	15	2	.88	+	2.27	2.43E-01	8.43E-01
GO:0060389	pathway-restricted SMAD protein phosphorylation (GO:0060389)	15	2	.88	+	2.27	2.43E-01	8.43E-01
GO:0021554	optic nerve development (GO:0021554)	15	2	.88	+	2.27	2.43E-01	8.42E-01
GO:0001977	renal system process involved in regulation of blood volume (GO:0001977)	15	2	.88	+	2.27	2.43E-01	8.42E-01
GO:0007202	activation of phospholipase C activity (GO:0007202)	30	4	1.76	+	2.27	1.17E-01	5.79E-01
GO:0060211	regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)	15	2	.88	+	2.27	2.43E-01	8.42E-01
GO:0071786	endoplasmic reticulum tubular network organization (GO:0071786)	15	2	.88	+	2.27	2.43E-01	8.42E-01
GO:0001774	microglial cell activation (GO:0001774)	30	4	1.76	+	2.27	1.17E-01	5.79E-01
GO:0006582	melanin metabolic process (GO:0006582)	15	2	.88	+	2.27	2.43E-01	8.42E-01
GO:0051956	negative regulation of amino acid transport (GO:0051956)	15	2	.88	+	2.27	2.43E-01	8.42E-01
GO:0033173	calcineurin-NFAT signaling cascade (GO:0033173)	15	2	.88	+	2.27	2.43E-01	8.41E-01
GO:0033147	negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147)	15	2	.88	+	2.27	2.43E-01	8.41E-01
GO:0001504	neurotransmitter uptake (GO:0001504)	30	4	1.76	+	2.27	1.17E-01	5.79E-01
GO:0051785	positive regulation of nuclear division (GO:0051785)	60	8	3.52	+	2.27	5.45E-02	3.92E-01
GO:0070885	negative regulation of calcineurin-NFAT signaling cascade (GO:0070885)	15	2	.88	+	2.27	2.43E-01	8.41E-01
GO:0048935	peripheral nervous system neuron development (GO:0048935)	15	2	.88	+	2.27	2.43E-01	8.41E-01
GO:0048934	peripheral nervous system neuron differentiation (GO:0048934)	15	2	.88	+	2.27	2.43E-01	8.41E-01
GO:1901533	negative regulation of hematopoietic progenitor cell differentiation (GO:1901533)	15	2	.88	+	2.27	2.43E-01	8.40E-01
GO:0032387	negative regulation of intracellular transport (GO:0032387)	60	8	3.52	+	2.27	5.45E-02	3.92E-01
GO:0090140	regulation of mitochondrial fission (GO:0090140)	30	4	1.76	+	2.27	1.17E-01	5.79E-01
GO:0106057	negative regulation of calcineurin-mediated signaling (GO:0106057)	15	2	.88	+	2.27	2.43E-01	8.40E-01
GO:0051284	positive regulation of sequestering of calcium ion (GO:0051284)	15	2	.88	+	2.27	2.43E-01	8.40E-01
GO:0070365	hepatocyte differentiation (GO:0070365)	15	2	.88	+	2.27	2.43E-01	8.40E-01
GO:0044065	regulation of respiratory system process (GO:0044065)	15	2	.88	+	2.27	2.43E-01	8.40E-01
GO:0070296	sarcoplasmic reticulum calcium ion transport (GO:0070296)	15	2	.88	+	2.27	2.43E-01	8.39E-01
GO:0070207	protein homotrimerization (GO:0070207)	15	2	.88	+	2.27	2.43E-01	8.39E-01
GO:0048311	mitochondrion distribution (GO:0048311)	15	2	.88	+	2.27	2.43E-01	8.39E-01
GO:0030947	regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)	30	4	1.76	+	2.27	1.17E-01	5.79E-01
GO:0030865	cortical cytoskeleton organization (GO:0030865)	60	8	3.52	+	2.27	5.45E-02	3.91E-01
GO:0042772	DNA damage response, signal transduction resulting in transcription (GO:0042772)	15	2	.88	+	2.27	2.43E-01	8.39E-01
GO:0016446	somatic hypermutation of immunoglobulin genes (GO:0016446)	15	2	.88	+	2.27	2.43E-01	8.39E-01
GO:0061744	motor behavior (GO:0061744)	15	2	.88	+	2.27	2.43E-01	8.39E-01
GO:0042417	dopamine metabolic process (GO:0042417)	30	4	1.76	+	2.27	1.17E-01	5.78E-01
GO:0010818	T cell chemotaxis (GO:0010818)	15	2	.88	+	2.27	2.43E-01	8.38E-01
GO:0034766	negative regulation of ion transmembrane transport (GO:0034766)	105	14	6.17	+	2.27	7.32E-03	1.01E-01
GO:0010669	epithelial structure maintenance (GO:0010669)	30	4	1.76	+	2.27	1.17E-01	5.78E-01
GO:0030219	megakaryocyte differentiation (GO:0030219)	30	4	1.76	+	2.27	1.17E-01	5.78E-01
GO:0030204	chondroitin sulfate metabolic process (GO:0030204)	30	4	1.76	+	2.27	1.17E-01	5.78E-01
GO:0060766	negative regulation of androgen receptor signaling pathway (GO:0060766)	15	2	.88	+	2.27	2.43E-01	8.38E-01
GO:0045987	positive regulation of smooth muscle contraction (GO:0045987)	30	4	1.76	+	2.27	1.17E-01	5.78E-01
GO:0008045	motor neuron axon guidance (GO:0008045)	30	4	1.76	+	2.27	1.17E-01	5.77E-01
GO:0021819	layer formation in cerebral cortex (GO:0021819)	15	2	.88	+	2.27	2.43E-01	8.38E-01
GO:0060425	lung morphogenesis (GO:0060425)	45	6	2.64	+	2.27	6.19E-02	4.26E-01
GO:0045598	regulation of fat cell differentiation (GO:0045598)	135	18	7.93	+	2.27	2.25E-03	3.97E-02
GO:0007098	centrosome cycle (GO:0007098)	90	12	5.28	+	2.27	1.38E-02	1.60E-01
GO:0051955	regulation of amino acid transport (GO:0051955)	45	6	2.64	+	2.27	6.19E-02	4.26E-01
GO:0016126	sterol biosynthetic process (GO:0016126)	45	6	2.64	+	2.27	6.19E-02	4.26E-01
GO:0045840	positive regulation of mitotic nuclear division (GO:0045840)	45	6	2.64	+	2.27	6.19E-02	4.26E-01
GO:0000902	cell morphogenesis (GO:0000902)	713	95	41.87	+	2.27	3.40E-12	4.68E-10
GO:0006302	double-strand break repair (GO:0006302)	203	27	11.92	+	2.27	2.23E-04	5.48E-03
GO:0071900	regulation of protein serine/threonine kinase activity (GO:0071900)	391	52	22.96	+	2.26	3.08E-07	1.58E-05
GO:0007596	blood coagulation (GO:0007596)	173	23	10.16	+	2.26	7.33E-04	1.55E-02
GO:0033135	regulation of peptidyl-serine phosphorylation (GO:0033135)	143	19	8.40	+	2.26	2.64E-03	4.52E-02
GO:0031333	negative regulation of protein-containing complex assembly (GO:0031333)	143	19	8.40	+	2.26	2.64E-03	4.52E-02
GO:0021761	limbic system development (GO:0021761)	113	15	6.64	+	2.26	5.56E-03	8.15E-02
GO:1904035	regulation of epithelial cell apoptotic process (GO:1904035)	98	13	5.75	+	2.26	1.03E-02	1.29E-01
GO:0010975	regulation of neuron projection development (GO:0010975)	445	59	26.13	+	2.26	5.82E-08	3.35E-06
GO:0051924	regulation of calcium ion transport (GO:0051924)	264	35	15.50	+	2.26	3.16E-05	1.04E-03
GO:0010770	positive regulation of cell morphogenesis involved in differentiation (GO:0010770)	83	11	4.87	+	2.26	1.95E-02	2.03E-01
GO:0030888	regulation of B cell proliferation (GO:0030888)	68	9	3.99	+	2.25	3.86E-02	3.23E-01
GO:0007155	cell adhesion (GO:0007155)	969	128	56.90	+	2.25	6.57E-16	1.64E-13
GO:1901985	positive regulation of protein acetylation (GO:1901985)	53	7	3.11	+	2.25	4.75E-02	3.63E-01
GO:1901655	cellular response to ketone (GO:1901655)	106	14	6.22	+	2.25	7.73E-03	1.03E-01
GO:0051496	positive regulation of stress fiber assembly (GO:0051496)	53	7	3.11	+	2.25	4.75E-02	3.63E-01
GO:0030316	osteoclast differentiation (GO:0030316)	53	7	3.11	+	2.25	4.75E-02	3.62E-01
GO:0046580	negative regulation of Ras protein signal transduction (GO:0046580)	53	7	3.11	+	2.25	4.75E-02	3.62E-01
GO:0060562	epithelial tube morphogenesis (GO:0060562)	318	42	18.67	+	2.25	6.39E-06	2.52E-04
GO:0071901	negative regulation of protein serine/threonine kinase activity (GO:0071901)	114	15	6.69	+	2.24	5.89E-03	8.52E-02
GO:0051931	regulation of sensory perception (GO:0051931)	38	5	2.23	+	2.24	8.80E-02	5.22E-01
GO:0051930	regulation of sensory perception of pain (GO:0051930)	38	5	2.23	+	2.24	8.80E-02	5.22E-01
GO:0071260	cellular response to mechanical stimulus (GO:0071260)	76	10	4.46	+	2.24	2.78E-02	2.54E-01
GO:0032376	positive regulation of cholesterol transport (GO:0032376)	38	5	2.23	+	2.24	8.80E-02	5.22E-01
GO:0032373	positive regulation of sterol transport (GO:0032373)	38	5	2.23	+	2.24	8.80E-02	5.21E-01
GO:0032272	negative regulation of protein polymerization (GO:0032272)	76	10	4.46	+	2.24	2.78E-02	2.53E-01
GO:0031646	positive regulation of nervous system process (GO:0031646)	38	5	2.23	+	2.24	8.80E-02	5.21E-01
GO:0009309	amine biosynthetic process (GO:0009309)	38	5	2.23	+	2.24	8.80E-02	5.21E-01
GO:1900077	negative regulation of cellular response to insulin stimulus (GO:1900077)	38	5	2.23	+	2.24	8.80E-02	5.21E-01
GO:0003161	cardiac conduction system development (GO:0003161)	38	5	2.23	+	2.24	8.80E-02	5.21E-01
GO:0034762	regulation of transmembrane transport (GO:0034762)	593	78	34.82	+	2.24	5.53E-10	4.85E-08
GO:0050817	coagulation (GO:0050817)	175	23	10.28	+	2.24	8.03E-04	1.68E-02
GO:0034765	regulation of ion transmembrane transport (GO:0034765)	510	67	29.95	+	2.24	9.92E-09	6.40E-07
GO:0010035	response to inorganic substance (GO:0010035)	533	70	31.30	+	2.24	6.51E-09	4.44E-07
GO:0033043	regulation of organelle organization (GO:0033043)	1189	156	69.82	+	2.23	4.93E-19	2.03E-16
GO:0030036	actin cytoskeleton organization (GO:0030036)	549	72	32.24	+	2.23	3.54E-09	2.60E-07
GO:0050848	regulation of calcium-mediated signaling (GO:0050848)	84	11	4.93	+	2.23	2.04E-02	2.09E-01
GO:0048469	cell maturation (GO:0048469)	168	22	9.87	+	2.23	1.11E-03	2.21E-02
GO:0008283	cell population proliferation (GO:0008283)	718	94	42.16	+	2.23	1.20E-11	1.49E-09
GO:0043244	regulation of protein-containing complex disassembly (GO:0043244)	130	17	7.63	+	2.23	5.42E-03	7.99E-02
GO:0034763	negative regulation of transmembrane transport (GO:0034763)	130	17	7.63	+	2.23	5.42E-03	7.98E-02
GO:0061041	regulation of wound healing (GO:0061041)	130	17	7.63	+	2.23	5.42E-03	7.98E-02
GO:0048646	anatomical structure formation involved in morphogenesis (GO:0048646)	941	123	55.26	+	2.23	7.01E-15	1.39E-12
GO:0034599	cellular response to oxidative stress (GO:0034599)	222	29	13.04	+	2.22	2.23E-04	5.49E-03
GO:1905114	cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	383	50	22.49	+	2.22	1.09E-06	5.02E-05
GO:0060444	branching involved in mammary gland duct morphogenesis (GO:0060444)	23	3	1.35	+	2.22	1.73E-01	7.00E-01
GO:2000831	regulation of steroid hormone secretion (GO:2000831)	23	3	1.35	+	2.22	1.73E-01	7.00E-01
GO:2000647	negative regulation of stem cell proliferation (GO:2000647)	23	3	1.35	+	2.22	1.73E-01	6.99E-01
GO:1902254	negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)	23	3	1.35	+	2.22	1.73E-01	6.99E-01
GO:0002070	epithelial cell maturation (GO:0002070)	23	3	1.35	+	2.22	1.73E-01	6.99E-01
GO:0070886	positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)	23	3	1.35	+	2.22	1.73E-01	6.99E-01
GO:0106058	positive regulation of calcineurin-mediated signaling (GO:0106058)	23	3	1.35	+	2.22	1.73E-01	6.99E-01
GO:0098810	neurotransmitter reuptake (GO:0098810)	23	3	1.35	+	2.22	1.73E-01	6.98E-01
GO:0098719	sodium ion import across plasma membrane (GO:0098719)	23	3	1.35	+	2.22	1.73E-01	6.98E-01
GO:0031579	membrane raft organization (GO:0031579)	23	3	1.35	+	2.22	1.73E-01	6.98E-01
GO:0035902	response to immobilization stress (GO:0035902)	23	3	1.35	+	2.22	1.73E-01	6.98E-01
GO:1904996	positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996)	23	3	1.35	+	2.22	1.73E-01	6.98E-01
GO:0035518	histone H2A monoubiquitination (GO:0035518)	23	3	1.35	+	2.22	1.73E-01	6.98E-01
GO:0030517	negative regulation of axon extension (GO:0030517)	46	6	2.70	+	2.22	6.68E-02	4.49E-01
GO:0035162	embryonic hemopoiesis (GO:0035162)	23	3	1.35	+	2.22	1.73E-01	6.97E-01
GO:0010667	negative regulation of cardiac muscle cell apoptotic process (GO:0010667)	23	3	1.35	+	2.22	1.73E-01	6.97E-01
GO:0010623	programmed cell death involved in cell development (GO:0010623)	23	3	1.35	+	2.22	1.73E-01	6.97E-01
GO:0019835	cytolysis (GO:0019835)	23	3	1.35	+	2.22	1.73E-01	6.97E-01
GO:0046599	regulation of centriole replication (GO:0046599)	23	3	1.35	+	2.22	1.73E-01	6.97E-01
GO:0003283	atrial septum development (GO:0003283)	23	3	1.35	+	2.22	1.73E-01	6.97E-01
GO:0008217	regulation of blood pressure (GO:0008217)	192	25	11.27	+	2.22	4.96E-04	1.10E-02
GO:0006816	calcium ion transport (GO:0006816)	246	32	14.45	+	2.22	9.47E-05	2.68E-03
GO:0003073	regulation of systemic arterial blood pressure (GO:0003073)	100	13	5.87	+	2.21	1.14E-02	1.39E-01
GO:0071869	response to catecholamine (GO:0071869)	100	13	5.87	+	2.21	1.14E-02	1.39E-01
GO:0071867	response to monoamine (GO:0071867)	100	13	5.87	+	2.21	1.14E-02	1.38E-01
GO:0043279	response to alkaloid (GO:0043279)	100	13	5.87	+	2.21	1.14E-02	1.38E-01
GO:0061351	neural precursor cell proliferation (GO:0061351)	100	13	5.87	+	2.21	1.14E-02	1.38E-01
GO:0021543	pallium development (GO:0021543)	177	23	10.39	+	2.21	8.86E-04	1.82E-02
GO:2000756	regulation of peptidyl-lysine acetylation (GO:2000756)	77	10	4.52	+	2.21	2.90E-02	2.62E-01
GO:0005977	glycogen metabolic process (GO:0005977)	54	7	3.17	+	2.21	8.18E-02	5.09E-01
GO:0043392	negative regulation of DNA binding (GO:0043392)	54	7	3.17	+	2.21	8.18E-02	5.09E-01
GO:0016477	cell migration (GO:0016477)	903	117	53.02	+	2.21	6.02E-14	1.05E-11
GO:0010038	response to metal ion (GO:0010038)	363	47	21.32	+	2.20	2.99E-06	1.27E-04
GO:0055074	calcium ion homeostasis (GO:0055074)	224	29	13.15	+	2.20	2.39E-04	5.82E-03
GO:0021675	nerve development (GO:0021675)	85	11	4.99	+	2.20	2.13E-02	2.17E-01
GO:1903035	negative regulation of response to wounding (GO:1903035)	85	11	4.99	+	2.20	2.13E-02	2.17E-01
GO:0001656	metanephros development (GO:0001656)	85	11	4.99	+	2.20	2.13E-02	2.17E-01
GO:1901214	regulation of neuron death (GO:1901214)	325	42	19.08	+	2.20	8.61E-06	3.26E-04
GO:0007599	hemostasis (GO:0007599)	178	23	10.45	+	2.20	9.33E-04	1.90E-02
GO:0045648	positive regulation of erythrocyte differentiation (GO:0045648)	31	4	1.82	+	2.20	1.27E-01	6.07E-01
GO:0022029	telencephalon cell migration (GO:0022029)	62	8	3.64	+	2.20	5.77E-02	4.04E-01
GO:0010039	response to iron ion (GO:0010039)	31	4	1.82	+	2.20	1.27E-01	6.06E-01
GO:0051965	positive regulation of synapse assembly (GO:0051965)	62	8	3.64	+	2.20	5.77E-02	4.04E-01
GO:0001662	behavioral fear response (GO:0001662)	31	4	1.82	+	2.20	1.27E-01	6.06E-01
GO:0140467	integrated stress response signaling (GO:0140467)	31	4	1.82	+	2.20	1.27E-01	6.06E-01
GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)	31	4	1.82	+	2.20	1.27E-01	6.06E-01
GO:2000316	regulation of T-helper 17 type immune response (GO:2000316)	31	4	1.82	+	2.20	1.27E-01	6.06E-01
GO:2000147	positive regulation of cell motility (GO:2000147)	558	72	32.77	+	2.20	5.24E-09	3.62E-07
GO:0048741	skeletal muscle fiber development (GO:0048741)	31	4	1.82	+	2.20	1.27E-01	6.05E-01
GO:0051491	positive regulation of filopodium assembly (GO:0051491)	31	4	1.82	+	2.20	1.27E-01	6.05E-01
GO:0035590	purinergic nucleotide receptor signaling pathway (GO:0035590)	31	4	1.82	+	2.20	1.27E-01	6.05E-01
GO:0031069	hair follicle morphogenesis (GO:0031069)	31	4	1.82	+	2.20	1.27E-01	6.05E-01
GO:1900024	regulation of substrate adhesion-dependent cell spreading (GO:1900024)	62	8	3.64	+	2.20	5.77E-02	4.03E-01
GO:0042306	regulation of protein import into nucleus (GO:0042306)	62	8	3.64	+	2.20	5.77E-02	4.03E-01
GO:0060674	placenta blood vessel development (GO:0060674)	31	4	1.82	+	2.20	1.27E-01	6.05E-01
GO:0071322	cellular response to carbohydrate stimulus (GO:0071322)	93	12	5.46	+	2.20	1.59E-02	1.77E-01
GO:0040017	positive regulation of locomotion (GO:0040017)	574	74	33.71	+	2.20	4.48E-09	3.17E-07
GO:0051100	negative regulation of binding (GO:0051100)	163	21	9.57	+	2.19	1.69E-03	3.14E-02
GO:0045859	regulation of protein kinase activity (GO:0045859)	668	86	39.23	+	2.19	2.04E-10	1.95E-08
GO:0060284	regulation of cell development (GO:0060284)	513	66	30.12	+	2.19	3.07E-08	1.82E-06
GO:0050807	regulation of synapse organization (GO:0050807)	210	27	12.33	+	2.19	4.60E-04	1.02E-02
GO:0002009	morphogenesis of an epithelium (GO:0002009)	459	59	26.95	+	2.19	1.57E-07	8.56E-06
GO:0070482	response to oxygen levels (GO:0070482)	319	41	18.73	+	2.19	1.24E-05	4.51E-04
GO:0048640	negative regulation of developmental growth (GO:0048640)	109	14	6.40	+	2.19	9.16E-03	1.18E-01
GO:0045773	positive regulation of axon extension (GO:0045773)	39	5	2.29	+	2.18	9.50E-02	5.57E-01
GO:0071634	regulation of transforming growth factor beta production (GO:0071634)	39	5	2.29	+	2.18	9.50E-02	5.57E-01
GO:1902229	regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)	39	5	2.29	+	2.18	9.50E-02	5.56E-01
GO:0140253	cell-cell fusion (GO:0140253)	39	5	2.29	+	2.18	9.50E-02	5.56E-01
GO:0000768	syncytium formation by plasma membrane fusion (GO:0000768)	39	5	2.29	+	2.18	9.50E-02	5.56E-01
GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)	78	10	4.58	+	2.18	3.02E-02	2.72E-01
GO:0062197	cellular response to chemical stress (GO:0062197)	273	35	16.03	+	2.18	7.20E-05	2.15E-03
GO:0010923	negative regulation of phosphatase activity (GO:0010923)	39	5	2.29	+	2.18	9.50E-02	5.56E-01
GO:0035136	forelimb morphogenesis (GO:0035136)	39	5	2.29	+	2.18	9.50E-02	5.56E-01
GO:0030279	negative regulation of ossification (GO:0030279)	39	5	2.29	+	2.18	9.50E-02	5.55E-01
GO:0045920	negative regulation of exocytosis (GO:0045920)	39	5	2.29	+	2.18	9.50E-02	5.55E-01
GO:0045823	positive regulation of heart contraction (GO:0045823)	39	5	2.29	+	2.18	9.50E-02	5.55E-01
GO:2000278	regulation of DNA biosynthetic process (GO:2000278)	125	16	7.34	+	2.18	8.04E-03	1.06E-01
GO:0071363	cellular response to growth factor stimulus (GO:0071363)	477	61	28.01	+	2.18	1.52E-07	8.30E-06
GO:0010977	negative regulation of neuron projection development (GO:0010977)	141	18	8.28	+	2.17	4.34E-03	6.77E-02
GO:1902622	regulation of neutrophil migration (GO:1902622)	47	6	2.76	+	2.17	7.20E-02	4.67E-01
GO:1901861	regulation of muscle tissue development (GO:1901861)	47	6	2.76	+	2.17	7.20E-02	4.66E-01
GO:0043620	regulation of DNA-templated transcription in response to stress (GO:0043620)	47	6	2.76	+	2.17	7.20E-02	4.66E-01
GO:0048477	oogenesis (GO:0048477)	94	12	5.52	+	2.17	1.68E-02	1.84E-01
GO:0032091	negative regulation of protein binding (GO:0032091)	94	12	5.52	+	2.17	1.68E-02	1.84E-01
GO:1900544	positive regulation of purine nucleotide metabolic process (GO:1900544)	47	6	2.76	+	2.17	7.20E-02	4.66E-01
GO:0045981	positive regulation of nucleotide metabolic process (GO:0045981)	47	6	2.76	+	2.17	7.20E-02	4.66E-01
GO:0008284	positive regulation of cell population proliferation (GO:0008284)	949	121	55.73	+	2.17	4.83E-14	8.50E-12
GO:0010631	epithelial cell migration (GO:0010631)	102	13	5.99	+	2.17	1.27E-02	1.52E-01
GO:0001933	negative regulation of protein phosphorylation (GO:0001933)	322	41	18.91	+	2.17	1.44E-05	5.11E-04
GO:0006073	cellular glucan metabolic process (GO:0006073)	55	7	3.23	+	2.17	8.40E-02	5.19E-01
GO:0044042	glucan metabolic process (GO:0044042)	55	7	3.23	+	2.17	8.40E-02	5.18E-01
GO:0043525	positive regulation of neuron apoptotic process (GO:0043525)	55	7	3.23	+	2.17	8.40E-02	5.18E-01
GO:0031113	regulation of microtubule polymerization (GO:0031113)	55	7	3.23	+	2.17	8.40E-02	5.18E-01
GO:1904031	positive regulation of cyclin-dependent protein kinase activity (GO:1904031)	55	7	3.23	+	2.17	8.40E-02	5.18E-01
GO:0098609	cell-cell adhesion (GO:0098609)	543	69	31.89	+	2.16	2.56E-08	1.54E-06
GO:0031175	neuron projection development (GO:0031175)	677	86	39.75	+	2.16	4.54E-10	4.02E-08
GO:0060395	SMAD protein signal transduction (GO:0060395)	63	8	3.70	+	2.16	5.96E-02	4.15E-01
GO:0035825	homologous recombination (GO:0035825)	63	8	3.70	+	2.16	5.96E-02	4.15E-01
GO:0032886	regulation of microtubule-based process (GO:0032886)	260	33	15.27	+	2.16	1.42E-04	3.80E-03
GO:0022603	regulation of anatomical structure morphogenesis (GO:0022603)	924	117	54.26	+	2.16	2.01E-13	3.39E-11
GO:0031960	response to corticosteroid (GO:0031960)	166	21	9.75	+	2.15	1.95E-03	3.53E-02
GO:0071407	cellular response to organic cyclic compound (GO:0071407)	514	65	30.18	+	2.15	5.94E-08	3.40E-06
GO:0007568	aging (GO:0007568)	174	22	10.22	+	2.15	1.50E-03	2.83E-02
GO:2000145	regulation of cell motility (GO:2000145)	989	125	58.07	+	2.15	3.08E-14	5.75E-12
GO:0071478	cellular response to radiation (GO:0071478)	182	23	10.69	+	2.15	1.73E-03	3.21E-02
GO:0060840	artery development (GO:0060840)	95	12	5.58	+	2.15	1.77E-02	1.88E-01
GO:0071417	cellular response to organonitrogen compound (GO:0071417)	578	73	33.94	+	2.15	9.38E-09	6.11E-07
GO:0050773	regulation of dendrite development (GO:0050773)	103	13	6.05	+	2.15	1.34E-02	1.57E-01
GO:0000226	microtubule cytoskeleton organization (GO:0000226)	547	69	32.12	+	2.15	2.90E-08	1.72E-06
GO:0007507	heart development (GO:0007507)	555	70	32.59	+	2.15	2.20E-08	1.34E-06
GO:0051960	regulation of nervous system development (GO:0051960)	452	57	26.54	+	2.15	6.01E-07	2.93E-05
GO:0042326	negative regulation of phosphorylation (GO:0042326)	365	46	21.43	+	2.15	5.85E-06	2.32E-04
GO:0050767	regulation of neurogenesis (GO:0050767)	373	47	21.90	+	2.15	4.51E-06	1.84E-04
GO:0042770	signal transduction in response to DNA damage (GO:0042770)	135	17	7.93	+	2.14	6.28E-03	8.88E-02
GO:0031345	negative regulation of cell projection organization (GO:0031345)	191	24	11.22	+	2.14	1.31E-03	2.54E-02
GO:0009653	anatomical structure morphogenesis (GO:0009653)	2237	281	131.36	+	2.14	3.08E-32	6.91E-29
GO:0051094	positive regulation of developmental process (GO:0051094)	1339	168	78.63	+	2.14	9.37E-19	3.67E-16
GO:0060322	head development (GO:0060322)	823	103	48.33	+	2.13	1.14E-11	1.43E-09
GO:0045445	myoblast differentiation (GO:0045445)	40	5	2.35	+	2.13	1.02E-01	5.86E-01
GO:0007131	reciprocal meiotic recombination (GO:0007131)	56	7	3.29	+	2.13	8.64E-02	5.13E-01
GO:0140527	reciprocal homologous recombination (GO:0140527)	56	7	3.29	+	2.13	8.64E-02	5.13E-01
GO:0033273	response to vitamin (GO:0033273)	80	10	4.70	+	2.13	3.31E-02	2.88E-01
GO:0071392	cellular response to estradiol stimulus (GO:0071392)	40	5	2.35	+	2.13	1.02E-01	5.86E-01
GO:0050803	regulation of synapse structure or activity (GO:0050803)	216	27	12.68	+	2.13	5.79E-04	1.27E-02
GO:0044060	regulation of endocrine process (GO:0044060)	40	5	2.35	+	2.13	1.02E-01	5.86E-01
GO:0030834	regulation of actin filament depolymerization (GO:0030834)	56	7	3.29	+	2.13	8.64E-02	5.13E-01
GO:1904646	cellular response to amyloid-beta (GO:1904646)	40	5	2.35	+	2.13	1.02E-01	5.85E-01
GO:0008584	male gonad development (GO:0008584)	144	18	8.46	+	2.13	4.88E-03	7.43E-02
GO:0061333	renal tubule morphogenesis (GO:0061333)	72	9	4.23	+	2.13	4.48E-02	3.50E-01
GO:1903524	positive regulation of blood circulation (GO:1903524)	40	5	2.35	+	2.13	1.02E-01	5.85E-01
GO:0021987	cerebral cortex development (GO:0021987)	120	15	7.05	+	2.13	1.19E-02	1.44E-01
GO:0002634	regulation of germinal center formation (GO:0002634)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0045760	positive regulation of action potential (GO:0045760)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0010226	response to lithium ion (GO:0010226)	24	3	1.41	+	2.13	1.87E-01	7.35E-01
GO:1903286	regulation of potassium ion import (GO:1903286)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0045717	negative regulation of fatty acid biosynthetic process (GO:0045717)	16	2	.94	+	2.13	2.64E-01	8.53E-01
GO:1903223	positive regulation of oxidative stress-induced neuron death (GO:1903223)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0021707	cerebellar granule cell differentiation (GO:0021707)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0015014	heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0046184	aldehyde biosynthetic process (GO:0046184)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0060456	positive regulation of digestive system process (GO:0060456)	16	2	.94	+	2.13	2.64E-01	8.53E-01
GO:0006975	DNA damage induced protein phosphorylation (GO:0006975)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0034114	regulation of heterotypic cell-cell adhesion (GO:0034114)	24	3	1.41	+	2.13	1.87E-01	7.34E-01
GO:0002566	somatic diversification of immune receptors via somatic mutation (GO:0002566)	16	2	.94	+	2.13	2.64E-01	8.53E-01
GO:0034104	negative regulation of tissue remodeling (GO:0034104)	24	3	1.41	+	2.13	1.87E-01	7.34E-01
GO:0045684	positive regulation of epidermis development (GO:0045684)	32	4	1.88	+	2.13	1.37E-01	6.45E-01
GO:0045668	negative regulation of osteoblast differentiation (GO:0045668)	48	6	2.82	+	2.13	1.23E-01	5.90E-01
GO:0021684	cerebellar granular layer formation (GO:0021684)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0033601	positive regulation of mammary gland epithelial cell proliferation (GO:0033601)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0021612	facial nerve structural organization (GO:0021612)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0007315	pole plasm assembly (GO:0007315)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0007314	oocyte anterior/posterior axis specification (GO:0007314)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0072318	clathrin coat disassembly (GO:0072318)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0002486	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0006828	manganese ion transport (GO:0006828)	16	2	.94	+	2.13	2.64E-01	8.53E-01
GO:0006825	copper ion transport (GO:0006825)	16	2	.94	+	2.13	2.64E-01	8.52E-01
GO:0033561	regulation of water loss via skin (GO:0033561)	32	4	1.88	+	2.13	1.37E-01	6.44E-01
GO:1903071	positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0021553	olfactory nerve development (GO:0021553)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0021542	dentate gyrus development (GO:0021542)	16	2	.94	+	2.13	2.64E-01	8.52E-01
GO:0021535	cell migration in hindbrain (GO:0021535)	16	2	.94	+	2.13	2.64E-01	8.52E-01
GO:2000739	regulation of mesenchymal stem cell differentiation (GO:2000739)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:2001137	positive regulation of endocytic recycling (GO:2001137)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0007172	signal complex assembly (GO:0007172)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0072161	mesenchymal cell differentiation involved in kidney development (GO:0072161)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0060192	negative regulation of lipase activity (GO:0060192)	16	2	.94	+	2.13	2.64E-01	8.52E-01
GO:0001826	inner cell mass cell differentiation (GO:0001826)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:2000659	regulation of interleukin-1-mediated signaling pathway (GO:2000659)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0060158	phospholipase C-activating dopamine receptor signaling pathway (GO:0060158)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0006677	glycosylceramide metabolic process (GO:0006677)	16	2	.94	+	2.13	2.64E-01	8.52E-01
GO:1901984	negative regulation of protein acetylation (GO:1901984)	24	3	1.41	+	2.13	1.87E-01	7.34E-01
GO:0002209	behavioral defense response (GO:0002209)	32	4	1.88	+	2.13	1.37E-01	6.44E-01
GO:0045343	regulation of MHC class I biosynthetic process (GO:0045343)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:2001012	mesenchymal cell differentiation involved in renal system development (GO:2001012)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:2000586	regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0060099	regulation of phagocytosis, engulfment (GO:0060099)	16	2	.94	+	2.13	2.64E-01	8.52E-01
GO:0007028	cytoplasm organization (GO:0007028)	16	2	.94	+	2.13	2.64E-01	8.51E-01
GO:0007021	tubulin complex assembly (GO:0007021)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0060081	membrane hyperpolarization (GO:0060081)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:2000556	positive regulation of T-helper 1 cell cytokine production (GO:2000556)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:2000554	regulation of T-helper 1 cell cytokine production (GO:2000554)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0060050	positive regulation of protein glycosylation (GO:0060050)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0060022	hard palate development (GO:0060022)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:2000501	regulation of natural killer cell chemotaxis (GO:2000501)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0006553	lysine metabolic process (GO:0006553)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0051940	regulation of catecholamine uptake involved in synaptic transmission (GO:0051940)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0002118	aggressive behavior (GO:0002118)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0051901	positive regulation of mitochondrial depolarization (GO:0051901)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0001696	gastric acid secretion (GO:0001696)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0001659	temperature homeostasis (GO:0001659)	32	4	1.88	+	2.13	1.37E-01	6.44E-01
GO:0071472	cellular response to salt stress (GO:0071472)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0051893	regulation of focal adhesion assembly (GO:0051893)	64	8	3.76	+	2.13	6.17E-02	4.26E-01
GO:0014047	glutamate secretion (GO:0014047)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0045187	regulation of circadian sleep/wake cycle, sleep (GO:0045187)	16	2	.94	+	2.13	2.64E-01	8.51E-01
GO:0071425	hematopoietic stem cell proliferation (GO:0071425)	24	3	1.41	+	2.13	1.87E-01	7.34E-01
GO:0045144	meiotic sister chromatid segregation (GO:0045144)	16	2	.94	+	2.13	2.64E-01	8.51E-01
GO:0070973	protein localization to endoplasmic reticulum exit site (GO:0070973)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0070933	histone H4 deacetylation (GO:0070933)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0032682	negative regulation of chemokine production (GO:0032682)	24	3	1.41	+	2.13	1.87E-01	7.34E-01
GO:2000321	positive regulation of T-helper 17 cell differentiation (GO:2000321)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)	16	2	.94	+	2.13	2.64E-01	8.51E-01
GO:2000318	positive regulation of T-helper 17 type immune response (GO:2000318)	16	2	.94	+	2.13	2.64E-01	8.51E-01
GO:0075733	intracellular transport of virus (GO:0075733)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0070875	positive regulation of glycogen metabolic process (GO:0070875)	16	2	.94	+	2.13	2.64E-01	8.51E-01
GO:0070874	negative regulation of glycogen metabolic process (GO:0070874)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0033029	regulation of neutrophil apoptotic process (GO:0033029)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0070837	dehydroascorbic acid transport (GO:0070837)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0099645	neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0099633	protein localization to postsynaptic specialization membrane (GO:0099633)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	48	6	2.82	+	2.13	1.23E-01	5.90E-01
GO:0051683	establishment of Golgi localization (GO:0051683)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1905920	positive regulation of CoA-transferase activity (GO:1905920)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1905918	regulation of CoA-transferase activity (GO:1905918)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0090324	negative regulation of oxidative phosphorylation (GO:0090324)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0070734	histone H3-K27 methylation (GO:0070734)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0032493	response to bacterial lipoprotein (GO:0032493)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0032489	regulation of Cdc42 protein signal transduction (GO:0032489)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0140112	extracellular vesicle biogenesis (GO:0140112)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0006195	purine nucleotide catabolic process (GO:0006195)	48	6	2.82	+	2.13	1.23E-01	5.90E-01
GO:0040016	embryonic cleavage (GO:0040016)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0051584	regulation of dopamine uptake involved in synaptic transmission (GO:0051584)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0000820	regulation of glutamine family amino acid metabolic process (GO:0000820)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1990403	embryonic brain development (GO:1990403)	16	2	.94	+	2.13	2.64E-01	8.50E-01
GO:0090279	regulation of calcium ion import (GO:0090279)	32	4	1.88	+	2.13	1.37E-01	6.44E-01
GO:0070666	regulation of mast cell proliferation (GO:0070666)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:2000020	positive regulation of male gonad development (GO:2000020)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0044314	protein K27-linked ubiquitination (GO:0044314)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0032347	regulation of aldosterone biosynthetic process (GO:0032347)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0032344	regulation of aldosterone metabolic process (GO:0032344)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1901388	regulation of transforming growth factor beta activation (GO:1901388)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0070537	histone H2A K63-linked deubiquitination (GO:0070537)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0090109	regulation of cell-substrate junction assembly (GO:0090109)	64	8	3.76	+	2.13	6.17E-02	4.26E-01
GO:0032230	positive regulation of synaptic transmission, GABAergic (GO:0032230)	16	2	.94	+	2.13	2.64E-01	8.50E-01
GO:0009886	post-embryonic animal morphogenesis (GO:0009886)	16	2	.94	+	2.13	2.64E-01	8.50E-01
GO:1905603	regulation of blood-brain barrier permeability (GO:1905603)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0070474	positive regulation of uterine smooth muscle contraction (GO:0070474)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0050861	positive regulation of B cell receptor signaling pathway (GO:0050861)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1901163	regulation of trophoblast cell migration (GO:1901163)	16	2	.94	+	2.13	2.64E-01	8.50E-01
GO:0043576	regulation of respiratory gaseous exchange (GO:0043576)	24	3	1.41	+	2.13	1.87E-01	7.33E-01
GO:0051177	meiotic sister chromatid cohesion (GO:0051177)	16	2	.94	+	2.13	2.64E-01	8.50E-01
GO:0051151	negative regulation of smooth muscle cell differentiation (GO:0051151)	16	2	.94	+	2.13	2.64E-01	8.50E-01
GO:0051149	positive regulation of muscle cell differentiation (GO:0051149)	64	8	3.76	+	2.13	6.17E-02	4.25E-01
GO:0035912	dorsal aorta morphogenesis (GO:0035912)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0043517	positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)	16	2	.94	+	2.13	2.64E-01	8.49E-01
GO:0048385	regulation of retinoic acid receptor signaling pathway (GO:0048385)	16	2	.94	+	2.13	2.64E-01	8.49E-01
GO:0050651	dermatan sulfate proteoglycan biosynthetic process (GO:0050651)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0051045	negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1904861	excitatory synapse assembly (GO:1904861)	16	2	.94	+	2.13	2.64E-01	8.49E-01
GO:0070127	tRNA aminoacylation for mitochondrial protein translation (GO:0070127)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0009448	gamma-aminobutyric acid metabolic process (GO:0009448)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0009414	response to water deprivation (GO:0009414)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0030851	granulocyte differentiation (GO:0030851)	24	3	1.41	+	2.13	1.87E-01	7.33E-01
GO:1904714	regulation of chaperone-mediated autophagy (GO:1904714)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1905153	regulation of membrane invagination (GO:1905153)	16	2	.94	+	2.13	2.64E-01	8.49E-01
GO:1904628	cellular response to phorbol 13-acetate 12-myristate (GO:1904628)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1904627	response to phorbol 13-acetate 12-myristate (GO:1904627)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0016479	negative regulation of transcription by RNA polymerase I (GO:0016479)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0030719	P granule organization (GO:0030719)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0036006	cellular response to macrophage colony-stimulating factor stimulus (GO:0036006)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0000097	sulfur amino acid biosynthetic process (GO:0000097)	16	2	.94	+	2.13	2.64E-01	8.49E-01
GO:0015949	nucleobase-containing small molecule interconversion (GO:0015949)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0043129	surfactant homeostasis (GO:0043129)	16	2	.94	+	2.13	2.64E-01	8.48E-01
GO:0009265	2'-deoxyribonucleotide biosynthetic process (GO:0009265)	16	2	.94	+	2.13	2.64E-01	8.48E-01
GO:0009263	deoxyribonucleotide biosynthetic process (GO:0009263)	16	2	.94	+	2.13	2.64E-01	8.48E-01
GO:0009221	pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0061743	motor learning (GO:0061743)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0009191	ribonucleoside diphosphate catabolic process (GO:0009191)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0031077	post-embryonic camera-type eye development (GO:0031077)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0034983	peptidyl-lysine deacetylation (GO:0034983)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1904424	regulation of GTP binding (GO:1904424)	16	2	.94	+	2.13	2.64E-01	8.48E-01
GO:0030539	male genitalia development (GO:0030539)	24	3	1.41	+	2.13	1.87E-01	7.33E-01
GO:0010919	regulation of inositol phosphate biosynthetic process (GO:0010919)	16	2	.94	+	2.13	2.64E-01	8.48E-01
GO:0010912	positive regulation of isomerase activity (GO:0010912)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0010911	regulation of isomerase activity (GO:0010911)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1903980	positive regulation of microglial cell activation (GO:1903980)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0061647	histone H3-K9 modification (GO:0061647)	16	2	.94	+	2.13	2.64E-01	8.48E-01
GO:1904383	response to sodium phosphate (GO:1904383)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0010884	positive regulation of lipid storage (GO:0010884)	24	3	1.41	+	2.13	1.87E-01	7.33E-01
GO:0016114	terpenoid biosynthetic process (GO:0016114)	16	2	.94	+	2.13	2.64E-01	8.47E-01
GO:0010807	regulation of synaptic vesicle priming (GO:0010807)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0034773	histone H4-K20 trimethylation (GO:0034773)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0010728	regulation of hydrogen peroxide biosynthetic process (GO:0010728)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1903799	negative regulation of miRNA maturation (GO:1903799)	16	2	.94	+	2.13	2.64E-01	8.47E-01
GO:1903748	negative regulation of establishment of protein localization to mitochondrion (GO:1903748)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1903719	regulation of I-kappaB phosphorylation (GO:1903719)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0035115	embryonic forelimb morphogenesis (GO:0035115)	32	4	1.88	+	2.13	1.37E-01	6.44E-01
GO:0060986	endocrine hormone secretion (GO:0060986)	16	2	.94	+	2.13	2.64E-01	8.47E-01
GO:0060923	cardiac muscle cell fate commitment (GO:0060923)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0046621	negative regulation of organ growth (GO:0046621)	32	4	1.88	+	2.13	1.37E-01	6.43E-01
GO:1904139	regulation of microglial cell migration (GO:1904139)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1904117	cellular response to vasopressin (GO:1904117)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1904116	response to vasopressin (GO:1904116)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0008358	maternal determination of anterior/posterior axis, embryo (GO:0008358)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0010657	muscle cell apoptotic process (GO:0010657)	16	2	.94	+	2.13	2.64E-01	8.47E-01
GO:0010640	regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640)	24	3	1.41	+	2.13	1.87E-01	7.33E-01
GO:0010637	negative regulation of mitochondrial fusion (GO:0010637)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0010626	negative regulation of Schwann cell proliferation (GO:0010626)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1903689	regulation of wound healing, spreading of epidermal cells (GO:1903689)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1903659	regulation of complement-dependent cytotoxicity (GO:1903659)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0035024	negative regulation of Rho protein signal transduction (GO:0035024)	24	3	1.41	+	2.13	1.87E-01	7.32E-01
GO:0046597	negative regulation of viral entry into host cell (GO:0046597)	24	3	1.41	+	2.13	1.87E-01	7.32E-01
GO:0003433	chondrocyte development involved in endochondral bone morphogenesis (GO:0003433)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0003413	chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413)	16	2	.94	+	2.13	2.64E-01	8.47E-01
GO:0042182	ketone catabolic process (GO:0042182)	16	2	.94	+	2.13	2.64E-01	8.47E-01
GO:0010519	negative regulation of phospholipase activity (GO:0010519)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0003344	pericardium morphogenesis (GO:0003344)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0060740	prostate gland epithelium morphogenesis (GO:0060740)	24	3	1.41	+	2.13	1.87E-01	7.32E-01
GO:0046469	platelet activating factor metabolic process (GO:0046469)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0060706	cell differentiation involved in embryonic placenta development (GO:0060706)	24	3	1.41	+	2.13	1.87E-01	7.32E-01
GO:0097154	GABAergic neuron differentiation (GO:0097154)	16	2	.94	+	2.13	2.64E-01	8.46E-01
GO:0014850	response to muscle activity (GO:0014850)	24	3	1.41	+	2.13	1.87E-01	7.32E-01
GO:0002866	positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0014819	regulation of skeletal muscle contraction (GO:0014819)	16	2	.94	+	2.13	2.64E-01	8.46E-01
GO:0010455	positive regulation of cell fate commitment (GO:0010455)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0014808	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0045955	negative regulation of calcium ion-dependent exocytosis (GO:0045955)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0045933	positive regulation of muscle contraction (GO:0045933)	48	6	2.82	+	2.13	1.23E-01	5.90E-01
GO:1903423	positive regulation of synaptic vesicle recycling (GO:1903423)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0021932	hindbrain radial glia guided cell migration (GO:0021932)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0072683	T cell extravasation (GO:0072683)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0046385	deoxyribose phosphate biosynthetic process (GO:0046385)	16	2	.94	+	2.13	2.64E-01	8.46E-01
GO:0003223	ventricular compact myocardium morphogenesis (GO:0003223)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:1902961	positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0034374	low-density lipoprotein particle remodeling (GO:0034374)	16	2	.94	+	2.13	2.64E-01	8.46E-01
GO:0060600	dichotomous subdivision of an epithelial terminal unit (GO:0060600)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0045836	positive regulation of meiotic nuclear division (GO:0045836)	16	2	.94	+	2.13	2.64E-01	8.46E-01
GO:0072576	liver morphogenesis (GO:0072576)	8	1	.47	+	2.13	4.02E-01	1.00E00
GO:0050678	regulation of epithelial cell proliferation (GO:0050678)	369	46	21.67	+	2.12	1.03E-05	3.82E-04
GO:0051338	regulation of transferase activity (GO:0051338)	915	114	53.73	+	2.12	1.23E-12	1.82E-10
GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	193	24	11.33	+	2.12	1.39E-03	2.65E-02
GO:0007010	cytoskeleton organization (GO:0007010)	1240	154	72.81	+	2.11	9.29E-17	2.56E-14
GO:0046546	development of primary male sexual characteristics (GO:0046546)	145	18	8.51	+	2.11	5.10E-03	7.60E-02
GO:0001932	regulation of protein phosphorylation (GO:0001932)	1105	137	64.89	+	2.11	6.40E-15	1.30E-12
GO:0007420	brain development (GO:0007420)	775	96	45.51	+	2.11	1.09E-10	1.11E-08
GO:0071773	cellular response to BMP stimulus (GO:0071773)	105	13	6.17	+	2.11	1.50E-02	1.73E-01
GO:0071772	response to BMP (GO:0071772)	105	13	6.17	+	2.11	1.50E-02	1.73E-01
GO:1901890	positive regulation of cell junction assembly (GO:1901890)	105	13	6.17	+	2.11	1.50E-02	1.73E-01
GO:0090132	epithelium migration (GO:0090132)	105	13	6.17	+	2.11	1.50E-02	1.73E-01
GO:0000077	DNA damage checkpoint signaling (GO:0000077)	105	13	6.17	+	2.11	1.50E-02	1.73E-01
GO:0040012	regulation of locomotion (GO:0040012)	1034	128	60.72	+	2.11	6.12E-14	1.05E-11
GO:0071495	cellular response to endogenous stimulus (GO:0071495)	1107	137	65.00	+	2.11	6.91E-15	1.39E-12
GO:0051347	positive regulation of transferase activity (GO:0051347)	590	73	34.65	+	2.11	2.12E-08	1.30E-06
GO:0048167	regulation of synaptic plasticity (GO:0048167)	194	24	11.39	+	2.11	1.44E-03	2.74E-02
GO:1901983	regulation of protein acetylation (GO:1901983)	89	11	5.23	+	2.10	2.60E-02	2.50E-01
GO:1903510	mucopolysaccharide metabolic process (GO:1903510)	89	11	5.23	+	2.10	2.60E-02	2.50E-01
GO:0001558	regulation of cell growth (GO:0001558)	429	53	25.19	+	2.10	2.46E-06	1.05E-04
GO:0003281	ventricular septum development (GO:0003281)	73	9	4.29	+	2.10	4.68E-02	3.64E-01
GO:0060326	cell chemotaxis (GO:0060326)	211	26	12.39	+	2.10	8.65E-04	1.78E-02
GO:0007623	circadian rhythm (GO:0007623)	138	17	8.10	+	2.10	7.05E-03	9.74E-02
GO:0044703	multi-organism reproductive process (GO:0044703)	195	24	11.45	+	2.10	1.50E-03	2.83E-02
GO:0050890	cognition (GO:0050890)	317	39	18.61	+	2.10	5.38E-05	1.67E-03
GO:0010001	glial cell differentiation (GO:0010001)	187	23	10.98	+	2.09	1.99E-03	3.59E-02
GO:0050808	synapse organization (GO:0050808)	301	37	17.67	+	2.09	9.48E-05	2.68E-03
GO:2000026	regulation of multicellular organismal development (GO:2000026)	1383	170	81.21	+	2.09	4.48E-18	1.63E-15
GO:0021545	cranial nerve development (GO:0021545)	57	7	3.35	+	2.09	8.91E-02	5.27E-01
GO:0051438	regulation of ubiquitin-protein transferase activity (GO:0051438)	57	7	3.35	+	2.09	8.91E-02	5.27E-01
GO:0022612	gland morphogenesis (GO:0022612)	106	13	6.22	+	2.09	2.36E-02	2.34E-01
GO:0050730	regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	261	32	15.33	+	2.09	2.56E-04	6.18E-03
GO:0042325	regulation of phosphorylation (GO:0042325)	1248	153	73.28	+	2.09	3.24E-16	8.46E-14
GO:0043271	negative regulation of ion transport (GO:0043271)	155	19	9.10	+	2.09	4.26E-03	6.66E-02
GO:0008360	regulation of cell shape (GO:0008360)	155	19	9.10	+	2.09	4.26E-03	6.65E-02
GO:0042127	regulation of cell population proliferation (GO:0042127)	1674	205	98.30	+	2.09	8.20E-22	4.59E-19
GO:0006874	cellular calcium ion homeostasis (GO:0006874)	196	24	11.51	+	2.09	1.56E-03	2.92E-02
GO:2001222	regulation of neuron migration (GO:2001222)	49	6	2.88	+	2.09	1.26E-01	6.04E-01
GO:0032873	negative regulation of stress-activated MAPK cascade (GO:0032873)	49	6	2.88	+	2.09	1.26E-01	6.04E-01
GO:0031644	regulation of nervous system process (GO:0031644)	147	18	8.63	+	2.09	5.57E-03	8.17E-02
GO:0120162	positive regulation of cold-induced thermogenesis (GO:0120162)	98	12	5.75	+	2.09	2.07E-02	2.12E-01
GO:0070303	negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)	49	6	2.88	+	2.09	1.26E-01	6.04E-01
GO:0008277	regulation of G protein-coupled receptor signaling pathway (GO:0008277)	139	17	8.16	+	2.08	7.35E-03	1.01E-01
GO:0070848	response to growth factor (GO:0070848)	507	62	29.77	+	2.08	3.67E-07	1.87E-05
GO:0060993	kidney morphogenesis (GO:0060993)	90	11	5.28	+	2.08	2.73E-02	2.56E-01
GO:0019098	reproductive behavior (GO:0019098)	41	5	2.41	+	2.08	1.10E-01	5.47E-01
GO:1905314	semi-lunar valve development (GO:1905314)	41	5	2.41	+	2.08	1.10E-01	5.47E-01
GO:0017158	regulation of calcium ion-dependent exocytosis (GO:0017158)	41	5	2.41	+	2.08	1.10E-01	5.47E-01
GO:0036297	interstrand cross-link repair (GO:0036297)	41	5	2.41	+	2.08	1.10E-01	5.46E-01
GO:0030835	negative regulation of actin filament depolymerization (GO:0030835)	41	5	2.41	+	2.08	1.10E-01	5.46E-01
GO:0031018	endocrine pancreas development (GO:0031018)	41	5	2.41	+	2.08	1.10E-01	5.46E-01
GO:0042398	cellular modified amino acid biosynthetic process (GO:0042398)	41	5	2.41	+	2.08	1.10E-01	5.46E-01
GO:0030902	hindbrain development (GO:0030902)	156	19	9.16	+	2.07	4.47E-03	6.94E-02
GO:0009888	tissue development (GO:0009888)	1726	210	101.35	+	2.07	5.63E-22	3.27E-19
GO:1904888	cranial skeletal system development (GO:1904888)	74	9	4.35	+	2.07	4.88E-02	3.71E-01
GO:0003279	cardiac septum development (GO:0003279)	107	13	6.28	+	2.07	2.42E-02	2.38E-01
GO:0050680	negative regulation of epithelial cell proliferation (GO:0050680)	140	17	8.22	+	2.07	7.67E-03	1.04E-01
GO:0043549	regulation of kinase activity (GO:0043549)	783	95	45.98	+	2.07	3.67E-10	3.31E-08
GO:0042060	wound healing (GO:0042060)	338	41	19.85	+	2.07	5.55E-05	1.72E-03
GO:0002269	leukocyte activation involved in inflammatory response (GO:0002269)	33	4	1.94	+	2.06	1.47E-01	6.72E-01
GO:0071347	cellular response to interleukin-1 (GO:0071347)	99	12	5.81	+	2.06	3.33E-02	2.90E-01
GO:0099587	inorganic ion import across plasma membrane (GO:0099587)	99	12	5.81	+	2.06	3.33E-02	2.90E-01
GO:0048814	regulation of dendrite morphogenesis (GO:0048814)	66	8	3.88	+	2.06	6.66E-02	4.50E-01
GO:0098659	inorganic cation import across plasma membrane (GO:0098659)	99	12	5.81	+	2.06	3.33E-02	2.90E-01
GO:0042558	pteridine-containing compound metabolic process (GO:0042558)	33	4	1.94	+	2.06	1.47E-01	6.72E-01
GO:0010574	regulation of vascular endothelial growth factor production (GO:0010574)	33	4	1.94	+	2.06	1.47E-01	6.71E-01
GO:0042044	fluid transport (GO:0042044)	33	4	1.94	+	2.06	1.47E-01	6.71E-01
GO:0002828	regulation of type 2 immune response (GO:0002828)	33	4	1.94	+	2.06	1.47E-01	6.71E-01
GO:0060603	mammary gland duct morphogenesis (GO:0060603)	33	4	1.94	+	2.06	1.47E-01	6.71E-01
GO:0034260	negative regulation of GTPase activity (GO:0034260)	33	4	1.94	+	2.06	1.47E-01	6.71E-01
GO:0090287	regulation of cellular response to growth factor stimulus (GO:0090287)	314	38	18.44	+	2.06	8.55E-05	2.47E-03
GO:0050728	negative regulation of inflammatory response (GO:0050728)	149	18	8.75	+	2.06	6.12E-03	8.74E-02
GO:0045761	regulation of adenylate cyclase activity (GO:0045761)	58	7	3.41	+	2.06	9.21E-02	5.42E-01
GO:0048168	regulation of neuronal synaptic plasticity (GO:0048168)	58	7	3.41	+	2.06	9.21E-02	5.41E-01
GO:0002685	regulation of leukocyte migration (GO:0002685)	232	28	13.62	+	2.06	8.65E-04	1.78E-02
GO:0048872	homeostasis of number of cells (GO:0048872)	257	31	15.09	+	2.05	3.94E-04	9.02E-03
GO:0008285	negative regulation of cell population proliferation (GO:0008285)	713	86	41.87	+	2.05	3.36E-09	2.48E-07
GO:0072080	nephron tubule development (GO:0072080)	83	10	4.87	+	2.05	3.81E-02	3.20E-01
GO:0035050	embryonic heart tube development (GO:0035050)	83	10	4.87	+	2.05	3.81E-02	3.20E-01
GO:0048638	regulation of developmental growth (GO:0048638)	324	39	19.03	+	2.05	1.05E-04	2.94E-03
GO:0033555	multicellular organismal response to stress (GO:0033555)	75	9	4.40	+	2.04	5.11E-02	3.86E-01
GO:0030595	leukocyte chemotaxis (GO:0030595)	150	18	8.81	+	2.04	6.42E-03	9.05E-02
GO:1903317	regulation of protein maturation (GO:1903317)	75	9	4.40	+	2.04	5.11E-02	3.86E-01
GO:0007405	neuroblast proliferation (GO:0007405)	50	6	2.94	+	2.04	1.30E-01	6.16E-01
GO:0046039	GTP metabolic process (GO:0046039)	25	3	1.47	+	2.04	2.01E-01	7.69E-01
GO:0002446	neutrophil mediated immunity (GO:0002446)	25	3	1.47	+	2.04	2.01E-01	7.69E-01
GO:2001258	negative regulation of cation channel activity (GO:2001258)	50	6	2.94	+	2.04	1.30E-01	6.16E-01
GO:2001238	positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	50	6	2.94	+	2.04	1.30E-01	6.16E-01
GO:0065004	protein-DNA complex assembly (GO:0065004)	200	24	11.74	+	2.04	1.84E-03	3.37E-02
GO:0002279	mast cell activation involved in immune response (GO:0002279)	25	3	1.47	+	2.04	2.01E-01	7.68E-01
GO:1901863	positive regulation of muscle tissue development (GO:1901863)	25	3	1.47	+	2.04	2.01E-01	7.68E-01
GO:2000351	regulation of endothelial cell apoptotic process (GO:2000351)	50	6	2.94	+	2.04	1.30E-01	6.16E-01
GO:0032331	negative regulation of chondrocyte differentiation (GO:0032331)	25	3	1.47	+	2.04	2.01E-01	7.68E-01
GO:0036473	cell death in response to oxidative stress (GO:0036473)	25	3	1.47	+	2.04	2.01E-01	7.68E-01
GO:0044030	regulation of DNA methylation (GO:0044030)	25	3	1.47	+	2.04	2.01E-01	7.68E-01
GO:0051043	regulation of membrane protein ectodomain proteolysis (GO:0051043)	25	3	1.47	+	2.04	2.01E-01	7.67E-01
GO:0070193	synaptonemal complex organization (GO:0070193)	25	3	1.47	+	2.04	2.01E-01	7.67E-01
GO:0043303	mast cell degranulation (GO:0043303)	25	3	1.47	+	2.04	2.01E-01	7.67E-01
GO:1900373	positive regulation of purine nucleotide biosynthetic process (GO:1900373)	25	3	1.47	+	2.04	2.01E-01	7.67E-01
GO:0030810	positive regulation of nucleotide biosynthetic process (GO:0030810)	25	3	1.47	+	2.04	2.01E-01	7.67E-01
GO:0031281	positive regulation of cyclase activity (GO:0031281)	50	6	2.94	+	2.04	1.30E-01	6.16E-01
GO:0009261	ribonucleotide catabolic process (GO:0009261)	50	6	2.94	+	2.04	1.30E-01	6.16E-01
GO:0031103	axon regeneration (GO:0031103)	25	3	1.47	+	2.04	2.01E-01	7.66E-01
GO:1900016	negative regulation of cytokine production involved in inflammatory response (GO:1900016)	25	3	1.47	+	2.04	2.01E-01	7.66E-01
GO:0010883	regulation of lipid storage (GO:0010883)	50	6	2.94	+	2.04	1.30E-01	6.15E-01
GO:0021884	forebrain neuron development (GO:0021884)	25	3	1.47	+	2.04	2.01E-01	7.66E-01
GO:0045807	positive regulation of endocytosis (GO:0045807)	100	12	5.87	+	2.04	3.40E-02	2.92E-01
GO:0006979	response to oxidative stress (GO:0006979)	367	44	21.55	+	2.04	2.85E-05	9.50E-04
GO:0046661	male sex differentiation (GO:0046661)	167	20	9.81	+	2.04	5.39E-03	7.99E-02
GO:0048545	response to steroid hormone (GO:0048545)	284	34	16.68	+	2.04	2.73E-04	6.56E-03
GO:0031346	positive regulation of cell projection organization (GO:0031346)	351	42	20.61	+	2.04	4.85E-05	1.52E-03
GO:0032273	positive regulation of protein polymerization (GO:0032273)	92	11	5.40	+	2.04	3.03E-02	2.72E-01
GO:0043393	regulation of protein binding (GO:0043393)	201	24	11.80	+	2.03	1.92E-03	3.50E-02
GO:0090066	regulation of anatomical structure size (GO:0090066)	511	61	30.01	+	2.03	1.03E-06	4.80E-05
GO:0070884	regulation of calcineurin-NFAT signaling cascade (GO:0070884)	42	5	2.47	+	2.03	1.86E-01	7.31E-01
GO:0019915	lipid storage (GO:0019915)	42	5	2.47	+	2.03	1.86E-01	7.31E-01
GO:0051258	protein polymerization (GO:0051258)	101	12	5.93	+	2.02	3.48E-02	2.98E-01
GO:0010769	regulation of cell morphogenesis involved in differentiation (GO:0010769)	101	12	5.93	+	2.02	3.48E-02	2.98E-01
GO:0042327	positive regulation of phosphorylation (GO:0042327)	826	98	48.50	+	2.02	6.13E-10	5.31E-08
GO:0050806	positive regulation of synaptic transmission (GO:0050806)	135	16	7.93	+	2.02	1.15E-02	1.40E-01
GO:0072507	divalent inorganic cation homeostasis (GO:0072507)	270	32	15.85	+	2.02	5.09E-04	1.12E-02
GO:0045860	positive regulation of protein kinase activity (GO:0045860)	422	50	24.78	+	2.02	1.45E-05	5.11E-04
GO:0050795	regulation of behavior (GO:0050795)	76	9	4.46	+	2.02	5.34E-02	3.96E-01
GO:0050766	positive regulation of phagocytosis (GO:0050766)	76	9	4.46	+	2.02	5.34E-02	3.96E-01
GO:0030856	regulation of epithelial cell differentiation (GO:0030856)	152	18	8.93	+	2.02	1.01E-02	1.27E-01
GO:0042509	regulation of tyrosine phosphorylation of STAT protein (GO:0042509)	76	9	4.46	+	2.02	5.34E-02	3.96E-01
GO:0007369	gastrulation (GO:0007369)	169	20	9.92	+	2.02	5.73E-03	8.37E-02
GO:0010594	regulation of endothelial cell migration (GO:0010594)	169	20	9.92	+	2.02	5.73E-03	8.36E-02
GO:0014070	response to organic cyclic compound (GO:0014070)	879	104	51.62	+	2.01	1.93E-10	1.87E-08
GO:0033138	positive regulation of peptidyl-serine phosphorylation (GO:0033138)	110	13	6.46	+	2.01	2.63E-02	2.52E-01
GO:0050729	positive regulation of inflammatory response (GO:0050729)	144	17	8.46	+	2.01	1.37E-02	1.59E-01
GO:0010632	regulation of epithelial cell migration (GO:0010632)	229	27	13.45	+	2.01	1.35E-03	2.58E-02
GO:0048468	cell development (GO:0048468)	1725	203	101.29	+	2.00	9.27E-20	4.04E-17
GO:2000846	regulation of corticosteroid hormone secretion (GO:2000846)	17	2	1.00	+	2.00	2.85E-01	9.01E-01
GO:0033599	regulation of mammary gland epithelial cell proliferation (GO:0033599)	17	2	1.00	+	2.00	2.85E-01	9.00E-01
GO:0019228	neuronal action potential (GO:0019228)	34	4	2.00	+	2.00	1.58E-01	6.59E-01
GO:0001934	positive regulation of protein phosphorylation (GO:0001934)	748	88	43.92	+	2.00	7.27E-09	4.89E-07
GO:0007204	positive regulation of cytosolic calcium ion concentration (GO:0007204)	204	24	11.98	+	2.00	3.06E-03	5.11E-02
GO:0071732	cellular response to nitric oxide (GO:0071732)	17	2	1.00	+	2.00	2.85E-01	9.00E-01
GO:2000696	regulation of epithelial cell differentiation involved in kidney development (GO:2000696)	17	2	1.00	+	2.00	2.85E-01	9.00E-01
GO:0007135	meiosis II (GO:0007135)	17	2	1.00	+	2.00	2.85E-01	9.00E-01
GO:0001779	natural killer cell differentiation (GO:0001779)	17	2	1.00	+	2.00	2.85E-01	9.00E-01
GO:0072078	nephron tubule morphogenesis (GO:0072078)	68	8	3.99	+	2.00	7.22E-02	4.66E-01
GO:0002062	chondrocyte differentiation (GO:0002062)	85	10	4.99	+	2.00	4.20E-02	3.33E-01
GO:0001574	ganglioside biosynthetic process (GO:0001574)	17	2	1.00	+	2.00	2.85E-01	8.99E-01
GO:0070873	regulation of glycogen metabolic process (GO:0070873)	34	4	2.00	+	2.00	1.58E-01	6.59E-01
GO:1905906	regulation of amyloid fibril formation (GO:1905906)	17	2	1.00	+	2.00	2.85E-01	8.99E-01
GO:0048857	neural nucleus development (GO:0048857)	68	8	3.99	+	2.00	7.22E-02	4.66E-01
GO:0006089	lactate metabolic process (GO:0006089)	17	2	1.00	+	2.00	2.85E-01	8.99E-01
GO:0090183	regulation of kidney development (GO:0090183)	34	4	2.00	+	2.00	1.58E-01	6.59E-01
GO:0070528	protein kinase C signaling (GO:0070528)	17	2	1.00	+	2.00	2.85E-01	8.99E-01
GO:0051349	positive regulation of lyase activity (GO:0051349)	51	6	2.99	+	2.00	1.33E-01	6.29E-01
GO:1901096	regulation of autophagosome maturation (GO:1901096)	17	2	1.00	+	2.00	2.85E-01	8.99E-01
GO:0031573	mitotic intra-S DNA damage checkpoint signaling (GO:0031573)	17	2	1.00	+	2.00	2.85E-01	8.99E-01
GO:0051044	positive regulation of membrane protein ectodomain proteolysis (GO:0051044)	17	2	1.00	+	2.00	2.85E-01	8.98E-01
GO:0043372	positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)	34	4	2.00	+	2.00	1.58E-01	6.58E-01
GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	34	4	2.00	+	2.00	1.58E-01	6.58E-01
GO:0048147	negative regulation of fibroblast proliferation (GO:0048147)	34	4	2.00	+	2.00	1.58E-01	6.58E-01
GO:0030852	regulation of granulocyte differentiation (GO:0030852)	17	2	1.00	+	2.00	2.85E-01	8.98E-01
GO:0061983	meiosis II cell cycle process (GO:0061983)	17	2	1.00	+	2.00	2.85E-01	8.98E-01
GO:0043217	myelin maintenance (GO:0043217)	17	2	1.00	+	2.00	2.85E-01	8.98E-01
GO:0042693	muscle cell fate commitment (GO:0042693)	17	2	1.00	+	2.00	2.85E-01	8.98E-01
GO:0016202	regulation of striated muscle tissue development (GO:0016202)	17	2	1.00	+	2.00	2.85E-01	8.97E-01
GO:0009084	glutamine family amino acid biosynthetic process (GO:0009084)	17	2	1.00	+	2.00	2.85E-01	8.97E-01
GO:0035308	negative regulation of protein dephosphorylation (GO:0035308)	34	4	2.00	+	2.00	1.58E-01	6.58E-01
GO:0008344	adult locomotory behavior (GO:0008344)	85	10	4.99	+	2.00	4.20E-02	3.33E-01
GO:0010566	regulation of ketone biosynthetic process (GO:0010566)	17	2	1.00	+	2.00	2.85E-01	8.97E-01
GO:0034405	response to fluid shear stress (GO:0034405)	34	4	2.00	+	2.00	1.58E-01	6.58E-01
GO:0045956	positive regulation of calcium ion-dependent exocytosis (GO:0045956)	17	2	1.00	+	2.00	2.85E-01	8.97E-01
GO:0061158	3'-UTR-mediated mRNA destabilization (GO:0061158)	17	2	1.00	+	2.00	2.85E-01	8.97E-01
GO:0021984	adenohypophysis development (GO:0021984)	17	2	1.00	+	2.00	2.85E-01	8.97E-01
GO:0072678	T cell migration (GO:0072678)	34	4	2.00	+	2.00	1.58E-01	6.57E-01
GO:0046321	positive regulation of fatty acid oxidation (GO:0046321)	17	2	1.00	+	2.00	2.85E-01	8.96E-01
GO:0031400	negative regulation of protein modification process (GO:0031400)	503	59	29.54	+	2.00	2.35E-06	1.01E-04
GO:0035556	intracellular signal transduction (GO:0035556)	1511	177	88.73	+	1.99	5.67E-17	1.59E-14
GO:0044706	multi-multicellular organism process (GO:0044706)	205	24	12.04	+	1.99	3.13E-03	5.22E-02
GO:0046928	regulation of neurotransmitter secretion (GO:0046928)	94	11	5.52	+	1.99	4.89E-02	3.72E-01
GO:1901699	cellular response to nitrogen compound (GO:1901699)	641	75	37.64	+	1.99	1.15E-07	6.45E-06
GO:0045137	development of primary sexual characteristics (GO:0045137)	231	27	13.56	+	1.99	1.45E-03	2.75E-02
GO:0070192	chromosome organization involved in meiotic cell cycle (GO:0070192)	77	9	4.52	+	1.99	5.59E-02	3.96E-01
GO:0031279	regulation of cyclase activity (GO:0031279)	77	9	4.52	+	1.99	5.59E-02	3.95E-01
GO:0019220	regulation of phosphate metabolic process (GO:0019220)	1404	164	82.44	+	1.99	1.13E-15	2.65E-13
GO:0051174	regulation of phosphorus metabolic process (GO:0051174)	1405	164	82.50	+	1.99	1.18E-15	2.72E-13
GO:0009719	response to endogenous stimulus (GO:0009719)	1371	160	80.51	+	1.99	3.44E-15	7.40E-13
GO:0034109	homotypic cell-cell adhesion (GO:0034109)	60	7	3.52	+	1.99	9.88E-02	5.71E-01
GO:0060135	maternal process involved in female pregnancy (GO:0060135)	60	7	3.52	+	1.99	9.88E-02	5.71E-01
GO:0090303	positive regulation of wound healing (GO:0090303)	60	7	3.52	+	1.99	9.88E-02	5.71E-01
GO:0042752	regulation of circadian rhythm (GO:0042752)	120	14	7.05	+	1.99	2.10E-02	2.13E-01
GO:0030199	collagen fibril organization (GO:0030199)	60	7	3.52	+	1.99	9.88E-02	5.71E-01
GO:0061098	positive regulation of protein tyrosine kinase activity (GO:0061098)	60	7	3.52	+	1.99	9.88E-02	5.71E-01
GO:0032870	cellular response to hormone stimulus (GO:0032870)	489	57	28.71	+	1.99	4.26E-06	1.76E-04
GO:0050804	modulation of chemical synaptic transmission (GO:0050804)	438	51	25.72	+	1.98	1.40E-05	4.99E-04
GO:0040008	regulation of growth (GO:0040008)	627	73	36.82	+	1.98	2.11E-07	1.12E-05
GO:0045595	regulation of cell differentiation (GO:0045595)	1581	184	92.84	+	1.98	2.30E-17	6.92E-15
GO:0009636	response to toxic substance (GO:0009636)	232	27	13.62	+	1.98	1.51E-03	2.84E-02
GO:0007015	actin filament organization (GO:0007015)	275	32	16.15	+	1.98	5.95E-04	1.29E-02
GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	275	32	16.15	+	1.98	5.95E-04	1.29E-02
GO:0010562	positive regulation of phosphorus metabolic process (GO:0010562)	911	106	53.49	+	1.98	2.65E-10	2.50E-08
GO:0045937	positive regulation of phosphate metabolic process (GO:0045937)	911	106	53.49	+	1.98	2.65E-10	2.49E-08
GO:0009611	response to wounding (GO:0009611)	447	52	26.25	+	1.98	1.59E-05	5.57E-04
GO:0051128	regulation of cellular component organization (GO:0051128)	2364	275	138.82	+	1.98	1.71E-26	1.41E-23
GO:0006949	syncytium formation (GO:0006949)	43	5	2.52	+	1.98	1.90E-01	7.43E-01
GO:0022008	neurogenesis (GO:0022008)	1290	150	75.75	+	1.98	4.21E-14	7.59E-12
GO:0001937	negative regulation of endothelial cell proliferation (GO:0001937)	43	5	2.52	+	1.98	1.90E-01	7.43E-01
GO:0045429	positive regulation of nitric oxide biosynthetic process (GO:0045429)	43	5	2.52	+	1.98	1.90E-01	7.43E-01
GO:0001892	embryonic placenta development (GO:0001892)	86	10	5.05	+	1.98	4.42E-02	3.47E-01
GO:2000516	positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)	43	5	2.52	+	1.98	1.90E-01	7.43E-01
GO:0106056	regulation of calcineurin-mediated signaling (GO:0106056)	43	5	2.52	+	1.98	1.90E-01	7.43E-01
GO:0008306	associative learning (GO:0008306)	86	10	5.05	+	1.98	4.42E-02	3.46E-01
GO:0097009	energy homeostasis (GO:0097009)	43	5	2.52	+	1.98	1.90E-01	7.42E-01
GO:0048666	neuron development (GO:0048666)	843	98	49.50	+	1.98	1.48E-09	1.20E-07
GO:0033674	positive regulation of kinase activity (GO:0033674)	499	58	29.30	+	1.98	4.98E-06	2.01E-04
GO:0099177	regulation of trans-synaptic signaling (GO:0099177)	439	51	25.78	+	1.98	1.45E-05	5.12E-04
GO:0045936	negative regulation of phosphate metabolic process (GO:0045936)	422	49	24.78	+	1.98	2.36E-05	7.96E-04
GO:0070613	regulation of protein processing (GO:0070613)	69	8	4.05	+	1.97	7.52E-02	4.76E-01
GO:0150116	regulation of cell-substrate junction organization (GO:0150116)	69	8	4.05	+	1.97	7.52E-02	4.75E-01
GO:0061045	negative regulation of wound healing (GO:0061045)	69	8	4.05	+	1.97	7.52E-02	4.75E-01
GO:0003143	embryonic heart tube morphogenesis (GO:0003143)	69	8	4.05	+	1.97	7.52E-02	4.75E-01
GO:0072503	cellular divalent inorganic cation homeostasis (GO:0072503)	233	27	13.68	+	1.97	1.57E-03	2.95E-02
GO:0010563	negative regulation of phosphorus metabolic process (GO:0010563)	423	49	24.84	+	1.97	2.44E-05	8.21E-04
GO:0008361	regulation of cell size (GO:0008361)	190	22	11.16	+	1.97	5.76E-03	8.40E-02
GO:0120035	regulation of plasma membrane bounded cell projection organization (GO:0120035)	640	74	37.58	+	1.97	2.74E-07	1.42E-05
GO:0050727	regulation of inflammatory response (GO:0050727)	372	43	21.84	+	1.97	8.00E-05	2.34E-03
GO:0097435	supramolecular fiber organization (GO:0097435)	580	67	34.06	+	1.97	7.95E-07	3.79E-05
GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	234	27	13.74	+	1.96	2.37E-03	4.14E-02
GO:0021695	cerebellar cortex development (GO:0021695)	52	6	3.05	+	1.96	1.38E-01	6.46E-01
GO:0060384	innervation (GO:0060384)	26	3	1.53	+	1.96	2.16E-01	7.70E-01
GO:1903077	negative regulation of protein localization to plasma membrane (GO:1903077)	26	3	1.53	+	1.96	2.16E-01	7.70E-01
GO:0045453	bone resorption (GO:0045453)	26	3	1.53	+	1.96	2.16E-01	7.69E-01
GO:2000679	positive regulation of transcription regulatory region DNA binding (GO:2000679)	26	3	1.53	+	1.96	2.16E-01	7.69E-01
GO:0071622	regulation of granulocyte chemotaxis (GO:0071622)	52	6	3.05	+	1.96	1.38E-01	6.46E-01
GO:0051873	killing by host of symbiont cells (GO:0051873)	26	3	1.53	+	1.96	2.16E-01	7.69E-01
GO:0048714	positive regulation of oligodendrocyte differentiation (GO:0048714)	26	3	1.53	+	1.96	2.16E-01	7.69E-01
GO:1904353	regulation of telomere capping (GO:1904353)	26	3	1.53	+	1.96	2.16E-01	7.69E-01
GO:0062009	secondary palate development (GO:0062009)	26	3	1.53	+	1.96	2.16E-01	7.68E-01
GO:0010804	negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804)	26	3	1.53	+	1.96	2.16E-01	7.68E-01
GO:0010664	negative regulation of striated muscle cell apoptotic process (GO:0010664)	26	3	1.53	+	1.96	2.16E-01	7.68E-01
GO:0010460	positive regulation of heart rate (GO:0010460)	26	3	1.53	+	1.96	2.16E-01	7.68E-01
GO:0060669	embryonic placenta morphogenesis (GO:0060669)	26	3	1.53	+	1.96	2.16E-01	7.68E-01
GO:1902993	positive regulation of amyloid precursor protein catabolic process (GO:1902993)	26	3	1.53	+	1.96	2.16E-01	7.68E-01
GO:1903306	negative regulation of regulated secretory pathway (GO:1903306)	26	3	1.53	+	1.96	2.16E-01	7.67E-01
GO:0060544	regulation of necroptotic process (GO:0060544)	26	3	1.53	+	1.96	2.16E-01	7.67E-01
GO:0060512	prostate gland morphogenesis (GO:0060512)	26	3	1.53	+	1.96	2.16E-01	7.67E-01
GO:0009880	embryonic pattern specification (GO:0009880)	78	9	4.58	+	1.96	5.86E-02	4.09E-01
GO:0002064	epithelial cell development (GO:0002064)	191	22	11.22	+	1.96	5.87E-03	8.52E-02
GO:0001936	regulation of endothelial cell proliferation (GO:0001936)	139	16	8.16	+	1.96	1.96E-02	2.04E-01
GO:0032526	response to retinoic acid (GO:0032526)	113	13	6.64	+	1.96	2.90E-02	2.62E-01
GO:0008406	gonad development (GO:0008406)	226	26	13.27	+	1.96	2.12E-03	3.79E-02
GO:0032410	negative regulation of transporter activity (GO:0032410)	87	10	5.11	+	1.96	6.87E-02	4.58E-01
GO:0061326	renal tubule development (GO:0061326)	87	10	5.11	+	1.96	6.87E-02	4.58E-01
GO:0032720	negative regulation of tumor necrosis factor production (GO:0032720)	61	7	3.58	+	1.95	1.03E-01	5.87E-01
GO:0050922	negative regulation of chemotaxis (GO:0050922)	61	7	3.58	+	1.95	1.03E-01	5.86E-01
GO:0030837	negative regulation of actin filament polymerization (GO:0030837)	61	7	3.58	+	1.95	1.03E-01	5.86E-01
GO:0046686	response to cadmium ion (GO:0046686)	61	7	3.58	+	1.95	1.03E-01	5.86E-01
GO:0044087	regulation of cellular component biogenesis (GO:0044087)	951	109	55.84	+	1.95	3.59E-10	3.25E-08
GO:0098657	import into cell (GO:0098657)	192	22	11.27	+	1.95	6.00E-03	8.62E-02
GO:0001501	skeletal system development (GO:0001501)	515	59	30.24	+	1.95	4.72E-06	1.92E-04
GO:0048568	embryonic organ development (GO:0048568)	454	52	26.66	+	1.95	1.88E-05	6.49E-04
GO:0030879	mammary gland development (GO:0030879)	131	15	7.69	+	1.95	1.80E-02	1.91E-01
GO:0032271	regulation of protein polymerization (GO:0032271)	201	23	11.80	+	1.95	4.63E-03	7.08E-02
GO:0007626	locomotory behavior (GO:0007626)	201	23	11.80	+	1.95	4.63E-03	7.07E-02
GO:0021696	cerebellar cortex morphogenesis (GO:0021696)	35	4	2.06	+	1.95	1.69E-01	6.89E-01
GO:0060251	regulation of glial cell proliferation (GO:0060251)	35	4	2.06	+	1.95	1.69E-01	6.88E-01
GO:0001893	maternal placenta development (GO:0001893)	35	4	2.06	+	1.95	1.69E-01	6.88E-01
GO:0002294	CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)	35	4	2.06	+	1.95	1.69E-01	6.88E-01
GO:0072088	nephron epithelium morphogenesis (GO:0072088)	70	8	4.11	+	1.95	7.85E-02	4.93E-01
GO:0071542	dopaminergic neuron differentiation (GO:0071542)	35	4	2.06	+	1.95	1.69E-01	6.88E-01
GO:0033238	regulation of cellular amine metabolic process (GO:0033238)	35	4	2.06	+	1.95	1.69E-01	6.88E-01
GO:0002065	columnar/cuboidal epithelial cell differentiation (GO:0002065)	105	12	6.17	+	1.95	3.88E-02	3.25E-01
GO:0018107	peptidyl-threonine phosphorylation (GO:0018107)	70	8	4.11	+	1.95	7.85E-02	4.93E-01
GO:0050654	chondroitin sulfate proteoglycan metabolic process (GO:0050654)	35	4	2.06	+	1.95	1.69E-01	6.87E-01
GO:0016242	negative regulation of macroautophagy (GO:0016242)	35	4	2.06	+	1.95	1.69E-01	6.87E-01
GO:0035137	hindlimb morphogenesis (GO:0035137)	35	4	2.06	+	1.95	1.69E-01	6.87E-01
GO:0030193	regulation of blood coagulation (GO:0030193)	70	8	4.11	+	1.95	7.85E-02	4.93E-01
GO:0042093	T-helper cell differentiation (GO:0042093)	35	4	2.06	+	1.95	1.69E-01	6.87E-01
GO:0010390	histone monoubiquitination (GO:0010390)	35	4	2.06	+	1.95	1.69E-01	6.87E-01
GO:0007417	central nervous system development (GO:0007417)	1034	118	60.72	+	1.94	8.12E-11	8.60E-09
GO:0051961	negative regulation of nervous system development (GO:0051961)	149	17	8.75	+	1.94	1.53E-02	1.71E-01
GO:0048870	cell motility (GO:0048870)	1061	121	62.30	+	1.94	5.60E-11	6.18E-09
GO:0071674	mononuclear cell migration (GO:0071674)	114	13	6.69	+	1.94	3.00E-02	2.71E-01
GO:0071331	cellular response to hexose stimulus (GO:0071331)	79	9	4.64	+	1.94	6.14E-02	4.24E-01
GO:0032413	negative regulation of ion transmembrane transporter activity (GO:0032413)	79	9	4.64	+	1.94	6.14E-02	4.24E-01
GO:0050770	regulation of axonogenesis (GO:0050770)	158	18	9.28	+	1.94	1.18E-02	1.43E-01
GO:0008064	regulation of actin polymerization or depolymerization (GO:0008064)	158	18	9.28	+	1.94	1.18E-02	1.43E-01
GO:0001709	cell fate determination (GO:0001709)	44	5	2.58	+	1.94	1.95E-01	7.58E-01
GO:1902116	negative regulation of organelle assembly (GO:1902116)	44	5	2.58	+	1.94	1.95E-01	7.58E-01
GO:1990573	potassium ion import across plasma membrane (GO:1990573)	44	5	2.58	+	1.94	1.95E-01	7.58E-01
GO:0051602	response to electrical stimulus (GO:0051602)	44	5	2.58	+	1.94	1.95E-01	7.58E-01
GO:0090317	negative regulation of intracellular protein transport (GO:0090317)	44	5	2.58	+	1.94	1.95E-01	7.57E-01
GO:0048713	regulation of oligodendrocyte differentiation (GO:0048713)	44	5	2.58	+	1.94	1.95E-01	7.57E-01
GO:0010837	regulation of keratinocyte proliferation (GO:0010837)	44	5	2.58	+	1.94	1.95E-01	7.57E-01
GO:0030099	myeloid cell differentiation (GO:0030099)	264	30	15.50	+	1.94	1.21E-03	2.38E-02
GO:0071214	cellular response to abiotic stimulus (GO:0071214)	326	37	19.14	+	1.93	4.34E-04	9.76E-03
GO:0104004	cellular response to environmental stimulus (GO:0104004)	326	37	19.14	+	1.93	4.34E-04	9.74E-03
GO:1900180	regulation of protein localization to nucleus (GO:1900180)	141	16	8.28	+	1.93	2.05E-02	2.09E-01
GO:0001938	positive regulation of endothelial cell proliferation (GO:0001938)	97	11	5.70	+	1.93	5.25E-02	3.95E-01
GO:1901701	cellular response to oxygen-containing compound (GO:1901701)	1059	120	62.19	+	1.93	8.44E-11	8.82E-09
GO:0030838	positive regulation of actin filament polymerization (GO:0030838)	53	6	3.11	+	1.93	1.42E-01	6.54E-01
GO:0031023	microtubule organizing center organization (GO:0031023)	106	12	6.22	+	1.93	4.01E-02	3.22E-01
GO:0010823	negative regulation of mitochondrion organization (GO:0010823)	53	6	3.11	+	1.93	1.42E-01	6.54E-01
GO:0010676	positive regulation of cellular carbohydrate metabolic process (GO:0010676)	53	6	3.11	+	1.93	1.42E-01	6.54E-01
GO:0018108	peptidyl-tyrosine phosphorylation (GO:0018108)	168	19	9.87	+	1.93	9.67E-03	1.23E-01
GO:0090311	regulation of protein deacetylation (GO:0090311)	62	7	3.64	+	1.92	1.07E-01	5.95E-01
GO:1901700	response to oxygen-containing compound (GO:1901700)	1551	175	91.08	+	1.92	2.12E-15	4.75E-13
GO:0031344	regulation of cell projection organization (GO:0031344)	656	74	38.52	+	1.92	5.81E-07	2.85E-05
GO:0033993	response to lipid (GO:0033993)	843	95	49.50	+	1.92	1.31E-08	8.26E-07
GO:0051881	regulation of mitochondrial membrane potential (GO:0051881)	71	8	4.17	+	1.92	8.20E-02	5.10E-01
GO:0055067	monovalent inorganic cation homeostasis (GO:0055067)	151	17	8.87	+	1.92	1.62E-02	1.79E-01
GO:0010634	positive regulation of epithelial cell migration (GO:0010634)	151	17	8.87	+	1.92	1.62E-02	1.79E-01
GO:0007167	enzyme-linked receptor protein signaling pathway (GO:0007167)	640	72	37.58	+	1.92	1.02E-06	4.75E-05
GO:0050772	positive regulation of axonogenesis (GO:0050772)	80	9	4.70	+	1.92	9.67E-02	5.61E-01
GO:0034330	cell junction organization (GO:0034330)	498	56	29.24	+	1.91	1.83E-05	6.34E-04
GO:0030901	midbrain development (GO:0030901)	89	10	5.23	+	1.91	7.16E-02	4.64E-01
GO:0060249	anatomical structure homeostasis (GO:0060249)	303	34	17.79	+	1.91	7.07E-04	1.51E-02
GO:0009725	response to hormone (GO:0009725)	767	86	45.04	+	1.91	6.85E-08	3.91E-06
GO:0001505	regulation of neurotransmitter levels (GO:0001505)	223	25	13.09	+	1.91	4.61E-03	7.06E-02
GO:0003014	renal system process (GO:0003014)	116	13	6.81	+	1.91	3.23E-02	2.83E-01
GO:0031399	regulation of protein modification process (GO:0031399)	1563	175	91.78	+	1.91	4.12E-15	8.72E-13
GO:0002573	myeloid leukocyte differentiation (GO:0002573)	134	15	7.87	+	1.91	2.81E-02	2.56E-01
GO:0030832	regulation of actin filament length (GO:0030832)	161	18	9.45	+	1.90	1.31E-02	1.55E-01
GO:0051896	regulation of protein kinase B signaling (GO:0051896)	170	19	9.98	+	1.90	1.50E-02	1.73E-01
GO:0018212	peptidyl-tyrosine modification (GO:0018212)	170	19	9.98	+	1.90	1.50E-02	1.73E-01
GO:0050673	epithelial cell proliferation (GO:0050673)	170	19	9.98	+	1.90	1.50E-02	1.73E-01
GO:0009887	animal organ morphogenesis (GO:0009887)	1003	112	58.90	+	1.90	9.43E-10	7.86E-08
GO:0051241	negative regulation of multicellular organismal process (GO:0051241)	1039	116	61.01	+	1.90	3.54E-10	3.23E-08
GO:0043269	regulation of ion transport (GO:0043269)	708	79	41.57	+	1.90	2.94E-07	1.51E-05
GO:0048732	gland development (GO:0048732)	422	47	24.78	+	1.90	8.93E-05	2.55E-03
GO:0050793	regulation of developmental process (GO:0050793)	2489	277	146.16	+	1.90	5.59E-24	3.37E-21
GO:0002666	positive regulation of T cell tolerance induction (GO:0002666)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0045777	positive regulation of blood pressure (GO:0045777)	36	4	2.11	+	1.89	2.81E-01	8.94E-01
GO:0010212	response to ionizing radiation (GO:0010212)	144	16	8.46	+	1.89	2.21E-02	2.22E-01
GO:1903251	multi-ciliated epithelial cell differentiation (GO:1903251)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:2000980	regulation of inner ear receptor cell differentiation (GO:2000980)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0003056	regulation of vascular associated smooth muscle contraction (GO:0003056)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0060452	positive regulation of cardiac muscle contraction (GO:0060452)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0060430	lung saccule development (GO:0060430)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1902732	positive regulation of chondrocyte proliferation (GO:1902732)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0034139	regulation of toll-like receptor 3 signaling pathway (GO:0034139)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0034138	toll-like receptor 3 signaling pathway (GO:0034138)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0006930	substrate-dependent cell migration, cell extension (GO:0006930)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0002578	negative regulation of antigen processing and presentation (GO:0002578)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0045647	negative regulation of erythrocyte differentiation (GO:0045647)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0045631	regulation of mechanoreceptor differentiation (GO:0045631)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0045618	positive regulation of keratinocyte differentiation (GO:0045618)	18	2	1.06	+	1.89	3.05E-01	9.17E-01
GO:0045617	negative regulation of keratinocyte differentiation (GO:0045617)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0045607	regulation of inner ear auditory receptor cell differentiation (GO:0045607)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0045602	negative regulation of endothelial cell differentiation (GO:0045602)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0060392	negative regulation of SMAD protein signal transduction (GO:0060392)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0007309	oocyte axis specification (GO:0007309)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0007308	oocyte construction (GO:0007308)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1902683	regulation of receptor localization to synapse (GO:1902683)	18	2	1.06	+	1.89	3.05E-01	9.17E-01
GO:0072319	vesicle uncoating (GO:0072319)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:2000826	regulation of heart morphogenesis (GO:2000826)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0002484	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)	36	4	2.11	+	1.89	2.81E-01	8.93E-01
GO:1903036	positive regulation of response to wounding (GO:1903036)	72	8	4.23	+	1.89	8.56E-02	5.09E-01
GO:1903010	regulation of bone development (GO:1903010)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0060242	contact inhibition (GO:0060242)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0072202	cell differentiation involved in metanephros development (GO:0072202)	18	2	1.06	+	1.89	3.05E-01	9.17E-01
GO:0060216	definitive hemopoiesis (GO:0060216)	18	2	1.06	+	1.89	3.05E-01	9.17E-01
GO:0006702	androgen biosynthetic process (GO:0006702)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:2001187	positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0002314	germinal center B cell differentiation (GO:0002314)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0007196	adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway (GO:0007196)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0072172	mesonephric tubule formation (GO:0072172)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:2000674	regulation of type B pancreatic cell apoptotic process (GO:2000674)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0140627	ubiquitin-dependent protein catabolic process via the C-end degron rule pathway (GO:0140627)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0032909	regulation of transforming growth factor beta2 production (GO:0032909)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0002293	alpha-beta T cell differentiation involved in immune response (GO:0002293)	36	4	2.11	+	1.89	2.81E-01	8.93E-01
GO:0002287	alpha-beta T cell activation involved in immune response (GO:0002287)	36	4	2.11	+	1.89	2.81E-01	8.93E-01
GO:0006621	protein retention in ER lumen (GO:0006621)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0007084	mitotic nuclear membrane reassembly (GO:0007084)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0001768	establishment of T cell polarity (GO:0001768)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0001765	membrane raft assembly (GO:0001765)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0032885	regulation of polysaccharide biosynthetic process (GO:0032885)	36	4	2.11	+	1.89	2.81E-01	8.93E-01
GO:0006591	ornithine metabolic process (GO:0006591)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0038130	ERBB4 signaling pathway (GO:0038130)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0038128	ERBB2 signaling pathway (GO:0038128)	18	2	1.06	+	1.89	3.05E-01	9.16E-01
GO:0006569	tryptophan catabolic process (GO:0006569)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1901858	regulation of mitochondrial DNA metabolic process (GO:1901858)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0033240	positive regulation of cellular amine metabolic process (GO:0033240)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:2000465	regulation of glycogen (starch) synthase activity (GO:2000465)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0002071	glandular epithelial cell maturation (GO:0002071)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1901725	regulation of histone deacetylase activity (GO:1901725)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0070944	neutrophil-mediated killing of bacterium (GO:0070944)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0070943	neutrophil-mediated killing of symbiont cell (GO:0070943)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0070942	neutrophil mediated cytotoxicity (GO:0070942)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0032650	regulation of interleukin-1 alpha production (GO:0032650)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1902165	regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)	18	2	1.06	+	1.89	3.05E-01	9.16E-01
GO:0051709	regulation of killing of cells of another organism (GO:0051709)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1905941	positive regulation of gonad development (GO:1905941)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0090394	negative regulation of excitatory postsynaptic potential (GO:0090394)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0051608	histamine transport (GO:0051608)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1901537	positive regulation of DNA demethylation (GO:1901537)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0048875	chemical homeostasis within a tissue (GO:0048875)	18	2	1.06	+	1.89	3.05E-01	9.16E-01
GO:0031946	regulation of glucocorticoid biosynthetic process (GO:0031946)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0090281	negative regulation of calcium ion import (GO:0090281)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0048743	positive regulation of skeletal muscle fiber development (GO:0048743)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0048702	embryonic neurocranium morphogenesis (GO:0048702)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0032377	regulation of intracellular lipid transport (GO:0032377)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:2000018	regulation of male gonad development (GO:2000018)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0000712	resolution of meiotic recombination intermediates (GO:0000712)	18	2	1.06	+	1.89	3.05E-01	9.16E-01
GO:0048699	generation of neurons (GO:0048699)	1134	126	66.59	+	1.89	9.11E-11	9.40E-09
GO:0032287	peripheral nervous system myelin maintenance (GO:0032287)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0050910	detection of mechanical stimulus involved in sensory perception of sound (GO:0050910)	18	2	1.06	+	1.89	3.05E-01	9.16E-01
GO:0090091	positive regulation of extracellular matrix disassembly (GO:0090091)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0090083	regulation of inclusion body assembly (GO:0090083)	18	2	1.06	+	1.89	3.05E-01	9.15E-01
GO:0090045	positive regulation of deacetylase activity (GO:0090045)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0050869	negative regulation of B cell activation (GO:0050869)	36	4	2.11	+	1.89	2.81E-01	8.93E-01
GO:0050847	progesterone receptor signaling pathway (GO:0050847)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0048536	spleen development (GO:0048536)	36	4	2.11	+	1.89	2.81E-01	8.92E-01
GO:0043691	reverse cholesterol transport (GO:0043691)	18	2	1.06	+	1.89	3.05E-01	9.15E-01
GO:0043649	dicarboxylic acid catabolic process (GO:0043649)	18	2	1.06	+	1.89	3.05E-01	9.15E-01
GO:0031652	positive regulation of heat generation (GO:0031652)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0101024	mitotic nuclear membrane organization (GO:0101024)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0050775	positive regulation of dendrite morphogenesis (GO:0050775)	36	4	2.11	+	1.89	2.81E-01	8.92E-01
GO:0050774	negative regulation of dendrite morphogenesis (GO:0050774)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0050768	negative regulation of neurogenesis (GO:0050768)	144	16	8.46	+	1.89	2.21E-02	2.22E-01
GO:0050746	regulation of lipoprotein metabolic process (GO:0050746)	18	2	1.06	+	1.89	3.05E-01	9.15E-01
GO:0120127	response to zinc ion starvation (GO:0120127)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0098693	regulation of synaptic vesicle cycle (GO:0098693)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0035970	peptidyl-threonine dephosphorylation (GO:0035970)	18	2	1.06	+	1.89	3.05E-01	9.15E-01
GO:1901099	negative regulation of signal transduction in absence of ligand (GO:1901099)	36	4	2.11	+	1.89	2.81E-01	8.92E-01
GO:1901072	glucosamine-containing compound catabolic process (GO:1901072)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0051126	negative regulation of actin nucleation (GO:0051126)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0048387	negative regulation of retinoic acid receptor signaling pathway (GO:0048387)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0050655	dermatan sulfate proteoglycan metabolic process (GO:0050655)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0070206	protein trimerization (GO:0070206)	18	2	1.06	+	1.89	3.05E-01	9.15E-01
GO:0031497	chromatin organization (GO:0031497)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0043416	regulation of skeletal muscle tissue regeneration (GO:0043416)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0043406	positive regulation of MAP kinase activity (GO:0043406)	117	13	6.87	+	1.89	3.36E-02	2.91E-01
GO:0051006	positive regulation of lipoprotein lipase activity (GO:0051006)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0051004	regulation of lipoprotein lipase activity (GO:0051004)	18	2	1.06	+	1.89	3.05E-01	9.14E-01
GO:0043353	enucleate erythrocyte differentiation (GO:0043353)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1905247	positive regulation of aspartic-type peptidase activity (GO:1905247)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0031340	positive regulation of vesicle fusion (GO:0031340)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0009445	putrescine metabolic process (GO:0009445)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1900378	positive regulation of secondary metabolite biosynthetic process (GO:1900378)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0036150	phosphatidylserine acyl-chain remodeling (GO:0036150)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0061952	midbody abscission (GO:0061952)	18	2	1.06	+	1.89	3.05E-01	9.14E-01
GO:0061900	glial cell activation (GO:0061900)	36	4	2.11	+	1.89	2.81E-01	8.92E-01
GO:0009396	folic acid-containing compound biosynthetic process (GO:0009396)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0048023	positive regulation of melanin biosynthetic process (GO:0048023)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0000098	sulfur amino acid catabolic process (GO:0000098)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0035562	negative regulation of chromatin binding (GO:0035562)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0015866	ADP transport (GO:0015866)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0009188	ribonucleoside diphosphate biosynthetic process (GO:0009188)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0046950	cellular ketone body metabolic process (GO:0046950)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0097646	calcitonin family receptor signaling pathway (GO:0097646)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0030540	female genitalia development (GO:0030540)	18	2	1.06	+	1.89	3.05E-01	9.14E-01
GO:1900046	regulation of hemostasis (GO:1900046)	72	8	4.23	+	1.89	8.56E-02	5.09E-01
GO:1900038	negative regulation of cellular response to hypoxia (GO:1900038)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0010922	positive regulation of phosphatase activity (GO:0010922)	36	4	2.11	+	1.89	2.81E-01	8.92E-01
GO:0015793	glycerol transmembrane transport (GO:0015793)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0086070	SA node cell to atrial cardiac muscle cell communication (GO:0086070)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0046827	positive regulation of protein export from nucleus (GO:0046827)	18	2	1.06	+	1.89	3.05E-01	9.14E-01
GO:0062043	positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0042436	indole-containing compound catabolic process (GO:0042436)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0042420	dopamine catabolic process (GO:0042420)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0016115	terpenoid catabolic process (GO:0016115)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0035234	ectopic germ cell programmed cell death (GO:0035234)	18	2	1.06	+	1.89	3.05E-01	9.14E-01
GO:0010755	regulation of plasminogen activation (GO:0010755)	18	2	1.06	+	1.89	3.05E-01	9.14E-01
GO:0030321	transepithelial chloride transport (GO:0030321)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0010744	positive regulation of macrophage derived foam cell differentiation (GO:0010744)	18	2	1.06	+	1.89	3.05E-01	9.13E-01
GO:0010737	protein kinase A signaling (GO:0010737)	18	2	1.06	+	1.89	3.05E-01	9.13E-01
GO:0060982	coronary artery morphogenesis (GO:0060982)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0046653	tetrahydrofolate metabolic process (GO:0046653)	18	2	1.06	+	1.89	3.05E-01	9.13E-01
GO:0060914	heart formation (GO:0060914)	18	2	1.06	+	1.89	3.05E-01	9.13E-01
GO:0046637	regulation of alpha-beta T cell differentiation (GO:0046637)	72	8	4.23	+	1.89	8.56E-02	5.09E-01
GO:0008354	germ cell migration (GO:0008354)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0030220	platelet formation (GO:0030220)	18	2	1.06	+	1.89	3.05E-01	9.13E-01
GO:0022605	mammalian oogenesis stage (GO:0022605)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0010624	regulation of Schwann cell proliferation (GO:0010624)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0035067	negative regulation of histone acetylation (GO:0035067)	18	2	1.06	+	1.89	3.05E-01	9.12E-01
GO:0060872	semicircular canal development (GO:0060872)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0097254	renal tubular secretion (GO:0097254)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0030167	proteoglycan catabolic process (GO:0030167)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0008272	sulfate transport (GO:0008272)	18	2	1.06	+	1.89	3.05E-01	9.12E-01
GO:0010533	regulation of activation of Janus kinase activity (GO:0010533)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0002921	negative regulation of humoral immune response (GO:0002921)	18	2	1.06	+	1.89	3.05E-01	9.12E-01
GO:1903589	positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:1903514	release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0060767	epithelial cell proliferation involved in prostate gland development (GO:0060767)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0002883	regulation of hypersensitivity (GO:0002883)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0007620	copulation (GO:0007620)	18	2	1.06	+	1.89	3.05E-01	9.12E-01
GO:0097091	synaptic vesicle clustering (GO:0097091)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0046323	glucose import (GO:0046323)	18	2	1.06	+	1.89	3.05E-01	9.12E-01
GO:0045876	positive regulation of sister chromatid cohesion (GO:0045876)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0007506	gonadal mesoderm development (GO:0007506)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0034224	cellular response to zinc ion starvation (GO:0034224)	9	1	.53	+	1.89	4.35E-01	1.00E00
GO:0060348	bone development (GO:0060348)	216	24	12.68	+	1.89	6.24E-03	8.84E-02
GO:0110148	biomineralization (GO:0110148)	108	12	6.34	+	1.89	4.29E-02	3.37E-01
GO:0021544	subpallium development (GO:0021544)	27	3	1.59	+	1.89	2.31E-01	8.07E-01
GO:0002313	mature B cell differentiation involved in immune response (GO:0002313)	27	3	1.59	+	1.89	2.31E-01	8.06E-01
GO:1902414	protein localization to cell junction (GO:1902414)	81	9	4.76	+	1.89	9.83E-02	5.69E-01
GO:0033344	cholesterol efflux (GO:0033344)	27	3	1.59	+	1.89	2.31E-01	8.06E-01
GO:0032753	positive regulation of interleukin-4 production (GO:0032753)	27	3	1.59	+	1.89	2.31E-01	8.06E-01
GO:0006469	negative regulation of protein kinase activity (GO:0006469)	207	23	12.16	+	1.89	5.61E-03	8.21E-02
GO:0032703	negative regulation of interleukin-2 production (GO:0032703)	27	3	1.59	+	1.89	2.31E-01	8.06E-01
GO:0001541	ovarian follicle development (GO:0001541)	54	6	3.17	+	1.89	1.47E-01	6.71E-01
GO:0071326	cellular response to monosaccharide stimulus (GO:0071326)	81	9	4.76	+	1.89	9.83E-02	5.69E-01
GO:0051571	positive regulation of histone H3-K4 methylation (GO:0051571)	27	3	1.59	+	1.89	2.31E-01	8.06E-01
GO:0051570	regulation of histone H3-K9 methylation (GO:0051570)	27	3	1.59	+	1.89	2.31E-01	8.05E-01
GO:0032330	regulation of chondrocyte differentiation (GO:0032330)	54	6	3.17	+	1.89	1.47E-01	6.71E-01
GO:0043491	protein kinase B signaling (GO:0043491)	54	6	3.17	+	1.89	1.47E-01	6.71E-01
GO:0048016	inositol phosphate-mediated signaling (GO:0048016)	27	3	1.59	+	1.89	2.31E-01	8.05E-01
GO:0043032	positive regulation of macrophage activation (GO:0043032)	27	3	1.59	+	1.89	2.31E-01	8.05E-01
GO:0016048	detection of temperature stimulus (GO:0016048)	27	3	1.59	+	1.89	2.31E-01	8.05E-01
GO:0021895	cerebral cortex neuron differentiation (GO:0021895)	27	3	1.59	+	1.89	2.31E-01	8.05E-01
GO:0072523	purine-containing compound catabolic process (GO:0072523)	54	6	3.17	+	1.89	1.47E-01	6.70E-01
GO:0045646	regulation of erythrocyte differentiation (GO:0045646)	45	5	2.64	+	1.89	2.00E-01	7.74E-01
GO:0021575	hindbrain morphogenesis (GO:0021575)	45	5	2.64	+	1.89	2.00E-01	7.74E-01
GO:0001947	heart looping (GO:0001947)	63	7	3.70	+	1.89	1.11E-01	5.50E-01
GO:2000300	regulation of synaptic vesicle exocytosis (GO:2000300)	63	7	3.70	+	1.89	1.11E-01	5.50E-01
GO:0050918	positive chemotaxis (GO:0050918)	45	5	2.64	+	1.89	2.00E-01	7.73E-01
GO:0044091	membrane biogenesis (GO:0044091)	63	7	3.70	+	1.89	1.11E-01	5.50E-01
GO:1904407	positive regulation of nitric oxide metabolic process (GO:1904407)	45	5	2.64	+	1.89	2.00E-01	7.73E-01
GO:0034644	cellular response to UV (GO:0034644)	90	10	5.28	+	1.89	7.32E-02	4.72E-01
GO:1903556	negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)	63	7	3.70	+	1.89	1.11E-01	5.50E-01
GO:0048513	animal organ development (GO:0048513)	3254	360	191.08	+	1.88	6.53E-32	1.14E-28
GO:0010243	response to organonitrogen compound (GO:0010243)	968	107	56.84	+	1.88	4.20E-09	3.05E-07
GO:0071560	cellular response to transforming growth factor beta stimulus (GO:0071560)	154	17	9.04	+	1.88	1.78E-02	1.89E-01
GO:1904375	regulation of protein localization to cell periphery (GO:1904375)	127	14	7.46	+	1.88	3.86E-02	3.23E-01
GO:0006310	DNA recombination (GO:0006310)	245	27	14.39	+	1.88	3.13E-03	5.23E-02
GO:0051346	negative regulation of hydrolase activity (GO:0051346)	363	40	21.32	+	1.88	3.78E-04	8.72E-03
GO:1901652	response to peptide (GO:1901652)	445	49	26.13	+	1.88	8.75E-05	2.52E-03
GO:0050679	positive regulation of epithelial cell proliferation (GO:0050679)	209	23	12.27	+	1.87	8.45E-03	1.10E-01
GO:0048608	reproductive structure development (GO:0048608)	300	33	17.62	+	1.87	1.48E-03	2.80E-02
GO:0032102	negative regulation of response to external stimulus (GO:0032102)	391	43	22.96	+	1.87	2.66E-04	6.42E-03
GO:0007548	sex differentiation (GO:0007548)	282	31	16.56	+	1.87	1.70E-03	3.15E-02
GO:2000117	negative regulation of cysteine-type endopeptidase activity (GO:2000117)	91	10	5.34	+	1.87	7.51E-02	4.75E-01
GO:0099175	regulation of postsynapse organization (GO:0099175)	91	10	5.34	+	1.87	7.51E-02	4.75E-01
GO:0043535	regulation of blood vessel endothelial cell migration (GO:0043535)	91	10	5.34	+	1.87	7.51E-02	4.75E-01
GO:0030509	BMP signaling pathway (GO:0030509)	91	10	5.34	+	1.87	7.51E-02	4.75E-01
GO:0030182	neuron differentiation (GO:0030182)	1065	117	62.54	+	1.87	8.04E-10	6.85E-08
GO:2000736	regulation of stem cell differentiation (GO:2000736)	82	9	4.82	+	1.87	1.00E-01	5.75E-01
GO:0072091	regulation of stem cell proliferation (GO:0072091)	82	9	4.82	+	1.87	1.00E-01	5.75E-01
GO:0061053	somite development (GO:0061053)	82	9	4.82	+	1.87	1.00E-01	5.75E-01
GO:0072028	nephron morphogenesis (GO:0072028)	73	8	4.29	+	1.87	8.95E-02	5.29E-01
GO:0033143	regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)	73	8	4.29	+	1.87	8.95E-02	5.28E-01
GO:0043542	endothelial cell migration (GO:0043542)	73	8	4.29	+	1.87	8.95E-02	5.28E-01
GO:0061515	myeloid cell development (GO:0061515)	73	8	4.29	+	1.87	8.95E-02	5.28E-01
GO:0055065	metal ion homeostasis (GO:0055065)	420	46	24.66	+	1.87	1.94E-04	4.94E-03
GO:0001756	somitogenesis (GO:0001756)	64	7	3.76	+	1.86	1.15E-01	5.71E-01
GO:0050805	negative regulation of synaptic transmission (GO:0050805)	64	7	3.76	+	1.86	1.15E-01	5.70E-01
GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	64	7	3.76	+	1.86	1.15E-01	5.70E-01
GO:0010721	negative regulation of cell development (GO:0010721)	183	20	10.75	+	1.86	1.25E-02	1.51E-01
GO:0007565	female pregnancy (GO:0007565)	174	19	10.22	+	1.86	1.62E-02	1.78E-01
GO:0006875	cellular metal ion homeostasis (GO:0006875)	330	36	19.38	+	1.86	1.10E-03	2.18E-02
GO:0035418	protein localization to synapse (GO:0035418)	55	6	3.23	+	1.86	1.52E-01	6.89E-01
GO:0046324	regulation of glucose import (GO:0046324)	55	6	3.23	+	1.86	1.52E-01	6.89E-01
GO:0031401	positive regulation of protein modification process (GO:0031401)	1019	111	59.84	+	1.86	4.34E-09	3.09E-07
GO:0001678	cellular glucose homeostasis (GO:0001678)	101	11	5.93	+	1.85	5.91E-02	4.11E-01
GO:0120161	regulation of cold-induced thermogenesis (GO:0120161)	147	16	8.63	+	1.85	2.42E-02	2.38E-01
GO:0051239	regulation of multicellular organismal process (GO:0051239)	2750	299	161.48	+	1.85	1.26E-24	8.98E-22
GO:0007215	glutamate receptor signaling pathway (GO:0007215)	46	5	2.70	+	1.85	2.05E-01	7.39E-01
GO:0048701	embryonic cranial skeleton morphogenesis (GO:0048701)	46	5	2.70	+	1.85	2.05E-01	7.39E-01
GO:1990090	cellular response to nerve growth factor stimulus (GO:1990090)	46	5	2.70	+	1.85	2.05E-01	7.39E-01
GO:0043405	regulation of MAP kinase activity (GO:0043405)	184	20	10.80	+	1.85	1.29E-02	1.53E-01
GO:0046849	bone remodeling (GO:0046849)	46	5	2.70	+	1.85	2.05E-01	7.38E-01
GO:0030195	negative regulation of blood coagulation (GO:0030195)	46	5	2.70	+	1.85	2.05E-01	7.38E-01
GO:0002920	regulation of humoral immune response (GO:0002920)	46	5	2.70	+	1.85	2.05E-01	7.38E-01
GO:0098742	cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	267	29	15.68	+	1.85	2.95E-03	4.98E-02
GO:0021953	central nervous system neuron differentiation (GO:0021953)	175	19	10.28	+	1.85	1.65E-02	1.82E-01
GO:0061458	reproductive system development (GO:0061458)	304	33	17.85	+	1.85	1.61E-03	3.00E-02
GO:0051093	negative regulation of developmental process (GO:0051093)	923	100	54.20	+	1.85	3.45E-08	2.04E-06
GO:0031334	positive regulation of protein-containing complex assembly (GO:0031334)	194	21	11.39	+	1.84	1.05E-02	1.31E-01
GO:0014059	regulation of dopamine secretion (GO:0014059)	37	4	2.17	+	1.84	2.87E-01	9.02E-01
GO:0032692	negative regulation of interleukin-1 production (GO:0032692)	37	4	2.17	+	1.84	2.87E-01	9.02E-01
GO:0048821	erythrocyte development (GO:0048821)	37	4	2.17	+	1.84	2.87E-01	9.02E-01
GO:0032228	regulation of synaptic transmission, GABAergic (GO:0032228)	37	4	2.17	+	1.84	2.87E-01	9.02E-01
GO:0051385	response to mineralocorticoid (GO:0051385)	37	4	2.17	+	1.84	2.87E-01	9.02E-01
GO:1905332	positive regulation of morphogenesis of an epithelium (GO:1905332)	37	4	2.17	+	1.84	2.87E-01	9.01E-01
GO:0030534	adult behavior (GO:0030534)	148	16	8.69	+	1.84	2.50E-02	2.45E-01
GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	74	8	4.35	+	1.84	1.38E-01	6.48E-01
GO:0010874	regulation of cholesterol efflux (GO:0010874)	37	4	2.17	+	1.84	2.87E-01	9.01E-01
GO:0060999	positive regulation of dendritic spine development (GO:0060999)	37	4	2.17	+	1.84	2.87E-01	9.01E-01
GO:0010665	regulation of cardiac muscle cell apoptotic process (GO:0010665)	37	4	2.17	+	1.84	2.87E-01	9.01E-01
GO:0035066	positive regulation of histone acetylation (GO:0035066)	37	4	2.17	+	1.84	2.87E-01	9.01E-01
GO:0003230	cardiac atrium development (GO:0003230)	37	4	2.17	+	1.84	2.87E-01	9.01E-01
GO:0050900	leukocyte migration (GO:0050900)	250	27	14.68	+	1.84	4.94E-03	7.52E-02
GO:0009628	response to abiotic stimulus (GO:0009628)	1121	121	65.83	+	1.84	9.47E-10	7.86E-08
GO:0044089	positive regulation of cellular component biogenesis (GO:0044089)	501	54	29.42	+	1.84	6.65E-05	2.00E-03
GO:0071902	positive regulation of protein serine/threonine kinase activity (GO:0071902)	232	25	13.62	+	1.84	5.80E-03	8.44E-02
GO:2001235	positive regulation of apoptotic signaling pathway (GO:2001235)	130	14	7.63	+	1.83	4.12E-02	3.29E-01
GO:0002067	glandular epithelial cell differentiation (GO:0002067)	65	7	3.82	+	1.83	1.20E-01	5.86E-01
GO:0035270	endocrine system development (GO:0035270)	130	14	7.63	+	1.83	4.12E-02	3.29E-01
GO:0018105	peptidyl-serine phosphorylation (GO:0018105)	186	20	10.92	+	1.83	1.37E-02	1.59E-01
GO:0043065	positive regulation of apoptotic process (GO:0043065)	503	54	29.54	+	1.83	6.93E-05	2.08E-03
GO:0071824	protein-DNA complex subunit organization (GO:0071824)	233	25	13.68	+	1.83	5.98E-03	8.60E-02
GO:0060429	epithelium development (GO:0060429)	1072	115	62.95	+	1.83	4.50E-09	3.16E-07
GO:0045638	negative regulation of myeloid cell differentiation (GO:0045638)	84	9	4.93	+	1.82	1.04E-01	5.84E-01
GO:0021680	cerebellar Purkinje cell layer development (GO:0021680)	28	3	1.64	+	1.82	2.46E-01	8.48E-01
GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	56	6	3.29	+	1.82	1.57E-01	7.12E-01
GO:0002448	mast cell mediated immunity (GO:0002448)	28	3	1.64	+	1.82	2.46E-01	8.48E-01
GO:1903055	positive regulation of extracellular matrix organization (GO:1903055)	28	3	1.64	+	1.82	2.46E-01	8.47E-01
GO:0033522	histone H2A ubiquitination (GO:0033522)	28	3	1.64	+	1.82	2.46E-01	8.47E-01
GO:0007159	leukocyte cell-cell adhesion (GO:0007159)	56	6	3.29	+	1.82	1.57E-01	7.12E-01
GO:0007141	male meiosis I (GO:0007141)	28	3	1.64	+	1.82	2.46E-01	8.47E-01
GO:0001816	cytokine production (GO:0001816)	28	3	1.64	+	1.82	2.46E-01	8.47E-01
GO:0032816	positive regulation of natural killer cell activation (GO:0032816)	28	3	1.64	+	1.82	2.46E-01	8.47E-01
GO:0071385	cellular response to glucocorticoid stimulus (GO:0071385)	56	6	3.29	+	1.82	1.57E-01	7.12E-01
GO:0033081	regulation of T cell differentiation in thymus (GO:0033081)	28	3	1.64	+	1.82	2.46E-01	8.46E-01
GO:0048520	positive regulation of behavior (GO:0048520)	28	3	1.64	+	1.82	2.46E-01	8.46E-01
GO:1900745	positive regulation of p38MAPK cascade (GO:1900745)	28	3	1.64	+	1.82	2.46E-01	8.46E-01
GO:0048260	positive regulation of receptor-mediated endocytosis (GO:0048260)	56	6	3.29	+	1.82	1.57E-01	7.11E-01
GO:1903901	negative regulation of viral life cycle (GO:1903901)	28	3	1.64	+	1.82	2.46E-01	8.46E-01
GO:1903828	negative regulation of protein localization (GO:1903828)	196	21	11.51	+	1.82	1.56E-02	1.73E-01
GO:0061436	establishment of skin barrier (GO:0061436)	28	3	1.64	+	1.82	2.46E-01	8.46E-01
GO:0048731	system development (GO:0048731)	3838	410	225.37	+	1.82	4.68E-34	1.22E-30
GO:0007399	nervous system development (GO:0007399)	2191	234	128.66	+	1.82	4.90E-18	1.74E-15
GO:0018209	peptidyl-serine modification (GO:0018209)	206	22	12.10	+	1.82	1.22E-02	1.47E-01
GO:0032200	telomere organization (GO:0032200)	103	11	6.05	+	1.82	6.31E-02	4.33E-01
GO:0009408	response to heat (GO:0009408)	103	11	6.05	+	1.82	6.31E-02	4.32E-01
GO:0043254	regulation of protein-containing complex assembly (GO:0043254)	412	44	24.19	+	1.82	3.81E-04	8.75E-03
GO:0031214	biomineral tissue development (GO:0031214)	103	11	6.05	+	1.82	6.31E-02	4.32E-01
GO:0050818	regulation of coagulation (GO:0050818)	75	8	4.40	+	1.82	1.40E-01	6.57E-01
GO:0045913	positive regulation of carbohydrate metabolic process (GO:0045913)	75	8	4.40	+	1.82	1.40E-01	6.57E-01
GO:0071310	cellular response to organic substance (GO:0071310)	2026	216	118.97	+	1.82	1.94E-16	5.25E-14
GO:0048598	embryonic morphogenesis (GO:0048598)	591	63	34.70	+	1.82	1.85E-05	6.40E-04
GO:0043068	positive regulation of programmed cell death (GO:0043068)	516	55	30.30	+	1.82	8.41E-05	2.44E-03
GO:0045785	positive regulation of cell adhesion (GO:0045785)	488	52	28.66	+	1.81	1.19E-04	3.29E-03
GO:0045596	negative regulation of cell differentiation (GO:0045596)	676	72	39.70	+	1.81	6.29E-06	2.48E-04
GO:0021795	cerebral cortex cell migration (GO:0021795)	47	5	2.76	+	1.81	2.11E-01	7.57E-01
GO:0021762	substantia nigra development (GO:0021762)	47	5	2.76	+	1.81	2.11E-01	7.57E-01
GO:1905953	negative regulation of lipid localization (GO:1905953)	47	5	2.76	+	1.81	2.11E-01	7.56E-01
GO:0048806	genitalia development (GO:0048806)	47	5	2.76	+	1.81	2.11E-01	7.56E-01
GO:0000723	telomere maintenance (GO:0000723)	94	10	5.52	+	1.81	8.15E-02	5.08E-01
GO:1900047	negative regulation of hemostasis (GO:1900047)	47	5	2.76	+	1.81	2.11E-01	7.56E-01
GO:0060711	labyrinthine layer development (GO:0060711)	47	5	2.76	+	1.81	2.11E-01	7.56E-01
GO:0002701	negative regulation of production of molecular mediator of immune response (GO:0002701)	47	5	2.76	+	1.81	2.11E-01	7.56E-01
GO:0048562	embryonic organ morphogenesis (GO:0048562)	301	32	17.67	+	1.81	2.37E-03	4.14E-02
GO:0051240	positive regulation of multicellular organismal process (GO:0051240)	1515	161	88.96	+	1.81	3.48E-12	4.75E-10
GO:0051130	positive regulation of cellular component organization (GO:0051130)	1054	112	61.89	+	1.81	1.12E-08	7.09E-07
GO:0001824	blastocyst development (GO:0001824)	113	12	6.64	+	1.81	7.26E-02	4.68E-01
GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	424	45	24.90	+	1.81	3.26E-04	7.65E-03
GO:0001894	tissue homeostasis (GO:0001894)	245	26	14.39	+	1.81	6.88E-03	9.54E-02
GO:0031348	negative regulation of defense response (GO:0031348)	236	25	13.86	+	1.80	8.84E-03	1.15E-01
GO:0098773	skin epidermis development (GO:0098773)	85	9	4.99	+	1.80	1.07E-01	5.97E-01
GO:0043409	negative regulation of MAPK cascade (GO:0043409)	170	18	9.98	+	1.80	2.34E-02	2.32E-01
GO:1901796	regulation of signal transduction by p53 class mediator (GO:1901796)	104	11	6.11	+	1.80	6.53E-02	4.41E-01
GO:0051056	regulation of small GTPase mediated signal transduction (GO:0051056)	312	33	18.32	+	1.80	2.71E-03	4.63E-02
GO:0032355	response to estradiol (GO:0032355)	123	13	7.22	+	1.80	5.62E-02	3.97E-01
GO:0043408	regulation of MAPK cascade (GO:0043408)	672	71	39.46	+	1.80	8.67E-06	3.28E-04
GO:0048534	hematopoietic or lymphoid organ development (GO:0048534)	710	75	41.69	+	1.80	4.83E-06	1.96E-04
GO:0001649	osteoblast differentiation (GO:0001649)	142	15	8.34	+	1.80	3.49E-02	2.98E-01
GO:1901653	cellular response to peptide (GO:1901653)	303	32	17.79	+	1.80	2.51E-03	4.33E-02
GO:0007610	behavior (GO:0007610)	606	64	35.58	+	1.80	2.25E-05	7.64E-04
GO:0071559	response to transforming growth factor beta (GO:0071559)	161	17	9.45	+	1.80	3.01E-02	2.71E-01
GO:0098771	inorganic ion homeostasis (GO:0098771)	521	55	30.59	+	1.80	9.14E-05	2.61E-03
GO:0051348	negative regulation of transferase activity (GO:0051348)	275	29	16.15	+	1.80	4.97E-03	7.54E-02
GO:0043410	positive regulation of MAPK cascade (GO:0043410)	484	51	28.42	+	1.79	1.67E-04	4.34E-03
GO:0034204	lipid translocation (GO:0034204)	57	6	3.35	+	1.79	1.63E-01	6.68E-01
GO:0045655	regulation of monocyte differentiation (GO:0045655)	19	2	1.12	+	1.79	3.26E-01	9.67E-01
GO:0060350	endochondral bone morphogenesis (GO:0060350)	57	6	3.35	+	1.79	1.63E-01	6.68E-01
GO:0006862	nucleotide transport (GO:0006862)	38	4	2.23	+	1.79	2.93E-01	8.84E-01
GO:2001224	positive regulation of neuron migration (GO:2001224)	19	2	1.12	+	1.79	3.26E-01	9.67E-01
GO:0019217	regulation of fatty acid metabolic process (GO:0019217)	95	10	5.58	+	1.79	8.39E-02	5.19E-01
GO:2001135	regulation of endocytic recycling (GO:2001135)	19	2	1.12	+	1.79	3.26E-01	9.66E-01
GO:0001829	trophectodermal cell differentiation (GO:0001829)	19	2	1.12	+	1.79	3.26E-01	9.66E-01
GO:1902170	cellular response to reactive nitrogen species (GO:1902170)	19	2	1.12	+	1.79	3.26E-01	9.66E-01
GO:0071360	cellular response to exogenous dsRNA (GO:0071360)	19	2	1.12	+	1.79	3.26E-01	9.66E-01
GO:0006306	DNA methylation (GO:0006306)	57	6	3.35	+	1.79	1.63E-01	6.68E-01
GO:0006305	DNA alkylation (GO:0006305)	57	6	3.35	+	1.79	1.63E-01	6.68E-01
GO:0045061	thymic T cell selection (GO:0045061)	19	2	1.12	+	1.79	3.26E-01	9.66E-01
GO:0071276	cellular response to cadmium ion (GO:0071276)	38	4	2.23	+	1.79	2.93E-01	8.84E-01
GO:0050920	regulation of chemotaxis (GO:0050920)	228	24	13.39	+	1.79	1.16E-02	1.41E-01
GO:0051339	regulation of lyase activity (GO:0051339)	76	8	4.46	+	1.79	1.43E-01	6.57E-01
GO:0048535	lymph node development (GO:0048535)	19	2	1.12	+	1.79	3.26E-01	9.65E-01
GO:0044070	regulation of anion transport (GO:0044070)	95	10	5.58	+	1.79	8.39E-02	5.19E-01
GO:0032026	response to magnesium ion (GO:0032026)	19	2	1.12	+	1.79	3.26E-01	9.65E-01
GO:0043551	regulation of phosphatidylinositol 3-kinase activity (GO:0043551)	57	6	3.35	+	1.79	1.63E-01	6.68E-01
GO:0036303	lymph vessel morphogenesis (GO:0036303)	19	2	1.12	+	1.79	3.26E-01	9.65E-01
GO:0097720	calcineurin-mediated signaling (GO:0097720)	19	2	1.12	+	1.79	3.26E-01	9.65E-01
GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)	19	2	1.12	+	1.79	3.26E-01	9.65E-01
GO:0046851	negative regulation of bone remodeling (GO:0046851)	19	2	1.12	+	1.79	3.26E-01	9.65E-01
GO:1903818	positive regulation of voltage-gated potassium channel activity (GO:1903818)	19	2	1.12	+	1.79	3.26E-01	9.64E-01
GO:0030224	monocyte differentiation (GO:0030224)	19	2	1.12	+	1.79	3.26E-01	9.64E-01
GO:0010544	negative regulation of platelet activation (GO:0010544)	19	2	1.12	+	1.79	3.26E-01	9.64E-01
GO:0097094	craniofacial suture morphogenesis (GO:0097094)	19	2	1.12	+	1.79	3.26E-01	9.64E-01
GO:0097028	dendritic cell differentiation (GO:0097028)	38	4	2.23	+	1.79	2.93E-01	8.84E-01
GO:0061097	regulation of protein tyrosine kinase activity (GO:0061097)	95	10	5.58	+	1.79	8.39E-02	5.18E-01
GO:0002724	regulation of T cell cytokine production (GO:0002724)	38	4	2.23	+	1.79	2.93E-01	8.84E-01
GO:0010310	regulation of hydrogen peroxide metabolic process (GO:0010310)	19	2	1.12	+	1.79	3.26E-01	9.64E-01
GO:0002687	positive regulation of leukocyte migration (GO:0002687)	152	16	8.93	+	1.79	3.93E-02	3.24E-01
GO:0010466	negative regulation of peptidase activity (GO:0010466)	257	27	15.09	+	1.79	5.84E-03	8.49E-02
GO:0007275	multicellular organism development (GO:0007275)	4228	444	248.27	+	1.79	6.59E-36	2.58E-32
GO:0045637	regulation of myeloid cell differentiation (GO:0045637)	200	21	11.74	+	1.79	1.67E-02	1.84E-01
GO:0010951	negative regulation of endopeptidase activity (GO:0010951)	248	26	14.56	+	1.79	7.36E-03	1.01E-01
GO:0032535	regulation of cellular component size (GO:0032535)	372	39	21.84	+	1.79	1.02E-03	2.06E-02
GO:0009790	embryo development (GO:0009790)	1059	111	62.19	+	1.78	2.59E-08	1.55E-06
GO:0045619	regulation of lymphocyte differentiation (GO:0045619)	210	22	12.33	+	1.78	1.34E-02	1.57E-01
GO:0090263	positive regulation of canonical Wnt signaling pathway (GO:0090263)	105	11	6.17	+	1.78	6.76E-02	4.54E-01
GO:0055080	cation homeostasis (GO:0055080)	506	53	29.71	+	1.78	1.56E-04	4.08E-03
GO:0060548	negative regulation of cell death (GO:0060548)	1022	107	60.01	+	1.78	4.82E-08	2.81E-06
GO:0043434	response to peptide hormone (GO:0043434)	363	38	21.32	+	1.78	1.28E-03	2.50E-02
GO:1904892	regulation of receptor signaling pathway via STAT (GO:1904892)	86	9	5.05	+	1.78	1.10E-01	5.46E-01
GO:0010921	regulation of phosphatase activity (GO:0010921)	86	9	5.05	+	1.78	1.10E-01	5.46E-01
GO:0010507	negative regulation of autophagy (GO:0010507)	86	9	5.05	+	1.78	1.10E-01	5.46E-01
GO:0010942	positive regulation of cell death (GO:0010942)	583	61	34.23	+	1.78	4.93E-05	1.54E-03
GO:0019725	cellular homeostasis (GO:0019725)	641	67	37.64	+	1.78	1.81E-05	6.29E-04
GO:0002520	immune system development (GO:0002520)	757	79	44.45	+	1.78	3.24E-06	1.36E-04
GO:0044092	negative regulation of molecular function (GO:0044092)	1150	120	67.53	+	1.78	9.54E-09	6.18E-07
GO:0032680	regulation of tumor necrosis factor production (GO:0032680)	163	17	9.57	+	1.78	3.15E-02	2.79E-01
GO:0060759	regulation of response to cytokine stimulus (GO:0060759)	163	17	9.57	+	1.78	3.15E-02	2.79E-01
GO:0097193	intrinsic apoptotic signaling pathway (GO:0097193)	163	17	9.57	+	1.78	3.15E-02	2.79E-01
GO:0051098	regulation of binding (GO:0051098)	374	39	21.96	+	1.78	1.47E-03	2.79E-02
GO:1990089	response to nerve growth factor (GO:1990089)	48	5	2.82	+	1.77	2.18E-01	7.74E-01
GO:0043367	CD4-positive, alpha-beta T cell differentiation (GO:0043367)	48	5	2.82	+	1.77	2.18E-01	7.74E-01
GO:0031146	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	48	5	2.82	+	1.77	2.18E-01	7.74E-01
GO:0071396	cellular response to lipid (GO:0071396)	519	54	30.48	+	1.77	1.35E-04	3.63E-03
GO:0071675	regulation of mononuclear cell migration (GO:0071675)	125	13	7.34	+	1.77	5.88E-02	4.10E-01
GO:2001236	regulation of extrinsic apoptotic signaling pathway (GO:2001236)	154	16	9.04	+	1.77	4.06E-02	3.25E-01
GO:0021536	diencephalon development (GO:0021536)	77	8	4.52	+	1.77	1.45E-01	6.65E-01
GO:0071333	cellular response to glucose stimulus (GO:0071333)	77	8	4.52	+	1.77	1.45E-01	6.65E-01
GO:0007017	microtubule-based process (GO:0007017)	809	84	47.51	+	1.77	2.09E-06	9.06E-05
GO:0043086	negative regulation of catalytic activity (GO:0043086)	781	81	45.86	+	1.77	3.08E-06	1.30E-04
GO:0010565	regulation of cellular ketone metabolic process (GO:0010565)	135	14	7.93	+	1.77	4.71E-02	3.61E-01
GO:0043066	negative regulation of apoptotic process (GO:0043066)	898	93	52.73	+	1.76	5.55E-07	2.74E-05
GO:0043069	negative regulation of programmed cell death (GO:0043069)	918	95	53.91	+	1.76	4.80E-07	2.41E-05
GO:2000765	regulation of cytoplasmic translation (GO:2000765)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0071709	membrane assembly (GO:0071709)	58	6	3.41	+	1.76	1.69E-01	6.88E-01
GO:0007189	adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	145	15	8.51	+	1.76	5.30E-02	3.95E-01
GO:0060142	regulation of syncytium formation by plasma membrane fusion (GO:0060142)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0032924	activin receptor signaling pathway (GO:0032924)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0071482	cellular response to light stimulus (GO:0071482)	116	12	6.81	+	1.76	7.65E-02	4.82E-01
GO:0071480	cellular response to gamma radiation (GO:0071480)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0002092	positive regulation of receptor internalization (GO:0002092)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:1901798	positive regulation of signal transduction by p53 class mediator (GO:1901798)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0051654	establishment of mitochondrion localization (GO:0051654)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0048678	response to axon injury (GO:0048678)	58	6	3.41	+	1.76	1.69E-01	6.88E-01
GO:0050951	sensory perception of temperature stimulus (GO:0050951)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0043583	ear development (GO:0043583)	232	24	13.62	+	1.76	1.24E-02	1.50E-01
GO:0043407	negative regulation of MAP kinase activity (GO:0043407)	58	6	3.41	+	1.76	1.69E-01	6.88E-01
GO:0048265	response to pain (GO:0048265)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0035640	exploration behavior (GO:0035640)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0016358	dendrite development (GO:0016358)	116	12	6.81	+	1.76	7.65E-02	4.81E-01
GO:0030514	negative regulation of BMP signaling pathway (GO:0030514)	58	6	3.41	+	1.76	1.69E-01	6.87E-01
GO:0010800	positive regulation of peptidyl-threonine phosphorylation (GO:0010800)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0042133	neurotransmitter metabolic process (GO:0042133)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:1904036	negative regulation of epithelial cell apoptotic process (GO:1904036)	58	6	3.41	+	1.76	1.69E-01	6.87E-01
GO:0008209	androgen metabolic process (GO:0008209)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0060795	cell fate commitment involved in formation of primary germ layer (GO:0060795)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0003209	cardiac atrium morphogenesis (GO:0003209)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0034369	plasma lipoprotein particle remodeling (GO:0034369)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0034368	protein-lipid complex remodeling (GO:0034368)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0097066	response to thyroid hormone (GO:0097066)	29	3	1.70	+	1.76	4.22E-01	1.00E00
GO:0048869	cellular developmental process (GO:0048869)	3542	366	207.99	+	1.76	4.57E-27	4.21E-24
GO:0098739	import across plasma membrane (GO:0098739)	155	16	9.10	+	1.76	4.14E-02	3.28E-01
GO:0030154	cell differentiation (GO:0030154)	3519	363	206.64	+	1.76	1.21E-26	1.05E-23
GO:0007423	sensory organ development (GO:0007423)	582	60	34.18	+	1.76	7.33E-05	2.18E-03
GO:0050801	ion homeostasis (GO:0050801)	534	55	31.36	+	1.75	1.61E-04	4.20E-03
GO:0055082	cellular chemical homeostasis (GO:0055082)	534	55	31.36	+	1.75	1.61E-04	4.20E-03
GO:0045600	positive regulation of fat cell differentiation (GO:0045600)	68	7	3.99	+	1.75	1.96E-01	7.62E-01
GO:0071300	cellular response to retinoic acid (GO:0071300)	68	7	3.99	+	1.75	1.96E-01	7.62E-01
GO:0035065	regulation of histone acetylation (GO:0035065)	68	7	3.99	+	1.75	1.96E-01	7.61E-01
GO:0006873	cellular ion homeostasis (GO:0006873)	428	44	25.13	+	1.75	7.32E-04	1.55E-02
GO:0043473	pigmentation (GO:0043473)	107	11	6.28	+	1.75	1.01E-01	5.77E-01
GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	146	15	8.57	+	1.75	5.37E-02	3.88E-01
GO:1901698	response to nitrogen compound (GO:1901698)	1062	109	62.36	+	1.75	8.51E-08	4.80E-06
GO:0030203	glycosaminoglycan metabolic process (GO:0030203)	117	12	6.87	+	1.75	7.80E-02	4.90E-01
GO:0006970	response to osmotic stress (GO:0006970)	78	8	4.58	+	1.75	1.48E-01	6.75E-01
GO:0006636	unsaturated fatty acid biosynthetic process (GO:0006636)	39	4	2.29	+	1.75	3.00E-01	9.02E-01
GO:0072089	stem cell proliferation (GO:0072089)	78	8	4.58	+	1.75	1.48E-01	6.75E-01
GO:0014037	Schwann cell differentiation (GO:0014037)	39	4	2.29	+	1.75	3.00E-01	9.02E-01
GO:0044264	cellular polysaccharide metabolic process (GO:0044264)	78	8	4.58	+	1.75	1.48E-01	6.75E-01
GO:0030866	cortical actin cytoskeleton organization (GO:0030866)	39	4	2.29	+	1.75	3.00E-01	9.02E-01
GO:0010907	positive regulation of glucose metabolic process (GO:0010907)	39	4	2.29	+	1.75	3.00E-01	9.02E-01
GO:0046785	microtubule polymerization (GO:0046785)	39	4	2.29	+	1.75	3.00E-01	9.02E-01
GO:0007267	cell-cell signaling (GO:0007267)	1083	111	63.59	+	1.75	7.54E-08	4.28E-06
GO:0048585	negative regulation of response to stimulus (GO:0048585)	1620	166	95.13	+	1.75	2.19E-11	2.60E-09
GO:0072330	monocarboxylic acid biosynthetic process (GO:0072330)	166	17	9.75	+	1.74	3.38E-02	2.93E-01
GO:0070372	regulation of ERK1 and ERK2 cascade (GO:0070372)	303	31	17.79	+	1.74	5.17E-03	7.67E-02
GO:0035264	multicellular organism growth (GO:0035264)	88	9	5.17	+	1.74	1.15E-01	5.71E-01
GO:0010469	regulation of signaling receptor activity (GO:0010469)	176	18	10.33	+	1.74	3.80E-02	3.21E-01
GO:0120036	plasma membrane bounded cell projection organization (GO:0120036)	1115	114	65.47	+	1.74	5.51E-08	3.19E-06
GO:0030003	cellular cation homeostasis (GO:0030003)	411	42	24.13	+	1.74	1.18E-03	2.33E-02
GO:0033628	regulation of cell adhesion mediated by integrin (GO:0033628)	49	5	2.88	+	1.74	2.24E-01	7.87E-01
GO:2000648	positive regulation of stem cell proliferation (GO:2000648)	49	5	2.88	+	1.74	2.24E-01	7.87E-01
GO:0051952	regulation of amine transport (GO:0051952)	98	10	5.75	+	1.74	9.22E-02	5.41E-01
GO:2000404	regulation of T cell migration (GO:2000404)	49	5	2.88	+	1.74	2.24E-01	7.86E-01
GO:0035305	negative regulation of dephosphorylation (GO:0035305)	49	5	2.88	+	1.74	2.24E-01	7.86E-01
GO:0046364	monosaccharide biosynthetic process (GO:0046364)	49	5	2.88	+	1.74	2.24E-01	7.86E-01
GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	206	21	12.10	+	1.74	1.93E-02	2.01E-01
GO:0022604	regulation of cell morphogenesis (GO:0022604)	314	32	18.44	+	1.74	4.30E-03	6.71E-02
GO:0001841	neural tube formation (GO:0001841)	108	11	6.34	+	1.73	1.02E-01	5.86E-01
GO:0006954	inflammatory response (GO:0006954)	540	55	31.71	+	1.73	2.47E-04	6.00E-03
GO:0051248	negative regulation of protein metabolic process (GO:0051248)	1042	106	61.19	+	1.73	1.95E-07	1.05E-05
GO:0002444	myeloid leukocyte mediated immunity (GO:0002444)	59	6	3.46	+	1.73	1.75E-01	7.04E-01
GO:0040029	epigenetic regulation of gene expression (GO:0040029)	118	12	6.93	+	1.73	7.97E-02	5.00E-01
GO:0043666	regulation of phosphoprotein phosphatase activity (GO:0043666)	59	6	3.46	+	1.73	1.75E-01	7.04E-01
GO:0120193	tight junction organization (GO:0120193)	59	6	3.46	+	1.73	1.75E-01	7.04E-01
GO:0070887	cellular response to chemical stimulus (GO:0070887)	2616	266	153.61	+	1.73	5.43E-18	1.89E-15
GO:0006022	aminoglycan metabolic process (GO:0006022)	128	13	7.52	+	1.73	6.35E-02	4.35E-01
GO:0030097	hemopoiesis (GO:0030097)	660	67	38.76	+	1.73	4.69E-05	1.48E-03
GO:2000401	regulation of lymphocyte migration (GO:2000401)	69	7	4.05	+	1.73	1.99E-01	7.71E-01
GO:0061371	determination of heart left/right asymmetry (GO:0061371)	69	7	4.05	+	1.73	1.99E-01	7.71E-01
GO:0001818	negative regulation of cytokine production (GO:0001818)	286	29	16.79	+	1.73	8.51E-03	1.11E-01
GO:0070374	positive regulation of ERK1 and ERK2 cascade (GO:0070374)	217	22	12.74	+	1.73	2.15E-02	2.18E-01
GO:0050878	regulation of body fluid levels (GO:0050878)	375	38	22.02	+	1.73	2.21E-03	3.91E-02
GO:0048856	anatomical structure development (GO:0048856)	5144	521	302.06	+	1.72	3.26E-40	5.11E-36
GO:0001701	in utero embryonic development (GO:0001701)	395	40	23.19	+	1.72	1.95E-03	3.53E-02
GO:0018210	peptidyl-threonine modification (GO:0018210)	79	8	4.64	+	1.72	1.52E-01	6.89E-01
GO:0046425	regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	79	8	4.64	+	1.72	1.52E-01	6.89E-01
GO:0072676	lymphocyte migration (GO:0072676)	79	8	4.64	+	1.72	1.52E-01	6.89E-01
GO:1903555	regulation of tumor necrosis factor superfamily cytokine production (GO:1903555)	168	17	9.87	+	1.72	3.57E-02	3.05E-01
GO:0032092	positive regulation of protein binding (GO:0032092)	89	9	5.23	+	1.72	1.19E-01	5.84E-01
GO:1900182	positive regulation of protein localization to nucleus (GO:1900182)	89	9	5.23	+	1.72	1.19E-01	5.84E-01
GO:0035023	regulation of Rho protein signal transduction (GO:0035023)	89	9	5.23	+	1.72	1.19E-01	5.84E-01
GO:0009968	negative regulation of signal transduction (GO:0009968)	1257	127	73.81	+	1.72	1.81E-08	1.12E-06
GO:0042472	inner ear morphogenesis (GO:0042472)	109	11	6.40	+	1.72	1.04E-01	5.82E-01
GO:0048705	skeletal system morphogenesis (GO:0048705)	228	23	13.39	+	1.72	1.75E-02	1.88E-01
GO:1901800	positive regulation of proteasomal protein catabolic process (GO:1901800)	119	12	6.99	+	1.72	8.15E-02	5.08E-01
GO:0017015	regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	139	14	8.16	+	1.72	7.22E-02	4.67E-01
GO:0030833	regulation of actin filament polymerization (GO:0030833)	139	14	8.16	+	1.72	7.22E-02	4.66E-01
GO:0097529	myeloid leukocyte migration (GO:0097529)	139	14	8.16	+	1.72	7.22E-02	4.66E-01
GO:0007584	response to nutrient (GO:0007584)	149	15	8.75	+	1.71	5.66E-02	3.99E-01
GO:0042445	hormone metabolic process (GO:0042445)	209	21	12.27	+	1.71	2.80E-02	2.55E-01
GO:0009314	response to radiation (GO:0009314)	449	45	26.37	+	1.71	1.33E-03	2.55E-02
GO:0010648	negative regulation of cell communication (GO:0010648)	1357	136	79.68	+	1.71	7.25E-09	4.90E-07
GO:0030155	regulation of cell adhesion (GO:0030155)	789	79	46.33	+	1.71	1.41E-05	5.01E-04
GO:0002643	regulation of tolerance induction (GO:0002643)	20	2	1.17	+	1.70	3.47E-01	9.84E-01
GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:0033762	response to glucagon (GO:0033762)	20	2	1.17	+	1.70	3.47E-01	9.84E-01
GO:1903242	regulation of cardiac muscle hypertrophy in response to stress (GO:1903242)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0019433	triglyceride catabolic process (GO:0019433)	20	2	1.17	+	1.70	3.47E-01	9.84E-01
GO:0002579	positive regulation of antigen processing and presentation (GO:0002579)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0045657	positive regulation of monocyte differentiation (GO:0045657)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0046085	adenosine metabolic process (GO:0046085)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0002467	germinal center formation (GO:0002467)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:2001269	positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0033572	transferrin transport (GO:0033572)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1903078	positive regulation of protein localization to plasma membrane (GO:1903078)	60	6	3.52	+	1.70	1.82E-01	7.17E-01
GO:1903069	regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0001973	G protein-coupled adenosine receptor signaling pathway (GO:0001973)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0001915	negative regulation of T cell mediated cytotoxicity (GO:0001915)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0060245	detection of cell density (GO:0060245)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1902513	regulation of organelle transport along microtubule (GO:1902513)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0006700	C21-steroid hormone biosynthetic process (GO:0006700)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0071711	basement membrane organization (GO:0071711)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:0033483	gas homeostasis (GO:0033483)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0007176	regulation of epidermal growth factor-activated receptor activity (GO:0007176)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:1902473	regulation of protein localization to synapse (GO:1902473)	20	2	1.17	+	1.70	3.47E-01	9.84E-01
GO:0002292	T cell differentiation involved in immune response (GO:0002292)	40	4	2.35	+	1.70	3.07E-01	9.16E-01
GO:0006646	phosphatidylethanolamine biosynthetic process (GO:0006646)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1901977	negative regulation of cell cycle checkpoint (GO:1901977)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0001782	B cell homeostasis (GO:0001782)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:0001767	establishment of lymphocyte polarity (GO:0001767)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0060080	inhibitory postsynaptic potential (GO:0060080)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:2000563	positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0060075	regulation of resting membrane potential (GO:0060075)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0006560	proline metabolic process (GO:0006560)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1901856	negative regulation of cellular respiration (GO:1901856)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1902236	negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)	20	2	1.17	+	1.70	3.47E-01	9.84E-01
GO:1902224	ketone body metabolic process (GO:1902224)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0071476	cellular hypotonic response (GO:0071476)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0014048	regulation of glutamate secretion (GO:0014048)	20	2	1.17	+	1.70	3.47E-01	9.83E-01
GO:0071421	manganese ion transmembrane transport (GO:0071421)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0045136	development of secondary sexual characteristics (GO:0045136)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0032691	negative regulation of interleukin-1 beta production (GO:0032691)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:2000352	negative regulation of endothelial cell apoptotic process (GO:2000352)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:0032653	regulation of interleukin-10 production (GO:0032653)	60	6	3.52	+	1.70	1.82E-01	7.17E-01
GO:0071394	cellular response to testosterone stimulus (GO:0071394)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0006312	mitotic recombination (GO:0006312)	20	2	1.17	+	1.70	3.47E-01	9.83E-01
GO:0033034	positive regulation of myeloid cell apoptotic process (GO:0033034)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0033007	negative regulation of mast cell activation involved in immune response (GO:0033007)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0006266	DNA ligation (GO:0006266)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0006265	DNA topological change (GO:0006265)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0006264	mitochondrial DNA replication (GO:0006264)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0071243	cellular response to arsenic-containing substance (GO:0071243)	20	2	1.17	+	1.70	3.47E-01	9.83E-01
GO:1901538	changes to DNA methylation involved in embryo development (GO:1901538)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0099527	postsynapse to nucleus signaling pathway (GO:0099527)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:2000109	regulation of macrophage apoptotic process (GO:2000109)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0048733	sebaceous gland development (GO:0048733)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0048708	astrocyte differentiation (GO:0048708)	60	6	3.52	+	1.70	1.82E-01	7.17E-01
GO:0048703	embryonic viscerocranium morphogenesis (GO:0048703)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:2000048	negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0032369	negative regulation of lipid transport (GO:0032369)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:0032353	negative regulation of hormone biosynthetic process (GO:0032353)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1901386	negative regulation of voltage-gated calcium channel activity (GO:1901386)	20	2	1.17	+	1.70	3.47E-01	9.83E-01
GO:0070584	mitochondrion morphogenesis (GO:0070584)	20	2	1.17	+	1.70	3.47E-01	9.83E-01
GO:0048680	positive regulation of axon regeneration (GO:0048680)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0048645	animal organ formation (GO:0048645)	40	4	2.35	+	1.70	3.07E-01	9.16E-01
GO:0051342	regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0070498	interleukin-1-mediated signaling pathway (GO:0070498)	20	2	1.17	+	1.70	3.47E-01	9.82E-01
GO:1901203	positive regulation of extracellular matrix assembly (GO:1901203)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0090009	primitive streak formation (GO:0090009)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0032107	regulation of response to nutrient levels (GO:0032107)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:0032104	regulation of response to extracellular stimulus (GO:0032104)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:0043653	mitochondrial fragmentation involved in apoptotic process (GO:0043653)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0070327	thyroid hormone transport (GO:0070327)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0036444	calcium import into the mitochondrion (GO:0036444)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0032025	response to cobalt ion (GO:0032025)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1905459	regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0050665	hydrogen peroxide biosynthetic process (GO:0050665)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1904953	Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0036344	platelet morphogenesis (GO:0036344)	20	2	1.17	+	1.70	3.47E-01	9.82E-01
GO:0048304	positive regulation of isotype switching to IgG isotypes (GO:0048304)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0035878	nail development (GO:0035878)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0051017	actin filament bundle assembly (GO:0051017)	60	6	3.52	+	1.70	1.82E-01	7.17E-01
GO:1900424	regulation of defense response to bacterium (GO:1900424)	20	2	1.17	+	1.70	3.47E-01	9.82E-01
GO:0035795	negative regulation of mitochondrial membrane permeability (GO:0035795)	20	2	1.17	+	1.70	3.47E-01	9.82E-01
GO:0070092	regulation of glucagon secretion (GO:0070092)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1904749	regulation of protein localization to nucleolus (GO:1904749)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0030853	negative regulation of granulocyte differentiation (GO:0030853)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0009310	amine catabolic process (GO:0009310)	20	2	1.17	+	1.70	3.47E-01	9.82E-01
GO:1904672	regulation of somatic stem cell population maintenance (GO:1904672)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0042749	regulation of circadian sleep/wake cycle (GO:0042749)	20	2	1.17	+	1.70	3.47E-01	9.82E-01
GO:0035588	G protein-coupled purinergic receptor signaling pathway (GO:0035588)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1905097	regulation of guanyl-nucleotide exchange factor activity (GO:1905097)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1904526	regulation of microtubule binding (GO:1904526)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0030643	cellular phosphate ion homeostasis (GO:0030643)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0055083	monovalent inorganic anion homeostasis (GO:0055083)	20	2	1.17	+	1.70	3.47E-01	9.81E-01
GO:0055064	chloride ion homeostasis (GO:0055064)	20	2	1.17	+	1.70	3.47E-01	9.81E-01
GO:0055015	ventricular cardiac muscle cell development (GO:0055015)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0043045	DNA methylation involved in embryo development (GO:0043045)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0009169	purine ribonucleoside monophosphate catabolic process (GO:0009169)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0009128	purine nucleoside monophosphate catabolic process (GO:0009128)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0010992	ubiquitin recycling (GO:0010992)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0010917	negative regulation of mitochondrial membrane potential (GO:0010917)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1903977	positive regulation of glial cell migration (GO:1903977)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0061626	pharyngeal arch artery morphogenesis (GO:0061626)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0150172	regulation of phosphatidylcholine metabolic process (GO:0150172)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0046886	positive regulation of hormone biosynthetic process (GO:0046886)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0062042	regulation of cardiac epithelial to mesenchymal transition (GO:0062042)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0010887	negative regulation of cholesterol storage (GO:0010887)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0042428	serotonin metabolic process (GO:0042428)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0042424	catecholamine catabolic process (GO:0042424)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0010866	regulation of triglyceride biosynthetic process (GO:0010866)	20	2	1.17	+	1.70	3.47E-01	9.81E-01
GO:0042402	cellular biogenic amine catabolic process (GO:0042402)	20	2	1.17	+	1.70	3.47E-01	9.81E-01
GO:0150076	neuroinflammatory response (GO:0150076)	40	4	2.35	+	1.70	3.07E-01	9.16E-01
GO:0046794	transport of virus (GO:0046794)	20	2	1.17	+	1.70	3.47E-01	9.81E-01
GO:0034770	histone H4-K20 methylation (GO:0034770)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0097484	dendrite extension (GO:0097484)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0060965	negative regulation of miRNA-mediated gene silencing (GO:0060965)	20	2	1.17	+	1.70	3.47E-01	9.81E-01
GO:0046689	response to mercury ion (GO:0046689)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1904181	positive regulation of membrane depolarization (GO:1904181)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0042276	error-prone translesion synthesis (GO:0042276)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0030277	maintenance of gastrointestinal epithelium (GO:0030277)	20	2	1.17	+	1.70	3.47E-01	9.80E-01
GO:0010662	regulation of striated muscle cell apoptotic process (GO:0010662)	40	4	2.35	+	1.70	3.07E-01	9.16E-01
GO:0010612	regulation of cardiac muscle adaptation (GO:0010612)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0061365	positive regulation of triglyceride lipase activity (GO:0061365)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0023035	CD40 signaling pathway (GO:0023035)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0060837	blood vessel endothelial cell differentiation (GO:0060837)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0046548	retinal rod cell development (GO:0046548)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1904030	negative regulation of cyclin-dependent protein kinase activity (GO:1904030)	30	3	1.76	+	1.70	4.28E-01	1.00E00
GO:0010522	regulation of calcium ion transport into cytosol (GO:0010522)	20	2	1.17	+	1.70	3.47E-01	9.80E-01
GO:0060768	regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0003310	pancreatic A cell differentiation (GO:0003310)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0060716	labyrinthine layer blood vessel development (GO:0060716)	20	2	1.17	+	1.70	3.47E-01	9.80E-01
GO:0010496	intercellular transport (GO:0010496)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0014824	artery smooth muscle contraction (GO:0014824)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0014821	phasic smooth muscle contraction (GO:0014821)	20	2	1.17	+	1.70	3.47E-01	9.80E-01
GO:0010453	regulation of cell fate commitment (GO:0010453)	40	4	2.35	+	1.70	3.07E-01	9.15E-01
GO:0030002	cellular anion homeostasis (GO:0030002)	20	2	1.17	+	1.70	3.47E-01	9.80E-01
GO:1903441	protein localization to ciliary membrane (GO:1903441)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:1903421	regulation of synaptic vesicle recycling (GO:1903421)	20	2	1.17	+	1.70	3.47E-01	9.79E-01
GO:0019614	catechol-containing compound catabolic process (GO:0019614)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0034392	negative regulation of smooth muscle cell apoptotic process (GO:0034392)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0034379	very-low-density lipoprotein particle assembly (GO:0034379)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0034356	NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0010359	regulation of anion channel activity (GO:0010359)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0002711	positive regulation of T cell mediated immunity (GO:0002711)	60	6	3.52	+	1.70	1.82E-01	7.16E-01
GO:0060561	apoptotic process involved in morphogenesis (GO:0060561)	20	2	1.17	+	1.70	3.47E-01	9.79E-01
GO:1902884	positive regulation of response to oxidative stress (GO:1902884)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0072502	cellular trivalent inorganic anion homeostasis (GO:0072502)	10	1	.59	+	1.70	4.66E-01	1.00E00
GO:0045639	positive regulation of myeloid cell differentiation (GO:0045639)	100	10	5.87	+	1.70	1.37E-01	6.44E-01
GO:0001776	leukocyte homeostasis (GO:0001776)	90	9	5.28	+	1.70	1.22E-01	5.86E-01
GO:0014020	primary neural tube formation (GO:0014020)	100	10	5.87	+	1.70	1.37E-01	6.44E-01
GO:0051646	mitochondrion localization (GO:0051646)	50	5	2.94	+	1.70	2.32E-01	8.08E-01
GO:0050819	negative regulation of coagulation (GO:0050819)	50	5	2.94	+	1.70	2.32E-01	8.08E-01
GO:0000165	MAPK cascade (GO:0000165)	220	22	12.92	+	1.70	2.26E-02	2.26E-01
GO:0042471	ear morphogenesis (GO:0042471)	130	13	7.63	+	1.70	6.71E-02	4.51E-01
GO:0045806	negative regulation of endocytosis (GO:0045806)	50	5	2.94	+	1.70	2.32E-01	8.07E-01
GO:0030030	cell projection organization (GO:0030030)	1161	116	68.17	+	1.70	1.36E-07	7.45E-06
GO:0023057	negative regulation of signaling (GO:0023057)	1363	136	80.04	+	1.70	1.09E-08	6.94E-07
GO:0071375	cellular response to peptide hormone stimulus (GO:0071375)	241	24	14.15	+	1.70	2.03E-02	2.09E-01
GO:0033673	negative regulation of kinase activity (GO:0033673)	231	23	13.56	+	1.70	1.87E-02	1.97E-01
GO:0010033	response to organic substance (GO:0010033)	2704	269	158.78	+	1.69	4.69E-17	1.36E-14
GO:0009743	response to carbohydrate (GO:0009743)	181	18	10.63	+	1.69	4.10E-02	3.28E-01
GO:0001890	placenta development (GO:0001890)	151	15	8.87	+	1.69	5.89E-02	4.10E-01
GO:0009411	response to UV (GO:0009411)	151	15	8.87	+	1.69	5.89E-02	4.10E-01
GO:0045621	positive regulation of lymphocyte differentiation (GO:0045621)	131	13	7.69	+	1.69	9.55E-02	5.58E-01
GO:0031398	positive regulation of protein ubiquitination (GO:0031398)	121	12	7.11	+	1.69	8.55E-02	5.09E-01
GO:0007200	phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	101	10	5.93	+	1.69	1.39E-01	6.52E-01
GO:2001233	regulation of apoptotic signaling pathway (GO:2001233)	364	36	21.37	+	1.68	4.00E-03	6.33E-02
GO:0043085	positive regulation of catalytic activity (GO:0043085)	1194	118	70.11	+	1.68	1.96E-07	1.05E-05
GO:0001942	hair follicle development (GO:0001942)	81	8	4.76	+	1.68	1.59E-01	6.60E-01
GO:0006915	apoptotic process (GO:0006915)	1033	102	60.66	+	1.68	1.36E-06	6.07E-05
GO:0001959	regulation of cytokine-mediated signaling pathway (GO:0001959)	152	15	8.93	+	1.68	6.02E-02	4.16E-01
GO:0071383	cellular response to steroid hormone stimulus (GO:0071383)	152	15	8.93	+	1.68	6.02E-02	4.16E-01
GO:0001707	mesoderm formation (GO:0001707)	71	7	4.17	+	1.68	2.06E-01	7.39E-01
GO:1903844	regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	142	14	8.34	+	1.68	7.56E-02	4.77E-01
GO:0030177	positive regulation of Wnt signaling pathway (GO:0030177)	142	14	8.34	+	1.68	7.56E-02	4.77E-01
GO:0071496	cellular response to external stimulus (GO:0071496)	325	32	19.08	+	1.68	7.07E-03	9.76E-02
GO:1902532	negative regulation of intracellular signal transduction (GO:1902532)	518	51	30.42	+	1.68	7.66E-04	1.61E-02
GO:0008219	cell death (GO:0008219)	1108	109	65.06	+	1.68	5.97E-07	2.92E-05
GO:0051054	positive regulation of DNA metabolic process (GO:0051054)	305	30	17.91	+	1.68	1.08E-02	1.35E-01
GO:2001244	positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)	61	6	3.58	+	1.68	2.74E-01	8.74E-01
GO:0030858	positive regulation of epithelial cell differentiation (GO:0030858)	61	6	3.58	+	1.68	2.74E-01	8.74E-01
GO:1902107	positive regulation of leukocyte differentiation (GO:1902107)	183	18	10.75	+	1.68	4.26E-02	3.36E-01
GO:1903708	positive regulation of hemopoiesis (GO:1903708)	183	18	10.75	+	1.68	4.26E-02	3.36E-01
GO:0006259	DNA metabolic process (GO:0006259)	794	78	46.62	+	1.67	2.94E-05	9.76E-04
GO:0048839	inner ear development (GO:0048839)	204	20	11.98	+	1.67	3.79E-02	3.20E-01
GO:0007265	Ras protein signal transduction (GO:0007265)	194	19	11.39	+	1.67	4.80E-02	3.66E-01
GO:0072331	signal transduction by p53 class mediator (GO:0072331)	92	9	5.40	+	1.67	1.29E-01	6.16E-01
GO:0034329	cell junction assembly (GO:0034329)	276	27	16.21	+	1.67	1.55E-02	1.72E-01
GO:1901617	organic hydroxy compound biosynthetic process (GO:1901617)	174	17	10.22	+	1.66	5.42E-02	3.91E-01
GO:0043433	negative regulation of DNA-binding transcription factor activity (GO:0043433)	174	17	10.22	+	1.66	5.42E-02	3.90E-01
GO:0051656	establishment of organelle localization (GO:0051656)	379	37	22.26	+	1.66	4.65E-03	7.10E-02
GO:0065009	regulation of molecular function (GO:0065009)	3094	302	181.68	+	1.66	2.77E-18	1.04E-15
GO:0071805	potassium ion transmembrane transport (GO:0071805)	164	16	9.63	+	1.66	6.86E-02	4.59E-01
GO:0014014	negative regulation of gliogenesis (GO:0014014)	41	4	2.41	+	1.66	3.15E-01	9.36E-01
GO:0005976	polysaccharide metabolic process (GO:0005976)	82	8	4.82	+	1.66	1.63E-01	6.68E-01
GO:0030574	collagen catabolic process (GO:0030574)	41	4	2.41	+	1.66	3.15E-01	9.36E-01
GO:0010656	negative regulation of muscle cell apoptotic process (GO:0010656)	41	4	2.41	+	1.66	3.15E-01	9.36E-01
GO:0021879	forebrain neuron differentiation (GO:0021879)	41	4	2.41	+	1.66	3.15E-01	9.36E-01
GO:0022411	cellular component disassembly (GO:0022411)	318	31	18.67	+	1.66	9.18E-03	1.18E-01
GO:0051640	organelle localization (GO:0051640)	513	50	30.12	+	1.66	1.02E-03	2.06E-02
GO:0048871	multicellular organismal homeostasis (GO:0048871)	380	37	22.31	+	1.66	4.73E-03	7.22E-02
GO:0043627	response to estrogen (GO:0043627)	72	7	4.23	+	1.66	2.10E-01	7.51E-01
GO:0070373	negative regulation of ERK1 and ERK2 cascade (GO:0070373)	72	7	4.23	+	1.66	2.10E-01	7.51E-01
GO:0010569	regulation of double-strand break repair via homologous recombination (GO:0010569)	72	7	4.23	+	1.66	2.10E-01	7.51E-01
GO:0006813	potassium ion transport (GO:0006813)	175	17	10.28	+	1.65	5.52E-02	3.96E-01
GO:0051336	regulation of hydrolase activity (GO:0051336)	1020	99	59.90	+	1.65	4.40E-06	1.81E-04
GO:0061008	hepaticobiliary system development (GO:0061008)	134	13	7.87	+	1.65	9.92E-02	5.71E-01
GO:0048523	negative regulation of cellular process (GO:0048523)	4732	459	277.87	+	1.65	1.24E-29	1.62E-26
GO:0044093	positive regulation of molecular function (GO:0044093)	1590	154	93.37	+	1.65	5.82E-09	4.00E-07
GO:0043067	regulation of programmed cell death (GO:0043067)	1498	145	87.96	+	1.65	1.69E-08	1.05E-06
GO:0022011	myelination in peripheral nervous system (GO:0022011)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0021591	ventricular system development (GO:0021591)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0006536	glutamate metabolic process (GO:0006536)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0070828	heterochromatin organization (GO:0070828)	62	6	3.64	+	1.65	2.77E-01	8.83E-01
GO:0048873	homeostasis of number of cells within a tissue (GO:0048873)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0090312	positive regulation of protein deacetylation (GO:0090312)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0043949	regulation of cAMP-mediated signaling (GO:0043949)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0051443	positive regulation of ubiquitin-protein transferase activity (GO:0051443)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0032292	peripheral nervous system axon ensheathment (GO:0032292)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0090025	regulation of monocyte chemotaxis (GO:0090025)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0098751	bone cell development (GO:0098751)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0120178	steroid hormone biosynthetic process (GO:0120178)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0051101	regulation of DNA binding (GO:0051101)	124	12	7.28	+	1.65	1.27E-01	6.07E-01
GO:0031102	neuron projection regeneration (GO:0031102)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:1900027	regulation of ruffle assembly (GO:1900027)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0010743	regulation of macrophage derived foam cell differentiation (GO:0010743)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0046475	glycerophospholipid catabolic process (GO:0046475)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0034367	protein-containing complex remodeling (GO:0034367)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0061037	negative regulation of cartilage development (GO:0061037)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:0060563	neuroepithelial cell differentiation (GO:0060563)	31	3	1.82	+	1.65	4.35E-01	1.00E00
GO:1990830	cellular response to leukemia inhibitory factor (GO:1990830)	93	9	5.46	+	1.65	1.86E-01	7.32E-01
GO:0042981	regulation of apoptotic process (GO:0042981)	1468	142	86.20	+	1.65	2.43E-08	1.47E-06
GO:0051051	negative regulation of transport (GO:0051051)	435	42	25.54	+	1.64	3.16E-03	5.22E-02
GO:0032502	developmental process (GO:0032502)	5677	548	333.36	+	1.64	3.80E-37	2.98E-33
GO:0050790	regulation of catalytic activity (GO:0050790)	2373	229	139.34	+	1.64	3.93E-13	6.42E-11
GO:1902531	regulation of intracellular signal transduction (GO:1902531)	1721	166	101.06	+	1.64	1.56E-09	1.26E-07
GO:0031397	negative regulation of protein ubiquitination (GO:0031397)	83	8	4.87	+	1.64	1.67E-01	6.83E-01
GO:0045332	phospholipid translocation (GO:0045332)	52	5	3.05	+	1.64	2.47E-01	8.48E-01
GO:0031507	heterochromatin formation (GO:0031507)	52	5	3.05	+	1.64	2.47E-01	8.48E-01
GO:0010677	negative regulation of cellular carbohydrate metabolic process (GO:0010677)	52	5	3.05	+	1.64	2.47E-01	8.48E-01
GO:0030100	regulation of endocytosis (GO:0030100)	208	20	12.21	+	1.64	4.05E-02	3.25E-01
GO:0021872	forebrain generation of neurons (GO:0021872)	52	5	3.05	+	1.64	2.47E-01	8.48E-01
GO:0045927	positive regulation of growth (GO:0045927)	260	25	15.27	+	1.64	2.54E-02	2.48E-01
GO:0010941	regulation of cell death (GO:0010941)	1654	159	97.12	+	1.64	4.28E-09	3.07E-07
GO:2001234	negative regulation of apoptotic signaling pathway (GO:2001234)	229	22	13.45	+	1.64	3.57E-02	3.05E-01
GO:0045165	cell fate commitment (GO:0045165)	250	24	14.68	+	1.63	3.20E-02	2.83E-01
GO:0006468	protein phosphorylation (GO:0006468)	719	69	42.22	+	1.63	1.78E-04	4.59E-03
GO:0120032	regulation of plasma membrane bounded cell projection assembly (GO:0120032)	198	19	11.63	+	1.63	5.04E-02	3.81E-01
GO:0012501	programmed cell death (GO:0012501)	1074	103	63.07	+	1.63	3.99E-06	1.66E-04
GO:0048332	mesoderm morphogenesis (GO:0048332)	73	7	4.29	+	1.63	2.14E-01	7.64E-01
GO:0046635	positive regulation of alpha-beta T cell activation (GO:0046635)	73	7	4.29	+	1.63	2.14E-01	7.64E-01
GO:0043010	camera-type eye development (GO:0043010)	334	32	19.61	+	1.63	1.08E-02	1.35E-01
GO:0001843	neural tube closure (GO:0001843)	94	9	5.52	+	1.63	1.88E-01	7.36E-01
GO:1990823	response to leukemia inhibitory factor (GO:1990823)	94	9	5.52	+	1.63	1.88E-01	7.36E-01
GO:2000106	regulation of leukocyte apoptotic process (GO:2000106)	94	9	5.52	+	1.63	1.88E-01	7.36E-01
GO:0009791	post-embryonic development (GO:0009791)	94	9	5.52	+	1.63	1.88E-01	7.36E-01
GO:0022037	metencephalon development (GO:0022037)	115	11	6.75	+	1.63	1.18E-01	5.79E-01
GO:0030004	cellular monovalent inorganic cation homeostasis (GO:0030004)	115	11	6.75	+	1.63	1.18E-01	5.79E-01
GO:0032101	regulation of response to external stimulus (GO:0032101)	973	93	57.14	+	1.63	1.37E-05	4.94E-04
GO:0071356	cellular response to tumor necrosis factor (GO:0071356)	178	17	10.45	+	1.63	5.85E-02	4.08E-01
GO:0009266	response to temperature stimulus (GO:0009266)	178	17	10.45	+	1.63	5.85E-02	4.08E-01
GO:0042592	homeostatic process (GO:0042592)	1424	136	83.62	+	1.63	1.07E-07	6.04E-06
GO:0150063	visual system development (GO:0150063)	388	37	22.78	+	1.62	7.05E-03	9.74E-02
GO:0034097	response to cytokine (GO:0034097)	808	77	47.45	+	1.62	8.82E-05	2.54E-03
GO:0002577	regulation of antigen processing and presentation (GO:0002577)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:0045622	regulation of T-helper cell differentiation (GO:0045622)	42	4	2.47	+	1.62	3.23E-01	9.58E-01
GO:0010042	response to manganese ion (GO:0010042)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:1903076	regulation of protein localization to plasma membrane (GO:1903076)	105	10	6.17	+	1.62	1.48E-01	6.75E-01
GO:0021587	cerebellum morphogenesis (GO:0021587)	42	4	2.47	+	1.62	3.23E-01	9.58E-01
GO:0007263	nitric oxide mediated signal transduction (GO:0007263)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:0071731	response to nitric oxide (GO:0071731)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:0007194	negative regulation of adenylate cyclase activity (GO:0007194)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:2000678	negative regulation of transcription regulatory region DNA binding (GO:2000678)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:0060149	negative regulation of post-transcriptional gene silencing (GO:0060149)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:0032881	regulation of polysaccharide metabolic process (GO:0032881)	42	4	2.47	+	1.62	3.23E-01	9.57E-01
GO:0060008	Sertoli cell differentiation (GO:0060008)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:1990845	adaptive thermogenesis (GO:1990845)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:0002066	columnar/cuboidal epithelial cell development (GO:0002066)	42	4	2.47	+	1.62	3.23E-01	9.57E-01
GO:1901739	regulation of myoblast fusion (GO:1901739)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:0005978	glycogen biosynthetic process (GO:0005978)	21	2	1.23	+	1.62	3.67E-01	1.00E00
GO:2000319	regulation of T-helper 17 cell differentiation (GO:2000319)	21	2	1.23	+	1.62	3.67E-01	9.99E-01
GO:1901679	nucleotide transmembrane transport (GO:1901679)	21	2	1.23	+	1.62	3.67E-01	9.99E-01
GO:0006094	gluconeogenesis (GO:0006094)	42	4	2.47	+	1.62	3.23E-01	9.57E-01
GO:0048643	positive regulation of skeletal muscle tissue development (GO:0048643)	21	2	1.23	+	1.62	3.67E-01	9.99E-01
GO:0050855	regulation of B cell receptor signaling pathway (GO:0050855)	21	2	1.23	+	1.62	3.67E-01	9.99E-01
GO:1900746	regulation of vascular endothelial growth factor signaling pathway (GO:1900746)	21	2	1.23	+	1.62	3.67E-01	9.99E-01
GO:0050764	regulation of phagocytosis (GO:0050764)	105	10	6.17	+	1.62	1.48E-01	6.75E-01
GO:0030903	notochord development (GO:0030903)	21	2	1.23	+	1.62	3.67E-01	9.98E-01
GO:1900369	negative regulation of post-transcriptional gene silencing by RNA (GO:1900369)	21	2	1.23	+	1.62	3.67E-01	9.98E-01
GO:0009250	glucan biosynthetic process (GO:0009250)	21	2	1.23	+	1.62	3.67E-01	9.98E-01
GO:0016338	calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)	21	2	1.23	+	1.62	3.67E-01	9.98E-01
GO:0010984	regulation of lipoprotein particle clearance (GO:0010984)	21	2	1.23	+	1.62	3.67E-01	9.98E-01
GO:0030520	intracellular estrogen receptor signaling pathway (GO:0030520)	21	2	1.23	+	1.62	3.67E-01	9.98E-01
GO:0030510	regulation of BMP signaling pathway (GO:0030510)	105	10	6.17	+	1.62	1.48E-01	6.75E-01
GO:0062014	negative regulation of small molecule metabolic process (GO:0062014)	105	10	6.17	+	1.62	1.48E-01	6.75E-01
GO:0042304	regulation of fatty acid biosynthetic process (GO:0042304)	42	4	2.47	+	1.62	3.23E-01	9.57E-01
GO:0060967	negative regulation of gene silencing by RNA (GO:0060967)	21	2	1.23	+	1.62	3.67E-01	9.97E-01
GO:0008340	determination of adult lifespan (GO:0008340)	21	2	1.23	+	1.62	3.67E-01	9.97E-01
GO:0002902	regulation of B cell apoptotic process (GO:0002902)	21	2	1.23	+	1.62	3.67E-01	9.97E-01
GO:0048813	dendrite morphogenesis (GO:0048813)	63	6	3.70	+	1.62	2.81E-01	8.94E-01
GO:0006109	regulation of carbohydrate metabolic process (GO:0006109)	189	18	11.10	+	1.62	6.42E-02	4.39E-01
GO:0043903	regulation of biological process involved in symbiotic interaction (GO:0043903)	63	6	3.70	+	1.62	2.81E-01	8.93E-01
GO:0006081	cellular aldehyde metabolic process (GO:0006081)	63	6	3.70	+	1.62	2.81E-01	8.93E-01
GO:0043087	regulation of GTPase activity (GO:0043087)	378	36	22.20	+	1.62	8.74E-03	1.14E-01
GO:0061572	actin filament bundle organization (GO:0061572)	63	6	3.70	+	1.62	2.81E-01	8.93E-01
GO:0060491	regulation of cell projection assembly (GO:0060491)	200	19	11.74	+	1.62	5.20E-02	3.92E-01
GO:1902105	regulation of leukocyte differentiation (GO:1902105)	316	30	18.56	+	1.62	1.70E-02	1.86E-01
GO:0010675	regulation of cellular carbohydrate metabolic process (GO:0010675)	158	15	9.28	+	1.62	9.16E-02	5.39E-01
GO:1903052	positive regulation of proteolysis involved in protein catabolic process (GO:1903052)	137	13	8.04	+	1.62	1.04E-01	5.83E-01
GO:0009855	determination of bilateral symmetry (GO:0009855)	137	13	8.04	+	1.62	1.04E-01	5.83E-01
GO:0031396	regulation of protein ubiquitination (GO:0031396)	211	20	12.39	+	1.61	4.29E-02	3.38E-01
GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	95	9	5.58	+	1.61	1.90E-01	7.43E-01
GO:0060606	tube closure (GO:0060606)	95	9	5.58	+	1.61	1.90E-01	7.43E-01
GO:0051050	positive regulation of transport (GO:0051050)	919	87	53.96	+	1.61	3.87E-05	1.24E-03
GO:0048519	negative regulation of biological process (GO:0048519)	5314	503	312.04	+	1.61	6.68E-31	1.05E-27
GO:0023051	regulation of signaling (GO:0023051)	3381	320	198.53	+	1.61	1.36E-17	4.44E-15
GO:0009416	response to light stimulus (GO:0009416)	317	30	18.61	+	1.61	1.72E-02	1.85E-01
GO:0050921	positive regulation of chemotaxis (GO:0050921)	148	14	8.69	+	1.61	8.53E-02	5.23E-01
GO:0009410	response to xenobiotic stimulus (GO:0009410)	423	40	24.84	+	1.61	5.37E-03	7.96E-02
GO:0042593	glucose homeostasis (GO:0042593)	201	19	11.80	+	1.61	5.28E-02	3.95E-01
GO:0006281	DNA repair (GO:0006281)	508	48	29.83	+	1.61	2.51E-03	4.34E-02
GO:0010638	positive regulation of organelle organization (GO:0010638)	508	48	29.83	+	1.61	2.51E-03	4.33E-02
GO:0010646	regulation of cell communication (GO:0010646)	3369	318	197.83	+	1.61	2.47E-17	7.30E-15
GO:0002639	positive regulation of immunoglobulin production (GO:0002639)	53	5	3.11	+	1.61	2.54E-01	8.33E-01
GO:0010043	response to zinc ion (GO:0010043)	53	5	3.11	+	1.61	2.54E-01	8.33E-01
GO:0007140	male meiotic nuclear division (GO:0007140)	53	5	3.11	+	1.61	2.54E-01	8.33E-01
GO:0007129	homologous chromosome pairing at meiosis (GO:0007129)	53	5	3.11	+	1.61	2.54E-01	8.33E-01
GO:0051703	biological process involved in intraspecies interaction between organisms (GO:0051703)	53	5	3.11	+	1.61	2.54E-01	8.33E-01
GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)	53	5	3.11	+	1.61	2.54E-01	8.33E-01
GO:0009409	response to cold (GO:0009409)	53	5	3.11	+	1.61	2.54E-01	8.32E-01
GO:0035176	social behavior (GO:0035176)	53	5	3.11	+	1.61	2.54E-01	8.32E-01
GO:0009799	specification of symmetry (GO:0009799)	138	13	8.10	+	1.60	1.06E-01	5.93E-01
GO:0007269	neurotransmitter secretion (GO:0007269)	85	8	4.99	+	1.60	1.76E-01	7.07E-01
GO:0099643	signal release from synapse (GO:0099643)	85	8	4.99	+	1.60	1.76E-01	7.07E-01
GO:0022405	hair cycle process (GO:0022405)	85	8	4.99	+	1.60	1.76E-01	7.06E-01
GO:0022404	molting cycle process (GO:0022404)	85	8	4.99	+	1.60	1.76E-01	7.06E-01
GO:0060828	regulation of canonical Wnt signaling pathway (GO:0060828)	255	24	14.97	+	1.60	3.38E-02	2.92E-01
GO:0033500	carbohydrate homeostasis (GO:0033500)	202	19	11.86	+	1.60	5.38E-02	3.88E-01
GO:0034612	response to tumor necrosis factor (GO:0034612)	202	19	11.86	+	1.60	5.38E-02	3.87E-01
GO:0009966	regulation of signal transduction (GO:0009966)	2989	281	175.52	+	1.60	6.22E-15	1.28E-12
GO:0048880	sensory system development (GO:0048880)	394	37	23.14	+	1.60	7.76E-03	1.03E-01
GO:0060390	regulation of SMAD protein signal transduction (GO:0060390)	32	3	1.88	+	1.60	4.42E-01	1.00E00
GO:0006879	cellular iron ion homeostasis (GO:0006879)	64	6	3.76	+	1.60	2.85E-01	8.99E-01
GO:0001654	eye development (GO:0001654)	384	36	22.55	+	1.60	9.43E-03	1.20E-01
GO:0032374	regulation of cholesterol transport (GO:0032374)	64	6	3.76	+	1.60	2.85E-01	8.98E-01
GO:0032371	regulation of sterol transport (GO:0032371)	64	6	3.76	+	1.60	2.85E-01	8.98E-01
GO:0051482	positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482)	32	3	1.88	+	1.60	4.42E-01	1.00E00
GO:0009798	axis specification (GO:0009798)	96	9	5.64	+	1.60	1.93E-01	7.52E-01
GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	32	3	1.88	+	1.60	4.42E-01	1.00E00
GO:0031116	positive regulation of microtubule polymerization (GO:0031116)	32	3	1.88	+	1.60	4.42E-01	1.00E00
GO:0035306	positive regulation of dephosphorylation (GO:0035306)	64	6	3.76	+	1.60	2.85E-01	8.98E-01
GO:0046685	response to arsenic-containing substance (GO:0046685)	32	3	1.88	+	1.60	4.42E-01	1.00E00
GO:0061036	positive regulation of cartilage development (GO:0061036)	32	3	1.88	+	1.60	4.42E-01	1.00E00
GO:0051247	positive regulation of protein metabolic process (GO:0051247)	1515	142	88.96	+	1.60	1.75E-07	9.48E-06
GO:0010595	positive regulation of endothelial cell migration (GO:0010595)	107	10	6.28	+	1.59	1.54E-01	6.98E-01
GO:0070925	organelle assembly (GO:0070925)	803	75	47.15	+	1.59	2.08E-04	5.20E-03
GO:0030111	regulation of Wnt signaling pathway (GO:0030111)	332	31	19.50	+	1.59	1.98E-02	2.05E-01
GO:0030001	metal ion transport (GO:0030001)	632	59	37.11	+	1.59	9.47E-04	1.92E-02
GO:0016239	positive regulation of macroautophagy (GO:0016239)	75	7	4.40	+	1.59	2.23E-01	7.82E-01
GO:0051091	positive regulation of DNA-binding transcription factor activity (GO:0051091)	268	25	15.74	+	1.59	3.82E-02	3.20E-01
GO:0043009	chordate embryonic development (GO:0043009)	655	61	38.46	+	1.59	8.50E-04	1.76E-02
GO:0009792	embryo development ending in birth or egg hatching (GO:0009792)	677	63	39.75	+	1.58	7.54E-04	1.59E-02
GO:2000403	positive regulation of lymphocyte migration (GO:2000403)	43	4	2.52	+	1.58	3.31E-01	9.44E-01
GO:0032689	negative regulation of interferon-gamma production (GO:0032689)	43	4	2.52	+	1.58	3.31E-01	9.44E-01
GO:0050881	musculoskeletal movement (GO:0050881)	43	4	2.52	+	1.58	3.31E-01	9.44E-01
GO:0050879	multicellular organismal movement (GO:0050879)	43	4	2.52	+	1.58	3.31E-01	9.44E-01
GO:0010939	regulation of necrotic cell death (GO:0010939)	43	4	2.52	+	1.58	3.31E-01	9.44E-01
GO:0097120	receptor localization to synapse (GO:0097120)	43	4	2.52	+	1.58	3.31E-01	9.43E-01
GO:0021983	pituitary gland development (GO:0021983)	43	4	2.52	+	1.58	3.31E-01	9.43E-01
GO:0001838	embryonic epithelial tube formation (GO:0001838)	129	12	7.57	+	1.58	1.36E-01	6.39E-01
GO:0002688	regulation of leukocyte chemotaxis (GO:0002688)	129	12	7.57	+	1.58	1.36E-01	6.39E-01
GO:0090090	negative regulation of canonical Wnt signaling pathway (GO:0090090)	140	13	8.22	+	1.58	1.10E-01	5.48E-01
GO:1903322	positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	140	13	8.22	+	1.58	1.10E-01	5.47E-01
GO:0051246	regulation of protein metabolic process (GO:0051246)	2587	240	151.91	+	1.58	4.75E-12	6.37E-10
GO:0007416	synapse assembly (GO:0007416)	108	10	6.34	+	1.58	1.57E-01	7.12E-01
GO:0006826	iron ion transport (GO:0006826)	54	5	3.17	+	1.58	3.82E-01	1.00E00
GO:0043536	positive regulation of blood vessel endothelial cell migration (GO:0043536)	54	5	3.17	+	1.58	3.82E-01	1.00E00
GO:0046503	glycerolipid catabolic process (GO:0046503)	54	5	3.17	+	1.58	3.82E-01	1.00E00
GO:0007264	small GTPase mediated signal transduction (GO:0007264)	270	25	15.85	+	1.58	3.88E-02	3.25E-01
GO:0030178	negative regulation of Wnt signaling pathway (GO:0030178)	173	16	10.16	+	1.58	7.97E-02	5.00E-01
GO:0065008	regulation of biological quality (GO:0065008)	3677	340	215.92	+	1.57	2.02E-17	6.23E-15
GO:0007219	Notch signaling pathway (GO:0007219)	119	11	6.99	+	1.57	1.73E-01	6.97E-01
GO:1990778	protein localization to cell periphery (GO:1990778)	238	22	13.98	+	1.57	5.42E-02	3.91E-01
GO:0071384	cellular response to corticosteroid stimulus (GO:0071384)	65	6	3.82	+	1.57	2.90E-01	9.08E-01
GO:0030301	cholesterol transport (GO:0030301)	65	6	3.82	+	1.57	2.90E-01	9.08E-01
GO:0097035	regulation of membrane lipid distribution (GO:0097035)	65	6	3.82	+	1.57	2.90E-01	9.08E-01
GO:0032879	regulation of localization (GO:0032879)	2104	194	123.55	+	1.57	1.42E-09	1.17E-07
GO:0019233	sensory perception of pain (GO:0019233)	76	7	4.46	+	1.57	2.28E-01	7.98E-01
GO:0035148	tube formation (GO:0035148)	152	14	8.93	+	1.57	1.22E-01	5.83E-01
GO:0030855	epithelial cell differentiation (GO:0030855)	620	57	36.41	+	1.57	2.01E-03	3.62E-02
GO:2001237	negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	98	9	5.75	+	1.56	1.99E-01	7.71E-01
GO:0042633	hair cycle (GO:0042633)	98	9	5.75	+	1.56	1.99E-01	7.71E-01
GO:0042303	molting cycle (GO:0042303)	98	9	5.75	+	1.56	1.99E-01	7.71E-01
GO:0048878	chemical homeostasis (GO:0048878)	916	84	53.79	+	1.56	1.64E-04	4.25E-03
GO:0007368	determination of left/right symmetry (GO:0007368)	131	12	7.69	+	1.56	1.40E-01	6.57E-01
GO:0001889	liver development (GO:0001889)	131	12	7.69	+	1.56	1.40E-01	6.57E-01
GO:0035725	sodium ion transmembrane transport (GO:0035725)	131	12	7.69	+	1.56	1.40E-01	6.56E-01
GO:0006814	sodium ion transport (GO:0006814)	186	17	10.92	+	1.56	8.79E-02	5.21E-01
GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	208	19	12.21	+	1.56	7.76E-02	4.88E-01
GO:0051090	regulation of DNA-binding transcription factor activity (GO:0051090)	438	40	25.72	+	1.56	1.10E-02	1.37E-01
GO:0016053	organic acid biosynthetic process (GO:0016053)	274	25	16.09	+	1.55	4.06E-02	3.25E-01
GO:0071345	cellular response to cytokine stimulus (GO:0071345)	714	65	41.93	+	1.55	1.03E-03	2.06E-02
GO:0009967	positive regulation of signal transduction (GO:0009967)	1528	139	89.73	+	1.55	1.12E-06	5.13E-05
GO:0010248	establishment or maintenance of transmembrane electrochemical gradient (GO:0010248)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0072488	ammonium transmembrane transport (GO:0072488)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0003085	negative regulation of systemic arterial blood pressure (GO:0003085)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0060453	regulation of gastric acid secretion (GO:0060453)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0060439	trachea morphogenesis (GO:0060439)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:2000849	regulation of glucocorticoid secretion (GO:2000849)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0060315	negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:2001225	regulation of chloride transport (GO:2001225)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:1903054	negative regulation of extracellular matrix organization (GO:1903054)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0021548	pons development (GO:0021548)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0072283	metanephric renal vesicle morphogenesis (GO:0072283)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0001919	regulation of receptor recycling (GO:0001919)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0060272	embryonic skeletal joint morphogenesis (GO:0060272)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0006751	glutathione catabolic process (GO:0006751)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0110011	regulation of basement membrane organization (GO:0110011)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:2000672	negative regulation of motor neuron apoptotic process (GO:2000672)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0060174	limb bud formation (GO:0060174)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0072111	cell proliferation involved in kidney development (GO:0072111)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0032926	negative regulation of activin receptor signaling pathway (GO:0032926)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:1902410	mitotic cytokinetic process (GO:1902410)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0019065	receptor-mediated endocytosis of virus by host cell (GO:0019065)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0001783	B cell apoptotic process (GO:0001783)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0072015	podocyte development (GO:0072015)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0032836	glomerular basement membrane development (GO:0032836)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0006568	tryptophan metabolic process (GO:0006568)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0006534	cysteine metabolic process (GO:0006534)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0033210	leptin-mediated signaling pathway (GO:0033210)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0071492	cellular response to UV-A (GO:0071492)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0090527	actin filament reorganization (GO:0090527)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:2000392	regulation of lamellipodium morphogenesis (GO:2000392)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0140353	lipid export from cell (GO:0140353)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:2000378	negative regulation of reactive oxygen species metabolic process (GO:2000378)	44	4	2.58	+	1.55	3.40E-01	9.66E-01
GO:0033089	positive regulation of T cell differentiation in thymus (GO:0033089)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0070857	regulation of bile acid biosynthetic process (GO:0070857)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:2000253	positive regulation of feeding behavior (GO:2000253)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:1990535	neuron projection maintenance (GO:1990535)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0032486	Rap protein signal transduction (GO:0032486)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0032429	regulation of phospholipase A2 activity (GO:0032429)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0006123	mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0051561	positive regulation of mitochondrial calcium ion concentration (GO:0051561)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0031952	regulation of protein autophosphorylation (GO:0031952)	44	4	2.58	+	1.55	3.40E-01	9.66E-01
GO:0031943	regulation of glucocorticoid metabolic process (GO:0031943)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0009950	dorsal/ventral axis specification (GO:0009950)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0090184	positive regulation of kidney development (GO:0090184)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:1901317	regulation of flagellated sperm motility (GO:1901317)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0048672	positive regulation of collateral sprouting (GO:0048672)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0050962	detection of light stimulus involved in sensory perception (GO:0050962)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0050961	detection of temperature stimulus involved in sensory perception (GO:0050961)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0048634	regulation of muscle organ development (GO:0048634)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0050908	detection of light stimulus involved in visual perception (GO:0050908)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:1901298	regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:1905634	regulation of protein localization to chromatin (GO:1905634)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0090084	negative regulation of inclusion body assembly (GO:0090084)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0070486	leukocyte aggregation (GO:0070486)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:1905521	regulation of macrophage migration (GO:1905521)	44	4	2.58	+	1.55	3.40E-01	9.65E-01
GO:0031642	negative regulation of myelination (GO:0031642)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0070262	peptidyl-serine dephosphorylation (GO:0070262)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0099054	presynapse assembly (GO:0099054)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0035809	regulation of urine volume (GO:0035809)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0051016	barbed-end actin filament capping (GO:0051016)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0042996	regulation of Golgi to plasma membrane protein transport (GO:0042996)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0042989	sequestering of actin monomers (GO:0042989)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0030953	astral microtubule organization (GO:0030953)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0000289	nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0043277	apoptotic cell clearance (GO:0043277)	44	4	2.58	+	1.55	3.40E-01	9.65E-01
GO:0031284	positive regulation of guanylate cyclase activity (GO:0031284)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:1900272	negative regulation of long-term synaptic potentiation (GO:1900272)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:1900247	regulation of cytoplasmic translational elongation (GO:1900247)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0000050	urea cycle (GO:0000050)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0030644	cellular chloride ion homeostasis (GO:0030644)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0009120	deoxyribonucleoside metabolic process (GO:0009120)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0010985	negative regulation of lipoprotein particle clearance (GO:0010985)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0008611	ether lipid biosynthetic process (GO:0008611)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0042403	thyroid hormone metabolic process (GO:0042403)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0046710	GDP metabolic process (GO:0046710)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0030330	DNA damage response, signal transduction by p53 class mediator (GO:0030330)	44	4	2.58	+	1.55	3.40E-01	9.65E-01
GO:0030320	cellular monovalent inorganic anion homeostasis (GO:0030320)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0097384	cellular lipid biosynthetic process (GO:0097384)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0046628	positive regulation of insulin receptor signaling pathway (GO:0046628)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0008300	isoprenoid catabolic process (GO:0008300)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0046504	glycerol ether biosynthetic process (GO:0046504)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0097250	mitochondrial respirasome assembly (GO:0097250)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0042117	monocyte activation (GO:0042117)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0030033	microvillus assembly (GO:0030033)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0010459	negative regulation of heart rate (GO:0010459)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0021903	rostrocaudal neural tube patterning (GO:0021903)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0002759	regulation of antimicrobial humoral response (GO:0002759)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0002732	positive regulation of dendritic cell cytokine production (GO:0002732)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0045837	negative regulation of membrane potential (GO:0045837)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0033860	regulation of NAD(P)H oxidase activity (GO:0033860)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0021892	cerebral cortex GABAergic interneuron differentiation (GO:0021892)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0061043	regulation of vascular wound healing (GO:0061043)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0021889	olfactory bulb interneuron differentiation (GO:0021889)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0019532	oxalate transport (GO:0019532)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0072577	endothelial cell apoptotic process (GO:0072577)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0007530	sex determination (GO:0007530)	22	2	1.29	+	1.55	3.88E-01	1.00E00
GO:0003139	secondary heart field specification (GO:0003139)	11	1	.65	+	1.55	4.96E-01	1.00E00
GO:0003008	system process (GO:0003008)	2079	189	122.08	+	1.55	6.87E-09	4.66E-07
GO:2001243	negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	99	9	5.81	+	1.55	2.02E-01	7.70E-01
GO:2000677	regulation of transcription regulatory region DNA binding (GO:2000677)	55	5	3.23	+	1.55	3.86E-01	1.00E00
GO:0006633	fatty acid biosynthetic process (GO:0006633)	121	11	7.11	+	1.55	1.77E-01	7.09E-01
GO:0052372	modulation by symbiont of entry into host (GO:0052372)	55	5	3.23	+	1.55	3.86E-01	1.00E00
GO:0051865	protein autoubiquitination (GO:0051865)	77	7	4.52	+	1.55	2.33E-01	8.13E-01
GO:0043370	regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)	55	5	3.23	+	1.55	3.86E-01	1.00E00
GO:2000780	negative regulation of double-strand break repair (GO:2000780)	33	3	1.94	+	1.55	4.50E-01	1.00E00
GO:0002335	mature B cell differentiation (GO:0002335)	33	3	1.94	+	1.55	4.50E-01	1.00E00
GO:0043171	peptide catabolic process (GO:0043171)	33	3	1.94	+	1.55	4.50E-01	1.00E00
GO:0034389	lipid droplet organization (GO:0034389)	33	3	1.94	+	1.55	4.50E-01	1.00E00
GO:1903320	regulation of protein modification by small protein conjugation or removal (GO:1903320)	253	23	14.86	+	1.55	4.69E-02	3.65E-01
GO:0007166	cell surface receptor signaling pathway (GO:0007166)	2174	197	127.66	+	1.54	4.20E-09	3.03E-07
GO:0099537	trans-synaptic signaling (GO:0099537)	431	39	25.31	+	1.54	1.39E-02	1.62E-01
GO:0016310	phosphorylation (GO:0016310)	918	83	53.91	+	1.54	2.26E-04	5.54E-03
GO:0031347	regulation of defense response (GO:0031347)	642	58	37.70	+	1.54	2.39E-03	4.17E-02
GO:2000377	regulation of reactive oxygen species metabolic process (GO:2000377)	144	13	8.46	+	1.54	1.57E-01	7.11E-01
GO:1904950	negative regulation of establishment of protein localization (GO:1904950)	122	11	7.16	+	1.54	1.79E-01	7.17E-01
GO:0002761	regulation of myeloid leukocyte differentiation (GO:0002761)	122	11	7.16	+	1.54	1.79E-01	7.17E-01
GO:1902533	positive regulation of intracellular signal transduction (GO:1902533)	999	90	58.66	+	1.53	1.36E-04	3.65E-03
GO:0062012	regulation of small molecule metabolic process (GO:0062012)	333	30	19.55	+	1.53	2.76E-02	2.52E-01
GO:0051049	regulation of transport (GO:0051049)	1766	159	103.70	+	1.53	2.81E-07	1.45E-05
GO:0002521	leukocyte differentiation (GO:0002521)	400	36	23.49	+	1.53	1.93E-02	2.01E-01
GO:0060349	bone morphogenesis (GO:0060349)	100	9	5.87	+	1.53	2.06E-01	7.39E-01
GO:0006885	regulation of pH (GO:0006885)	100	9	5.87	+	1.53	2.06E-01	7.39E-01
GO:0046578	regulation of Ras protein signal transduction (GO:0046578)	200	18	11.74	+	1.53	9.88E-02	5.72E-01
GO:0051345	positive regulation of hydrolase activity (GO:0051345)	589	53	34.59	+	1.53	3.75E-03	6.01E-02
GO:0045861	negative regulation of proteolysis (GO:0045861)	345	31	20.26	+	1.53	2.97E-02	2.69E-01
GO:0000003	reproduction (GO:0000003)	1447	130	84.97	+	1.53	4.44E-06	1.82E-04
GO:0022414	reproductive process (GO:0022414)	1437	129	84.38	+	1.53	5.40E-06	2.16E-04
GO:0006513	protein monoubiquitination (GO:0006513)	78	7	4.58	+	1.53	2.38E-01	8.31E-01
GO:0015748	organophosphate ester transport (GO:0015748)	145	13	8.51	+	1.53	1.58E-01	6.61E-01
GO:0090596	sensory organ morphogenesis (GO:0090596)	279	25	16.38	+	1.53	5.66E-02	4.00E-01
GO:0072659	protein localization to plasma membrane (GO:0072659)	201	18	11.80	+	1.53	9.97E-02	5.73E-01
GO:0045580	regulation of T cell differentiation (GO:0045580)	179	16	10.51	+	1.52	1.14E-01	5.63E-01
GO:0023056	positive regulation of signaling (GO:0023056)	1701	152	99.88	+	1.52	7.32E-07	3.50E-05
GO:1903053	regulation of extracellular matrix organization (GO:1903053)	56	5	3.29	+	1.52	3.90E-01	1.00E00
GO:0002312	B cell activation involved in immune response (GO:0002312)	56	5	3.29	+	1.52	3.90E-01	1.00E00
GO:0070665	positive regulation of leukocyte proliferation (GO:0070665)	168	15	9.87	+	1.52	1.40E-01	6.58E-01
GO:0120192	tight junction assembly (GO:0120192)	56	5	3.29	+	1.52	3.90E-01	1.00E00
GO:0046822	regulation of nucleocytoplasmic transport (GO:0046822)	112	10	6.58	+	1.52	2.28E-01	7.98E-01
GO:0060998	regulation of dendritic spine development (GO:0060998)	56	5	3.29	+	1.52	3.90E-01	1.00E00
GO:0046605	regulation of centrosome cycle (GO:0046605)	56	5	3.29	+	1.52	3.90E-01	1.00E00
GO:0035019	somatic stem cell population maintenance (GO:0035019)	56	5	3.29	+	1.52	3.90E-01	1.00E00
GO:0007229	integrin-mediated signaling pathway (GO:0007229)	101	9	5.93	+	1.52	2.09E-01	7.51E-01
GO:0015914	phospholipid transport (GO:0015914)	101	9	5.93	+	1.52	2.09E-01	7.51E-01
GO:0009746	response to hexose (GO:0009746)	146	13	8.57	+	1.52	1.60E-01	6.58E-01
GO:0010647	positive regulation of cell communication (GO:0010647)	1696	151	99.59	+	1.52	1.18E-06	5.39E-05
GO:0045944	positive regulation of transcription by RNA polymerase II (GO:0045944)	1259	112	73.93	+	1.51	3.20E-05	1.04E-03
GO:0099536	synaptic signaling (GO:0099536)	461	41	27.07	+	1.51	1.33E-02	1.56E-01
GO:0042221	response to chemical (GO:0042221)	4060	361	238.41	+	1.51	3.85E-16	9.90E-14
GO:0045663	positive regulation of myoblast differentiation (GO:0045663)	45	4	2.64	+	1.51	3.49E-01	9.84E-01
GO:0019319	hexose biosynthetic process (GO:0019319)	45	4	2.64	+	1.51	3.49E-01	9.84E-01
GO:0071825	protein-lipid complex subunit organization (GO:0071825)	45	4	2.64	+	1.51	3.49E-01	9.84E-01
GO:0007224	smoothened signaling pathway (GO:0007224)	90	8	5.28	+	1.51	2.62E-01	8.51E-01
GO:0033003	regulation of mast cell activation (GO:0033003)	45	4	2.64	+	1.51	3.49E-01	9.83E-01
GO:0000578	embryonic axis specification (GO:0000578)	45	4	2.64	+	1.51	3.49E-01	9.83E-01
GO:0035924	cellular response to vascular endothelial growth factor stimulus (GO:0035924)	45	4	2.64	+	1.51	3.49E-01	9.83E-01
GO:0045910	negative regulation of DNA recombination (GO:0045910)	45	4	2.64	+	1.51	3.49E-01	9.83E-01
GO:0061001	regulation of dendritic spine morphogenesis (GO:0061001)	45	4	2.64	+	1.51	3.49E-01	9.83E-01
GO:0051172	negative regulation of nitrogen compound metabolic process (GO:0051172)	2409	214	141.46	+	1.51	3.73E-09	2.73E-07
GO:0033554	cellular response to stress (GO:0033554)	1599	142	93.89	+	1.51	2.48E-06	1.06E-04
GO:0048583	regulation of response to stimulus (GO:0048583)	4034	358	236.88	+	1.51	8.06E-16	1.97E-13
GO:0051052	regulation of DNA metabolic process (GO:0051052)	541	48	31.77	+	1.51	7.85E-03	1.04E-01
GO:0097190	apoptotic signaling pathway (GO:0097190)	316	28	18.56	+	1.51	4.25E-02	3.35E-01
GO:0048522	positive regulation of cellular process (GO:0048522)	5670	502	332.95	+	1.51	4.26E-24	2.67E-21
GO:0052547	regulation of peptidase activity (GO:0052547)	452	40	26.54	+	1.51	1.62E-02	1.79E-01
GO:0000122	negative regulation of transcription by RNA polymerase II (GO:0000122)	974	86	57.19	+	1.50	4.24E-04	9.57E-03
GO:0032501	multicellular organismal process (GO:0032501)	6581	581	386.44	+	1.50	2.30E-29	2.78E-26
GO:0007156	homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	170	15	9.98	+	1.50	1.43E-01	6.58E-01
GO:0006884	cell volume homeostasis (GO:0006884)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:0006688	glycosphingolipid biosynthetic process (GO:0006688)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:0014044	Schwann cell development (GO:0014044)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:1901797	negative regulation of signal transduction by p53 class mediator (GO:1901797)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:0002021	response to dietary excess (GO:0002021)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:0032673	regulation of interleukin-4 production (GO:0032673)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:0006301	postreplication repair (GO:0006301)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:0032212	positive regulation of telomere maintenance via telomerase (GO:0032212)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:1905476	negative regulation of protein localization to membrane (GO:1905476)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:1900076	regulation of cellular response to insulin stimulus (GO:1900076)	68	6	3.99	+	1.50	3.05E-01	9.16E-01
GO:1904377	positive regulation of protein localization to cell periphery (GO:1904377)	68	6	3.99	+	1.50	3.05E-01	9.16E-01
GO:0046632	alpha-beta T cell differentiation (GO:0046632)	68	6	3.99	+	1.50	3.05E-01	9.16E-01
GO:0046626	regulation of insulin receptor signaling pathway (GO:0046626)	68	6	3.99	+	1.50	3.05E-01	9.16E-01
GO:0003382	epithelial cell morphogenesis (GO:0003382)	34	3	2.00	+	1.50	4.59E-01	1.00E00
GO:0046394	carboxylic acid biosynthetic process (GO:0046394)	272	24	15.97	+	1.50	7.14E-02	4.63E-01
GO:0048518	positive regulation of biological process (GO:0048518)	6304	556	370.18	+	1.50	1.86E-27	1.82E-24
GO:0023052	signaling (GO:0023052)	5231	461	307.17	+	1.50	4.19E-21	2.27E-18
GO:1903706	regulation of hemopoiesis (GO:1903706)	398	35	23.37	+	1.50	2.54E-02	2.48E-01
GO:0099173	postsynapse organization (GO:0099173)	91	8	5.34	+	1.50	2.66E-01	8.53E-01
GO:0006996	organelle organization (GO:0006996)	3026	266	177.69	+	1.50	5.36E-11	5.96E-09
GO:0120254	olefinic compound metabolic process (GO:0120254)	148	13	8.69	+	1.50	1.64E-01	6.72E-01
GO:0050671	positive regulation of lymphocyte proliferation (GO:0050671)	148	13	8.69	+	1.50	1.64E-01	6.72E-01
GO:0051053	negative regulation of DNA metabolic process (GO:0051053)	148	13	8.69	+	1.50	1.64E-01	6.72E-01
GO:0045620	negative regulation of lymphocyte differentiation (GO:0045620)	57	5	3.35	+	1.49	3.94E-01	1.00E00
GO:0050433	regulation of catecholamine secretion (GO:0050433)	57	5	3.35	+	1.49	3.94E-01	1.00E00
GO:1900015	regulation of cytokine production involved in inflammatory response (GO:1900015)	57	5	3.35	+	1.49	3.94E-01	1.00E00
GO:0002237	response to molecule of bacterial origin (GO:0002237)	331	29	19.44	+	1.49	4.70E-02	3.61E-01
GO:0072175	epithelial tube formation (GO:0072175)	137	12	8.04	+	1.49	2.04E-01	7.76E-01
GO:0010605	negative regulation of macromolecule metabolic process (GO:0010605)	2764	242	162.30	+	1.49	9.19E-10	7.71E-08
GO:0048592	eye morphogenesis (GO:0048592)	160	14	9.40	+	1.49	1.79E-01	7.17E-01
GO:0030593	neutrophil chemotaxis (GO:0030593)	80	7	4.70	+	1.49	3.40E-01	9.65E-01
GO:1902679	negative regulation of RNA biosynthetic process (GO:1902679)	1327	116	77.92	+	1.49	4.86E-05	1.52E-03
GO:0007165	signal transduction (GO:0007165)	4887	427	286.97	+	1.49	1.78E-18	6.81E-16
GO:0042476	odontogenesis (GO:0042476)	126	11	7.40	+	1.49	1.90E-01	7.42E-01
GO:1903305	regulation of regulated secretory pathway (GO:1903305)	149	13	8.75	+	1.49	1.66E-01	6.80E-01
GO:0043550	regulation of lipid kinase activity (GO:0043550)	69	6	4.05	+	1.48	3.11E-01	9.25E-01
GO:0007268	chemical synaptic transmission (GO:0007268)	414	36	24.31	+	1.48	2.81E-02	2.56E-01
GO:0021533	cell differentiation in hindbrain (GO:0021533)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0002204	somatic recombination of immunoglobulin genes involved in immune response (GO:0002204)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0007099	centriole replication (GO:0007099)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0007097	nuclear migration (GO:0007097)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0032891	negative regulation of organic acid transport (GO:0032891)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0060065	uterus development (GO:0060065)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0045190	isotype switching (GO:0045190)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0098916	anterograde trans-synaptic signaling (GO:0098916)	414	36	24.31	+	1.48	2.81E-02	2.56E-01
GO:0050829	defense response to Gram-negative bacterium (GO:0050829)	92	8	5.40	+	1.48	2.70E-01	8.62E-01
GO:0016574	histone ubiquitination (GO:0016574)	46	4	2.70	+	1.48	3.58E-01	1.00E00
GO:1900273	positive regulation of long-term synaptic potentiation (GO:1900273)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0035561	regulation of chromatin binding (GO:0035561)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0035455	response to interferon-alpha (GO:0035455)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0042430	indole-containing compound metabolic process (GO:0042430)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0010839	negative regulation of keratinocyte proliferation (GO:0010839)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0097150	neuronal stem cell population maintenance (GO:0097150)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0021846	cell proliferation in forebrain (GO:0021846)	23	2	1.35	+	1.48	6.47E-01	1.00E00
GO:0045892	negative regulation of DNA-templated transcription (GO:0045892)	1323	115	77.69	+	1.48	6.20E-05	1.89E-03
GO:0010628	positive regulation of gene expression (GO:0010628)	1151	100	67.59	+	1.48	2.13E-04	5.31E-03
GO:0007154	cell communication (GO:0007154)	5342	464	313.69	+	1.48	5.04E-20	2.26E-17
GO:0009890	negative regulation of biosynthetic process (GO:0009890)	1624	141	95.36	+	1.48	1.03E-05	3.82E-04
GO:1903507	negative regulation of nucleic acid-templated transcription (GO:1903507)	1325	115	77.80	+	1.48	7.88E-05	2.33E-03
GO:0019216	regulation of lipid metabolic process (GO:0019216)	346	30	20.32	+	1.48	5.19E-02	3.92E-01
GO:0009892	negative regulation of metabolic process (GO:0009892)	2988	259	175.46	+	1.48	3.86E-10	3.46E-08
GO:0035282	segmentation (GO:0035282)	104	9	6.11	+	1.47	2.97E-01	8.92E-01
GO:0022409	positive regulation of cell-cell adhesion (GO:0022409)	324	28	19.03	+	1.47	5.88E-02	4.10E-01
GO:0016043	cellular component organization (GO:0016043)	5523	477	324.31	+	1.47	2.60E-20	1.28E-17
GO:0032496	response to lipopolysaccharide (GO:0032496)	313	27	18.38	+	1.47	5.59E-02	3.96E-01
GO:0019369	arachidonic acid metabolic process (GO:0019369)	58	5	3.41	+	1.47	3.99E-01	1.00E00
GO:0008637	apoptotic mitochondrial changes (GO:0008637)	58	5	3.41	+	1.47	3.99E-01	1.00E00
GO:0045912	negative regulation of carbohydrate metabolic process (GO:0045912)	58	5	3.41	+	1.47	3.99E-01	1.00E00
GO:0002763	positive regulation of myeloid leukocyte differentiation (GO:0002763)	58	5	3.41	+	1.47	3.99E-01	1.00E00
GO:0007162	negative regulation of cell adhesion (GO:0007162)	290	25	17.03	+	1.47	8.06E-02	5.04E-01
GO:0051716	cellular response to stimulus (GO:0051716)	6569	566	385.74	+	1.47	1.43E-25	1.12E-22
GO:0032946	positive regulation of mononuclear cell proliferation (GO:0032946)	151	13	8.87	+	1.47	1.71E-01	6.95E-01
GO:0016331	morphogenesis of embryonic epithelium (GO:0016331)	151	13	8.87	+	1.47	1.71E-01	6.95E-01
GO:0006974	cellular response to DNA damage stimulus (GO:0006974)	756	65	44.39	+	1.46	3.90E-03	6.22E-02
GO:0080134	regulation of response to stress (GO:0080134)	1373	118	80.62	+	1.46	8.13E-05	2.37E-03
GO:0031668	cellular response to extracellular stimulus (GO:0031668)	256	22	15.03	+	1.46	8.61E-02	5.11E-01
GO:0045738	negative regulation of DNA repair (GO:0045738)	35	3	2.06	+	1.46	4.67E-01	1.00E00
GO:0021799	cerebral cortex radially oriented cell migration (GO:0021799)	35	3	2.06	+	1.46	4.67E-01	1.00E00
GO:0006956	complement activation (GO:0006956)	140	12	8.22	+	1.46	2.10E-01	7.51E-01
GO:0021549	cerebellum development (GO:0021549)	105	9	6.17	+	1.46	2.99E-01	8.99E-01
GO:2000406	positive regulation of T cell migration (GO:2000406)	35	3	2.06	+	1.46	4.67E-01	1.00E00
GO:0071398	cellular response to fatty acid (GO:0071398)	35	3	2.06	+	1.46	4.67E-01	1.00E00
GO:0090181	regulation of cholesterol metabolic process (GO:0090181)	35	3	2.06	+	1.46	4.67E-01	1.00E00
GO:0035335	peptidyl-tyrosine dephosphorylation (GO:0035335)	35	3	2.06	+	1.46	4.67E-01	1.00E00
GO:0002719	negative regulation of cytokine production involved in immune response (GO:0002719)	35	3	2.06	+	1.46	4.67E-01	1.00E00
GO:0072593	reactive oxygen species metabolic process (GO:0072593)	105	9	6.17	+	1.46	2.99E-01	8.99E-01
GO:0032675	regulation of interleukin-6 production (GO:0032675)	152	13	8.93	+	1.46	1.74E-01	7.00E-01
GO:0010821	regulation of mitochondrion organization (GO:0010821)	152	13	8.93	+	1.46	1.74E-01	7.00E-01
GO:0022412	cellular process involved in reproduction in multicellular organism (GO:0022412)	421	36	24.72	+	1.46	3.78E-02	3.20E-01
GO:0045582	positive regulation of T cell differentiation (GO:0045582)	117	10	6.87	+	1.46	2.41E-01	8.39E-01
GO:0006694	steroid biosynthetic process (GO:0006694)	117	10	6.87	+	1.46	2.41E-01	8.39E-01
GO:0051173	positive regulation of nitrogen compound metabolic process (GO:0051173)	3174	271	186.38	+	1.45	5.95E-10	5.19E-08
GO:0071229	cellular response to acid chemical (GO:0071229)	82	7	4.82	+	1.45	3.46E-01	9.82E-01
GO:0015850	organic hydroxy compound transport (GO:0015850)	164	14	9.63	+	1.45	1.85E-01	7.29E-01
GO:1903351	cellular response to dopamine (GO:1903351)	82	7	4.82	+	1.45	3.46E-01	9.82E-01
GO:0031327	negative regulation of cellular biosynthetic process (GO:0031327)	1594	136	93.60	+	1.45	2.99E-05	9.86E-04
GO:0052548	regulation of endopeptidase activity (GO:0052548)	422	36	24.78	+	1.45	3.81E-02	3.20E-01
GO:0048706	embryonic skeletal system development (GO:0048706)	129	11	7.57	+	1.45	2.61E-01	8.49E-01
GO:0009749	response to glucose (GO:0009749)	141	12	8.28	+	1.45	2.12E-01	7.57E-01
GO:1903202	negative regulation of oxidative stress-induced cell death (GO:1903202)	47	4	2.76	+	1.45	3.67E-01	9.97E-01
GO:0048704	embryonic skeletal system morphogenesis (GO:0048704)	94	8	5.52	+	1.45	2.78E-01	8.84E-01
GO:0120163	negative regulation of cold-induced thermogenesis (GO:0120163)	47	4	2.76	+	1.45	3.67E-01	9.97E-01
GO:0051180	vitamin transport (GO:0051180)	47	4	2.76	+	1.45	3.67E-01	9.97E-01
GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)	94	8	5.52	+	1.45	2.78E-01	8.83E-01
GO:0035304	regulation of protein dephosphorylation (GO:0035304)	94	8	5.52	+	1.45	2.78E-01	8.83E-01
GO:0050865	regulation of cell activation (GO:0050865)	741	63	43.51	+	1.45	5.82E-03	8.47E-02
GO:0031325	positive regulation of cellular metabolic process (GO:0031325)	3122	265	183.33	+	1.45	1.66E-09	1.32E-07
GO:0098727	maintenance of cell number (GO:0098727)	118	10	6.93	+	1.44	2.44E-01	8.42E-01
GO:0051224	negative regulation of protein transport (GO:0051224)	118	10	6.93	+	1.44	2.44E-01	8.42E-01
GO:0045471	response to ethanol (GO:0045471)	130	11	7.63	+	1.44	2.63E-01	8.52E-01
GO:0048584	positive regulation of response to stimulus (GO:0048584)	2223	188	130.54	+	1.44	1.08E-06	4.98E-05
GO:0010604	positive regulation of macromolecule metabolic process (GO:0010604)	3542	299	207.99	+	1.44	1.60E-10	1.58E-08
GO:0034284	response to monosaccharide (GO:0034284)	154	13	9.04	+	1.44	2.30E-01	8.06E-01
GO:0031324	negative regulation of cellular metabolic process (GO:0031324)	2264	191	132.94	+	1.44	1.03E-06	4.81E-05
GO:2001021	negative regulation of response to DNA damage stimulus (GO:2001021)	83	7	4.87	+	1.44	3.50E-01	9.85E-01
GO:0015918	sterol transport (GO:0015918)	83	7	4.87	+	1.44	3.50E-01	9.85E-01
GO:1903350	response to dopamine (GO:1903350)	83	7	4.87	+	1.44	3.50E-01	9.85E-01
GO:0006950	response to stress (GO:0006950)	3466	292	203.53	+	1.43	4.00E-10	3.56E-08
GO:0032872	regulation of stress-activated MAPK cascade (GO:0032872)	190	16	11.16	+	1.43	1.67E-01	6.81E-01
GO:1903321	negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	95	8	5.58	+	1.43	2.82E-01	8.94E-01
GO:0043547	positive regulation of GTPase activity (GO:0043547)	286	24	16.79	+	1.43	1.02E-01	5.85E-01
GO:0045934	negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	1562	131	91.72	+	1.43	8.37E-05	2.43E-03
GO:2001242	regulation of intrinsic apoptotic signaling pathway (GO:2001242)	167	14	9.81	+	1.43	1.91E-01	7.45E-01
GO:1905952	regulation of lipid localization (GO:1905952)	167	14	9.81	+	1.43	1.91E-01	7.45E-01
GO:0010558	negative regulation of macromolecule biosynthetic process (GO:0010558)	1533	128	90.02	+	1.42	1.42E-04	3.79E-03
GO:0071840	cellular component organization or biogenesis (GO:0071840)	5727	478	336.29	+	1.42	1.81E-17	5.69E-15
GO:0030162	regulation of proteolysis (GO:0030162)	743	62	43.63	+	1.42	9.37E-03	1.20E-01
GO:0009605	response to external stimulus (GO:0009605)	2469	206	144.98	+	1.42	6.49E-07	3.12E-05
GO:0033146	regulation of intracellular estrogen receptor signaling pathway (GO:0033146)	36	3	2.11	+	1.42	4.76E-01	1.00E00
GO:0018149	peptide cross-linking (GO:0018149)	36	3	2.11	+	1.42	4.76E-01	1.00E00
GO:0098930	axonal transport (GO:0098930)	60	5	3.52	+	1.42	4.10E-01	1.00E00
GO:0050974	detection of mechanical stimulus involved in sensory perception (GO:0050974)	36	3	2.11	+	1.42	4.76E-01	1.00E00
GO:0031112	positive regulation of microtubule polymerization or depolymerization (GO:0031112)	36	3	2.11	+	1.42	4.76E-01	1.00E00
GO:0046676	negative regulation of insulin secretion (GO:0046676)	36	3	2.11	+	1.42	4.76E-01	1.00E00
GO:1903531	negative regulation of secretion by cell (GO:1903531)	144	12	8.46	+	1.42	2.20E-01	7.80E-01
GO:0002821	positive regulation of adaptive immune response (GO:0002821)	120	10	7.05	+	1.42	2.51E-01	8.22E-01
GO:0046326	positive regulation of glucose import (GO:0046326)	36	3	2.11	+	1.42	4.76E-01	1.00E00
GO:0045793	positive regulation of cell size (GO:0045793)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0021702	cerebellar Purkinje cell differentiation (GO:0021702)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0006972	hyperosmotic response (GO:0006972)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0006971	hypotonic response (GO:0006971)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0046129	purine ribonucleoside biosynthetic process (GO:0046129)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0071941	nitrogen cycle metabolic process (GO:0071941)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0045652	regulation of megakaryocyte differentiation (GO:0045652)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0033629	negative regulation of cell adhesion mediated by integrin (GO:0033629)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:2000833	positive regulation of steroid hormone secretion (GO:2000833)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0072310	glomerular epithelial cell development (GO:0072310)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1902667	regulation of axon guidance (GO:1902667)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0033540	fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0001967	suckling behavior (GO:0001967)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1902510	regulation of apoptotic DNA fragmentation (GO:1902510)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0002347	response to tumor cell (GO:0002347)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0007179	transforming growth factor beta receptor signaling pathway (GO:0007179)	96	8	5.64	+	1.42	2.87E-01	9.02E-01
GO:0072178	nephric duct morphogenesis (GO:0072178)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:2000637	positive regulation of miRNA-mediated gene silencing (GO:2000637)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0060143	positive regulation of syncytium formation by plasma membrane fusion (GO:0060143)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0033327	Leydig cell differentiation (GO:0033327)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0001771	immunological synapse formation (GO:0001771)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0072070	loop of Henle development (GO:0072070)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0060026	convergent extension (GO:0060026)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0051932	synaptic transmission, GABAergic (GO:0051932)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0038095	Fc-epsilon receptor signaling pathway (GO:0038095)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0038063	collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1902260	negative regulation of delayed rectifier potassium channel activity (GO:1902260)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0014049	positive regulation of glutamate secretion (GO:0014049)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0005980	glycogen catabolic process (GO:0005980)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0033148	positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:2000344	positive regulation of acrosome reaction (GO:2000344)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0071359	cellular response to dsRNA (GO:0071359)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:1901673	regulation of mitotic spindle assembly (GO:1901673)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0018231	peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0018230	peptidyl-L-cysteine S-palmitoylation (GO:0018230)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0071287	cellular response to manganese ion (GO:0071287)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0051639	actin filament network formation (GO:0051639)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1901535	regulation of DNA demethylation (GO:1901535)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1901503	ether biosynthetic process (GO:1901503)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0090331	negative regulation of platelet aggregation (GO:0090331)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:2000178	negative regulation of neural precursor cell proliferation (GO:2000178)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0032490	detection of molecule of bacterial origin (GO:0032490)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0099563	modification of synaptic structure (GO:0099563)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0032351	negative regulation of hormone metabolic process (GO:0032351)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0006068	ethanol catabolic process (GO:0006068)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1905665	positive regulation of calcium ion import across plasma membrane (GO:1905665)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0051340	regulation of ligase activity (GO:0051340)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0050866	negative regulation of cell activation (GO:0050866)	216	18	12.68	+	1.42	1.50E-01	6.82E-01
GO:0120255	olefinic compound biosynthetic process (GO:0120255)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1901142	insulin metabolic process (GO:1901142)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0032094	response to food (GO:0032094)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0032008	positive regulation of TOR signaling (GO:0032008)	48	4	2.82	+	1.42	5.34E-01	1.00E00
GO:0020027	hemoglobin metabolic process (GO:0020027)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0043589	skin morphogenesis (GO:0043589)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0048313	Golgi inheritance (GO:0048313)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0048308	organelle inheritance (GO:0048308)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0051095	regulation of helicase activity (GO:0051095)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1904894	positive regulation of receptor signaling pathway via STAT (GO:1904894)	48	4	2.82	+	1.42	5.34E-01	1.00E00
GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0035773	insulin secretion involved in cellular response to glucose stimulus (GO:0035773)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0043380	regulation of memory T cell differentiation (GO:0043380)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0036152	phosphatidylethanolamine acyl-chain remodeling (GO:0036152)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0043276	anoikis (GO:0043276)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0031280	negative regulation of cyclase activity (GO:0031280)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0009395	phospholipid catabolic process (GO:0009395)	48	4	2.82	+	1.42	5.34E-01	1.00E00
GO:0042756	drinking behavior (GO:0042756)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0031145	anaphase-promoting complex-dependent catabolic process (GO:0031145)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0015812	gamma-aminobutyric acid transport (GO:0015812)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0009134	nucleoside diphosphate catabolic process (GO:0009134)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0046940	nucleoside monophosphate phosphorylation (GO:0046940)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0046929	negative regulation of neurotransmitter secretion (GO:0046929)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0009086	methionine biosynthetic process (GO:0009086)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0042455	ribonucleoside biosynthetic process (GO:0042455)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0042451	purine nucleoside biosynthetic process (GO:0042451)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0016188	synaptic vesicle maturation (GO:0016188)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0010826	negative regulation of centrosome duplication (GO:0010826)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1903800	positive regulation of miRNA maturation (GO:1903800)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0150065	regulation of deacetylase activity (GO:0150065)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0034754	cellular hormone metabolic process (GO:0034754)	132	11	7.75	+	1.42	2.67E-01	8.56E-01
GO:0046718	viral entry into host cell (GO:0046718)	108	9	6.34	+	1.42	3.07E-01	9.15E-01
GO:0019985	translesion synthesis (GO:0019985)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0046606	negative regulation of centrosome cycle (GO:0046606)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0019755	one-carbon compound transport (GO:0019755)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0060736	prostate gland growth (GO:0060736)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0042092	type 2 immune response (GO:0042092)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0003309	type B pancreatic cell differentiation (GO:0003309)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0002887	negative regulation of myeloid leukocyte mediated immunity (GO:0002887)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0061162	establishment of monopolar cell polarity (GO:0061162)	24	2	1.41	+	1.42	6.54E-01	1.00E00
GO:0019627	urea metabolic process (GO:0019627)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:1902930	regulation of alcohol biosynthetic process (GO:1902930)	48	4	2.82	+	1.42	5.34E-01	1.00E00
GO:0014733	regulation of skeletal muscle adaptation (GO:0014733)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0021860	pyramidal neuron development (GO:0021860)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0003157	endocardium development (GO:0003157)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0003128	heart field specification (GO:0003128)	12	1	.70	+	1.42	5.24E-01	1.00E00
GO:0060341	regulation of cellular localization (GO:0060341)	962	80	56.49	+	1.42	3.47E-03	5.60E-02
GO:0007389	pattern specification process (GO:0007389)	457	38	26.84	+	1.42	4.60E-02	3.58E-01
GO:0002683	negative regulation of immune system process (GO:0002683)	434	36	25.48	+	1.41	5.20E-02	3.92E-01
GO:0070302	regulation of stress-activated protein kinase signaling cascade (GO:0070302)	193	16	11.33	+	1.41	1.72E-01	6.98E-01
GO:0060173	limb development (GO:0060173)	181	15	10.63	+	1.41	2.07E-01	7.41E-01
GO:0048736	appendage development (GO:0048736)	181	15	10.63	+	1.41	2.07E-01	7.41E-01
GO:0051099	positive regulation of binding (GO:0051099)	181	15	10.63	+	1.41	2.07E-01	7.41E-01
GO:0030217	T cell differentiation (GO:0030217)	169	14	9.92	+	1.41	1.95E-01	7.59E-01
GO:0035108	limb morphogenesis (GO:0035108)	145	12	8.51	+	1.41	2.23E-01	7.81E-01
GO:0035107	appendage morphogenesis (GO:0035107)	145	12	8.51	+	1.41	2.23E-01	7.81E-01
GO:0000018	regulation of DNA recombination (GO:0000018)	133	11	7.81	+	1.41	2.70E-01	8.62E-01
GO:0009893	positive regulation of metabolic process (GO:0009893)	3858	319	226.54	+	1.41	2.93E-10	2.73E-08
GO:0030326	embryonic limb morphogenesis (GO:0030326)	121	10	7.11	+	1.41	3.33E-01	9.49E-01
GO:0035113	embryonic appendage morphogenesis (GO:0035113)	121	10	7.11	+	1.41	3.33E-01	9.49E-01
GO:0050896	response to stimulus (GO:0050896)	8209	678	482.04	+	1.41	3.26E-28	3.41E-25
GO:0098662	inorganic cation transmembrane transport (GO:0098662)	606	50	35.58	+	1.41	2.38E-02	2.36E-01
GO:0051453	regulation of intracellular pH (GO:0051453)	85	7	4.99	+	1.40	3.58E-01	1.00E00
GO:0048017	inositol lipid-mediated signaling (GO:0048017)	85	7	4.99	+	1.40	3.58E-01	1.00E00
GO:0051253	negative regulation of RNA metabolic process (GO:0051253)	1435	118	84.26	+	1.40	4.36E-04	9.75E-03
GO:0002286	T cell activation involved in immune response (GO:0002286)	73	6	4.29	+	1.40	4.52E-01	1.00E00
GO:0008088	axo-dendritic transport (GO:0008088)	73	6	4.29	+	1.40	4.52E-01	1.00E00
GO:0061035	regulation of cartilage development (GO:0061035)	73	6	4.29	+	1.40	4.52E-01	1.00E00
GO:0010629	negative regulation of gene expression (GO:0010629)	902	74	52.97	+	1.40	6.40E-03	9.03E-02
GO:0009991	response to extracellular stimulus (GO:0009991)	500	41	29.36	+	1.40	4.50E-02	3.50E-01
GO:0006998	nuclear envelope organization (GO:0006998)	61	5	3.58	+	1.40	4.16E-01	1.00E00
GO:0032963	collagen metabolic process (GO:0032963)	61	5	3.58	+	1.40	4.16E-01	1.00E00
GO:0002090	regulation of receptor internalization (GO:0002090)	61	5	3.58	+	1.40	4.16E-01	1.00E00
GO:0061512	protein localization to cilium (GO:0061512)	61	5	3.58	+	1.40	4.16E-01	1.00E00
GO:0071466	cellular response to xenobiotic stimulus (GO:0071466)	183	15	10.75	+	1.40	2.10E-01	7.52E-01
GO:0044409	entry into host (GO:0044409)	110	9	6.46	+	1.39	3.13E-01	9.31E-01
GO:0048259	regulation of receptor-mediated endocytosis (GO:0048259)	110	9	6.46	+	1.39	3.13E-01	9.31E-01
GO:0045776	negative regulation of blood pressure (GO:0045776)	49	4	2.88	+	1.39	5.38E-01	1.00E00
GO:0007009	plasma membrane organization (GO:0007009)	147	12	8.63	+	1.39	2.92E-01	8.82E-01
GO:0030857	negative regulation of epithelial cell differentiation (GO:0030857)	49	4	2.88	+	1.39	5.38E-01	1.00E00
GO:0030850	prostate gland development (GO:0030850)	49	4	2.88	+	1.39	5.38E-01	1.00E00
GO:0055081	anion homeostasis (GO:0055081)	49	4	2.88	+	1.39	5.38E-01	1.00E00
GO:0062013	positive regulation of small molecule metabolic process (GO:0062013)	147	12	8.63	+	1.39	2.92E-01	8.81E-01
GO:0046677	response to antibiotic (GO:0046677)	49	4	2.88	+	1.39	5.38E-01	1.00E00
GO:0034308	primary alcohol metabolic process (GO:0034308)	98	8	5.75	+	1.39	3.89E-01	1.00E00
GO:0032504	multicellular organism reproduction (GO:0032504)	908	74	53.32	+	1.39	8.10E-03	1.06E-01
GO:0035303	regulation of dephosphorylation (GO:0035303)	135	11	7.93	+	1.39	2.75E-01	8.76E-01
GO:1901292	nucleoside phosphate catabolic process (GO:1901292)	86	7	5.05	+	1.39	3.62E-01	1.00E00
GO:0055072	iron ion homeostasis (GO:0055072)	86	7	5.05	+	1.39	3.62E-01	1.00E00
GO:1902680	positive regulation of RNA biosynthetic process (GO:1902680)	1721	140	101.06	+	1.39	2.01E-04	5.08E-03
GO:1902115	regulation of organelle assembly (GO:1902115)	209	17	12.27	+	1.39	1.88E-01	7.35E-01
GO:0098660	inorganic ion transmembrane transport (GO:0098660)	701	57	41.16	+	1.38	1.90E-02	1.99E-01
GO:0003006	developmental process involved in reproduction (GO:0003006)	947	77	55.61	+	1.38	6.30E-03	8.90E-02
GO:0002698	negative regulation of immune effector process (GO:0002698)	123	10	7.22	+	1.38	3.37E-01	9.58E-01
GO:1905954	positive regulation of lipid localization (GO:1905954)	111	9	6.52	+	1.38	3.16E-01	9.41E-01
GO:2000060	positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	111	9	6.52	+	1.38	3.16E-01	9.40E-01
GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)	37	3	2.17	+	1.38	4.86E-01	1.00E00
GO:0006882	cellular zinc ion homeostasis (GO:0006882)	37	3	2.17	+	1.38	4.86E-01	1.00E00
GO:0071230	cellular response to amino acid stimulus (GO:0071230)	74	6	4.35	+	1.38	4.56E-01	1.00E00
GO:0070229	negative regulation of lymphocyte apoptotic process (GO:0070229)	37	3	2.17	+	1.38	4.86E-01	1.00E00
GO:0031016	pancreas development (GO:0031016)	74	6	4.35	+	1.38	4.56E-01	1.00E00
GO:1904358	positive regulation of telomere maintenance via telomere lengthening (GO:1904358)	37	3	2.17	+	1.38	4.86E-01	1.00E00
GO:0022600	digestive system process (GO:0022600)	74	6	4.35	+	1.38	4.56E-01	1.00E00
GO:0010876	lipid localization (GO:0010876)	370	30	21.73	+	1.38	9.68E-02	5.61E-01
GO:0022607	cellular component assembly (GO:0022607)	2394	194	140.58	+	1.38	8.73E-06	3.29E-04
GO:0002682	regulation of immune system process (GO:0002682)	1520	123	89.26	+	1.38	6.09E-04	1.32E-02
GO:0098754	detoxification (GO:0098754)	136	11	7.99	+	1.38	2.78E-01	8.83E-01
GO:0043255	regulation of carbohydrate biosynthetic process (GO:0043255)	99	8	5.81	+	1.38	3.91E-01	1.00E00
GO:0010970	transport along microtubule (GO:0010970)	161	13	9.45	+	1.38	2.45E-01	8.45E-01
GO:0002684	positive regulation of immune system process (GO:0002684)	967	78	56.78	+	1.37	8.29E-03	1.09E-01
GO:0035710	CD4-positive, alpha-beta T cell activation (GO:0035710)	62	5	3.64	+	1.37	4.22E-01	1.00E00
GO:0071621	granulocyte chemotaxis (GO:0071621)	87	7	5.11	+	1.37	3.67E-01	1.00E00
GO:0001523	retinoid metabolic process (GO:0001523)	87	7	5.11	+	1.37	3.67E-01	1.00E00
GO:0006029	proteoglycan metabolic process (GO:0006029)	87	7	5.11	+	1.37	3.67E-01	1.00E00
GO:0045862	positive regulation of proteolysis (GO:0045862)	373	30	21.90	+	1.37	9.86E-02	5.71E-01
GO:0120034	positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)	112	9	6.58	+	1.37	3.20E-01	9.51E-01
GO:0046916	cellular transition metal ion homeostasis (GO:0046916)	112	9	6.58	+	1.37	3.20E-01	9.51E-01
GO:0010557	positive regulation of macromolecule biosynthetic process (GO:0010557)	1943	156	114.09	+	1.37	1.33E-04	3.60E-03
GO:0045935	positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	2058	165	120.85	+	1.37	8.83E-05	2.53E-03
GO:0045665	negative regulation of neuron differentiation (GO:0045665)	75	6	4.40	+	1.36	4.59E-01	1.00E00
GO:0032880	regulation of protein localization (GO:0032880)	850	68	49.91	+	1.36	1.49E-02	1.72E-01
GO:0015908	fatty acid transport (GO:0015908)	75	6	4.40	+	1.36	4.59E-01	1.00E00
GO:1901136	carbohydrate derivative catabolic process (GO:1901136)	175	14	10.28	+	1.36	2.61E-01	8.49E-01
GO:0018904	ether metabolic process (GO:0018904)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0045686	negative regulation of glial cell differentiation (GO:0045686)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0046033	AMP metabolic process (GO:0046033)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0060148	positive regulation of post-transcriptional gene silencing (GO:0060148)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0033233	regulation of protein sumoylation (GO:0033233)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0032727	positive regulation of interferon-alpha production (GO:0032727)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0051788	response to misfolded protein (GO:0051788)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0070830	bicellular tight junction assembly (GO:0070830)	50	4	2.94	+	1.36	5.43E-01	1.00E00
GO:1902074	response to salt (GO:1902074)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0051560	mitochondrial calcium ion homeostasis (GO:0051560)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0090023	positive regulation of neutrophil chemotaxis (GO:0090023)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0043687	post-translational protein modification (GO:0043687)	50	4	2.94	+	1.36	5.43E-01	1.00E00
GO:0031648	protein destabilization (GO:0031648)	50	4	2.94	+	1.36	5.43E-01	1.00E00
GO:0070233	negative regulation of T cell apoptotic process (GO:0070233)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0009435	NAD biosynthetic process (GO:0009435)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0050482	arachidonic acid secretion (GO:0050482)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:1900370	positive regulation of post-transcriptional gene silencing by RNA (GO:1900370)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0048013	ephrin receptor signaling pathway (GO:0048013)	50	4	2.94	+	1.36	5.43E-01	1.00E00
GO:0047497	mitochondrion transport along microtubule (GO:0047497)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0031065	positive regulation of histone deacetylation (GO:0031065)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0031061	negative regulation of histone methylation (GO:0031061)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0009162	deoxyribonucleoside monophosphate metabolic process (GO:0009162)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:1900078	positive regulation of cellular response to insulin stimulus (GO:1900078)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:1903963	arachidonate transport (GO:1903963)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:1903902	positive regulation of viral life cycle (GO:1903902)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0009065	glutamine family amino acid catabolic process (GO:0009065)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0046885	regulation of hormone biosynthetic process (GO:0046885)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:1903792	negative regulation of anion transport (GO:1903792)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0034643	establishment of mitochondrion localization, microtubule-mediated (GO:0034643)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0061339	establishment or maintenance of monopolar cell polarity (GO:0061339)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:0046456	icosanoid biosynthetic process (GO:0046456)	50	4	2.94	+	1.36	5.43E-01	1.00E00
GO:0021854	hypothalamus development (GO:0021854)	25	2	1.47	+	1.36	6.60E-01	1.00E00
GO:1903508	positive regulation of nucleic acid-templated transcription (GO:1903508)	1715	137	100.71	+	1.36	4.50E-04	1.00E-02
GO:0045893	positive regulation of DNA-templated transcription (GO:0045893)	1715	137	100.71	+	1.36	4.50E-04	1.00E-02
GO:1903131	mononuclear cell differentiation (GO:1903131)	326	26	19.14	+	1.36	1.27E-01	6.05E-01
GO:0009895	negative regulation of catabolic process (GO:0009895)	326	26	19.14	+	1.36	1.27E-01	6.05E-01
GO:0006836	neurotransmitter transport (GO:0006836)	138	11	8.10	+	1.36	2.84E-01	8.99E-01
GO:1903039	positive regulation of leukocyte cell-cell adhesion (GO:1903039)	276	22	16.21	+	1.36	1.61E-01	6.60E-01
GO:0060627	regulation of vesicle-mediated transport (GO:0060627)	552	44	32.41	+	1.36	5.59E-02	3.96E-01
GO:0010817	regulation of hormone levels (GO:0010817)	528	42	31.00	+	1.35	6.28E-02	4.32E-01
GO:2000116	regulation of cysteine-type endopeptidase activity (GO:2000116)	239	19	14.03	+	1.35	2.16E-01	7.69E-01
GO:0050994	regulation of lipid catabolic process (GO:0050994)	63	5	3.70	+	1.35	4.28E-01	1.00E00
GO:0046777	protein autophosphorylation (GO:0046777)	189	15	11.10	+	1.35	2.79E-01	8.85E-01
GO:0048609	multicellular organismal reproductive process (GO:0048609)	870	69	51.09	+	1.35	1.61E-02	1.78E-01
GO:0032760	positive regulation of tumor necrosis factor production (GO:0032760)	101	8	5.93	+	1.35	3.97E-01	1.00E00
GO:0051341	regulation of oxidoreductase activity (GO:0051341)	101	8	5.93	+	1.35	3.97E-01	1.00E00
GO:0015718	monocarboxylic acid transport (GO:0015718)	101	8	5.93	+	1.35	3.97E-01	1.00E00
GO:0045732	positive regulation of protein catabolic process (GO:0045732)	215	17	12.62	+	1.35	2.46E-01	8.46E-01
GO:0002637	regulation of immunoglobulin production (GO:0002637)	76	6	4.46	+	1.34	4.63E-01	1.00E00
GO:0072337	modified amino acid transport (GO:0072337)	38	3	2.23	+	1.34	4.95E-01	1.00E00
GO:1902653	secondary alcohol biosynthetic process (GO:1902653)	38	3	2.23	+	1.34	4.95E-01	1.00E00
GO:0006695	cholesterol biosynthetic process (GO:0006695)	38	3	2.23	+	1.34	4.95E-01	1.00E00
GO:0071677	positive regulation of mononuclear cell migration (GO:0071677)	76	6	4.46	+	1.34	4.63E-01	1.00E00
GO:0032890	regulation of organic acid transport (GO:0032890)	76	6	4.46	+	1.34	4.63E-01	1.00E00
GO:0044728	DNA methylation or demethylation (GO:0044728)	76	6	4.46	+	1.34	4.63E-01	1.00E00
GO:0051403	stress-activated MAPK cascade (GO:0051403)	76	6	4.46	+	1.34	4.63E-01	1.00E00
GO:0050999	regulation of nitric-oxide synthase activity (GO:0050999)	38	3	2.23	+	1.34	4.95E-01	1.00E00
GO:0044273	sulfur compound catabolic process (GO:0044273)	38	3	2.23	+	1.34	4.95E-01	1.00E00
GO:1901264	carbohydrate derivative transport (GO:1901264)	76	6	4.46	+	1.34	4.63E-01	1.00E00
GO:0043516	regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)	38	3	2.23	+	1.34	4.95E-01	1.00E00
GO:1905144	response to acetylcholine (GO:1905144)	38	3	2.23	+	1.34	4.95E-01	1.00E00
GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)	114	9	6.69	+	1.34	4.24E-01	1.00E00
GO:0045923	positive regulation of fatty acid metabolic process (GO:0045923)	38	3	2.23	+	1.34	4.95E-01	1.00E00
GO:0002694	regulation of leukocyte activation (GO:0002694)	684	54	40.16	+	1.34	4.02E-02	3.23E-01
GO:0021915	neural tube development (GO:0021915)	165	13	9.69	+	1.34	3.20E-01	9.51E-01
GO:0002709	regulation of T cell mediated immunity (GO:0002709)	89	7	5.23	+	1.34	3.76E-01	1.00E00
GO:0042113	B cell activation (GO:0042113)	191	15	11.22	+	1.34	2.81E-01	8.92E-01
GO:0031330	negative regulation of cellular catabolic process (GO:0031330)	242	19	14.21	+	1.34	2.19E-01	7.78E-01
GO:0051254	positive regulation of RNA metabolic process (GO:0051254)	1848	145	108.52	+	1.34	6.84E-04	1.47E-02
GO:0006812	cation transport (GO:0006812)	854	67	50.15	+	1.34	2.24E-02	2.24E-01
GO:0032768	regulation of monooxygenase activity (GO:0032768)	51	4	2.99	+	1.34	5.47E-01	1.00E00
GO:0097530	granulocyte migration (GO:0097530)	102	8	5.99	+	1.34	4.00E-01	1.00E00
GO:0061178	regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178)	51	4	2.99	+	1.34	5.47E-01	1.00E00
GO:0050867	positive regulation of cell activation (GO:0050867)	486	38	28.54	+	1.33	9.93E-02	5.71E-01
GO:0032663	regulation of interleukin-2 production (GO:0032663)	64	5	3.76	+	1.33	4.34E-01	1.00E00
GO:2000272	negative regulation of signaling receptor activity (GO:2000272)	64	5	3.76	+	1.33	4.34E-01	1.00E00
GO:0001101	response to acid chemical (GO:0001101)	128	10	7.52	+	1.33	3.50E-01	9.85E-01
GO:0050891	multicellular organismal water homeostasis (GO:0050891)	64	5	3.76	+	1.33	4.34E-01	1.00E00
GO:0046888	negative regulation of hormone secretion (GO:0046888)	64	5	3.76	+	1.33	4.34E-01	1.00E00
GO:0046824	positive regulation of nucleocytoplasmic transport (GO:0046824)	64	5	3.76	+	1.33	4.34E-01	1.00E00
GO:0060760	positive regulation of response to cytokine stimulus (GO:0060760)	64	5	3.76	+	1.33	4.34E-01	1.00E00
GO:0009891	positive regulation of biosynthetic process (GO:0009891)	2087	163	122.55	+	1.33	3.14E-04	7.40E-03
GO:0006869	lipid transport (GO:0006869)	333	26	19.55	+	1.33	1.62E-01	6.64E-01
GO:0050821	protein stabilization (GO:0050821)	218	17	12.80	+	1.33	2.50E-01	8.20E-01
GO:0044283	small molecule biosynthetic process (GO:0044283)	449	35	26.37	+	1.33	1.07E-01	5.99E-01
GO:0007018	microtubule-based movement (GO:0007018)	385	30	22.61	+	1.33	1.29E-01	6.16E-01
GO:0050796	regulation of insulin secretion (GO:0050796)	154	12	9.04	+	1.33	3.08E-01	9.17E-01
GO:0043401	steroid hormone mediated signaling pathway (GO:0043401)	77	6	4.52	+	1.33	4.67E-01	1.00E00
GO:0009166	nucleotide catabolic process (GO:0009166)	77	6	4.52	+	1.33	4.67E-01	1.00E00
GO:0045834	positive regulation of lipid metabolic process (GO:0045834)	154	12	9.04	+	1.33	3.08E-01	9.17E-01
GO:0051048	negative regulation of secretion (GO:0051048)	167	13	9.81	+	1.33	3.24E-01	9.59E-01
GO:0060079	excitatory postsynaptic potential (GO:0060079)	90	7	5.28	+	1.32	4.99E-01	1.00E00
GO:0032088	negative regulation of NF-kappaB transcription factor activity (GO:0032088)	90	7	5.28	+	1.32	4.99E-01	1.00E00
GO:0016101	diterpenoid metabolic process (GO:0016101)	90	7	5.28	+	1.32	4.99E-01	1.00E00
GO:0031328	positive regulation of cellular biosynthetic process (GO:0031328)	2048	159	120.26	+	1.32	4.90E-04	1.09E-02
GO:0007498	mesoderm development (GO:0007498)	129	10	7.57	+	1.32	3.53E-01	9.93E-01
GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	142	11	8.34	+	1.32	3.72E-01	1.00E00
GO:0006338	chromatin remodeling (GO:0006338)	323	25	18.97	+	1.32	1.92E-01	7.49E-01
GO:0030307	positive regulation of cell growth (GO:0030307)	168	13	9.87	+	1.32	3.26E-01	9.65E-01
GO:0061136	regulation of proteasomal protein catabolic process (GO:0061136)	194	15	11.39	+	1.32	2.87E-01	9.01E-01
GO:0002674	negative regulation of acute inflammatory response (GO:0002674)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0002664	regulation of T cell tolerance induction (GO:0002664)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0019430	removal of superoxide radicals (GO:0019430)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0060441	epithelial tube branching involved in lung morphogenesis (GO:0060441)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0045672	positive regulation of osteoclast differentiation (GO:0045672)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0021697	cerebellar cortex formation (GO:0021697)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0019336	phenol-containing compound catabolic process (GO:0019336)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0033605	positive regulation of catecholamine secretion (GO:0033605)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0022030	telencephalon glial cell migration (GO:0022030)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0002438	acute inflammatory response to antigenic stimulus (GO:0002438)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:2001223	negative regulation of neuron migration (GO:2001223)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0007259	receptor signaling pathway via JAK-STAT (GO:0007259)	52	4	3.05	+	1.31	5.52E-01	1.00E00
GO:0140718	facultative heterochromatin formation (GO:0140718)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0006730	one-carbon metabolic process (GO:0006730)	39	3	2.29	+	1.31	5.05E-01	1.00E00
GO:0045472	response to ether (GO:0045472)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0002327	immature B cell differentiation (GO:0002327)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0065005	protein-lipid complex assembly (GO:0065005)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0001878	response to yeast (GO:0001878)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0001835	blastocyst hatching (GO:0001835)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0060134	prepulse inhibition (GO:0060134)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0006699	bile acid biosynthetic process (GO:0006699)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0006693	prostaglandin metabolic process (GO:0006693)	39	3	2.29	+	1.31	5.05E-01	1.00E00
GO:0006692	prostanoid metabolic process (GO:0006692)	39	3	2.29	+	1.31	5.05E-01	1.00E00
GO:0071684	organism emergence from protective structure (GO:0071684)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:2001053	regulation of mesenchymal cell apoptotic process (GO:2001053)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0072077	renal vesicle morphogenesis (GO:0072077)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0060049	regulation of protein glycosylation (GO:0060049)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:2000514	regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)	78	6	4.58	+	1.31	4.71E-01	1.00E00
GO:0006586	indolalkylamine metabolic process (GO:0006586)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0051974	negative regulation of telomerase activity (GO:0051974)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0006521	regulation of cellular amino acid metabolic process (GO:0006521)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:1901862	negative regulation of muscle tissue development (GO:1901862)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0033235	positive regulation of protein sumoylation (GO:0033235)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0044793	negative regulation by host of viral process (GO:0044793)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0051894	positive regulation of focal adhesion assembly (GO:0051894)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0002024	diet induced thermogenesis (GO:0002024)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0032688	negative regulation of interferon-beta production (GO:0032688)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0006390	mitochondrial transcription (GO:0006390)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0006336	chromatin organization (GO:0006336)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0051775	response to redox state (GO:0051775)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0071305	cellular response to vitamin D (GO:0071305)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:1902093	positive regulation of flagellated sperm motility (GO:1902093)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0032530	regulation of microvillus organization (GO:0032530)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0032528	microvillus organization (GO:0032528)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0071257	cellular response to electrical stimulus (GO:0071257)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:1901524	regulation of mitophagy (GO:1901524)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0048854	brain morphogenesis (GO:0048854)	39	3	2.29	+	1.31	5.05E-01	1.00E00
GO:0048853	forebrain morphogenesis (GO:0048853)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:2000155	positive regulation of cilium-dependent cell motility (GO:2000155)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0040015	negative regulation of multicellular organism growth (GO:0040015)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0075509	endocytosis involved in viral entry into host cell (GO:0075509)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0051569	regulation of histone H3-K4 methylation (GO:0051569)	39	3	2.29	+	1.31	5.05E-01	1.00E00
GO:0051567	histone H3-K9 methylation (GO:0051567)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0048712	negative regulation of astrocyte differentiation (GO:0048712)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0018095	protein polyglutamylation (GO:0018095)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0050927	positive regulation of positive chemotaxis (GO:0050927)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0051350	negative regulation of lyase activity (GO:0051350)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0070424	regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0051280	negative regulation of release of sequestered calcium ion into cytosol (GO:0051280)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:1901186	positive regulation of ERBB signaling pathway (GO:1901186)	39	3	2.29	+	1.31	5.05E-01	1.00E00
GO:1901160	primary amino compound metabolic process (GO:1901160)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0031629	synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0099172	presynapse organization (GO:0099172)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0099149	regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0009651	response to salt stress (GO:0009651)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:1990000	amyloid fibril formation (GO:1990000)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0050687	negative regulation of defense response to virus (GO:0050687)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0048368	lateral mesoderm development (GO:0048368)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0036302	atrioventricular canal development (GO:0036302)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0043471	regulation of cellular carbohydrate catabolic process (GO:0043471)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0009595	detection of biotic stimulus (GO:0009595)	39	3	2.29	+	1.31	5.05E-01	1.00E00
GO:0036295	cellular response to increased oxygen levels (GO:0036295)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0043299	leukocyte degranulation (GO:0043299)	39	3	2.29	+	1.31	5.05E-01	1.00E00
GO:0048011	neurotrophin TRK receptor signaling pathway (GO:0048011)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:1900242	regulation of synaptic vesicle endocytosis (GO:1900242)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0009251	glucan catabolic process (GO:0009251)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0035437	maintenance of protein localization in endoplasmic reticulum (GO:0035437)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0009176	pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0009143	nucleoside triphosphate catabolic process (GO:0009143)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0009133	nucleoside diphosphate biosynthetic process (GO:0009133)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0030513	positive regulation of BMP signaling pathway (GO:0030513)	39	3	2.29	+	1.31	5.05E-01	1.00E00
GO:1900025	negative regulation of substrate adhesion-dependent cell spreading (GO:1900025)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0010906	regulation of glucose metabolic process (GO:0010906)	104	8	6.11	+	1.31	4.07E-01	1.00E00
GO:1903961	positive regulation of anion transmembrane transport (GO:1903961)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0035331	negative regulation of hippo signaling (GO:0035331)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0030431	sleep (GO:0030431)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0010831	positive regulation of myotube differentiation (GO:0010831)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0097499	protein localization to non-motile cilium (GO:0097499)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0010771	negative regulation of cell morphogenesis involved in differentiation (GO:0010771)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0010745	negative regulation of macrophage derived foam cell differentiation (GO:0010745)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:1903798	regulation of miRNA maturation (GO:1903798)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0035188	hatching (GO:0035188)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0097398	cellular response to interleukin-17 (GO:0097398)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0019883	antigen processing and presentation of endogenous antigen (GO:0019883)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0097284	hepatocyte apoptotic process (GO:0097284)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:1903599	positive regulation of autophagy of mitochondrion (GO:1903599)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:0002863	positive regulation of inflammatory response to antigenic stimulus (GO:0002863)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:1902932	positive regulation of alcohol biosynthetic process (GO:1902932)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:1902931	negative regulation of alcohol biosynthetic process (GO:1902931)	13	1	.76	+	1.31	5.50E-01	1.00E00
GO:1903307	positive regulation of regulated secretory pathway (GO:1903307)	52	4	3.05	+	1.31	5.52E-01	1.00E00
GO:0021801	cerebral cortex radial glia-guided migration (GO:0021801)	26	2	1.53	+	1.31	6.67E-01	1.00E00
GO:0032103	positive regulation of response to external stimulus (GO:0032103)	455	35	26.72	+	1.31	1.33E-01	6.27E-01
GO:0030641	regulation of cellular pH (GO:0030641)	91	7	5.34	+	1.31	5.01E-01	1.00E00
GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822)	182	14	10.69	+	1.31	3.44E-01	9.76E-01
GO:0006959	humoral immune response (GO:0006959)	339	26	19.91	+	1.31	2.03E-01	7.72E-01
GO:0050789	regulation of biological process (GO:0050789)	11806	904	693.26	+	1.30	1.31E-34	4.11E-31
GO:0023061	signal release (GO:0023061)	183	14	10.75	+	1.30	3.45E-01	9.79E-01
GO:0022407	regulation of cell-cell adhesion (GO:0022407)	484	37	28.42	+	1.30	1.21E-01	5.88E-01
GO:0002708	positive regulation of lymphocyte mediated immunity (GO:0002708)	118	9	6.93	+	1.30	4.33E-01	1.00E00
GO:0050794	regulation of cellular process (GO:0050794)	11187	853	656.91	+	1.30	3.47E-29	3.89E-26
GO:1903557	positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)	105	8	6.17	+	1.30	4.11E-01	1.00E00
GO:1990266	neutrophil migration (GO:1990266)	92	7	5.40	+	1.30	5.04E-01	1.00E00
GO:0006898	receptor-mediated endocytosis (GO:0006898)	171	13	10.04	+	1.29	3.32E-01	9.46E-01
GO:0035966	response to topologically incorrect protein (GO:0035966)	145	11	8.51	+	1.29	3.79E-01	1.00E00
GO:0006366	transcription by RNA polymerase II (GO:0006366)	356	27	20.90	+	1.29	2.14E-01	7.63E-01
GO:0070972	protein localization to endoplasmic reticulum (GO:0070972)	66	5	3.88	+	1.29	5.97E-01	1.00E00
GO:0002819	regulation of adaptive immune response (GO:0002819)	198	15	11.63	+	1.29	3.64E-01	1.00E00
GO:0045814	negative regulation of gene expression, epigenetic (GO:0045814)	66	5	3.88	+	1.29	5.97E-01	1.00E00
GO:0001775	cell activation (GO:0001775)	700	53	41.10	+	1.29	7.42E-02	4.78E-01
GO:0051171	regulation of nitrogen compound metabolic process (GO:0051171)	5709	432	335.24	+	1.29	4.37E-09	3.10E-07
GO:0050830	defense response to Gram-positive bacterium (GO:0050830)	119	9	6.99	+	1.29	4.36E-01	1.00E00
GO:0080090	regulation of primary metabolic process (GO:0080090)	5872	444	344.81	+	1.29	2.19E-09	1.67E-07
GO:0006575	cellular modified amino acid metabolic process (GO:0006575)	172	13	10.10	+	1.29	3.35E-01	9.52E-01
GO:0098655	cation transmembrane transport (GO:0098655)	675	51	39.64	+	1.29	8.28E-02	5.12E-01
GO:0065007	biological regulation (GO:0065007)	12544	947	736.59	+	1.29	3.54E-36	1.85E-32
GO:2001252	positive regulation of chromosome organization (GO:2001252)	106	8	6.22	+	1.29	4.15E-01	1.00E00
GO:0097696	receptor signaling pathway via STAT (GO:0097696)	53	4	3.11	+	1.29	5.58E-01	1.00E00
GO:0002762	negative regulation of myeloid leukocyte differentiation (GO:0002762)	53	4	3.11	+	1.29	5.58E-01	1.00E00
GO:0072657	protein localization to membrane (GO:0072657)	451	34	26.48	+	1.28	1.59E-01	6.62E-01
GO:0006334	nucleosome assembly (GO:0006334)	93	7	5.46	+	1.28	5.07E-01	1.00E00
GO:0031669	cellular response to nutrient levels (GO:0031669)	226	17	13.27	+	1.28	3.22E-01	9.55E-01
GO:0002697	regulation of immune effector process (GO:0002697)	386	29	22.67	+	1.28	1.93E-01	7.53E-01
GO:0032868	response to insulin (GO:0032868)	213	16	12.51	+	1.28	3.10E-01	9.24E-01
GO:0050870	positive regulation of T cell activation (GO:0050870)	253	19	14.86	+	1.28	2.85E-01	8.98E-01
GO:0031647	regulation of protein stability (GO:0031647)	333	25	19.55	+	1.28	2.43E-01	8.38E-01
GO:0060338	regulation of type I interferon-mediated signaling pathway (GO:0060338)	40	3	2.35	+	1.28	5.15E-01	1.00E00
GO:0006775	fat-soluble vitamin metabolic process (GO:0006775)	40	3	2.35	+	1.28	5.15E-01	1.00E00
GO:0002088	lens development in camera-type eye (GO:0002088)	80	6	4.70	+	1.28	4.80E-01	1.00E00
GO:2000279	negative regulation of DNA biosynthetic process (GO:2000279)	40	3	2.35	+	1.28	5.15E-01	1.00E00
GO:0042743	hydrogen peroxide metabolic process (GO:0042743)	40	3	2.35	+	1.28	5.15E-01	1.00E00
GO:0055069	zinc ion homeostasis (GO:0055069)	40	3	2.35	+	1.28	5.15E-01	1.00E00
GO:0031098	stress-activated protein kinase signaling cascade (GO:0031098)	80	6	4.70	+	1.28	4.80E-01	1.00E00
GO:0043029	T cell homeostasis (GO:0043029)	40	3	2.35	+	1.28	5.15E-01	1.00E00
GO:0045922	negative regulation of fatty acid metabolic process (GO:0045922)	40	3	2.35	+	1.28	5.15E-01	1.00E00
GO:0002718	regulation of cytokine production involved in immune response (GO:0002718)	120	9	7.05	+	1.28	4.39E-01	1.00E00
GO:0140352	export from cell (GO:0140352)	467	35	27.42	+	1.28	1.66E-01	6.80E-01
GO:0044085	cellular component biogenesis (GO:0044085)	2633	197	154.61	+	1.27	5.88E-04	1.28E-02
GO:0071346	cellular response to interferon-gamma (GO:0071346)	107	8	6.28	+	1.27	5.36E-01	1.00E00
GO:0031058	positive regulation of histone modification (GO:0031058)	107	8	6.28	+	1.27	5.36E-01	1.00E00
GO:0032984	protein-containing complex disassembly (GO:0032984)	134	10	7.87	+	1.27	4.61E-01	1.00E00
GO:0002696	positive regulation of leukocyte activation (GO:0002696)	469	35	27.54	+	1.27	1.67E-01	6.84E-01
GO:0031667	response to nutrient levels (GO:0031667)	470	35	27.60	+	1.27	1.68E-01	6.87E-01
GO:0099565	chemical synaptic transmission, postsynaptic (GO:0099565)	94	7	5.52	+	1.27	5.10E-01	1.00E00
GO:1902882	regulation of response to oxidative stress (GO:1902882)	94	7	5.52	+	1.27	5.10E-01	1.00E00
GO:0030031	cell projection assembly (GO:0030031)	430	32	25.25	+	1.27	1.82E-01	7.18E-01
GO:0008203	cholesterol metabolic process (GO:0008203)	121	9	7.11	+	1.27	4.42E-01	1.00E00
GO:0002274	myeloid leukocyte activation (GO:0002274)	148	11	8.69	+	1.27	3.87E-01	1.00E00
GO:0031349	positive regulation of defense response (GO:0031349)	296	22	17.38	+	1.27	2.67E-01	8.54E-01
GO:1901615	organic hydroxy compound metabolic process (GO:1901615)	485	36	28.48	+	1.26	1.74E-01	7.01E-01
GO:0060255	regulation of macromolecule metabolic process (GO:0060255)	6214	461	364.89	+	1.26	1.03E-08	6.65E-07
GO:0007435	salivary gland morphogenesis (GO:0007435)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0019363	pyridine nucleotide biosynthetic process (GO:0019363)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0019359	nicotinamide nucleotide biosynthetic process (GO:0019359)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0001964	startle response (GO:0001964)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0001945	lymph vessel development (GO:0001945)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0007205	protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0060259	regulation of feeding behavior (GO:0060259)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0032967	positive regulation of collagen biosynthetic process (GO:0032967)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0002208	somatic diversification of immunoglobulins involved in immune response (GO:0002208)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0001778	plasma membrane repair (GO:0001778)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0001573	ganglioside metabolic process (GO:0001573)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0070920	regulation of production of small RNA involved in gene silencing by RNA (GO:0070920)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:1901623	regulation of lymphocyte chemotaxis (GO:1901623)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0032469	endoplasmic reticulum calcium ion homeostasis (GO:0032469)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0050926	regulation of positive chemotaxis (GO:0050926)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0032210	regulation of telomere maintenance via telomerase (GO:0032210)	54	4	3.17	+	1.26	5.63E-01	1.00E00
GO:1905523	positive regulation of macrophage migration (GO:1905523)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0016540	protein autoprocessing (GO:0016540)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0048015	phosphatidylinositol-mediated signaling (GO:0048015)	81	6	4.76	+	1.26	4.85E-01	1.00E00
GO:0042537	benzene-containing compound metabolic process (GO:0042537)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0046835	carbohydrate phosphorylation (GO:0046835)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0008207	C21-steroid hormone metabolic process (GO:0008207)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0046337	phosphatidylethanolamine metabolic process (GO:0046337)	27	2	1.59	+	1.26	6.74E-01	1.00E00
GO:0002720	positive regulation of cytokine production involved in immune response (GO:0002720)	81	6	4.76	+	1.26	4.85E-01	1.00E00
GO:0045833	negative regulation of lipid metabolic process (GO:0045833)	108	8	6.34	+	1.26	5.37E-01	1.00E00
GO:0007586	digestion (GO:0007586)	108	8	6.34	+	1.26	5.37E-01	1.00E00
GO:0034220	ion transmembrane transport (GO:0034220)	891	66	52.32	+	1.26	7.05E-02	4.58E-01
GO:0002702	positive regulation of production of molecular mediator of immune response (GO:0002702)	135	10	7.93	+	1.26	4.63E-01	1.00E00
GO:0002700	regulation of production of molecular mediator of immune response (GO:0002700)	189	14	11.10	+	1.26	3.57E-01	1.00E00
GO:0006811	ion transport (GO:0006811)	1202	89	70.58	+	1.26	3.29E-02	2.87E-01
GO:0051235	maintenance of location (GO:0051235)	176	13	10.33	+	1.26	4.22E-01	1.00E00
GO:1905475	regulation of protein localization to membrane (GO:1905475)	176	13	10.33	+	1.26	4.22E-01	1.00E00
GO:0032642	regulation of chemokine production (GO:0032642)	95	7	5.58	+	1.25	5.13E-01	1.00E00
GO:1903829	positive regulation of protein localization (GO:1903829)	462	34	27.13	+	1.25	1.97E-01	7.63E-01
GO:0019222	regulation of metabolic process (GO:0019222)	6754	497	396.60	+	1.25	4.80E-09	3.33E-07
GO:0040014	regulation of multicellular organism growth (GO:0040014)	68	5	3.99	+	1.25	6.03E-01	1.00E00
GO:0016125	sterol metabolic process (GO:0016125)	136	10	7.99	+	1.25	4.66E-01	1.00E00
GO:0010660	regulation of muscle cell apoptotic process (GO:0010660)	68	5	3.99	+	1.25	6.03E-01	1.00E00
GO:0060078	regulation of postsynaptic membrane potential (GO:0060078)	109	8	6.40	+	1.25	5.39E-01	1.00E00
GO:0006986	response to unfolded protein (GO:0006986)	123	9	7.22	+	1.25	4.48E-01	1.00E00
GO:0001914	regulation of T cell mediated cytotoxicity (GO:0001914)	41	3	2.41	+	1.25	7.35E-01	1.00E00
GO:0032660	regulation of interleukin-17 production (GO:0032660)	41	3	2.41	+	1.25	7.35E-01	1.00E00
GO:0031295	T cell costimulation (GO:0031295)	41	3	2.41	+	1.25	7.35E-01	1.00E00
GO:0035272	exocrine system development (GO:0035272)	41	3	2.41	+	1.25	7.35E-01	1.00E00
GO:0007595	lactation (GO:0007595)	41	3	2.41	+	1.25	7.35E-01	1.00E00
GO:1903037	regulation of leukocyte cell-cell adhesion (GO:1903037)	369	27	21.67	+	1.25	2.67E-01	8.54E-01
GO:0031323	regulation of cellular metabolic process (GO:0031323)	5647	413	331.60	+	1.25	6.94E-07	3.33E-05
GO:0019058	viral life cycle (GO:0019058)	178	13	10.45	+	1.24	4.25E-01	1.00E00
GO:0009267	cellular response to starvation (GO:0009267)	178	13	10.45	+	1.24	4.25E-01	1.00E00
GO:0046165	alcohol biosynthetic process (GO:0046165)	96	7	5.64	+	1.24	5.16E-01	1.00E00
GO:0034249	negative regulation of cellular amide metabolic process (GO:0034249)	192	14	11.27	+	1.24	4.42E-01	1.00E00
GO:0051055	negative regulation of lipid biosynthetic process (GO:0051055)	55	4	3.23	+	1.24	5.69E-01	1.00E00
GO:0042572	retinol metabolic process (GO:0042572)	55	4	3.23	+	1.24	5.69E-01	1.00E00
GO:0035088	establishment or maintenance of apical/basal cell polarity (GO:0035088)	55	4	3.23	+	1.24	5.69E-01	1.00E00
GO:0061245	establishment or maintenance of bipolar cell polarity (GO:0061245)	55	4	3.23	+	1.24	5.69E-01	1.00E00
GO:0097191	extrinsic apoptotic signaling pathway (GO:0097191)	110	8	6.46	+	1.24	5.42E-01	1.00E00
GO:0045055	regulated exocytosis (GO:0045055)	138	10	8.10	+	1.23	4.71E-01	1.00E00
GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	83	6	4.87	+	1.23	6.38E-01	1.00E00
GO:0045321	leukocyte activation (GO:0045321)	581	42	34.12	+	1.23	1.83E-01	7.20E-01
GO:0042475	odontogenesis of dentin-containing tooth (GO:0042475)	83	6	4.87	+	1.23	6.38E-01	1.00E00
GO:0051046	regulation of secretion (GO:0051046)	623	45	36.58	+	1.23	1.70E-01	6.90E-01
GO:0051651	maintenance of location in cell (GO:0051651)	97	7	5.70	+	1.23	5.20E-01	1.00E00
GO:0071222	cellular response to lipopolysaccharide (GO:0071222)	194	14	11.39	+	1.23	4.44E-01	1.00E00
GO:0002695	negative regulation of leukocyte activation (GO:0002695)	194	14	11.39	+	1.23	4.44E-01	1.00E00
GO:0046903	secretion (GO:0046903)	527	38	30.95	+	1.23	2.25E-01	7.88E-01
GO:0032368	regulation of lipid transport (GO:0032368)	139	10	8.16	+	1.23	4.73E-01	1.00E00
GO:0080135	regulation of cellular response to stress (GO:0080135)	709	51	41.63	+	1.22	1.69E-01	6.89E-01
GO:0051260	protein homooligomerization (GO:0051260)	195	14	11.45	+	1.22	4.46E-01	1.00E00
GO:0050863	regulation of T cell activation (GO:0050863)	377	27	22.14	+	1.22	3.22E-01	9.56E-01
GO:0010269	response to selenium ion (GO:0010269)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0045745	positive regulation of G protein-coupled receptor signaling pathway (GO:0045745)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0034111	negative regulation of homotypic cell-cell adhesion (GO:0034111)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0045683	negative regulation of epidermis development (GO:0045683)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0033692	cellular polysaccharide biosynthetic process (GO:0033692)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0021694	cerebellar Purkinje cell layer formation (GO:0021694)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0045605	negative regulation of epidermal cell differentiation (GO:0045605)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0071897	DNA biosynthetic process (GO:0071897)	98	7	5.75	+	1.22	5.24E-01	1.00E00
GO:0006835	dicarboxylic acid transport (GO:0006835)	70	5	4.11	+	1.22	6.10E-01	1.00E00
GO:0071827	plasma lipoprotein particle organization (GO:0071827)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0071801	regulation of podosome assembly (GO:0071801)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0007260	tyrosine phosphorylation of STAT protein (GO:0007260)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0001958	endochondral ossification (GO:0001958)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0019218	regulation of steroid metabolic process (GO:0019218)	98	7	5.75	+	1.22	5.24E-01	1.00E00
GO:0007216	G protein-coupled glutamate receptor signaling pathway (GO:0007216)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0007214	gamma-aminobutyric acid signaling pathway (GO:0007214)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:2000737	negative regulation of stem cell differentiation (GO:2000737)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0060221	retinal rod cell differentiation (GO:0060221)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0006750	glutathione biosynthetic process (GO:0006750)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:2000650	negative regulation of sodium ion transmembrane transporter activity (GO:2000650)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0006641	triglyceride metabolic process (GO:0006641)	70	5	4.11	+	1.22	6.10E-01	1.00E00
GO:0006638	neutral lipid metabolic process (GO:0006638)	98	7	5.75	+	1.22	5.24E-01	1.00E00
GO:0071624	positive regulation of granulocyte chemotaxis (GO:0071624)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0072087	renal vesicle development (GO:0072087)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0007020	microtubule nucleation (GO:0007020)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0006596	polyamine biosynthetic process (GO:0006596)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0060009	Sertoli cell development (GO:0060009)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0071599	otic vesicle development (GO:0071599)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0071549	cellular response to dexamethasone stimulus (GO:0071549)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:1902287	semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0032740	positive regulation of interleukin-17 production (GO:0032740)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0006465	signal peptide processing (GO:0006465)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0014061	regulation of norepinephrine secretion (GO:0014061)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0002063	chondrocyte development (GO:0002063)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0006418	tRNA aminoacylation for protein translation (GO:0006418)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:2000379	positive regulation of reactive oxygen species metabolic process (GO:2000379)	70	5	4.11	+	1.22	6.10E-01	1.00E00
GO:0071361	cellular response to ethanol (GO:0071361)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0033004	negative regulation of mast cell activation (GO:0033004)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0006287	base-excision repair, gap-filling (GO:0006287)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0006284	base-excision repair (GO:0006284)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0051645	Golgi localization (GO:0051645)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0032482	Rab protein signal transduction (GO:0032482)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0099500	vesicle fusion to plasma membrane (GO:0099500)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0090278	negative regulation of peptide hormone secretion (GO:0090278)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0048791	calcium ion-regulated exocytosis of neurotransmitter (GO:0048791)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0090239	regulation of histone H4 acetylation (GO:0090239)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0090205	positive regulation of cholesterol metabolic process (GO:0090205)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0044342	type B pancreatic cell proliferation (GO:0044342)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0032375	negative regulation of cholesterol transport (GO:0032375)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0032372	negative regulation of sterol transport (GO:0032372)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0006000	fructose metabolic process (GO:0006000)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0050966	detection of mechanical stimulus involved in sensory perception of pain (GO:0050966)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0048641	regulation of skeletal muscle tissue development (GO:0048641)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0044247	cellular polysaccharide catabolic process (GO:0044247)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:1905664	regulation of calcium ion import across plasma membrane (GO:1905664)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0050850	positive regulation of calcium-mediated signaling (GO:0050850)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0098761	cellular response to interleukin-7 (GO:0098761)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0098760	response to interleukin-7 (GO:0098760)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0070307	lens fiber cell development (GO:0070307)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0048302	regulation of isotype switching to IgG isotypes (GO:0048302)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0070168	negative regulation of biomineral tissue development (GO:0070168)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0070141	response to UV-A (GO:0070141)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:1900426	positive regulation of defense response to bacterium (GO:1900426)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:1900407	regulation of cellular response to oxidative stress (GO:1900407)	84	6	4.93	+	1.22	6.40E-01	1.00E00
GO:0000271	polysaccharide biosynthetic process (GO:0000271)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0035721	intraciliary retrograde transport (GO:0035721)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0048148	behavioral response to cocaine (GO:0048148)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0031282	regulation of guanylate cyclase activity (GO:0031282)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0042744	hydrogen peroxide catabolic process (GO:0042744)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0036075	replacement ossification (GO:0036075)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0035589	G protein-coupled purinergic nucleotide receptor signaling pathway (GO:0035589)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0035563	positive regulation of chromatin binding (GO:0035563)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:1905063	regulation of vascular associated smooth muscle cell differentiation (GO:1905063)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0042634	regulation of hair cycle (GO:0042634)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0016339	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0055076	transition metal ion homeostasis (GO:0055076)	140	10	8.22	+	1.22	4.76E-01	1.00E00
GO:0009167	purine ribonucleoside monophosphate metabolic process (GO:0009167)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0042559	pteridine-containing compound biosynthetic process (GO:0042559)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:1900048	positive regulation of hemostasis (GO:1900048)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:1900037	regulation of cellular response to hypoxia (GO:1900037)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0030518	intracellular steroid hormone receptor signaling pathway (GO:0030518)	56	4	3.29	+	1.22	5.75E-01	1.00E00
GO:0035372	protein localization to microtubule (GO:0035372)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0009071	serine family amino acid catabolic process (GO:0009071)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0042438	melanin biosynthetic process (GO:0042438)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0010867	positive regulation of triglyceride biosynthetic process (GO:0010867)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0010833	telomere maintenance via telomere lengthening (GO:0010833)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0015697	quaternary ammonium group transport (GO:0015697)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0042359	vitamin D metabolic process (GO:0042359)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0042307	positive regulation of protein import into nucleus (GO:0042307)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0010714	positive regulation of collagen metabolic process (GO:0010714)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0060964	regulation of miRNA-mediated gene silencing (GO:0060964)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0046655	folic acid metabolic process (GO:0046655)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0097396	response to interleukin-17 (GO:0097396)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0097320	plasma membrane tubulation (GO:0097320)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0010666	positive regulation of cardiac muscle cell apoptotic process (GO:0010666)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0010663	positive regulation of striated muscle cell apoptotic process (GO:0010663)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0030238	male sex determination (GO:0030238)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0030194	positive regulation of blood coagulation (GO:0030194)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0042136	neurotransmitter biosynthetic process (GO:0042136)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0030104	water homeostasis (GO:0030104)	70	5	4.11	+	1.22	6.10E-01	1.00E00
GO:0010524	positive regulation of calcium ion transport into cytosol (GO:0010524)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0003353	positive regulation of cilium movement (GO:0003353)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0060765	regulation of androgen receptor signaling pathway (GO:0060765)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0046462	monoacylglycerol metabolic process (GO:0046462)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0030098	lymphocyte differentiation (GO:0030098)	280	20	16.44	+	1.22	3.73E-01	1.00E00
GO:0002891	positive regulation of immunoglobulin mediated immune response (GO:0002891)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0010458	exit from mitosis (GO:0010458)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0045989	positive regulation of striated muscle contraction (GO:0045989)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0046348	amino sugar catabolic process (GO:0046348)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0034333	adherens junction assembly (GO:0034333)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0002714	positive regulation of B cell mediated immunity (GO:0002714)	42	3	2.47	+	1.22	7.38E-01	1.00E00
GO:0002705	positive regulation of leukocyte mediated immunity (GO:0002705)	140	10	8.22	+	1.22	4.76E-01	1.00E00
GO:0045830	positive regulation of isotype switching (GO:0045830)	28	2	1.64	+	1.22	6.82E-01	1.00E00
GO:0072531	pyrimidine-containing compound transmembrane transport (GO:0072531)	14	1	.82	+	1.22	5.75E-01	1.00E00
GO:0032874	positive regulation of stress-activated MAPK cascade (GO:0032874)	126	9	7.40	+	1.22	5.68E-01	1.00E00
GO:0001578	microtubule bundle formation (GO:0001578)	126	9	7.40	+	1.22	5.68E-01	1.00E00
GO:0002699	positive regulation of immune effector process (GO:0002699)	267	19	15.68	+	1.21	4.33E-01	1.00E00
GO:0019221	cytokine-mediated signaling pathway (GO:0019221)	366	26	21.49	+	1.21	3.17E-01	9.42E-01
GO:0046649	lymphocyte activation (GO:0046649)	465	33	27.31	+	1.21	2.76E-01	8.79E-01
GO:0032787	monocarboxylic acid metabolic process (GO:0032787)	508	36	29.83	+	1.21	2.55E-01	8.35E-01
GO:0042176	regulation of protein catabolic process (GO:0042176)	367	26	21.55	+	1.21	3.72E-01	1.00E00
GO:0051701	biological process involved in interaction with host (GO:0051701)	156	11	9.16	+	1.20	4.98E-01	1.00E00
GO:0046434	organophosphate catabolic process (GO:0046434)	156	11	9.16	+	1.20	4.98E-01	1.00E00
GO:0032722	positive regulation of chemokine production (GO:0032722)	71	5	4.17	+	1.20	6.14E-01	1.00E00
GO:0042886	amide transport (GO:0042886)	142	10	8.34	+	1.20	5.91E-01	1.00E00
GO:0042490	mechanoreceptor differentiation (GO:0042490)	71	5	4.17	+	1.20	6.14E-01	1.00E00
GO:0046470	phosphatidylcholine metabolic process (GO:0046470)	71	5	4.17	+	1.20	6.14E-01	1.00E00
GO:0061077	chaperone-mediated protein folding (GO:0061077)	71	5	4.17	+	1.20	6.14E-01	1.00E00
GO:0006952	defense response (GO:0006952)	1478	104	86.79	+	1.20	6.78E-02	4.55E-01
GO:0002285	lymphocyte activation involved in immune response (GO:0002285)	128	9	7.52	+	1.20	5.72E-01	1.00E00
GO:0070304	positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	128	9	7.52	+	1.20	5.72E-01	1.00E00
GO:0046883	regulation of hormone secretion (GO:0046883)	242	17	14.21	+	1.20	4.93E-01	1.00E00
GO:0002253	activation of immune response (GO:0002253)	356	25	20.90	+	1.20	3.66E-01	1.00E00
GO:0034219	carbohydrate transmembrane transport (GO:0034219)	57	4	3.35	+	1.20	5.81E-01	1.00E00
GO:1903050	regulation of proteolysis involved in protein catabolic process (GO:1903050)	228	16	13.39	+	1.20	4.80E-01	1.00E00
GO:0001961	positive regulation of cytokine-mediated signaling pathway (GO:0001961)	57	4	3.35	+	1.20	5.81E-01	1.00E00
GO:1990849	vacuolar localization (GO:1990849)	57	4	3.35	+	1.20	5.81E-01	1.00E00
GO:0140238	presynaptic endocytosis (GO:0140238)	57	4	3.35	+	1.20	5.81E-01	1.00E00
GO:0032418	lysosome localization (GO:0032418)	57	4	3.35	+	1.20	5.81E-01	1.00E00
GO:0048488	synaptic vesicle endocytosis (GO:0048488)	57	4	3.35	+	1.20	5.81E-01	1.00E00
GO:0019827	stem cell population maintenance (GO:0019827)	114	8	6.69	+	1.20	5.52E-01	1.00E00
GO:0046513	ceramide biosynthetic process (GO:0046513)	57	4	3.35	+	1.20	5.81E-01	1.00E00
GO:0003002	regionalization (GO:0003002)	342	24	20.08	+	1.20	3.58E-01	1.00E00
GO:0007276	gamete generation (GO:0007276)	756	53	44.39	+	1.19	2.10E-01	7.52E-01
GO:0006325	chromatin organization (GO:0006325)	585	41	34.35	+	1.19	2.50E-01	8.20E-01
GO:0001817	regulation of cytokine production (GO:0001817)	742	52	43.57	+	1.19	2.06E-01	7.40E-01
GO:0002690	positive regulation of leukocyte chemotaxis (GO:0002690)	100	7	5.87	+	1.19	6.69E-01	1.00E00
GO:0071364	cellular response to epidermal growth factor stimulus (GO:0071364)	43	3	2.52	+	1.19	7.41E-01	1.00E00
GO:0031294	lymphocyte costimulation (GO:0031294)	43	3	2.52	+	1.19	7.41E-01	1.00E00
GO:1903426	regulation of reactive oxygen species biosynthetic process (GO:1903426)	43	3	2.52	+	1.19	7.41E-01	1.00E00
GO:0002792	negative regulation of peptide secretion (GO:0002792)	43	3	2.52	+	1.19	7.41E-01	1.00E00
GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	129	9	7.57	+	1.19	5.74E-01	1.00E00
GO:0042594	response to starvation (GO:0042594)	215	15	12.62	+	1.19	4.69E-01	1.00E00
GO:0060041	retina development in camera-type eye (GO:0060041)	158	11	9.28	+	1.19	5.03E-01	1.00E00
GO:0050905	neuromuscular process (GO:0050905)	144	10	8.46	+	1.18	5.94E-01	1.00E00
GO:0031623	receptor internalization (GO:0031623)	72	5	4.23	+	1.18	6.18E-01	1.00E00
GO:0007589	body fluid secretion (GO:0007589)	72	5	4.23	+	1.18	6.18E-01	1.00E00
GO:0120031	plasma membrane bounded cell projection assembly (GO:0120031)	418	29	24.55	+	1.18	3.49E-01	9.83E-01
GO:0051249	regulation of lymphocyte activation (GO:0051249)	591	41	34.70	+	1.18	2.90E-01	9.08E-01
GO:0006721	terpenoid metabolic process (GO:0006721)	101	7	5.93	+	1.18	6.70E-01	1.00E00
GO:0016485	protein processing (GO:0016485)	202	14	11.86	+	1.18	5.48E-01	1.00E00
GO:0000041	transition metal ion transport (GO:0000041)	101	7	5.93	+	1.18	6.70E-01	1.00E00
GO:0048593	camera-type eye morphogenesis (GO:0048593)	130	9	7.63	+	1.18	5.76E-01	1.00E00
GO:0034341	response to interferon-gamma (GO:0034341)	130	9	7.63	+	1.18	5.76E-01	1.00E00
GO:0002366	leukocyte activation involved in immune response (GO:0002366)	188	13	11.04	+	1.18	5.35E-01	1.00E00
GO:0017157	regulation of exocytosis (GO:0017157)	217	15	12.74	+	1.18	5.62E-01	1.00E00
GO:0007431	salivary gland development (GO:0007431)	29	2	1.70	+	1.17	6.90E-01	1.00E00
GO:0110150	negative regulation of biomineralization (GO:0110150)	29	2	1.70	+	1.17	6.90E-01	1.00E00
GO:0002068	glandular epithelial cell development (GO:0002068)	29	2	1.70	+	1.17	6.90E-01	1.00E00
GO:0070661	leukocyte proliferation (GO:0070661)	145	10	8.51	+	1.17	5.95E-01	1.00E00
GO:0031638	zymogen activation (GO:0031638)	58	4	3.41	+	1.17	7.77E-01	1.00E00
GO:0070306	lens fiber cell differentiation (GO:0070306)	29	2	1.70	+	1.17	6.90E-01	1.00E00
GO:0009617	response to bacterium (GO:0009617)	754	52	44.28	+	1.17	2.40E-01	8.36E-01
GO:0098534	centriole assembly (GO:0098534)	29	2	1.70	+	1.17	6.90E-01	1.00E00
GO:0043388	positive regulation of DNA binding (GO:0043388)	58	4	3.41	+	1.17	7.77E-01	1.00E00
GO:0042759	long-chain fatty acid biosynthetic process (GO:0042759)	29	2	1.70	+	1.17	6.90E-01	1.00E00
GO:0015701	bicarbonate transport (GO:0015701)	29	2	1.70	+	1.17	6.90E-01	1.00E00
GO:0046634	regulation of alpha-beta T cell activation (GO:0046634)	116	8	6.81	+	1.17	5.58E-01	1.00E00
GO:0009987	cellular process (GO:0009987)	15044	1037	883.39	+	1.17	4.60E-25	3.44E-22
GO:0051251	positive regulation of lymphocyte activation (GO:0051251)	421	29	24.72	+	1.17	4.04E-01	1.00E00
GO:0009952	anterior/posterior pattern specification (GO:0009952)	218	15	12.80	+	1.17	5.63E-01	1.00E00
GO:0051179	localization (GO:0051179)	4566	314	268.12	+	1.17	2.53E-03	4.36E-02
GO:0006665	sphingolipid metabolic process (GO:0006665)	160	11	9.40	+	1.17	6.12E-01	1.00E00
GO:0016241	regulation of macroautophagy (GO:0016241)	160	11	9.40	+	1.17	6.12E-01	1.00E00
GO:1902652	secondary alcohol metabolic process (GO:1902652)	131	9	7.69	+	1.17	5.79E-01	1.00E00
GO:0071219	cellular response to molecule of bacterial origin (GO:0071219)	204	14	11.98	+	1.17	5.50E-01	1.00E00
GO:0001819	positive regulation of cytokine production (GO:0001819)	481	33	28.24	+	1.17	3.79E-01	1.00E00
GO:0015698	inorganic anion transport (GO:0015698)	175	12	10.28	+	1.17	5.23E-01	1.00E00
GO:0055085	transmembrane transport (GO:0055085)	1225	84	71.93	+	1.17	1.52E-01	6.91E-01
GO:0008544	epidermis development (GO:0008544)	321	22	18.85	+	1.17	4.74E-01	1.00E00
GO:1903201	regulation of oxidative stress-induced cell death (GO:1903201)	73	5	4.29	+	1.17	6.22E-01	1.00E00
GO:0006997	nucleus organization (GO:0006997)	146	10	8.57	+	1.17	5.97E-01	1.00E00
GO:0034121	regulation of toll-like receptor signaling pathway (GO:0034121)	73	5	4.29	+	1.17	6.22E-01	1.00E00
GO:0090559	regulation of membrane permeability (GO:0090559)	73	5	4.29	+	1.17	6.22E-01	1.00E00
GO:0010508	positive regulation of autophagy (GO:0010508)	146	10	8.57	+	1.17	5.97E-01	1.00E00
GO:0071763	nuclear membrane organization (GO:0071763)	44	3	2.58	+	1.16	7.45E-01	1.00E00
GO:0045216	cell-cell junction organization (GO:0045216)	176	12	10.33	+	1.16	6.29E-01	1.00E00
GO:0044058	regulation of digestive system process (GO:0044058)	44	3	2.58	+	1.16	7.45E-01	1.00E00
GO:1900368	regulation of post-transcriptional gene silencing by RNA (GO:1900368)	44	3	2.58	+	1.16	7.45E-01	1.00E00
GO:0016445	somatic diversification of immunoglobulins (GO:0016445)	44	3	2.58	+	1.16	7.45E-01	1.00E00
GO:0009126	purine nucleoside monophosphate metabolic process (GO:0009126)	44	3	2.58	+	1.16	7.45E-01	1.00E00
GO:0010799	regulation of peptidyl-threonine phosphorylation (GO:0010799)	44	3	2.58	+	1.16	7.45E-01	1.00E00
GO:1903573	negative regulation of response to endoplasmic reticulum stress (GO:1903573)	44	3	2.58	+	1.16	7.45E-01	1.00E00
GO:0046427	positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	44	3	2.58	+	1.16	7.45E-01	1.00E00
GO:0006897	endocytosis (GO:0006897)	528	36	31.00	+	1.16	3.52E-01	9.91E-01
GO:0030183	B cell differentiation (GO:0030183)	132	9	7.75	+	1.16	5.81E-01	1.00E00
GO:0031331	positive regulation of cellular catabolic process (GO:0031331)	411	28	24.13	+	1.16	4.60E-01	1.00E00
GO:2001141	regulation of RNA biosynthetic process (GO:2001141)	3465	236	203.47	+	1.16	1.80E-02	1.91E-01
GO:0006793	phosphorus metabolic process (GO:0006793)	1881	128	110.45	+	1.16	9.14E-02	5.39E-01
GO:0032869	cellular response to insulin stimulus (GO:0032869)	147	10	8.63	+	1.16	5.99E-01	1.00E00
GO:0006796	phosphate-containing compound metabolic process (GO:0006796)	1855	126	108.93	+	1.16	9.94E-02	5.72E-01
GO:0055088	lipid homeostasis (GO:0055088)	162	11	9.51	+	1.16	6.15E-01	1.00E00
GO:0019219	regulation of nucleobase-containing compound metabolic process (GO:0019219)	4067	276	238.82	+	1.16	1.05E-02	1.32E-01
GO:0051641	cellular localization (GO:0051641)	2655	180	155.90	+	1.15	4.77E-02	3.64E-01
GO:0051289	protein homotetramerization (GO:0051289)	59	4	3.46	+	1.15	7.79E-01	1.00E00
GO:0043297	apical junction assembly (GO:0043297)	59	4	3.46	+	1.15	7.79E-01	1.00E00
GO:0002263	cell activation involved in immune response (GO:0002263)	192	13	11.27	+	1.15	5.42E-01	1.00E00
GO:0090087	regulation of peptide transport (GO:0090087)	192	13	11.27	+	1.15	5.42E-01	1.00E00
GO:0051057	positive regulation of small GTPase mediated signal transduction (GO:0051057)	74	5	4.35	+	1.15	6.26E-01	1.00E00
GO:0030522	intracellular receptor signaling pathway (GO:0030522)	148	10	8.69	+	1.15	6.01E-01	1.00E00
GO:0007281	germ cell development (GO:0007281)	311	21	18.26	+	1.15	5.44E-01	1.00E00
GO:0032370	positive regulation of lipid transport (GO:0032370)	89	6	5.23	+	1.15	6.53E-01	1.00E00
GO:0042632	cholesterol homeostasis (GO:0042632)	89	6	5.23	+	1.15	6.53E-01	1.00E00
GO:0010952	positive regulation of peptidase activity (GO:0010952)	193	13	11.33	+	1.15	6.44E-01	1.00E00
GO:0009889	regulation of biosynthetic process (GO:0009889)	4163	280	244.45	+	1.15	1.53E-02	1.71E-01
GO:0032386	regulation of intracellular transport (GO:0032386)	342	23	20.08	+	1.15	4.89E-01	1.00E00
GO:0032649	regulation of interferon-gamma production (GO:0032649)	119	8	6.99	+	1.14	6.95E-01	1.00E00
GO:0006355	regulation of DNA-templated transcription (GO:0006355)	3454	232	202.82	+	1.14	3.29E-02	2.88E-01
GO:0043588	skin development (GO:0043588)	268	18	15.74	+	1.14	5.17E-01	1.00E00
GO:1903530	regulation of secretion by cell (GO:1903530)	566	38	33.24	+	1.14	4.16E-01	1.00E00
GO:1903506	regulation of nucleic acid-templated transcription (GO:1903506)	3456	232	202.94	+	1.14	3.30E-02	2.88E-01
GO:0002376	immune system process (GO:0002376)	2429	163	142.63	+	1.14	8.23E-02	5.09E-01
GO:0006631	fatty acid metabolic process (GO:0006631)	328	22	19.26	+	1.14	5.55E-01	1.00E00
GO:0050792	regulation of viral process (GO:0050792)	164	11	9.63	+	1.14	6.18E-01	1.00E00
GO:0034504	protein localization to nucleus (GO:0034504)	194	13	11.39	+	1.14	6.45E-01	1.00E00
GO:2001020	regulation of response to DNA damage stimulus (GO:2001020)	314	21	18.44	+	1.14	5.47E-01	1.00E00
GO:0010556	regulation of macromolecule biosynthetic process (GO:0010556)	3938	263	231.24	+	1.14	2.68E-02	2.53E-01
GO:0006357	regulation of transcription by RNA polymerase II (GO:0006357)	2606	174	153.03	+	1.14	8.35E-02	5.17E-01
GO:0043933	protein-containing complex organization (GO:0043933)	1423	95	83.56	+	1.14	2.22E-01	7.78E-01
GO:0010225	response to UV-C (GO:0010225)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0060445	branching involved in salivary gland morphogenesis (GO:0060445)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0003009	skeletal muscle contraction (GO:0003009)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:0034116	positive regulation of heterotypic cell-cell adhesion (GO:0034116)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:1902644	tertiary alcohol metabolic process (GO:1902644)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:1902563	regulation of neutrophil activation (GO:1902563)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:2001140	positive regulation of phospholipid transport (GO:2001140)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:2000671	regulation of motor neuron apoptotic process (GO:2000671)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0045348	positive regulation of MHC class II biosynthetic process (GO:0045348)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0001710	mesodermal cell fate commitment (GO:0001710)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:1902306	negative regulation of sodium ion transmembrane transport (GO:1902306)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0006516	glycoprotein catabolic process (GO:0006516)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:0032700	negative regulation of interleukin-17 production (GO:0032700)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0071451	cellular response to superoxide (GO:0071451)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0071450	cellular response to oxygen radical (GO:0071450)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0045176	apical protein localization (GO:0045176)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0070986	left/right axis specification (GO:0070986)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0070979	protein K11-linked ubiquitination (GO:0070979)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:0051791	medium-chain fatty acid metabolic process (GO:0051791)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0033008	positive regulation of mast cell activation involved in immune response (GO:0033008)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0090398	cellular senescence (GO:0090398)	60	4	3.52	+	1.14	7.81E-01	1.00E00
GO:0032352	positive regulation of hormone metabolic process (GO:0032352)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0032309	icosanoid secretion (GO:0032309)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:0050930	induction of positive chemotaxis (GO:0050930)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0032268	regulation of cellular protein metabolic process (GO:0032268)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0051353	positive regulation of oxidoreductase activity (GO:0051353)	60	4	3.52	+	1.14	7.81E-01	1.00E00
GO:1901201	regulation of extracellular matrix assembly (GO:1901201)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0050820	positive regulation of coagulation (GO:0050820)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:0051290	protein heterotetramerization (GO:0051290)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0043508	negative regulation of JUN kinase activity (GO:0043508)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0043506	regulation of JUN kinase activity (GO:0043506)	60	4	3.52	+	1.14	7.81E-01	1.00E00
GO:1904936	interneuron migration (GO:1904936)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0035883	enteroendocrine cell differentiation (GO:0035883)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:0043455	regulation of secondary metabolic process (GO:0043455)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0070199	establishment of protein localization to chromosome (GO:0070199)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0070166	enamel mineralization (GO:0070166)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0048261	negative regulation of receptor-mediated endocytosis (GO:0048261)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:1904862	inhibitory synapse assembly (GO:1904862)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0043306	positive regulation of mast cell degranulation (GO:0043306)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:1900376	regulation of secondary metabolite biosynthetic process (GO:1900376)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0036151	phosphatidylcholine acyl-chain remodeling (GO:0036151)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0043249	erythrocyte maturation (GO:0043249)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0048021	regulation of melanin biosynthetic process (GO:0048021)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:1905048	regulation of metallopeptidase activity (GO:1905048)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:1900153	positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0009158	ribonucleoside monophosphate catabolic process (GO:0009158)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0010955	negative regulation of protein processing (GO:0010955)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:1900029	positive regulation of ruffle assembly (GO:1900029)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:1903909	regulation of receptor clustering (GO:1903909)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0035278	miRNA-mediated gene silencing by inhibition of translation (GO:0035278)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:1904294	positive regulation of ERAD pathway (GO:1904294)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0008299	isoprenoid biosynthetic process (GO:0008299)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:0046500	S-adenosylmethionine metabolic process (GO:0046500)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0042116	macrophage activation (GO:0042116)	60	4	3.52	+	1.14	7.81E-01	1.00E00
GO:0030148	sphingolipid biosynthetic process (GO:0030148)	105	7	6.17	+	1.14	6.78E-01	1.00E00
GO:0008211	glucocorticoid metabolic process (GO:0008211)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0003376	sphingosine-1-phosphate receptor signaling pathway (GO:0003376)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0046464	acylglycerol catabolic process (GO:0046464)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:0046461	neutral lipid catabolic process (GO:0046461)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:0002864	regulation of acute inflammatory response to antigenic stimulus (GO:0002864)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0045940	positive regulation of steroid metabolic process (GO:0045940)	30	2	1.76	+	1.14	6.97E-01	1.00E00
GO:1903409	reactive oxygen species biosynthetic process (GO:1903409)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0046322	negative regulation of fatty acid oxidation (GO:0046322)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0034310	primary alcohol catabolic process (GO:0034310)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:0021859	pyramidal neuron differentiation (GO:0021859)	15	1	.88	+	1.14	5.99E-01	1.00E00
GO:2000785	regulation of autophagosome assembly (GO:2000785)	45	3	2.64	+	1.14	7.48E-01	1.00E00
GO:0060147	regulation of post-transcriptional gene silencing (GO:0060147)	45	3	2.64	+	1.14	7.48E-01	1.00E00
GO:0032814	regulation of natural killer cell activation (GO:0032814)	45	3	2.64	+	1.14	7.48E-01	1.00E00
GO:0043648	dicarboxylic acid metabolic process (GO:0043648)	90	6	5.28	+	1.14	6.56E-01	1.00E00
GO:0017156	calcium-ion regulated exocytosis (GO:0017156)	45	3	2.64	+	1.14	7.48E-01	1.00E00
GO:1900271	regulation of long-term synaptic potentiation (GO:1900271)	45	3	2.64	+	1.14	7.48E-01	1.00E00
GO:0055092	sterol homeostasis (GO:0055092)	90	6	5.28	+	1.14	6.56E-01	1.00E00
GO:0043039	tRNA aminoacylation (GO:0043039)	45	3	2.64	+	1.14	7.48E-01	1.00E00
GO:0031063	regulation of histone deacetylation (GO:0031063)	45	3	2.64	+	1.14	7.48E-01	1.00E00
GO:0042446	hormone biosynthetic process (GO:0042446)	45	3	2.64	+	1.14	7.48E-01	1.00E00
GO:0045995	regulation of embryonic development (GO:0045995)	90	6	5.28	+	1.14	6.56E-01	1.00E00
GO:0008089	anterograde axonal transport (GO:0008089)	45	3	2.64	+	1.14	7.48E-01	1.00E00
GO:0051668	localization within membrane (GO:0051668)	541	36	31.77	+	1.13	4.60E-01	1.00E00
GO:0006091	generation of precursor metabolites and energy (GO:0006091)	406	27	23.84	+	1.13	5.24E-01	1.00E00
GO:0006629	lipid metabolic process (GO:0006629)	1234	82	72.46	+	1.13	2.63E-01	8.53E-01
GO:0070663	regulation of leukocyte proliferation (GO:0070663)	271	18	15.91	+	1.13	6.04E-01	1.00E00
GO:0050776	regulation of immune response (GO:0050776)	935	62	54.90	+	1.13	3.57E-01	1.00E00
GO:0031326	regulation of cellular biosynthetic process (GO:0031326)	4102	272	240.87	+	1.13	3.21E-02	2.81E-01
GO:0031056	regulation of histone modification (GO:0031056)	181	12	10.63	+	1.13	6.35E-01	1.00E00
GO:0009896	positive regulation of catabolic process (GO:0009896)	513	34	30.12	+	1.13	4.50E-01	1.00E00
GO:0031503	protein-containing complex localization (GO:0031503)	151	10	8.87	+	1.13	7.28E-01	1.00E00
GO:0065003	protein-containing complex assembly (GO:0065003)	1270	84	74.58	+	1.13	2.70E-01	8.62E-01
GO:0010468	regulation of gene expression (GO:0010468)	4855	321	285.09	+	1.13	1.98E-02	2.05E-01
GO:0050778	positive regulation of immune response (GO:0050778)	590	39	34.65	+	1.13	4.79E-01	1.00E00
GO:1990869	cellular response to chemokine (GO:1990869)	91	6	5.34	+	1.12	6.59E-01	1.00E00
GO:1990868	response to chemokine (GO:1990868)	91	6	5.34	+	1.12	6.59E-01	1.00E00
GO:0010822	positive regulation of mitochondrion organization (GO:0010822)	76	5	4.46	+	1.12	8.05E-01	1.00E00
GO:0045824	negative regulation of innate immune response (GO:0045824)	76	5	4.46	+	1.12	8.05E-01	1.00E00
GO:0006687	glycosphingolipid metabolic process (GO:0006687)	61	4	3.58	+	1.12	7.83E-01	1.00E00
GO:0002275	myeloid cell activation involved in immune response (GO:0002275)	61	4	3.58	+	1.12	7.83E-01	1.00E00
GO:1902106	negative regulation of leukocyte differentiation (GO:1902106)	107	7	6.28	+	1.11	6.83E-01	1.00E00
GO:0019953	sexual reproduction (GO:0019953)	887	58	52.09	+	1.11	4.24E-01	1.00E00
GO:0030705	cytoskeleton-dependent intracellular transport (GO:0030705)	199	13	11.69	+	1.11	6.51E-01	1.00E00
GO:0045747	positive regulation of Notch signaling pathway (GO:0045747)	46	3	2.70	+	1.11	7.52E-01	1.00E00
GO:0021517	ventral spinal cord development (GO:0021517)	46	3	2.70	+	1.11	7.52E-01	1.00E00
GO:0001825	blastocyst formation (GO:0001825)	46	3	2.70	+	1.11	7.52E-01	1.00E00
GO:0043038	amino acid activation (GO:0043038)	46	3	2.70	+	1.11	7.52E-01	1.00E00
GO:0097581	lamellipodium organization (GO:0097581)	46	3	2.70	+	1.11	7.52E-01	1.00E00
GO:0060966	regulation of gene silencing by RNA (GO:0060966)	46	3	2.70	+	1.11	7.52E-01	1.00E00
GO:0015980	energy derivation by oxidation of organic compounds (GO:0015980)	261	17	15.33	+	1.11	6.91E-01	1.00E00
GO:0051252	regulation of RNA metabolic process (GO:0051252)	3752	244	220.32	+	1.11	9.24E-02	5.42E-01
GO:0071216	cellular response to biotic stimulus (GO:0071216)	231	15	13.56	+	1.11	6.74E-01	1.00E00
GO:0045661	regulation of myoblast differentiation (GO:0045661)	77	5	4.52	+	1.11	8.07E-01	1.00E00
GO:2000142	regulation of DNA-templated transcription initiation (GO:2000142)	77	5	4.52	+	1.11	8.07E-01	1.00E00
GO:0044000	movement in host (GO:0044000)	139	9	8.16	+	1.10	7.18E-01	1.00E00
GO:0009582	detection of abiotic stimulus (GO:0009582)	139	9	8.16	+	1.10	7.18E-01	1.00E00
GO:1903203	regulation of oxidative stress-induced neuron death (GO:1903203)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0001916	positive regulation of T cell mediated cytotoxicity (GO:0001916)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0032647	regulation of interferon-alpha production (GO:0032647)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0090322	regulation of superoxide metabolic process (GO:0090322)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0044458	motile cilium assembly (GO:0044458)	62	4	3.64	+	1.10	7.85E-01	1.00E00
GO:0050709	negative regulation of protein secretion (GO:0050709)	62	4	3.64	+	1.10	7.85E-01	1.00E00
GO:0098661	inorganic anion transmembrane transport (GO:0098661)	124	8	7.28	+	1.10	7.04E-01	1.00E00
GO:0000381	regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	62	4	3.64	+	1.10	7.85E-01	1.00E00
GO:0016447	somatic recombination of immunoglobulin gene segments (GO:0016447)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0000096	sulfur amino acid metabolic process (GO:0000096)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:1900117	regulation of execution phase of apoptosis (GO:1900117)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0150117	positive regulation of cell-substrate junction organization (GO:0150117)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:1904356	regulation of telomere maintenance via telomere lengthening (GO:1904356)	62	4	3.64	+	1.10	7.85E-01	1.00E00
GO:0030149	sphingolipid catabolic process (GO:0030149)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0002825	regulation of T-helper 1 type immune response (GO:0002825)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0045948	positive regulation of translational initiation (GO:0045948)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0061099	negative regulation of protein tyrosine kinase activity (GO:0061099)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:1903318	negative regulation of protein maturation (GO:1903318)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0072525	pyridine-containing compound biosynthetic process (GO:0072525)	31	2	1.82	+	1.10	7.05E-01	1.00E00
GO:0098869	cellular oxidant detoxification (GO:0098869)	93	6	5.46	+	1.10	8.24E-01	1.00E00
GO:0051262	protein tetramerization (GO:0051262)	93	6	5.46	+	1.10	8.24E-01	1.00E00
GO:0051047	positive regulation of secretion (GO:0051047)	311	20	18.26	+	1.10	6.29E-01	1.00E00
GO:0051234	establishment of localization (GO:0051234)	3997	257	234.71	+	1.09	1.17E-01	5.78E-01
GO:0008150	biological_process (GO:0008150)	17864	1148	1048.99	+	1.09	4.07E-20	1.88E-17
GO:0090276	regulation of peptide hormone secretion (GO:0090276)	187	12	10.98	+	1.09	7.54E-01	1.00E00
GO:0051092	positive regulation of NF-kappaB transcription factor activity (GO:0051092)	156	10	9.16	+	1.09	7.33E-01	1.00E00
GO:0099111	microtubule-based transport (GO:0099111)	203	13	11.92	+	1.09	7.64E-01	1.00E00
GO:0050708	regulation of protein secretion (GO:0050708)	250	16	14.68	+	1.09	6.86E-01	1.00E00
GO:0016042	lipid catabolic process (GO:0016042)	297	19	17.44	+	1.09	7.09E-01	1.00E00
GO:0033036	macromolecule localization (GO:0033036)	2345	150	137.70	+	1.09	2.85E-01	8.98E-01
GO:2000058	regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	172	11	10.10	+	1.09	7.45E-01	1.00E00
GO:0070849	response to epidermal growth factor (GO:0070849)	47	3	2.76	+	1.09	7.56E-01	1.00E00
GO:0090199	regulation of release of cytochrome c from mitochondria (GO:0090199)	47	3	2.76	+	1.09	7.56E-01	1.00E00
GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	47	3	2.76	+	1.09	7.56E-01	1.00E00
GO:0008542	visual learning (GO:0008542)	47	3	2.76	+	1.09	7.56E-01	1.00E00
GO:0010824	regulation of centrosome duplication (GO:0010824)	47	3	2.76	+	1.09	7.56E-01	1.00E00
GO:0034332	adherens junction organization (GO:0034332)	47	3	2.76	+	1.09	7.56E-01	1.00E00
GO:0042177	negative regulation of protein catabolic process (GO:0042177)	110	7	6.46	+	1.08	8.38E-01	1.00E00
GO:0051604	protein maturation (GO:0051604)	283	18	16.62	+	1.08	7.03E-01	1.00E00
GO:0046890	regulation of lipid biosynthetic process (GO:0046890)	173	11	10.16	+	1.08	7.46E-01	1.00E00
GO:0008104	protein localization (GO:0008104)	1919	122	112.68	+	1.08	3.61E-01	1.00E00
GO:0007043	cell-cell junction assembly (GO:0007043)	126	8	7.40	+	1.08	8.49E-01	1.00E00
GO:0033077	T cell differentiation in thymus (GO:0033077)	63	4	3.70	+	1.08	7.88E-01	1.00E00
GO:0018193	peptidyl-amino acid modification (GO:0018193)	882	56	51.79	+	1.08	5.59E-01	1.00E00
GO:0070542	response to fatty acid (GO:0070542)	63	4	3.70	+	1.08	7.88E-01	1.00E00
GO:1903900	regulation of viral life cycle (GO:1903900)	142	9	8.34	+	1.08	7.23E-01	1.00E00
GO:0070727	cellular macromolecule localization (GO:0070727)	1925	122	113.04	+	1.08	3.88E-01	1.00E00
GO:0042110	T cell activation (GO:0042110)	300	19	17.62	+	1.08	7.11E-01	1.00E00
GO:0009123	nucleoside monophosphate metabolic process (GO:0009123)	79	5	4.64	+	1.08	8.10E-01	1.00E00
GO:2000113	negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	190	12	11.16	+	1.08	7.57E-01	1.00E00
GO:0048525	negative regulation of viral process (GO:0048525)	95	6	5.58	+	1.08	8.26E-01	1.00E00
GO:0002791	regulation of peptide secretion (GO:0002791)	190	12	11.16	+	1.08	7.57E-01	1.00E00
GO:0032940	secretion by cell (GO:0032940)	412	26	24.19	+	1.07	6.73E-01	1.00E00
GO:0001676	long-chain fatty acid metabolic process (GO:0001676)	111	7	6.52	+	1.07	8.39E-01	1.00E00
GO:1903707	negative regulation of hemopoiesis (GO:1903707)	111	7	6.52	+	1.07	8.39E-01	1.00E00
GO:0051259	protein complex oligomerization (GO:0051259)	254	16	14.92	+	1.07	7.88E-01	1.00E00
GO:0009607	response to biotic stimulus (GO:0009607)	1478	93	86.79	+	1.07	4.92E-01	1.00E00
GO:0008610	lipid biosynthetic process (GO:0008610)	604	38	35.47	+	1.07	6.61E-01	1.00E00
GO:0006820	anion transport (GO:0006820)	446	28	26.19	+	1.07	6.85E-01	1.00E00
GO:0050864	regulation of B cell activation (GO:0050864)	223	14	13.09	+	1.07	7.75E-01	1.00E00
GO:1901616	organic hydroxy compound catabolic process (GO:1901616)	80	5	4.70	+	1.06	8.11E-01	1.00E00
GO:0034620	cellular response to unfolded protein (GO:0034620)	80	5	4.70	+	1.06	8.11E-01	1.00E00
GO:0007605	sensory perception of sound (GO:0007605)	160	10	9.40	+	1.06	8.66E-01	1.00E00
GO:0045722	positive regulation of gluconeogenesis (GO:0045722)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0046173	polyol biosynthetic process (GO:0046173)	48	3	2.82	+	1.06	7.60E-01	1.00E00
GO:0060416	response to growth hormone (GO:0060416)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0002532	production of molecular mediator involved in inflammatory response (GO:0002532)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0006878	cellular copper ion homeostasis (GO:0006878)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0045579	positive regulation of B cell differentiation (GO:0045579)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0001963	synaptic transmission, dopaminergic (GO:0001963)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0060295	regulation of cilium movement involved in cell motility (GO:0060295)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0072234	metanephric nephron tubule development (GO:0072234)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0060253	negative regulation of glial cell proliferation (GO:0060253)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0060231	mesenchymal to epithelial transition (GO:0060231)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:2001138	regulation of phospholipid transport (GO:2001138)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0019184	nonribosomal peptide biosynthetic process (GO:0019184)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0072176	nephric duct development (GO:0072176)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0002260	lymphocyte homeostasis (GO:0002260)	64	4	3.76	+	1.06	7.90E-01	1.00E00
GO:0002220	innate immune response activating cell surface receptor signaling pathway (GO:0002220)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0032897	negative regulation of viral transcription (GO:0032897)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0060046	regulation of acrosome reaction (GO:0060046)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0006590	thyroid hormone generation (GO:0006590)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0006555	methionine metabolic process (GO:0006555)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0006525	arginine metabolic process (GO:0006525)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:1902285	semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0006476	protein deacetylation (GO:0006476)	64	4	3.76	+	1.06	7.90E-01	1.00E00
GO:0045185	maintenance of protein location (GO:0045185)	96	6	5.64	+	1.06	8.27E-01	1.00E00
GO:1901741	positive regulation of myoblast fusion (GO:1901741)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0090520	sphingolipid mediated signaling pathway (GO:0090520)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:2000345	regulation of hepatocyte proliferation (GO:2000345)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0018345	protein palmitoylation (GO:0018345)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0045070	positive regulation of viral genome replication (GO:0045070)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0045010	actin nucleation (GO:0045010)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0044550	secondary metabolite biosynthetic process (GO:0044550)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:1902019	regulation of cilium-dependent cell motility (GO:1902019)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0006206	pyrimidine nucleobase metabolic process (GO:0006206)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0090399	replicative senescence (GO:0090399)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0090336	positive regulation of brown fat cell differentiation (GO:0090336)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0140058	neuron projection arborization (GO:0140058)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0044241	lipid digestion (GO:0044241)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0050892	intestinal absorption (GO:0050892)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0090030	regulation of steroid hormone biosynthetic process (GO:0090030)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0043652	engulfment of apoptotic cell (GO:0043652)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0051127	positive regulation of actin nucleation (GO:0051127)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0051085	chaperone cofactor-dependent protein refolding (GO:0051085)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0070198	protein localization to chromosome, telomeric region (GO:0070198)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0048268	clathrin coat assembly (GO:0048268)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0048266	behavioral response to pain (GO:0048266)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0000272	polysaccharide catabolic process (GO:0000272)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0035729	cellular response to hepatocyte growth factor stimulus (GO:0035729)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0043304	regulation of mast cell degranulation (GO:0043304)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0055089	fatty acid homeostasis (GO:0055089)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0035435	phosphate ion transmembrane transport (GO:0035435)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0009163	nucleoside biosynthetic process (GO:0009163)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0009074	aromatic amino acid family catabolic process (GO:0009074)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0009048	dosage compensation by inactivation of X chromosome (GO:0009048)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0046887	positive regulation of hormone secretion (GO:0046887)	128	8	7.52	+	1.06	8.50E-01	1.00E00
GO:0046834	lipid phosphorylation (GO:0046834)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0046825	regulation of protein export from nucleus (GO:0046825)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0010820	positive regulation of T cell chemotaxis (GO:0010820)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0010715	regulation of extracellular matrix disassembly (GO:0010715)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0042220	response to cocaine (GO:0042220)	48	3	2.82	+	1.06	7.60E-01	1.00E00
GO:0046596	regulation of viral entry into host cell (GO:0046596)	48	3	2.82	+	1.06	7.60E-01	1.00E00
GO:0060841	venous blood vessel development (GO:0060841)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0042074	cell migration involved in gastrulation (GO:0042074)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0034404	nucleobase-containing small molecule biosynthetic process (GO:0034404)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0045907	positive regulation of vasoconstriction (GO:0045907)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0061101	neuroendocrine cell differentiation (GO:0061101)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0034375	high-density lipoprotein particle remodeling (GO:0034375)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0002730	regulation of dendritic cell cytokine production (GO:0002730)	16	1	.94	+	1.06	6.21E-01	1.00E00
GO:0072583	clathrin-dependent endocytosis (GO:0072583)	32	2	1.88	+	1.06	7.13E-01	1.00E00
GO:0051707	response to other organism (GO:0051707)	1429	89	83.91	+	1.06	5.61E-01	1.00E00
GO:0043207	response to external biotic stimulus (GO:0043207)	1432	89	84.09	+	1.06	6.01E-01	1.00E00
GO:0050670	regulation of lymphocyte proliferation (GO:0050670)	242	15	14.21	+	1.06	7.84E-01	1.00E00
GO:0043200	response to amino acid (GO:0043200)	113	7	6.64	+	1.05	8.41E-01	1.00E00
GO:0006639	acylglycerol metabolic process (GO:0006639)	97	6	5.70	+	1.05	8.28E-01	1.00E00
GO:0002706	regulation of lymphocyte mediated immunity (GO:0002706)	178	11	10.45	+	1.05	8.72E-01	1.00E00
GO:0072384	organelle transport along microtubule (GO:0072384)	81	5	4.76	+	1.05	8.13E-01	1.00E00
GO:0032507	maintenance of protein location in cell (GO:0032507)	65	4	3.82	+	1.05	7.93E-01	1.00E00
GO:0048524	positive regulation of viral process (GO:0048524)	65	4	3.82	+	1.05	7.93E-01	1.00E00
GO:0044255	cellular lipid metabolic process (GO:0044255)	928	57	54.49	+	1.05	7.22E-01	1.00E00
GO:0002832	negative regulation of response to biotic stimulus (GO:0002832)	114	7	6.69	+	1.05	8.42E-01	1.00E00
GO:0006066	alcohol metabolic process (GO:0006066)	326	20	19.14	+	1.04	8.13E-01	1.00E00
GO:0008202	steroid metabolic process (GO:0008202)	261	16	15.33	+	1.04	7.92E-01	1.00E00
GO:0007173	epidermal growth factor receptor signaling pathway (GO:0007173)	49	3	2.88	+	1.04	7.65E-01	1.00E00
GO:0043330	response to exogenous dsRNA (GO:0043330)	49	3	2.88	+	1.04	7.65E-01	1.00E00
GO:0031057	negative regulation of histone modification (GO:0031057)	49	3	2.88	+	1.04	7.65E-01	1.00E00
GO:0035307	positive regulation of protein dephosphorylation (GO:0035307)	49	3	2.88	+	1.04	7.65E-01	1.00E00
GO:0046631	alpha-beta T cell activation (GO:0046631)	98	6	5.75	+	1.04	8.30E-01	1.00E00
GO:0035094	response to nicotine (GO:0035094)	49	3	2.88	+	1.04	7.65E-01	1.00E00
GO:0044419	biological process involved in interspecies interaction between organisms (GO:0044419)	1602	98	94.07	+	1.04	6.59E-01	1.00E00
GO:0009755	hormone-mediated signaling pathway (GO:0009755)	131	8	7.69	+	1.04	8.52E-01	1.00E00
GO:0016051	carbohydrate biosynthetic process (GO:0016051)	131	8	7.69	+	1.04	8.52E-01	1.00E00
GO:0032944	regulation of mononuclear cell proliferation (GO:0032944)	246	15	14.45	+	1.04	8.91E-01	1.00E00
GO:0070098	chemokine-mediated signaling pathway (GO:0070098)	82	5	4.82	+	1.04	8.15E-01	1.00E00
GO:0019752	carboxylic acid metabolic process (GO:0019752)	822	50	48.27	+	1.04	7.63E-01	1.00E00
GO:2001056	positive regulation of cysteine-type endopeptidase activity (GO:2001056)	148	9	8.69	+	1.04	8.61E-01	1.00E00
GO:0009894	regulation of catabolic process (GO:0009894)	987	60	57.96	+	1.04	7.82E-01	1.00E00
GO:0050954	sensory perception of mechanical stimulus (GO:0050954)	181	11	10.63	+	1.03	8.74E-01	1.00E00
GO:0006082	organic acid metabolic process (GO:0006082)	857	52	50.32	+	1.03	8.24E-01	1.00E00
GO:0060113	inner ear receptor cell differentiation (GO:0060113)	66	4	3.88	+	1.03	7.96E-01	1.00E00
GO:1902235	regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)	33	2	1.94	+	1.03	7.21E-01	1.00E00
GO:2000144	positive regulation of DNA-templated transcription initiation (GO:2000144)	66	4	3.88	+	1.03	7.96E-01	1.00E00
GO:0040018	positive regulation of multicellular organism growth (GO:0040018)	33	2	1.94	+	1.03	7.21E-01	1.00E00
GO:0036465	synaptic vesicle recycling (GO:0036465)	66	4	3.88	+	1.03	7.96E-01	1.00E00
GO:0046579	positive regulation of Ras protein signal transduction (GO:0046579)	66	4	3.88	+	1.03	7.96E-01	1.00E00
GO:0002758	innate immune response-activating signal transduction (GO:0002758)	33	2	1.94	+	1.03	7.21E-01	1.00E00
GO:0033365	protein localization to organelle (GO:0033365)	694	42	40.75	+	1.03	8.06E-01	1.00E00
GO:0043436	oxoacid metabolic process (GO:0043436)	848	51	49.80	+	1.02	8.24E-01	1.00E00
GO:0006470	protein dephosphorylation (GO:0006470)	183	11	10.75	+	1.02	8.75E-01	1.00E00
GO:0006766	vitamin metabolic process (GO:0006766)	100	6	5.87	+	1.02	8.33E-01	1.00E00
GO:0006304	DNA modification (GO:0006304)	100	6	5.87	+	1.02	8.33E-01	1.00E00
GO:0043300	regulation of leukocyte degranulation (GO:0043300)	50	3	2.94	+	1.02	7.69E-01	1.00E00
GO:0051649	establishment of localization in cell (GO:0051649)	1752	105	102.88	+	1.02	8.32E-01	1.00E00
GO:1903532	positive regulation of secretion by cell (GO:1903532)	284	17	16.68	+	1.02	8.99E-01	1.00E00
GO:0031329	regulation of cellular catabolic process (GO:0031329)	786	47	46.15	+	1.02	8.77E-01	1.00E00
GO:0051223	regulation of protein transport (GO:0051223)	502	30	29.48	+	1.02	9.23E-01	1.00E00
GO:0016032	viral process (GO:0016032)	251	15	14.74	+	1.02	8.93E-01	1.00E00
GO:0006810	transport (GO:0006810)	3840	229	225.49	+	1.02	7.90E-01	1.00E00
GO:0002252	immune effector process (GO:0002252)	470	28	27.60	+	1.01	9.21E-01	1.00E00
GO:2001022	positive regulation of response to DNA damage stimulus (GO:2001022)	168	10	9.87	+	1.01	8.70E-01	1.00E00
GO:1905897	regulation of response to endoplasmic reticulum stress (GO:1905897)	84	5	4.93	+	1.01	8.19E-01	1.00E00
GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)	252	15	14.80	+	1.01	8.93E-01	1.00E00
GO:2000779	regulation of double-strand break repair (GO:2000779)	135	8	7.93	+	1.01	8.56E-01	1.00E00
GO:0045779	negative regulation of bone resorption (GO:0045779)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0060457	negative regulation of digestive system process (GO:0060457)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0006968	cellular defense response (GO:0006968)	51	3	2.99	+	1.00	1.00E00	1.00E00
GO:1903140	regulation of establishment of endothelial barrier (GO:1903140)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0006851	mitochondrial calcium ion transmembrane transport (GO:0006851)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:2001267	regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:2000651	positive regulation of sodium ion transmembrane transporter activity (GO:2000651)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:1902476	chloride transmembrane transport (GO:1902476)	102	6	5.99	+	1.00	1.00E00	1.00E00
GO:0060033	anatomical structure regression (GO:0060033)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:1902358	sulfate transmembrane transport (GO:1902358)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0006577	amino-acid betaine metabolic process (GO:0006577)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0045217	cell-cell junction maintenance (GO:0045217)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0038065	collagen-activated signaling pathway (GO:0038065)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0038034	signal transduction in absence of ligand (GO:0038034)	34	2	2.00	+	1.00	1.00E00	1.00E00
GO:0045198	establishment of epithelial cell apical/basal polarity (GO:0045198)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0045197	establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	51	3	2.99	+	1.00	1.00E00	1.00E00
GO:2000341	regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0033006	regulation of mast cell activation involved in immune response (GO:0033006)	34	2	2.00	+	1.00	1.00E00	1.00E00
GO:0006298	mismatch repair (GO:0006298)	34	2	2.00	+	1.00	1.00E00	1.00E00
GO:1902018	negative regulation of cilium assembly (GO:1902018)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:1901550	regulation of endothelial cell development (GO:1901550)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:2000112	regulation of cellular macromolecule biosynthetic process (GO:2000112)	493	29	28.95	+	1.00	1.00E00	1.00E00
GO:0006103	2-oxoglutarate metabolic process (GO:0006103)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0009914	hormone transport (GO:0009914)	102	6	5.99	+	1.00	1.00E00	1.00E00
GO:0044154	histone H3-K14 acetylation (GO:0044154)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0044088	regulation of vacuole organization (GO:0044088)	51	3	2.99	+	1.00	1.00E00	1.00E00
GO:0032042	mitochondrial DNA metabolic process (GO:0032042)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0009642	response to light intensity (GO:0009642)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0070201	regulation of establishment of protein localization (GO:0070201)	527	31	30.95	+	1.00	1.00E00	1.00E00
GO:0042953	lipoprotein transport (GO:0042953)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:1905269	positive regulation of chromatin organization (GO:1905269)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0048172	regulation of short-term neuronal synaptic plasticity (GO:0048172)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0009130	pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0030575	nuclear body organization (GO:0030575)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:1900034	regulation of cellular response to heat (GO:1900034)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0010885	regulation of cholesterol storage (GO:0010885)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0010819	regulation of T cell chemotaxis (GO:0010819)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0034755	iron ion transmembrane transport (GO:0034755)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0030322	stabilization of membrane potential (GO:0030322)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0016045	detection of bacterium (GO:0016045)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0019896	axonal transport of mitochondrion (GO:0019896)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0019885	antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0035025	positive regulation of Rho protein signal transduction (GO:0035025)	34	2	2.00	+	1.00	1.00E00	1.00E00
GO:0003323	type B pancreatic cell development (GO:0003323)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	34	2	2.00	+	1.00	1.00E00	1.00E00
GO:1903427	negative regulation of reactive oxygen species biosynthetic process (GO:1903427)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0045879	negative regulation of smoothened signaling pathway (GO:0045879)	34	2	2.00	+	1.00	1.00E00	1.00E00
GO:0003184	pulmonary valve morphogenesis (GO:0003184)	17	1	1.00	+	1.00	1.00E00	1.00E00
GO:0006351	DNA-templated transcription (GO:0006351)	613	36	36.00	+	1.00	1.00E00	1.00E00
GO:0050877	nervous system process (GO:0050877)	1465	86	86.03	-	1.00	1.00E00	1.00E00
GO:0097659	nucleic acid-templated transcription (GO:0097659)	614	36	36.05	-	1.00	1.00E00	1.00E00
GO:0050777	negative regulation of immune response (GO:0050777)	188	11	11.04	-	1.00	1.00E00	1.00E00
GO:0009581	detection of external stimulus (GO:0009581)	137	8	8.04	-	.99	1.00E00	1.00E00
GO:1901362	organic cyclic compound biosynthetic process (GO:1901362)	1216	71	71.40	-	.99	1.00E00	1.00E00
GO:0033559	unsaturated fatty acid metabolic process (GO:0033559)	103	6	6.05	-	.99	1.00E00	1.00E00
GO:0031341	regulation of cell killing (GO:0031341)	103	6	6.05	-	.99	1.00E00	1.00E00
GO:0032677	regulation of interleukin-8 production (GO:0032677)	86	5	5.05	-	.99	1.00E00	1.00E00
GO:0015711	organic anion transport (GO:0015711)	327	19	19.20	-	.99	1.00E00	1.00E00
GO:0002703	regulation of leukocyte mediated immunity (GO:0002703)	241	14	14.15	-	.99	1.00E00	1.00E00
GO:0006473	protein acetylation (GO:0006473)	155	9	9.10	-	.99	1.00E00	1.00E00
GO:0010506	regulation of autophagy (GO:0010506)	345	20	20.26	-	.99	1.00E00	1.00E00
GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)	190	11	11.16	-	.99	1.00E00	1.00E00
GO:0006720	isoprenoid metabolic process (GO:0006720)	121	7	7.11	-	.99	1.00E00	1.00E00
GO:0060119	inner ear receptor cell development (GO:0060119)	52	3	3.05	-	.98	1.00E00	1.00E00
GO:0038093	Fc receptor signaling pathway (GO:0038093)	52	3	3.05	-	.98	1.00E00	1.00E00
GO:1905477	positive regulation of protein localization to membrane (GO:1905477)	104	6	6.11	-	.98	1.00E00	1.00E00
GO:0031062	positive regulation of histone methylation (GO:0031062)	52	3	3.05	-	.98	1.00E00	1.00E00
GO:0032774	RNA biosynthetic process (GO:0032774)	624	36	36.64	-	.98	1.00E00	1.00E00
GO:0010950	positive regulation of endopeptidase activity (GO:0010950)	174	10	10.22	-	.98	1.00E00	1.00E00
GO:0045921	positive regulation of exocytosis (GO:0045921)	87	5	5.11	-	.98	1.00E00	1.00E00
GO:0044403	biological process involved in symbiotic interaction (GO:0044403)	261	15	15.33	-	.98	1.00E00	1.00E00
GO:0048232	male gamete generation (GO:0048232)	611	35	35.88	-	.98	1.00E00	1.00E00
GO:0046942	carboxylic acid transport (GO:0046942)	245	14	14.39	-	.97	1.00E00	1.00E00
GO:0045670	regulation of osteoclast differentiation (GO:0045670)	70	4	4.11	-	.97	1.00E00	1.00E00
GO:1902624	positive regulation of neutrophil migration (GO:1902624)	35	2	2.06	-	.97	1.00E00	1.00E00
GO:0045589	regulation of regulatory T cell differentiation (GO:0045589)	35	2	2.06	-	.97	1.00E00	1.00E00
GO:0050810	regulation of steroid biosynthetic process (GO:0050810)	70	4	4.11	-	.97	1.00E00	1.00E00
GO:1905145	cellular response to acetylcholine (GO:1905145)	35	2	2.06	-	.97	1.00E00	1.00E00
GO:0043112	receptor metabolic process (GO:0043112)	35	2	2.06	-	.97	1.00E00	1.00E00
GO:0046328	regulation of JNK cascade (GO:0046328)	140	8	8.22	-	.97	1.00E00	1.00E00
GO:0061081	positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)	35	2	2.06	-	.97	1.00E00	1.00E00
GO:0090304	nucleic acid metabolic process (GO:0090304)	2276	130	133.65	-	.97	7.77E-01	1.00E00
GO:0071704	organic substance metabolic process (GO:0071704)	7697	438	451.97	-	.97	4.27E-01	1.00E00
GO:0008152	metabolic process (GO:0008152)	8131	462	477.46	-	.97	3.80E-01	1.00E00
GO:1901360	organic cyclic compound metabolic process (GO:1901360)	3292	187	193.31	-	.97	6.57E-01	1.00E00
GO:0044237	cellular metabolic process (GO:0044237)	6606	375	387.91	-	.97	4.47E-01	1.00E00
GO:0043170	macromolecule metabolic process (GO:0043170)	5941	337	348.86	-	.97	4.72E-01	1.00E00
GO:1902743	regulation of lamellipodium organization (GO:1902743)	53	3	3.11	-	.96	1.00E00	1.00E00
GO:0032006	regulation of TOR signaling (GO:0032006)	106	6	6.22	-	.96	1.00E00	1.00E00
GO:0007632	visual behavior (GO:0007632)	53	3	3.11	-	.96	1.00E00	1.00E00
GO:0044238	primary metabolic process (GO:0044238)	7228	409	424.43	-	.96	3.85E-01	1.00E00
GO:0008037	cell recognition (GO:0008037)	230	13	13.51	-	.96	1.00E00	1.00E00
GO:0043543	protein acylation (GO:0043543)	195	11	11.45	-	.96	1.00E00	1.00E00
GO:0022408	negative regulation of cell-cell adhesion (GO:0022408)	195	11	11.45	-	.96	1.00E00	1.00E00
GO:0061024	membrane organization (GO:0061024)	851	48	49.97	-	.96	8.82E-01	1.00E00
GO:0140029	exocytic process (GO:0140029)	71	4	4.17	-	.96	1.00E00	1.00E00
GO:0032024	positive regulation of insulin secretion (GO:0032024)	71	4	4.17	-	.96	1.00E00	1.00E00
GO:0044281	small molecule metabolic process (GO:0044281)	1654	93	97.12	-	.96	7.03E-01	1.00E00
GO:0006508	proteolysis (GO:0006508)	1266	71	74.34	-	.96	7.58E-01	1.00E00
GO:0006725	cellular aromatic compound metabolic process (GO:0006725)	3050	171	179.10	-	.95	5.59E-01	1.00E00
GO:0009615	response to virus (GO:0009615)	357	20	20.96	-	.95	1.00E00	1.00E00
GO:0034728	nucleosome organization (GO:0034728)	125	7	7.34	-	.95	1.00E00	1.00E00
GO:0010256	endomembrane system organization (GO:0010256)	554	31	32.53	-	.95	8.55E-01	1.00E00
GO:0007283	spermatogenesis (GO:0007283)	592	33	34.76	-	.95	8.59E-01	1.00E00
GO:0045721	negative regulation of gluconeogenesis (GO:0045721)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0010092	specification of animal organ identity (GO:0010092)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0007250	activation of NF-kappaB-inducing kinase activity (GO:0007250)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0072243	metanephric nephron epithelium development (GO:0072243)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0002251	organ or tissue specific immune response (GO:0002251)	36	2	2.11	-	.95	1.00E00	1.00E00
GO:0044872	lipoprotein localization (GO:0044872)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0032801	receptor catabolic process (GO:0032801)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0051917	regulation of fibrinolysis (GO:0051917)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0038061	NIK/NF-kappaB signaling (GO:0038061)	36	2	2.11	-	.95	1.00E00	1.00E00
GO:0032743	positive regulation of interleukin-2 production (GO:0032743)	36	2	2.11	-	.95	1.00E00	1.00E00
GO:0002029	desensitization of G protein-coupled receptor signaling pathway (GO:0002029)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0071404	cellular response to low-density lipoprotein particle stimulus (GO:0071404)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0032695	negative regulation of interleukin-12 production (GO:0032695)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0071318	cellular response to ATP (GO:0071318)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:1902036	regulation of hematopoietic stem cell differentiation (GO:1902036)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0050965	detection of temperature stimulus involved in sensory perception of pain (GO:0050965)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0050884	neuromuscular process controlling posture (GO:0050884)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0048499	synaptic vesicle membrane organization (GO:0048499)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0036342	post-anal tail morphogenesis (GO:0036342)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0000303	response to superoxide (GO:0000303)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0035728	response to hepatocyte growth factor (GO:0035728)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0009068	aspartate family amino acid catabolic process (GO:0009068)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0046838	phosphorylated carbohydrate dephosphorylation (GO:0046838)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0150105	protein localization to cell-cell junction (GO:0150105)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:1903729	regulation of plasma membrane organization (GO:1903729)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0030206	chondroitin sulfate biosynthetic process (GO:0030206)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0046473	phosphatidic acid metabolic process (GO:0046473)	36	2	2.11	-	.95	1.00E00	1.00E00
GO:0046466	membrane lipid catabolic process (GO:0046466)	36	2	2.11	-	.95	1.00E00	1.00E00
GO:0042058	regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	72	4	4.23	-	.95	1.00E00	1.00E00
GO:0022401	negative adaptation of signaling pathway (GO:0022401)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0045911	positive regulation of DNA recombination (GO:0045911)	72	4	4.23	-	.95	1.00E00	1.00E00
GO:1902916	positive regulation of protein polyubiquitination (GO:1902916)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0007549	dosage compensation (GO:0007549)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:0034244	negative regulation of transcription elongation by RNA polymerase II (GO:0034244)	18	1	1.06	-	.95	1.00E00	1.00E00
GO:1990748	cellular detoxification (GO:1990748)	108	6	6.34	-	.95	1.00E00	1.00E00
GO:0050982	detection of mechanical stimulus (GO:0050982)	54	3	3.17	-	.95	1.00E00	1.00E00
GO:0050885	neuromuscular process controlling balance (GO:0050885)	54	3	3.17	-	.95	1.00E00	1.00E00
GO:0030968	endoplasmic reticulum unfolded protein response (GO:0030968)	54	3	3.17	-	.95	1.00E00	1.00E00
GO:0015909	long-chain fatty acid transport (GO:0015909)	54	3	3.17	-	.95	1.00E00	1.00E00
GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)	54	3	3.17	-	.95	1.00E00	1.00E00
GO:0034637	cellular carbohydrate biosynthetic process (GO:0034637)	54	3	3.17	-	.95	1.00E00	1.00E00
GO:0042102	positive regulation of T cell proliferation (GO:0042102)	108	6	6.34	-	.95	1.00E00	1.00E00
GO:0097006	regulation of plasma lipoprotein particle levels (GO:0097006)	54	3	3.17	-	.95	1.00E00	1.00E00
GO:0007585	respiratory gaseous exchange by respiratory system (GO:0007585)	54	3	3.17	-	.95	1.00E00	1.00E00
GO:0090502	RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)	90	5	5.28	-	.95	1.00E00	1.00E00
GO:0099504	synaptic vesicle cycle (GO:0099504)	126	7	7.40	-	.95	1.00E00	1.00E00
GO:0006807	nitrogen compound metabolic process (GO:0006807)	6710	372	394.02	-	.94	1.95E-01	7.59E-01
GO:0015849	organic acid transport (GO:0015849)	272	15	15.97	-	.94	1.00E00	1.00E00
GO:0019438	aromatic compound biosynthetic process (GO:0019438)	1089	60	63.95	-	.94	6.91E-01	1.00E00
GO:0007029	endoplasmic reticulum organization (GO:0007029)	91	5	5.34	-	.94	1.00E00	1.00E00
GO:0007631	feeding behavior (GO:0007631)	91	5	5.34	-	.94	1.00E00	1.00E00
GO:0051250	negative regulation of lymphocyte activation (GO:0051250)	164	9	9.63	-	.93	1.00E00	1.00E00
GO:0006139	nucleobase-containing compound metabolic process (GO:0006139)	2825	155	165.89	-	.93	3.89E-01	1.00E00
GO:0009150	purine ribonucleotide metabolic process (GO:0009150)	383	21	22.49	-	.93	9.12E-01	1.00E00
GO:0009185	ribonucleoside diphosphate metabolic process (GO:0009185)	73	4	4.29	-	.93	1.00E00	1.00E00
GO:0009064	glutamine family amino acid metabolic process (GO:0009064)	73	4	4.29	-	.93	1.00E00	1.00E00
GO:0008333	endosome to lysosome transport (GO:0008333)	73	4	4.29	-	.93	1.00E00	1.00E00
GO:0046483	heterocycle metabolic process (GO:0046483)	2999	164	176.10	-	.93	3.55E-01	1.00E00
GO:0034654	nucleobase-containing compound biosynthetic process (GO:0034654)	1007	55	59.13	-	.93	6.31E-01	1.00E00
GO:0046164	alcohol catabolic process (GO:0046164)	55	3	3.23	-	.93	1.00E00	1.00E00
GO:0002200	somatic diversification of immune receptors (GO:0002200)	55	3	3.23	-	.93	1.00E00	1.00E00
GO:0042149	cellular response to glucose starvation (GO:0042149)	55	3	3.23	-	.93	1.00E00	1.00E00
GO:0006644	phospholipid metabolic process (GO:0006644)	367	20	21.55	-	.93	8.23E-01	1.00E00
GO:1901564	organonitrogen compound metabolic process (GO:1901564)	5013	273	294.37	-	.93	1.67E-01	6.84E-01
GO:1901606	alpha-amino acid catabolic process (GO:1901606)	92	5	5.40	-	.93	1.00E00	1.00E00
GO:0006821	chloride transport (GO:0006821)	111	6	6.52	-	.92	1.00E00	1.00E00
GO:0034122	negative regulation of toll-like receptor signaling pathway (GO:0034122)	37	2	2.17	-	.92	1.00E00	1.00E00
GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	37	2	2.17	-	.92	1.00E00	1.00E00
GO:0051084	'de novo' post-translational protein folding (GO:0051084)	37	2	2.17	-	.92	1.00E00	1.00E00
GO:0009225	nucleotide-sugar metabolic process (GO:0009225)	37	2	2.17	-	.92	1.00E00	1.00E00
GO:0031076	embryonic camera-type eye development (GO:0031076)	37	2	2.17	-	.92	1.00E00	1.00E00
GO:0015695	organic cation transport (GO:0015695)	37	2	2.17	-	.92	1.00E00	1.00E00
GO:0030032	lamellipodium assembly (GO:0030032)	37	2	2.17	-	.92	1.00E00	1.00E00
GO:0002768	immune response-regulating cell surface receptor signaling pathway (GO:0002768)	315	17	18.50	-	.92	9.04E-01	1.00E00
GO:0007186	G protein-coupled receptor signaling pathway (GO:0007186)	1223	66	71.82	-	.92	5.31E-01	1.00E00
GO:0022900	electron transport chain (GO:0022900)	167	9	9.81	-	.92	1.00E00	1.00E00
GO:0045103	intermediate filament-based process (GO:0045103)	93	5	5.46	-	.92	1.00E00	1.00E00
GO:0046879	hormone secretion (GO:0046879)	93	5	5.46	-	.92	1.00E00	1.00E00
GO:0018130	heterocycle biosynthetic process (GO:0018130)	1079	58	63.36	-	.92	5.49E-01	1.00E00
GO:0072348	sulfur compound transport (GO:0072348)	56	3	3.29	-	.91	1.00E00	1.00E00
GO:0048255	mRNA stabilization (GO:0048255)	56	3	3.29	-	.91	1.00E00	1.00E00
GO:0043331	response to dsRNA (GO:0043331)	56	3	3.29	-	.91	1.00E00	1.00E00
GO:0006643	membrane lipid metabolic process (GO:0006643)	206	11	12.10	-	.91	8.82E-01	1.00E00
GO:0035601	protein deacylation (GO:0035601)	75	4	4.40	-	.91	1.00E00	1.00E00
GO:0000045	autophagosome assembly (GO:0000045)	75	4	4.40	-	.91	1.00E00	1.00E00
GO:0008652	cellular amino acid biosynthetic process (GO:0008652)	75	4	4.40	-	.91	1.00E00	1.00E00
GO:0019538	protein metabolic process (GO:0019538)	3920	208	230.19	-	.90	1.21E-01	5.83E-01
GO:0036211	protein modification process (GO:0036211)	2658	141	156.08	-	.90	2.16E-01	7.70E-01
GO:0006163	purine nucleotide metabolic process (GO:0006163)	396	21	23.25	-	.90	7.46E-01	1.00E00
GO:0050714	positive regulation of protein secretion (GO:0050714)	132	7	7.75	-	.90	1.00E00	1.00E00
GO:0002429	immune response-activating cell surface receptor signaling pathway (GO:0002429)	283	15	16.62	-	.90	7.99E-01	1.00E00
GO:0002757	immune response-activating signal transduction (GO:0002757)	283	15	16.62	-	.90	7.99E-01	1.00E00
GO:0017148	negative regulation of translation (GO:0017148)	170	9	9.98	-	.90	1.00E00	1.00E00
GO:0034641	cellular nitrogen compound metabolic process (GO:0034641)	3573	189	209.81	-	.90	1.27E-01	6.06E-01
GO:0098656	anion transmembrane transport (GO:0098656)	246	13	14.45	-	.90	8.91E-01	1.00E00
GO:0016311	dephosphorylation (GO:0016311)	246	13	14.45	-	.90	8.91E-01	1.00E00
GO:0044260	cellular macromolecule metabolic process (GO:0044260)	2518	133	147.86	-	.90	2.21E-01	7.86E-01
GO:0045746	negative regulation of Notch signaling pathway (GO:0045746)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:1902745	positive regulation of lamellipodium organization (GO:1902745)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:0060391	positive regulation of SMAD protein signal transduction (GO:0060391)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0060340	positive regulation of type I interferon-mediated signaling pathway (GO:0060340)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0002483	antigen processing and presentation of endogenous peptide antigen (GO:0002483)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0045540	regulation of cholesterol biosynthetic process (GO:0045540)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0021516	dorsal spinal cord development (GO:0021516)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0021511	spinal cord patterning (GO:0021511)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0007213	G protein-coupled acetylcholine receptor signaling pathway (GO:0007213)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:2001185	regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0071715	icosanoid transport (GO:0071715)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:0001845	phagolysosome assembly (GO:0001845)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0072170	metanephric tubule development (GO:0072170)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0060122	inner ear receptor cell stereocilium organization (GO:0060122)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:0002281	macrophage activation involved in immune response (GO:0002281)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0006607	NLS-bearing protein import into nucleus (GO:0006607)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0072079	nephron tubule formation (GO:0072079)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0006595	polyamine metabolic process (GO:0006595)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0045191	regulation of isotype switching (GO:0045191)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:0005975	carbohydrate metabolic process (GO:0005975)	475	25	27.89	-	.90	6.92E-01	1.00E00
GO:0032652	regulation of interleukin-1 production (GO:0032652)	114	6	6.69	-	.90	1.00E00	1.00E00
GO:0032651	regulation of interleukin-1 beta production (GO:0032651)	95	5	5.58	-	.90	1.00E00	1.00E00
GO:0051797	regulation of hair follicle development (GO:0051797)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0045091	regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:2000251	positive regulation of actin cytoskeleton reorganization (GO:2000251)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0106118	regulation of sterol biosynthetic process (GO:0106118)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0006006	glucose metabolic process (GO:0006006)	114	6	6.69	-	.90	1.00E00	1.00E00
GO:0000305	response to oxygen radical (GO:0000305)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0016553	base conversion or substitution editing (GO:0016553)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:1904659	glucose transmembrane transport (GO:1904659)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:0042730	fibrinolysis (GO:0042730)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0055070	copper ion homeostasis (GO:0055070)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0009148	pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0009125	nucleoside monophosphate catabolic process (GO:0009125)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0042574	retinal metabolic process (GO:0042574)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0010935	regulation of macrophage cytokine production (GO:0010935)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:0030502	negative regulation of bone mineralization (GO:0030502)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0008593	regulation of Notch signaling pathway (GO:0008593)	95	5	5.58	-	.90	1.00E00	1.00E00
GO:0010759	positive regulation of macrophage chemotaxis (GO:0010759)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0060997	dendritic spine morphogenesis (GO:0060997)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0008206	bile acid metabolic process (GO:0008206)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:0002827	positive regulation of T-helper 1 type immune response (GO:0002827)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0045945	positive regulation of transcription by RNA polymerase III (GO:0045945)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:1903428	positive regulation of reactive oxygen species biosynthetic process (GO:1903428)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0046330	positive regulation of JNK cascade (GO:0046330)	95	5	5.58	-	.90	1.00E00	1.00E00
GO:0046329	negative regulation of JNK cascade (GO:0046329)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:0045880	positive regulation of smoothened signaling pathway (GO:0045880)	38	2	2.23	-	.90	1.00E00	1.00E00
GO:0060571	morphogenesis of an epithelial fold (GO:0060571)	19	1	1.12	-	.90	1.00E00	1.00E00
GO:0098542	defense response to other organism (GO:0098542)	1068	56	62.71	-	.89	4.23E-01	1.00E00
GO:0007286	spermatid development (GO:0007286)	191	10	11.22	-	.89	8.77E-01	1.00E00
GO:0044262	cellular carbohydrate metabolic process (GO:0044262)	172	9	10.10	-	.89	8.71E-01	1.00E00
GO:0009259	ribonucleotide metabolic process (GO:0009259)	404	21	23.72	-	.89	6.69E-01	1.00E00
GO:0033157	regulation of intracellular protein transport (GO:0033157)	231	12	13.56	-	.88	7.79E-01	1.00E00
GO:0099003	vesicle-mediated transport in synapse (GO:0099003)	135	7	7.93	-	.88	1.00E00	1.00E00
GO:0007254	JNK cascade (GO:0007254)	58	3	3.41	-	.88	1.00E00	1.00E00
GO:0006690	icosanoid metabolic process (GO:0006690)	116	6	6.81	-	.88	1.00E00	1.00E00
GO:0032648	regulation of interferon-beta production (GO:0032648)	58	3	3.41	-	.88	1.00E00	1.00E00
GO:0016079	synaptic vesicle exocytosis (GO:0016079)	58	3	3.41	-	.88	1.00E00	1.00E00
GO:0097237	cellular response to toxic substance (GO:0097237)	116	6	6.81	-	.88	1.00E00	1.00E00
GO:0019637	organophosphate metabolic process (GO:0019637)	931	48	54.67	-	.88	4.31E-01	1.00E00
GO:0050871	positive regulation of B cell activation (GO:0050871)	175	9	10.28	-	.88	8.71E-01	1.00E00
GO:0032729	positive regulation of interferon-gamma production (GO:0032729)	78	4	4.58	-	.87	1.00E00	1.00E00
GO:0018198	peptidyl-cysteine modification (GO:0018198)	39	2	2.29	-	.87	1.00E00	1.00E00
GO:0032365	intracellular lipid transport (GO:0032365)	39	2	2.29	-	.87	1.00E00	1.00E00
GO:0000731	DNA synthesis involved in DNA repair (GO:0000731)	39	2	2.29	-	.87	1.00E00	1.00E00
GO:1901184	regulation of ERBB signaling pathway (GO:1901184)	78	4	4.58	-	.87	1.00E00	1.00E00
GO:1905168	positive regulation of double-strand break repair via homologous recombination (GO:1905168)	39	2	2.29	-	.87	1.00E00	1.00E00
GO:0005996	monosaccharide metabolic process (GO:0005996)	176	9	10.33	-	.87	8.71E-01	1.00E00
GO:0032755	positive regulation of interleukin-6 production (GO:0032755)	98	5	5.75	-	.87	1.00E00	1.00E00
GO:0043412	macromolecule modification (GO:0043412)	2883	147	169.29	-	.87	7.25E-02	4.68E-01
GO:0009948	anterior/posterior axis specification (GO:0009948)	59	3	3.46	-	.87	1.00E00	1.00E00
GO:0042733	embryonic digit morphogenesis (GO:0042733)	59	3	3.46	-	.87	1.00E00	1.00E00
GO:0019693	ribose phosphate metabolic process (GO:0019693)	413	21	24.25	-	.87	5.96E-01	1.00E00
GO:0060632	regulation of microtubule-based movement (GO:0060632)	59	3	3.46	-	.87	1.00E00	1.00E00
GO:1901361	organic cyclic compound catabolic process (GO:1901361)	374	19	21.96	-	.87	6.56E-01	1.00E00
GO:1901135	carbohydrate derivative metabolic process (GO:1901135)	1005	51	59.01	-	.86	3.34E-01	9.52E-01
GO:1903038	negative regulation of leukocyte cell-cell adhesion (GO:1903038)	138	7	8.10	-	.86	8.56E-01	1.00E00
GO:0044782	cilium organization (GO:0044782)	355	18	20.85	-	.86	6.48E-01	1.00E00
GO:0016192	vesicle-mediated transport (GO:0016192)	1382	70	81.15	-	.86	2.35E-01	8.19E-01
GO:0006887	exocytosis (GO:0006887)	237	12	13.92	-	.86	7.80E-01	1.00E00
GO:0098732	macromolecule deacylation (GO:0098732)	79	4	4.64	-	.86	1.00E00	1.00E00
GO:0021510	spinal cord development (GO:0021510)	99	5	5.81	-	.86	1.00E00	1.00E00
GO:0006672	ceramide metabolic process (GO:0006672)	99	5	5.81	-	.86	1.00E00	1.00E00
GO:0002221	pattern recognition receptor signaling pathway (GO:0002221)	99	5	5.81	-	.86	1.00E00	1.00E00
GO:0048515	spermatid differentiation (GO:0048515)	198	10	11.63	-	.86	7.61E-01	1.00E00
GO:0071702	organic substance transport (GO:0071702)	1964	99	115.33	-	.86	1.29E-01	6.15E-01
GO:0002764	immune response-regulating signaling pathway (GO:0002764)	397	20	23.31	-	.86	5.89E-01	1.00E00
GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0060396	growth hormone receptor signaling pathway (GO:0060396)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:2000810	regulation of bicellular tight junction assembly (GO:2000810)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0034035	purine ribonucleoside bisphosphate metabolic process (GO:0034035)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0006767	water-soluble vitamin metabolic process (GO:0006767)	60	3	3.52	-	.85	1.00E00	1.00E00
GO:0006662	glycerol ether metabolic process (GO:0006662)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0071637	regulation of monocyte chemotactic protein-1 production (GO:0071637)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0045346	regulation of MHC class II biosynthetic process (GO:0045346)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:2000434	regulation of protein neddylation (GO:2000434)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0006491	N-glycan processing (GO:0006491)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0006448	regulation of translational elongation (GO:0006448)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0070935	3'-UTR-mediated mRNA stabilization (GO:0070935)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0006379	mRNA cleavage (GO:0006379)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0071378	cellular response to growth hormone stimulus (GO:0071378)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0045088	regulation of innate immune response (GO:0045088)	240	12	14.09	-	.85	6.79E-01	1.00E00
GO:1901659	glycosyl compound biosynthetic process (GO:1901659)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:1902004	positive regulation of amyloid-beta formation (GO:1902004)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0032495	response to muramyl dipeptide (GO:0032495)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0031998	regulation of fatty acid beta-oxidation (GO:0031998)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0043954	cellular component maintenance (GO:0043954)	60	3	3.52	-	.85	1.00E00	1.00E00
GO:0090207	regulation of triglyceride metabolic process (GO:0090207)	40	2	2.35	-	.85	1.00E00	1.00E00
GO:0032350	regulation of hormone metabolic process (GO:0032350)	40	2	2.35	-	.85	1.00E00	1.00E00
GO:0098962	regulation of postsynaptic neurotransmitter receptor activity (GO:0098962)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0031645	negative regulation of nervous system process (GO:0031645)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0098543	detection of other organism (GO:0098543)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0016575	histone deacetylation (GO:0016575)	60	3	3.52	-	.85	1.00E00	1.00E00
GO:0050427	3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0055062	phosphate ion homeostasis (GO:0055062)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0043046	DNA methylation involved in gamete generation (GO:0043046)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0046902	regulation of mitochondrial membrane permeability (GO:0046902)	60	3	3.52	-	.85	1.00E00	1.00E00
GO:0046782	regulation of viral transcription (GO:0046782)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0097479	synaptic vesicle localization (GO:0097479)	40	2	2.35	-	.85	1.00E00	1.00E00
GO:0010766	negative regulation of sodium ion transport (GO:0010766)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0046629	gamma-delta T cell activation (GO:0046629)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0030262	apoptotic nuclear changes (GO:0030262)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0023058	adaptation of signaling pathway (GO:0023058)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0046485	ether lipid metabolic process (GO:0046485)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0030011	maintenance of cell polarity (GO:0030011)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0060612	adipose tissue development (GO:0060612)	40	2	2.35	-	.85	1.00E00	1.00E00
GO:0002755	MyD88-dependent toll-like receptor signaling pathway (GO:0002755)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0072599	establishment of protein localization to endoplasmic reticulum (GO:0072599)	40	2	2.35	-	.85	1.00E00	1.00E00
GO:0072506	trivalent inorganic anion homeostasis (GO:0072506)	20	1	1.17	-	.85	1.00E00	1.00E00
GO:0035967	cellular response to topologically incorrect protein (GO:0035967)	100	5	5.87	-	.85	1.00E00	1.00E00
GO:0009913	epidermal cell differentiation (GO:0009913)	201	10	11.80	-	.85	7.62E-01	1.00E00
GO:0046486	glycerolipid metabolic process (GO:0046486)	362	18	21.26	-	.85	5.72E-01	1.00E00
GO:0060271	cilium assembly (GO:0060271)	322	16	18.91	-	.85	6.31E-01	1.00E00
GO:0006753	nucleoside phosphate metabolic process (GO:0006753)	525	26	30.83	-	.84	4.50E-01	1.00E00
GO:0032204	regulation of telomere maintenance (GO:0032204)	101	5	5.93	-	.84	1.00E00	1.00E00
GO:0002831	regulation of response to biotic stimulus (GO:0002831)	364	18	21.37	-	.84	5.72E-01	1.00E00
GO:1901576	organic substance biosynthetic process (GO:1901576)	2534	125	148.80	-	.84	4.19E-02	3.32E-01
GO:0032388	positive regulation of intracellular transport (GO:0032388)	203	10	11.92	-	.84	7.62E-01	1.00E00
GO:0032731	positive regulation of interleukin-1 beta production (GO:0032731)	61	3	3.58	-	.84	1.00E00	1.00E00
GO:0043967	histone H4 acetylation (GO:0043967)	61	3	3.58	-	.84	1.00E00	1.00E00
GO:0009161	ribonucleoside monophosphate metabolic process (GO:0009161)	61	3	3.58	-	.84	1.00E00	1.00E00
GO:0002886	regulation of myeloid leukocyte mediated immunity (GO:0002886)	61	3	3.58	-	.84	1.00E00	1.00E00
GO:0034248	regulation of cellular amide metabolic process (GO:0034248)	469	23	27.54	-	.84	4.85E-01	1.00E00
GO:0006906	vesicle fusion (GO:0006906)	102	5	5.99	-	.83	1.00E00	1.00E00
GO:0072521	purine-containing compound metabolic process (GO:0072521)	429	21	25.19	-	.83	4.67E-01	1.00E00
GO:0046467	membrane lipid biosynthetic process (GO:0046467)	143	7	8.40	-	.83	8.57E-01	1.00E00
GO:0009058	biosynthetic process (GO:0009058)	2603	127	152.85	-	.83	2.85E-02	2.58E-01
GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:0001895	retina homeostasis (GO:0001895)	82	4	4.82	-	.83	1.00E00	1.00E00
GO:0032728	positive regulation of interferon-beta production (GO:0032728)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:0006458	'de novo' protein folding (GO:0006458)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:1902117	positive regulation of organelle assembly (GO:1902117)	82	4	4.82	-	.83	1.00E00	1.00E00
GO:1901532	regulation of hematopoietic progenitor cell differentiation (GO:1901532)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:0006040	amino sugar metabolic process (GO:0006040)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:0016444	somatic cell DNA recombination (GO:0016444)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:1905037	autophagosome organization (GO:1905037)	82	4	4.82	-	.83	1.00E00	1.00E00
GO:0047496	vesicle transport along microtubule (GO:0047496)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:0008645	hexose transmembrane transport (GO:0008645)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:0010591	regulation of lamellipodium assembly (GO:0010591)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:0072595	maintenance of protein localization in organelle (GO:0072595)	41	2	2.41	-	.83	1.00E00	1.00E00
GO:0050851	antigen receptor-mediated signaling pathway (GO:0050851)	226	11	13.27	-	.83	6.68E-01	1.00E00
GO:0032259	methylation (GO:0032259)	329	16	19.32	-	.83	5.53E-01	1.00E00
GO:0019730	antimicrobial humoral response (GO:0019730)	144	7	8.46	-	.83	8.57E-01	1.00E00
GO:0038127	ERBB signaling pathway (GO:0038127)	62	3	3.64	-	.82	1.00E00	1.00E00
GO:0090630	activation of GTPase activity (GO:0090630)	124	6	7.28	-	.82	8.47E-01	1.00E00
GO:0043966	histone H3 acetylation (GO:0043966)	62	3	3.64	-	.82	1.00E00	1.00E00
GO:0009117	nucleotide metabolic process (GO:0009117)	517	25	30.36	-	.82	3.92E-01	1.00E00
GO:0009953	dorsal/ventral pattern formation (GO:0009953)	83	4	4.87	-	.82	1.00E00	1.00E00
GO:1901293	nucleoside phosphate biosynthetic process (GO:1901293)	270	13	15.85	-	.82	6.00E-01	1.00E00
GO:0006955	immune response (GO:0006955)	1621	78	95.19	-	.82	7.72E-02	4.85E-01
GO:0090174	organelle membrane fusion (GO:0090174)	104	5	6.11	-	.82	8.34E-01	1.00E00
GO:0061844	antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	104	5	6.11	-	.82	8.34E-01	1.00E00
GO:0062207	regulation of pattern recognition receptor signaling pathway (GO:0062207)	104	5	6.11	-	.82	8.34E-01	1.00E00
GO:0002455	humoral immune response mediated by circulating immunoglobulin (GO:0002455)	125	6	7.34	-	.82	8.47E-01	1.00E00
GO:0048284	organelle fusion (GO:0048284)	125	6	7.34	-	.82	8.47E-01	1.00E00
GO:0042742	defense response to bacterium (GO:0042742)	376	18	22.08	-	.82	4.38E-01	1.00E00
GO:0045723	positive regulation of fatty acid biosynthetic process (GO:0045723)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:1903204	negative regulation of oxidative stress-induced neuron death (GO:1903204)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0019370	leukotriene biosynthetic process (GO:0019370)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0007342	fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0006809	nitric oxide biosynthetic process (GO:0006809)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0033574	response to testosterone (GO:0033574)	42	2	2.47	-	.81	1.00E00	1.00E00
GO:0072273	metanephric nephron morphogenesis (GO:0072273)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0032986	protein-DNA complex disassembly (GO:0032986)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0006670	sphingosine metabolic process (GO:0006670)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:1901998	toxin transport (GO:1901998)	42	2	2.47	-	.81	1.00E00	1.00E00
GO:0007004	telomere maintenance via telomerase (GO:0007004)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0032785	negative regulation of DNA-templated transcription, elongation (GO:0032785)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0002089	lens morphogenesis in camera-type eye (GO:0002089)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:2000047	regulation of cell-cell adhesion mediated by cadherin (GO:2000047)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0032367	intracellular cholesterol transport (GO:0032367)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0050913	sensory perception of bitter taste (GO:0050913)	42	2	2.47	-	.81	1.00E00	1.00E00
GO:0032211	negative regulation of telomere maintenance via telomerase (GO:0032211)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0043647	inositol phosphate metabolic process (GO:0043647)	42	2	2.47	-	.81	1.00E00	1.00E00
GO:0032012	regulation of ARF protein signal transduction (GO:0032012)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0043507	positive regulation of JUN kinase activity (GO:0043507)	42	2	2.47	-	.81	1.00E00	1.00E00
GO:0055093	response to hyperoxia (GO:0055093)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0043011	myeloid dendritic cell differentiation (GO:0043011)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0009067	aspartate family amino acid biosynthetic process (GO:0009067)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:1904292	regulation of ERAD pathway (GO:1904292)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0039535	regulation of RIG-I signaling pathway (GO:0039535)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0002888	positive regulation of myeloid leukocyte mediated immunity (GO:0002888)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0045947	negative regulation of translational initiation (GO:0045947)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0003177	pulmonary valve development (GO:0003177)	21	1	1.23	-	.81	1.00E00	1.00E00
GO:0032481	positive regulation of type I interferon production (GO:0032481)	63	3	3.70	-	.81	1.00E00	1.00E00
GO:0070228	regulation of lymphocyte apoptotic process (GO:0070228)	63	3	3.70	-	.81	1.00E00	1.00E00
GO:0016573	histone acetylation (GO:0016573)	126	6	7.40	-	.81	8.48E-01	1.00E00
GO:0009179	purine ribonucleoside diphosphate metabolic process (GO:0009179)	63	3	3.70	-	.81	1.00E00	1.00E00
GO:0009135	purine nucleoside diphosphate metabolic process (GO:0009135)	63	3	3.70	-	.81	1.00E00	1.00E00
GO:0008286	insulin receptor signaling pathway (GO:0008286)	63	3	3.70	-	.81	1.00E00	1.00E00
GO:0044249	cellular biosynthetic process (GO:0044249)	2464	117	144.69	-	.81	1.71E-02	1.85E-01
GO:0044271	cellular nitrogen compound biosynthetic process (GO:0044271)	1588	75	93.25	-	.80	5.78E-02	4.04E-01
GO:0006282	regulation of DNA repair (GO:0006282)	212	10	12.45	-	.80	6.57E-01	1.00E00
GO:0001708	cell fate specification (GO:0001708)	85	4	4.99	-	.80	1.00E00	1.00E00
GO:0055086	nucleobase-containing small molecule metabolic process (GO:0055086)	595	28	34.94	-	.80	2.86E-01	8.99E-01
GO:0008643	carbohydrate transport (GO:0008643)	85	4	4.99	-	.80	1.00E00	1.00E00
GO:1901575	organic substance catabolic process (GO:1901575)	1679	79	98.59	-	.80	4.43E-02	3.47E-01
GO:0045087	innate immune response (GO:0045087)	832	39	48.86	-	.80	1.74E-01	7.00E-01
GO:1904951	positive regulation of establishment of protein localization (GO:1904951)	320	15	18.79	-	.80	4.70E-01	1.00E00
GO:0071806	protein transmembrane transport (GO:0071806)	64	3	3.76	-	.80	1.00E00	1.00E00
GO:0070936	protein K48-linked ubiquitination (GO:0070936)	64	3	3.76	-	.80	1.00E00	1.00E00
GO:0009311	oligosaccharide metabolic process (GO:0009311)	64	3	3.76	-	.80	1.00E00	1.00E00
GO:0002889	regulation of immunoglobulin mediated immune response (GO:0002889)	64	3	3.76	-	.80	1.00E00	1.00E00
GO:0002712	regulation of B cell mediated immunity (GO:0002712)	64	3	3.76	-	.80	1.00E00	1.00E00
GO:1901565	organonitrogen compound catabolic process (GO:1901565)	1112	52	65.30	-	.80	1.00E-01	5.75E-01
GO:0007030	Golgi organization (GO:0007030)	150	7	8.81	-	.79	7.25E-01	1.00E00
GO:0051954	positive regulation of amine transport (GO:0051954)	43	2	2.52	-	.79	1.00E00	1.00E00
GO:0006303	double-strand break repair via nonhomologous end joining (GO:0006303)	43	2	2.52	-	.79	1.00E00	1.00E00
GO:0000959	mitochondrial RNA metabolic process (GO:0000959)	43	2	2.52	-	.79	1.00E00	1.00E00
GO:0098926	postsynaptic signal transduction (GO:0098926)	43	2	2.52	-	.79	1.00E00	1.00E00
GO:0051125	regulation of actin nucleation (GO:0051125)	43	2	2.52	-	.79	1.00E00	1.00E00
GO:0070232	regulation of T cell apoptotic process (GO:0070232)	43	2	2.52	-	.79	1.00E00	1.00E00
GO:0015800	acidic amino acid transport (GO:0015800)	43	2	2.52	-	.79	1.00E00	1.00E00
GO:0008589	regulation of smoothened signaling pathway (GO:0008589)	86	4	5.05	-	.79	8.19E-01	1.00E00
GO:0003352	regulation of cilium movement (GO:0003352)	43	2	2.52	-	.79	1.00E00	1.00E00
GO:0001906	cell killing (GO:0001906)	129	6	7.57	-	.79	7.07E-01	1.00E00
GO:0050853	B cell receptor signaling pathway (GO:0050853)	129	6	7.57	-	.79	7.07E-01	1.00E00
GO:0043489	RNA stabilization (GO:0043489)	65	3	3.82	-	.79	1.00E00	1.00E00
GO:0048278	vesicle docking (GO:0048278)	65	3	3.82	-	.79	1.00E00	1.00E00
GO:0009056	catabolic process (GO:0009056)	1974	91	115.91	-	.79	1.74E-02	1.87E-01
GO:0051222	positive regulation of protein transport (GO:0051222)	304	14	17.85	-	.78	4.58E-01	1.00E00
GO:0001910	regulation of leukocyte mediated cytotoxicity (GO:0001910)	87	4	5.11	-	.78	8.19E-01	1.00E00
GO:0045069	regulation of viral genome replication (GO:0045069)	87	4	5.11	-	.78	8.19E-01	1.00E00
GO:0042180	cellular ketone metabolic process (GO:0042180)	87	4	5.11	-	.78	8.19E-01	1.00E00
GO:1903209	positive regulation of oxidative stress-induced cell death (GO:1903209)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0006921	cellular component disassembly involved in execution phase of apoptosis (GO:0006921)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0007351	tripartite regional subdivision (GO:0007351)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0071887	leukocyte apoptotic process (GO:0071887)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0006817	phosphate ion transport (GO:0006817)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0072207	metanephric epithelium development (GO:0072207)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0045494	photoreceptor cell maintenance (GO:0045494)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0007130	synaptonemal complex assembly (GO:0007130)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0071548	response to dexamethasone (GO:0071548)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:1902275	regulation of chromatin organization (GO:1902275)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0006356	regulation of transcription by RNA polymerase I (GO:0006356)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0045056	transcytosis (GO:0045056)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0032516	positive regulation of phosphoprotein phosphatase activity (GO:0032516)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0140131	positive regulation of lymphocyte chemotaxis (GO:0140131)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0106027	neuron projection organization (GO:0106027)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0050765	negative regulation of phagocytosis (GO:0050765)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0032098	regulation of appetite (GO:0032098)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0051131	chaperone-mediated protein complex assembly (GO:0051131)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0098586	cellular response to virus (GO:0098586)	88	4	5.17	-	.77	8.19E-01	1.00E00
GO:0051000	positive regulation of nitric-oxide synthase activity (GO:0051000)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0000288	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0030859	polarized epithelial cell differentiation (GO:0030859)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0009394	2'-deoxyribonucleotide metabolic process (GO:0009394)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0009124	nucleoside monophosphate biosynthetic process (GO:0009124)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0015749	monosaccharide transmembrane transport (GO:0015749)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0046839	phospholipid dephosphorylation (GO:0046839)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0008595	anterior/posterior axis specification, embryo (GO:0008595)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0035268	protein mannosylation (GO:0035268)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0035089	establishment of apical/basal cell polarity (GO:0035089)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0034505	tooth mineralization (GO:0034505)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0002922	positive regulation of humoral immune response (GO:0002922)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:0034331	cell junction maintenance (GO:0034331)	44	2	2.58	-	.77	1.00E00	1.00E00
GO:0080182	histone H3-K4 trimethylation (GO:0080182)	22	1	1.29	-	.77	1.00E00	1.00E00
GO:1901605	alpha-amino acid metabolic process (GO:1901605)	198	9	11.63	-	.77	5.42E-01	1.00E00
GO:0050852	T cell receptor signaling pathway (GO:0050852)	110	5	6.46	-	.77	8.37E-01	1.00E00
GO:0009063	cellular amino acid catabolic process (GO:0009063)	110	5	6.46	-	.77	8.37E-01	1.00E00
GO:0018393	internal peptidyl-lysine acetylation (GO:0018393)	132	6	7.75	-	.77	7.08E-01	1.00E00
GO:0032206	positive regulation of telomere maintenance (GO:0032206)	66	3	3.88	-	.77	1.00E00	1.00E00
GO:0030101	natural killer cell activation (GO:0030101)	66	3	3.88	-	.77	1.00E00	1.00E00
GO:0071705	nitrogen compound transport (GO:0071705)	1589	72	93.31	-	.77	2.55E-02	2.49E-01
GO:0006457	protein folding (GO:0006457)	221	10	12.98	-	.77	5.61E-01	1.00E00
GO:0002443	leukocyte mediated immunity (GO:0002443)	310	14	18.20	-	.77	3.92E-01	1.00E00
GO:0045184	establishment of protein localization (GO:0045184)	1267	57	74.40	-	.77	4.09E-02	3.26E-01
GO:0061014	positive regulation of mRNA catabolic process (GO:0061014)	89	4	5.23	-	.77	8.20E-01	1.00E00
GO:0019318	hexose metabolic process (GO:0019318)	156	7	9.16	-	.76	6.07E-01	1.00E00
GO:0007249	I-kappaB kinase/NF-kappaB signaling (GO:0007249)	67	3	3.93	-	.76	1.00E00	1.00E00
GO:0060260	regulation of transcription initiation by RNA polymerase II (GO:0060260)	67	3	3.93	-	.76	1.00E00	1.00E00
GO:1902373	negative regulation of mRNA catabolic process (GO:1902373)	67	3	3.93	-	.76	1.00E00	1.00E00
GO:0006475	internal protein amino acid acetylation (GO:0006475)	134	6	7.87	-	.76	7.09E-01	1.00E00
GO:1901607	alpha-amino acid biosynthetic process (GO:1901607)	67	3	3.93	-	.76	1.00E00	1.00E00
GO:0009988	cell-cell recognition (GO:0009988)	67	3	3.93	-	.76	1.00E00	1.00E00
GO:0031640	killing of cells of another organism (GO:0031640)	67	3	3.93	-	.76	1.00E00	1.00E00
GO:0009165	nucleotide biosynthetic process (GO:0009165)	268	12	15.74	-	.76	4.30E-01	1.00E00
GO:1903214	regulation of protein targeting to mitochondrion (GO:1903214)	45	2	2.64	-	.76	1.00E00	1.00E00
GO:0018394	peptidyl-lysine acetylation (GO:0018394)	135	6	7.93	-	.76	7.10E-01	1.00E00
GO:0050691	regulation of defense response to virus by host (GO:0050691)	45	2	2.64	-	.76	1.00E00	1.00E00
GO:0042789	mRNA transcription by RNA polymerase II (GO:0042789)	45	2	2.64	-	.76	1.00E00	1.00E00
GO:0009262	deoxyribonucleotide metabolic process (GO:0009262)	45	2	2.64	-	.76	1.00E00	1.00E00
GO:0019692	deoxyribose phosphate metabolic process (GO:0019692)	45	2	2.64	-	.76	1.00E00	1.00E00
GO:0061025	membrane fusion (GO:0061025)	158	7	9.28	-	.75	6.07E-01	1.00E00
GO:0046854	phosphatidylinositol phosphate biosynthetic process (GO:0046854)	68	3	3.99	-	.75	1.00E00	1.00E00
GO:0006650	glycerophospholipid metabolic process (GO:0006650)	295	13	17.32	-	.75	3.79E-01	1.00E00
GO:0009205	purine ribonucleoside triphosphate metabolic process (GO:0009205)	182	8	10.69	-	.75	5.24E-01	1.00E00
GO:0009132	nucleoside diphosphate metabolic process (GO:0009132)	91	4	5.34	-	.75	8.21E-01	1.00E00
GO:0016567	protein ubiquitination (GO:0016567)	684	30	40.16	-	.75	1.14E-01	5.67E-01
GO:0016570	histone modification (GO:0016570)	365	16	21.43	-	.75	3.08E-01	9.18E-01
GO:0032446	protein modification by small protein conjugation (GO:0032446)	753	33	44.22	-	.75	9.56E-02	5.58E-01
GO:1902600	proton transmembrane transport (GO:1902600)	137	6	8.04	-	.75	5.85E-01	1.00E00
GO:0090407	organophosphate biosynthetic process (GO:0090407)	549	24	32.24	-	.74	1.65E-01	6.76E-01
GO:0044248	cellular catabolic process (GO:0044248)	1625	71	95.42	-	.74	9.39E-03	1.20E-01
GO:0009620	response to fungus (GO:0009620)	69	3	4.05	-	.74	7.99E-01	1.00E00
GO:0003091	renal water homeostasis (GO:0003091)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0046128	purine ribonucleoside metabolic process (GO:0046128)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0002381	immunoglobulin production involved in immunoglobulin-mediated immune response (GO:0002381)	46	2	2.70	-	.74	1.00E00	1.00E00
GO:2000561	regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0006509	membrane protein ectodomain proteolysis (GO:0006509)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0045104	intermediate filament cytoskeleton organization (GO:0045104)	92	4	5.40	-	.74	8.21E-01	1.00E00
GO:0090335	regulation of brown fat cell differentiation (GO:0090335)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0090208	positive regulation of triglyceride metabolic process (GO:0090208)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0051457	maintenance of protein location in nucleus (GO:0051457)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0090026	positive regulation of monocyte chemotaxis (GO:0090026)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0051238	sequestering of metal ion (GO:0051238)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0050650	chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0009268	response to pH (GO:0009268)	46	2	2.70	-	.74	1.00E00	1.00E00
GO:0009141	nucleoside triphosphate metabolic process (GO:0009141)	207	9	12.16	-	.74	4.55E-01	1.00E00
GO:0046847	filopodium assembly (GO:0046847)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:1903861	positive regulation of dendrite extension (GO:1903861)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0046519	sphingoid metabolic process (GO:0046519)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0097242	amyloid-beta clearance (GO:0097242)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0034391	regulation of smooth muscle cell apoptotic process (GO:0034391)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0034377	plasma lipoprotein particle assembly (GO:0034377)	23	1	1.35	-	.74	1.00E00	1.00E00
GO:0019439	aromatic compound catabolic process (GO:0019439)	346	15	20.32	-	.74	2.96E-01	8.90E-01
GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	347	15	20.38	-	.74	2.96E-01	8.91E-01
GO:0044272	sulfur compound biosynthetic process (GO:0044272)	139	6	8.16	-	.74	5.85E-01	1.00E00
GO:1905039	carboxylic acid transmembrane transport (GO:1905039)	139	6	8.16	-	.74	5.85E-01	1.00E00
GO:2000036	regulation of stem cell population maintenance (GO:2000036)	70	3	4.11	-	.73	7.99E-01	1.00E00
GO:0006024	glycosaminoglycan biosynthetic process (GO:0006024)	70	3	4.11	-	.73	7.99E-01	1.00E00
GO:1903825	organic acid transmembrane transport (GO:1903825)	140	6	8.22	-	.73	5.85E-01	1.00E00
GO:0009144	purine nucleoside triphosphate metabolic process (GO:0009144)	187	8	10.98	-	.73	5.27E-01	1.00E00
GO:0007005	mitochondrion organization (GO:0007005)	445	19	26.13	-	.73	1.83E-01	7.21E-01
GO:0090305	nucleic acid phosphodiester bond hydrolysis (GO:0090305)	258	11	15.15	-	.73	3.48E-01	9.83E-01
GO:1902459	positive regulation of stem cell population maintenance (GO:1902459)	47	2	2.76	-	.72	1.00E00	1.00E00
GO:0009584	detection of visible light (GO:0009584)	47	2	2.76	-	.72	1.00E00	1.00E00
GO:0042073	intraciliary transport (GO:0042073)	47	2	2.76	-	.72	1.00E00	1.00E00
GO:0006790	sulfur compound metabolic process (GO:0006790)	330	14	19.38	-	.72	2.84E-01	8.99E-01
GO:0006520	cellular amino acid metabolic process (GO:0006520)	283	12	16.62	-	.72	3.06E-01	9.14E-01
GO:0009059	macromolecule biosynthetic process (GO:0009059)	1487	63	87.32	-	.72	6.78E-03	9.47E-02
GO:0009199	ribonucleoside triphosphate metabolic process (GO:0009199)	189	8	11.10	-	.72	4.35E-01	1.00E00
GO:0034655	nucleobase-containing compound catabolic process (GO:0034655)	284	12	16.68	-	.72	3.06E-01	9.14E-01
GO:0044242	cellular lipid catabolic process (GO:0044242)	191	8	11.22	-	.71	4.36E-01	1.00E00
GO:0009247	glycolipid biosynthetic process (GO:0009247)	72	3	4.23	-	.71	8.00E-01	1.00E00
GO:0030072	peptide hormone secretion (GO:0030072)	72	3	4.23	-	.71	8.00E-01	1.00E00
GO:0007340	acrosome reaction (GO:0007340)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0006833	water transport (GO:0006833)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0002431	Fc receptor mediated stimulatory signaling pathway (GO:0002431)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:2000773	negative regulation of cellular senescence (GO:2000773)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0006658	phosphatidylserine metabolic process (GO:0006658)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0038084	vascular endothelial growth factor signaling pathway (GO:0038084)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0006213	pyrimidine nucleoside metabolic process (GO:0006213)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0050857	positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0043616	keratinocyte proliferation (GO:0043616)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0009129	pyrimidine nucleoside monophosphate metabolic process (GO:0009129)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:1900017	positive regulation of cytokine production involved in inflammatory response (GO:1900017)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0010894	negative regulation of steroid biosynthetic process (GO:0010894)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0039531	regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0060972	left/right pattern formation (GO:0060972)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0061311	cell surface receptor signaling pathway involved in heart development (GO:0061311)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0035020	regulation of Rac protein signal transduction (GO:0035020)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0034587	piRNA metabolic process (GO:0034587)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0097186	amelogenesis (GO:0097186)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0034381	plasma lipoprotein particle clearance (GO:0034381)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0021871	forebrain regionalization (GO:0021871)	24	1	1.41	-	.71	1.00E00	1.00E00
GO:0072522	purine-containing compound biosynthetic process (GO:0072522)	216	9	12.68	-	.71	3.79E-01	1.00E00
GO:0006958	complement activation, classical pathway (GO:0006958)	121	5	7.11	-	.70	5.59E-01	1.00E00
GO:0090277	positive regulation of peptide hormone secretion (GO:0090277)	97	4	5.70	-	.70	6.62E-01	1.00E00
GO:0046907	intracellular transport (GO:0046907)	1360	56	79.86	-	.70	5.68E-03	8.30E-02
GO:0045727	positive regulation of translation (GO:0045727)	146	6	8.57	-	.70	4.79E-01	1.00E00
GO:0032732	positive regulation of interleukin-1 production (GO:0032732)	73	3	4.29	-	.70	8.00E-01	1.00E00
GO:1901799	negative regulation of proteasomal protein catabolic process (GO:1901799)	49	2	2.88	-	.70	1.00E00	1.00E00
GO:0016925	protein sumoylation (GO:0016925)	49	2	2.88	-	.70	1.00E00	1.00E00
GO:0015833	peptide transport (GO:0015833)	98	4	5.75	-	.70	6.63E-01	1.00E00
GO:0009066	aspartate family amino acid metabolic process (GO:0009066)	49	2	2.88	-	.70	1.00E00	1.00E00
GO:0019884	antigen processing and presentation of exogenous antigen (GO:0019884)	49	2	2.88	-	.70	1.00E00	1.00E00
GO:0007601	visual perception (GO:0007601)	221	9	12.98	-	.69	3.82E-01	1.00E00
GO:0015031	protein transport (GO:0015031)	1179	48	69.23	-	.69	8.42E-03	1.10E-01
GO:0008654	phospholipid biosynthetic process (GO:0008654)	246	10	14.45	-	.69	3.34E-01	9.51E-01
GO:0009152	purine ribonucleotide biosynthetic process (GO:0009152)	197	8	11.57	-	.69	3.59E-01	1.00E00
GO:0006023	aminoglycan biosynthetic process (GO:0006023)	74	3	4.35	-	.69	8.01E-01	1.00E00
GO:0061157	mRNA destabilization (GO:0061157)	74	3	4.35	-	.69	8.01E-01	1.00E00
GO:0009100	glycoprotein metabolic process (GO:0009100)	346	14	20.32	-	.69	2.00E-01	7.74E-01
GO:0034250	positive regulation of cellular amide metabolic process (GO:0034250)	173	7	10.16	-	.69	4.13E-01	1.00E00
GO:0009057	macromolecule catabolic process (GO:0009057)	989	40	58.07	-	.69	1.74E-02	1.87E-01
GO:0002793	positive regulation of peptide secretion (GO:0002793)	99	4	5.81	-	.69	6.64E-01	1.00E00
GO:0050953	sensory perception of light stimulus (GO:0050953)	224	9	13.15	-	.68	3.14E-01	9.33E-01
GO:0046700	heterocycle catabolic process (GO:0046700)	324	13	19.03	-	.68	1.88E-01	7.36E-01
GO:0070647	protein modification by small protein conjugation or removal (GO:0070647)	898	36	52.73	-	.68	1.92E-02	2.01E-01
GO:0002790	peptide secretion (GO:0002790)	75	3	4.40	-	.68	8.02E-01	1.00E00
GO:0045730	respiratory burst (GO:0045730)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0034198	cellular response to amino acid starvation (GO:0034198)	50	2	2.94	-	.68	1.00E00	1.00E00
GO:0003016	respiratory system process (GO:0003016)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0001911	negative regulation of leukocyte mediated cytotoxicity (GO:0001911)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0032941	secretion by tissue (GO:0032941)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:1902455	negative regulation of stem cell population maintenance (GO:1902455)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0032925	regulation of activin receptor signaling pathway (GO:0032925)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0006656	phosphatidylcholine biosynthetic process (GO:0006656)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0001773	myeloid dendritic cell activation (GO:0001773)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0001738	morphogenesis of a polarized epithelium (GO:0001738)	50	2	2.94	-	.68	1.00E00	1.00E00
GO:0051938	L-glutamate import (GO:0051938)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0045026	plasma membrane fusion (GO:0045026)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0045022	early endosome to late endosome transport (GO:0045022)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0099558	maintenance of synapse structure (GO:0099558)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:2000114	regulation of establishment of cell polarity (GO:2000114)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0032366	intracellular sterol transport (GO:0032366)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0032007	negative regulation of TOR signaling (GO:0032007)	50	2	2.94	-	.68	1.00E00	1.00E00
GO:1901071	glucosamine-containing compound metabolic process (GO:1901071)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0098581	detection of external biotic stimulus (GO:0098581)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0031468	nuclear membrane reassembly (GO:0031468)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0017121	plasma membrane phospholipid scrambling (GO:0017121)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0016601	Rac protein signal transduction (GO:0016601)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0009219	pyrimidine deoxyribonucleotide metabolic process (GO:0009219)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0015813	L-glutamate transmembrane transport (GO:0015813)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0009147	pyrimidine nucleoside triphosphate metabolic process (GO:0009147)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0035330	regulation of hippo signaling (GO:0035330)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0019748	secondary metabolic process (GO:0019748)	50	2	2.94	-	.68	1.00E00	1.00E00
GO:0097194	execution phase of apoptosis (GO:0097194)	50	2	2.94	-	.68	1.00E00	1.00E00
GO:0046339	diacylglycerol metabolic process (GO:0046339)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0046209	nitric oxide metabolic process (GO:0046209)	25	1	1.47	-	.68	1.00E00	1.00E00
GO:0010498	proteasomal protein catabolic process (GO:0010498)	378	15	22.20	-	.68	1.48E-01	6.73E-01
GO:0006886	intracellular protein transport (GO:0006886)	682	27	40.05	-	.67	3.70E-02	3.15E-01
GO:0051607	defense response to virus (GO:0051607)	253	10	14.86	-	.67	2.76E-01	8.80E-01
GO:0050688	regulation of defense response to virus (GO:0050688)	76	3	4.46	-	.67	8.03E-01	1.00E00
GO:0044270	cellular nitrogen compound catabolic process (GO:0044270)	330	13	19.38	-	.67	1.89E-01	7.40E-01
GO:0006909	phagocytosis (GO:0006909)	254	10	14.92	-	.67	2.77E-01	8.81E-01
GO:0140546	defense response to symbiont (GO:0140546)	254	10	14.92	-	.67	2.77E-01	8.81E-01
GO:0046031	ADP metabolic process (GO:0046031)	51	2	2.99	-	.67	1.00E00	1.00E00
GO:0006111	regulation of gluconeogenesis (GO:0006111)	51	2	2.99	-	.67	1.00E00	1.00E00
GO:2000059	negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059)	51	2	2.99	-	.67	1.00E00	1.00E00
GO:0009299	mRNA transcription (GO:0009299)	51	2	2.99	-	.67	1.00E00	1.00E00
GO:1903793	positive regulation of anion transport (GO:1903793)	51	2	2.99	-	.67	1.00E00	1.00E00
GO:1903747	regulation of establishment of protein localization to mitochondrion (GO:1903747)	51	2	2.99	-	.67	1.00E00	1.00E00
GO:0000209	protein polyubiquitination (GO:0000209)	230	9	13.51	-	.67	2.57E-01	8.41E-01
GO:0007033	vacuole organization (GO:0007033)	179	7	10.51	-	.67	3.37E-01	9.58E-01
GO:0007041	lysosomal transport (GO:0007041)	128	5	7.52	-	.67	4.50E-01	1.00E00
GO:0006417	regulation of translation (GO:0006417)	410	16	24.08	-	.66	1.09E-01	5.43E-01
GO:0006164	purine nucleotide biosynthetic process (GO:0006164)	205	8	12.04	-	.66	2.94E-01	8.85E-01
GO:0046474	glycerophospholipid biosynthetic process (GO:0046474)	205	8	12.04	-	.66	2.94E-01	8.85E-01
GO:1901566	organonitrogen compound biosynthetic process (GO:1901566)	1333	52	78.27	-	.66	1.93E-03	3.51E-02
GO:0032479	regulation of type I interferon production (GO:0032479)	103	4	6.05	-	.66	5.28E-01	1.00E00
GO:0006661	phosphatidylinositol biosynthetic process (GO:0006661)	129	5	7.57	-	.66	4.51E-01	1.00E00
GO:0045739	positive regulation of DNA repair (GO:0045739)	130	5	7.63	-	.65	4.51E-01	1.00E00
GO:0006664	glycolipid metabolic process (GO:0006664)	104	4	6.11	-	.65	5.28E-01	1.00E00
GO:1990928	response to amino acid starvation (GO:1990928)	52	2	3.05	-	.65	7.69E-01	1.00E00
GO:0071577	zinc ion transmembrane transport (GO:0071577)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:0051957	positive regulation of amino acid transport (GO:0051957)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:0048596	embryonic camera-type eye morphogenesis (GO:0048596)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:0051220	cytoplasmic sequestering of protein (GO:0051220)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:0050779	RNA destabilization (GO:0050779)	78	3	4.58	-	.65	6.29E-01	1.00E00
GO:0035751	regulation of lysosomal lumen pH (GO:0035751)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:0043302	positive regulation of leukocyte degranulation (GO:0043302)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:0042832	defense response to protozoan (GO:0042832)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:1900151	regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:1903859	regulation of dendrite extension (GO:1903859)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:0010661	positive regulation of muscle cell apoptotic process (GO:0010661)	26	1	1.53	-	.65	1.00E00	1.00E00
GO:0042100	B cell proliferation (GO:0042100)	52	2	3.05	-	.65	7.69E-01	1.00E00
GO:0046488	phosphatidylinositol metabolic process (GO:0046488)	156	6	9.16	-	.65	3.89E-01	1.00E00
GO:0034340	response to type I interferon (GO:0034340)	52	2	3.05	-	.65	7.69E-01	1.00E00
GO:0046034	ATP metabolic process (GO:0046034)	157	6	9.22	-	.65	3.89E-01	1.00E00
GO:0010608	post-transcriptional regulation of gene expression (GO:0010608)	498	19	29.24	-	.65	6.39E-02	4.38E-01
GO:0019751	polyol metabolic process (GO:0019751)	105	4	6.17	-	.65	5.29E-01	1.00E00
GO:1903509	liposaccharide metabolic process (GO:1903509)	105	4	6.17	-	.65	5.29E-01	1.00E00
GO:1902369	negative regulation of RNA catabolic process (GO:1902369)	79	3	4.64	-	.65	6.29E-01	1.00E00
GO:0006354	DNA-templated transcription elongation (GO:0006354)	185	7	10.86	-	.64	3.39E-01	9.64E-01
GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	265	10	15.56	-	.64	1.85E-01	7.29E-01
GO:0009260	ribonucleotide biosynthetic process (GO:0009260)	212	8	12.45	-	.64	2.97E-01	8.94E-01
GO:0042129	regulation of T cell proliferation (GO:0042129)	186	7	10.92	-	.64	3.40E-01	9.66E-01
GO:0019941	modification-dependent protein catabolic process (GO:0019941)	586	22	34.41	-	.64	3.80E-02	3.19E-01
GO:0090316	positive regulation of intracellular protein transport (GO:0090316)	160	6	9.40	-	.64	3.91E-01	1.00E00
GO:0010467	gene expression (GO:0010467)	2314	86	135.88	-	.63	3.36E-06	1.41E-04
GO:0051603	proteolysis involved in protein catabolic process (GO:0051603)	647	24	37.99	-	.63	2.06E-02	2.11E-01
GO:0007350	blastoderm segmentation (GO:0007350)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0046037	GMP metabolic process (GO:0046037)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0007271	synaptic transmission, cholinergic (GO:0007271)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0007164	establishment of tissue polarity (GO:0007164)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:2001057	reactive nitrogen species metabolic process (GO:2001057)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0001736	establishment of planar polarity (GO:0001736)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0007034	vacuolar transport (GO:0007034)	162	6	9.51	-	.63	3.12E-01	9.29E-01
GO:0071467	cellular response to pH (GO:0071467)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0001562	response to protozoan (GO:0001562)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0090501	RNA phosphodiester bond hydrolysis (GO:0090501)	162	6	9.51	-	.63	3.12E-01	9.29E-01
GO:0090382	phagosome maturation (GO:0090382)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0098927	vesicle-mediated transport between endosomal compartments (GO:0098927)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0051291	protein heterooligomerization (GO:0051291)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0070269	pyroptosis (GO:0070269)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0016571	histone methylation (GO:0016571)	108	4	6.34	-	.63	5.31E-01	1.00E00
GO:0062149	detection of stimulus involved in sensory perception of pain (GO:0062149)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0035315	hair cell differentiation (GO:0035315)	54	2	3.17	-	.63	7.70E-01	1.00E00
GO:0030325	adrenal gland development (GO:0030325)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0035195	miRNA-mediated gene silencing (GO:0035195)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0034605	cellular response to heat (GO:0034605)	54	2	3.17	-	.63	7.70E-01	1.00E00
GO:0042104	positive regulation of activated T cell proliferation (GO:0042104)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:1903539	protein localization to postsynaptic membrane (GO:1903539)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0045939	negative regulation of steroid metabolic process (GO:0045939)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0002710	negative regulation of T cell mediated immunity (GO:0002710)	27	1	1.59	-	.63	1.00E00	1.00E00
GO:0044265	cellular macromolecule catabolic process (GO:0044265)	785	29	46.10	-	.63	9.84E-03	1.25E-01
GO:0045333	cellular respiration (GO:0045333)	190	7	11.16	-	.63	2.73E-01	8.71E-01
GO:0043632	modification-dependent macromolecule catabolic process (GO:0043632)	598	22	35.11	-	.63	2.57E-02	2.48E-01
GO:1901137	carbohydrate derivative biosynthetic process (GO:1901137)	599	22	35.17	-	.63	2.57E-02	2.48E-01
GO:0046390	ribose phosphate biosynthetic process (GO:0046390)	219	8	12.86	-	.62	2.41E-01	8.39E-01
GO:0006511	ubiquitin-dependent protein catabolic process (GO:0006511)	575	21	33.76	-	.62	2.89E-02	2.62E-01
GO:0016064	immunoglobulin mediated immune response (GO:0016064)	192	7	11.27	-	.62	2.74E-01	8.73E-01
GO:0048024	regulation of mRNA splicing, via spliceosome (GO:0048024)	110	4	6.46	-	.62	5.34E-01	1.00E00
GO:0030216	keratinocyte differentiation (GO:0030216)	138	5	8.10	-	.62	3.60E-01	1.00E00
GO:0140056	organelle localization by membrane tethering (GO:0140056)	83	3	4.87	-	.62	6.33E-01	1.00E00
GO:0034976	response to endoplasmic reticulum stress (GO:0034976)	222	8	13.04	-	.61	1.93E-01	7.52E-01
GO:0015012	heparan sulfate proteoglycan biosynthetic process (GO:0015012)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0001702	gastrulation with mouth forming second (GO:0001702)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0006446	regulation of translational initiation (GO:0006446)	84	3	4.93	-	.61	6.34E-01	1.00E00
GO:0006289	nucleotide-excision repair (GO:0006289)	56	2	3.29	-	.61	7.71E-01	1.00E00
GO:0032511	late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0031954	positive regulation of protein autophosphorylation (GO:0031954)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0031664	regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0043414	macromolecule methylation (GO:0043414)	280	10	16.44	-	.61	1.53E-01	6.94E-01
GO:0036296	response to increased oxygen levels (GO:0036296)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0031342	negative regulation of cell killing (GO:0031342)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0009312	oligosaccharide biosynthetic process (GO:0009312)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0062237	protein localization to postsynapse (GO:0062237)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0055094	response to lipoprotein particle (GO:0055094)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0031060	regulation of histone methylation (GO:0031060)	84	3	4.93	-	.61	6.34E-01	1.00E00
GO:1904357	negative regulation of telomere maintenance via telomere lengthening (GO:1904357)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0042278	purine nucleoside metabolic process (GO:0042278)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0019724	B cell mediated immunity (GO:0019724)	196	7	11.51	-	.61	2.19E-01	7.78E-01
GO:0003338	metanephros morphogenesis (GO:0003338)	28	1	1.64	-	.61	1.00E00	1.00E00
GO:0030163	protein catabolic process (GO:0030163)	756	27	44.39	-	.61	6.79E-03	9.47E-02
GO:0045017	glycerolipid biosynthetic process (GO:0045017)	225	8	13.21	-	.61	1.94E-01	7.54E-01
GO:0015931	nucleobase-containing compound transport (GO:0015931)	225	8	13.21	-	.61	1.94E-01	7.53E-01
GO:0016070	RNA metabolic process (GO:0016070)	1635	58	96.01	-	.60	3.18E-05	1.04E-03
GO:0051702	biological process involved in interaction with symbiont (GO:0051702)	113	4	6.64	-	.60	4.18E-01	1.00E00
GO:0022904	respiratory electron transport chain (GO:0022904)	113	4	6.64	-	.60	4.18E-01	1.00E00
GO:0018205	peptidyl-lysine modification (GO:0018205)	311	11	18.26	-	.60	1.09E-01	5.45E-01
GO:0019395	fatty acid oxidation (GO:0019395)	85	3	4.99	-	.60	4.89E-01	1.00E00
GO:0006749	glutathione metabolic process (GO:0006749)	57	2	3.35	-	.60	7.73E-01	1.00E00
GO:0009116	nucleoside metabolic process (GO:0009116)	57	2	3.35	-	.60	7.73E-01	1.00E00
GO:0002823	negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823)	57	2	3.35	-	.60	7.73E-01	1.00E00
GO:0043603	cellular amide metabolic process (GO:0043603)	802	28	47.09	-	.59	4.09E-03	6.42E-02
GO:0046889	positive regulation of lipid biosynthetic process (GO:0046889)	86	3	5.05	-	.59	4.89E-01	1.00E00
GO:0006606	protein import into nucleus (GO:0006606)	115	4	6.75	-	.59	4.19E-01	1.00E00
GO:0007006	mitochondrial membrane organization (GO:0007006)	115	4	6.75	-	.59	4.19E-01	1.00E00
GO:0034123	positive regulation of toll-like receptor signaling pathway (GO:0034123)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0006829	zinc ion transport (GO:0006829)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0032878	regulation of establishment or maintenance of cell polarity (GO:0032878)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0018200	peptidyl-glutamic acid modification (GO:0018200)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0006084	acetyl-CoA metabolic process (GO:0006084)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:1901223	negative regulation of NIK/NF-kappaB signaling (GO:1901223)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0050832	defense response to fungus (GO:0050832)	58	2	3.41	-	.59	7.74E-01	1.00E00
GO:0070231	T cell apoptotic process (GO:0070231)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0035821	modulation of process of another organism (GO:0035821)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0048240	sperm capacitation (GO:0048240)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0009072	aromatic amino acid family metabolic process (GO:0009072)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0010758	regulation of macrophage chemotaxis (GO:0010758)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0060996	dendritic spine development (GO:0060996)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0046641	positive regulation of alpha-beta T cell proliferation (GO:0046641)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:1903649	regulation of cytoplasmic transport (GO:1903649)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0042119	neutrophil activation (GO:0042119)	29	1	1.70	-	.59	1.00E00	1.00E00
GO:0006865	amino acid transport (GO:0006865)	118	4	6.93	-	.58	4.23E-01	1.00E00
GO:0001912	positive regulation of leukocyte mediated cytotoxicity (GO:0001912)	59	2	3.46	-	.58	7.75E-01	1.00E00
GO:0001909	leukocyte mediated cytotoxicity (GO:0001909)	59	2	3.46	-	.58	7.75E-01	1.00E00
GO:0060261	positive regulation of transcription initiation by RNA polymerase II (GO:0060261)	59	2	3.46	-	.58	7.75E-01	1.00E00
GO:0002224	toll-like receptor signaling pathway (GO:0002224)	59	2	3.46	-	.58	7.75E-01	1.00E00
GO:0030166	proteoglycan biosynthetic process (GO:0030166)	59	2	3.46	-	.58	7.75E-01	1.00E00
GO:2000781	positive regulation of double-strand break repair (GO:2000781)	89	3	5.23	-	.57	4.91E-01	1.00E00
GO:0016050	vesicle organization (GO:0016050)	327	11	19.20	-	.57	7.11E-02	4.61E-01
GO:0051170	import into nucleus (GO:0051170)	119	4	6.99	-	.57	3.26E-01	9.64E-01
GO:0006479	protein methylation (GO:0006479)	149	5	8.75	-	.57	2.86E-01	9.00E-01
GO:0008213	protein alkylation (GO:0008213)	149	5	8.75	-	.57	2.86E-01	9.00E-01
GO:0006518	peptide metabolic process (GO:0006518)	537	18	31.53	-	.57	1.42E-02	1.65E-01
GO:0002250	adaptive immune response (GO:0002250)	659	22	38.70	-	.57	6.24E-03	8.85E-02
GO:0002474	antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0060219	camera-type eye photoreceptor cell differentiation (GO:0060219)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0006622	protein targeting to lysosome (GO:0006622)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0006359	regulation of transcription by RNA polymerase III (GO:0006359)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0071353	cellular response to interleukin-4 (GO:0071353)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0030225	macrophage differentiation (GO:0030225)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0019886	antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0042181	ketone biosynthetic process (GO:0042181)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0010592	positive regulation of lamellipodium assembly (GO:0010592)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0010447	response to acidic pH (GO:0010447)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:1902914	regulation of protein polyubiquitination (GO:1902914)	30	1	1.76	-	.57	1.00E00	1.00E00
GO:0030258	lipid modification (GO:0030258)	180	6	10.57	-	.57	1.98E-01	7.66E-01
GO:0034440	lipid oxidation (GO:0034440)	90	3	5.28	-	.57	4.92E-01	1.00E00
GO:0043484	regulation of RNA splicing (GO:0043484)	181	6	10.63	-	.56	1.98E-01	7.67E-01
GO:0061013	regulation of mRNA catabolic process (GO:0061013)	181	6	10.63	-	.56	1.98E-01	7.67E-01
GO:0006914	autophagy (GO:0006914)	303	10	17.79	-	.56	7.98E-02	5.00E-01
GO:0061919	process utilizing autophagic mechanism (GO:0061919)	303	10	17.79	-	.56	7.98E-02	5.00E-01
GO:0042775	mitochondrial ATP synthesis coupled electron transport (GO:0042775)	91	3	5.34	-	.56	4.94E-01	1.00E00
GO:0042773	ATP synthesis coupled electron transport (GO:0042773)	91	3	5.34	-	.56	4.94E-01	1.00E00
GO:1903313	positive regulation of mRNA metabolic process (GO:1903313)	122	4	7.16	-	.56	3.27E-01	9.66E-01
GO:0022406	membrane docking (GO:0022406)	92	3	5.40	-	.56	4.95E-01	1.00E00
GO:1903312	negative regulation of mRNA metabolic process (GO:1903312)	92	3	5.40	-	.56	4.95E-01	1.00E00
GO:0046651	lymphocyte proliferation (GO:0046651)	123	4	7.22	-	.55	3.28E-01	9.68E-01
GO:0042157	lipoprotein metabolic process (GO:0042157)	123	4	7.22	-	.55	3.28E-01	9.68E-01
GO:0021522	spinal cord motor neuron differentiation (GO:0021522)	31	1	1.82	-	.55	1.00E00	1.00E00
GO:0019082	viral protein processing (GO:0019082)	31	1	1.82	-	.55	1.00E00	1.00E00
GO:0071402	cellular response to lipoprotein particle stimulus (GO:0071402)	31	1	1.82	-	.55	1.00E00	1.00E00
GO:2000108	positive regulation of leukocyte apoptotic process (GO:2000108)	31	1	1.82	-	.55	1.00E00	1.00E00
GO:0048665	neuron fate specification (GO:0048665)	31	1	1.82	-	.55	1.00E00	1.00E00
GO:0009583	detection of light stimulus (GO:0009583)	62	2	3.64	-	.55	5.85E-01	1.00E00
GO:0048002	antigen processing and presentation of peptide antigen (GO:0048002)	62	2	3.64	-	.55	5.85E-01	1.00E00
GO:0043094	cellular metabolic compound salvage (GO:0043094)	31	1	1.82	-	.55	1.00E00	1.00E00
GO:0002820	negative regulation of adaptive immune response (GO:0002820)	62	2	3.64	-	.55	5.85E-01	1.00E00
GO:0034311	diol metabolic process (GO:0034311)	31	1	1.82	-	.55	1.00E00	1.00E00
GO:0032655	regulation of interleukin-12 production (GO:0032655)	63	2	3.70	-	.54	5.86E-01	1.00E00
GO:0031122	cytoplasmic microtubule organization (GO:0031122)	63	2	3.70	-	.54	5.86E-01	1.00E00
GO:0032943	mononuclear cell proliferation (GO:0032943)	127	4	7.46	-	.54	2.53E-01	8.30E-01
GO:0050868	negative regulation of T cell activation (GO:0050868)	127	4	7.46	-	.54	2.53E-01	8.30E-01
GO:0002495	antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	32	1	1.88	-	.53	1.00E00	1.00E00
GO:0006654	phosphatidic acid biosynthetic process (GO:0006654)	32	1	1.88	-	.53	1.00E00	1.00E00
GO:0007040	lysosome organization (GO:0007040)	96	3	5.64	-	.53	3.78E-01	1.00E00
GO:0032770	positive regulation of monooxygenase activity (GO:0032770)	32	1	1.88	-	.53	1.00E00	1.00E00
GO:0006376	mRNA splice site selection (GO:0006376)	32	1	1.88	-	.53	1.00E00	1.00E00
GO:0032480	negative regulation of type I interferon production (GO:0032480)	32	1	1.88	-	.53	1.00E00	1.00E00
GO:0050854	regulation of antigen receptor-mediated signaling pathway (GO:0050854)	64	2	3.76	-	.53	5.87E-01	1.00E00
GO:0000413	protein peptidyl-prolyl isomerization (GO:0000413)	32	1	1.88	-	.53	1.00E00	1.00E00
GO:0031571	mitotic G1 DNA damage checkpoint signaling (GO:0031571)	32	1	1.88	-	.53	1.00E00	1.00E00
GO:1903955	positive regulation of protein targeting to mitochondrion (GO:1903955)	32	1	1.88	-	.53	1.00E00	1.00E00
GO:0019882	antigen processing and presentation (GO:0019882)	96	3	5.64	-	.53	3.78E-01	1.00E00
GO:0080171	lytic vacuole organization (GO:0080171)	96	3	5.64	-	.53	3.78E-01	1.00E00
GO:0002449	lymphocyte mediated immunity (GO:0002449)	257	8	15.09	-	.53	7.78E-02	4.89E-01
GO:0006401	RNA catabolic process (GO:0006401)	162	5	9.51	-	.53	1.74E-01	7.02E-01
GO:1903051	negative regulation of proteolysis involved in protein catabolic process (GO:1903051)	65	2	3.82	-	.52	5.88E-01	1.00E00
GO:0002218	activation of innate immune response (GO:0002218)	65	2	3.82	-	.52	5.88E-01	1.00E00
GO:0032757	positive regulation of interleukin-8 production (GO:0032757)	65	2	3.82	-	.52	5.88E-01	1.00E00
GO:0099518	vesicle cytoskeletal trafficking (GO:0099518)	65	2	3.82	-	.52	5.88E-01	1.00E00
GO:0042440	pigment metabolic process (GO:0042440)	65	2	3.82	-	.52	5.88E-01	1.00E00
GO:0043488	regulation of mRNA stability (GO:0043488)	163	5	9.57	-	.52	1.75E-01	7.03E-01
GO:0045671	negative regulation of osteoclast differentiation (GO:0045671)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0019362	pyridine nucleotide metabolic process (GO:0019362)	66	2	3.88	-	.52	5.90E-01	1.00E00
GO:0021532	neural tube patterning (GO:0021532)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0006611	protein export from nucleus (GO:0006611)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0007035	vacuolar acidification (GO:0007035)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0044819	mitotic G1/S transition checkpoint signaling (GO:0044819)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0095500	acetylcholine receptor signaling pathway (GO:0095500)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:1902017	regulation of cilium assembly (GO:1902017)	66	2	3.88	-	.52	5.90E-01	1.00E00
GO:0070670	response to interleukin-4 (GO:0070670)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0050858	negative regulation of antigen receptor-mediated signaling pathway (GO:0050858)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0048489	synaptic vesicle transport (GO:0048489)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0036230	granulocyte activation (GO:0036230)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0031343	positive regulation of cell killing (GO:0031343)	66	2	3.88	-	.52	5.90E-01	1.00E00
GO:0042755	eating behavior (GO:0042755)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0035194	post-transcriptional gene silencing by RNA (GO:0035194)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0042267	natural killer cell mediated cytotoxicity (GO:0042267)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0042219	cellular modified amino acid catabolic process (GO:0042219)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0046496	nicotinamide nucleotide metabolic process (GO:0046496)	66	2	3.88	-	.52	5.90E-01	1.00E00
GO:0007628	adult walking behavior (GO:0007628)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0097061	dendritic spine organization (GO:0097061)	33	1	1.94	-	.52	1.00E00	1.00E00
GO:0044282	small molecule catabolic process (GO:0044282)	364	11	21.37	-	.51	2.24E-02	2.24E-01
GO:0007600	sensory perception (GO:0007600)	997	30	58.54	-	.51	6.30E-05	1.91E-03
GO:1901222	regulation of NIK/NF-kappaB signaling (GO:1901222)	100	3	5.87	-	.51	3.82E-01	1.00E00
GO:1903311	regulation of mRNA metabolic process (GO:1903311)	301	9	17.67	-	.51	4.41E-02	3.46E-01
GO:0007187	G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	67	2	3.93	-	.51	5.92E-01	1.00E00
GO:1901224	positive regulation of NIK/NF-kappaB signaling (GO:1901224)	67	2	3.93	-	.51	5.92E-01	1.00E00
GO:0002504	antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	34	1	2.00	-	.50	1.00E00	1.00E00
GO:1902475	L-alpha-amino acid transmembrane transport (GO:1902475)	68	2	3.99	-	.50	4.39E-01	1.00E00
GO:0090659	walking behavior (GO:0090659)	34	1	2.00	-	.50	1.00E00	1.00E00
GO:0006278	RNA-templated DNA biosynthetic process (GO:0006278)	34	1	2.00	-	.50	1.00E00	1.00E00
GO:0006221	pyrimidine nucleotide biosynthetic process (GO:0006221)	34	1	2.00	-	.50	1.00E00	1.00E00
GO:0090162	establishment of epithelial cell polarity (GO:0090162)	34	1	2.00	-	.50	1.00E00	1.00E00
GO:0048663	neuron fate commitment (GO:0048663)	68	2	3.99	-	.50	4.39E-01	1.00E00
GO:0070227	lymphocyte apoptotic process (GO:0070227)	34	1	2.00	-	.50	1.00E00	1.00E00
GO:0015807	L-amino acid transport (GO:0015807)	68	2	3.99	-	.50	4.39E-01	1.00E00
GO:0045943	positive regulation of transcription by RNA polymerase I (GO:0045943)	34	1	2.00	-	.50	1.00E00	1.00E00
GO:0034315	regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315)	34	1	2.00	-	.50	1.00E00	1.00E00
GO:0002704	negative regulation of leukocyte mediated immunity (GO:0002704)	68	2	3.99	-	.50	4.39E-01	1.00E00
GO:0009101	glycoprotein biosynthetic process (GO:0009101)	277	8	16.27	-	.49	3.71E-02	3.15E-01
GO:0043487	regulation of RNA stability (GO:0043487)	175	5	10.28	-	.49	1.38E-01	6.46E-01
GO:1903008	organelle disassembly (GO:1903008)	105	3	6.17	-	.49	2.89E-01	9.07E-01
GO:0006691	leukotriene metabolic process (GO:0006691)	35	1	2.06	-	.49	7.21E-01	1.00E00
GO:0002228	natural killer cell mediated immunity (GO:0002228)	35	1	2.06	-	.49	7.21E-01	1.00E00
GO:0045109	intermediate filament organization (GO:0045109)	70	2	4.11	-	.49	4.39E-01	1.00E00
GO:0044275	cellular carbohydrate catabolic process (GO:0044275)	35	1	2.06	-	.49	7.21E-01	1.00E00
GO:0050909	sensory perception of taste (GO:0050909)	70	2	4.11	-	.49	4.39E-01	1.00E00
GO:0098664	G protein-coupled serotonin receptor signaling pathway (GO:0098664)	35	1	2.06	-	.49	7.21E-01	1.00E00
GO:0050684	regulation of mRNA processing (GO:0050684)	140	4	8.22	-	.49	1.97E-01	7.65E-01
GO:0048010	vascular endothelial growth factor receptor signaling pathway (GO:0048010)	35	1	2.06	-	.49	7.21E-01	1.00E00
GO:0000038	very long-chain fatty acid metabolic process (GO:0000038)	35	1	2.06	-	.49	7.21E-01	1.00E00
GO:0009112	nucleobase metabolic process (GO:0009112)	35	1	2.06	-	.49	7.21E-01	1.00E00
GO:0097502	mannosylation (GO:0097502)	35	1	2.06	-	.49	7.21E-01	1.00E00
GO:0099024	plasma membrane invagination (GO:0099024)	141	4	8.28	-	.48	1.98E-01	7.68E-01
GO:0051648	vesicle localization (GO:0051648)	179	5	10.51	-	.48	1.04E-01	5.84E-01
GO:1903146	regulation of autophagy of mitochondrion (GO:1903146)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:0006891	intra-Golgi vesicle-mediated transport (GO:0006891)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:0006378	mRNA polyadenylation (GO:0006378)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:0045047	protein targeting to ER (GO:0045047)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:1905710	positive regulation of membrane permeability (GO:1905710)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:0070536	protein K63-linked deubiquitination (GO:0070536)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:0120316	sperm flagellum assembly (GO:0120316)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:0032205	negative regulation of telomere maintenance (GO:0032205)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:0042462	eye photoreceptor cell development (GO:0042462)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:1903749	positive regulation of establishment of protein localization to mitochondrion (GO:1903749)	36	1	2.11	-	.47	7.22E-01	1.00E00
GO:0072524	pyridine-containing compound metabolic process (GO:0072524)	73	2	4.29	-	.47	4.43E-01	1.00E00
GO:0006486	protein glycosylation (GO:0006486)	220	6	12.92	-	.46	5.66E-02	3.99E-01
GO:0043413	macromolecule glycosylation (GO:0043413)	220	6	12.92	-	.46	5.66E-02	3.99E-01
GO:0033619	membrane protein proteolysis (GO:0033619)	37	1	2.17	-	.46	7.23E-01	1.00E00
GO:0006839	mitochondrial transport (GO:0006839)	148	4	8.69	-	.46	1.51E-01	6.87E-01
GO:0001580	detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	37	1	2.17	-	.46	7.23E-01	1.00E00
GO:0006368	transcription elongation by RNA polymerase II promoter (GO:0006368)	37	1	2.17	-	.46	7.23E-01	1.00E00
GO:1905898	positive regulation of response to endoplasmic reticulum stress (GO:1905898)	37	1	2.17	-	.46	7.23E-01	1.00E00
GO:0031929	TOR signaling (GO:0031929)	37	1	2.17	-	.46	7.23E-01	1.00E00
GO:0070316	regulation of G0 to G1 transition (GO:0070316)	37	1	2.17	-	.46	7.23E-01	1.00E00
GO:0009119	ribonucleoside metabolic process (GO:0009119)	37	1	2.17	-	.46	7.23E-01	1.00E00
GO:0030201	heparan sulfate proteoglycan metabolic process (GO:0030201)	37	1	2.17	-	.46	7.23E-01	1.00E00
GO:0010324	membrane invagination (GO:0010324)	148	4	8.69	-	.46	1.51E-01	6.87E-01
GO:0046395	carboxylic acid catabolic process (GO:0046395)	224	6	13.15	-	.46	5.75E-02	4.03E-01
GO:0043604	amide biosynthetic process (GO:0043604)	527	14	30.95	-	.45	1.16E-03	2.29E-02
GO:0007218	neuropeptide signaling pathway (GO:0007218)	113	3	6.64	-	.45	2.19E-01	7.79E-01
GO:0016579	protein deubiquitination (GO:0016579)	151	4	8.87	-	.45	1.14E-01	5.63E-01
GO:0016482	cytosolic transport (GO:0016482)	151	4	8.87	-	.45	1.14E-01	5.63E-01
GO:0045324	late endosome to vacuole transport (GO:0045324)	38	1	2.23	-	.45	7.24E-01	1.00E00
GO:0043631	RNA polyadenylation (GO:0043631)	38	1	2.23	-	.45	7.24E-01	1.00E00
GO:0070328	triglyceride homeostasis (GO:0070328)	38	1	2.23	-	.45	7.24E-01	1.00E00
GO:0055090	acylglycerol homeostasis (GO:0055090)	38	1	2.23	-	.45	7.24E-01	1.00E00
GO:0009142	nucleoside triphosphate biosynthetic process (GO:0009142)	114	3	6.69	-	.45	2.20E-01	7.81E-01
GO:0009069	serine family amino acid metabolic process (GO:0009069)	38	1	2.23	-	.45	7.24E-01	1.00E00
GO:0016054	organic acid catabolic process (GO:0016054)	228	6	13.39	-	.45	4.34E-02	3.41E-01
GO:1903725	regulation of phospholipid metabolic process (GO:1903725)	38	1	2.23	-	.45	7.24E-01	1.00E00
GO:0003407	neural retina development (GO:0003407)	76	2	4.46	-	.45	3.27E-01	9.64E-01
GO:0034968	histone lysine methylation (GO:0034968)	77	2	4.52	-	.44	3.27E-01	9.64E-01
GO:0002437	inflammatory response to antigenic stimulus (GO:0002437)	39	1	2.29	-	.44	7.25E-01	1.00E00
GO:0048753	pigment granule organization (GO:0048753)	39	1	2.29	-	.44	7.25E-01	1.00E00
GO:0031663	lipopolysaccharide-mediated signaling pathway (GO:0031663)	39	1	2.29	-	.44	7.25E-01	1.00E00
GO:0016441	post-transcriptional gene silencing (GO:0016441)	39	1	2.29	-	.44	7.25E-01	1.00E00
GO:0008210	estrogen metabolic process (GO:0008210)	39	1	2.29	-	.44	7.25E-01	1.00E00
GO:0072528	pyrimidine-containing compound biosynthetic process (GO:0072528)	39	1	2.29	-	.44	7.25E-01	1.00E00
GO:0006367	transcription initiation at RNA polymerase II promoter (GO:0006367)	79	2	4.64	-	.43	3.28E-01	9.68E-01
GO:0006119	oxidative phosphorylation (GO:0006119)	119	3	6.99	-	.43	1.64E-01	6.73E-01
GO:0070085	glycosylation (GO:0070085)	239	6	14.03	-	.43	3.36E-02	2.91E-01
GO:0002478	antigen processing and presentation of exogenous peptide antigen (GO:0002478)	40	1	2.35	-	.43	7.27E-01	1.00E00
GO:0007210	serotonin receptor signaling pathway (GO:0007210)	40	1	2.35	-	.43	7.27E-01	1.00E00
GO:0033120	positive regulation of RNA splicing (GO:0033120)	40	1	2.35	-	.43	7.27E-01	1.00E00
GO:1903533	regulation of protein targeting (GO:1903533)	80	2	4.70	-	.43	3.29E-01	9.71E-01
GO:0051606	detection of stimulus (GO:0051606)	686	17	40.28	-	.42	7.25E-05	2.16E-03
GO:0071616	acyl-CoA biosynthetic process (GO:0071616)	41	1	2.41	-	.42	7.30E-01	1.00E00
GO:0035384	thioester biosynthetic process (GO:0035384)	41	1	2.41	-	.42	7.30E-01	1.00E00
GO:0006913	nucleocytoplasmic transport (GO:0006913)	248	6	14.56	-	.41	2.59E-02	2.49E-01
GO:0051169	nuclear transport (GO:0051169)	248	6	14.56	-	.41	2.59E-02	2.49E-01
GO:0070585	protein localization to mitochondrion (GO:0070585)	83	2	4.87	-	.41	3.35E-01	9.52E-01
GO:0031424	keratinization (GO:0031424)	83	2	4.87	-	.41	3.35E-01	9.52E-01
GO:0072594	establishment of protein localization to organelle (GO:0072594)	334	8	19.61	-	.41	5.85E-03	8.49E-02
GO:0046148	pigment biosynthetic process (GO:0046148)	42	1	2.47	-	.41	7.32E-01	1.00E00
GO:0006801	superoxide metabolic process (GO:0006801)	42	1	2.47	-	.41	7.32E-01	1.00E00
GO:0051898	negative regulation of protein kinase B signaling (GO:0051898)	42	1	2.47	-	.41	7.32E-01	1.00E00
GO:1901657	glycosyl compound metabolic process (GO:1901657)	84	2	4.93	-	.41	2.41E-01	8.40E-01
GO:0032509	endosome transport via multivesicular body sorting pathway (GO:0032509)	42	1	2.47	-	.41	7.32E-01	1.00E00
GO:0051650	establishment of vesicle localization (GO:0051650)	168	4	9.87	-	.41	6.48E-02	4.39E-01
GO:0018023	peptidyl-lysine trimethylation (GO:0018023)	42	1	2.47	-	.41	7.32E-01	1.00E00
GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	42	1	2.47	-	.41	7.32E-01	1.00E00
GO:0072527	pyrimidine-containing compound metabolic process (GO:0072527)	84	2	4.93	-	.41	2.41E-01	8.40E-01
GO:0070646	protein modification by small protein removal (GO:0070646)	169	4	9.92	-	.40	6.50E-02	4.39E-01
GO:0006497	protein lipidation (GO:0006497)	85	2	4.99	-	.40	2.41E-01	8.40E-01
GO:0034645	cellular macromolecule biosynthetic process (GO:0034645)	773	18	45.39	-	.40	7.85E-06	3.02E-04
GO:0046006	regulation of activated T cell proliferation (GO:0046006)	43	1	2.52	-	.40	5.17E-01	1.00E00
GO:0006623	protein targeting to vacuole (GO:0006623)	43	1	2.52	-	.40	5.17E-01	1.00E00
GO:0032735	positive regulation of interleukin-12 production (GO:0032735)	43	1	2.52	-	.40	5.17E-01	1.00E00
GO:0050912	detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	43	1	2.52	-	.40	5.17E-01	1.00E00
GO:0016266	O-glycan processing (GO:0016266)	43	1	2.52	-	.40	5.17E-01	1.00E00
GO:0002861	regulation of inflammatory response to antigenic stimulus (GO:0002861)	43	1	2.52	-	.40	5.17E-01	1.00E00
GO:0019646	aerobic electron transport chain (GO:0019646)	86	2	5.05	-	.40	2.42E-01	8.42E-01
GO:0034243	regulation of transcription elongation by RNA polymerase II (GO:0034243)	86	2	5.05	-	.40	2.42E-01	8.42E-01
GO:0016071	mRNA metabolic process (GO:0016071)	607	14	35.64	-	.39	7.92E-05	2.33E-03
GO:0006904	vesicle docking involved in exocytosis (GO:0006904)	44	1	2.58	-	.39	5.17E-01	1.00E00
GO:0016578	histone deubiquitination (GO:0016578)	44	1	2.58	-	.39	5.17E-01	1.00E00
GO:0006911	phagocytosis, engulfment (GO:0006911)	132	3	7.75	-	.39	1.26E-01	6.04E-01
GO:0071692	protein localization to extracellular region (GO:0071692)	132	3	7.75	-	.39	1.26E-01	6.04E-01
GO:0071692	Unclassified (UNCLASSIFIED)	2725	61	160.01	-	.38	4.07E-20	1.94E-17
GO:0044788	modulation by host of viral process (GO:0044788)	45	1	2.64	-	.38	5.18E-01	1.00E00
GO:0014065	phosphatidylinositol 3-kinase signaling (GO:0014065)	45	1	2.64	-	.38	5.18E-01	1.00E00
GO:1990542	mitochondrial transmembrane transport (GO:1990542)	90	2	5.28	-	.38	2.47E-01	8.49E-01
GO:0070534	protein K63-linked ubiquitination (GO:0070534)	45	1	2.64	-	.38	5.18E-01	1.00E00
GO:0099072	regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	45	1	2.64	-	.38	5.18E-01	1.00E00
GO:0042491	inner ear auditory receptor cell differentiation (GO:0042491)	45	1	2.64	-	.38	5.18E-01	1.00E00
GO:0042158	lipoprotein biosynthetic process (GO:0042158)	90	2	5.28	-	.38	2.47E-01	8.48E-01
GO:0060285	cilium-dependent cell motility (GO:0060285)	136	3	7.99	-	.38	9.18E-02	5.40E-01
GO:0001539	cilium or flagellum-dependent cell motility (GO:0001539)	136	3	7.99	-	.38	9.18E-02	5.40E-01
GO:0006612	protein targeting to membrane (GO:0006612)	91	2	5.34	-	.37	2.49E-01	8.16E-01
GO:0018022	peptidyl-lysine methylation (GO:0018022)	91	2	5.34	-	.37	2.49E-01	8.16E-01
GO:0042147	retrograde transport, endosome to Golgi (GO:0042147)	91	2	5.34	-	.37	2.49E-01	8.16E-01
GO:2000772	regulation of cellular senescence (GO:2000772)	46	1	2.70	-	.37	5.20E-01	1.00E00
GO:0051568	histone H3-K4 methylation (GO:0051568)	46	1	2.70	-	.37	5.20E-01	1.00E00
GO:0062208	positive regulation of pattern recognition receptor signaling pathway (GO:0062208)	46	1	2.70	-	.37	5.20E-01	1.00E00
GO:0042269	regulation of natural killer cell mediated cytotoxicity (GO:0042269)	46	1	2.70	-	.37	5.20E-01	1.00E00
GO:0140053	mitochondrial gene expression (GO:0140053)	141	3	8.28	-	.36	6.76E-02	4.53E-01
GO:0045581	negative regulation of T cell differentiation (GO:0045581)	47	1	2.76	-	.36	5.22E-01	1.00E00
GO:0003333	amino acid transmembrane transport (GO:0003333)	94	2	5.52	-	.36	1.78E-01	7.13E-01
GO:0016197	endosomal transport (GO:0016197)	236	5	13.86	-	.36	1.50E-02	1.73E-01
GO:0016236	macroautophagy (GO:0016236)	189	4	11.10	-	.36	3.76E-02	3.18E-01
GO:0002833	positive regulation of response to biotic stimulus (GO:0002833)	189	4	11.10	-	.36	3.76E-02	3.18E-01
GO:0035082	axoneme assembly (GO:0035082)	95	2	5.58	-	.36	1.79E-01	7.16E-01
GO:0045089	positive regulation of innate immune response (GO:0045089)	144	3	8.46	-	.35	6.81E-02	4.57E-01
GO:0032892	positive regulation of organic acid transport (GO:0032892)	48	1	2.82	-	.35	5.24E-01	1.00E00
GO:0046640	regulation of alpha-beta T cell proliferation (GO:0046640)	48	1	2.82	-	.35	5.24E-01	1.00E00
GO:0030073	insulin secretion (GO:0030073)	48	1	2.82	-	.35	5.24E-01	1.00E00
GO:0009566	fertilization (GO:0009566)	193	4	11.33	-	.35	2.72E-02	2.56E-01
GO:0006605	protein targeting (GO:0006605)	243	5	14.27	-	.35	1.11E-02	1.37E-01
GO:0071985	multivesicular body sorting pathway (GO:0071985)	49	1	2.88	-	.35	5.27E-01	1.00E00
GO:0006892	post-Golgi vesicle-mediated transport (GO:0006892)	98	2	5.75	-	.35	1.82E-01	7.18E-01
GO:0070664	negative regulation of leukocyte proliferation (GO:0070664)	98	2	5.75	-	.35	1.82E-01	7.18E-01
GO:0015804	neutral amino acid transport (GO:0015804)	49	1	2.88	-	.35	5.27E-01	1.00E00
GO:0035036	sperm-egg recognition (GO:0035036)	49	1	2.88	-	.35	5.27E-01	1.00E00
GO:0021515	cell differentiation in spinal cord (GO:0021515)	50	1	2.94	-	.34	5.30E-01	1.00E00
GO:0032968	positive regulation of transcription elongation by RNA polymerase II (GO:0032968)	50	1	2.94	-	.34	5.30E-01	1.00E00
GO:0001754	eye photoreceptor cell differentiation (GO:0001754)	50	1	2.94	-	.34	5.30E-01	1.00E00
GO:0018208	peptidyl-proline modification (GO:0018208)	50	1	2.94	-	.34	5.30E-01	1.00E00
GO:0051452	intracellular pH reduction (GO:0051452)	50	1	2.94	-	.34	5.30E-01	1.00E00
GO:0061462	protein localization to lysosome (GO:0061462)	50	1	2.94	-	.34	5.30E-01	1.00E00
GO:0002715	regulation of natural killer cell mediated immunity (GO:0002715)	50	1	2.94	-	.34	5.30E-01	1.00E00
GO:0006397	mRNA processing (GO:0006397)	451	9	26.48	-	.34	1.85E-04	4.75E-03
GO:0007338	single fertilization (GO:0007338)	151	3	8.87	-	.34	5.01E-02	3.79E-01
GO:0006890	retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	51	1	2.99	-	.33	3.68E-01	9.99E-01
GO:0000956	nuclear-transcribed mRNA catabolic process (GO:0000956)	102	2	5.99	-	.33	1.30E-01	6.17E-01
GO:1901570	fatty acid derivative biosynthetic process (GO:1901570)	51	1	2.99	-	.33	3.68E-01	9.99E-01
GO:0042461	photoreceptor cell development (GO:0042461)	51	1	2.99	-	.33	3.68E-01	9.99E-01
GO:0032784	regulation of DNA-templated transcription elongation (GO:0032784)	103	2	6.05	-	.33	1.31E-01	6.20E-01
GO:0019080	viral gene expression (GO:0019080)	52	1	3.05	-	.33	3.69E-01	1.00E00
GO:0120009	intermembrane lipid transfer (GO:0120009)	52	1	3.05	-	.33	3.69E-01	1.00E00
GO:0006893	Golgi to plasma membrane transport (GO:0006893)	53	1	3.11	-	.32	3.70E-01	1.00E00
GO:0009060	aerobic respiration (GO:0009060)	159	3	9.34	-	.32	3.69E-02	3.14E-01
GO:0006910	phagocytosis, recognition (GO:0006910)	107	2	6.28	-	.32	9.41E-02	5.52E-01
GO:0090150	establishment of protein localization to membrane (GO:0090150)	214	4	12.57	-	.32	1.08E-02	1.35E-01
GO:0031124	mRNA 3'-end processing (GO:0031124)	54	1	3.17	-	.32	3.71E-01	1.00E00
GO:0002377	immunoglobulin production (GO:0002377)	164	3	9.63	-	.31	2.68E-02	2.53E-01
GO:0032543	mitochondrial translation (GO:0032543)	110	2	6.46	-	.31	9.48E-02	5.56E-01
GO:0006220	pyrimidine nucleotide metabolic process (GO:0006220)	55	1	3.23	-	.31	3.73E-01	1.00E00
GO:0034033	purine nucleoside bisphosphate biosynthetic process (GO:0034033)	56	1	3.29	-	.30	3.76E-01	1.00E00
GO:0034030	ribonucleoside bisphosphate biosynthetic process (GO:0034030)	56	1	3.29	-	.30	3.76E-01	1.00E00
GO:0050658	RNA transport (GO:0050658)	168	3	9.87	-	.30	2.72E-02	2.57E-01
GO:0050657	nucleic acid transport (GO:0050657)	168	3	9.87	-	.30	2.72E-02	2.57E-01
GO:0002707	negative regulation of lymphocyte mediated immunity (GO:0002707)	56	1	3.29	-	.30	3.76E-01	1.00E00
GO:0033866	nucleoside bisphosphate biosynthetic process (GO:0033866)	56	1	3.29	-	.30	3.76E-01	1.00E00
GO:0002440	production of molecular mediator of immune response (GO:0002440)	169	3	9.92	-	.30	2.75E-02	2.51E-01
GO:0051236	establishment of RNA localization (GO:0051236)	170	3	9.98	-	.30	2.78E-02	2.53E-01
GO:0033209	tumor necrosis factor-mediated signaling pathway (GO:0033209)	57	1	3.35	-	.30	3.79E-01	1.00E00
GO:0006352	DNA-templated transcription initiation (GO:0006352)	114	2	6.69	-	.30	9.80E-02	5.68E-01
GO:0045071	negative regulation of viral genome replication (GO:0045071)	57	1	3.35	-	.30	3.79E-01	1.00E00
GO:1905515	non-motile cilium assembly (GO:1905515)	57	1	3.35	-	.30	3.79E-01	1.00E00
GO:0033363	secretory granule organization (GO:0033363)	58	1	3.41	-	.29	2.61E-01	8.49E-01
GO:0097722	sperm motility (GO:0097722)	116	2	6.81	-	.29	6.82E-02	4.57E-01
GO:0030317	flagellated sperm motility (GO:0030317)	116	2	6.81	-	.29	6.82E-02	4.57E-01
GO:0043043	peptide biosynthetic process (GO:0043043)	408	7	23.96	-	.29	1.25E-04	3.44E-03
GO:0006805	xenobiotic metabolic process (GO:0006805)	117	2	6.87	-	.29	6.84E-02	4.58E-01
GO:0006165	nucleoside diphosphate phosphorylation (GO:0006165)	59	1	3.46	-	.29	2.61E-01	8.49E-01
GO:0006635	fatty acid beta-oxidation (GO:0006635)	60	1	3.52	-	.28	2.62E-01	8.51E-01
GO:0032786	positive regulation of DNA-templated transcription, elongation (GO:0032786)	60	1	3.52	-	.28	2.62E-01	8.51E-01
GO:0019731	antibacterial humoral response (GO:0019731)	60	1	3.52	-	.28	2.62E-01	8.50E-01
GO:0034032	purine nucleoside bisphosphate metabolic process (GO:0034032)	121	2	7.11	-	.28	7.07E-02	4.59E-01
GO:0033875	ribonucleoside bisphosphate metabolic process (GO:0033875)	121	2	7.11	-	.28	7.07E-02	4.59E-01
GO:0033865	nucleoside bisphosphate metabolic process (GO:0033865)	121	2	7.11	-	.28	7.07E-02	4.59E-01
GO:0046939	nucleotide phosphorylation (GO:0046939)	61	1	3.58	-	.28	2.63E-01	8.52E-01
GO:0072666	establishment of protein localization to vacuole (GO:0072666)	61	1	3.58	-	.28	2.63E-01	8.52E-01
GO:0008380	RNA splicing (GO:0008380)	368	6	21.61	-	.28	2.18E-04	5.42E-03
GO:0060294	cilium movement involved in cell motility (GO:0060294)	123	2	7.22	-	.28	4.91E-02	3.73E-01
GO:0033059	cellular pigmentation (GO:0033059)	62	1	3.64	-	.27	2.64E-01	8.48E-01
GO:0009306	protein secretion (GO:0009306)	124	2	7.28	-	.27	4.92E-02	3.74E-01
GO:0035592	establishment of protein localization to extracellular region (GO:0035592)	125	2	7.34	-	.27	4.95E-02	3.75E-01
GO:0006402	mRNA catabolic process (GO:0006402)	126	2	7.40	-	.27	4.98E-02	3.78E-01
GO:0006090	pyruvate metabolic process (GO:0006090)	63	1	3.70	-	.27	2.66E-01	8.53E-01
GO:0051205	protein insertion into membrane (GO:0051205)	63	1	3.70	-	.27	2.66E-01	8.53E-01
GO:0006403	RNA localization (GO:0006403)	190	3	11.16	-	.27	1.04E-02	1.31E-01
GO:0060042	retina morphogenesis in camera-type eye (GO:0060042)	64	1	3.76	-	.27	2.68E-01	8.58E-01
GO:0046530	photoreceptor cell differentiation (GO:0046530)	64	1	3.76	-	.27	2.68E-01	8.58E-01
GO:0006399	tRNA metabolic process (GO:0006399)	196	3	11.51	-	.26	7.47E-03	1.03E-01
GO:0098876	vesicle-mediated transport to the plasma membrane (GO:0098876)	133	2	7.81	-	.26	3.57E-02	3.05E-01
GO:0051028	mRNA transport (GO:0051028)	138	2	8.10	-	.25	2.53E-02	2.47E-01
GO:0042098	T cell proliferation (GO:0042098)	72	1	4.23	-	.24	1.91E-01	7.46E-01
GO:0000245	spliceosomal complex assembly (GO:0000245)	73	1	4.29	-	.23	1.94E-01	7.54E-01
GO:0042130	negative regulation of T cell proliferation (GO:0042130)	73	1	4.29	-	.23	1.94E-01	7.54E-01
GO:0032456	endocytic recycling (GO:0032456)	75	1	4.40	-	.23	1.30E-01	6.18E-01
GO:0006412	translation (GO:0006412)	379	5	22.26	-	.22	3.81E-05	1.23E-03
GO:0072665	protein localization to vacuole (GO:0072665)	77	1	4.52	-	.22	1.32E-01	6.25E-01
GO:1901568	fatty acid derivative metabolic process (GO:1901568)	78	1	4.58	-	.22	1.33E-01	6.27E-01
GO:0050906	detection of stimulus involved in sensory perception (GO:0050906)	560	7	32.88	-	.21	1.27E-07	7.01E-06
GO:0051851	modulation by host of symbiont process (GO:0051851)	83	1	4.87	-	.21	9.17E-02	5.40E-01
GO:0006754	ATP biosynthetic process (GO:0006754)	85	1	4.99	-	.20	9.31E-02	5.46E-01
GO:0009062	fatty acid catabolic process (GO:0009062)	85	1	4.99	-	.20	9.31E-02	5.46E-01
GO:0003341	cilium movement (GO:0003341)	170	2	9.98	-	.20	6.57E-03	9.25E-02
GO:0006396	RNA processing (GO:0006396)	868	10	50.97	-	.20	8.65E-12	1.11E-09
GO:0050672	negative regulation of lymphocyte proliferation (GO:0050672)	89	1	5.23	-	.19	6.40E-02	4.38E-01
GO:0032945	negative regulation of mononuclear cell proliferation (GO:0032945)	90	1	5.28	-	.19	6.41E-02	4.39E-01
GO:0006637	acyl-CoA metabolic process (GO:0006637)	90	1	5.28	-	.19	6.41E-02	4.38E-01
GO:0006493	protein O-linked glycosylation (GO:0006493)	90	1	5.28	-	.19	6.41E-02	4.38E-01
GO:0035383	thioester metabolic process (GO:0035383)	90	1	5.28	-	.19	6.41E-02	4.38E-01
GO:0007032	endosome organization (GO:0007032)	92	1	5.40	-	.19	6.50E-02	4.40E-01
GO:0009206	purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	96	1	5.64	-	.18	4.47E-02	3.49E-01
GO:0031047	gene silencing by RNA (GO:0031047)	96	1	5.64	-	.18	4.47E-02	3.49E-01
GO:0048193	Golgi vesicle transport (GO:0048193)	290	3	17.03	-	.18	9.05E-05	2.58E-03
GO:0009145	purine nucleoside triphosphate biosynthetic process (GO:0009145)	97	1	5.70	-	.18	4.48E-02	3.49E-01
GO:0009201	ribonucleoside triphosphate biosynthetic process (GO:0009201)	102	1	5.99	-	.17	4.71E-02	3.60E-01
GO:0009593	detection of chemical stimulus (GO:0009593)	526	5	30.89	-	.16	2.55E-08	1.54E-06
GO:0031123	RNA 3'-end processing (GO:0031123)	109	1	6.40	-	.16	3.28E-02	2.86E-01
GO:0072329	monocarboxylic acid catabolic process (GO:0072329)	110	1	6.46	-	.15	2.17E-02	2.20E-01
GO:0016052	carbohydrate catabolic process (GO:0016052)	110	1	6.46	-	.15	2.17E-02	2.20E-01
GO:0000398	mRNA splicing, via spliceosome (GO:0000398)	243	2	14.27	-	.14	1.95E-04	4.95E-03
GO:0000377	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	243	2	14.27	-	.14	1.95E-04	4.94E-03
GO:0000375	RNA splicing, via transesterification reactions (GO:0000375)	247	2	14.50	-	.14	1.33E-04	3.59E-03
GO:0051168	nuclear export (GO:0051168)	133	1	7.81	-	.13	7.26E-03	1.00E-01
GO:0034660	ncRNA metabolic process (GO:0034660)	536	4	31.47	-	.13	2.83E-09	2.12E-07
GO:0007606	sensory perception of chemical stimulus (GO:0007606)	551	4	32.36	-	.12	1.37E-09	1.13E-07
GO:0009451	RNA modification (GO:0009451)	179	1	10.51	-	.10	8.09E-04	1.69E-02
GO:0022618	ribonucleoprotein complex assembly (GO:0022618)	201	1	11.80	-	.08	2.67E-04	6.43E-03
GO:0071826	ribonucleoprotein complex subunit organization (GO:0071826)	209	1	12.27	-	.08	1.87E-04	4.76E-03
GO:0022613	ribonucleoprotein complex biogenesis (GO:0022613)	449	2	26.37	-	.08	4.08E-09	2.98E-07
GO:0042254	ribosome biogenesis (GO:0042254)	303	1	17.79	-	.06	8.53E-07	4.05E-05
GO:0007608	sensory perception of smell (GO:0007608)	470	1	27.60	-	.04	7.56E-11	8.06E-09
GO:0050907	detection of chemical stimulus involved in sensory perception (GO:0050907)	489	1	28.71	-	.03	3.71E-11	4.22E-09
GO:0002679	respiratory burst involved in defense response (GO:0002679)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0010288	response to lead ion (GO:0010288)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0002678	positive regulation of chronic inflammatory response (GO:0002678)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002677	negative regulation of chronic inflammatory response (GO:0002677)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010286	heat acclimation (GO:0010286)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002676	regulation of chronic inflammatory response (GO:0002676)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0034214	protein hexamerization (GO:0034214)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0034213	quinolinate catabolic process (GO:0034213)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002669	positive regulation of T cell anergy (GO:0002669)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002667	regulation of T cell anergy (GO:0002667)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0010272	response to silver ion (GO:0010272)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002660	positive regulation of peripheral tolerance induction (GO:0002660)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034205	amyloid-beta formation (GO:0034205)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0034203	glycolipid translocation (GO:0034203)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034201	response to oleic acid (GO:0034201)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002658	regulation of peripheral tolerance induction (GO:0002658)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010266	response to vitamin B1 (GO:0010266)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010265	SCF complex assembly (GO:0010265)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002654	positive regulation of tolerance induction dependent upon immune response (GO:0002654)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002652	regulation of tolerance induction dependent upon immune response (GO:0002652)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045797	positive regulation of intestinal cholesterol absorption (GO:0045797)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045796	negative regulation of intestinal cholesterol absorption (GO:0045796)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045795	positive regulation of cell volume (GO:0045795)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045792	negative regulation of cell size (GO:0045792)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0002648	positive regulation of central tolerance induction (GO:0002648)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010257	NADH dehydrogenase complex assembly (GO:0010257)	60	0	3.52	-	 < 0.01	7.99E-02	5.00E-01
GO:0002646	regulation of central tolerance induction (GO:0002646)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010255	glucose mediated signaling pathway (GO:0010255)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002644	negative regulation of tolerance induction (GO:0002644)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002636	positive regulation of germinal center formation (GO:0002636)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002635	negative regulation of germinal center formation (GO:0002635)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002626	negative regulation of T cell antigen processing and presentation (GO:0002626)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002625	regulation of T cell antigen processing and presentation (GO:0002625)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002622	regulation of B cell antigen processing and presentation (GO:0002622)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045764	positive regulation of cellular amino acid metabolic process (GO:0045764)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045751	negative regulation of Toll signaling pathway (GO:0045751)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903299	regulation of hexokinase activity (GO:1903299)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1903298	negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903297	regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903292	protein localization to Golgi membrane (GO:1903292)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019493	arginine catabolic process to proline (GO:0019493)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903281	positive regulation of calcium:sodium antiporter activity (GO:1903281)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021798	forebrain dorsal/ventral pattern formation (GO:0021798)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0021797	forebrain anterior/posterior pattern specification (GO:0021797)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021796	cerebral cortex regionalization (GO:0021796)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0021794	thalamus development (GO:0021794)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0021793	chemorepulsion of branchiomotor axon (GO:0021793)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045728	respiratory burst after phagocytosis (GO:0045728)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019483	beta-alanine biosynthetic process (GO:0019483)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019482	beta-alanine metabolic process (GO:0019482)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045726	positive regulation of integrin biosynthetic process (GO:0045726)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019481	L-alanine catabolic process, by transamination (GO:0019481)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045724	positive regulation of cilium assembly (GO:0045724)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0045720	negative regulation of integrin biosynthetic process (GO:0045720)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033750	ribosome localization (GO:0033750)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0021785	branchiomotor neuron axon guidance (GO:0021785)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0021784	postganglionic parasympathetic fiber development (GO:0021784)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019478	D-amino acid catabolic process (GO:0019478)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021781	glial cell fate commitment (GO:0021781)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0019477	L-lysine catabolic process (GO:0019477)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021780	glial cell fate specification (GO:0021780)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019474	L-lysine catabolic process to acetyl-CoA (GO:0019474)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903265	positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0019471	4-hydroxyproline metabolic process (GO:0019471)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019470	4-hydroxyproline catabolic process (GO:0019470)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021779	oligodendrocyte cell fate commitment (GO:0021779)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021778	oligodendrocyte cell fate specification (GO:0021778)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021776	smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021775	smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021771	lateral geniculate nucleus development (GO:0021771)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903259	exon-exon junction complex disassembly (GO:1903259)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019464	glycine decarboxylation via glycine cleavage system (GO:0019464)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0007499	ectoderm and mesoderm interaction (GO:0007499)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007495	visceral mesoderm-endoderm interaction involved in midgut development (GO:0007495)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021769	orbitofrontal cortex development (GO:0021769)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021768	nucleus accumbens development (GO:0021768)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021767	mammillary body development (GO:0021767)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019452	L-cysteine catabolic process to taurine (GO:0019452)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903244	positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903241	U2-type prespliceosome assembly (GO:1903241)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0021759	globus pallidus development (GO:0021759)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0039023	pronephric duct morphogenesis (GO:0039023)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0039022	pronephric duct development (GO:0039022)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021754	facial nucleus development (GO:0021754)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0039020	pronephric nephron tubule development (GO:0039020)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019449	L-cysteine catabolic process to hypotaurine (GO:0019449)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021750	vestibular nucleus development (GO:0021750)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019442	tryptophan catabolic process to acetyl-CoA (GO:0019442)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903235	positive regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903235)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019441	tryptophan catabolic process to kynurenine (GO:0019441)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019440	tryptophan catabolic process to indole-3-acetate (GO:0019440)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903233	regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903232	melanosome assembly (GO:1903232)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0039019	pronephric nephron development (GO:0039019)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0039017	pattern specification involved in pronephros development (GO:0039017)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021743	hypoglossal nucleus development (GO:0021743)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021742	abducens nucleus development (GO:0021742)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072497	mesenchymal stem cell differentiation (GO:0072497)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019432	triglyceride biosynthetic process (GO:0019432)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:1903225	negative regulation of endodermal cell differentiation (GO:1903225)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015074	DNA integration (GO:0015074)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0039008	pronephric nephron tubule morphogenesis (GO:0039008)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0039007	pronephric nephron morphogenesis (GO:0039007)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0039003	pronephric field specification (GO:0039003)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021732	midbrain-hindbrain boundary maturation (GO:0021732)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019427	acetyl-CoA biosynthetic process from acetate (GO:0019427)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003099	positive regulation of the force of heart contraction by chemical signal (GO:0003099)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003095	pressure natriuresis (GO:0003095)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003092	renal water retention (GO:0003092)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021723	medullary reticular formation development (GO:0021723)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021722	superior olivary nucleus maturation (GO:0021722)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019418	sulfide oxidation (GO:0019418)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019417	sulfur oxidation (GO:0019417)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019413	acetate biosynthetic process (GO:0019413)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903200	positive regulation of L-dopa decarboxylase activity (GO:1903200)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007442	hindgut morphogenesis (GO:0007442)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0003084	positive regulation of systemic arterial blood pressure (GO:0003084)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0003083	negative regulation of renal output by angiotensin (GO:0003083)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021718	superior olivary nucleus development (GO:0021718)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019408	dolichol biosynthetic process (GO:0019408)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019407	hexitol catabolic process (GO:0019407)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000984	negative regulation of ATP citrate synthase activity (GO:2000984)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019405	alditol catabolic process (GO:0019405)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:2000983	regulation of ATP citrate synthase activity (GO:2000983)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000981	negative regulation of inner ear receptor cell differentiation (GO:2000981)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019402	galactitol metabolic process (GO:0019402)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019401	alditol biosynthetic process (GO:0019401)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019400	alditol metabolic process (GO:0019400)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0060496	mesenchymal-epithelial cell signaling involved in lung development (GO:0060496)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060495	cell-cell signaling involved in lung development (GO:0060495)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060490	lateral sprouting involved in lung morphogenesis (GO:0060490)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003070	regulation of systemic arterial blood pressure by neurotransmitter (GO:0003070)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000979	positive regulation of forebrain neuron differentiation (GO:2000979)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021703	locus ceruleus development (GO:0021703)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000978	negative regulation of forebrain neuron differentiation (GO:2000978)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000977	regulation of forebrain neuron differentiation (GO:2000977)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000975	positive regulation of pro-B cell differentiation (GO:2000975)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000974	negative regulation of pro-B cell differentiation (GO:2000974)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000973	regulation of pro-B cell differentiation (GO:2000973)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:2000971	negative regulation of detection of glucose (GO:2000971)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000970	regulation of detection of glucose (GO:2000970)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060489	planar dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060489)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060488	orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060488)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060484	lung-associated mesenchyme development (GO:0060484)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0060482	lobar bronchus development (GO:0060482)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060481	lobar bronchus epithelium development (GO:0060481)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0003069	acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0003069)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060480	lung goblet cell differentiation (GO:0060480)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003068	regulation of systemic arterial blood pressure by acetylcholine (GO:0003068)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0080058	protein deglutathionylation (GO:0080058)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007418	ventral midline development (GO:0007418)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060478	acrosomal vesicle exocytosis (GO:0060478)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060474	positive regulation of flagellated sperm motility involved in capacitation (GO:0060474)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060471	cortical granule exocytosis (GO:0060471)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060470	positive regulation of cytosolic calcium ion concentration involved in egg activation (GO:0060470)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003058	hormonal regulation of the force of heart contraction (GO:0003058)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003050	regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072432	response to G1 DNA damage checkpoint signaling (GO:0072432)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060468	prevention of polyspermy (GO:0060468)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060467	negative regulation of fertilization (GO:0060467)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0007406	negative regulation of neuroblast proliferation (GO:0007406)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0015015	heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060466	activation of meiosis involved in egg activation (GO:0060466)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007403	glial cell fate determination (GO:0007403)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007402	ganglion mother cell fate determination (GO:0007402)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007400	neuroblast fate determination (GO:0007400)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060460	left lung morphogenesis (GO:0060460)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060459	left lung development (GO:0060459)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018993	somatic sex determination (GO:0018993)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018992	germ-line sex determination (GO:0018992)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060454	positive regulation of gastric acid secretion (GO:0060454)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060450	positive regulation of hindgut contraction (GO:0060450)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003032	detection of oxygen (GO:0003032)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046177	D-gluconate catabolic process (GO:0046177)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046176	aldonic acid catabolic process (GO:0046176)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046174	polyol catabolic process (GO:0046174)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0072414	response to mitotic cell cycle checkpoint signaling (GO:0072414)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060448	dichotomous subdivision of terminal units involved in lung branching (GO:0060448)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060447	bud outgrowth involved in lung branching (GO:0060447)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902775	mitochondrial large ribosomal subunit assembly (GO:1902775)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902774	late endosome to lysosome transport (GO:1902774)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0003029	detection of hypoxic conditions in blood by carotid body chemoreceptor signaling (GO:0003029)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902771	positive regulation of choline O-acetyltransferase activity (GO:1902771)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003027	regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling (GO:0003027)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003026	regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback (GO:0003026)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003025	regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046168	glycerol-3-phosphate catabolic process (GO:0046168)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046167	glycerol-3-phosphate biosynthetic process (GO:0046167)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046166	glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046160	heme a metabolic process (GO:0046160)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034199	activation of protein kinase A activity (GO:0034199)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034197	triglyceride transport (GO:0034197)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034196	acylglycerol transport (GO:0034196)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902769	regulation of choline O-acetyltransferase activity (GO:1902769)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060436	bronchiole morphogenesis (GO:0060436)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902767	isoprenoid biosynthetic process via mevalonate (GO:1902767)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902766	skeletal muscle satellite cell migration (GO:1902766)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060432	lung pattern specification process (GO:0060432)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060431	primary lung bud formation (GO:0060431)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902761	positive regulation of chondrocyte development (GO:1902761)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003011	involuntary skeletal muscle contraction (GO:0003011)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0080009	mRNA methylation (GO:0080009)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0018969	thiocyanate metabolic process (GO:0018969)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034184	positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034183	negative regulation of maintenance of mitotic sister chromatid cohesion (GO:0034183)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060427	lung connective tissue development (GO:0060427)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018964	propylene metabolic process (GO:0018964)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034182	regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0018963	phthalate metabolic process (GO:0018963)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018960	4-nitrophenol metabolic process (GO:0018960)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006999	nuclear pore organization (GO:0006999)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0006995	cellular response to nitrogen starvation (GO:0006995)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0006991	response to sterol depletion (GO:0006991)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0006990	positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046149	pigment catabolic process (GO:0046149)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0046146	tetrahydrobiopterin metabolic process (GO:0046146)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0046144	D-alanine family amino acid metabolic process (GO:0046144)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0052805	imidazole-containing compound catabolic process (GO:0052805)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006984	ER-nucleus signaling pathway (GO:0006984)	33	0	1.94	-	 < 0.01	2.60E-01	8.47E-01
GO:0006983	ER overload response (GO:0006983)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0046137	negative regulation of vitamin metabolic process (GO:0046137)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0046136	positive regulation of vitamin metabolic process (GO:0046136)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046135	pyrimidine nucleoside catabolic process (GO:0046135)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0046134	pyrimidine nucleoside biosynthetic process (GO:0046134)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046133	pyrimidine ribonucleoside catabolic process (GO:0046133)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0046131	pyrimidine ribonucleoside metabolic process (GO:0046131)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0046130	purine ribonucleoside catabolic process (GO:0046130)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0034166	toll-like receptor 10 signaling pathway (GO:0034166)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034165	positive regulation of toll-like receptor 9 signaling pathway (GO:0034165)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034164	negative regulation of toll-like receptor 9 signaling pathway (GO:0034164)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060408	regulation of acetylcholine metabolic process (GO:0060408)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034163	regulation of toll-like receptor 9 signaling pathway (GO:0034163)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0060407	negative regulation of penile erection (GO:0060407)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034162	toll-like receptor 9 signaling pathway (GO:0034162)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0034161	positive regulation of toll-like receptor 8 signaling pathway (GO:0034161)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060404	axonemal microtubule depolymerization (GO:0060404)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902731	negative regulation of chondrocyte proliferation (GO:1902731)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046127	pyrimidine deoxyribonucleoside catabolic process (GO:0046127)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046126	pyrimidine deoxyribonucleoside biosynthetic process (GO:0046126)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046124	purine deoxyribonucleoside catabolic process (GO:0046124)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046122	purine deoxyribonucleoside metabolic process (GO:0046122)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046121	deoxyribonucleoside catabolic process (GO:0046121)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0046120	deoxyribonucleoside biosynthetic process (GO:0046120)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034159	regulation of toll-like receptor 8 signaling pathway (GO:0034159)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034158	toll-like receptor 8 signaling pathway (GO:0034158)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034157	positive regulation of toll-like receptor 7 signaling pathway (GO:0034157)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034156	negative regulation of toll-like receptor 7 signaling pathway (GO:0034156)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034155	regulation of toll-like receptor 7 signaling pathway (GO:0034155)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0034154	toll-like receptor 7 signaling pathway (GO:0034154)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902729	negative regulation of proteoglycan biosynthetic process (GO:1902729)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902728	positive regulation of growth factor dependent skeletal muscle satellite cell proliferation (GO:1902728)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034151	regulation of toll-like receptor 6 signaling pathway (GO:0034151)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034150	toll-like receptor 6 signaling pathway (GO:0034150)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902724	positive regulation of skeletal muscle satellite cell proliferation (GO:1902724)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902723	negative regulation of skeletal muscle satellite cell proliferation (GO:1902723)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902722	positive regulation of prolactin secretion (GO:1902722)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006965	positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0006965)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006963	positive regulation of antibacterial peptide biosynthetic process (GO:0006963)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046113	nucleobase catabolic process (GO:0046113)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046112	nucleobase biosynthetic process (GO:0046112)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0046111	xanthine biosynthetic process (GO:0046111)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046110	xanthine metabolic process (GO:0046110)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034148	negative regulation of toll-like receptor 5 signaling pathway (GO:0034148)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034147	regulation of toll-like receptor 5 signaling pathway (GO:0034147)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034146	toll-like receptor 5 signaling pathway (GO:0034146)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071988	protein localization to spindle pole body (GO:0071988)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034145	positive regulation of toll-like receptor 4 signaling pathway (GO:0034145)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0034144	negative regulation of toll-like receptor 4 signaling pathway (GO:0034144)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0034143	regulation of toll-like receptor 4 signaling pathway (GO:0034143)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0034142	toll-like receptor 4 signaling pathway (GO:0034142)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0034140	negative regulation of toll-like receptor 3 signaling pathway (GO:0034140)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046108	uridine metabolic process (GO:0046108)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046105	thymidine biosynthetic process (GO:0046105)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046103	inosine biosynthetic process (GO:0046103)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046102	inosine metabolic process (GO:0046102)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046101	hypoxanthine biosynthetic process (GO:0046101)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002590	negative regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002590)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046100	hypoxanthine metabolic process (GO:0046100)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034137	positive regulation of toll-like receptor 2 signaling pathway (GO:0034137)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034136	negative regulation of toll-like receptor 2 signaling pathway (GO:0034136)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0034135	regulation of toll-like receptor 2 signaling pathway (GO:0034135)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0018916	nitrobenzene metabolic process (GO:0018916)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034134	toll-like receptor 2 signaling pathway (GO:0034134)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0071976	cell gliding (GO:0071976)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034130	toll-like receptor 1 signaling pathway (GO:0034130)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018910	benzene metabolic process (GO:0018910)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002589	regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002589)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002588	positive regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002588)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002587	negative regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002587)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002586	regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002586)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002585	positive regulation of antigen processing and presentation of peptide antigen (GO:0002585)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002584	negative regulation of antigen processing and presentation of peptide antigen (GO:0002584)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002583	regulation of antigen processing and presentation of peptide antigen (GO:0002583)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002582	positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002582)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002581	negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002581)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002580	regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034128	negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034127	regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034125	negative regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034125)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034124	regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034124)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071963	establishment or maintenance of cell polarity regulating cell shape (GO:0071963)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071962	mitotic sister chromatid cohesion, centromeric (GO:0071962)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006933	negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006931	substrate-dependent cell migration, cell attachment to substrate (GO:0006931)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010189	vitamin E biosynthetic process (GO:0010189)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002575	basophil chemotaxis (GO:0002575)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002574	thrombocyte differentiation (GO:0002574)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010182	sugar mediated signaling pathway (GO:0010182)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002572	pro-T cell differentiation (GO:0002572)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071955	recycling endosome to Golgi transport (GO:0071955)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071951	conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006924	activation-induced cell death of T cells (GO:0006924)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002568	somatic diversification of T cell receptor genes (GO:0002568)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034105	positive regulation of tissue remodeling (GO:0034105)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0071947	protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0010166	wax metabolic process (GO:0010166)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002553	histamine secretion by mast cell (GO:0002553)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010160	formation of animal organ boundary (GO:0010160)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071939	vitamin A import into cell (GO:0071939)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071938	vitamin A transport (GO:0071938)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071934	thiamine transmembrane transport (GO:0071934)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006907	pinocytosis (GO:0006907)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0006903	vesicle targeting (GO:0006903)	63	0	3.70	-	 < 0.01	4.99E-02	3.78E-01
GO:0006901	vesicle coating (GO:0006901)	36	0	2.11	-	 < 0.01	2.65E-01	8.50E-01
GO:0010159	specification of animal organ position (GO:0010159)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006900	vesicle budding from membrane (GO:0006900)	76	0	4.46	-	 < 0.01	2.20E-02	2.22E-01
GO:0010157	response to chlorate (GO:0010157)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010155	regulation of proton transport (GO:0010155)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0002544	chronic inflammatory response (GO:0002544)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0002543	activation of blood coagulation via clotting cascade (GO:0002543)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002541	activation of plasma proteins involved in acute inflammatory response (GO:0002541)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002540	leukotriene production involved in inflammatory response (GO:0002540)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071929	alpha-tubulin acetylation (GO:0071929)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071926	endocannabinoid signaling pathway (GO:0071926)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071921	cohesin loading (GO:0071921)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002538	arachidonic acid metabolite production involved in inflammatory response (GO:0002538)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002537	nitric oxide production involved in inflammatory response (GO:0002537)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002536	respiratory burst involved in inflammatory response (GO:0002536)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010142	farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071919	G-quadruplex DNA formation (GO:0071919)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071918	urea transmembrane transport (GO:0071918)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0071911	synchronous neurotransmitter secretion (GO:0071911)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071910	determination of liver left/right asymmetry (GO:0071910)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010138	pyrimidine ribonucleotide salvage (GO:0010138)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002524	hypersensitivity (GO:0002524)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010133	proline catabolic process to glutamate (GO:0010133)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002522	leukocyte migration involved in immune response (GO:0002522)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071909	determination of stomach left/right asymmetry (GO:0071909)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071908	determination of intestine left/right asymmetry (GO:0071908)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071907	determination of digestive tract left/right asymmetry (GO:0071907)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0045662	negative regulation of myoblast differentiation (GO:0045662)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0045660	positive regulation of neutrophil differentiation (GO:0045660)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033693	neurofilament bundle assembly (GO:0033693)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002519	natural killer cell tolerance induction (GO:0002519)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002518	lymphocyte chemotaxis across high endothelial venule (GO:0002518)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002517	T cell tolerance induction (GO:0002517)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010124	phenylacetate catabolic process (GO:0010124)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002514	B cell tolerance induction (GO:0002514)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002513	tolerance induction to self antigen (GO:0002513)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010121	arginine catabolic process to proline via ornithine (GO:0010121)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045659	negative regulation of neutrophil differentiation (GO:0045659)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045658	regulation of neutrophil differentiation (GO:0045658)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045654	positive regulation of megakaryocyte differentiation (GO:0045654)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0033686	positive regulation of luteinizing hormone secretion (GO:0033686)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0033685	negative regulation of luteinizing hormone secretion (GO:0033685)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033684	regulation of luteinizing hormone secretion (GO:0033684)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0033683	nucleotide-excision repair, DNA incision (GO:0033683)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0002509	central tolerance induction to self antigen (GO:0002509)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002508	central tolerance induction (GO:0002508)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002507	tolerance induction (GO:0002507)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0002505	antigen processing and presentation of polysaccharide antigen via MHC class II (GO:0002505)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002503	peptide antigen assembly with MHC class II protein complex (GO:0002503)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0002502	peptide antigen assembly with MHC class I protein complex (GO:0002502)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002501	peptide antigen assembly with MHC protein complex (GO:0002501)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:1903198	regulation of L-dopa decarboxylase activity (GO:1903198)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903197	positive regulation of L-dopa biosynthetic process (GO:1903197)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903195	regulation of L-dopa biosynthetic process (GO:1903195)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045645	positive regulation of eosinophil differentiation (GO:0045645)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045643	regulation of eosinophil differentiation (GO:0045643)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903190	glyoxal catabolic process (GO:1903190)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903189	glyoxal metabolic process (GO:1903189)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019391	glucuronoside catabolic process (GO:0019391)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903182	regulation of SUMO transferase activity (GO:1903182)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045632	negative regulation of mechanoreceptor differentiation (GO:0045632)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903181	positive regulation of dopamine biosynthetic process (GO:1903181)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033668	negative regulation by symbiont of host apoptotic process (GO:0033668)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021699	cerebellar cortex maturation (GO:0021699)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019389	glucuronoside metabolic process (GO:0019389)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019388	galactose catabolic process (GO:0019388)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0021691	cerebellar Purkinje cell layer maturation (GO:0021691)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045629	negative regulation of T-helper 2 cell differentiation (GO:0045629)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903178	positive regulation of tyrosine 3-monooxygenase activity (GO:1903178)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045627	positive regulation of T-helper 1 cell differentiation (GO:0045627)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903176	regulation of tyrosine 3-monooxygenase activity (GO:1903176)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045626	negative regulation of T-helper 1 cell differentiation (GO:0045626)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045625	regulation of T-helper 1 cell differentiation (GO:0045625)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1903173	fatty alcohol metabolic process (GO:1903173)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045623	negative regulation of T-helper cell differentiation (GO:0045623)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0021688	cerebellar molecular layer formation (GO:0021688)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021687	cerebellar molecular layer morphogenesis (GO:0021687)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021686	cerebellar granular layer maturation (GO:0021686)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021682	nerve maturation (GO:0021682)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019377	glycolipid catabolic process (GO:0019377)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0019376	galactolipid catabolic process (GO:0019376)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019375	galactolipid biosynthetic process (GO:0019375)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903168	positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019374	galactolipid metabolic process (GO:0019374)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1903167	regulation of pyrroline-5-carboxylate reductase activity (GO:1903167)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019373	epoxygenase P450 pathway (GO:0019373)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0019372	lipoxygenase pathway (GO:0019372)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0045611	negative regulation of hemocyte differentiation (GO:0045611)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045610	regulation of hemocyte differentiation (GO:0045610)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021679	cerebellar molecular layer development (GO:0021679)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001311	lysobisphosphatidic acid metabolic process (GO:2001311)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019368	fatty acid elongation, unsaturated fatty acid (GO:0019368)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0019367	fatty acid elongation, saturated fatty acid (GO:0019367)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0019365	pyridine nucleotide salvage (GO:0019365)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019364	pyridine nucleotide catabolic process (GO:0019364)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0045608	negative regulation of inner ear auditory receptor cell differentiation (GO:0045608)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0007398	ectoderm development (GO:0007398)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0033634	positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0033633	negative regulation of cell-cell adhesion mediated by integrin (GO:0033633)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033632	regulation of cell-cell adhesion mediated by integrin (GO:0033632)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:2001306	lipoxin B4 biosynthetic process (GO:2001306)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001304	lipoxin B4 metabolic process (GO:2001304)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001303	lipoxin A4 biosynthetic process (GO:2001303)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001302	lipoxin A4 metabolic process (GO:2001302)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2001301	lipoxin biosynthetic process (GO:2001301)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2001300	lipoxin metabolic process (GO:2001300)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903147	negative regulation of autophagy of mitochondrion (GO:1903147)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0007388	posterior compartment specification (GO:0007388)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903141	negative regulation of establishment of endothelial barrier (GO:1903141)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007387	anterior compartment pattern formation (GO:0007387)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007386	compartment pattern specification (GO:0007386)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0033626	positive regulation of integrin activation by cell surface receptor linked signal transduction (GO:0033626)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019348	dolichol metabolic process (GO:0019348)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0021650	vestibulocochlear nerve formation (GO:0021650)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019346	transsulfuration (GO:0019346)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019344	cysteine biosynthetic process (GO:0019344)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019343	cysteine biosynthetic process via cystathionine (GO:0019343)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019341	dibenzo-p-dioxin catabolic process (GO:0019341)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033617	mitochondrial cytochrome c oxidase assembly (GO:0033617)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0007371	ventral midline determination (GO:0007371)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033615	mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0021649	vestibulocochlear nerve structural organization (GO:0021649)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021648	vestibulocochlear nerve morphogenesis (GO:0021648)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0021644	vagus nerve morphogenesis (GO:0021644)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021642	trochlear nerve formation (GO:0021642)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072393	microtubule anchoring at microtubule organizing center (GO:0072393)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1903122	negative regulation of TRAIL-activated apoptotic signaling pathway (GO:1903122)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033609	oxalate metabolic process (GO:0033609)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033606	chemokine receptor transport within lipid bilayer (GO:0033606)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021639	trochlear nerve morphogenesis (GO:0021639)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021637	trigeminal nerve structural organization (GO:0021637)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021636	trigeminal nerve morphogenesis (GO:0021636)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021633	optic nerve structural organization (GO:0021633)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072389	flavin adenine dinucleotide catabolic process (GO:0072389)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072388	flavin adenine dinucleotide biosynthetic process (GO:0072388)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021630	olfactory nerve maturation (GO:0021630)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072387	flavin adenine dinucleotide metabolic process (GO:0072387)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903119	protein localization to actin cytoskeleton (GO:1903119)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072385	minus-end-directed organelle transport along microtubule (GO:0072385)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903118	urate homeostasis (GO:1903118)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019323	pentose catabolic process (GO:0019323)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019322	pentose biosynthetic process (GO:0019322)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072382	minus-end-directed vesicle transport along microtubule (GO:0072382)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019321	pentose metabolic process (GO:0019321)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0019320	hexose catabolic process (GO:0019320)	39	0	2.29	-	 < 0.01	2.76E-01	8.81E-01
GO:0007356	thorax and anterior abdomen determination (GO:0007356)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0007354	zygotic determination of anterior/posterior axis, embryo (GO:0007354)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0007352	zygotic specification of dorsal/ventral axis (GO:0007352)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021628	olfactory nerve formation (GO:0021628)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021626	central nervous system maturation (GO:0021626)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0021623	oculomotor nerve formation (GO:0021623)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021622	oculomotor nerve morphogenesis (GO:0021622)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019317	fucose catabolic process (GO:0019317)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1903109	positive regulation of mitochondrial transcription (GO:1903109)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903108	regulation of mitochondrial transcription (GO:1903108)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000892	cellobiose catabolic process (GO:2000892)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000891	cellobiose metabolic process (GO:2000891)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019310	inositol catabolic process (GO:0019310)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007349	cellularization (GO:0007349)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903100	1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process (GO:1903100)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007343	egg activation (GO:0007343)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0007341	penetration of zona pellucida (GO:0007341)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0021615	glossopharyngeal nerve morphogenesis (GO:0021615)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019303	D-ribose catabolic process (GO:0019303)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007339	binding of sperm to zona pellucida (GO:0007339)	40	0	2.35	-	 < 0.01	1.71E-01	6.94E-01
GO:0060399	positive regulation of growth hormone receptor signaling pathway (GO:0060399)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060397	growth hormone receptor signaling pathway via JAK-STAT (GO:0060397)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0021605	cranial nerve maturation (GO:0021605)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021603	cranial nerve formation (GO:0021603)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0072356	chromosome passenger complex localization to kinetochore (GO:0072356)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000872	positive regulation of progesterone secretion (GO:2000872)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000870	regulation of progesterone secretion (GO:2000870)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072350	tricarboxylic acid metabolic process (GO:0072350)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0060386	synapse assembly involved in innervation (GO:0060386)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060383	positive regulation of DNA strand elongation (GO:0060383)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060382	regulation of DNA strand elongation (GO:0060382)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0007321	sperm displacement (GO:0007321)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060381	positive regulation of single-stranded telomeric DNA binding (GO:0060381)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060380	regulation of single-stranded telomeric DNA binding (GO:0060380)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072347	response to anesthetic (GO:0072347)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072344	rescue of stalled ribosome (GO:0072344)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:2000860	positive regulation of aldosterone secretion (GO:2000860)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072340	cellular lactam catabolic process (GO:0072340)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140820	cytosol to Golgi apparatus transport (GO:0140820)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060378	regulation of brood size (GO:0060378)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060377	negative regulation of mast cell differentiation (GO:0060377)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060376	positive regulation of mast cell differentiation (GO:0060376)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060375	regulation of mast cell differentiation (GO:0060375)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060370	susceptibility to T cell mediated cytotoxicity (GO:0060370)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046099	guanine biosynthetic process (GO:0046099)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046098	guanine metabolic process (GO:0046098)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000857	positive regulation of mineralocorticoid secretion (GO:2000857)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046094	deoxyinosine metabolic process (GO:0046094)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072338	cellular lactam metabolic process (GO:0072338)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046092	deoxycytidine metabolic process (GO:0046092)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000854	positive regulation of corticosterone secretion (GO:2000854)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000853	negative regulation of corticosterone secretion (GO:2000853)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046090	deoxyadenosine metabolic process (GO:0046090)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072334	UDP-galactose transmembrane transport (GO:0072334)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000852	regulation of corticosterone secretion (GO:2000852)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000851	positive regulation of glucocorticoid secretion (GO:2000851)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060369	positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060368	regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0060367	sagittal suture morphogenesis (GO:0060367)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060366	lambdoid suture morphogenesis (GO:0060366)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060364	frontal suture morphogenesis (GO:0060364)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060363	cranial suture morphogenesis (GO:0060363)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1902691	respiratory basal cell differentiation (GO:1902691)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046087	cytidine metabolic process (GO:0046087)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:2000848	positive regulation of corticosteroid hormone secretion (GO:2000848)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0046084	adenine biosynthetic process (GO:0046084)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046083	adenine metabolic process (GO:0046083)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000845	positive regulation of testosterone secretion (GO:2000845)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046081	dUTP catabolic process (GO:0046081)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000843	regulation of testosterone secretion (GO:2000843)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046080	dUTP metabolic process (GO:0046080)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060359	response to ammonium ion (GO:0060359)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902688	regulation of NAD metabolic process (GO:1902688)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018894	dibenzo-p-dioxin metabolic process (GO:0018894)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0052746	inositol phosphorylation (GO:0052746)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:1902685	positive regulation of receptor localization to synapse (GO:1902685)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902684	negative regulation of receptor localization to synapse (GO:1902684)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060352	cell adhesion molecule production (GO:0060352)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902682	protein localization to pericentric heterochromatin (GO:1902682)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046079	dUMP catabolic process (GO:0046079)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0046078	dUMP metabolic process (GO:0046078)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0046077	dUDP metabolic process (GO:0046077)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046074	dTMP catabolic process (GO:0046074)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000836	positive regulation of androgen secretion (GO:2000836)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046072	dTDP metabolic process (GO:0046072)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000834	regulation of androgen secretion (GO:2000834)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046070	dGTP metabolic process (GO:0046070)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072313	metanephric glomerular epithelial cell development (GO:0072313)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072312	metanephric glomerular epithelial cell differentiation (GO:0072312)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018885	carbon tetrachloride metabolic process (GO:0018885)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060345	spleen trabecula formation (GO:0060345)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046067	dGDP catabolic process (GO:0046067)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046066	dGDP metabolic process (GO:0046066)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046065	dCTP metabolic process (GO:0046065)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000827	mitochondrial RNA surveillance (GO:2000827)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072308	negative regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072308)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046063	dCMP metabolic process (GO:0046063)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000825	positive regulation of androgen receptor activity (GO:2000825)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046061	dATP catabolic process (GO:0046061)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072305	negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072305)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046060	dATP metabolic process (GO:0046060)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072304	regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072304)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072302	negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000820	negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0018879	biphenyl metabolic process (GO:0018879)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072300	positive regulation of metanephric glomerulus development (GO:0072300)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902669	positive regulation of axon guidance (GO:1902669)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060337	type I interferon signaling pathway (GO:0060337)	42	0	2.47	-	 < 0.01	1.72E-01	6.99E-01
GO:0034093	positive regulation of maintenance of sister chromatid cohesion (GO:0034093)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060336	negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0018874	benzoate metabolic process (GO:0018874)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034092	negative regulation of maintenance of sister chromatid cohesion (GO:0034092)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060335	positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034091	regulation of maintenance of sister chromatid cohesion (GO:0034091)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0060334	regulation of interferon-gamma-mediated signaling pathway (GO:0060334)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0018872	arsonoacetate metabolic process (GO:0018872)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060333	interferon-gamma-mediated signaling pathway (GO:0060333)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0060332	positive regulation of response to interferon-gamma (GO:0060332)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060331	negative regulation of response to interferon-gamma (GO:0060331)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0060330	regulation of response to interferon-gamma (GO:0060330)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:1902661	positive regulation of glucose mediated signaling pathway (GO:1902661)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046059	dAMP catabolic process (GO:0046059)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046057	dADP catabolic process (GO:0046057)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000819	regulation of nucleotide-excision repair (GO:2000819)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0046056	dADP metabolic process (GO:0046056)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000818	negative regulation of myoblast proliferation (GO:2000818)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046055	dGMP catabolic process (GO:0046055)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046054	dGMP metabolic process (GO:0046054)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046053	dAMP metabolic process (GO:0046053)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000815	regulation of mRNA stability involved in response to oxidative stress (GO:2000815)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046052	UTP catabolic process (GO:0046052)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046051	UTP metabolic process (GO:0046051)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:2000813	negative regulation of barbed-end actin filament capping (GO:2000813)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046050	UMP catabolic process (GO:0046050)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000812	regulation of barbed-end actin filament capping (GO:2000812)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034089	establishment of meiotic sister chromatid cohesion (GO:0034089)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034087	establishment of mitotic sister chromatid cohesion (GO:0034087)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034085	establishment of sister chromatid cohesion (GO:0034085)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1902659	regulation of glucose mediated signaling pathway (GO:1902659)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060327	cytoplasmic actin-based contraction involved in cell motility (GO:0060327)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902656	calcium ion import into cytosol (GO:1902656)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006896	Golgi to vacuole transport (GO:0006896)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0006895	Golgi to endosome transport (GO:0006895)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0046049	UMP metabolic process (GO:0046049)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0046048	UDP metabolic process (GO:0046048)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000809	positive regulation of synaptic vesicle clustering (GO:2000809)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000808	negative regulation of synaptic vesicle clustering (GO:2000808)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000807	regulation of synaptic vesicle clustering (GO:2000807)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000806	positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000806)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000805	negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000804	regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000804)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046041	ITP metabolic process (GO:0046041)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000802	positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000802)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046040	IMP metabolic process (GO:0046040)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:2000800	regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000800)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060319	primitive erythrocyte differentiation (GO:0060319)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060313	negative regulation of blood vessel remodeling (GO:0060313)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060312	regulation of blood vessel remodeling (GO:0060312)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060311	negative regulation of elastin catabolic process (GO:0060311)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060310	regulation of elastin catabolic process (GO:0060310)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	127	0	7.46	-	 < 0.01	1.35E-03	2.59E-02
GO:0006880	intracellular sequestering of iron ion (GO:0006880)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0046038	GMP catabolic process (GO:0046038)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046036	CTP metabolic process (GO:0046036)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0046035	CMP metabolic process (GO:0046035)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0034067	protein localization to Golgi apparatus (GO:0034067)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:0110156	methylguanosine-cap decapping (GO:0110156)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0110155	NAD-cap decapping (GO:0110155)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0110154	RNA decapping (GO:0110154)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0034063	stress granule assembly (GO:0034063)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0060305	regulation of cell diameter (GO:0060305)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060304	regulation of phosphatidylinositol dephosphorylation (GO:0060304)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902635	1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process (GO:1902635)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060302	negative regulation of cytokine activity (GO:0060302)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902633	1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process (GO:1902633)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060301	positive regulation of cytokine activity (GO:0060301)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902632	positive regulation of membrane hyperpolarization (GO:1902632)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902631	negative regulation of membrane hyperpolarization (GO:1902631)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902630	regulation of membrane hyperpolarization (GO:1902630)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006876	cellular cadmium ion homeostasis (GO:0006876)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034059	response to anoxia (GO:0034059)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034058	endosomal vesicle fusion (GO:0034058)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0071896	protein localization to adherens junction (GO:0071896)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902629	regulation of mRNA stability involved in cellular response to UV (GO:1902629)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071894	histone H2B conserved C-terminal lysine ubiquitination (GO:0071894)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071893	BMP signaling pathway involved in nephric duct formation (GO:0071893)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902626	assembly of large subunit precursor of preribosome (GO:1902626)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034050	programmed cell death induced by symbiont (GO:0034050)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006868	glutamine transport (GO:0006868)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0006867	asparagine transport (GO:0006867)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006864	pyrimidine nucleotide transport (GO:0006864)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046013	regulation of T cell homeostatic proliferation (GO:0046013)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046010	positive regulation of circadian sleep/wake cycle, non-REM sleep (GO:0046010)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071888	macrophage apoptotic process (GO:0071888)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0110135	Norrin signaling pathway (GO:0110135)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902618	cellular response to fluoride (GO:1902618)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902617	response to fluoride (GO:1902617)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902616	acyl carnitine transmembrane transport (GO:1902616)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902613	negative regulation of anti-Mullerian hormone signaling pathway (GO:1902613)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902612	regulation of anti-Mullerian hormone signaling pathway (GO:1902612)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006858	extracellular transport (GO:0006858)	45	0	2.64	-	 < 0.01	1.79E-01	7.17E-01
GO:0006857	oligopeptide transport (GO:0006857)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0006853	carnitine shuttle (GO:0006853)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006850	mitochondrial pyruvate transmembrane transport (GO:0006850)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046007	negative regulation of activated T cell proliferation (GO:0046007)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0046005	positive regulation of circadian sleep/wake cycle, REM sleep (GO:0046005)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002491	antigen processing and presentation of endogenous peptide antigen via MHC class II (GO:0002491)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071879	positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071879)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034036	purine ribonucleoside bisphosphate biosynthetic process (GO:0034036)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034034	purine nucleoside bisphosphate catabolic process (GO:0034034)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1902608	positive regulation of large conductance calcium-activated potassium channel activity (GO:1902608)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902607	negative regulation of large conductance calcium-activated potassium channel activity (GO:1902607)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071874	cellular response to norepinephrine stimulus (GO:0071874)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902606	regulation of large conductance calcium-activated potassium channel activity (GO:1902606)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034031	ribonucleoside bisphosphate catabolic process (GO:0034031)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0071873	response to norepinephrine (GO:0071873)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902605	heterotrimeric G-protein complex assembly (GO:1902605)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902603	carnitine transmembrane transport (GO:1902603)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006848	pyruvate transport (GO:0006848)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006844	acyl carnitine transport (GO:0006844)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006843	mitochondrial citrate transmembrane transport (GO:0006843)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006842	tricarboxylic acid transport (GO:0006842)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002489	antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent (GO:0002489)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002488	antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway (GO:0002488)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002485	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent (GO:0002485)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002481	antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent (GO:0002481)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002480	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110114	negative regulation of lipid transporter activity (GO:0110114)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071866	negative regulation of apoptotic process in bone marrow cell (GO:0071866)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0110113	positive regulation of lipid transporter activity (GO:0110113)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071865	regulation of apoptotic process in bone marrow cell (GO:0071865)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0110112	regulation of lipid transporter activity (GO:0110112)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071864	positive regulation of cell proliferation in bone marrow (GO:0071864)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0110111	negative regulation of animal organ morphogenesis (GO:0110111)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034021	response to silicon dioxide (GO:0034021)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071863	regulation of cell proliferation in bone marrow (GO:0071863)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002479	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002477	antigen processing and presentation of exogenous peptide antigen via MHC class Ib (GO:0002477)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010085	polarity specification of proximal/distal axis (GO:0010085)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002470	plasmacytoid dendritic cell antigen processing and presentation (GO:0002470)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110104	mRNA alternative polyadenylation (GO:0110104)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034014	response to triglyceride (GO:0034014)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006824	cobalt ion transport (GO:0006824)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002469	myeloid dendritic cell antigen processing and presentation (GO:0002469)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002468	dendritic cell antigen processing and presentation (GO:0002468)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002465	peripheral tolerance induction (GO:0002465)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002461	tolerance induction dependent upon immune response (GO:0002461)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010070	zygote asymmetric cell division (GO:0010070)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071848	positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling (GO:0071848)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071847	TNFSF11-mediated signaling pathway (GO:0071847)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002458	peripheral T cell tolerance induction (GO:0002458)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002457	T cell antigen processing and presentation (GO:0002457)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002456	T cell mediated immunity (GO:0002456)	35	0	2.06	-	 < 0.01	2.62E-01	8.52E-01
GO:0002451	peripheral B cell tolerance induction (GO:0002451)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071839	apoptotic process in bone marrow cell (GO:0071839)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071838	cell proliferation in bone marrow (GO:0071838)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045591	positive regulation of regulatory T cell differentiation (GO:0045591)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0045590	negative regulation of regulatory T cell differentiation (GO:0045590)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0071831	intermediate-density lipoprotein particle clearance (GO:0071831)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0022027	interkinetic nuclear migration (GO:0022027)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2001294	malonyl-CoA catabolic process (GO:2001294)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002447	eosinophil mediated immunity (GO:0002447)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002445	type II hypersensitivity (GO:0002445)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002441	histamine secretion involved in inflammatory response (GO:0002441)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0045585	positive regulation of cytotoxic T cell differentiation (GO:0045585)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045584	negative regulation of cytotoxic T cell differentiation (GO:0045584)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045583	regulation of cytotoxic T cell differentiation (GO:0045583)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0022018	lateral ganglionic eminence cell proliferation (GO:0022018)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001288	positive regulation of caveolin-mediated endocytosis (GO:2001288)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0022013	pallium cell proliferation in forebrain (GO:0022013)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001287	negative regulation of caveolin-mediated endocytosis (GO:2001287)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0022012	subpallium cell proliferation in forebrain (GO:0022012)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001286	regulation of caveolin-mediated endocytosis (GO:2001286)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002439	chronic inflammatory response to antigenic stimulus (GO:0002439)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010046	response to mycotoxin (GO:0010046)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001280	positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0002436	immune complex clearance by monocytes and macrophages (GO:0002436)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010045	response to nickel cation (GO:0010045)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002435	immune complex clearance by erythrocytes (GO:0002435)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002433	immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0002432	granuloma formation (GO:0002432)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010041	response to iron(III) ion (GO:0010041)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002430	complement receptor mediated signaling pathway (GO:0002430)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0045575	basophil activation (GO:0045575)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071816	tail-anchored membrane protein insertion into ER membrane (GO:0071816)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0071812	positive regulation of fever generation by positive regulation of prostaglandin secretion (GO:0071812)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0022009	central nervous system vasculogenesis (GO:0022009)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0022007	convergent extension involved in neural plate elongation (GO:0022007)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001279	regulation of unsaturated fatty acid biosynthetic process (GO:2001279)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0022004	midbrain-hindbrain boundary maturation during brain development (GO:0022004)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001272	positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001272)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001271	negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001270	regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002424	T cell mediated immune response to tumor cell (GO:0002424)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002423	natural killer cell mediated immune response to tumor cell (GO:0002423)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002420	natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002420)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071803	positive regulation of podosome assembly (GO:0071803)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0033595	response to genistein (GO:0033595)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033594	response to hydroxyisoflavone (GO:0033594)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001268	negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0033591	response to L-ascorbic acid (GO:0033591)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2001264	negative regulation of C-C chemokine binding (GO:2001264)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001263	regulation of C-C chemokine binding (GO:2001263)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002419	T cell mediated cytotoxicity directed against tumor cell target (GO:0002419)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002418	immune response to tumor cell (GO:0002418)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002416	IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor (GO:0002416)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010025	wax biosynthetic process (GO:0010025)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002415	immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor (GO:0002415)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002414	immunoglobulin transcytosis in epithelial cells (GO:0002414)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002412	antigen transcytosis by M cells in mucosal-associated lymphoid tissue (GO:0002412)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001256	regulation of store-operated calcium entry (GO:2001256)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:2001255	positive regulation of histone H3-K36 trimethylation (GO:2001255)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001253	regulation of histone H3-K36 trimethylation (GO:2001253)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002408	myeloid dendritic cell chemotaxis (GO:0002408)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001250	positive regulation of ammonia assimilation cycle (GO:2001250)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002406	antigen sampling by M cells in mucosal-associated lymphoid tissue (GO:0002406)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002404	antigen sampling in mucosal-associated lymphoid tissue (GO:0002404)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903094	negative regulation of protein K48-linked deubiquitination (GO:1903094)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903093	regulation of protein K48-linked deubiquitination (GO:1903093)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045542	positive regulation of cholesterol biosynthetic process (GO:0045542)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0045541	negative regulation of cholesterol biosynthetic process (GO:0045541)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2001248	regulation of ammonia assimilation cycle (GO:2001248)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001247	positive regulation of phosphatidylcholine biosynthetic process (GO:2001247)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001246	negative regulation of phosphatidylcholine biosynthetic process (GO:2001246)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001245	regulation of phosphatidylcholine biosynthetic process (GO:2001245)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019293	tyrosine biosynthetic process, by oxidation of phenylalanine (GO:0019293)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019290	siderophore biosynthetic process (GO:0019290)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903082	positive regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903082)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903080	regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903080)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033566	gamma-tubulin complex localization (GO:0033566)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033563	dorsal/ventral axon guidance (GO:0033563)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021599	abducens nerve formation (GO:0021599)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021598	abducens nerve morphogenesis (GO:0021598)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021592	fourth ventricle development (GO:0021592)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019287	isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021590	cerebellum maturation (GO:0021590)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019284	L-methionine salvage from S-adenosylmethionine (GO:0019284)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903073	negative regulation of death-inducing signaling complex assembly (GO:1903073)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903072	regulation of death-inducing signaling complex assembly (GO:1903072)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903070	negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001228	regulation of response to gamma radiation (GO:2001228)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001226	negative regulation of chloride transport (GO:2001226)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021589	cerebellum structural organization (GO:0021589)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021588	cerebellum formation (GO:0021588)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021586	pons maturation (GO:0021586)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903064	positive regulation of reverse cholesterol transport (GO:1903064)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903062	regulation of reverse cholesterol transport (GO:1903062)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903061	positive regulation of protein lipidation (GO:1903061)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903060	negative regulation of protein lipidation (GO:1903060)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021578	hindbrain maturation (GO:0021578)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0021577	hindbrain structural organization (GO:0021577)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001213	negative regulation of vasculogenesis (GO:2001213)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021576	hindbrain formation (GO:0021576)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021572	rhombomere 6 development (GO:0021572)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021570	rhombomere 4 development (GO:0021570)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903059	regulation of protein lipidation (GO:1903059)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0019265	glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001998	angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001998)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019264	glycine biosynthetic process from serine (GO:0019264)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001997	positive regulation of the force of heart contraction by epinephrine-norepinephrine (GO:0001997)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019262	N-acetylneuraminate catabolic process (GO:0019262)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0001994	norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001992	regulation of systemic arterial blood pressure by vasopressin (GO:0001992)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0007291	sperm individualization (GO:0007291)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007290	spermatid nucleus elongation (GO:0007290)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2001206	positive regulation of osteoclast development (GO:2001206)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2001205	negative regulation of osteoclast development (GO:2001205)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0021568	rhombomere 2 development (GO:0021568)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001204	regulation of osteoclast development (GO:2001204)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0021564	vagus nerve development (GO:0021564)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001200	positive regulation of dendritic cell differentiation (GO:2001200)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021563	glossopharyngeal nerve development (GO:0021563)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0021562	vestibulocochlear nerve development (GO:0021562)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0021560	abducens nerve development (GO:0021560)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903049	negative regulation of acetylcholine-gated cation channel activity (GO:1903049)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903048	regulation of acetylcholine-gated cation channel activity (GO:1903048)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019255	glucose 1-phosphate metabolic process (GO:0019255)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019254	carnitine metabolic process, CoA-linked (GO:0019254)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0001985	negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001985)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903043	positive regulation of chondrocyte hypertrophy (GO:1903043)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001984	artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001984)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001983	baroreceptor response to increased systemic arterial blood pressure (GO:0001983)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007289	spermatid nucleus differentiation (GO:0007289)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:1903041	regulation of chondrocyte hypertrophy (GO:1903041)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007288	sperm axoneme assembly (GO:0007288)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0001980	regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033523	histone H2B ubiquitination (GO:0033523)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0021559	trigeminal nerve development (GO:0021559)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0021558	trochlear nerve development (GO:0021558)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021557	oculomotor nerve development (GO:0021557)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021556	central nervous system formation (GO:0021556)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021555	midbrain-hindbrain boundary morphogenesis (GO:0021555)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021551	central nervous system morphogenesis (GO:0021551)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021550	medulla oblongata development (GO:0021550)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0001979	regulation of systemic arterial blood pressure by chemoreceptor signaling (GO:0001979)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001978	regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback (GO:0001978)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019244	lactate biosynthetic process from pyruvate (GO:0019244)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019242	methylglyoxal biosynthetic process (GO:0019242)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019240	citrulline biosynthetic process (GO:0019240)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0001971	negative regulation of activation of membrane attack complex (GO:0001971)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007270	neuron-neuron synaptic transmission (GO:0007270)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0033514	L-lysine catabolic process to acetyl-CoA via L-pipecolate (GO:0033514)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033512	L-lysine catabolic process to acetyl-CoA via saccharopine (GO:0033512)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021547	midbrain-hindbrain boundary initiation (GO:0021547)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072298	regulation of metanephric glomerulus development (GO:0072298)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021540	corpus callosum morphogenesis (GO:0021540)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019236	response to pheromone (GO:0019236)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1903026	negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903025	regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0001966	thigmotaxis (GO:0001966)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019230	proprioception (GO:0019230)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0033505	floor plate morphogenesis (GO:0033505)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021539	subthalamus development (GO:0021539)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072289	metanephric nephron tubule formation (GO:0072289)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021530	spinal cord oligodendrocyte cell fate specification (GO:0021530)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072287	metanephric distal tubule morphogenesis (GO:0072287)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072286	metanephric connecting tubule development (GO:0072286)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140766	siRNA-mediated gene silencing (GO:0140766)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072285	mesenchymal to epithelial transition involved in metanephric renal vesicle formation (GO:0072285)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903017	positive regulation of exo-alpha-sialidase activity (GO:1903017)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072284	metanephric S-shaped body morphogenesis (GO:0072284)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072282	metanephric nephron tubule morphogenesis (GO:0072282)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1903012	positive regulation of bone development (GO:1903012)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0007258	JUN phosphorylation (GO:0007258)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001951	intestinal D-glucose absorption (GO:0001951)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0007253	cytoplasmic sequestering of NF-kappaB (GO:0007253)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0007252	I-kappaB phosphorylation (GO:0007252)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0021529	spinal cord oligodendrocyte cell differentiation (GO:0021529)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0021528	commissural neuron differentiation in spinal cord (GO:0021528)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021527	spinal cord association neuron differentiation (GO:0021527)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0021526	medial motor column neuron differentiation (GO:0021526)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021524	visceral motor neuron differentiation (GO:0021524)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000798	negative regulation of amniotic stem cell differentiation (GO:2000798)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021523	somatic motor neuron differentiation (GO:0021523)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000797	regulation of amniotic stem cell differentiation (GO:2000797)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021521	ventral spinal cord interneuron specification (GO:0021521)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0072278	metanephric comma-shaped body morphogenesis (GO:0072278)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021520	spinal cord motor neuron cell fate specification (GO:0021520)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:2000793	cell proliferation involved in heart valve development (GO:2000793)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903007	positive regulation of Lys63-specific deubiquitinase activity (GO:1903007)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072274	metanephric glomerular basement membrane development (GO:0072274)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140754	reorganization of cellular membranes to establish viral sites of replication (GO:0140754)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903006	positive regulation of protein K63-linked deubiquitination (GO:1903006)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001946	lymphangiogenesis (GO:0001946)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0072272	proximal/distal pattern formation involved in metanephric nephron development (GO:0072272)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903004	regulation of protein K63-linked deubiquitination (GO:1903004)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903003	positive regulation of protein deubiquitination (GO:1903003)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903002	positive regulation of lipid transport across blood-brain barrier (GO:1903002)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903001	negative regulation of lipid transport across blood-brain barrier (GO:1903001)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903000	regulation of lipid transport across blood-brain barrier (GO:1903000)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0052697	xenobiotic glucuronidation (GO:0052697)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0052696	flavonoid glucuronidation (GO:0052696)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0052695	cellular glucuronidation (GO:0052695)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0021514	ventral spinal cord interneuron differentiation (GO:0021514)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0021513	spinal cord dorsal/ventral patterning (GO:0021513)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0021512	spinal cord anterior/posterior patterning (GO:0021512)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000786	positive regulation of autophagosome assembly (GO:2000786)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0072268	pattern specification involved in metanephros development (GO:0072268)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0072267	metanephric capsule specification (GO:0072267)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140747	regulation of ncRNA transcription (GO:0140747)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0072266	metanephric capsule formation (GO:0072266)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072265	metanephric capsule morphogenesis (GO:0072265)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140745	siRNA transcription (GO:0140745)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140744	negative regulation of lncRNA transcription (GO:0140744)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0140743	regulation of lncRNA transcription (GO:0140743)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072262	metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060299	negative regulation of sarcomere organization (GO:0060299)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060298	positive regulation of sarcomere organization (GO:0060298)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060297	regulation of sarcomere organization (GO:0060297)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060296	regulation of cilium beat frequency involved in ciliary motility (GO:0060296)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0021509	roof plate formation (GO:0021509)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021508	floor plate formation (GO:0021508)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021503	neural fold bending (GO:0021503)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000777	positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072259	metanephric interstitial fibroblast development (GO:0072259)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140739	NLRP6 inflammasome complex assembly (GO:0140739)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021501	prechordal plate formation (GO:0021501)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072258	metanephric interstitial fibroblast differentiation (GO:0072258)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000774	positive regulation of cellular senescence (GO:2000774)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0072255	metanephric glomerular mesangial cell development (GO:0072255)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001928	regulation of exocyst assembly (GO:0001928)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000771	positive regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000771)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001923	B-1 B cell differentiation (GO:0001923)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0001922	B-1 B cell homeostasis (GO:0001922)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0007228	positive regulation of hh target transcription factor activity (GO:0007228)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0007227	signal transduction downstream of smoothened (GO:0007227)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060287	epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0001920	negative regulation of receptor recycling (GO:0001920)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0007223	Wnt signaling pathway, calcium modulating pathway (GO:0007223)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0007221	positive regulation of transcription of Notch receptor target (GO:0007221)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0007220	Notch receptor processing (GO:0007220)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0060280	negative regulation of ovulation (GO:0060280)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000769	regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000768	positive regulation of nephron tubule epithelial cell differentiation (GO:2000768)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000767	positive regulation of cytoplasmic translation (GO:2000767)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0072249	metanephric podocyte development (GO:0072249)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072248	metanephric podocyte differentiation (GO:0072248)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072244	metanephric glomerular epithelium development (GO:0072244)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072240	metanephric DCT cell differentiation (GO:0072240)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001913	T cell mediated cytotoxicity (GO:0001913)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:2000755	positive regulation of sphingomyelin catabolic process (GO:2000755)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000754	regulation of sphingomyelin catabolic process (GO:2000754)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000753	positive regulation of glucosylceramide catabolic process (GO:2000753)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072235	metanephric distal tubule development (GO:0072235)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000752	regulation of glucosylceramide catabolic process (GO:2000752)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072233	metanephric thick ascending limb development (GO:0072233)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007208	phospholipase C-activating serotonin receptor signaling pathway (GO:0007208)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060268	negative regulation of respiratory burst (GO:0060268)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0007207	phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway (GO:0007207)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060267	positive regulation of respiratory burst (GO:0060267)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0007206	phospholipase C-activating G protein-coupled glutamate receptor signaling pathway (GO:0007206)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060266	negative regulation of respiratory burst involved in inflammatory response (GO:0060266)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060265	positive regulation of respiratory burst involved in inflammatory response (GO:0060265)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060264	regulation of respiratory burst involved in inflammatory response (GO:0060264)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060263	regulation of respiratory burst (GO:0060263)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0060262	negative regulation of N-terminal protein palmitoylation (GO:0060262)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140708	CAT tailing (GO:0140708)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072227	metanephric macula densa development (GO:0072227)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000744	positive regulation of anterior head development (GO:2000744)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0140706	protein-containing complex localization to centriolar satellite (GO:0140706)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000742	regulation of anterior head development (GO:2000742)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000741	positive regulation of mesenchymal stem cell differentiation (GO:2000741)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000740	negative regulation of mesenchymal stem cell differentiation (GO:2000740)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072221	metanephric distal convoluted tubule development (GO:0072221)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0052646	alditol phosphate metabolic process (GO:0052646)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0060254	regulation of N-terminal protein palmitoylation (GO:0060254)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072219	metanephric cortical collecting duct development (GO:0072219)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072218	metanephric ascending thin limb development (GO:0072218)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0072217	negative regulation of metanephros development (GO:0072217)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000734	negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000734)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072216	positive regulation of metanephros development (GO:0072216)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000733	regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000733)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072215	regulation of metanephros development (GO:0072215)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0072214	metanephric cortex development (GO:0072214)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110099	negative regulation of calcium import into the mitochondrion (GO:0110099)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072213	metanephric capsule development (GO:0072213)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000730	regulation of termination of RNA polymerase I transcription (GO:2000730)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110097	regulation of calcium import into the mitochondrion (GO:0110097)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0110096	cellular response to aldehyde (GO:0110096)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0110095	cellular detoxification of aldehyde (GO:0110095)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1902576	negative regulation of nuclear cell cycle DNA replication (GO:1902576)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110090	positive regulation of hippocampal neuron apoptotic process (GO:0110090)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060243	negative regulation of cell growth involved in contact inhibition (GO:0060243)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902573	positive regulation of serine-type peptidase activity (GO:1902573)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902572	negative regulation of serine-type peptidase activity (GO:1902572)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1902571	regulation of serine-type peptidase activity (GO:1902571)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1902570	protein localization to nucleolus (GO:1902570)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0072208	metanephric smooth muscle tissue development (GO:0072208)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000724	positive regulation of cardiac vascular smooth muscle cell differentiation (GO:2000724)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072206	metanephric juxtaglomerular apparatus development (GO:0072206)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000723	negative regulation of cardiac vascular smooth muscle cell differentiation (GO:2000723)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072205	metanephric collecting duct development (GO:0072205)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:2000722	regulation of cardiac vascular smooth muscle cell differentiation (GO:2000722)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072204	cell-cell signaling involved in metanephros development (GO:0072204)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072203	cell proliferation involved in metanephros development (GO:0072203)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0110088	hippocampal neuron apoptotic process (GO:0110088)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072200	negative regulation of mesenchymal cell proliferation involved in ureter development (GO:0072200)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902569	negative regulation of activation of Janus kinase activity (GO:1902569)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902568	positive regulation of eosinophil activation (GO:1902568)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902567	negative regulation of eosinophil activation (GO:1902567)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902566	regulation of eosinophil activation (GO:1902566)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060235	lens induction in camera-type eye (GO:0060235)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902565	positive regulation of neutrophil activation (GO:1902565)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060234	neuroblast delamination (GO:0060234)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902564	negative regulation of neutrophil activation (GO:1902564)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000719	negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000719)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000718	regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000718)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110076	negative regulation of ferroptosis (GO:0110076)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0110075	regulation of ferroptosis (GO:0110075)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902559	3'-phospho-5'-adenylyl sulfate transmembrane transport (GO:1902559)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902553	positive regulation of catalase activity (GO:1902553)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902551	regulation of catalase activity (GO:1902551)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060220	camera-type eye photoreceptor cell fate commitment (GO:0060220)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006797	polyphosphate metabolic process (GO:0006797)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000707	positive regulation of dense core granule biogenesis (GO:2000707)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000706	negative regulation of dense core granule biogenesis (GO:2000706)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000705	regulation of dense core granule biogenesis (GO:2000705)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000703	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000703)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000702	regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000702)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110064	lncRNA catabolic process (GO:0110064)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0110061	regulation of angiotensin-activated signaling pathway (GO:0110061)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902546	positive regulation of DNA N-glycosylase activity (GO:1902546)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060215	primitive hemopoiesis (GO:0060215)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1902544	regulation of DNA N-glycosylase activity (GO:1902544)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060212	negative regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060212)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006789	bilirubin conjugation (GO:0006789)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006788	heme oxidation (GO:0006788)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006787	porphyrin-containing compound catabolic process (GO:0006787)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0006784	heme A biosynthetic process (GO:0006784)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006783	heme biosynthetic process (GO:0006783)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0006782	protoporphyrinogen IX biosynthetic process (GO:0006782)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0006781	succinyl-CoA pathway (GO:0006781)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006780	uroporphyrinogen III biosynthetic process (GO:0006780)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0110059	negative regulation of blood vessel endothelial cell differentiation (GO:0110059)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110057	regulation of blood vessel endothelial cell differentiation (GO:0110057)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110051	metabolite repair (GO:0110051)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006779	porphyrin-containing compound biosynthetic process (GO:0006779)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:0006778	porphyrin-containing compound metabolic process (GO:0006778)	48	0	2.82	-	 < 0.01	1.13E-01	5.60E-01
GO:1902530	positive regulation of protein linear polyubiquitination (GO:1902530)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006777	Mo-molybdopterin cofactor biosynthetic process (GO:0006777)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006772	thiamine metabolic process (GO:0006772)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006771	riboflavin metabolic process (GO:0006771)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902528	regulation of protein linear polyubiquitination (GO:1902528)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902527	positive regulation of protein monoubiquitination (GO:1902527)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902525	regulation of protein monoubiquitination (GO:1902525)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902524	positive regulation of protein K48-linked ubiquitination (GO:1902524)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902523	positive regulation of protein K63-linked ubiquitination (GO:1902523)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006769	nicotinamide metabolic process (GO:0006769)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006768	biotin metabolic process (GO:0006768)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071788	endoplasmic reticulum tubular network maintenance (GO:0071788)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071787	endoplasmic reticulum tubular network formation (GO:0071787)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902511	negative regulation of apoptotic DNA fragmentation (GO:1902511)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006757	ATP generation from ADP (GO:0006757)	43	0	2.52	-	 < 0.01	1.74E-01	7.00E-01
GO:0006756	AMP phosphorylation (GO:0006756)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002399	MHC class II protein complex assembly (GO:0002399)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0002398	MHC class Ib protein complex assembly (GO:0002398)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002397	MHC class I protein complex assembly (GO:0002397)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002396	MHC protein complex assembly (GO:0002396)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0002395	immune response in nasopharyngeal-associated lymphoid tissue (GO:0002395)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0110026	regulation of DNA strand resection involved in replication fork processing (GO:0110026)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006747	FAD biosynthetic process (GO:0006747)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006744	ubiquinone biosynthetic process (GO:0006744)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0006743	ubiquinone metabolic process (GO:0006743)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0006742	NADP catabolic process (GO:0006742)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006741	NADP biosynthetic process (GO:0006741)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006740	NADPH regeneration (GO:0006740)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0002387	immune response in gut-associated lymphoid tissue (GO:0002387)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002385	mucosal immune response (GO:0002385)	32	0	1.88	-	 < 0.01	2.60E-01	8.49E-01
GO:0002383	immune response in brain or nervous system (GO:0002383)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110017	cap-independent translational initiation of linear mRNA (GO:0110017)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071765	nuclear inner membrane organization (GO:0071765)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110012	protein localization to P-body (GO:0110012)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110010	basolateral protein secretion (GO:0110010)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006739	NADP metabolic process (GO:0006739)	37	0	2.17	-	 < 0.01	2.68E-01	8.58E-01
GO:0006738	nicotinamide riboside catabolic process (GO:0006738)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006735	NADH regeneration (GO:0006735)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0006734	NADH metabolic process (GO:0006734)	34	0	2.00	-	 < 0.01	2.61E-01	8.49E-01
GO:0002373	plasmacytoid dendritic cell cytokine production (GO:0002373)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002371	dendritic cell cytokine production (GO:0002371)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0110009	formin-nucleated actin cable organization (GO:0110009)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0110008	ncRNA deadenylation (GO:0110008)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006729	tetrahydrobiopterin biosynthetic process (GO:0006729)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006726	eye pigment biosynthetic process (GO:0006726)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006722	triterpenoid metabolic process (GO:0006722)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002367	cytokine production involved in immune response (GO:0002367)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006714	sesquiterpenoid metabolic process (GO:0006714)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006713	glucocorticoid catabolic process (GO:0006713)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006711	estrogen catabolic process (GO:0006711)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002358	B cell homeostatic proliferation (GO:0002358)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002355	detection of tumor cell (GO:0002355)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002352	B cell negative selection (GO:0002352)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001199	negative regulation of dendritic cell differentiation (GO:2001199)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2001198	regulation of dendritic cell differentiation (GO:2001198)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0006703	estrogen biosynthetic process (GO:0006703)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0006701	progesterone biosynthetic process (GO:0006701)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2001193	positive regulation of gamma-delta T cell activation involved in immune response (GO:2001193)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002349	histamine production involved in inflammatory response (GO:0002349)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2001191	regulation of gamma-delta T cell activation involved in immune response (GO:2001191)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001190	positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001190)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002344	B cell affinity maturation (GO:0002344)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002343	peripheral B cell selection (GO:0002343)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071727	cellular response to triacyl bacterial lipopeptide (GO:0071727)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071726	cellular response to diacyl bacterial lipopeptide (GO:0071726)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071725	response to triacyl bacterial lipopeptide (GO:0071725)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071724	response to diacyl bacterial lipopeptide (GO:0071724)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2001189	negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001189)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2001188	regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2001186	negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002339	B cell selection (GO:0002339)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002337	B-1a B cell differentiation (GO:0002337)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002336	B-1 B cell lineage commitment (GO:0002336)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002334	transitional two stage B cell differentiation (GO:0002334)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002333	transitional one stage B cell differentiation (GO:0002333)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002332	transitional stage B cell differentiation (GO:0002332)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002331	pre-B cell allelic exclusion (GO:0002331)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071716	leukotriene transport (GO:0071716)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0071712	ER-associated misfolded protein catabolic process (GO:0071712)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:2001178	positive regulation of mediator complex assembly (GO:2001178)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001176	regulation of mediator complex assembly (GO:2001176)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002329	pre-B cell differentiation (GO:0002329)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002323	natural killer cell activation involved in immune response (GO:0002323)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0002322	B cell proliferation involved in immune response (GO:0002322)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0071707	immunoglobulin heavy chain V-D-J recombination (GO:0071707)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033499	galactose catabolic process via UDP-galactose (GO:0033499)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071701	regulation of MAPK export from nucleus (GO:0071701)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001165	positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001165)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001163	regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001163)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002319	memory B cell differentiation (GO:0002319)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001162	positive regulation of histone H3-K79 methylation (GO:2001162)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001161	negative regulation of histone H3-K79 methylation (GO:2001161)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001160	regulation of histone H3-K79 methylation (GO:2001160)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002316	follicular B cell differentiation (GO:0002316)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002315	marginal zone B cell differentiation (GO:0002315)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0045454	cell redox homeostasis (GO:0045454)	42	0	2.47	-	 < 0.01	1.72E-01	6.99E-01
GO:2001153	positive regulation of renal water transport (GO:2001153)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002309	T cell proliferation involved in immune response (GO:0002309)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2001151	regulation of renal water transport (GO:2001151)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002305	CD8-positive, gamma-delta intraepithelial T cell differentiation (GO:0002305)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002304	gamma-delta intraepithelial T cell differentiation (GO:0002304)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002302	CD8-positive, alpha-beta T cell differentiation involved in immune response (GO:0002302)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002300	CD8-positive, alpha-beta intraepithelial T cell differentiation (GO:0002300)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001145	negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001144	regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001142	nicotinate transport (GO:2001142)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001139	negative regulation of phospholipid transport (GO:2001139)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001136	negative regulation of endocytic recycling (GO:2001136)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0065002	intracellular protein transmembrane transport (GO:0065002)	53	0	3.11	-	 < 0.01	1.20E-01	5.88E-01
GO:0065001	specification of axis polarity (GO:0065001)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2001125	negative regulation of translational frameshifting (GO:2001125)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001124	regulation of translational frameshifting (GO:2001124)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001114	positive regulation of cellular response to hepatocyte growth factor stimulus (GO:2001114)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001111	positive regulation of lens epithelial cell proliferation (GO:2001111)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007199	G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007198	adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0007197	adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:2001109	regulation of lens epithelial cell proliferation (GO:2001109)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001108	positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001107	negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001106	regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001887	selenium compound metabolic process (GO:0001887)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001881	receptor recycling (GO:0001881)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0001880	Mullerian duct regression (GO:0001880)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0007183	SMAD protein complex assembly (GO:0007183)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0001879	detection of yeast (GO:0001879)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007175	negative regulation of epidermal growth factor-activated receptor activity (GO:0007175)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0007174	epidermal growth factor catabolic process (GO:0007174)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072197	ureter morphogenesis (GO:0072197)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0072194	kidney smooth muscle tissue development (GO:0072194)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001866	NK T cell proliferation (GO:0001866)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072192	ureter epithelial cell differentiation (GO:0072192)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072190	ureter urothelium development (GO:0072190)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0007161	calcium-independent cell-matrix adhesion (GO:0007161)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0140668	positive regulation of oxytocin production (GO:0140668)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072186	metanephric cap morphogenesis (GO:0072186)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140667	regulation of oxytocin production (GO:0140667)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072185	metanephric cap development (GO:0072185)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072184	renal vesicle progenitor cell differentiation (GO:0072184)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072183	negative regulation of nephron tubule epithelial cell differentiation (GO:0072183)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072181	mesonephric duct formation (GO:0072181)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072180	mesonephric duct morphogenesis (GO:0072180)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000698	positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000697	negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0072179	nephric duct formation (GO:0072179)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072177	mesonephric duct development (GO:0072177)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0072174	metanephric tubule formation (GO:0072174)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000691	negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072173	metanephric tubule morphogenesis (GO:0072173)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:2000690	regulation of cardiac muscle cell myoblast differentiation (GO:2000690)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001844	protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0140650	radial glia-guided pyramidal neuron migration (GO:0140650)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0007147	female meiosis II (GO:0007147)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001840	neural plate development (GO:0001840)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:2000689	actomyosin contractile ring assembly actin filament organization (GO:2000689)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072169	specification of posterior mesonephric tubule identity (GO:0072169)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072168	specification of anterior mesonephric tubule identity (GO:0072168)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072167	specification of mesonephric tubule identity (GO:0072167)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072166	posterior mesonephric tubule development (GO:0072166)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0140647	P450-containing electron transport chain (GO:0140647)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000683	regulation of cellular response to X-ray (GO:2000683)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001839	neural plate morphogenesis (GO:0001839)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0072165	anterior mesonephric tubule development (GO:0072165)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019102	male somatic sex determination (GO:0019102)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019101	female somatic sex determination (GO:0019101)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001834	trophectodermal cell proliferation (GO:0001834)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019100	male germ-line sex determination (GO:0019100)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001831	trophectodermal cellular morphogenesis (GO:0001831)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060197	cloacal septation (GO:0060197)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0001830	trophectodermal cell fate commitment (GO:0001830)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000675	negative regulation of type B pancreatic cell apoptotic process (GO:2000675)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0072156	distal tubule morphogenesis (GO:0072156)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000673	positive regulation of motor neuron apoptotic process (GO:2000673)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001827	inner cell mass cell fate commitment (GO:0001827)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000670	positive regulation of dendritic cell apoptotic process (GO:2000670)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0140633	CARD8 inflammasome complex assembly (GO:0140633)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001821	histamine secretion (GO:0001821)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060184	cell cycle switching (GO:0060184)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060183	apelin receptor signaling pathway (GO:0060183)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072148	epithelial cell fate commitment (GO:0072148)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:2000661	positive regulation of interleukin-1-mediated signaling pathway (GO:2000661)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001815	positive regulation of antibody-dependent cellular cytotoxicity (GO:0001815)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072141	renal interstitial fibroblast development (GO:0072141)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001814	negative regulation of antibody-dependent cellular cytotoxicity (GO:0001814)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001813	regulation of antibody-dependent cellular cytotoxicity (GO:0001813)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060179	male mating behavior (GO:0060179)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0001812	positive regulation of type I hypersensitivity (GO:0001812)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060178	regulation of exocyst localization (GO:0060178)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001811	negative regulation of type I hypersensitivity (GO:0001811)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060177	regulation of angiotensin metabolic process (GO:0060177)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001810	regulation of type I hypersensitivity (GO:0001810)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007113	endomitotic cell cycle (GO:0007113)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0007112	male meiosis cytokinesis (GO:0007112)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032988	ribonucleoprotein complex disassembly (GO:0032988)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0032981	mitochondrial respiratory chain complex I assembly (GO:0032981)	60	0	3.52	-	 < 0.01	7.99E-02	5.00E-01
GO:2000657	negative regulation of apolipoprotein binding (GO:2000657)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032980	keratinocyte activation (GO:0032980)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072139	glomerular parietal epithelial cell differentiation (GO:0072139)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000656	regulation of apolipoprotein binding (GO:2000656)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072138	mesenchymal cell proliferation involved in ureteric bud development (GO:0072138)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000655	negative regulation of cellular response to testosterone stimulus (GO:2000655)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000654	regulation of cellular response to testosterone stimulus (GO:2000654)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072136	metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000653	regulation of genetic imprinting (GO:2000653)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0001809	positive regulation of type IV hypersensitivity (GO:0001809)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072135	kidney mesenchymal cell proliferation (GO:0072135)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0001808	negative regulation of type IV hypersensitivity (GO:0001808)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072134	nephrogenic mesenchyme morphogenesis (GO:0072134)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001807	regulation of type IV hypersensitivity (GO:0001807)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072133	metanephric mesenchyme morphogenesis (GO:0072133)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0001806	type IV hypersensitivity (GO:0001806)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001805	positive regulation of type III hypersensitivity (GO:0001805)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072131	kidney mesenchyme morphogenesis (GO:0072131)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072130	renal capsule specification (GO:0072130)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001803	regulation of type III hypersensitivity (GO:0001803)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060169	negative regulation of adenosine receptor signaling pathway (GO:0060169)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060168	positive regulation of adenosine receptor signaling pathway (GO:0060168)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060167	regulation of adenosine receptor signaling pathway (GO:0060167)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902497	iron-sulfur cluster transmembrane transport (GO:1902497)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060166	olfactory pit development (GO:0060166)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060165	regulation of timing of subpallium neuron differentiation (GO:0060165)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060164	regulation of timing of neuron differentiation (GO:0060164)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060163	subpallium neuron fate commitment (GO:0060163)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902491	negative regulation of sperm capacitation (GO:1902491)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902490	regulation of sperm capacitation (GO:1902490)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032979	protein insertion into mitochondrial inner membrane from matrix (GO:0032979)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032978	protein insertion into membrane from inner side (GO:0032978)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032976	release of matrix enzymes from mitochondria (GO:0032976)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032974	amino acid transmembrane export from vacuole (GO:0032974)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072129	renal capsule formation (GO:0072129)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000646	positive regulation of receptor catabolic process (GO:2000646)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0072128	renal capsule morphogenesis (GO:0072128)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000645	negative regulation of receptor catabolic process (GO:2000645)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072127	renal capsule development (GO:0072127)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000644	regulation of receptor catabolic process (GO:2000644)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:2000643	positive regulation of early endosome to late endosome transport (GO:2000643)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0072125	negative regulation of glomerular mesangial cell proliferation (GO:0072125)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000642	negative regulation of early endosome to late endosome transport (GO:2000642)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000641	regulation of early endosome to late endosome transport (GO:2000641)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:2000640	positive regulation of SREBP signaling pathway (GO:2000640)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060155	platelet dense granule organization (GO:0060155)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:1902483	cytotoxic T cell pyroptotic process (GO:1902483)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060152	microtubule-based peroxisome localization (GO:0060152)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902482	regulatory T cell apoptotic process (GO:1902482)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060151	peroxisome localization (GO:0060151)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902480	protein localization to mitotic spindle (GO:1902480)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032964	collagen biosynthetic process (GO:0032964)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:2000639	negative regulation of SREBP signaling pathway (GO:2000639)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032962	positive regulation of inositol trisphosphate biosynthetic process (GO:0032962)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000638	regulation of SREBP signaling pathway (GO:2000638)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032960	regulation of inositol trisphosphate biosynthetic process (GO:0032960)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000633	positive regulation of pre-miRNA processing (GO:2000633)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000632	negative regulation of pre-miRNA processing (GO:2000632)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072114	pronephros morphogenesis (GO:0072114)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000631	regulation of pre-miRNA processing (GO:2000631)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902474	positive regulation of protein localization to synapse (GO:1902474)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032959	inositol trisphosphate biosynthetic process (GO:0032959)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000627	positive regulation of miRNA catabolic process (GO:2000627)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000626	negative regulation of miRNA catabolic process (GO:2000626)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072108	positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000625	regulation of miRNA catabolic process (GO:2000625)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000623	negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0072105	ureteric peristalsis (GO:0072105)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000622	regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0072101	specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway (GO:0072101)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072100	specification of ureteric bud anterior/posterior symmetry (GO:0072100)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060137	maternal process involved in parturition (GO:0060137)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902466	positive regulation of histone H3-K27 trimethylation (GO:1902466)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902465	negative regulation of histone H3-K27 trimethylation (GO:1902465)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902464	regulation of histone H3-K27 trimethylation (GO:1902464)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060133	somatotropin secreting cell development (GO:0060133)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902463	protein localization to cell leading edge (GO:1902463)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000619	negative regulation of histone H4-K16 acetylation (GO:2000619)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000616	negative regulation of histone H3-K9 acetylation (GO:2000616)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000612	regulation of thyroid-stimulating hormone secretion (GO:2000612)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000611	positive regulation of thyroid hormone generation (GO:2000611)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060125	negative regulation of growth hormone secretion (GO:0060125)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060124	positive regulation of growth hormone secretion (GO:0060124)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0060123	regulation of growth hormone secretion (GO:0060123)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0060121	vestibular receptor cell stereocilium organization (GO:0060121)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060120	inner ear receptor cell fate commitment (GO:0060120)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032938	negative regulation of translation in response to oxidative stress (GO:0032938)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032933	SREBP signaling pathway (GO:0032933)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:2000609	regulation of thyroid hormone generation (GO:2000609)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000607	negative regulation of cell proliferation involved in mesonephros development (GO:2000607)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032930	positive regulation of superoxide anion generation (GO:0032930)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:2000606	regulation of cell proliferation involved in mesonephros development (GO:2000606)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000601	positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0060118	vestibular receptor cell development (GO:0060118)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060117	auditory receptor cell development (GO:0060117)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0060116	vestibular receptor cell morphogenesis (GO:0060116)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902445	regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060114	vestibular receptor cell differentiation (GO:0060114)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902443	negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060112	generation of ovulation cycle rhythm (GO:0060112)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902442	regulation of ripoptosome assembly involved in necroptotic process (GO:1902442)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006689	ganglioside catabolic process (GO:0006689)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1902440	protein localization to mitotic spindle pole body (GO:1902440)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032929	negative regulation of superoxide anion generation (GO:0032929)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032928	regulation of superoxide anion generation (GO:0032928)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0006683	galactosylceramide catabolic process (GO:0006683)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032927	positive regulation of activin receptor signaling pathway (GO:0032927)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0006682	galactosylceramide biosynthetic process (GO:0006682)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006681	galactosylceramide metabolic process (GO:0006681)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0006680	glucosylceramide catabolic process (GO:0006680)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032920	putrescine acetylation (GO:0032920)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006679	glucosylceramide biosynthetic process (GO:0006679)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060101	negative regulation of phagocytosis, engulfment (GO:0060101)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006678	glucosylceramide metabolic process (GO:0006678)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032919	spermine acetylation (GO:0032919)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032918	spermidine acetylation (GO:0032918)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032917	polyamine acetylation (GO:0032917)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032916	positive regulation of transforming growth factor beta3 production (GO:0032916)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006671	phytosphingosine metabolic process (GO:0006671)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032915	positive regulation of transforming growth factor beta2 production (GO:0032915)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032913	negative regulation of transforming growth factor beta3 production (GO:0032913)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032910	regulation of transforming growth factor beta3 production (GO:0032910)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071693	protein transport within extracellular region (GO:0071693)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071691	cardiac muscle thin filament assembly (GO:0071691)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006669	sphinganine-1-phosphate biosynthetic process (GO:0006669)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006667	sphinganine metabolic process (GO:0006667)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006666	3-keto-sphinganine metabolic process (GO:0006666)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032905	transforming growth factor beta1 production (GO:0032905)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006660	phosphatidylserine catabolic process (GO:0006660)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032903	regulation of nerve growth factor production (GO:0032903)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032902	nerve growth factor production (GO:0032902)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032901	positive regulation of neurotrophin production (GO:0032901)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032900	negative regulation of neurotrophin production (GO:0032900)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038203	TORC2 signaling (GO:0038203)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0038202	TORC1 signaling (GO:0038202)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1902416	positive regulation of mRNA binding (GO:1902416)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1902415	regulation of mRNA binding (GO:1902415)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0006659	phosphatidylserine biosynthetic process (GO:0006659)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006655	phosphatidylglycerol biosynthetic process (GO:0006655)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0006651	diacylglycerol biosynthetic process (GO:0006651)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0002299	alpha-beta intraepithelial T cell differentiation (GO:0002299)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002296	T-helper 1 cell lineage commitment (GO:0002296)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071678	olfactory bulb axon guidance (GO:0071678)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006649	phospholipid transfer to membrane (GO:0006649)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006642	triglyceride mobilization (GO:0006642)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006640	monoacylglycerol biosynthetic process (GO:0006640)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002283	neutrophil activation involved in immune response (GO:0002283)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0002280	monocyte activation involved in immune response (GO:0002280)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071663	positive regulation of granzyme B production (GO:0071663)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071661	regulation of granzyme B production (GO:0071661)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071660	positive regulation of IP-10 production (GO:0071660)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990983	tRNA demethylation (GO:1990983)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002278	eosinophil activation involved in immune response (GO:0002278)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002277	myeloid dendritic cell activation involved in immune response (GO:0002277)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002276	basophil activation involved in immune response (GO:0002276)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002273	plasmacytoid dendritic cell differentiation (GO:0002273)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002270	plasmacytoid dendritic cell activation (GO:0002270)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071659	negative regulation of IP-10 production (GO:0071659)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071658	regulation of IP-10 production (GO:0071658)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071656	negative regulation of granulocyte colony-stimulating factor production (GO:0071656)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071651	positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0071650	negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006627	protein processing involved in protein targeting to mitochondrion (GO:0006627)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006626	protein targeting to mitochondrion (GO:0006626)	60	0	3.52	-	 < 0.01	7.99E-02	5.00E-01
GO:0006625	protein targeting to peroxisome (GO:0006625)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0006624	vacuolar protein processing (GO:0006624)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006620	post-translational protein targeting to endoplasmic reticulum membrane (GO:0006620)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0002268	follicular dendritic cell differentiation (GO:0002268)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002266	follicular dendritic cell activation (GO:0002266)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002265	astrocyte activation involved in immune response (GO:0002265)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002264	endothelial cell activation involved in immune response (GO:0002264)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071649	regulation of chemokine (C-C motif) ligand 5 production (GO:0071649)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0071644	negative regulation of chemokine (C-C motif) ligand 4 production (GO:0071644)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071643	regulation of chemokine (C-C motif) ligand 4 production (GO:0071643)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071642	positive regulation of macrophage inflammatory protein 1 alpha production (GO:0071642)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071641	negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071640	regulation of macrophage inflammatory protein 1 alpha production (GO:0071640)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1990969	modulation by host of viral RNA-binding transcription factor activity (GO:1990969)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006617	SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990968	modulation by host of RNA binding by virus (GO:1990968)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006616	SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1990966	ATP generation from poly-ADP-D-ribose (GO:1990966)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006614	SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0006613	cotranslational protein targeting to membrane (GO:0006613)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0006610	ribosomal protein import into nucleus (GO:0006610)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990960	basophil homeostasis (GO:1990960)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071639	positive regulation of monocyte chemotactic protein-1 production (GO:0071639)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0071630	nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901999	homogentisate metabolic process (GO:1901999)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990959	eosinophil homeostasis (GO:1990959)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1990953	intramanchette transport (GO:1990953)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002249	lymphocyte anergy (GO:0002249)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002248	connective tissue replacement involved in inflammatory response wound healing (GO:0002248)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002246	wound healing involved in inflammatory response (GO:0002246)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0071629	cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071626	mastication (GO:0071626)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071620	phosphorylation of RNA polymerase II C-terminal domain serine 5 residues (GO:0071620)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901986	response to ketamine (GO:1901986)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901980	positive regulation of inward rectifier potassium channel activity (GO:1901980)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002238	response to molecule of fungal origin (GO:0002238)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002232	leukocyte chemotaxis involved in inflammatory response (GO:0002232)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0002230	positive regulation of defense response to virus by host (GO:0002230)	34	0	2.00	-	 < 0.01	2.61E-01	8.49E-01
GO:0071619	phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:0071619)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990938	peptidyl-aspartic acid autophosphorylation (GO:1990938)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001076	positive regulation of metanephric ureteric bud development (GO:2001076)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001074	regulation of metanephric ureteric bud development (GO:2001074)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002227	innate immune response in mucosa (GO:0002227)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0002225	positive regulation of antimicrobial peptide production (GO:0002225)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002223	stimulatory C-type lectin receptor signaling pathway (GO:0002223)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0002222	stimulatory killer cell immunoglobulin-like receptor signaling pathway (GO:0002222)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071604	transforming growth factor beta production (GO:0071604)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0071603	endothelial cell-cell adhesion (GO:0071603)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071602	phytosphingosine biosynthetic process (GO:0071602)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033396	beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071600	otic vesicle morphogenesis (GO:0071600)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1990926	short-term synaptic potentiation (GO:1990926)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901964	positive regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901964)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901963	regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901963)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901962	S-adenosyl-L-methionine transmembrane transport (GO:1901962)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002215	defense response to nematode (GO:0002215)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033389	putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033388	putrescine biosynthetic process from arginine (GO:0033388)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033386	geranylgeranyl diphosphate biosynthetic process (GO:0033386)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033385	geranylgeranyl diphosphate metabolic process (GO:0033385)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033384	geranyl diphosphate biosynthetic process (GO:0033384)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033383	geranyl diphosphate metabolic process (GO:0033383)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033382	maintenance of granzyme B location in T cell secretory granule (GO:0033382)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033380	granzyme B localization to T cell secretory granule (GO:0033380)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901953	positive regulation of anterograde dense core granule transport (GO:1901953)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001054	negative regulation of mesenchymal cell apoptotic process (GO:2001054)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1901951	regulation of anterograde dense core granule transport (GO:1901951)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901950	dense core granule transport (GO:1901950)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1990910	response to hypobaric hypoxia (GO:1990910)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001051	positive regulation of tendon cell differentiation (GO:2001051)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045347	negative regulation of MHC class II biosynthetic process (GO:0045347)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045344	negative regulation of MHC class I biosynthetic process (GO:0045344)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045342	MHC class II biosynthetic process (GO:0045342)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033379	maintenance of protease location in T cell secretory granule (GO:0033379)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033377	maintenance of protein location in T cell secretory granule (GO:0033377)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033375	protease localization to T cell secretory granule (GO:0033375)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033374	protein localization to T cell secretory granule (GO:0033374)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033373	maintenance of protease location in mast cell secretory granule (GO:0033373)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001049	regulation of tendon cell differentiation (GO:2001049)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033371	T cell secretory granule organization (GO:0033371)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033370	maintenance of protein location in mast cell secretory granule (GO:0033370)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001045	negative regulation of integrin-mediated signaling pathway (GO:2001045)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045339	farnesyl diphosphate catabolic process (GO:0045339)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045338	farnesyl diphosphate metabolic process (GO:0045338)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045337	farnesyl diphosphate biosynthetic process (GO:0045337)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0033368	protease localization to mast cell secretory granule (GO:0033368)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033367	protein localization to mast cell secretory granule (GO:0033367)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033366	protein localization to secretory granule (GO:0033366)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0033364	mast cell secretory granule organization (GO:0033364)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001037	positive regulation of tongue muscle cell differentiation (GO:2001037)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001035	regulation of tongue muscle cell differentiation (GO:2001035)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001034	positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:2001033	negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2001032	regulation of double-strand break repair via nonhomologous end joining (GO:2001032)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:2001031	positive regulation of cellular glucuronidation (GO:2001031)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001030	negative regulation of cellular glucuronidation (GO:2001030)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0019086	late viral transcription (GO:0019086)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019085	early viral transcription (GO:0019085)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045329	carnitine biosynthetic process (GO:0045329)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019083	viral transcription (GO:0019083)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0019081	viral translation (GO:0019081)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0033353	S-adenosylmethionine cycle (GO:0033353)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2001029	regulation of cellular glucuronidation (GO:2001029)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:2001027	negative regulation of endothelial cell chemotaxis (GO:2001027)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2001023	regulation of response to drug (GO:2001023)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019076	viral release from host cell (GO:0019076)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:0019075	virus maturation (GO:0019075)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019074	viral RNA genome packaging (GO:0019074)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019072	viral genome packaging (GO:0019072)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033345	asparagine catabolic process via L-aspartate (GO:0033345)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033343	positive regulation of collagen binding (GO:0033343)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2001019	positive regulation of retrograde axon cargo transport (GO:2001019)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033342	negative regulation of collagen binding (GO:0033342)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033341	regulation of collagen binding (GO:0033341)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2001017	regulation of retrograde axon cargo transport (GO:2001017)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901911	adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901910	adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019068	virion assembly (GO:0019068)	35	0	2.06	-	 < 0.01	2.62E-01	8.52E-01
GO:0001797	negative regulation of type IIa hypersensitivity (GO:0001797)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001794	type IIa hypersensitivity (GO:0001794)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019060	intracellular transport of viral protein in host cell (GO:0019060)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901909	diadenosine hexaphosphate catabolic process (GO:1901909)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901908	diadenosine hexaphosphate metabolic process (GO:1901908)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901907	diadenosine pentaphosphate catabolic process (GO:1901907)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901906	diadenosine pentaphosphate metabolic process (GO:1901906)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0001788	antibody-dependent cellular cytotoxicity (GO:0001788)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019054	modulation by virus of host cellular process (GO:0019054)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001787	natural killer cell proliferation (GO:0001787)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0019050	suppression by virus of host apoptotic process (GO:0019050)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140591	nuclear envelope budding (GO:0140591)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033320	UDP-D-xylose biosynthetic process (GO:0033320)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019048	modulation by virus of host process (GO:0019048)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140588	chromatin looping (GO:0140588)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019046	release from viral latency (GO:0019046)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019045	latent virus replication (GO:0019045)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001777	T cell homeostatic proliferation (GO:0001777)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019043	establishment of viral latency (GO:0019043)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019042	viral latency (GO:0019042)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0001770	establishment of natural killer cell polarity (GO:0001770)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033319	UDP-D-xylose metabolic process (GO:0033319)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007072	positive regulation of transcription involved in exit from mitosis (GO:0007072)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072099	anterior/posterior pattern specification involved in ureteric bud development (GO:0072099)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072098	anterior/posterior pattern specification involved in kidney development (GO:0072098)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072097	negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway (GO:0072097)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072096	negative regulation of branch elongation involved in ureteric bud branching (GO:0072096)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001766	membrane raft polarization (GO:0001766)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0140570	extraction of mislocalized protein from mitochondrial outer membrane (GO:0140570)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001762	beta-alanine transport (GO:0001762)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007066	female meiosis sister chromatid cohesion (GO:0007066)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090721	primary adaptive immune response involving T cells and B cells (GO:0090721)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090720	primary adaptive immune response (GO:0090720)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033306	phytol metabolic process (GO:0033306)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007060	male meiosis chromosome segregation (GO:0007060)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0140569	extraction of mislocalized protein from ER membrane (GO:0140569)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140568	extraction of mislocalized protein from membrane (GO:0140568)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072086	specification of loop of Henle identity (GO:0072086)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0072081	specification of nephron tubule identity (GO:0072081)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090715	immunological memory formation process (GO:0090715)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090713	immunological memory process (GO:0090713)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000597	positive regulation of optic nerve formation (GO:2000597)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000595	regulation of optic nerve formation (GO:2000595)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000594	positive regulation of metanephric DCT cell differentiation (GO:2000594)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072076	nephrogenic mesenchyme development (GO:0072076)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000592	regulation of metanephric DCT cell differentiation (GO:2000592)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000591	positive regulation of metanephric mesenchymal cell migration (GO:2000591)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000590	negative regulation of metanephric mesenchymal cell migration (GO:2000590)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072071	kidney interstitial fibroblast differentiation (GO:0072071)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001743	lens placode formation (GO:0001743)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007042	lysosomal lumen acidification (GO:0007042)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:2000589	regulation of metanephric mesenchymal cell migration (GO:2000589)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000588	positive regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000588)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072069	DCT cell differentiation (GO:0072069)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000584	negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000583	regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072061	inner medullary collecting duct development (GO:0072061)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072060	outer medullary collecting duct development (GO:0072060)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007039	protein catabolic process in the vacuole (GO:0007039)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0001732	formation of cytoplasmic translation initiation complex (GO:0001732)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0001731	formation of translation preinitiation complex (GO:0001731)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0060097	cytoskeletal rearrangement involved in phagocytosis, engulfment (GO:0060097)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060092	regulation of synaptic transmission, glycinergic (GO:0060092)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007031	peroxisome organization (GO:0007031)	33	0	1.94	-	 < 0.01	2.60E-01	8.47E-01
GO:0044873	lipoprotein localization to membrane (GO:0044873)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072059	cortical collecting duct development (GO:0072059)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072055	renal cortex development (GO:0072055)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000572	positive regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000572)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072054	renal outer medulla development (GO:0072054)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000571	regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000571)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072053	renal inner medulla development (GO:0072053)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000570	positive regulation of T-helper 2 cell activation (GO:2000570)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072051	juxtaglomerular apparatus development (GO:0072051)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072050	S-shaped body morphogenesis (GO:0072050)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060088	auditory receptor cell stereocilium organization (GO:0060088)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0060084	synaptic transmission involved in micturition (GO:0060084)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0007023	post-chaperonin tubulin folding pathway (GO:0007023)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060082	eye blink reflex (GO:0060082)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0052472	modulation by host of symbiont transcription (GO:0052472)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044861	protein transport into plasma membrane raft (GO:0044861)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032899	regulation of neurotrophin production (GO:0032899)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032898	neurotrophin production (GO:0032898)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000569	regulation of T-helper 2 cell activation (GO:2000569)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000568	positive regulation of memory T cell activation (GO:2000568)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000567	regulation of memory T cell activation (GO:2000567)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038196	type III interferon signaling pathway (GO:0038196)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0072049	comma-shaped body morphogenesis (GO:0072049)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000566	positive regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000566)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0038195	urokinase plasminogen activator signaling pathway (GO:0038195)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072048	renal system pattern specification (GO:0072048)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:2000565	negative regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000565)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038194	thyroid-stimulating hormone signaling pathway (GO:0038194)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072047	proximal/distal pattern formation involved in nephron development (GO:0072047)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000564	regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0038193	thromboxane A2 signaling pathway (GO:0038193)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072046	establishment of planar polarity involved in nephron morphogenesis (GO:0072046)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038192	gastric inhibitory peptide signaling pathway (GO:0038192)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000562	negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0072044	collecting duct development (GO:0072044)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0038190	VEGF-activated neuropilin signaling pathway (GO:0038190)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000560	positive regulation of CD24 production (GO:2000560)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072040	negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072040)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0001712	ectodermal cell fate commitment (GO:0001712)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007014	actin ubiquitination (GO:0007014)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044856	plasma membrane raft localization (GO:0044856)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044855	plasma membrane raft distribution (GO:0044855)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032888	regulation of mitotic spindle elongation (GO:0032888)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032887	regulation of spindle elongation (GO:0032887)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038189	neuropilin signaling pathway (GO:0038189)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000559	regulation of CD24 production (GO:2000559)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038188	cholecystokinin signaling pathway (GO:0038188)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000558	positive regulation of immunoglobulin production in mucosal tissue (GO:2000558)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000557	regulation of immunoglobulin production in mucosal tissue (GO:2000557)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072039	regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072039)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0038185	intracellular bile acid receptor signaling pathway (GO:0038185)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072038	mesenchymal stem cell maintenance involved in nephron morphogenesis (GO:0072038)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038184	cell surface bile acid receptor signaling pathway (GO:0038184)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038183	bile acid signaling pathway (GO:0038183)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0072036	mesenchymal to epithelial transition involved in renal vesicle formation (GO:0072036)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000552	negative regulation of T-helper 2 cell cytokine production (GO:2000552)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0072034	renal vesicle induction (GO:0072034)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0001705	ectoderm formation (GO:0001705)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007008	outer mitochondrial membrane organization (GO:0007008)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0007007	inner mitochondrial membrane organization (GO:0007007)	37	0	2.17	-	 < 0.01	2.68E-01	8.58E-01
GO:0060067	cervix development (GO:0060067)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902396	protein localization to bicellular tight junction (GO:1902396)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060064	Spemann organizer formation at the anterior end of the primitive streak (GO:0060064)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060061	Spemann organizer formation (GO:0060061)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0007000	nucleolus organization (GO:0007000)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0060060	post-embryonic retina morphogenesis in camera-type eye (GO:0060060)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032876	negative regulation of DNA endoreduplication (GO:0032876)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000549	positive regulation of dendritic cell dendrite assembly (GO:2000549)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038178	complement component C5a signaling pathway (GO:0038178)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000545	negative regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000545)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072027	connecting tubule development (GO:0072027)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038173	interleukin-17A-mediated signaling pathway (GO:0038173)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140507	granzyme-mediated programmed cell death signaling pathway (GO:0140507)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:2000543	positive regulation of gastrulation (GO:2000543)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0072025	distal convoluted tubule development (GO:0072025)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0038171	cannabinoid signaling pathway (GO:0038171)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0072024	macula densa development (GO:0072024)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000541	positive regulation of protein geranylgeranylation (GO:2000541)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038170	somatostatin signaling pathway (GO:0038170)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072023	thick ascending limb development (GO:0072023)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072021	ascending thin limb development (GO:0072021)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060059	embryonic retina morphogenesis in camera-type eye (GO:0060059)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902389	ceramide 1-phosphate transport (GO:1902389)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0060058	positive regulation of apoptotic process involved in mammary gland involution (GO:0060058)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060057	apoptotic process involved in mammary gland involution (GO:0060057)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060052	neurofilament cytoskeleton organization (GO:0060052)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0060051	negative regulation of protein glycosylation (GO:0060051)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902380	positive regulation of endoribonuclease activity (GO:1902380)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044830	modulation by host of viral RNA genome replication (GO:0044830)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0038169	somatostatin receptor signaling pathway (GO:0038169)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000539	regulation of protein geranylgeranylation (GO:2000539)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038168	epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade (GO:0038168)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000538	positive regulation of B cell chemotaxis (GO:2000538)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038167	epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity (GO:0038167)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000537	regulation of B cell chemotaxis (GO:2000537)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072017	distal tubule development (GO:0072017)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:2000534	positive regulation of renal albumin absorption (GO:2000534)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038163	thrombopoietin-mediated signaling pathway (GO:0038163)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072016	glomerular parietal epithelial cell development (GO:0072016)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038161	prolactin signaling pathway (GO:0038161)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038160	CXCL12-activated CXCR4 signaling pathway (GO:0038160)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902378	VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044829	positive regulation by host of viral genome replication (GO:0044829)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0044828	negative regulation by host of viral genome replication (GO:0044828)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0044827	modulation by host of viral genome replication (GO:0044827)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:1902374	regulation of rRNA catabolic process (GO:1902374)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902371	negative regulation of tRNA catabolic process (GO:1902371)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060040	retinal bipolar neuron differentiation (GO:0060040)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902370	regulation of tRNA catabolic process (GO:1902370)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044821	meiotic telomere tethering at nuclear periphery (GO:0044821)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0038159	C-X-C chemokine receptor CXCR4 signaling pathway (GO:0038159)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0038158	granulocyte colony-stimulating factor signaling pathway (GO:0038158)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038157	granulocyte-macrophage colony-stimulating factor signaling pathway (GO:0038157)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0038156	interleukin-3-mediated signaling pathway (GO:0038156)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000526	positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation (GO:2000526)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038155	interleukin-23-mediated signaling pathway (GO:0038155)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000525	positive regulation of T cell costimulation (GO:2000525)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000524	negative regulation of T cell costimulation (GO:2000524)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000523	regulation of T cell costimulation (GO:2000523)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000522	positive regulation of immunological synapse formation (GO:2000522)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072004	kidney field specification (GO:0072004)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000521	negative regulation of immunological synapse formation (GO:2000521)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072003	kidney rudiment formation (GO:0072003)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000520	regulation of immunological synapse formation (GO:2000520)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902367	negative regulation of Notch signaling pathway involved in somitogenesis (GO:1902367)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902366	regulation of Notch signaling pathway involved in somitogenesis (GO:1902366)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060035	notochord cell development (GO:0060035)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902365	positive regulation of protein localization to spindle pole body (GO:1902365)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060034	notochord cell differentiation (GO:0060034)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902363	regulation of protein localization to spindle pole body (GO:1902363)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060032	notochord regression (GO:0060032)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060031	mediolateral intercalation (GO:0060031)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032849	positive regulation of cellular pH reduction (GO:0032849)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000518	negative regulation of T-helper 1 cell activation (GO:2000518)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000517	regulation of T-helper 1 cell activation (GO:2000517)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038145	macrophage colony-stimulating factor signaling pathway (GO:0038145)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000515	negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)	35	0	2.06	-	 < 0.01	2.62E-01	8.51E-01
GO:2000513	positive regulation of granzyme A production (GO:2000513)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000511	regulation of granzyme A production (GO:2000511)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060029	convergent extension involved in organogenesis (GO:0060029)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902356	oxaloacetate(2-) transmembrane transport (GO:1902356)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060024	rhythmic synaptic transmission (GO:0060024)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044805	late nucleophagy (GO:0044805)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060023	soft palate development (GO:0060023)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0044804	autophagy of nucleus (GO:0044804)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0006598	polyamine catabolic process (GO:0006598)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060020	Bergmann glial cell differentiation (GO:0060020)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1902350	cellular response to chloroquine (GO:1902350)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006597	spermine biosynthetic process (GO:0006597)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006593	ornithine catabolic process (GO:0006593)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006592	ornithine biosynthetic process (GO:0006592)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032834	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032834)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000509	negative regulation of dendritic cell chemotaxis (GO:2000509)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032832	regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032832)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038138	ERBB4-ERBB4 signaling pathway (GO:0038138)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032831	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000504	positive regulation of blood vessel remodeling (GO:2000504)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038133	ERBB2-ERBB3 signaling pathway (GO:0038133)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000503	positive regulation of natural killer cell chemotaxis (GO:2000503)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060019	radial glial cell differentiation (GO:0060019)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1902349	response to chloroquine (GO:1902349)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060018	astrocyte fate commitment (GO:0060018)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060017	parathyroid gland development (GO:0060017)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060016	granulosa cell development (GO:0060016)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060014	granulosa cell differentiation (GO:0060014)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060013	righting reflex (GO:0060013)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0060012	synaptic transmission, glycinergic (GO:0060012)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006589	octopamine biosynthetic process (GO:0006589)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060011	Sertoli cell proliferation (GO:0060011)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060010	Sertoli cell fate commitment (GO:0060010)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902340	negative regulation of chromosome condensation (GO:1902340)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006585	dopamine biosynthetic process from tyrosine (GO:0006585)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032829	regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032829)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006583	melanin biosynthetic process from tyrosine (GO:0006583)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032827	negative regulation of natural killer cell differentiation involved in immune response (GO:0032827)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032826	regulation of natural killer cell differentiation involved in immune response (GO:0032826)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006581	acetylcholine catabolic process (GO:0006581)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006580	ethanolamine metabolic process (GO:0006580)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032824	negative regulation of natural killer cell differentiation (GO:0032824)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0038129	ERBB3 signaling pathway (GO:0038129)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0038124	toll-like receptor TLR6:TLR2 signaling pathway (GO:0038124)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038123	toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902339	positive regulation of apoptotic process involved in morphogenesis (GO:1902339)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902338	negative regulation of apoptotic process involved in morphogenesis (GO:1902338)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060007	linear vestibuloocular reflex (GO:0060007)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902337	regulation of apoptotic process involved in morphogenesis (GO:1902337)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1902336	positive regulation of retinal ganglion cell axon guidance (GO:1902336)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060005	vestibular reflex (GO:0060005)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060004	reflex (GO:0060004)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0060003	copper ion export (GO:0060003)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006579	amino-acid betaine catabolic process (GO:0006579)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032819	positive regulation of natural killer cell proliferation (GO:0032819)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0006574	valine catabolic process (GO:0006574)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006573	valine metabolic process (GO:0006573)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032817	regulation of natural killer cell proliferation (GO:0032817)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0006572	tyrosine catabolic process (GO:0006572)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006571	tyrosine biosynthetic process (GO:0006571)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032815	negative regulation of natural killer cell activation (GO:0032815)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0006570	tyrosine metabolic process (GO:0006570)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0032812	positive regulation of epinephrine secretion (GO:0032812)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038115	chemokine (C-C motif) ligand 19 signaling pathway (GO:0038115)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038114	interleukin-21-mediated signaling pathway (GO:0038114)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038113	interleukin-9-mediated signaling pathway (GO:0038113)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038112	interleukin-8-mediated signaling pathway (GO:0038112)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038111	interleukin-7-mediated signaling pathway (GO:0038111)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038110	interleukin-2-mediated signaling pathway (GO:0038110)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0071596	ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006567	threonine catabolic process (GO:0006567)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006566	threonine metabolic process (GO:0006566)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006565	L-serine catabolic process (GO:0006565)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006564	L-serine biosynthetic process (GO:0006564)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006563	L-serine metabolic process (GO:0006563)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0006562	proline catabolic process (GO:0006562)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032805	positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032804	negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032803	regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032802	low-density lipoprotein particle receptor catabolic process (GO:0032802)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038108	negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0038107	nodal signaling pathway involved in determination of left/right asymmetry (GO:0038107)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0038101	sequestering of nodal from receptor via nodal binding (GO:0038101)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071586	CAAX-box protein processing (GO:0071586)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071585	detoxification of cadmium ion (GO:0071585)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902317	nuclear DNA replication termination (GO:1902317)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071584	negative regulation of zinc ion transmembrane import (GO:0071584)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071583	negative regulation of zinc ion transmembrane transport (GO:0071583)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071582	negative regulation of zinc ion transport (GO:0071582)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071581	regulation of zinc ion transmembrane import (GO:0071581)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071580	regulation of zinc ion transmembrane transport (GO:0071580)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006559	L-phenylalanine catabolic process (GO:0006559)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1902311	regulation of copper ion transmembrane transport (GO:1902311)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006558	L-phenylalanine metabolic process (GO:0006558)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1902310	positive regulation of peptidyl-serine dephosphorylation (GO:1902310)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006556	S-adenosylmethionine biosynthetic process (GO:0006556)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006552	leucine catabolic process (GO:0006552)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006551	leucine metabolic process (GO:0006551)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0006550	isoleucine catabolic process (GO:0006550)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002194	hepatocyte cell migration (GO:0002194)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002192	IRES-dependent translational initiation of linear mRNA (GO:0002192)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002191	cap-dependent translational initiation (GO:0002191)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002190	cap-independent translational initiation (GO:0002190)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071579	regulation of zinc ion transport (GO:0071579)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071578	zinc ion import across plasma membrane (GO:0071578)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1902309	negative regulation of peptidyl-serine dephosphorylation (GO:1902309)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902308	regulation of peptidyl-serine dephosphorylation (GO:1902308)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006549	isoleucine metabolic process (GO:0006549)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006548	histidine catabolic process (GO:0006548)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0006547	histidine metabolic process (GO:0006547)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0006546	glycine catabolic process (GO:0006546)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006545	glycine biosynthetic process (GO:0006545)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006544	glycine metabolic process (GO:0006544)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0006543	glutamine catabolic process (GO:0006543)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006542	glutamine biosynthetic process (GO:0006542)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006541	glutamine metabolic process (GO:0006541)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0002188	translation reinitiation (GO:0002188)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002184	cytoplasmic translational termination (GO:0002184)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002183	cytoplasmic translational initiation (GO:0002183)	34	0	2.00	-	 < 0.01	2.61E-01	8.49E-01
GO:0002182	cytoplasmic translational elongation (GO:0002182)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002181	cytoplasmic translation (GO:0002181)	124	0	7.28	-	 < 0.01	1.32E-03	2.55E-02
GO:0071569	protein ufmylation (GO:0071569)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006537	glutamate biosynthetic process (GO:0006537)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006535	cysteine biosynthetic process from serine (GO:0006535)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006533	aspartate catabolic process (GO:0006533)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990884	RNA acetylation (GO:1990884)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006532	aspartate biosynthetic process (GO:0006532)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006531	aspartate metabolic process (GO:0006531)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1990882	rRNA acetylation (GO:1990882)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006530	asparagine catabolic process (GO:0006530)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002176	male germ cell proliferation (GO:0002176)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002175	protein localization to paranode region of axon (GO:0002175)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071557	histone H3-K27 demethylation (GO:0071557)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0071550	death-inducing signaling complex assembly (GO:0071550)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006529	asparagine biosynthetic process (GO:0006529)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006528	asparagine metabolic process (GO:0006528)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006527	arginine catabolic process (GO:0006527)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0051977	lysophospholipid transport (GO:0051977)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006524	alanine catabolic process (GO:0006524)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1990874	vascular associated smooth muscle cell proliferation (GO:1990874)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006522	alanine metabolic process (GO:0006522)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051971	positive regulation of transmission of nerve impulse (GO:0051971)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0051970	negative regulation of transmission of nerve impulse (GO:0051970)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0071545	inositol phosphate catabolic process (GO:0071545)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0071544	diphosphoinositol polyphosphate catabolic process (GO:0071544)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071543	diphosphoinositol polyphosphate metabolic process (GO:0071543)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051969	regulation of transmission of nerve impulse (GO:0051969)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0006517	protein deglycosylation (GO:0006517)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0006515	protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0002159	desmosome assembly (GO:0002159)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002152	bile acid conjugation (GO:0002152)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045299	otolith mineralization (GO:0045299)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045292	mRNA cis splicing, via spliceosome (GO:0045292)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:1901899	positive regulation of relaxation of cardiac muscle (GO:1901899)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990859	cellular response to endothelin (GO:1990859)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006507	GPI anchor release (GO:0006507)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990858	cellular response to lectin (GO:1990858)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0006506	GPI anchor biosynthetic process (GO:0006506)	31	0	1.82	-	 < 0.01	4.16E-01	1.00E00
GO:0006505	GPI anchor metabolic process (GO:0006505)	32	0	1.88	-	 < 0.01	2.60E-01	8.49E-01
GO:0006501	C-terminal protein lipidation (GO:0006501)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002149	hypochlorous acid biosynthetic process (GO:0002149)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006500	N-terminal protein palmitoylation (GO:0006500)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051951	positive regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051951)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002148	hypochlorous acid metabolic process (GO:0002148)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002143	tRNA wobble position uridine thiolation (GO:0002143)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071529	cementum mineralization (GO:0071529)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0071528	tRNA re-export from nucleus (GO:0071528)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051944	positive regulation of catecholamine uptake involved in synaptic transmission (GO:0051944)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051943	positive regulation of amino acid uptake involved in synaptic transmission (GO:0051943)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990840	response to lectin (GO:1990840)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0051939	gamma-aminobutyric acid import (GO:0051939)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051936	gamma-aminobutyric acid reuptake (GO:0051936)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051935	glutamate reuptake (GO:0051935)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901874	negative regulation of post-translational protein modification (GO:1901874)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990834	response to odorant (GO:1990834)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051933	amino acid neurotransmitter reuptake (GO:0051933)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1990832	slow axonal transport (GO:1990832)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002128	tRNA nucleoside ribose methylation (GO:0002128)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002127	tRNA wobble base cytosine methylation (GO:0002127)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002125	maternal aggressive behavior (GO:0002125)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002121	inter-male aggressive behavior (GO:0002121)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033299	secretion of lysosomal enzymes (GO:0033299)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0071501	cellular response to sterol depletion (GO:0071501)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0071500	cellular response to nitrosative stress (GO:0071500)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990828	hepatocyte dedifferentiation (GO:1990828)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051923	sulfation (GO:0051923)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:1990822	basic amino acid transmembrane transport (GO:1990822)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0002115	store-operated calcium entry (GO:0002115)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1901859	negative regulation of mitochondrial DNA metabolic process (GO:1901859)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051918	negative regulation of fibrinolysis (GO:0051918)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0002101	tRNA wobble cytosine modification (GO:0002101)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002100	tRNA wobble adenosine to inosine editing (GO:0002100)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033277	abortive mitotic cell cycle (GO:0033277)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033274	response to vitamin B2 (GO:0033274)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990809	endoplasmic reticulum tubular network membrane organization (GO:1990809)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051905	establishment of pigment granule localization (GO:0051905)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0051904	pigment granule transport (GO:0051904)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0045234	protein palmitoleylation (GO:0045234)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090685	RNA localization to nucleus (GO:0090685)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901838	positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1901837	negative regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901837)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901836	regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0045226	extracellular polysaccharide biosynthetic process (GO:0045226)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045225	negative regulation of CD4 production (GO:0045225)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090676	calcium ion transmembrane transport via low voltage-gated calcium channel (GO:0090676)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090675	intermicrovillar adhesion (GO:0090675)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045223	regulation of CD4 production (GO:0045223)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045221	negative regulation of FasL production (GO:0045221)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090672	telomerase RNA localization (GO:0090672)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090671	telomerase RNA localization to Cajal body (GO:0090671)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090670	RNA localization to Cajal body (GO:0090670)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901827	zeaxanthin biosynthetic process (GO:1901827)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045219	regulation of FasL production (GO:0045219)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045218	zonula adherens maintenance (GO:0045218)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090669	telomerase RNA stabilization (GO:0090669)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090668	endothelial cell chemotaxis to vascular endothelial growth factor (GO:0090668)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090667	cell chemotaxis to vascular endothelial growth factor (GO:0090667)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090666	scaRNA localization to Cajal body (GO:0090666)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090663	galanin-activated signaling pathway (GO:0090663)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045210	FasL biosynthetic process (GO:0045210)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090660	cerebrospinal fluid circulation (GO:0090660)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1901810	beta-carotene metabolic process (GO:1901810)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001698	gastrin-induced gastric acid secretion (GO:0001698)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001695	histamine catabolic process (GO:0001695)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001694	histamine biosynthetic process (GO:0001694)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045204	MAPK export from nucleus (GO:0045204)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090650	cellular response to oxygen-glucose deprivation (GO:0090650)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0033234	negative regulation of protein sumoylation (GO:0033234)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1901805	beta-glucoside catabolic process (GO:1901805)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901804	beta-glucoside metabolic process (GO:1901804)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090649	response to oxygen-glucose deprivation (GO:0090649)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0090648	response to environmental enrichment (GO:0090648)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140493	very long-chain fatty acid beta-oxidation (GO:0140493)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090646	mitochondrial tRNA processing (GO:0090646)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0001682	tRNA 5'-leader removal (GO:0001682)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0001680	tRNA 3'-terminal CCA addition (GO:0001680)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033227	dsRNA transport (GO:0033227)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0140484	5-aminolevulinic acid import across plasma membrane (GO:0140484)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001675	acrosome assembly (GO:0001675)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0033211	adiponectin-activated signaling pathway (GO:0033211)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0090625	siRNA-mediated gene silencing by mRNA destabilization (GO:0090625)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001660	fever generation (GO:0001660)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033206	meiotic cytokinesis (GO:0033206)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0140469	GCN2-mediated signaling (GO:0140469)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0140468	HRI-mediated signaling (GO:0140468)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0140466	iron-sulfur cluster export from the mitochondrion (GO:0140466)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090616	mitochondrial mRNA 3'-end processing (GO:0090616)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090615	mitochondrial mRNA processing (GO:0090615)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0140460	response to Gram-negative bacterium (GO:0140460)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090611	ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0044795	trans-Golgi network to recycling endosome transport (GO:0044795)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044794	positive regulation by host of viral process (GO:0044794)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0044790	suppression of viral release by host (GO:0044790)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0140459	response to Gram-positive bacterium (GO:0140459)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000494	positive regulation of interleukin-18-mediated signaling pathway (GO:2000494)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000493	negative regulation of interleukin-18-mediated signaling pathway (GO:2000493)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000492	regulation of interleukin-18-mediated signaling pathway (GO:2000492)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0140455	cytoplasm protein quality control (GO:0140455)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140454	protein aggregate center assembly (GO:0140454)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140450	protein targeting to Golgi apparatus (GO:0140450)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0160025	sensory perception of itch (GO:0160025)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0160024	Leydig cell proliferation (GO:0160024)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0160023	sneeze reflex (GO:0160023)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000487	positive regulation of glutamine transport (GO:2000487)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000486	negative regulation of glutamine transport (GO:2000486)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000485	regulation of glutamine transport (GO:2000485)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0140447	cytokine precursor processing (GO:0140447)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044778	meiotic DNA integrity checkpoint signaling (GO:0044778)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000478	positive regulation of metanephric podocyte development (GO:2000478)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000477	regulation of metanephric podocyte development (GO:2000477)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140438	protein stearoylation (GO:0140438)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000473	positive regulation of hematopoietic stem cell migration (GO:2000473)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000471	regulation of hematopoietic stem cell migration (GO:2000471)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0052373	suppression of symbiont entry into host (GO:0052373)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032799	low-density lipoprotein receptor particle metabolic process (GO:0032799)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0160007	glutathione import into mitochondrion (GO:0160007)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032796	uropod organization (GO:0032796)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032792	negative regulation of CREB transcription factor activity (GO:0032792)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000467	positive regulation of glycogen (starch) synthase activity (GO:2000467)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032790	ribosome disassembly (GO:0032790)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:2000466	negative regulation of glycogen (starch) synthase activity (GO:2000466)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0038094	Fc-gamma receptor signaling pathway (GO:0038094)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:2000464	positive regulation of astrocyte chemotaxis (GO:2000464)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038092	nodal signaling pathway (GO:0038092)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0032789	unsaturated monocarboxylic acid metabolic process (GO:0032789)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032788	saturated monocarboxylic acid metabolic process (GO:0032788)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038089	positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:2000454	positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000454)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038083	peptidyl-tyrosine autophosphorylation (GO:0038083)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:2000452	regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000452)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000451	positive regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000451)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902294	cell cycle DNA replication termination (GO:1902294)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044743	protein transmembrane import into intracellular organelle (GO:0044743)	36	0	2.11	-	 < 0.01	2.65E-01	8.49E-01
GO:0032775	DNA methylation on adenine (GO:0032775)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032773	positive regulation of tyrosinase activity (GO:0032773)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000449	regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000449)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000448	positive regulation of macrophage migration inhibitory factor signaling pathway (GO:2000448)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032771	regulation of tyrosinase activity (GO:0032771)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032764	negative regulation of mast cell cytokine production (GO:0032764)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000438	negative regulation of monocyte extravasation (GO:2000438)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032761	positive regulation of lymphotoxin A production (GO:0032761)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000436	positive regulation of protein neddylation (GO:2000436)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000435	negative regulation of protein neddylation (GO:2000435)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0038060	nitric oxide-cGMP-mediated signaling pathway (GO:0038060)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0052337	modification by host of symbiont membrane (GO:0052337)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044727	DNA demethylation of male pronucleus (GO:0044727)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044726	protection of DNA demethylation of female pronucleus (GO:0044726)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044725	chromatin reprogramming in the zygote (GO:0044725)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902270	(R)-carnitine transmembrane transport (GO:1902270)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044721	protein import into peroxisome matrix, substrate release (GO:0044721)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032759	positive regulation of TRAIL production (GO:0032759)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032752	positive regulation of interleukin-3 production (GO:0032752)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000426	negative regulation of apoptotic cell clearance (GO:2000426)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000424	positive regulation of eosinophil chemotaxis (GO:2000424)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000422	regulation of eosinophil chemotaxis (GO:2000422)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902269	positive regulation of polyamine transmembrane transport (GO:1902269)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902268	negative regulation of polyamine transmembrane transport (GO:1902268)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902267	regulation of polyamine transmembrane transport (GO:1902267)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902263	apoptotic process involved in embryonic digit morphogenesis (GO:1902263)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902262	apoptotic process involved in blood vessel morphogenesis (GO:1902262)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032747	positive regulation of interleukin-23 production (GO:0032747)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000418	positive regulation of eosinophil migration (GO:2000418)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032741	positive regulation of interleukin-18 production (GO:0032741)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:2000415	positive regulation of fibronectin-dependent thymocyte migration (GO:2000415)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038043	interleukin-5-mediated signaling pathway (GO:0038043)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000413	regulation of fibronectin-dependent thymocyte migration (GO:2000413)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000412	positive regulation of thymocyte migration (GO:2000412)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0038041	cross-receptor inhibition within G protein-coupled receptor heterodimer (GO:0038041)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000410	regulation of thymocyte migration (GO:2000410)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902257	negative regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902257)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902256	regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902256)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0052314	phytoalexin metabolic process (GO:0052314)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006499	N-terminal protein myristoylation (GO:0006499)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902251	negative regulation of erythrocyte apoptotic process (GO:1902251)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006498	N-terminal protein lipidation (GO:0006498)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902250	regulation of erythrocyte apoptotic process (GO:1902250)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032739	positive regulation of interleukin-16 production (GO:0032739)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032738	positive regulation of interleukin-15 production (GO:0032738)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006490	oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:2000409	positive regulation of T cell extravasation (GO:2000409)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000408	negative regulation of T cell extravasation (GO:2000408)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000407	regulation of T cell extravasation (GO:2000407)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032730	positive regulation of interleukin-1 alpha production (GO:0032730)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0038033	positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902247	geranylgeranyl diphosphate catabolic process (GO:1902247)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006489	dolichyl diphosphate biosynthetic process (GO:0006489)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006488	dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0006487	protein N-linked glycosylation (GO:0006487)	74	0	4.35	-	 < 0.01	3.54E-02	3.03E-01
GO:0006482	protein demethylation (GO:0006482)	32	0	1.88	-	 < 0.01	2.60E-01	8.49E-01
GO:0006481	C-terminal protein methylation (GO:0006481)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032725	positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0006480	N-terminal protein amino acid methylation (GO:0006480)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032724	positive regulation of fractalkine production (GO:0032724)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032723	positive regulation of connective tissue growth factor production (GO:0032723)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038029	epidermal growth factor receptor signaling pathway via MAPK cascade (GO:0038029)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038028	insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0038020	insulin receptor recycling (GO:0038020)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902237	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1902233	negative regulation of positive thymic T cell selection (GO:1902233)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006478	peptidyl-tyrosine sulfation (GO:0006478)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006477	protein sulfation (GO:0006477)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0006474	N-terminal protein amino acid acetylation (GO:0006474)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0006471	protein ADP-ribosylation (GO:0006471)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0032714	negative regulation of interleukin-5 production (GO:0032714)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0032713	negative regulation of interleukin-4 production (GO:0032713)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032712	negative regulation of interleukin-3 production (GO:0032712)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038018	Wnt receptor catabolic process (GO:0038018)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902228	positive regulation of macrophage colony-stimulating factor signaling pathway (GO:1902228)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902227	negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071494	cellular response to UV-C (GO:0071494)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902226	regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902225	negative regulation of acrosome reaction (GO:1902225)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902222	erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1902221	erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1902220	positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902220)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006463	steroid hormone receptor complex assembly (GO:0006463)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032707	negative regulation of interleukin-23 production (GO:0032707)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038009	regulation of signal transduction by receptor internalization (GO:0038009)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0038008	TRAF-mediated signal transduction (GO:0038008)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032701	negative regulation of interleukin-18 production (GO:0032701)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0038004	epidermal growth factor receptor ligand maturation (GO:0038004)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0038003	G protein-coupled opioid receptor signaling pathway (GO:0038003)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0038002	endocrine signaling (GO:0038002)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071486	cellular response to high light intensity (GO:0071486)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902217	erythrocyte apoptotic process (GO:1902217)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902216	positive regulation of interleukin-4-mediated signaling pathway (GO:1902216)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902215	negative regulation of interleukin-4-mediated signaling pathway (GO:1902215)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902214	regulation of interleukin-4-mediated signaling pathway (GO:1902214)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0014064	positive regulation of serotonin secretion (GO:0014064)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006451	translational readthrough (GO:0006451)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0006450	regulation of translational fidelity (GO:0006450)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0002098	tRNA wobble uridine modification (GO:0002098)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0002097	tRNA wobble base modification (GO:0002097)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0002093	auditory receptor cell morphogenesis (GO:0002093)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0002091	negative regulation of receptor internalization (GO:0002091)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0071477	cellular hypotonic salinity response (GO:0071477)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071475	cellular hyperosmotic salinity response (GO:0071475)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902206	negative regulation of interleukin-2-mediated signaling pathway (GO:1902206)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902205	regulation of interleukin-2-mediated signaling pathway (GO:1902205)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902204	positive regulation of hepatocyte growth factor receptor signaling pathway (GO:1902204)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071471	cellular response to non-ionic osmotic stress (GO:0071471)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018410	C-terminal protein amino acid modification (GO:0018410)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0006449	regulation of translational termination (GO:0006449)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0014057	positive regulation of acetylcholine secretion, neurotransmission (GO:0014057)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006447	regulation of translational initiation by iron (GO:0006447)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014056	regulation of acetylcholine secretion, neurotransmission (GO:0014056)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014054	positive regulation of gamma-aminobutyric acid secretion (GO:0014054)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0014053	negative regulation of gamma-aminobutyric acid secretion (GO:0014053)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014052	regulation of gamma-aminobutyric acid secretion (GO:0014052)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0014050	negative regulation of glutamate secretion (GO:0014050)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051892	negative regulation of cardioblast differentiation (GO:0051892)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002086	diaphragm contraction (GO:0002086)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002085	inhibition of neuroepithelial cell differentiation (GO:0002085)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002084	protein depalmitoylation (GO:0002084)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0071469	cellular response to alkaline pH (GO:0071469)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071468	cellular response to acidic pH (GO:0071468)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0071464	cellular response to hydrostatic pressure (GO:0071464)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071462	cellular response to water stimulus (GO:0071462)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0018401	peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0071461	cellular response to redox state (GO:0071461)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018400	peptidyl-proline hydroxylation to 3-hydroxy-L-proline (GO:0018400)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006438	valyl-tRNA aminoacylation (GO:0006438)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006437	tyrosyl-tRNA aminoacylation (GO:0006437)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014046	dopamine secretion (GO:0014046)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006436	tryptophanyl-tRNA aminoacylation (GO:0006436)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014045	establishment of endothelial blood-brain barrier (GO:0014045)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006435	threonyl-tRNA aminoacylation (GO:0006435)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051886	negative regulation of timing of anagen (GO:0051886)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990786	cellular response to dsDNA (GO:1990786)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006434	seryl-tRNA aminoacylation (GO:0006434)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051885	positive regulation of timing of anagen (GO:0051885)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990785	response to water-immersion restraint stress (GO:1990785)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006433	prolyl-tRNA aminoacylation (GO:0006433)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051884	regulation of timing of anagen (GO:0051884)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1990784	response to dsDNA (GO:1990784)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006432	phenylalanyl-tRNA aminoacylation (GO:0006432)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006431	methionyl-tRNA aminoacylation (GO:0006431)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051882	mitochondrial depolarization (GO:0051882)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006430	lysyl-tRNA aminoacylation (GO:0006430)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002077	acrosome matrix dispersal (GO:0002077)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002074	extraocular skeletal muscle development (GO:0002074)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002072	optic cup morphogenesis involved in camera-type eye development (GO:0002072)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0071454	cellular response to anoxia (GO:0071454)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006429	leucyl-tRNA aminoacylation (GO:0006429)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006428	isoleucyl-tRNA aminoacylation (GO:0006428)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006427	histidyl-tRNA aminoacylation (GO:0006427)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014036	neural crest cell fate specification (GO:0014036)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051878	lateral element assembly (GO:0051878)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006426	glycyl-tRNA aminoacylation (GO:0006426)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051877	pigment granule aggregation in cell center (GO:0051877)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006425	glutaminyl-tRNA aminoacylation (GO:0006425)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006424	glutamyl-tRNA aminoacylation (GO:0006424)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051875	pigment granule localization (GO:0051875)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0006423	cysteinyl-tRNA aminoacylation (GO:0006423)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006420	arginyl-tRNA aminoacylation (GO:0006420)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1990771	clathrin-dependent extracellular exosome endocytosis (GO:1990771)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071449	cellular response to lipid hydroperoxide (GO:0071449)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071447	cellular response to hydroperoxide (GO:0071447)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0071441	negative regulation of histone H3-K14 acetylation (GO:0071441)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006419	alanyl-tRNA aminoacylation (GO:0006419)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014028	notochord formation (GO:0014028)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051867	general adaptation syndrome, behavioral process (GO:0051867)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006415	translational termination (GO:0006415)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0006414	translational elongation (GO:0006414)	44	0	2.58	-	 < 0.01	1.76E-01	7.07E-01
GO:0006413	translational initiation (GO:0006413)	70	0	4.11	-	 < 0.01	3.32E-02	2.90E-01
GO:0014022	neural plate elongation (GO:0014022)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990764	myofibroblast contraction (GO:1990764)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002051	osteoblast fate commitment (GO:0002051)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045199	maintenance of epithelial cell apical/basal polarity (GO:0045199)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0006409	tRNA export from nucleus (GO:0006409)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006408	snRNA export from nucleus (GO:0006408)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0014017	neuroblast fate commitment (GO:0014017)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006407	rRNA export from nucleus (GO:0006407)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014016	neuroblast differentiation (GO:0014016)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1990758	mitotic sister chromatid biorientation (GO:1990758)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006406	mRNA export from nucleus (GO:0006406)	65	0	3.82	-	 < 0.01	5.11E-02	3.86E-01
GO:0006405	RNA export from nucleus (GO:0006405)	84	0	4.93	-	 < 0.01	1.48E-02	1.72E-01
GO:0006404	RNA import into nucleus (GO:0006404)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990755	mitotic spindle microtubule depolymerization (GO:1990755)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014010	Schwann cell proliferation (GO:0014010)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006400	tRNA modification (GO:0006400)	94	0	5.52	-	 < 0.01	1.04E-02	1.30E-01
GO:0002043	blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002041	intussusceptive angiogenesis (GO:0002041)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045188	regulation of circadian sleep/wake cycle, non-REM sleep (GO:0045188)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045186	zonula adherens assembly (GO:0045186)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071423	malate transmembrane transport (GO:0071423)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071422	succinate transmembrane transport (GO:0071422)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0071420	cellular response to histamine (GO:0071420)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0014008	positive regulation of microglia differentiation (GO:0014008)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014006	regulation of microglia differentiation (GO:0014006)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901787	benzoyl-CoA metabolic process (GO:1901787)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990743	protein sialylation (GO:1990743)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002038	positive regulation of L-glutamate import across plasma membrane (GO:0002038)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002037	negative regulation of L-glutamate import across plasma membrane (GO:0002037)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002033	angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002033)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002031	G protein-coupled receptor internalization (GO:0002031)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0045175	basal protein localization (GO:0045175)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071418	cellular response to amine stimulus (GO:0071418)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071413	cellular response to hydroxyisoflavone (GO:0071413)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071412	cellular response to genistein (GO:0071412)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990739	granulosa cell proliferation (GO:1990739)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990737	response to manganese-induced endoplasmic reticulum stress (GO:1990737)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051835	positive regulation of synapse structural plasticity (GO:0051835)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002023	reduction of food intake in response to dietary excess (GO:0002023)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045168	cell-cell signaling involved in cell fate commitment (GO:0045168)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045167	asymmetric protein localization involved in cell fate determination (GO:0045167)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045163	clustering of voltage-gated potassium channels (GO:0045163)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071403	cellular response to high density lipoprotein particle stimulus (GO:0071403)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033197	response to vitamin E (GO:0033197)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0071401	cellular response to triglyceride (GO:0071401)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071400	cellular response to oleic acid (GO:0071400)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051823	regulation of synapse structural plasticity (GO:0051823)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002019	regulation of renal output by angiotensin (GO:0002019)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002017	regulation of blood volume by renal aldosterone (GO:0002017)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033184	positive regulation of histone ubiquitination (GO:0033184)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033183	negative regulation of histone ubiquitination (GO:0033183)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0033182	regulation of histone ubiquitination (GO:0033182)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1901753	leukotriene A4 biosynthetic process (GO:1901753)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901751	leukotriene A4 metabolic process (GO:1901751)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0005998	xylulose catabolic process (GO:0005998)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901750	leukotriene D4 biosynthetic process (GO:1901750)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0005997	xylulose metabolic process (GO:0005997)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002007	detection of hypoxic conditions in blood by chemoreceptor signaling (GO:0002007)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0005993	trehalose catabolic process (GO:0005993)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0005991	trehalose metabolic process (GO:0005991)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0005990	lactose catabolic process (GO:0005990)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090598	male anatomical structure morphogenesis (GO:0090598)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090594	inflammatory response to wounding (GO:0090594)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0045141	meiotic telomere clustering (GO:0045141)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1901749	leukotriene D4 catabolic process (GO:1901749)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901748	leukotriene D4 metabolic process (GO:1901748)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1990709	presynaptic active zone organization (GO:1990709)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1990708	conditioned place preference (GO:1990708)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0005989	lactose biosynthetic process (GO:0005989)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0005988	lactose metabolic process (GO:0005988)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901740	negative regulation of myoblast fusion (GO:1901740)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0005987	sucrose catabolic process (GO:0005987)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990700	nucleolar chromatin organization (GO:1990700)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0005986	sucrose biosynthetic process (GO:0005986)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0005985	sucrose metabolic process (GO:0005985)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0005984	disaccharide metabolic process (GO:0005984)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0005983	starch catabolic process (GO:0005983)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0005982	starch metabolic process (GO:0005982)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033169	histone H3-K9 demethylation (GO:0033169)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1901733	quercetin catabolic process (GO:1901733)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901732	quercetin metabolic process (GO:1901732)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033153	T cell receptor V(D)J recombination (GO:0033153)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070995	NADPH oxidation (GO:0070995)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0033152	immunoglobulin V(D)J recombination (GO:0033152)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070994	detection of oxidative stress (GO:0070994)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901726	negative regulation of histone deacetylase activity (GO:1901726)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033151	V(D)J recombination (GO:0033151)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:1901723	negative regulation of cell proliferation involved in kidney development (GO:1901723)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0045117	azole transmembrane transport (GO:0045117)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0045116	protein neddylation (GO:0045116)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0045113	regulation of integrin biosynthetic process (GO:0045113)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0045112	integrin biosynthetic process (GO:0045112)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045110	intermediate filament bundle assembly (GO:0045110)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0070989	oxidative demethylation (GO:0070989)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0070988	demethylation (GO:0070988)	64	0	3.76	-	 < 0.01	5.04E-02	3.81E-01
GO:0070987	error-free translesion synthesis (GO:0070987)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0033141	positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0033140	negative regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033140)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070982	L-asparagine metabolic process (GO:0070982)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070981	L-asparagine biosynthetic process (GO:0070981)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070980	biphenyl catabolic process (GO:0070980)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045107	intermediate filament polymerization (GO:0045107)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090557	establishment of endothelial intestinal barrier (GO:0090557)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0045105	intermediate filament polymerization or depolymerization (GO:0045105)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033139	regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0033133	positive regulation of glucokinase activity (GO:0033133)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0033132	negative regulation of glucokinase activity (GO:0033132)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901706	mesenchymal cell differentiation involved in bone development (GO:1901706)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033131	regulation of glucokinase activity (GO:0033131)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0001582	detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001581	detection of chemical stimulus involved in sensory perception of sour taste (GO:0001581)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070966	nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070965	positive regulation of neutrophil mediated killing of fungus (GO:0070965)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070963	positive regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070963)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070962	positive regulation of neutrophil mediated killing of bacterium (GO:0070962)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070961	positive regulation of neutrophil mediated killing of symbiont cell (GO:0070961)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070960	positive regulation of neutrophil mediated cytotoxicity (GO:0070960)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0001579	medium-chain fatty acid transport (GO:0001579)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001576	globoside biosynthetic process (GO:0001576)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001575	globoside metabolic process (GO:0001575)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001572	lactosylceramide biosynthetic process (GO:0001572)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033119	negative regulation of RNA splicing (GO:0033119)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0070953	regulation of neutrophil mediated killing of fungus (GO:0070953)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070951	regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070951)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070950	regulation of neutrophil mediated killing of bacterium (GO:0070950)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090529	cell septum assembly (GO:0090529)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140374	antiviral innate immune response (GO:0140374)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0001561	fatty acid alpha-oxidation (GO:0001561)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0090522	vesicle tethering involved in exocytosis (GO:0090522)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0033108	mitochondrial respiratory chain complex assembly (GO:0033108)	99	0	5.81	-	 < 0.01	6.69E-03	9.36E-02
GO:0070949	regulation of neutrophil mediated killing of symbiont cell (GO:0070949)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070948	regulation of neutrophil mediated cytotoxicity (GO:0070948)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0070947	neutrophil-mediated killing of fungus (GO:0070947)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070945	neutrophil-mediated killing of gram-negative bacterium (GO:0070945)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070940	dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0001555	oocyte growth (GO:0001555)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001552	ovarian follicle atresia (GO:0001552)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070934	CRD-mediated mRNA stabilization (GO:0070934)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:2000397	positive regulation of ubiquitin-dependent endocytosis (GO:2000397)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000395	regulation of ubiquitin-dependent endocytosis (GO:2000395)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000393	negative regulation of lamellipodium morphogenesis (GO:2000393)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000391	positive regulation of neutrophil extravasation (GO:2000391)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0140354	lipid import into cell (GO:0140354)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0001546	preantral ovarian follicle growth (GO:0001546)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0001545	primary ovarian follicle growth (GO:0001545)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001544	initiation of primordial ovarian follicle growth (GO:0001544)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001543	ovarian follicle rupture (GO:0001543)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090503	RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	43	0	2.52	-	 < 0.01	1.74E-01	7.00E-01
GO:0090500	endocardial cushion to mesenchymal transition (GO:0090500)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070926	regulation of ATP:ADP antiporter activity (GO:0070926)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070922	RISC complex assembly (GO:0070922)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0070921	regulation of siRNA production (GO:0070921)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000389	regulation of neutrophil extravasation (GO:2000389)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:2000388	positive regulation of antral ovarian follicle growth (GO:2000388)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000387	regulation of antral ovarian follicle growth (GO:2000387)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000386	positive regulation of ovarian follicle development (GO:2000386)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000384	negative regulation of ectoderm development (GO:2000384)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000383	regulation of ectoderm development (GO:2000383)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000382	positive regulation of mesoderm development (GO:2000382)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000381	negative regulation of mesoderm development (GO:2000381)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000380	regulation of mesoderm development (GO:2000380)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0070918	small regulatory ncRNA processing (GO:0070918)	38	0	2.23	-	 < 0.01	2.72E-01	8.69E-01
GO:0070914	UV-damage excision repair (GO:0070914)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0070911	global genome nucleotide-excision repair (GO:0070911)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000376	positive regulation of oxygen metabolic process (GO:2000376)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000374	regulation of oxygen metabolic process (GO:2000374)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000370	positive regulation of clathrin-dependent endocytosis (GO:2000370)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0140331	aminophospholipid translocation (GO:0140331)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0001522	pseudouridine synthesis (GO:0001522)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0070902	mitochondrial tRNA pseudouridine synthesis (GO:0070902)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070901	mitochondrial tRNA methylation (GO:0070901)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032696	negative regulation of interleukin-13 production (GO:0032696)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0070900	mitochondrial tRNA modification (GO:0070900)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0032693	negative regulation of interleukin-10 production (GO:0032693)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:2000369	regulation of clathrin-dependent endocytosis (GO:2000369)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:2000368	positive regulation of acrosomal vesicle exocytosis (GO:2000368)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0140329	lysophospholipid translocation (GO:0140329)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000363	positive regulation of prostaglandin-E synthase activity (GO:2000363)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0001519	peptide amidation (GO:0001519)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000361	regulation of prostaglandin-E synthase activity (GO:2000361)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000360	negative regulation of binding of sperm to zona pellucida (GO:2000360)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0001514	selenocysteine incorporation (GO:0001514)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0001510	RNA methylation (GO:0001510)	92	0	5.40	-	 < 0.01	1.00E-02	1.27E-01
GO:0032687	negative regulation of interferon-alpha production (GO:0032687)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032685	negative regulation of granulocyte macrophage colony-stimulating factor production (GO:0032685)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032683	negative regulation of connective tissue growth factor production (GO:0032683)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000359	regulation of binding of sperm to zona pellucida (GO:2000359)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000358	positive regulation of kidney smooth muscle cell differentiation (GO:2000358)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032681	regulation of lymphotoxin A production (GO:0032681)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000357	negative regulation of kidney smooth muscle cell differentiation (GO:2000357)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000356	regulation of kidney smooth muscle cell differentiation (GO:2000356)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000355	negative regulation of ovarian follicle development (GO:2000355)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000354	regulation of ovarian follicle development (GO:2000354)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0001507	acetylcholine catabolic process in synaptic cleft (GO:0001507)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000350	positive regulation of CD40 signaling pathway (GO:2000350)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044648	histone H3-K4 dimethylation (GO:0044648)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032679	regulation of TRAIL production (GO:0032679)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000349	negative regulation of CD40 signaling pathway (GO:2000349)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032672	regulation of interleukin-3 production (GO:0032672)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000347	positive regulation of hepatocyte proliferation (GO:2000347)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:2000343	positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:2000340	positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0140300	serine import into mitochondrion (GO:0140300)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0018395	peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032667	regulation of interleukin-23 production (GO:0032667)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:2000338	regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000338)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032661	regulation of interleukin-18 production (GO:0032661)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:2000334	positive regulation of blood microparticle formation (GO:2000334)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000332	regulation of blood microparticle formation (GO:2000332)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000331	regulation of terminal button organization (GO:2000331)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000330	positive regulation of T-helper 17 cell lineage commitment (GO:2000330)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902178	fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902177	positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:1902175	regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:1902173	negative regulation of keratinocyte apoptotic process (GO:1902173)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032659	regulation of interleukin-16 production (GO:0032659)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032658	regulation of interleukin-15 production (GO:0032658)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000329	negative regulation of T-helper 17 cell lineage commitment (GO:2000329)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000328	regulation of T-helper 17 cell lineage commitment (GO:2000328)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000320	negative regulation of T-helper 17 cell differentiation (GO:2000320)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0018377	protein myristoylation (GO:0018377)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902167	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902164	positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902162	regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902161	positive regulation of cyclic nucleotide-gated ion channel activity (GO:1902161)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032645	regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0032644	regulation of fractalkine production (GO:0032644)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032643	regulation of connective tissue growth factor production (GO:0032643)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000317	negative regulation of T-helper 17 type immune response (GO:2000317)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:2000314	negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000314)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000313	regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000313)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000312	regulation of kainate selective glutamate receptor activity (GO:2000312)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902159	regulation of cyclic nucleotide-gated ion channel activity (GO:1902159)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018364	peptidyl-glutamine methylation (GO:0018364)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902153	regulation of response to DNA damage checkpoint signaling (GO:1902153)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902151	regulation of response to DNA integrity checkpoint signaling (GO:1902151)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006398	mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0044602	protein deadenylylation (GO:0044602)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044601	protein denucleotidylation (GO:0044601)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006393	termination of mitochondrial transcription (GO:0006393)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032637	interleukin-8 production (GO:0032637)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006392	transcription elongation by mitochondrial RNA polymerase (GO:0006392)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006391	transcription initiation at mitochondrial promoter (GO:0006391)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000309	positive regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000309)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000308	negative regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000308)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000307	regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000307)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000304	positive regulation of ceramide biosynthetic process (GO:2000304)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000303	regulation of ceramide biosynthetic process (GO:2000303)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:2000301	negative regulation of synaptic vesicle exocytosis (GO:2000301)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902145	regulation of response to cell cycle checkpoint signaling (GO:1902145)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006388	tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0006386	termination of RNA polymerase III transcription (GO:0006386)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006384	transcription initiation at RNA polymerase III promoter (GO:0006384)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0006383	transcription by RNA polymerase III (GO:0006383)	32	0	1.88	-	 < 0.01	2.60E-01	8.48E-01
GO:0018344	protein geranylgeranylation (GO:0018344)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0018343	protein farnesylation (GO:0018343)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0018342	protein prenylation (GO:0018342)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0006370	7-methylguanosine mRNA capping (GO:0006370)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0018335	protein succinylation (GO:0018335)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071395	cellular response to jasmonic acid stimulus (GO:0071395)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006369	termination of RNA polymerase II transcription (GO:0006369)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0006364	rRNA processing (GO:0006364)	223	0	13.09	-	 < 0.01	5.06E-06	2.04E-04
GO:0006363	termination of RNA polymerase I transcription (GO:0006363)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006362	transcription elongation by RNA polymerase I (GO:0006362)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006361	transcription initiation at RNA polymerase I promoter (GO:0006361)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0006360	transcription by RNA polymerase I (GO:0006360)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0032602	chemokine production (GO:0032602)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032600	chemokine receptor transport out of membrane raft (GO:0032600)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071389	cellular response to mineralocorticoid stimulus (GO:0071389)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0071386	cellular response to corticosterone stimulus (GO:0071386)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0006353	DNA-templated transcription termination (GO:0006353)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0071377	cellular response to glucagon stimulus (GO:0071377)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1902109	negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902108	regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0018315	molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018312	peptidyl-serine ADP-ribosylation (GO:0018312)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071370	cellular response to gibberellin stimulus (GO:0071370)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051798	positive regulation of hair follicle development (GO:0051798)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1990697	protein depalmitoleylation (GO:1990697)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051796	negative regulation of timing of catagen (GO:0051796)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051795	positive regulation of timing of catagen (GO:0051795)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051794	regulation of timing of catagen (GO:0051794)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051793	medium-chain fatty acid catabolic process (GO:0051793)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051792	medium-chain fatty acid biosynthetic process (GO:0051792)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0051790	short-chain fatty acid biosynthetic process (GO:0051790)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071362	cellular response to ether (GO:0071362)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0006337	nucleosome disassembly (GO:0006337)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0051780	behavioral response to nutrient (GO:0051780)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990680	response to melanocyte-stimulating hormone (GO:1990680)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0075713	establishment of integrated proviral latency (GO:0075713)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071358	cellular response to type III interferon (GO:0071358)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0071357	cellular response to type I interferon (GO:0071357)	44	0	2.58	-	 < 0.01	1.76E-01	7.07E-01
GO:0071355	cellular response to interleukin-9 (GO:0071355)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071352	cellular response to interleukin-2 (GO:0071352)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0071351	cellular response to interleukin-18 (GO:0071351)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0071350	cellular response to interleukin-15 (GO:0071350)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1990678	histone H4-K16 deacetylation (GO:1990678)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051771	negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071349	cellular response to interleukin-12 (GO:0071349)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0071348	cellular response to interleukin-11 (GO:0071348)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071344	diphosphate metabolic process (GO:0071344)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071340	skeletal muscle acetylcholine-gated channel clustering (GO:0071340)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006313	transposition, DNA-mediated (GO:0006313)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006311	meiotic gene conversion (GO:0006311)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071338	positive regulation of hair follicle cell proliferation (GO:0071338)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071336	regulation of hair follicle cell proliferation (GO:0071336)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071335	hair follicle cell proliferation (GO:0071335)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006309	apoptotic DNA fragmentation (GO:0006309)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0006308	DNA catabolic process (GO:0006308)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0006307	DNA dealkylation involved in DNA repair (GO:0006307)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0051758	homologous chromosome movement towards spindle pole in meiosis I anaphase (GO:0051758)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901696	cannabinoid biosynthetic process (GO:1901696)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990654	sebum secreting cell proliferation (GO:1990654)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071329	cellular response to sucrose stimulus (GO:0071329)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071324	cellular response to disaccharide stimulus (GO:0071324)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901687	glutathione derivative biosynthetic process (GO:1901687)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901685	glutathione derivative metabolic process (GO:1901685)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901684	arsenate ion transmembrane transport (GO:1901684)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990641	response to iron ion starvation (GO:1990641)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071317	cellular response to isoquinoline alkaloid (GO:0071317)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071316	cellular response to nicotine (GO:0071316)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0071315	cellular response to morphine (GO:0071315)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901678	iron coordination entity transport (GO:1901678)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1901676	positive regulation of histone H3-K27 acetylation (GO:1901676)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901675	negative regulation of histone H3-K27 acetylation (GO:1901675)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901674	regulation of histone H3-K27 acetylation (GO:1901674)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045065	cytotoxic T cell differentiation (GO:0045065)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045064	T-helper 2 cell differentiation (GO:0045064)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0045063	T-helper 1 cell differentiation (GO:0045063)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0045062	extrathymic T cell selection (GO:0045062)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071306	cellular response to vitamin E (GO:0071306)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045060	negative thymic T cell selection (GO:0045060)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0051729	germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051728	cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033092	positive regulation of immature T cell proliferation in thymus (GO:0033092)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901666	positive regulation of NAD+ ADP-ribosyltransferase activity (GO:1901666)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033091	positive regulation of immature T cell proliferation (GO:0033091)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0051725	protein de-ADP-ribosylation (GO:0051725)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901664	regulation of NAD+ ADP-ribosyltransferase activity (GO:1901664)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901663	quinone biosynthetic process (GO:1901663)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:1901662	quinone catabolic process (GO:1901662)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901661	quinone metabolic process (GO:1901661)	38	0	2.23	-	 < 0.01	2.72E-01	8.68E-01
GO:0045054	constitutive secretory pathway (GO:0045054)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0045053	protein retention in Golgi apparatus (GO:0045053)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0045050	protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0033088	negative regulation of immature T cell proliferation in thymus (GO:0033088)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0033087	negative regulation of immature T cell proliferation (GO:0033087)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0033085	negative regulation of T cell differentiation in thymus (GO:0033085)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0033084	regulation of immature T cell proliferation in thymus (GO:0033084)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1901658	glycosyl compound catabolic process (GO:1901658)	37	0	2.17	-	 < 0.01	2.68E-01	8.58E-01
GO:0033083	regulation of immature T cell proliferation (GO:0033083)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0033082	regulation of extrathymic T cell differentiation (GO:0033082)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033080	immature T cell proliferation in thymus (GO:0033080)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051715	cytolysis in another organism (GO:0051715)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051712	positive regulation of killing of cells of another organism (GO:0051712)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045048	protein insertion into ER membrane (GO:0045048)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0045046	protein import into peroxisome membrane (GO:0045046)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045041	protein import into mitochondrial intermembrane space (GO:0045041)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045040	protein insertion into mitochondrial outer membrane (GO:0045040)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0033079	immature T cell proliferation (GO:0033079)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0033078	extrathymic T cell differentiation (GO:0033078)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033076	isoquinoline alkaloid metabolic process (GO:0033076)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901647	positive regulation of synoviocyte proliferation (GO:1901647)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901645	regulation of synoviocyte proliferation (GO:1901645)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045039	protein insertion into mitochondrial inner membrane (GO:0045039)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0090481	pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0090480	purine nucleotide-sugar transmembrane transport (GO:0090480)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901634	positive regulation of synaptic vesicle membrane organization (GO:1901634)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901631	positive regulation of presynaptic membrane organization (GO:1901631)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090472	dibasic protein processing (GO:0090472)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033058	directional locomotion (GO:0033058)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070899	mitochondrial tRNA wobble uridine modification (GO:0070899)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070898	RNA polymerase III preinitiation complex assembly (GO:0070898)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070897	transcription preinitiation complex assembly (GO:0070897)	71	0	4.17	-	 < 0.01	3.36E-02	2.91E-01
GO:1901629	regulation of presynaptic membrane organization (GO:1901629)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901628	positive regulation of postsynaptic membrane organization (GO:1901628)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070895	negative regulation of transposon integration (GO:0070895)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901627	negative regulation of postsynaptic membrane organization (GO:1901627)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070894	regulation of transposon integration (GO:0070894)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901626	regulation of postsynaptic membrane organization (GO:1901626)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901625	cellular response to ergosterol (GO:1901625)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901622	positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901622)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901621	negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901620	regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0045016	mitochondrial magnesium ion transmembrane transport (GO:0045016)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090461	glutamate homeostasis (GO:0090461)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070889	platelet alpha granule organization (GO:0070889)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070881	regulation of proline transport (GO:0070881)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901610	positive regulation of vesicle transport along microtubule (GO:1901610)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0045008	depyrimidination (GO:0045008)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0045007	depurination (GO:0045007)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0045006	DNA deamination (GO:0045006)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0045004	DNA replication proofreading (GO:0045004)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045002	double-strand break repair via single-strand annealing (GO:0045002)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0033037	polysaccharide localization (GO:0033037)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901609	negative regulation of vesicle transport along microtubule (GO:1901609)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901608	regulation of vesicle transport along microtubule (GO:1901608)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0033031	positive regulation of neutrophil apoptotic process (GO:0033031)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0140298	endocytic iron import into cell (GO:0140298)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140291	peptidyl-glutamate ADP-deribosylation (GO:0140291)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0140290	peptidyl-serine ADP-deribosylation (GO:0140290)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033027	positive regulation of mast cell apoptotic process (GO:0033027)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033026	negative regulation of mast cell apoptotic process (GO:0033026)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033025	regulation of mast cell apoptotic process (GO:0033025)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033024	mast cell apoptotic process (GO:0033024)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033023	mast cell homeostasis (GO:0033023)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070863	positive regulation of protein exit from endoplasmic reticulum (GO:0070863)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0070862	negative regulation of protein exit from endoplasmic reticulum (GO:0070862)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0070861	regulation of protein exit from endoplasmic reticulum (GO:0070861)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0140289	protein mono-ADP-ribosylation (GO:0140289)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0140285	endosome fission (GO:0140285)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070859	positive regulation of bile acid biosynthetic process (GO:0070859)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070858	negative regulation of bile acid biosynthetic process (GO:0070858)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033015	tetrapyrrole catabolic process (GO:0033015)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0033014	tetrapyrrole biosynthetic process (GO:0033014)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:0033013	tetrapyrrole metabolic process (GO:0033013)	59	0	3.46	-	 < 0.01	7.83E-02	4.92E-01
GO:0090425	acinar cell differentiation (GO:0090425)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070846	Hsp90 deacetylation (GO:0070846)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070845	polyubiquitinated misfolded protein transport (GO:0070845)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070844	polyubiquitinated protein transport (GO:0070844)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070843	misfolded protein transport (GO:0070843)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070842	aggresome assembly (GO:0070842)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0070841	inclusion body assembly (GO:0070841)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0044598	doxorubicin metabolic process (GO:0044598)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0044597	daunorubicin metabolic process (GO:0044597)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0090410	malonate catabolic process (GO:0090410)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070831	basement membrane assembly (GO:0070831)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:2000296	negative regulation of hydrogen peroxide catabolic process (GO:2000296)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000293	negative regulation of defecation (GO:2000293)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000292	regulation of defecation (GO:2000292)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000290	regulation of myotome development (GO:2000290)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090403	oxidative stress-induced premature senescence (GO:0090403)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090402	oncogene-induced cell senescence (GO:0090402)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090400	stress-induced premature senescence (GO:0090400)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0044580	butyryl-CoA catabolic process (GO:0044580)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000287	positive regulation of myotome development (GO:2000287)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000284	positive regulation of cellular amino acid biosynthetic process (GO:2000284)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140245	regulation of translation at postsynapse (GO:0140245)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048936	peripheral nervous system neuron axonogenesis (GO:0048936)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0140244	regulation of translation at presynapse (GO:0140244)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140243	regulation of translation at synapse (GO:0140243)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0052187	modification by host of symbiont cellular component (GO:0052187)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0052183	modification by host of symbiont structure (GO:0052183)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044572	[4Fe-4S] cluster assembly (GO:0044572)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070816	phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0044571	[2Fe-2S] cluster assembly (GO:0044571)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0070814	hydrogen sulfide biosynthetic process (GO:0070814)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070813	hydrogen sulfide metabolic process (GO:0070813)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000277	positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000276	negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0140239	postsynaptic endocytosis (GO:0140239)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000275	regulation of oxidative phosphorylation uncoupler activity (GO:2000275)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0106383	dAMP salvage (GO:0106383)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0106381	purine deoxyribonucleotide salvage (GO:0106381)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048925	lateral line system development (GO:0048925)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0106380	purine ribonucleotide salvage (GO:0106380)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0048923	posterior lateral line neuromast hair cell differentiation (GO:0048923)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044565	dendritic cell proliferation (GO:0044565)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032599	protein transport out of membrane raft (GO:0032599)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032597	B cell receptor transport into membrane raft (GO:0032597)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032595	B cell receptor transport within lipid bilayer (GO:0032595)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000266	regulation of blood coagulation, intrinsic pathway (GO:2000266)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048919	posterior lateral line neuromast development (GO:0048919)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000261	negative regulation of blood coagulation, common pathway (GO:2000261)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048916	posterior lateral line development (GO:0048916)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000260	regulation of blood coagulation, common pathway (GO:2000260)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048915	posterior lateral line system development (GO:0048915)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000258	negative regulation of protein activation cascade (GO:2000258)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032581	ER-dependent peroxisome organization (GO:0032581)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000257	regulation of protein activation cascade (GO:2000257)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000256	positive regulation of male germ cell proliferation (GO:2000256)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000252	negative regulation of feeding behavior (GO:2000252)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0140214	positive regulation of long-chain fatty acid import into cell (GO:0140214)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000250	negative regulation of actin cytoskeleton reorganization (GO:2000250)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140213	negative regulation of long-chain fatty acid import into cell (GO:0140213)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0140212	regulation of long-chain fatty acid import into cell (GO:0140212)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0052150	modulation by symbiont of host apoptotic process (GO:0052150)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106354	tRNA surveillance (GO:0106354)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0140207	tripeptide import across plasma membrane (GO:0140207)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140206	dipeptide import across plasma membrane (GO:0140206)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0140205	oligopeptide import across plasma membrane (GO:0140205)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0044539	long-chain fatty acid import into cell (GO:0044539)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0018293	protein-FAD linkage (GO:0018293)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902082	positive regulation of calcium ion import into sarcoplasmic reticulum (GO:1902082)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0106349	snRNA methylation (GO:0106349)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000234	positive regulation of rRNA processing (GO:2000234)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:2000233	negative regulation of rRNA processing (GO:2000233)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000232	regulation of rRNA processing (GO:2000232)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0106342	omega-hydroxyceramide biosynthetic process (GO:0106342)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000231	positive regulation of pancreatic stellate cell proliferation (GO:2000231)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000230	negative regulation of pancreatic stellate cell proliferation (GO:2000230)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099639	neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0099638	endosome to plasma membrane protein transport (GO:0099638)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0099637	neurotransmitter receptor transport (GO:0099637)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0044528	regulation of mitochondrial mRNA stability (GO:0044528)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0018283	iron incorporation into metallo-sulfur cluster (GO:0018283)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902075	cellular response to salt (GO:1902075)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0018282	metal incorporation into metallo-sulfur cluster (GO:0018282)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902073	positive regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902073)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044524	protein sulfhydration (GO:0044524)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902071	regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099630	postsynaptic neurotransmitter receptor cycle (GO:0099630)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902070	positive regulation of sphingolipid mediated signaling pathway (GO:1902070)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000229	regulation of pancreatic stellate cell proliferation (GO:2000229)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000227	negative regulation of pancreatic A cell differentiation (GO:2000227)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000226	regulation of pancreatic A cell differentiation (GO:2000226)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000225	negative regulation of testosterone biosynthetic process (GO:2000225)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000224	regulation of testosterone biosynthetic process (GO:2000224)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0018279	protein N-linked glycosylation via asparagine (GO:0018279)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0018277	protein deamination (GO:0018277)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018276	isopeptide cross-linking via N6-glycyl-L-lysine (GO:0018276)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099628	neurotransmitter receptor diffusion trapping (GO:0099628)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1902068	regulation of sphingolipid mediated signaling pathway (GO:1902068)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099627	neurotransmitter receptor cycle (GO:0099627)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902065	response to L-glutamate (GO:1902065)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0018272	protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine (GO:0018272)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099624	atrial cardiac muscle cell membrane repolarization (GO:0099624)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000213	positive regulation of glutamate metabolic process (GO:2000213)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000212	negative regulation of glutamate metabolic process (GO:2000212)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000211	regulation of glutamate metabolic process (GO:2000211)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000210	positive regulation of anoikis (GO:2000210)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0018262	isopeptide cross-linking (GO:0018262)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099612	protein localization to axon (GO:0099612)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0006297	nucleotide-excision repair, DNA gap filling (GO:0006297)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006294	nucleotide-excision repair, preincision complex assembly (GO:0006294)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032536	regulation of cell projection size (GO:0032536)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0006290	pyrimidine dimer repair (GO:0006290)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0032532	regulation of microvillus length (GO:0032532)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000208	positive regulation of ribosomal small subunit export from nucleus (GO:2000208)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000206	regulation of ribosomal small subunit export from nucleus (GO:2000206)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000202	positive regulation of ribosomal subunit export from nucleus (GO:2000202)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000200	regulation of ribosomal subunit export from nucleus (GO:2000200)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099608	regulation of action potential firing pattern (GO:0099608)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902047	polyamine transmembrane transport (GO:1902047)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902045	negative regulation of Fas signaling pathway (GO:1902045)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902044	regulation of Fas signaling pathway (GO:1902044)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006288	base-excision repair, DNA ligation (GO:0006288)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006285	base-excision repair, AP site formation (GO:0006285)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0006283	transcription-coupled nucleotide-excision repair (GO:0006283)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0032527	protein exit from endoplasmic reticulum (GO:0032527)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0032525	somite rostral/caudal axis specification (GO:0032525)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1902038	positive regulation of hematopoietic stem cell differentiation (GO:1902038)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018243	protein O-linked glycosylation via threonine (GO:0018243)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1902035	positive regulation of hematopoietic stem cell proliferation (GO:1902035)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0018242	protein O-linked glycosylation via serine (GO:0018242)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1902034	negative regulation of hematopoietic stem cell proliferation (GO:1902034)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902033	regulation of hematopoietic stem cell proliferation (GO:1902033)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0000973	post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902031	regulation of NADP metabolic process (GO:1902031)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0000972	transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0000971	tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate (GO:0000971)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006274	DNA replication termination (GO:0006274)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006272	leading strand elongation (GO:0006272)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032510	endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0071298	cellular response to L-ascorbic acid (GO:0071298)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000968	tRNA exon ligation (GO:0000968)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000967	rRNA 5'-end processing (GO:0000967)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902025	nitrate import (GO:1902025)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000966	RNA 5'-end processing (GO:0000966)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:1902024	L-histidine transport (GO:1902024)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000965	mitochondrial RNA 3'-end processing (GO:0000965)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0000964	mitochondrial RNA 5'-end processing (GO:0000964)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902022	L-lysine transport (GO:1902022)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0000963	mitochondrial RNA processing (GO:0000963)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0006269	DNA replication, synthesis of RNA primer (GO:0006269)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0000962	positive regulation of mitochondrial RNA catabolic process (GO:0000962)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000961	negative regulation of mitochondrial RNA catabolic process (GO:0000961)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000960	regulation of mitochondrial RNA catabolic process (GO:0000960)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0000958	mitochondrial mRNA catabolic process (GO:0000958)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071284	cellular response to lead ion (GO:0071284)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0000957	mitochondrial RNA catabolic process (GO:0000957)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071283	cellular response to iron(III) ion (GO:0071283)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071281	cellular response to iron ion (GO:0071281)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0006258	UDP-glucose catabolic process (GO:0006258)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902010	negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006256	UDP catabolic process (GO:0006256)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006254	CTP catabolic process (GO:0006254)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006253	dCTP catabolic process (GO:0006253)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018217	peptidyl-aspartic acid phosphorylation (GO:0018217)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018216	peptidyl-arginine methylation (GO:0018216)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0018215	protein phosphopantetheinylation (GO:0018215)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071275	cellular response to aluminum ion (GO:0071275)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018214	protein carboxylation (GO:0018214)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006249	dCMP catabolic process (GO:0006249)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902001	fatty acid transmembrane transport (GO:1902001)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0006248	CMP catabolic process (GO:0006248)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902000	homogentisate catabolic process (GO:1902000)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051697	protein delipidation (GO:0051697)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006244	pyrimidine nucleotide catabolic process (GO:0006244)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0051695	actin filament uncapping (GO:0051695)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006241	CTP biosynthetic process (GO:0006241)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0051692	cellular oligosaccharide catabolic process (GO:0051692)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990592	protein K69-linked ufmylation (GO:1990592)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051691	cellular oligosaccharide metabolic process (GO:0051691)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018206	peptidyl-methionine modification (GO:0018206)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0071266	'de novo' L-methionine biosynthetic process (GO:0071266)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071264	positive regulation of translational initiation in response to starvation (GO:0071264)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018202	peptidyl-histidine modification (GO:0018202)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0071262	regulation of translational initiation in response to starvation (GO:0071262)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018201	peptidyl-glycine modification (GO:0018201)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051685	maintenance of ER location (GO:0051685)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006233	dTDP biosynthetic process (GO:0006233)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071259	cellular response to magnetism (GO:0071259)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071258	cellular response to gravity (GO:0071258)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006228	UTP biosynthetic process (GO:0006228)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1990579	peptidyl-serine trans-autophosphorylation (GO:1990579)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006227	dUDP biosynthetic process (GO:0006227)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006226	dUMP biosynthetic process (GO:0006226)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006225	UDP biosynthetic process (GO:0006225)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990575	mitochondrial L-ornithine transmembrane transport (GO:1990575)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006222	UMP biosynthetic process (GO:0006222)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0051673	membrane disruption in another organism (GO:0051673)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0075606	transport of viral material towards nucleus (GO:0075606)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071247	cellular response to chromate (GO:0071247)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071245	cellular response to carbon monoxide (GO:0071245)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071244	cellular response to carbon dioxide (GO:0071244)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000917	division septum assembly (GO:0000917)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000916	actomyosin contractile ring contraction (GO:0000916)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071242	cellular response to ammonium ion (GO:0071242)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905962	glutamatergic neuron differentiation (GO:1905962)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006218	uridine catabolic process (GO:0006218)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990569	UDP-N-acetylglucosamine transmembrane transport (GO:1990569)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006216	cytidine catabolic process (GO:0006216)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0051666	actin cortical patch localization (GO:0051666)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006214	thymidine catabolic process (GO:0006214)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051665	membrane raft localization (GO:0051665)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1990564	protein polyufmylation (GO:1990564)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006212	uracil catabolic process (GO:0006212)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006211	5-methylcytosine catabolic process (GO:0006211)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006210	thymine catabolic process (GO:0006210)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905957	regulation of cellular response to alcohol (GO:1905957)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905956	positive regulation of endothelial tube morphogenesis (GO:1905956)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071233	cellular response to leucine (GO:0071233)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0006208	pyrimidine nucleobase catabolic process (GO:0006208)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051659	maintenance of mitochondrion location (GO:0051659)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006207	'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006204	IMP catabolic process (GO:0006204)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901594	response to capsazepine (GO:1901594)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006203	dGTP catabolic process (GO:0006203)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990550	mitochondrial alpha-ketoglutarate transmembrane transport (GO:1990550)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071228	cellular response to tumor cell (GO:0071228)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905949	negative regulation of calcium ion import across plasma membrane (GO:1905949)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0071226	cellular response to molecule of fungal origin (GO:0071226)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071225	cellular response to muramyl dipeptide (GO:0071225)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1905945	regulation of response to calcium ion (GO:1905945)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071223	cellular response to lipoteichoic acid (GO:0071223)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0071221	cellular response to bacterial lipopeptide (GO:0071221)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0071220	cellular response to bacterial lipoprotein (GO:0071220)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1990549	mitochondrial NAD transmembrane transport (GO:1990549)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990548	mitochondrial FAD transmembrane transport (GO:1990548)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990547	mitochondrial phosphate ion transmembrane transport (GO:1990547)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901585	regulation of acid-sensing ion channel activity (GO:1901585)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990546	mitochondrial tricarboxylic acid transmembrane transport (GO:1990546)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051643	endoplasmic reticulum localization (GO:0051643)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1901582	positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901581	negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901580	regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990540	mitochondrial manganese ion transmembrane transport (GO:1990540)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071218	cellular response to misfolded protein (GO:0071218)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0071217	cellular response to external biotic stimulus (GO:0071217)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905938	positive regulation of germ cell proliferation (GO:1905938)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905934	negative regulation of cell fate determination (GO:1905934)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905932	positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905932)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905931	negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905931)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905930	regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905930)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1990539	fructose import across plasma membrane (GO:1990539)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051638	barbed-end actin filament uncapping (GO:0051638)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051631	regulation of acetylcholine uptake (GO:0051631)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071206	establishment of protein localization to juxtaparanode region of axon (GO:0071206)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071205	protein localization to juxtaparanode region of axon (GO:0071205)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901569	fatty acid derivative catabolic process (GO:1901569)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0051623	positive regulation of norepinephrine uptake (GO:0051623)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901561	response to benomyl (GO:1901561)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905917	positive regulation of cell differentiation involved in phenotypic switching (GO:1905917)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905916	negative regulation of cell differentiation involved in phenotypic switching (GO:1905916)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905915	regulation of cell differentiation involved in phenotypic switching (GO:1905915)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905913	negative regulation of calcium ion export across plasma membrane (GO:1905913)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905912	regulation of calcium ion export across plasma membrane (GO:1905912)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901558	response to metformin (GO:1901558)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990519	pyrimidine nucleotide import into mitochondrion (GO:1990519)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901554	response to paracetamol (GO:1901554)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901551	negative regulation of endothelial cell development (GO:1901551)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990511	piRNA biosynthetic process (GO:1990511)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901545	response to raffinose (GO:1901545)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990502	dense core granule maturation (GO:1990502)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051601	exocyst localization (GO:0051601)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090389	phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090387	phagolysosome assembly involved in apoptotic cell clearance (GO:0090387)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090386	phagosome maturation involved in apoptotic cell clearance (GO:0090386)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090385	phagosome-lysosome fusion (GO:0090385)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0090384	phagosome-lysosome docking (GO:0090384)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090383	phagosome acidification (GO:0090383)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901536	negative regulation of DNA demethylation (GO:1901536)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901534	positive regulation of hematopoietic progenitor cell differentiation (GO:1901534)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0090370	negative regulation of cholesterol efflux (GO:0090370)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901525	negative regulation of mitophagy (GO:1901525)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901523	icosanoid catabolic process (GO:1901523)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0090362	positive regulation of platelet-derived growth factor production (GO:0090362)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090361	regulation of platelet-derived growth factor production (GO:0090361)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070782	phosphatidylserine exposure on apoptotic cell surface (GO:0070782)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070781	response to biotin (GO:0070781)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090357	regulation of tryptophan metabolic process (GO:0090357)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048894	efferent axon development in a lateral line nerve (GO:0048894)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048892	lateral line nerve development (GO:0048892)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090350	negative regulation of cellular organofluorine metabolic process (GO:0090350)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070779	D-aspartate import across plasma membrane (GO:0070779)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070778	L-aspartate transmembrane transport (GO:0070778)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0070777	D-aspartate transport (GO:0070777)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901508	positive regulation of acylglycerol transport (GO:1901508)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901506	regulation of acylglycerol transport (GO:1901506)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901502	ether catabolic process (GO:1901502)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090349	negative regulation of cellular organohalogen metabolic process (GO:0090349)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048886	neuromast hair cell differentiation (GO:0048886)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090348	regulation of cellular organofluorine metabolic process (GO:0090348)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090347	regulation of cellular organohalogen metabolic process (GO:0090347)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048884	neuromast development (GO:0048884)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090346	cellular organofluorine metabolic process (GO:0090346)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090345	cellular organohalogen metabolic process (GO:0090345)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048882	lateral line development (GO:0048882)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048881	mechanosensory lateral line system development (GO:0048881)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090341	negative regulation of secretion of lysosomal enzymes (GO:0090341)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090340	positive regulation of secretion of lysosomal enzymes (GO:0090340)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048874	host-mediated regulation of intestinal microbiota composition (GO:0048874)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0070757	interleukin-35-mediated signaling pathway (GO:0070757)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090327	negative regulation of locomotion involved in locomotory behavior (GO:0090327)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090326	positive regulation of locomotion involved in locomotory behavior (GO:0090326)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090325	regulation of locomotion involved in locomotory behavior (GO:0090325)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0048859	formation of anatomical boundary (GO:0048859)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0048855	adenohypophysis morphogenesis (GO:0048855)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090315	negative regulation of protein targeting to membrane (GO:0090315)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0090314	positive regulation of protein targeting to membrane (GO:0090314)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0090313	regulation of protein targeting to membrane (GO:0090313)	35	0	2.06	-	 < 0.01	2.62E-01	8.51E-01
GO:0048850	hypophysis morphogenesis (GO:0048850)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090310	negative regulation of DNA methylation-dependent heterochromatin formation (GO:0090310)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070731	cGMP transport (GO:0070731)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070730	cAMP transport (GO:0070730)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000199	positive regulation of ribonucleoprotein complex localization (GO:2000199)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000197	regulation of ribonucleoprotein complex localization (GO:2000197)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:2000196	positive regulation of female gonad development (GO:2000196)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140157	ammonium import across plasma membrane (GO:0140157)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000193	positive regulation of fatty acid transport (GO:2000193)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:2000192	negative regulation of fatty acid transport (GO:2000192)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0090309	positive regulation of DNA methylation-dependent heterochromatin formation (GO:0090309)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:2000191	regulation of fatty acid transport (GO:2000191)	34	0	2.00	-	 < 0.01	2.61E-01	8.49E-01
GO:0090308	regulation of DNA methylation-dependent heterochromatin formation (GO:0090308)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0048845	venous blood vessel morphogenesis (GO:0048845)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0048840	otolith development (GO:0048840)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0090301	negative regulation of neural crest formation (GO:0090301)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099590	neurotransmitter receptor internalization (GO:0099590)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:2000187	positive regulation of phosphate transmembrane transport (GO:2000187)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000185	regulation of phosphate transmembrane transport (GO:2000185)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000184	positive regulation of progesterone biosynthetic process (GO:2000184)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000180	negative regulation of androgen biosynthetic process (GO:2000180)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140141	mitochondrial potassium ion transmembrane transport (GO:0140141)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070716	mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070715	sodium-dependent organic cation transport (GO:0070715)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106289	negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106289)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106288	regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106288)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000176	positive regulation of pro-T cell differentiation (GO:2000176)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000174	regulation of pro-T cell differentiation (GO:2000174)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000173	negative regulation of branching morphogenesis of a nerve (GO:2000173)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000171	negative regulation of dendrite development (GO:2000171)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:2000170	positive regulation of peptidyl-cysteine S-nitrosylation (GO:2000170)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048822	enucleate erythrocyte development (GO:0048822)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099578	regulation of translation at postsynapse, modulating synaptic transmission (GO:0099578)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048820	hair follicle maturation (GO:0048820)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0099577	regulation of translation at presynapse, modulating synaptic transmission (GO:0099577)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099576	regulation of protein catabolic process at postsynapse, modulating synaptic transmission (GO:0099576)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0099575	regulation of protein catabolic process at presynapse, modulating synaptic transmission (GO:0099575)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032499	detection of peptidoglycan (GO:0032499)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032498	detection of muramyl dipeptide (GO:0032498)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032497	detection of lipopolysaccharide (GO:0032497)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032491	detection of molecule of fungal origin (GO:0032491)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000167	regulation of planar cell polarity pathway involved in neural tube closure (GO:2000167)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048819	regulation of hair follicle maturation (GO:0048819)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0048818	positive regulation of hair follicle maturation (GO:0048818)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0106273	cytosol to ERGIC protein transport (GO:0106273)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048817	negative regulation of hair follicle maturation (GO:0048817)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0106272	protein localization to ERGIC (GO:0106272)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099564	modification of synaptic structure, modulating synaptic transmission (GO:0099564)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099562	maintenance of postsynaptic density structure (GO:0099562)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032485	regulation of Ral protein signal transduction (GO:0032485)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032484	Ral protein signal transduction (GO:0032484)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032483	regulation of Rab protein signal transduction (GO:0032483)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000158	positive regulation of ubiquitin-specific protease activity (GO:2000158)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000157	negative regulation of ubiquitin-specific protease activity (GO:2000157)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000156	regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048808	male genitalia morphogenesis (GO:0048808)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000152	regulation of ubiquitin-specific protease activity (GO:2000152)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0048807	female genitalia morphogenesis (GO:0048807)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0099555	trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099554	trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099553	trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0099553)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0099552	trans-synaptic signaling by lipid, modulating synaptic transmission (GO:0099552)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032475	otolith formation (GO:0032475)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032474	otolith morphogenesis (GO:0032474)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032472	Golgi calcium ion transport (GO:0032472)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032471	negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0032470	positive regulation of endoplasmic reticulum calcium ion concentration (GO:0032470)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0140105	interleukin-10-mediated signaling pathway (GO:0140105)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018199	peptidyl-glutamine modification (GO:0018199)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0018197	peptidyl-aspartic acid modification (GO:0018197)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0018196	peptidyl-asparagine modification (GO:0018196)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0099548	trans-synaptic signaling by nitric oxide (GO:0099548)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0018195	peptidyl-arginine modification (GO:0018195)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0099547	regulation of translation at synapse, modulating synaptic transmission (GO:0099547)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0018194	peptidyl-alanine modification (GO:0018194)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018191	peptidyl-serine octanoylation (GO:0018191)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099543	trans-synaptic signaling by soluble gas (GO:0099543)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0018190	protein octanoylation (GO:0018190)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0052041	negative regulation by symbiont of host programmed cell death (GO:0052041)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0052040	modulation by symbiont of host programmed cell death (GO:0052040)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032468	Golgi calcium ion homeostasis (GO:0032468)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032464	positive regulation of protein homooligomerization (GO:0032464)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032463	negative regulation of protein homooligomerization (GO:0032463)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032462	regulation of protein homooligomerization (GO:0032462)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000138	positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:2000137	negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032460	negative regulation of protein oligomerization (GO:0032460)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099532	synaptic vesicle endosomal processing (GO:0099532)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0032458	slow endocytic recycling (GO:0032458)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000120	positive regulation of sodium-dependent phosphate transport (GO:2000120)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0106230	protein depropionylation (GO:0106230)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018175	protein nucleotidylation (GO:0018175)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099526	presynapse to nucleus signaling pathway (GO:0099526)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044417	translocation of molecules into host (GO:0044417)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0018171	peptidyl-cysteine oxidation (GO:0018171)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032447	protein urmylation (GO:0032447)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000119	negative regulation of sodium-dependent phosphate transport (GO:2000119)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106227	peptidyl-lysine glutarylation (GO:0106227)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000110	negative regulation of macrophage apoptotic process (GO:2000110)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0099519	dense core granule cytoskeletal transport (GO:0099519)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0099517	synaptic vesicle transport along microtubule (GO:0099517)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0099515	actin filament-based transport (GO:0099515)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0099514	synaptic vesicle cytoskeletal transport (GO:0099514)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0018160	peptidyl-pyrromethane cofactor linkage (GO:0018160)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032438	melanosome organization (GO:0032438)	38	0	2.23	-	 < 0.01	2.72E-01	8.68E-01
GO:0006193	ITP catabolic process (GO:0006193)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032431	activation of phospholipase A2 activity (GO:0032431)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0040040	thermosensory behavior (GO:0040040)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106217	tRNA C3-cytosine methylation (GO:0106217)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000103	positive regulation of mammary stem cell proliferation (GO:2000103)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000101	regulation of mammary stem cell proliferation (GO:2000101)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018158	protein oxidation (GO:0018158)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0018153	isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine (GO:0018153)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099502	calcium-dependent activation of synaptic vesicle fusion (GO:0099502)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006189	'de novo' IMP biosynthetic process (GO:0006189)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006188	IMP biosynthetic process (GO:0006188)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0006186	dGDP phosphorylation (GO:0006186)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006185	dGDP biosynthetic process (GO:0006185)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0040038	polar body extrusion after meiotic divisions (GO:0040038)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006183	GTP biosynthetic process (GO:0006183)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0032425	positive regulation of mismatch repair (GO:0032425)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0040034	regulation of development, heterochronic (GO:0040034)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0032423	regulation of mismatch repair (GO:0032423)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0040031	snRNA modification (GO:0040031)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0018146	keratan sulfate biosynthetic process (GO:0018146)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0018143	nucleic acid-protein covalent cross-linking (GO:0018143)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018142	protein-DNA covalent cross-linking (GO:0018142)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006178	guanine salvage (GO:0006178)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006177	GMP biosynthetic process (GO:0006177)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0006175	dATP biosynthetic process (GO:0006175)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006174	dADP phosphorylation (GO:0006174)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006173	dADP biosynthetic process (GO:0006173)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032417	positive regulation of sodium:proton antiporter activity (GO:0032417)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032416	negative regulation of sodium:proton antiporter activity (GO:0032416)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032415	regulation of sodium:proton antiporter activity (GO:0032415)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006170	dAMP biosynthetic process (GO:0006170)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006168	adenine salvage (GO:0006168)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006167	AMP biosynthetic process (GO:0006167)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0006166	purine ribonucleoside salvage (GO:0006166)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0040019	positive regulation of embryonic development (GO:0040019)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0006161	deoxyguanosine catabolic process (GO:0006161)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032402	melanosome transport (GO:0032402)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0032401	establishment of melanosome localization (GO:0032401)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0040010	positive regulation of growth rate (GO:0040010)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032400	melanosome localization (GO:0032400)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0018126	protein hydroxylation (GO:0018126)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0018125	peptidyl-cysteine methylation (GO:0018125)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018120	peptidyl-arginine ADP-ribosylation (GO:0018120)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006157	deoxyadenosine catabolic process (GO:0006157)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0040009	regulation of growth rate (GO:0040009)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0006154	adenosine catabolic process (GO:0006154)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0006152	purine nucleoside catabolic process (GO:0006152)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0018119	peptidyl-cysteine S-nitrosylation (GO:0018119)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1905899	regulation of smooth muscle tissue development (GO:1905899)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018117	protein adenylylation (GO:0018117)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006149	deoxyinosine catabolic process (GO:0006149)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905890	regulation of cellular response to very-low-density lipoprotein particle stimulus (GO:1905890)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006148	inosine catabolic process (GO:0006148)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006147	guanine catabolic process (GO:0006147)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006145	purine nucleobase catabolic process (GO:0006145)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006144	purine nucleobase metabolic process (GO:0006144)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0051595	response to methylglyoxal (GO:0051595)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043985	histone H4-R3 methylation (GO:0043985)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0051594	detection of glucose (GO:0051594)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043984	histone H4-K16 acetylation (GO:0043984)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0043983	histone H4-K12 acetylation (GO:0043983)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0043982	histone H4-K8 acetylation (GO:0043982)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0043981	histone H4-K5 acetylation (GO:0043981)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0043980	histone H2B-K12 acetylation (GO:0043980)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0075525	viral translational termination-reinitiation (GO:0075525)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0075523	viral translational frameshifting (GO:0075523)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0075522	IRES-dependent viral translational initiation (GO:0075522)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0075521	microtubule-dependent intracellular transport of viral material towards nucleus (GO:0075521)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071169	establishment of protein localization to chromatin (GO:0071169)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0018106	peptidyl-histidine phosphorylation (GO:0018106)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071166	ribonucleoprotein complex localization (GO:0071166)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905885	positive regulation of triglyceride transport (GO:1905885)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905883	regulation of triglyceride transport (GO:1905883)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043979	histone H2B-K5 acetylation (GO:0043979)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043977	histone H2A-K5 acetylation (GO:0043977)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051586	positive regulation of dopamine uptake involved in synaptic transmission (GO:0051586)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043973	histone H3-K4 acetylation (GO:0043973)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051582	positive regulation of neurotransmitter uptake (GO:0051582)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0043972	histone H3-K23 acetylation (GO:0043972)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990481	mRNA pseudouridine synthesis (GO:1990481)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0075519	microtubule-dependent intracellular transport of viral material (GO:0075519)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0075512	clathrin-dependent endocytosis of virus by host cell (GO:0075512)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905875	negative regulation of postsynaptic density organization (GO:1905875)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905872	negative regulation of protein localization to cell leading edge (GO:1905872)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006127	glycerophosphate shuttle (GO:0006127)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043969	histone H2B acetylation (GO:0043969)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0043968	histone H2A acetylation (GO:0043968)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0006122	mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0006121	mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006120	mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	46	0	2.70	-	 < 0.01	1.82E-01	7.18E-01
GO:0031990	mRNA export from nucleus in response to heat stress (GO:0031990)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905869	negative regulation of 3'-UTR-mediated mRNA stabilization (GO:1905869)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905867	epididymis development (GO:1905867)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0071140	resolution of mitotic recombination intermediates (GO:0071140)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905860	positive regulation of heparan sulfate proteoglycan binding (GO:1905860)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006116	NADH oxidation (GO:0006116)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1990466	protein autosumoylation (GO:1990466)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006114	glycerol biosynthetic process (GO:0006114)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006113	fermentation (GO:0006113)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051563	smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051562	negative regulation of mitochondrial calcium ion concentration (GO:0051562)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043950	positive regulation of cAMP-mediated signaling (GO:0043950)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0031989	bombesin receptor signaling pathway (GO:0031989)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905858	regulation of heparan sulfate proteoglycan binding (GO:1905858)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905857	positive regulation of pentose-phosphate shunt (GO:1905857)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905856	negative regulation of pentose-phosphate shunt (GO:1905856)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905855	positive regulation of heparan sulfate binding (GO:1905855)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905853	regulation of heparan sulfate binding (GO:1905853)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006108	malate metabolic process (GO:0006108)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0006107	oxaloacetate metabolic process (GO:0006107)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0006106	fumarate metabolic process (GO:0006106)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006105	succinate metabolic process (GO:0006105)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1990456	mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006104	succinyl-CoA metabolic process (GO:0006104)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1901494	regulation of cysteine metabolic process (GO:1901494)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006102	isocitrate metabolic process (GO:0006102)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901492	positive regulation of lymphangiogenesis (GO:1901492)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006101	citrate metabolic process (GO:0006101)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051552	flavone metabolic process (GO:0051552)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901491	negative regulation of lymphangiogenesis (GO:1901491)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901490	regulation of lymphangiogenesis (GO:1901490)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1990451	cellular stress response to acidic pH (GO:1990451)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905843	regulation of cellular response to gamma radiation (GO:1905843)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051548	negative regulation of keratinocyte migration (GO:0051548)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051546	keratinocyte migration (GO:0051546)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901485	positive regulation of transcription factor catabolic process (GO:1901485)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901483	regulation of transcription factor catabolic process (GO:1901483)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990443	peptidyl-threonine autophosphorylation (GO:1990443)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051542	elastin biosynthetic process (GO:0051542)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990442	intrinsic apoptotic signaling pathway in response to nitrosative stress (GO:1990442)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990441	negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905839	negative regulation of telomeric D-loop disassembly (GO:1905839)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905838	regulation of telomeric D-loop disassembly (GO:1905838)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905835	cellular response to pyrimidine ribonucleotide (GO:1905835)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905834	response to pyrimidine ribonucleotide (GO:1905834)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905833	negative regulation of microtubule nucleation (GO:1905833)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990438	U6 2'-O-snRNA methylation (GO:1990438)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043928	exonucleolytic catabolism of deadenylated mRNA (GO:0043928)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1990437	snRNA 2'-O-methylation (GO:1990437)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901475	pyruvate transmembrane transport (GO:1901475)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0043923	positive regulation by host of viral transcription (GO:0043923)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0043922	negative regulation by host of viral transcription (GO:0043922)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0043921	modulation by host of viral transcription (GO:0043921)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031959	mineralocorticoid receptor signaling pathway (GO:0031959)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031958	corticosteroid receptor signaling pathway (GO:0031958)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0071109	superior temporal gyrus development (GO:0071109)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071108	protein K48-linked deubiquitination (GO:0071108)	34	0	2.00	-	 < 0.01	2.61E-01	8.48E-01
GO:1905828	regulation of prostaglandin catabolic process (GO:1905828)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071106	adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071105	response to interleukin-11 (GO:0071105)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071104	response to interleukin-9 (GO:0071104)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901465	positive regulation of tetrapyrrole biosynthetic process (GO:1901465)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901463	regulation of tetrapyrrole biosynthetic process (GO:1901463)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0031948	positive regulation of glucocorticoid biosynthetic process (GO:0031948)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031945	positive regulation of glucocorticoid metabolic process (GO:0031945)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990418	response to insulin-like growth factor stimulus (GO:1990418)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1990410	adrenomedullin receptor signaling pathway (GO:1990410)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090299	regulation of neural crest formation (GO:0090299)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090298	negative regulation of mitochondrial DNA replication (GO:0090298)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090297	positive regulation of mitochondrial DNA replication (GO:0090297)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0031930	mitochondria-nucleus signaling pathway (GO:0031930)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090296	regulation of mitochondrial DNA replication (GO:0090296)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090294	nitrogen catabolite activation of transcription (GO:0090294)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905808	positive regulation of synapse pruning (GO:1905808)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090293	nitrogen catabolite regulation of transcription (GO:0090293)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905806	regulation of synapse pruning (GO:1905806)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090291	negative regulation of osteoclast proliferation (GO:0090291)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905805	excitatory synapse pruning (GO:1905805)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090290	positive regulation of osteoclast proliferation (GO:0090290)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905802	regulation of cellular response to manganese ion (GO:1905802)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990401	embryonic lung development (GO:1990401)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090289	regulation of osteoclast proliferation (GO:0090289)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0090282	positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031914	negative regulation of synaptic plasticity (GO:0031914)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090275	negative regulation of somatostatin secretion (GO:0090275)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090274	positive regulation of somatostatin secretion (GO:0090274)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090273	regulation of somatostatin secretion (GO:0090273)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090272	negative regulation of fibroblast growth factor production (GO:0090272)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090271	positive regulation of fibroblast growth factor production (GO:0090271)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090270	regulation of fibroblast growth factor production (GO:0090270)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901423	response to benzene (GO:1901423)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090265	positive regulation of immune complex clearance by monocytes and macrophages (GO:0090265)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090264	regulation of immune complex clearance by monocytes and macrophages (GO:0090264)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090262	regulation of transcription-coupled nucleotide-excision repair (GO:0090262)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901419	regulation of response to alcohol (GO:1901419)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070684	seminal clot liquefaction (GO:0070684)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070682	proteasome regulatory particle assembly (GO:0070682)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070681	glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090258	negative regulation of mitochondrial fission (GO:0090258)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0048793	pronephros development (GO:0048793)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0048792	spontaneous exocytosis of neurotransmitter (GO:0048792)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048790	maintenance of presynaptic active zone structure (GO:0048790)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0090251	protein localization involved in establishment of planar polarity (GO:0090251)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901409	positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070676	intralumenal vesicle formation (GO:0070676)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901407	regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070673	response to interleukin-18 (GO:0070673)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0070672	response to interleukin-15 (GO:0070672)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070671	response to interleukin-12 (GO:0070671)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1901403	positive regulation of tetrapyrrole metabolic process (GO:1901403)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901401	regulation of tetrapyrrole metabolic process (GO:1901401)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0048789	cytoskeletal matrix organization at active zone (GO:0048789)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090249	regulation of cell migration involved in somitogenic axis elongation (GO:0090249)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090242	retinoic acid receptor signaling pathway involved in somitogenesis (GO:0090242)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090241	negative regulation of histone H4 acetylation (GO:0090241)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0070669	response to interleukin-2 (GO:0070669)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0070667	negative regulation of mast cell proliferation (GO:0070667)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090238	positive regulation of arachidonic acid secretion (GO:0090238)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0090237	regulation of arachidonic acid secretion (GO:0090237)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0048773	erythrophore differentiation (GO:0048773)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090234	regulation of kinetochore assembly (GO:0090234)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090230	regulation of centromere complex assembly (GO:0090230)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070651	nonfunctional rRNA decay (GO:0070651)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070650	actin filament bundle distribution (GO:0070650)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048769	sarcomerogenesis (GO:0048769)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0140074	cardiac endothelial to mesenchymal transition (GO:0140074)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090226	regulation of microtubule nucleation by Ran protein signal transduction (GO:0090226)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090222	centrosome-templated microtubule nucleation (GO:0090222)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090220	chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0070649	formin-nucleated actin cable assembly (GO:0070649)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0140067	peptidyl-lysine butyrylation (GO:0140067)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140066	peptidyl-lysine crotonylation (GO:0140066)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048757	pigment granule maturation (GO:0048757)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0090219	negative regulation of lipid kinase activity (GO:0090219)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0090217	negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090217)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090216	positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090216)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090215	regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090215)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0140060	axon arborization (GO:0140060)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090212	negative regulation of establishment of blood-brain barrier (GO:0090212)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070638	pyridine nucleoside catabolic process (GO:0070638)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070637	pyridine nucleoside metabolic process (GO:0070637)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070634	transepithelial ammonium transport (GO:0070634)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0140059	dendrite arborization (GO:0140059)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0090209	negative regulation of triglyceride metabolic process (GO:0090209)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0090206	negative regulation of cholesterol metabolic process (GO:0090206)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0140052	cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0140051	positive regulation of endocardial cushion to mesenchymal transition (GO:0140051)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090204	protein localization to nuclear pore (GO:0090204)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090200	positive regulation of release of cytochrome c from mitochondria (GO:0090200)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0070625	zymogen granule exocytosis (GO:0070625)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140049	regulation of endocardial cushion to mesenchymal transition (GO:0140049)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000081	positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140041	cellular detoxification of methylglyoxal (GO:0140041)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044375	regulation of peroxisome size (GO:0044375)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000078	positive regulation of type B pancreatic cell development (GO:2000078)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000077	negative regulation of type B pancreatic cell development (GO:2000077)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0140039	cell-cell adhesion in response to extracellular stimulus (GO:0140039)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000074	regulation of type B pancreatic cell development (GO:2000074)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0070602	regulation of centromeric sister chromatid cohesion (GO:0070602)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000066	positive regulation of cortisol biosynthetic process (GO:2000066)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000063	positive regulation of ureter smooth muscle cell differentiation (GO:2000063)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000062	negative regulation of ureter smooth muscle cell differentiation (GO:2000062)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000061	regulation of ureter smooth muscle cell differentiation (GO:2000061)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044357	regulation of rRNA stability (GO:0044357)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044355	clearance of foreign intracellular DNA (GO:0044355)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044351	macropinocytosis (GO:0044351)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032385	positive regulation of intracellular cholesterol transport (GO:0032385)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032384	negative regulation of intracellular cholesterol transport (GO:0032384)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032383	regulation of intracellular cholesterol transport (GO:0032383)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0032382	positive regulation of intracellular sterol transport (GO:0032382)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032381	negative regulation of intracellular sterol transport (GO:0032381)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000057	negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000057)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032380	regulation of intracellular sterol transport (GO:0032380)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:2000056	regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000056)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0140018	regulation of cytoplasmic translational fidelity (GO:0140018)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044349	DNA excision (GO:0044349)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044341	sodium-dependent phosphate transport (GO:0044341)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0044340	canonical Wnt signaling pathway involved in regulation of cell proliferation (GO:0044340)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032378	negative regulation of intracellular lipid transport (GO:0032378)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000049	positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0140009	L-aspartate import across plasma membrane (GO:0140009)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:2000044	negative regulation of cardiac cell fate specification (GO:2000044)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044339	canonical Wnt signaling pathway involved in osteoblast differentiation (GO:0044339)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0018094	protein polyglycylation (GO:0018094)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044338	canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044336	canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044335	canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0044335)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044334	canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition (GO:0044334)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044331	cell-cell adhesion mediated by cadherin (GO:0044331)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0032364	oxygen homeostasis (GO:0032364)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032361	pyridoxal phosphate catabolic process (GO:0032361)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106134	positive regulation of cardiac muscle cell contraction (GO:0106134)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018076	N-terminal peptidyl-lysine acetylation (GO:0018076)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044313	protein K6-linked deubiquitination (GO:0044313)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032349	positive regulation of aldosterone biosynthetic process (GO:0032349)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032346	positive regulation of aldosterone metabolic process (GO:0032346)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:2000019	negative regulation of male gonad development (GO:2000019)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000017	positive regulation of determination of dorsal identity (GO:2000017)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000016	negative regulation of determination of dorsal identity (GO:2000016)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:2000015	regulation of determination of dorsal identity (GO:2000015)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:2000011	regulation of adaxial/abaxial pattern formation (GO:2000011)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106121	positive regulation of cobalamin metabolic process (GO:0106121)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106120	positive regulation of sterol biosynthetic process (GO:0106120)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0018063	cytochrome c-heme linkage (GO:0018063)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006099	tricarboxylic acid cycle (GO:0006099)	31	0	1.82	-	 < 0.01	4.16E-01	1.00E00
GO:0006098	pentose-phosphate shunt (GO:0006098)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0006097	glyoxylate cycle (GO:0006097)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006096	glycolytic process (GO:0006096)	42	0	2.47	-	 < 0.01	1.72E-01	6.98E-01
GO:0106119	negative regulation of sterol biosynthetic process (GO:0106119)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:2000007	negative regulation of metanephric comma-shaped body morphogenesis (GO:2000007)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000006	regulation of metanephric comma-shaped body morphogenesis (GO:2000006)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000005	negative regulation of metanephric S-shaped body morphogenesis (GO:2000005)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000004	regulation of metanephric S-shaped body morphogenesis (GO:2000004)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:2000002	negative regulation of DNA damage checkpoint (GO:2000002)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0018057	peptidyl-lysine oxidation (GO:0018057)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006086	acetyl-CoA biosynthetic process from pyruvate (GO:0006086)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0006085	acetyl-CoA biosynthetic process (GO:0006085)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0032329	serine transport (GO:0032329)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0032328	alanine transport (GO:0032328)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0006083	acetate metabolic process (GO:0006083)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032324	molybdopterin cofactor biosynthetic process (GO:0032324)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0106104	regulation of glutamate receptor clustering (GO:0106104)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0106101	ER-dependent peroxisome localization (GO:0106101)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006072	glycerol-3-phosphate metabolic process (GO:0006072)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0006071	glycerol metabolic process (GO:0006071)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0032310	prostaglandin secretion (GO:0032310)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0018032	protein amidation (GO:0018032)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006065	UDP-glucuronate biosynthetic process (GO:0006065)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006064	glucuronate catabolic process (GO:0006064)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032308	positive regulation of prostaglandin secretion (GO:0032308)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0006063	uronic acid metabolic process (GO:0006063)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0032307	negative regulation of prostaglandin secretion (GO:0032307)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006062	sorbitol catabolic process (GO:0006062)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032306	regulation of prostaglandin secretion (GO:0032306)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0032305	positive regulation of icosanoid secretion (GO:0032305)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0006060	sorbitol metabolic process (GO:0006060)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032304	negative regulation of icosanoid secretion (GO:0032304)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032303	regulation of icosanoid secretion (GO:0032303)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0018027	peptidyl-lysine dimethylation (GO:0018027)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0018026	peptidyl-lysine monomethylation (GO:0018026)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0018021	peptidyl-histidine methylation (GO:0018021)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006059	hexitol metabolic process (GO:0006059)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006055	CMP-N-acetylneuraminate biosynthetic process (GO:0006055)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006054	N-acetylneuraminate metabolic process (GO:0006054)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0006051	N-acetylmannosamine metabolic process (GO:0006051)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006050	mannosamine metabolic process (GO:0006050)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905799	regulation of intraciliary retrograde transport (GO:1905799)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018016	N-terminal peptidyl-proline dimethylation (GO:0018016)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071076	RNA 3' uridylation (GO:0071076)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905795	cellular response to puromycin (GO:1905795)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018013	N-terminal peptidyl-glycine methylation (GO:0018013)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071073	positive regulation of phospholipid biosynthetic process (GO:0071073)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1905794	response to puromycin (GO:1905794)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0018012	N-terminal peptidyl-alanine trimethylation (GO:0018012)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071072	negative regulation of phospholipid biosynthetic process (GO:0071072)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1905793	protein localization to pericentriolar material (GO:1905793)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018011	N-terminal peptidyl-alanine methylation (GO:0018011)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071071	regulation of phospholipid biosynthetic process (GO:0071071)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0006049	UDP-N-acetylglucosamine catabolic process (GO:0006049)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006048	UDP-N-acetylglucosamine biosynthetic process (GO:0006048)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0006047	UDP-N-acetylglucosamine metabolic process (GO:0006047)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0006046	N-acetylglucosamine catabolic process (GO:0006046)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0006045	N-acetylglucosamine biosynthetic process (GO:0006045)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006044	N-acetylglucosamine metabolic process (GO:0006044)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0006043	glucosamine catabolic process (GO:0006043)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006041	glucosamine metabolic process (GO:0006041)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1990390	protein K33-linked ubiquitination (GO:1990390)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018009	N-terminal peptidyl-L-cysteine N-palmitoylation (GO:0018009)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018008	N-terminal peptidyl-glycine N-myristoylation (GO:0018008)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000738	DNA catabolic process, exonucleolytic (GO:0000738)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0000737	DNA catabolic process, endonucleolytic (GO:0000737)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0018003	peptidyl-lysine N6-acetylation (GO:0018003)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0018002	N-terminal peptidyl-glutamic acid acetylation (GO:0018002)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905782	positive regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905782)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098989	NMDA selective glutamate receptor signaling pathway (GO:0098989)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905780	regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905780)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000732	strand displacement (GO:0000732)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990386	mitotic cleavage furrow ingression (GO:1990386)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990384	hyaloid vascular plexus regression (GO:1990384)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1905778	negative regulation of exonuclease activity (GO:1905778)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905777	regulation of exonuclease activity (GO:1905777)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905776	positive regulation of DNA helicase activity (GO:1905776)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071051	polyadenylation-dependent snoRNA 3'-end processing (GO:0071051)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1905772	positive regulation of mesodermal cell differentiation (GO:1905772)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071050	sno(s)RNA polyadenylation (GO:0071050)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990379	lipid transport across blood-brain barrier (GO:1990379)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0098977	inhibitory chemical synaptic transmission (GO:0098977)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000720	pyrimidine dimer repair by nucleotide-excision repair (GO:0000720)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0098974	postsynaptic actin cytoskeleton organization (GO:0098974)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0098972	anterograde dendritic transport of mitochondrion (GO:0098972)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006021	inositol biosynthetic process (GO:0006021)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0098971	anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006020	inositol metabolic process (GO:0006020)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0098970	postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0071047	polyadenylation-dependent mRNA catabolic process (GO:0071047)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905768	negative regulation of double-stranded telomeric DNA binding (GO:1905768)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071046	nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1905767	regulation of double-stranded telomeric DNA binding (GO:1905767)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071045	nuclear histone mRNA catabolic process (GO:0071045)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000718	nucleotide-excision repair, DNA damage removal (GO:0000718)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071044	histone mRNA catabolic process (GO:0071044)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1905765	negative regulation of protection from non-homologous end joining at telomere (GO:1905765)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000717	nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071043	CUT metabolic process (GO:0071043)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905764	regulation of protection from non-homologous end joining at telomere (GO:1905764)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071042	nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0000715	nucleotide-excision repair, DNA damage recognition (GO:0000715)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071041	antisense RNA transcript catabolic process (GO:0071041)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071040	nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098969	neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0051469	vesicle fusion with vacuole (GO:0051469)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0098968	neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000711	meiotic DNA repair synthesis (GO:0000711)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0098967	exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0098967)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0000710	meiotic mismatch repair (GO:0000710)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006015	5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0051466	positive regulation of corticotropin-releasing hormone secretion (GO:0051466)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006014	D-ribose metabolic process (GO:0006014)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0098964	anterograde dendritic transport of messenger ribonucleoprotein complex (GO:0098964)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006013	mannose metabolic process (GO:0006013)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0051464	positive regulation of cortisol secretion (GO:0051464)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0098963	dendritic transport of messenger ribonucleoprotein complex (GO:0098963)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006012	galactose metabolic process (GO:0006012)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0051463	negative regulation of cortisol secretion (GO:0051463)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006011	UDP-glucose metabolic process (GO:0006011)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051462	regulation of cortisol secretion (GO:0051462)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0098961	dendritic transport of ribonucleoprotein complex (GO:0098961)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051461	positive regulation of corticotropin secretion (GO:0051461)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051460	negative regulation of corticotropin secretion (GO:0051460)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071039	nuclear polyadenylation-dependent CUT catabolic process (GO:0071039)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071038	nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0071037	nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0071036	nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000709	meiotic joint molecule formation (GO:0000709)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071035	nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0000708	meiotic strand invasion (GO:0000708)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071034	CUT catabolic process (GO:0071034)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905755	protein localization to cytoplasmic microtubule (GO:1905755)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000707	meiotic DNA recombinase assembly (GO:0000707)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071031	nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905751	positive regulation of endosome to plasma membrane protein transport (GO:1905751)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009997	negative regulation of cardioblast cell fate specification (GO:0009997)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051459	regulation of corticotropin secretion (GO:0051459)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0098958	retrograde axonal transport of mitochondrion (GO:0098958)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901398	regulation of transforming growth factor beta3 activation (GO:1901398)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990359	stress response to zinc ion (GO:1990359)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0006007	glucose catabolic process (GO:0006007)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0098957	anterograde axonal transport of mitochondrion (GO:0098957)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0006004	fucose metabolic process (GO:0006004)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0051455	monopolar spindle attachment to meiosis I kinetochore (GO:0051455)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901394	positive regulation of transforming growth factor beta1 activation (GO:1901394)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098953	receptor diffusion trapping (GO:0098953)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0006002	fructose 6-phosphate metabolic process (GO:0006002)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1901392	regulation of transforming growth factor beta1 activation (GO:1901392)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0006001	fructose catabolic process (GO:0006001)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071029	nuclear ncRNA surveillance (GO:0071029)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0071028	nuclear mRNA surveillance (GO:0071028)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1905749	regulation of endosome to plasma membrane protein transport (GO:1905749)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0071027	nuclear RNA surveillance (GO:0071027)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1905748	hard palate morphogenesis (GO:1905748)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071026	cytoplasmic RNA surveillance (GO:0071026)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905747	negative regulation of saliva secretion (GO:1905747)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0071025	RNA surveillance (GO:0071025)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:1901389	negative regulation of transforming growth factor beta activation (GO:1901389)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990349	gap junction-mediated intercellular transport (GO:1990349)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901384	positive regulation of chorionic trophoblast cell proliferation (GO:1901384)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098943	neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1901383	negative regulation of chorionic trophoblast cell proliferation (GO:1901383)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098942	retrograde trans-synaptic signaling by trans-synaptic protein complex (GO:0098942)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901382	regulation of chorionic trophoblast cell proliferation (GO:1901382)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0031860	telomeric 3' overhang formation (GO:0031860)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905737	positive regulation of L-proline import across plasma membrane (GO:1905737)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905735	regulation of L-proline import across plasma membrane (GO:1905735)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098939	dendritic transport of mitochondrion (GO:0098939)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098937	anterograde dendritic transport (GO:0098937)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1901377	organic heteropentacyclic compound catabolic process (GO:1901377)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901376	organic heteropentacyclic compound metabolic process (GO:1901376)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0098935	dendritic transport (GO:0098935)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1901374	acetate ester transport (GO:1901374)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009972	cytidine deamination (GO:0009972)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1901373	lipid hydroperoxide transport (GO:1901373)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0071000	response to magnetism (GO:0071000)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0098928	presynaptic signal transduction (GO:0098928)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098925	retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0098925)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098924	retrograde trans-synaptic signaling by nitric oxide (GO:0098924)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098923	retrograde trans-synaptic signaling by soluble gas (GO:0098923)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098921	retrograde trans-synaptic signaling by endocannabinoid (GO:0098921)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098920	retrograde trans-synaptic signaling by lipid (GO:0098920)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031848	protection from non-homologous end joining at telomere (GO:0031848)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1905719	protein localization to perinuclear region of cytoplasm (GO:1905719)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1905716	negative regulation of cornification (GO:1905716)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905715	regulation of cornification (GO:1905715)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905711	response to phosphatidylethanolamine (GO:1905711)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009956	radial pattern formation (GO:0009956)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098917	retrograde trans-synaptic signaling (GO:0098917)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0009954	proximal/distal pattern formation (GO:0009954)	35	0	2.06	-	 < 0.01	2.62E-01	8.51E-01
GO:1901355	response to rapamycin (GO:1901355)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051415	microtubule nucleation by interphase microtubule organizing center (GO:0051415)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098914	membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051413	response to cortisone (GO:0051413)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051410	detoxification of nitrogen compound (GO:0051410)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090194	negative regulation of glomerulus development (GO:0090194)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090193	positive regulation of glomerulus development (GO:0090193)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090192	regulation of glomerulus development (GO:0090192)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1905706	regulation of mitochondrial ATP synthesis coupled proton transport (GO:1905706)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090191	negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905704	positive regulation of inhibitory synapse assembly (GO:1905704)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905703	negative regulation of inhibitory synapse assembly (GO:1905703)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905702	regulation of inhibitory synapse assembly (GO:1905702)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0009949	polarity specification of anterior/posterior axis (GO:0009949)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051409	response to nitrosative stress (GO:0051409)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0098908	regulation of neuronal action potential (GO:0098908)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0009946	proximal/distal axis specification (GO:0009946)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0098906	regulation of Purkinje myocyte action potential (GO:0098906)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901346	negative regulation of vasculature development involved in avascular cornea development in camera-type eye (GO:1901346)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098905	regulation of bundle of His cell action potential (GO:0098905)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901344	response to leptomycin B (GO:1901344)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901341	positive regulation of store-operated calcium channel activity (GO:1901341)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901340	negative regulation of store-operated calcium channel activity (GO:1901340)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090188	negative regulation of pancreatic juice secretion (GO:0090188)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090187	positive regulation of pancreatic juice secretion (GO:0090187)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090186	regulation of pancreatic juice secretion (GO:0090186)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0090185	negative regulation of kidney development (GO:0090185)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090182	regulation of secretion of lysosomal enzymes (GO:0090182)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901339	regulation of store-operated calcium channel activity (GO:1901339)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1901337	thioester transport (GO:1901337)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009932	cell tip growth (GO:0009932)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901331	positive regulation of odontoblast differentiation (GO:1901331)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090176	microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090172	microtubule cytoskeleton organization involved in homologous chromosome segregation (GO:0090172)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090171	chondrocyte morphogenesis (GO:0090171)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090170	regulation of Golgi inheritance (GO:0090170)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901329	regulation of odontoblast differentiation (GO:1901329)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901328	response to cytochalasin B (GO:1901328)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901327	response to tacrolimus (GO:1901327)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901320	negative regulation of heart induction (GO:1901320)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090168	Golgi reassembly (GO:0090168)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090164	asymmetric Golgi ribbon formation (GO:0090164)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090161	Golgi ribbon formation (GO:0090161)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0090160	Golgi to lysosome transport (GO:0090160)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0070586	cell-cell adhesion involved in gastrulation (GO:0070586)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901315	negative regulation of histone H2A K63-linked ubiquitination (GO:1901315)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0009912	auditory receptor cell fate commitment (GO:0009912)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901314	regulation of histone H2A K63-linked ubiquitination (GO:1901314)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901310	positive regulation of sterol regulatory element binding protein cleavage (GO:1901310)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048698	negative regulation of collateral sprouting in absence of injury (GO:0048698)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048697	positive regulation of collateral sprouting in absence of injury (GO:0048697)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048696	regulation of collateral sprouting in absence of injury (GO:0048696)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090158	endoplasmic reticulum membrane organization (GO:0090158)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0090156	cellular sphingolipid homeostasis (GO:0090156)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0090155	negative regulation of sphingolipid biosynthetic process (GO:0090155)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0001193	maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II (GO:0001193)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048692	negative regulation of axon extension involved in regeneration (GO:0048692)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090154	positive regulation of sphingolipid biosynthetic process (GO:0090154)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0001192	maintenance of transcriptional fidelity during transcription elongation (GO:0001192)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090153	regulation of sphingolipid biosynthetic process (GO:0090153)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0048690	regulation of axon extension involved in regeneration (GO:0048690)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090152	establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090151	establishment of protein localization to mitochondrial membrane (GO:0090151)	33	0	1.94	-	 < 0.01	2.60E-01	8.47E-01
GO:1901308	regulation of sterol regulatory element binding protein cleavage (GO:1901308)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070574	cadmium ion transmembrane transport (GO:0070574)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901307	positive regulation of spermidine biosynthetic process (GO:1901307)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901304	regulation of spermidine biosynthetic process (GO:1901304)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901303	negative regulation of cargo loading into COPII-coated vesicle (GO:1901303)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901301	regulation of cargo loading into COPII-coated vesicle (GO:1901301)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901300	positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0050996	positive regulation of lipid catabolic process (GO:0050996)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0050993	dimethylallyl diphosphate metabolic process (GO:0050993)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0050992	dimethylallyl diphosphate biosynthetic process (GO:0050992)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048688	negative regulation of sprouting of injured axon (GO:0048688)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001188	RNA polymerase I preinitiation complex assembly (GO:0001188)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0090149	mitochondrial membrane fission (GO:0090149)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048686	regulation of sprouting of injured axon (GO:0048686)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090148	membrane fission (GO:0090148)	44	0	2.58	-	 < 0.01	1.76E-01	7.06E-01
GO:0048682	sprouting of injured axon (GO:0048682)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090144	mitochondrial nucleoid organization (GO:0090144)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090143	nucleoid organization (GO:0090143)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070561	vitamin D receptor signaling pathway (GO:0070561)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070560	protein secretion by platelet (GO:0070560)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048677	axon extension involved in regeneration (GO:0048677)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001174	transcriptional start site selection at RNA polymerase II promoter (GO:0001174)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090135	actin filament branching (GO:0090135)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001173	DNA-templated transcriptional start site selection (GO:0001173)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090134	cell migration involved in mesendoderm migration (GO:0090134)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001172	RNA-templated transcription (GO:0001172)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090133	mesendoderm migration (GO:0090133)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001171	reverse transcription (GO:0001171)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050976	detection of mechanical stimulus involved in sensory perception of touch (GO:0050976)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0050975	sensory perception of touch (GO:0050975)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0050973	detection of mechanical stimulus involved in equilibrioception (GO:0050973)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048664	neuron fate determination (GO:0048664)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0070544	histone H3-K36 demethylation (GO:0070544)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0070543	response to linoleic acid (GO:0070543)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070541	response to platinum ion (GO:0070541)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0050968	detection of chemical stimulus involved in sensory perception of pain (GO:0050968)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048659	smooth muscle cell proliferation (GO:0048659)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0090118	receptor-mediated endocytosis involved in cholesterol transport (GO:0090118)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090117	endosome to lysosome transport of low-density lipoprotein particle (GO:0090117)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090114	COPII-coated vesicle budding (GO:0090114)	39	0	2.29	-	 < 0.01	2.76E-01	8.80E-01
GO:0090110	COPII-coated vesicle cargo loading (GO:0090110)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0070535	histone H2A K63-linked ubiquitination (GO:0070535)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0050957	equilibrioception (GO:0050957)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0090108	positive regulation of high-density lipoprotein particle assembly (GO:0090108)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0090107	regulation of high-density lipoprotein particle assembly (GO:0090107)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048642	negative regulation of skeletal muscle tissue development (GO:0048642)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090104	pancreatic epsilon cell differentiation (GO:0090104)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070525	tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0048636	positive regulation of muscle organ development (GO:0048636)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0106091	glial cell projection elongation (GO:0106091)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048635	negative regulation of muscle organ development (GO:0048635)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0048633	positive regulation of skeletal muscle tissue growth (GO:0048633)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0048632	negative regulation of skeletal muscle tissue growth (GO:0048632)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048631	regulation of skeletal muscle tissue growth (GO:0048631)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0048630	skeletal muscle tissue growth (GO:0048630)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0044278	cell wall disruption in another organism (GO:0044278)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0106089	negative regulation of cell adhesion involved in sprouting angiogenesis (GO:0106089)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106088	regulation of cell adhesion involved in sprouting angiogenesis (GO:0106088)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048627	myoblast development (GO:0048627)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0048626	myoblast fate specification (GO:0048626)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048621	post-embryonic digestive tract morphogenesis (GO:0048621)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044269	glycerol ether catabolic process (GO:0044269)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001120	protein-DNA complex remodeling (GO:0001120)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070508	cholesterol import (GO:0070508)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032298	positive regulation of DNA-templated DNA replication initiation (GO:0032298)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0050928	negative regulation of positive chemotaxis (GO:0050928)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032290	peripheral nervous system myelin formation (GO:0032290)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0050925	negative regulation of negative chemotaxis (GO:0050925)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0106077	histone succinylation (GO:0106077)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900864	mitochondrial RNA modification (GO:1900864)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0048619	embryonic hindgut morphogenesis (GO:0048619)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0106074	aminoacyl-tRNA metabolism involved in translational fidelity (GO:0106074)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0106071	positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106071)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0001113	transcription open complex formation at RNA polymerase II promoter (GO:0001113)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001112	DNA-templated transcription open complex formation (GO:0001112)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001111	RNA polymerase II promoter clearance (GO:0001111)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050917	sensory perception of umami taste (GO:0050917)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0050915	sensory perception of sour taste (GO:0050915)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0050914	sensory perception of salty taste (GO:0050914)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0106064	regulation of cobalamin metabolic process (GO:0106064)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001109	promoter clearance during DNA-templated transcription (GO:0001109)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050911	detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	443	0	26.01	-	 < 0.01	1.39E-11	1.72E-09
GO:0001100	negative regulation of exit from mitosis (GO:0001100)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044245	polysaccharide digestion (GO:0044245)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032275	luteinizing hormone secretion (GO:0032275)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032274	gonadotropin secretion (GO:0032274)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0050904	diapedesis (GO:0050904)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0120323	lipid ubiquitination (GO:0120323)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0120322	lipid modification by small protein conjugation (GO:0120322)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032264	IMP salvage (GO:0032264)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032263	GMP salvage (GO:0032263)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032262	pyrimidine nucleotide salvage (GO:0032262)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032261	purine nucleotide salvage (GO:0032261)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0106048	spermidine deacetylation (GO:0106048)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106047	polyamine deacetylation (GO:0106047)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106046	guanine deglycation, glyoxal removal (GO:0106046)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106045	guanine deglycation, methylglyoxal removal (GO:0106045)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106044	guanine deglycation (GO:0106044)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106040	regulation of GABA-A receptor activity (GO:0106040)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032253	dense core granule localization (GO:0032253)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032252	secretory granule localization (GO:0032252)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1900827	positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900826	negative regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900826)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106035	protein maturation by [4Fe-4S] cluster transfer (GO:0106035)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0106034	protein maturation by [2Fe-2S] cluster transfer (GO:0106034)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044211	CTP salvage (GO:0044211)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044210	'de novo' CTP biosynthetic process (GO:0044210)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032244	positive regulation of nucleoside transport (GO:0032244)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032243	negative regulation of nucleoside transport (GO:0032243)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032242	regulation of nucleoside transport (GO:0032242)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032241	positive regulation of nucleobase-containing compound transport (GO:0032241)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032240	negative regulation of nucleobase-containing compound transport (GO:0032240)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044209	AMP salvage (GO:0044209)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0044208	'de novo' AMP biosynthetic process (GO:0044208)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0044206	UMP salvage (GO:0044206)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0044205	'de novo' UMP biosynthetic process (GO:0044205)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032239	regulation of nucleobase-containing compound transport (GO:0032239)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0032237	activation of store-operated calcium channel activity (GO:0032237)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0106016	positive regulation of inflammatory response to wounding (GO:0106016)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0106015	negative regulation of inflammatory response to wounding (GO:0106015)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0106014	regulation of inflammatory response to wounding (GO:0106014)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032227	negative regulation of synaptic transmission, dopaminergic (GO:0032227)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032226	positive regulation of synaptic transmission, dopaminergic (GO:0032226)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032225	regulation of synaptic transmission, dopaminergic (GO:0032225)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0032223	negative regulation of synaptic transmission, cholinergic (GO:0032223)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0106005	RNA 5'-cap (guanine-N7)-methylation (GO:0106005)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0106004	tRNA (guanine-N7)-methylation (GO:0106004)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0106001	intestinal hexose absorption (GO:0106001)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032218	riboflavin transport (GO:0032218)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032214	negative regulation of telomere maintenance via semi-conservative replication (GO:0032214)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032213	regulation of telomere maintenance via semi-conservative replication (GO:0032213)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032208	negative regulation of telomere maintenance via recombination (GO:0032208)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032207	regulation of telomere maintenance via recombination (GO:0032207)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032203	telomere formation via telomerase (GO:0032203)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032202	telomere assembly (GO:0032202)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905698	positive regulation of polysome binding (GO:1905698)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905696	regulation of polysome binding (GO:1905696)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905695	positive regulation of phosphatidic acid biosynthetic process (GO:1905695)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905693	regulation of phosphatidic acid biosynthetic process (GO:1905693)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051394	regulation of nerve growth factor receptor activity (GO:0051394)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051391	tRNA acetylation (GO:0051391)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905689	positive regulation of diacylglycerol kinase activity (GO:1905689)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905687	regulation of diacylglycerol kinase activity (GO:1905687)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905686	positive regulation of plasma membrane repair (GO:1905686)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905684	regulation of plasma membrane repair (GO:1905684)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0098887	neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0098885	modification of postsynaptic actin cytoskeleton (GO:0098885)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0098884	postsynaptic neurotransmitter receptor internalization (GO:0098884)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0098880	maintenance of postsynaptic specialization structure (GO:0098880)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1990280	RNA localization to chromatin (GO:1990280)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905676	positive regulation of adaptive immune memory response (GO:1905676)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905675	negative regulation of adaptive immune memory response (GO:1905675)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905674	regulation of adaptive immune memory response (GO:1905674)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905673	positive regulation of lysosome organization (GO:1905673)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905672	negative regulation of lysosome organization (GO:1905672)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905671	regulation of lysosome organization (GO:1905671)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0098877	neurotransmitter receptor transport to plasma membrane (GO:0098877)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:1905669	TORC1 complex assembly (GO:1905669)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905668	positive regulation of protein localization to endosome (GO:1905668)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1905667	negative regulation of protein localization to endosome (GO:1905667)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905666	regulation of protein localization to endosome (GO:1905666)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1905663	positive regulation of telomerase RNA reverse transcriptase activity (GO:1905663)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905662	negative regulation of telomerase RNA reverse transcriptase activity (GO:1905662)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905661	regulation of telomerase RNA reverse transcriptase activity (GO:1905661)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1990268	response to gold nanoparticle (GO:1990268)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051366	protein decanoylation (GO:0051366)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990267	response to transition metal nanoparticle (GO:1990267)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051365	cellular response to potassium ion starvation (GO:0051365)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990264	peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1990262	anti-Mullerian hormone signaling pathway (GO:1990262)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990261	pre-mRNA catabolic process (GO:1990261)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098856	intestinal lipid absorption (GO:0098856)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1901297	positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901297)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990258	histone glutamine methylation (GO:1990258)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051355	proprioception involved in equilibrioception (GO:0051355)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990256	signal clustering (GO:1990256)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990253	cellular response to leucine starvation (GO:1990253)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0051351	positive regulation of ligase activity (GO:0051351)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1901291	negative regulation of double-strand break repair via single-strand annealing (GO:1901291)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905647	proline import across plasma membrane (GO:1905647)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905642	negative regulation of DNA methylation (GO:1905642)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098849	cellular detoxification of cadmium ion (GO:0098849)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901289	succinyl-CoA catabolic process (GO:1901289)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1990248	regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051343	positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905636	positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905631	cellular response to glyceraldehyde (GO:1905631)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905630	response to glyceraldehyde (GO:1905630)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098829	intestinal folate absorption (GO:0098829)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098828	modulation of inhibitory postsynaptic potential (GO:0098828)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1990227	paranodal junction maintenance (GO:1990227)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051324	prophase (GO:0051324)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905612	positive regulation of mRNA cap binding (GO:1905612)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051319	G2 phase (GO:0051319)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905610	regulation of mRNA cap binding (GO:1905610)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051318	G1 phase (GO:0051318)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901257	negative regulation of macrophage colony-stimulating factor production (GO:1901257)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051316	attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098814	spontaneous synaptic transmission (GO:0098814)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1901255	nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901254	positive regulation of intracellular transport of viral material (GO:1901254)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901253	negative regulation of intracellular transport of viral material (GO:1901253)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009850	auxin metabolic process (GO:0009850)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901252	regulation of intracellular transport of viral material (GO:1901252)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051311	meiotic metaphase plate congression (GO:0051311)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901251	positive regulation of lung goblet cell differentiation (GO:1901251)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090094	metanephric cap mesenchymal cell proliferation involved in metanephros development (GO:0090094)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905609	positive regulation of smooth muscle cell-matrix adhesion (GO:1905609)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905604	negative regulation of blood-brain barrier permeability (GO:1905604)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905602	positive regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905602)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905601	negative regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905601)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901249	regulation of lung goblet cell differentiation (GO:1901249)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905600	regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051308	male meiosis chromosome separation (GO:0051308)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901248	positive regulation of lung ciliated cell differentiation (GO:1901248)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901247	negative regulation of lung ciliated cell differentiation (GO:1901247)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051306	mitotic sister chromatid separation (GO:0051306)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901246	regulation of lung ciliated cell differentiation (GO:1901246)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090086	negative regulation of protein deubiquitination (GO:0090086)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090085	regulation of protein deubiquitination (GO:0090085)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1901233	negative regulation of convergent extension involved in axis elongation (GO:1901233)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901232	regulation of convergent extension involved in axis elongation (GO:1901232)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901231	positive regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901231)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090077	foam cell differentiation (GO:0090077)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0090076	relaxation of skeletal muscle (GO:0090076)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0090074	negative regulation of protein homodimerization activity (GO:0090074)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090073	positive regulation of protein homodimerization activity (GO:0090073)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090071	negative regulation of ribosome biogenesis (GO:0090071)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901229	regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901229)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009826	unidimensional cell growth (GO:0009826)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070493	thrombin-activated receptor signaling pathway (GO:0070493)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0009822	alkaloid catabolic process (GO:0009822)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009820	alkaloid metabolic process (GO:0009820)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0090069	regulation of ribosome biogenesis (GO:0090069)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0090067	regulation of thalamus size (GO:0090067)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090063	positive regulation of microtubule nucleation (GO:0090063)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070489	T cell aggregation (GO:0070489)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070488	neutrophil aggregation (GO:0070488)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070487	monocyte aggregation (GO:0070487)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070483	detection of hypoxia (GO:0070483)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009812	flavonoid metabolic process (GO:0009812)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0070481	nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901211	negative regulation of cardiac chamber formation (GO:1901211)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901210	regulation of cardiac chamber formation (GO:1901210)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048597	post-embryonic camera-type eye morphogenesis (GO:0048597)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070478	nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070476	rRNA (guanine-N7)-methylation (GO:0070476)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070475	rRNA base methylation (GO:0070475)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1901208	negative regulation of heart looping (GO:1901208)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901207	regulation of heart looping (GO:1901207)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009804	coumarin metabolic process (GO:0009804)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070471	uterine smooth muscle contraction (GO:0070471)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901202	negative regulation of extracellular matrix assembly (GO:1901202)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050894	determination of affect (GO:0050894)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050893	sensory processing (GO:0050893)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0090044	positive regulation of tubulin deacetylation (GO:0090044)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0001080	nitrogen catabolite activation of transcription from RNA polymerase II promoter (GO:0001080)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070462	plus-end specific microtubule depolymerization (GO:0070462)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070460	thyroid-stimulating hormone secretion (GO:0070460)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0050883	musculoskeletal movement, spinal reflex action (GO:0050883)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0001079	nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090037	positive regulation of protein kinase C signaling (GO:0090037)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0090035	positive regulation of chaperone-mediated protein complex assembly (GO:0090035)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048572	short-day photoperiodism (GO:0048572)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0090034	regulation of chaperone-mediated protein complex assembly (GO:0090034)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048571	long-day photoperiodism (GO:0048571)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048570	notochord morphogenesis (GO:0048570)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0090031	positive regulation of steroid hormone biosynthetic process (GO:0090031)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070459	prolactin secretion (GO:0070459)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070458	cellular detoxification of nitrogen compound (GO:0070458)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070455	positive regulation of heme biosynthetic process (GO:0070455)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070453	regulation of heme biosynthetic process (GO:0070453)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0048561	establishment of animal organ orientation (GO:0048561)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048560	establishment of anatomical structure orientation (GO:0048560)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070446	negative regulation of oligodendrocyte progenitor proliferation (GO:0070446)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050862	positive regulation of T cell receptor signaling pathway (GO:0050862)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0050860	negative regulation of T cell receptor signaling pathway (GO:0050860)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0090010	transforming growth factor beta receptor signaling pathway involved in primitive streak formation (GO:0090010)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070434	positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070433	negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070432	regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0070430	positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0050856	regulation of T cell receptor signaling pathway (GO:0050856)	45	0	2.64	-	 < 0.01	1.79E-01	7.17E-01
GO:0070429	negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070428	regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070427	nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070426	positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0070425	negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0016999	antibiotic metabolic process (GO:0016999)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048539	bone marrow development (GO:0048539)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0070417	cellular response to cold (GO:0070417)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0120263	positive regulation of heterochromatin organization (GO:0120263)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0120262	negative regulation of heterochromatin organization (GO:0120262)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0120261	regulation of heterochromatin organization (GO:0120261)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0070413	trehalose metabolism in response to stress (GO:0070413)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048521	negative regulation of behavior (GO:0048521)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0070409	carbamoyl phosphate biosynthetic process (GO:0070409)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070408	carbamoyl phosphate metabolic process (GO:0070408)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070407	oxidation-dependent protein catabolic process (GO:0070407)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032199	reverse transcription involved in RNA-mediated transposition (GO:0032199)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032197	transposition, RNA-mediated (GO:0032197)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032196	transposition (GO:0032196)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032194	ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050828	regulation of liquid surface tension (GO:0050828)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016973	poly(A)+ mRNA export from nucleus (GO:0016973)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0050823	peptide antigen stabilization (GO:0050823)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050822	peptide stabilization (GO:0050822)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900758	negative regulation of D-amino-acid oxidase activity (GO:1900758)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900757	regulation of D-amino-acid oxidase activity (GO:1900757)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048505	regulation of timing of cell differentiation (GO:0048505)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0036531	glutathione deglycation (GO:0036531)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036530	protein deglycation, methylglyoxal removal (GO:0036530)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900749	(R)-carnitine transport (GO:1900749)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0050802	circadian sleep/wake cycle, sleep (GO:0050802)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900740	positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0120229	protein localization to motile cilium (GO:0120229)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0036529	protein deglycation, glyoxal removal (GO:0036529)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036528	peptidyl-lysine deglycation (GO:0036528)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036527	peptidyl-arginine deglycation (GO:0036527)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036526	peptidyl-cysteine deglycation (GO:0036526)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036525	protein deglycation (GO:0036525)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0120224	larynx development (GO:0120224)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0120223	larynx morphogenesis (GO:0120223)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0120221	maintenance of ciliary planar beating movement pattern (GO:0120221)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036520	astrocyte-dopaminergic neuron signaling (GO:0036520)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900739	regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900738	positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900738)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900737	negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900737)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900736	regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900736)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0036518	chemorepulsion of dopaminergic neuron axon (GO:0036518)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036517	chemoattraction of serotonergic neuron axon (GO:0036517)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036515	serotonergic neuron axon guidance (GO:0036515)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036514	dopaminergic neuron axon guidance (GO:0036514)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036512	trimming of second mannose on A branch (GO:0036512)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0120211	proacrosomal vesicle fusion (GO:0120211)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036511	trimming of first mannose on A branch (GO:0036511)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036510	trimming of terminal mannose on C branch (GO:0036510)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0075294	positive regulation by symbiont of entry into host (GO:0075294)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1900721	positive regulation of uterine smooth muscle relaxation (GO:1900721)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036509	trimming of terminal mannose on B branch (GO:0036509)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036508	protein alpha-1,2-demannosylation (GO:0036508)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0036507	protein demannosylation (GO:0036507)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0036506	maintenance of unfolded protein (GO:0036506)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036503	ERAD pathway (GO:0036503)	99	0	5.81	-	 < 0.01	6.69E-03	9.35E-02
GO:0044111	formation of structure involved in a symbiotic process (GO:0044111)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036500	ATF6-mediated unfolded protein response (GO:0036500)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0016926	protein desumoylation (GO:0016926)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1900719	regulation of uterine smooth muscle relaxation (GO:1900719)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032119	sequestering of zinc ion (GO:0032119)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032113	regulation of carbohydrate phosphatase activity (GO:0032113)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032109	positive regulation of response to nutrient levels (GO:0032109)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032108	negative regulation of response to nutrient levels (GO:0032108)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0032106	positive regulation of response to extracellular stimulus (GO:0032106)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032105	negative regulation of response to extracellular stimulus (GO:0032105)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0032100	positive regulation of appetite (GO:0032100)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905599	positive regulation of low-density lipoprotein receptor activity (GO:1905599)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905597	positive regulation of low-density lipoprotein particle receptor binding (GO:1905597)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905596	negative regulation of low-density lipoprotein particle receptor binding (GO:1905596)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905595	regulation of low-density lipoprotein particle receptor binding (GO:1905595)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905590	fibronectin fibril organization (GO:1905590)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051296	establishment of meiotic spindle orientation (GO:0051296)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098795	global gene silencing by mRNA cleavage (GO:0098795)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0043686	co-translational protein modification (GO:0043686)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051295	establishment of meiotic spindle localization (GO:0051295)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0098792	xenophagy (GO:0098792)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0051292	nuclear pore complex assembly (GO:0051292)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0012502	induction of programmed cell death (GO:0012502)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905589	positive regulation of L-arginine import across plasma membrane (GO:1905589)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905586	negative regulation of outer hair cell apoptotic process (GO:1905586)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905585	regulation of outer hair cell apoptotic process (GO:1905585)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905584	outer hair cell apoptotic process (GO:1905584)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098789	pre-mRNA cleavage required for polyadenylation (GO:0098789)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1905581	positive regulation of low-density lipoprotein particle clearance (GO:1905581)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905580	positive regulation of ERBB3 signaling pathway (GO:1905580)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098787	mRNA cleavage involved in mRNA processing (GO:0098787)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0098781	ncRNA transcription (GO:0098781)	42	0	2.47	-	 < 0.01	1.72E-01	6.98E-01
GO:0098780	response to mitochondrial depolarisation (GO:0098780)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:1990182	exosomal secretion (GO:1990182)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990180	mitochondrial tRNA 3'-end processing (GO:1990180)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905578	regulation of ERBB3 signaling pathway (GO:1905578)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905572	ganglioside GM1 transport to membrane (GO:1905572)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098779	positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1990173	protein localization to nucleoplasm (GO:1990173)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1990170	stress response to cadmium ion (GO:1990170)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990168	protein K33-linked deubiquitination (GO:1990168)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990167	protein K27-linked deubiquitination (GO:1990167)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0043654	recognition of apoptotic cell (GO:0043654)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0043651	linoleic acid metabolic process (GO:0043651)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:1905555	positive regulation of blood vessel branching (GO:1905555)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905553	regulation of blood vessel branching (GO:1905553)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905552	positive regulation of protein localization to endoplasmic reticulum (GO:1905552)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905551	negative regulation of protein localization to endoplasmic reticulum (GO:1905551)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905550	regulation of protein localization to endoplasmic reticulum (GO:1905550)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0098757	cellular response to interleukin-21 (GO:0098757)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051257	meiotic spindle midzone assembly (GO:0051257)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098756	response to interleukin-21 (GO:0098756)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009794	regulation of mitotic cell cycle, embryonic (GO:0009794)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1901194	negative regulation of formation of translation preinitiation complex (GO:1901194)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901193	regulation of formation of translation preinitiation complex (GO:1901193)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905546	cellular response to phenylpropanoid (GO:1905546)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009789	positive regulation of abscisic acid-activated signaling pathway (GO:0009789)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098749	cerebellar neuron development (GO:0098749)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905541	regulation of L-arginine import across plasma membrane (GO:1905541)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009787	regulation of abscisic acid-activated signaling pathway (GO:0009787)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901189	positive regulation of ephrin receptor signaling pathway (GO:1901189)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098746	fast, calcium ion-dependent exocytosis of neurotransmitter (GO:0098746)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901187	regulation of ephrin receptor signaling pathway (GO:1901187)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901185	negative regulation of ERBB signaling pathway (GO:1901185)	31	0	1.82	-	 < 0.01	4.16E-01	1.00E00
GO:1990145	maintenance of translational fidelity (GO:1990145)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043634	polyadenylation-dependent ncRNA catabolic process (GO:0043634)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1990144	intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043633	polyadenylation-dependent RNA catabolic process (GO:0043633)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0043630	ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process (GO:0043630)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031666	positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1905537	positive regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905537)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905535	regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905535)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905534	positive regulation of leucine import across plasma membrane (GO:1905534)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043629	ncRNA polyadenylation (GO:0043629)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098737	protein insertion into plasma membrane (GO:0098737)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043628	small regulatory ncRNA 3'-end processing (GO:0043628)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0098734	macromolecule depalmitoylation (GO:0098734)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1990134	epithelial cell apoptotic process involved in palatal shelf morphogenesis (GO:1990134)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051232	meiotic spindle elongation (GO:0051232)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043622	cortical microtubule organization (GO:0043622)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051230	spindle disassembly (GO:0051230)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901170	naphthalene catabolic process (GO:1901170)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031651	negative regulation of heat generation (GO:0031651)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905528	positive regulation of Golgi lumen acidification (GO:1905528)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905524	negative regulation of protein autoubiquitination (GO:1905524)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051228	mitotic spindle disassembly (GO:0051228)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901166	neural crest cell migration involved in autonomic nervous system development (GO:1901166)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901165	positive regulation of trophoblast cell migration (GO:1901165)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1901164	negative regulation of trophoblast cell migration (GO:1901164)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1901162	primary amino compound biosynthetic process (GO:1901162)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0043610	regulation of carbohydrate utilization (GO:0043610)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990120	messenger ribonucleoprotein complex assembly (GO:1990120)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905516	positive regulation of fertilization (GO:1905516)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905513	negative regulation of short-term synaptic potentiation (GO:1905513)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905512	regulation of short-term synaptic potentiation (GO:1905512)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009757	hexose mediated signaling (GO:0009757)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0098718	serine import across plasma membrane (GO:0098718)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901159	xylulose 5-phosphate biosynthetic process (GO:1901159)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1990117	B cell receptor apoptotic signaling pathway (GO:1990117)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009753	response to jasmonic acid (GO:0009753)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0043606	formamide metabolic process (GO:0043606)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1990116	ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0043605	cellular amide catabolic process (GO:0043605)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0098713	leucine import across plasma membrane (GO:0098713)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009751	response to salicylic acid (GO:0009751)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098712	L-glutamate import across plasma membrane (GO:0098712)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1990114	RNA polymerase II core complex assembly (GO:1990114)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098711	iron ion import across plasma membrane (GO:0098711)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043602	nitrate catabolic process (GO:0043602)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031639	plasminogen activation (GO:0031639)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0031635	adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031632	positive regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031632)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905505	positive regulation of motile cilium assembly (GO:1905505)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905503	regulation of motile cilium assembly (GO:1905503)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901148	gene expression involved in extracellular matrix organization (GO:1901148)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990108	protein linear deubiquitination (GO:1990108)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009744	response to sucrose (GO:0009744)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0098705	copper ion import across plasma membrane (GO:0098705)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901145	mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:1901145)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051204	protein insertion into mitochondrial membrane (GO:0051204)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:1901143	insulin catabolic process (GO:1901143)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009740	gibberellic acid mediated signaling pathway (GO:0009740)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0098700	neurotransmitter loading into synaptic vesicle (GO:0098700)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0031627	telomeric loop formation (GO:0031627)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009739	response to gibberellin (GO:0009739)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009732	detection of hexose stimulus (GO:0009732)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009730	detection of carbohydrate stimulus (GO:0009730)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009726	detection of endogenous stimulus (GO:0009726)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901128	gentamycin metabolic process (GO:1901128)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070392	detection of lipoteichoic acid (GO:0070392)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070391	response to lipoteichoic acid (GO:0070391)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0101030	tRNA-guanine transglycosylation (GO:0101030)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070384	Harderian gland development (GO:0070384)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0101023	vascular endothelial cell proliferation (GO:0101023)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070383	DNA cytosine deamination (GO:0070383)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0048496	maintenance of animal organ identity (GO:0048496)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0048490	anterograde synaptic vesicle transport (GO:0048490)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0070378	positive regulation of ERK5 cascade (GO:0070378)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070376	regulation of ERK5 cascade (GO:0070376)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070375	ERK5 cascade (GO:0070375)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070370	cellular heat acclimation (GO:0070370)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0050798	activated T cell proliferation (GO:0050798)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070368	positive regulation of hepatocyte differentiation (GO:0070368)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070367	negative regulation of hepatocyte differentiation (GO:0070367)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070366	regulation of hepatocyte differentiation (GO:0070366)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0050787	detoxification of mercury ion (GO:0050787)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050783	cocaine metabolic process (GO:0050783)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070352	positive regulation of white fat cell proliferation (GO:0070352)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070350	regulation of white fat cell proliferation (GO:0070350)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036499	PERK-mediated unfolded protein response (GO:0036499)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0036498	IRE1-mediated unfolded protein response (GO:0036498)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0120197	mucociliary clearance (GO:0120197)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0036496	regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036494	positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036493	positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0036492	eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0120191	negative regulation of termination of RNA polymerase II transcription (GO:0120191)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036491	regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036491)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0120190	negative regulation of bile acid secretion (GO:0120190)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036490	regulation of translation in response to endoplasmic reticulum stress (GO:0036490)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070343	white fat cell proliferation (GO:0070343)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070342	brown fat cell proliferation (GO:0070342)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070341	fat cell proliferation (GO:0070341)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070340	detection of bacterial lipopeptide (GO:0070340)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0120189	positive regulation of bile acid secretion (GO:0120189)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0120187	positive regulation of protein localization to chromatin (GO:0120187)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0120186	negative regulation of protein localization to chromatin (GO:0120186)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036486	ventral trunk neural crest cell migration (GO:0036486)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070339	response to bacterial lipopeptide (GO:0070339)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0036484	trunk neural crest cell migration (GO:0036484)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0120183	positive regulation of focal adhesion disassembly (GO:0120183)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0036483	neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0036483)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0120182	regulation of focal adhesion disassembly (GO:0120182)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0036481	intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044090	positive regulation of vacuole organization (GO:0044090)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0120179	adherens junction disassembly (GO:0120179)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036475	neuron death in response to oxidative stress (GO:0036475)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0036471	cellular response to glyoxal (GO:0036471)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050747	positive regulation of lipoprotein metabolic process (GO:0050747)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0099188	postsynaptic cytoskeleton organization (GO:0099188)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0099185	postsynaptic intermediate filament cytoskeleton organization (GO:0099185)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036466	synaptic vesicle recycling via endosome (GO:0036466)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0070318	positive regulation of G0 to G1 transition (GO:0070318)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0099180	zinc ion import into synaptic vesicle (GO:0099180)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036462	TRAIL-activated apoptotic signaling pathway (GO:0036462)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1900673	olefin metabolic process (GO:1900673)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099179	regulation of synaptic membrane adhesion (GO:0099179)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0099178	regulation of retrograde trans-synaptic signaling by endocanabinoid (GO:0099178)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044068	modulation by symbiont of host cellular process (GO:0044068)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0120158	positive regulation of collagen catabolic process (GO:0120158)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070309	lens fiber cell morphogenesis (GO:0070309)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0120154	negative regulation of ERBB4 signaling pathway (GO:0120154)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099170	postsynaptic modulation of chemical synaptic transmission (GO:0099170)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0036451	cap mRNA methylation (GO:0036451)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032099	negative regulation of appetite (GO:0032099)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0032097	positive regulation of response to food (GO:0032097)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032096	negative regulation of response to food (GO:0032096)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0032095	regulation of response to food (GO:0032095)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0036446	myofibroblast differentiation (GO:0036446)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099163	synaptic signaling by nitric oxide (GO:0099163)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036445	neuronal stem cell division (GO:0036445)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044053	translocation of peptides or proteins into host cell cytoplasm (GO:0044053)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099161	regulation of presynaptic dense core granule exocytosis (GO:0099161)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099159	regulation of modification of postsynaptic structure (GO:0099159)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0099158	regulation of recycling endosome localization within postsynapse (GO:0099158)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099156	cell-cell signaling via exosome (GO:0099156)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036438	maintenance of lens transparency (GO:0036438)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0099152	regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0099152)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032079	positive regulation of endodeoxyribonuclease activity (GO:0032079)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032078	negative regulation of endodeoxyribonuclease activity (GO:0032078)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032077	positive regulation of deoxyribonuclease activity (GO:0032077)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032076	negative regulation of deoxyribonuclease activity (GO:0032076)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032075	positive regulation of nuclease activity (GO:0032075)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032074	negative regulation of nuclease activity (GO:0032074)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0032072	regulation of restriction endodeoxyribonuclease activity (GO:0032072)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032071	regulation of endodeoxyribonuclease activity (GO:0032071)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0032070	regulation of deoxyribonuclease activity (GO:0032070)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0120126	response to copper ion starvation (GO:0120126)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0032069	regulation of nuclease activity (GO:0032069)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0044029	hypomethylation of CpG island (GO:0044029)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044028	DNA hypomethylation (GO:0044028)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0044027	hypermethylation of CpG island (GO:0044027)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0120117	T cell meandering migration (GO:0120117)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0044026	DNA hypermethylation (GO:0044026)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0120116	glucagon processing (GO:0120116)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036416	tRNA stabilization (GO:0036416)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036415	regulation of tRNA stability (GO:0036415)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032058	positive regulation of translational initiation in response to stress (GO:0032058)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032057	negative regulation of translational initiation in response to stress (GO:0032057)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0032056	positive regulation of translation in response to stress (GO:0032056)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0032055	negative regulation of translation in response to stress (GO:0032055)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0032053	ciliary basal body organization (GO:0032053)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1900620	acetate ester biosynthetic process (GO:1900620)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0032049	cardiolipin biosynthetic process (GO:0032049)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0032048	cardiolipin metabolic process (GO:0032048)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1900619	acetate ester metabolic process (GO:1900619)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0032043	mitochondrial DNA catabolic process (GO:0032043)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099116	tRNA 5'-end processing (GO:0099116)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0000495	box H/ACA RNA 3'-end processing (GO:0000495)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000494	box C/D RNA 3'-end processing (GO:0000494)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000493	box H/ACA snoRNP assembly (GO:0000493)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0044003	modulation by symbiont of host process (GO:0044003)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000492	box C/D snoRNP assembly (GO:0000492)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0000491	small nucleolar ribonucleoprotein complex assembly (GO:0000491)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0099105	ion channel modulating, G protein-coupled receptor signaling pathway (GO:0099105)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000481	maturation of 5S rRNA (GO:0000481)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000480	endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0032023	trypsinogen activation (GO:0032023)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000479	endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0000478	endonucleolytic cleavage involved in rRNA processing (GO:0000478)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0000472	endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0000470	maturation of LSU-rRNA (GO:0000470)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0032014	positive regulation of ARF protein signal transduction (GO:0032014)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000469	cleavage involved in rRNA processing (GO:0000469)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0000467	exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0000466	maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0000463	maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0000462	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	39	0	2.29	-	 < 0.01	2.76E-01	8.80E-01
GO:0000461	endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000460	maturation of 5.8S rRNA (GO:0000460)	36	0	2.11	-	 < 0.01	2.65E-01	8.49E-01
GO:0035998	7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035995	detection of muscle stretch (GO:0035995)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0035992	tendon formation (GO:0035992)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035990	tendon cell differentiation (GO:0035990)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0032000	positive regulation of fatty acid beta-oxidation (GO:0032000)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0000459	exonucleolytic trimming involved in rRNA processing (GO:0000459)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0000455	enzyme-directed rRNA pseudouridine synthesis (GO:0000455)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0000454	snoRNA guided rRNA pseudouridine synthesis (GO:0000454)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000453	enzyme-directed rRNA 2'-O-methylation (GO:0000453)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000451	rRNA 2'-O-methylation (GO:0000451)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0000448	cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000447	endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1905492	positive regulation of branching morphogenesis of a nerve (GO:1905492)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035977	protein deglycosylation involved in glycoprotein catabolic process (GO:0035977)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0043585	nose morphogenesis (GO:0043585)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035973	aggrephagy (GO:0035973)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1990092	calcium-dependent self proteolysis (GO:1990092)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035971	peptidyl-histidine dephosphorylation (GO:0035971)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000436	carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0000435	positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000432	positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051189	prosthetic group metabolic process (GO:0051189)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0000431	regulation of transcription from RNA polymerase II promoter by galactose (GO:0000431)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000430	regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035965	cardiolipin acyl-chain remodeling (GO:0035965)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0043574	peroxisomal transport (GO:0043574)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0035964	COPI-coated vesicle budding (GO:0035964)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035963	cellular response to interleukin-13 (GO:0035963)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035962	response to interleukin-13 (GO:0035962)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0000429	carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905474	canonical Wnt signaling pathway involved in stem cell proliferation (GO:1905474)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000425	pexophagy (GO:0000425)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000423	mitophagy (GO:0000423)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0000422	autophagy of mitochondrion (GO:0000422)	57	0	3.35	-	 < 0.01	7.59E-02	4.79E-01
GO:1990079	cartilage homeostasis (GO:1990079)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051176	positive regulation of sulfur metabolic process (GO:0051176)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1990074	polyuridylation-dependent mRNA catabolic process (GO:1990074)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043562	cellular response to nitrogen levels (GO:0043562)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0031591	wybutosine biosynthetic process (GO:0031591)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0031590	wybutosine metabolic process (GO:0031590)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0000416	positive regulation of histone H3-K36 methylation (GO:0000416)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905464	positive regulation of DNA duplex unwinding (GO:1905464)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000415	negative regulation of histone H3-K36 methylation (GO:0000415)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000414	regulation of histone H3-K36 methylation (GO:0000414)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1905461	positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0000411	positive regulation of transcription by galactose (GO:0000411)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043558	regulation of translational initiation in response to stress (GO:0043558)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0051167	xylulose 5-phosphate metabolic process (GO:0051167)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0043556	regulation of translation in response to oxidative stress (GO:0043556)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035946	mitochondrial mRNA surveillance (GO:0035946)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043555	regulation of translation in response to stress (GO:0043555)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0051164	L-xylitol metabolic process (GO:0051164)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035945	mitochondrial ncRNA surveillance (GO:0035945)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043553	negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0051160	L-xylitol catabolic process (GO:0051160)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031587	positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0031585	regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0031583	phospholipase D-activating G protein-coupled receptor signaling pathway (GO:0031583)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031581	hemidesmosome assembly (GO:0031581)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0031580	membrane raft distribution (GO:0031580)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1905458	positive regulation of lymphoid progenitor cell differentiation (GO:1905458)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000409	regulation of transcription by galactose (GO:0000409)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905457	negative regulation of lymphoid progenitor cell differentiation (GO:1905457)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905456	regulation of lymphoid progenitor cell differentiation (GO:1905456)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1905454	negative regulation of myeloid progenitor cell differentiation (GO:1905454)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905453	regulation of myeloid progenitor cell differentiation (GO:1905453)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009698	phenylpropanoid metabolic process (GO:0009698)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1905451	positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0098658	inorganic anion import across plasma membrane (GO:0098658)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905450	negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905450)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901097	negative regulation of autophagosome maturation (GO:1901097)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051156	glucose 6-phosphate metabolic process (GO:0051156)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0009692	ethylene metabolic process (GO:0009692)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043545	molybdopterin cofactor metabolic process (GO:0043545)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035934	corticosterone secretion (GO:0035934)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035933	glucocorticoid secretion (GO:0035933)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035932	aldosterone secretion (GO:0035932)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990051	activation of protein kinase C activity (GO:1990051)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035931	mineralocorticoid secretion (GO:0035931)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035930	corticosteroid hormone secretion (GO:0035930)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905449	regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1905445	positive regulation of clathrin coat assembly (GO:1905445)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905443	regulation of clathrin coat assembly (GO:1905443)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990049	retrograde neuronal dense core vesicle transport (GO:1990049)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0043538	regulation of actin phosphorylation (GO:0043538)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990048	anterograde neuronal dense core vesicle transport (GO:1990048)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035928	rRNA import into mitochondrion (GO:0035928)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009683	indoleacetic acid metabolic process (GO:0009683)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035927	RNA import into mitochondrion (GO:0035927)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1990046	stress-induced mitochondrial fusion (GO:1990046)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009682	induced systemic resistance (GO:0009682)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051142	positive regulation of NK T cell proliferation (GO:0051142)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1901082	positive regulation of relaxation of smooth muscle (GO:1901082)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051141	negative regulation of NK T cell proliferation (GO:0051141)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901081	negative regulation of relaxation of smooth muscle (GO:1901081)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035922	foramen ovale closure (GO:0035922)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051140	regulation of NK T cell proliferation (GO:0051140)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1901080	regulation of relaxation of smooth muscle (GO:1901080)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035921	desmosome disassembly (GO:0035921)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905438	non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1905438)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905437	positive regulation of histone H3-K4 trimethylation (GO:1905437)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905435	regulation of histone H3-K4 trimethylation (GO:1905435)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905433	negative regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905433)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905432	regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905432)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901079	positive regulation of relaxation of muscle (GO:1901079)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905430	cellular response to glycine (GO:1905430)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901076	positive regulation of engulfment of apoptotic cell (GO:1901076)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051135	positive regulation of NK T cell activation (GO:0051135)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1990036	calcium ion import into sarcoplasmic reticulum (GO:1990036)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051134	negative regulation of NK T cell activation (GO:0051134)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901074	regulation of engulfment of apoptotic cell (GO:1901074)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035915	pore formation in membrane of another organism (GO:0035915)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051133	regulation of NK T cell activation (GO:0051133)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1901073	glucosamine-containing compound biosynthetic process (GO:1901073)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1990034	calcium ion export across plasma membrane (GO:1990034)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051132	NK T cell activation (GO:0051132)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031554	regulation of termination of DNA-templated transcription (GO:0031554)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905429	response to glycine (GO:1905429)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905426	positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905426)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905424	regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905424)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0098629	trans-Golgi network membrane organization (GO:0098629)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043519	regulation of myosin II filament organization (GO:0043519)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901068	guanosine-containing compound metabolic process (GO:1901068)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990029	vasomotion (GO:1990029)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0035906	descending aorta development (GO:0035906)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051124	synaptic assembly at neuromuscular junction (GO:0051124)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051123	RNA polymerase II preinitiation complex assembly (GO:0051123)	57	0	3.35	-	 < 0.01	7.59E-02	4.79E-01
GO:0051122	hepoxilin biosynthetic process (GO:0051122)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0051121	hepoxilin metabolic process (GO:0051121)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0031549	negative regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031549)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035900	response to isolation stress (GO:0035900)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905415	positive regulation of dense core granule exocytosis (GO:1905415)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905413	regulation of dense core granule exocytosis (GO:1905413)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901053	sarcosine catabolic process (GO:1901053)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901052	sarcosine metabolic process (GO:1901052)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905408	negative regulation of creatine transmembrane transporter activity (GO:1905408)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905407	regulation of creatine transmembrane transporter activity (GO:1905407)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905404	positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905404)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905403	negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905403)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905402	regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905402)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1990009	retinal cell apoptotic process (GO:1990009)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009645	response to low light intensity stimulus (GO:0009645)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051107	negative regulation of DNA ligation (GO:0051107)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009644	response to high light intensity (GO:0009644)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051103	DNA ligation involved in DNA repair (GO:0051103)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051102	DNA ligation involved in DNA recombination (GO:0051102)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1990001	inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009635	response to herbicide (GO:0009635)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1901036	positive regulation of L-glutamine import across plasma membrane (GO:1901036)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901034	regulation of L-glutamine import across plasma membrane (GO:1901034)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009631	cold acclimation (GO:0009631)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1901033	positive regulation of response to reactive oxygen species (GO:1901033)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1901030	positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1901027	dextrin catabolic process (GO:1901027)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901026	ripoptosome assembly involved in necroptotic process (GO:1901026)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070292	N-acylphosphatidylethanolamine metabolic process (GO:0070292)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0070291	N-acylethanolamine metabolic process (GO:0070291)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070286	axonemal dynein complex assembly (GO:0070286)	40	0	2.35	-	 < 0.01	1.71E-01	6.93E-01
GO:0048392	intermediate mesodermal cell differentiation (GO:0048392)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048391	intermediate mesoderm formation (GO:0048391)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048390	intermediate mesoderm morphogenesis (GO:0048390)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009609	response to symbiotic bacterium (GO:0009609)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0009608	response to symbiont (GO:0009608)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904999	positive regulation of leukocyte adhesion to arterial endothelial cell (GO:1904999)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1901006	ubiquinone-6 biosynthetic process (GO:1901006)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901004	ubiquinone-6 metabolic process (GO:1901004)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1901003	negative regulation of fermentation (GO:1901003)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904992	positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904992)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904990	regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904990)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048389	intermediate mesoderm development (GO:0048389)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048388	endosomal lumen acidification (GO:0048388)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0048384	retinoic acid receptor signaling pathway (GO:0048384)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0048382	mesendoderm development (GO:0048382)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0070268	cornification (GO:0070268)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070267	oncosis (GO:0070267)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070266	necroptotic process (GO:0070266)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0070265	necrotic cell death (GO:0070265)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:1904985	negative regulation of quinolinate biosynthetic process (GO:1904985)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904984	regulation of quinolinate biosynthetic process (GO:1904984)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904983	glycine import into mitochondrion (GO:1904983)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904980	positive regulation of endosome organization (GO:1904980)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050686	negative regulation of mRNA processing (GO:0050686)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0050685	positive regulation of mRNA processing (GO:0050685)	35	0	2.06	-	 < 0.01	2.62E-01	8.51E-01
GO:0048378	regulation of lateral mesodermal cell fate specification (GO:0048378)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070257	positive regulation of mucus secretion (GO:0070257)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904979	negative regulation of endosome organization (GO:1904979)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070256	negative regulation of mucus secretion (GO:0070256)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904978	regulation of endosome organization (GO:1904978)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070255	regulation of mucus secretion (GO:0070255)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070254	mucus secretion (GO:0070254)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0070253	somatostatin secretion (GO:0070253)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904973	positive regulation of viral translation (GO:1904973)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904971	regulation of viral translation (GO:1904971)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904970	brush border assembly (GO:1904970)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0050677	positive regulation of urothelial cell proliferation (GO:0050677)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050675	regulation of urothelial cell proliferation (GO:0050675)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0050674	urothelial cell proliferation (GO:0050674)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036399	TCR signalosome assembly (GO:0036399)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0120094	negative regulation of peptidyl-lysine crotonylation (GO:0120094)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070247	regulation of natural killer cell apoptotic process (GO:0070247)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0120093	regulation of peptidyl-lysine crotonylation (GO:0120093)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070245	positive regulation of thymocyte apoptotic process (GO:0070245)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070244	negative regulation of thymocyte apoptotic process (GO:0070244)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0070243	regulation of thymocyte apoptotic process (GO:0070243)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0070242	thymocyte apoptotic process (GO:0070242)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0070241	positive regulation of activated T cell autonomous cell death (GO:0070241)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904960	positive regulation of cytochrome-c oxidase activity (GO:1904960)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0050667	homocysteine metabolic process (GO:0050667)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0050666	regulation of homocysteine metabolic process (GO:0050666)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048352	paraxial mesoderm structural organization (GO:0048352)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070239	regulation of activated T cell autonomous cell death (GO:0070239)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904959	regulation of cytochrome-c oxidase activity (GO:1904959)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0070234	positive regulation of T cell apoptotic process (GO:0070234)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:1904955	planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation (GO:1904955)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070230	positive regulation of lymphocyte apoptotic process (GO:0070230)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0050652	dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050652)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048343	paraxial mesodermal cell fate commitment (GO:0048343)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048342	paraxial mesodermal cell differentiation (GO:0048342)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048341	paraxial mesoderm formation (GO:0048341)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0048340	paraxial mesoderm morphogenesis (GO:0048340)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0120078	cell adhesion involved in sprouting angiogenesis (GO:0120078)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0120077	angiogenic sprout fusion (GO:0120077)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099093	calcium export from the mitochondrion (GO:0099093)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036372	opsin transport (GO:0036372)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904947	folate import into mitochondrion (GO:1904947)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070221	sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048339	paraxial mesoderm development (GO:0048339)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0048338	mesoderm structural organization (GO:0048338)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048337	positive regulation of mesodermal cell fate specification (GO:0048337)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099088	axonal transport of messenger ribonucleoprotein complex (GO:0099088)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099087	anterograde axonal transport of messenger ribonucleoprotein complex (GO:0099087)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036369	transcription factor catabolic process (GO:0036369)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036368	cone photoresponse recovery (GO:0036368)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036364	transforming growth factor beta1 activation (GO:0036364)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036363	transforming growth factor beta activation (GO:0036363)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904938	planar cell polarity pathway involved in axon guidance (GO:1904938)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070213	protein auto-ADP-ribosylation (GO:0070213)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0070212	protein poly-ADP-ribosylation (GO:0070212)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904934	negative regulation of cell proliferation in midbrain (GO:1904934)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048327	axial mesodermal cell fate specification (GO:0048327)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048322	axial mesodermal cell fate commitment (GO:0048322)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048321	axial mesodermal cell differentiation (GO:0048321)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048320	axial mesoderm formation (GO:0048320)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036359	renal potassium excretion (GO:0036359)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0120058	positive regulation of small intestinal transit (GO:0120058)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099075	mitochondrion-derived vesicle mediated transport (GO:0099075)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0120057	regulation of small intestinal transit (GO:0120057)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0099074	mitochondrion to lysosome transport (GO:0099074)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070208	protein heterotrimerization (GO:0070208)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036353	histone H2A-K119 monoubiquitination (GO:0036353)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0036352	histone H2A-K15 ubiquitination (GO:0036352)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036351	histone H2A-K13 ubiquitination (GO:0036351)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070203	regulation of establishment of protein localization to telomere (GO:0070203)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1904925	positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0070202	regulation of establishment of protein localization to chromosome (GO:0070202)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1904924	negative regulation of mitophagy in response to mitochondrial depolarization (GO:1904924)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904923	regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904923)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0048319	axial mesoderm morphogenesis (GO:0048319)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0048318	axial mesoderm development (GO:0048318)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0120049	snRNA (adenine-N6)-methylation (GO:0120049)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0120045	stereocilium maintenance (GO:0120045)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036345	platelet maturation (GO:0036345)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036343	psychomotor behavior (GO:0036343)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904914	negative regulation of establishment of protein-containing complex localization to telomere (GO:1904914)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904913	regulation of establishment of protein-containing complex localization to telomere (GO:1904913)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904911	negative regulation of establishment of RNA localization to telomere (GO:1904911)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904910	regulation of establishment of RNA localization to telomere (GO:1904910)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036339	lymphocyte adhesion to endothelial cell of high endothelial venule (GO:0036339)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036337	Fas signaling pathway (GO:0036337)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904908	negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904908)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904907	regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904907)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036331	avascular cornea development in camera-type eye (GO:0036331)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904903	ESCRT III complex disassembly (GO:1904903)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1904902	ESCRT III complex assembly (GO:1904902)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099046	clearance of foreign intracellular nucleic acids (GO:0099046)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0099044	vesicle tethering to endoplasmic reticulum (GO:0099044)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036325	vascular endothelial growth factor receptor-3 signaling pathway (GO:0036325)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036324	vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0099041	vesicle tethering to Golgi (GO:0099041)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0036323	vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036321	ghrelin secretion (GO:0036321)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900535	palmitic acid biosynthetic process (GO:1900535)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900533	palmitic acid metabolic process (GO:1900533)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036316	SREBP-SCAP complex retention in endoplasmic reticulum (GO:0036316)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0120012	intermembrane sphingolipid transfer (GO:0120012)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0120007	negative regulation of glutamatergic neuron differentiation (GO:0120007)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0120006	regulation of glutamatergic neuron differentiation (GO:0120006)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036306	embryonic heart tube elongation (GO:0036306)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036305	ameloblast differentiation (GO:0036305)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0099022	vesicle tethering (GO:0099022)	32	0	1.88	-	 < 0.01	2.60E-01	8.48E-01
GO:0036304	umbilical cord morphogenesis (GO:0036304)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000395	mRNA 5'-splice site recognition (GO:0000395)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0000394	RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0000393	spliceosomal conformational changes to generate catalytic conformation (GO:0000393)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0000390	spliceosomal complex disassembly (GO:0000390)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000389	mRNA 3'-splice site recognition (GO:0000389)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0000388	spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000387	spliceosomal snRNP assembly (GO:0000387)	38	0	2.23	-	 < 0.01	2.72E-01	8.68E-01
GO:0000380	alternative mRNA splicing, via spliceosome (GO:0000380)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0000379	tRNA-type intron splice site recognition and cleavage (GO:0000379)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000378	RNA exon ligation (GO:0000378)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035898	parathyroid hormone secretion (GO:0035898)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035891	exit from host cell (GO:0035891)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:0000354	cis assembly of pre-catalytic spliceosome (GO:0000354)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000350	generation of catalytic spliceosome for second transesterification step (GO:0000350)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043497	regulation of protein heterodimerization activity (GO:0043497)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043496	regulation of protein homodimerization activity (GO:0043496)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035881	amacrine cell differentiation (GO:0035881)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0043490	malate-aspartate shuttle (GO:0043490)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0000349	generation of catalytic spliceosome for first transesterification step (GO:0000349)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905396	cellular response to flavonoid (GO:1905396)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905395	response to flavonoid (GO:1905395)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035879	plasma membrane lactate transport (GO:0035879)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051096	positive regulation of helicase activity (GO:0051096)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0043486	histone exchange (GO:0043486)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0043485	endosome to pigment granule transport (GO:0043485)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0035874	cellular response to copper ion starvation (GO:0035874)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035873	lactate transmembrane transport (GO:0035873)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0043482	cellular pigment accumulation (GO:0043482)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0035872	nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0035871	protein K11-linked deubiquitination (GO:0035871)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0000338	protein deneddylation (GO:0000338)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1905386	positive regulation of protein localization to presynapse (GO:1905386)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905384	regulation of protein localization to presynapse (GO:1905384)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905382	positive regulation of snRNA transcription by RNA polymerase II (GO:1905382)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905381	negative regulation of snRNA transcription by RNA polymerase II (GO:1905381)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051089	constitutive protein ectodomain proteolysis (GO:0051089)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905380	regulation of snRNA transcription by RNA polymerase II (GO:1905380)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051086	chaperone mediated protein folding independent of cofactor (GO:0051086)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043476	pigment accumulation (GO:0043476)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0098583	learned vocalization behavior (GO:0098583)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043474	pigment metabolic process involved in pigmentation (GO:0043474)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0051083	'de novo' cotranslational protein folding (GO:0051083)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035863	dITP catabolic process (GO:0035863)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035862	dITP metabolic process (GO:0035862)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905373	ceramide phosphoethanolamine biosynthetic process (GO:1905373)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905371	ceramide phosphoethanolamine metabolic process (GO:1905371)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000320	re-entry into mitotic cell cycle (GO:0000320)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043465	regulation of fermentation (GO:0043465)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035854	eosinophil fate commitment (GO:0035854)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035853	chromosome passenger complex localization to spindle midzone (GO:0035853)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043461	proton-transporting ATP synthase complex assembly (GO:0043461)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1905366	negative regulation of intralumenal vesicle formation (GO:1905366)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905365	regulation of intralumenal vesicle formation (GO:1905365)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905364	regulation of endosomal vesicle fusion (GO:1905364)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035849	nephric duct elongation (GO:0035849)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051066	dihydrobiopterin metabolic process (GO:0051066)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035847	uterine epithelium development (GO:0035847)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043456	regulation of pentose-phosphate shunt (GO:0043456)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035845	photoreceptor cell outer segment organization (GO:0035845)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0035844	cloaca development (GO:0035844)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0000304	response to singlet oxygen (GO:0000304)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009597	detection of virus (GO:0009597)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0000301	retrograde transport, vesicle recycling within Golgi (GO:0000301)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0043449	cellular alkene metabolic process (GO:0043449)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009590	detection of gravity (GO:0009590)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905349	ciliary transition zone assembly (GO:1905349)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905344	prostaglandin catabolic process (GO:1905344)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009589	detection of UV (GO:0009589)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0017196	N-terminal peptidyl-methionine acetylation (GO:0017196)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0043438	acetoacetic acid metabolic process (GO:0043438)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0017192	N-terminal peptidyl-glutamine acetylation (GO:0017192)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0017190	N-terminal peptidyl-aspartic acid acetylation (GO:0017190)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051042	negative regulation of calcium-independent cell-cell adhesion (GO:0051042)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035822	gene conversion (GO:0035822)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0031460	glycine betaine transport (GO:0031460)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905333	regulation of gastric motility (GO:1905333)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905331	negative regulation of morphogenesis of an epithelium (GO:1905331)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0017187	peptidyl-glutamic acid carboxylation (GO:0017187)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0017186	peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0051039	positive regulation of transcription involved in meiotic cell cycle (GO:0051039)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0017185	peptidyl-lysine hydroxylation (GO:0017185)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0051037	regulation of transcription involved in meiotic cell cycle (GO:0051037)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051036	regulation of endosome size (GO:0051036)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0017183	peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0017182	peptidyl-diphthamide metabolic process (GO:0017182)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0035814	negative regulation of renal sodium excretion (GO:0035814)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051031	tRNA transport (GO:0051031)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0098530	positive regulation of strand invasion (GO:0098530)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0051030	snRNA transport (GO:0051030)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035811	negative regulation of urine volume (GO:0035811)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0031453	positive regulation of heterochromatin formation (GO:0031453)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0031452	negative regulation of heterochromatin formation (GO:0031452)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905327	tracheoesophageal septum formation (GO:1905327)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905323	telomerase holoenzyme complex assembly (GO:1905323)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905322	positive regulation of mesenchymal stem cell migration (GO:1905322)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0098529	neuromuscular junction development, skeletal muscle fiber (GO:0098529)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905320	regulation of mesenchymal stem cell migration (GO:1905320)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0051029	rRNA transport (GO:0051029)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0043418	homocysteine catabolic process (GO:0043418)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043417	negative regulation of skeletal muscle tissue regeneration (GO:0043417)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035803	egg coat formation (GO:0035803)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035802	adrenal cortex formation (GO:0035802)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035801	adrenal cortex development (GO:0035801)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0031449	regulation of slow-twitch skeletal muscle fiber contraction (GO:0031449)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031448	positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031446	regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031445	regulation of heterochromatin formation (GO:0031445)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0031444	slow-twitch skeletal muscle fiber contraction (GO:0031444)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031442	positive regulation of mRNA 3'-end processing (GO:0031442)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0031441	negative regulation of mRNA 3'-end processing (GO:0031441)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031440	regulation of mRNA 3'-end processing (GO:0031440)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:1905319	mesenchymal stem cell migration (GO:1905319)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905313	transforming growth factor beta receptor signaling pathway involved in heart development (GO:1905313)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905312	positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905312)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905310	regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905310)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0051013	microtubule severing (GO:0051013)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0051012	microtubule sliding (GO:0051012)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043402	glucocorticoid mediated signaling pathway (GO:0043402)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043400	cortisol secretion (GO:0043400)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031439	positive regulation of mRNA cleavage (GO:0031439)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031437	regulation of mRNA cleavage (GO:0031437)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905305	negative regulation of cardiac myofibril assembly (GO:1905305)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905304	regulation of cardiac myofibril assembly (GO:1905304)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905303	positive regulation of macropinocytosis (GO:1905303)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905302	negative regulation of macropinocytosis (GO:1905302)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905301	regulation of macropinocytosis (GO:1905301)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0098508	endothelial to hematopoietic transition (GO:0098508)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0031427	response to methotrexate (GO:0031427)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0017143	insecticide metabolic process (GO:0017143)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070197	meiotic attachment of telomere to nuclear envelope (GO:0070197)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0031408	oxylipin biosynthetic process (GO:0031408)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031407	oxylipin metabolic process (GO:0031407)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070189	kynurenine metabolic process (GO:0070189)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0017126	nucleologenesis (GO:0017126)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070184	mitochondrial tyrosyl-tRNA aminoacylation (GO:0070184)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070183	mitochondrial tryptophanyl-tRNA aminoacylation (GO:0070183)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042999	regulation of Golgi to plasma membrane CFTR protein transport (GO:0042999)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042998	positive regulation of Golgi to plasma membrane protein transport (GO:0042998)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0042994	cytoplasmic sequestering of transcription factor (GO:0042994)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0048298	positive regulation of isotype switching to IgA isotypes (GO:0048298)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0048297	negative regulation of isotype switching to IgA isotypes (GO:0048297)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048296	regulation of isotype switching to IgA isotypes (GO:0048296)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0048295	positive regulation of isotype switching to IgE isotypes (GO:0048295)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0048294	negative regulation of isotype switching to IgE isotypes (GO:0048294)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048293	regulation of isotype switching to IgE isotypes (GO:0048293)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0048291	isotype switching to IgG isotypes (GO:0048291)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048290	isotype switching to IgA isotypes (GO:0048290)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070179	D-serine biosynthetic process (GO:0070179)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070178	D-serine metabolic process (GO:0070178)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904899	positive regulation of hepatic stellate cell proliferation (GO:1904899)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070175	positive regulation of enamel mineralization (GO:0070175)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904897	regulation of hepatic stellate cell proliferation (GO:1904897)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904896	ESCRT complex disassembly (GO:1904896)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0070173	regulation of enamel mineralization (GO:0070173)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1904895	ESCRT complex assembly (GO:1904895)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070172	positive regulation of tooth mineralization (GO:0070172)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0070171	negative regulation of tooth mineralization (GO:0070171)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070170	regulation of tooth mineralization (GO:0070170)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1904891	positive regulation of excitatory synapse assembly (GO:1904891)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042987	amyloid precursor protein catabolic process (GO:0042987)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0042986	positive regulation of amyloid precursor protein biosynthetic process (GO:0042986)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0048289	isotype switching to IgE isotypes (GO:0048289)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042983	amyloid precursor protein biosynthetic process (GO:0042983)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042982	amyloid precursor protein metabolic process (GO:0042982)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0048280	vesicle fusion with Golgi apparatus (GO:0048280)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0070165	positive regulation of adiponectin secretion (GO:0070165)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070164	negative regulation of adiponectin secretion (GO:0070164)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904886	beta-catenin destruction complex disassembly (GO:1904886)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070163	regulation of adiponectin secretion (GO:0070163)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1904884	positive regulation of telomerase catalytic core complex assembly (GO:1904884)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904882	regulation of telomerase catalytic core complex assembly (GO:1904882)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904881	cellular response to hydrogen sulfide (GO:1904881)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904880	response to hydrogen sulfide (GO:1904880)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070159	mitochondrial threonyl-tRNA aminoacylation (GO:0070159)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070158	mitochondrial seryl-tRNA aminoacylation (GO:0070158)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904877	positive regulation of DNA ligase activity (GO:1904877)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904876	negative regulation of DNA ligase activity (GO:1904876)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904875	regulation of DNA ligase activity (GO:1904875)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904874	positive regulation of telomerase RNA localization to Cajal body (GO:1904874)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1904872	regulation of telomerase RNA localization to Cajal body (GO:1904872)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0070150	mitochondrial glycyl-tRNA aminoacylation (GO:0070150)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904871	positive regulation of protein localization to Cajal body (GO:1904871)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0048264	determination of ventral identity (GO:0048264)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036298	recombinational interstrand cross-link repair (GO:0036298)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904869	regulation of protein localization to Cajal body (GO:1904869)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0036292	DNA rewinding (GO:0036292)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904867	protein localization to Cajal body (GO:1904867)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070143	mitochondrial alanyl-tRNA aminoacylation (GO:0070143)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036290	protein trans-autophosphorylation (GO:0036290)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070142	synaptic vesicle budding (GO:0070142)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1904864	negative regulation of beta-catenin-TCF complex assembly (GO:1904864)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904863	regulation of beta-catenin-TCF complex assembly (GO:1904863)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048254	snoRNA localization (GO:0048254)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0048252	lauric acid metabolic process (GO:0048252)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048250	iron import into the mitochondrion (GO:0048250)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036289	peptidyl-serine autophosphorylation (GO:0036289)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0036285	SAGA complex assembly (GO:0036285)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070131	positive regulation of mitochondrial translation (GO:0070131)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0070130	negative regulation of mitochondrial translation (GO:0070130)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904851	positive regulation of establishment of protein localization to telomere (GO:1904851)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1904850	negative regulation of establishment of protein localization to telomere (GO:1904850)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042946	glucoside transport (GO:0042946)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042942	D-serine transport (GO:0042942)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042941	D-alanine transport (GO:0042941)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042940	D-amino acid transport (GO:0042940)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0048242	epinephrine secretion (GO:0048242)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030974	thiamine pyrophosphate transmembrane transport (GO:0030974)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070129	regulation of mitochondrial translation (GO:0070129)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0030970	retrograde protein transport, ER to cytosol (GO:0030970)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0070126	mitochondrial translational termination (GO:0070126)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904848	negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070125	mitochondrial translational elongation (GO:0070125)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070124	mitochondrial translational initiation (GO:0070124)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904845	cellular response to L-glutamine (GO:1904845)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904844	response to L-glutamine (GO:1904844)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070121	Kupffer's vesicle development (GO:0070121)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904843	cellular response to nitroglycerin (GO:1904843)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904842	response to nitroglycerin (GO:1904842)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042939	tripeptide transport (GO:0042939)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0042938	dipeptide transport (GO:0042938)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0048239	negative regulation of DNA recombination at telomere (GO:0048239)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900480	regulation of diacylglycerol biosynthetic process (GO:1900480)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042930	enterobactin transport (GO:0042930)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036269	swimming behavior (GO:0036269)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036268	swimming (GO:0036268)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030961	peptidyl-arginine hydroxylation (GO:0030961)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036265	RNA (guanine-N7)-methylation (GO:0036265)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1904837	beta-catenin-TCF complex assembly (GO:1904837)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036261	7-methylguanosine cap hypermethylation (GO:0036261)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0036260	RNA capping (GO:0036260)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:1904835	dorsal root ganglion morphogenesis (GO:1904835)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904831	positive regulation of aortic smooth muscle cell differentiation (GO:1904831)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048227	plasma membrane to endosome transport (GO:0048227)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0042921	glucocorticoid receptor signaling pathway (GO:0042921)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0030954	astral microtubule nucleation (GO:0030954)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036258	multivesicular body assembly (GO:0036258)	32	0	1.88	-	 < 0.01	2.60E-01	8.48E-01
GO:0036257	multivesicular body organization (GO:0036257)	33	0	1.94	-	 < 0.01	2.60E-01	8.47E-01
GO:0036255	response to methylamine (GO:0036255)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036254	cellular response to amiloride (GO:0036254)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904829	regulation of aortic smooth muscle cell differentiation (GO:1904829)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904828	positive regulation of hydrogen sulfide biosynthetic process (GO:1904828)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036253	response to amiloride (GO:0036253)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070105	positive regulation of interleukin-6-mediated signaling pathway (GO:0070105)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904826	regulation of hydrogen sulfide biosynthetic process (GO:1904826)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036250	peroxisome transport along microtubule (GO:0036250)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904823	purine nucleobase transmembrane transport (GO:1904823)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0070101	positive regulation of chemokine-mediated signaling pathway (GO:0070101)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042918	alkanesulfonate transport (GO:0042918)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0048219	inter-Golgi cisterna vesicle-mediated transport (GO:0048219)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048213	Golgi vesicle prefusion complex stabilization (GO:0048213)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048211	Golgi vesicle docking (GO:0048211)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048210	Golgi vesicle fusion to target membrane (GO:0048210)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0036245	cellular response to menadione (GO:0036245)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904816	positive regulation of protein localization to chromosome, telomeric region (GO:1904816)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1904815	negative regulation of protein localization to chromosome, telomeric region (GO:1904815)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904814	regulation of protein localization to chromosome, telomeric region (GO:1904814)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1904812	rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904811	positive regulation of dense core granule transport (GO:1904811)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900454	positive regulation of long-term synaptic depression (GO:1900454)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0042905	9-cis-retinoic acid metabolic process (GO:0042905)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900453	negative regulation of long-term synaptic depression (GO:1900453)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042904	9-cis-retinoic acid biosynthetic process (GO:0042904)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900452	regulation of long-term synaptic depression (GO:1900452)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0048208	COPII vesicle coating (GO:0048208)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:1900451	positive regulation of glutamate receptor signaling pathway (GO:1900451)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048207	vesicle targeting, rough ER to cis-Golgi (GO:0048207)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0048205	COPI coating of Golgi vesicle (GO:0048205)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0048203	vesicle targeting, trans-Golgi to endosome (GO:0048203)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0048200	Golgi transport vesicle coating (GO:0048200)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904809	regulation of dense core granule transport (GO:1904809)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904808	positive regulation of protein oxidation (GO:1904808)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904806	regulation of protein oxidation (GO:1904806)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904803	regulation of translation involved in cellular response to UV (GO:1904803)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904800	negative regulation of neuron remodeling (GO:1904800)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036228	protein localization to nuclear inner membrane (GO:0036228)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030917	midbrain-hindbrain boundary development (GO:0030917)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0030916	otic vesicle formation (GO:0030916)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0036213	contractile ring contraction (GO:0036213)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900425	negative regulation of defense response to bacterium (GO:1900425)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0030908	protein splicing (GO:0030908)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000296	spermine transport (GO:0000296)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000294	nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay (GO:0000294)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000291	nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0000290	deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1900408	negative regulation of cellular response to oxidative stress (GO:1900408)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000270	peptidoglycan metabolic process (GO:0000270)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0000266	mitochondrial fission (GO:0000266)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0035799	ureter maturation (GO:0035799)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035794	positive regulation of mitochondrial membrane permeability (GO:0035794)	32	0	1.88	-	 < 0.01	2.60E-01	8.48E-01
GO:0035793	positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035791	platelet-derived growth factor receptor-beta signaling pathway (GO:0035791)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0000256	allantoin catabolic process (GO:0000256)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000255	allantoin metabolic process (GO:0000255)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0035789	metanephric mesenchymal cell migration (GO:0035789)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035788	cell migration involved in metanephros development (GO:0035788)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043397	regulation of corticotropin-releasing hormone secretion (GO:0043397)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035787	cell migration involved in kidney development (GO:0035787)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035783	CD4-positive, alpha-beta T cell costimulation (GO:0035783)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035782	mature natural killer cell chemotaxis (GO:0035782)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035781	CD86 biosynthetic process (GO:0035781)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035780	CD80 biosynthetic process (GO:0035780)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000244	spliceosomal tri-snRNP complex assembly (GO:0000244)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1905291	positive regulation of CAMKK-AMPK signaling cascade (GO:1905291)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043387	mycotoxin catabolic process (GO:0043387)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043385	mycotoxin metabolic process (GO:0043385)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0043383	negative T cell selection (GO:0043383)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0043382	positive regulation of memory T cell differentiation (GO:0043382)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0035772	interleukin-13-mediated signaling pathway (GO:0035772)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035771	interleukin-4-mediated signaling pathway (GO:0035771)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905288	vascular associated smooth muscle cell apoptotic process (GO:1905288)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905285	fibrous ring of heart morphogenesis (GO:1905285)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905281	positive regulation of retrograde transport, endosome to Golgi (GO:1905281)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905280	negative regulation of retrograde transport, endosome to Golgi (GO:1905280)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043379	memory T cell differentiation (GO:0043379)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043377	negative regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043377)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035768	endothelial cell chemotaxis to fibroblast growth factor (GO:0035768)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035766	cell chemotaxis to fibroblast growth factor (GO:0035766)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043371	negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:1905274	regulation of modification of postsynaptic actin cytoskeleton (GO:1905274)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905273	positive regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905273)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905271	regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905271)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043366	beta selection (GO:0043366)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043363	nucleate erythrocyte differentiation (GO:0043363)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035752	lysosomal lumen pH elevation (GO:0035752)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035750	protein localization to myelin sheath abaxonal region (GO:0035750)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031394	positive regulation of prostaglandin biosynthetic process (GO:0031394)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0031393	negative regulation of prostaglandin biosynthetic process (GO:0031393)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031392	regulation of prostaglandin biosynthetic process (GO:0031392)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1905268	negative regulation of chromatin organization (GO:1905268)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905267	endonucleolytic cleavage involved in tRNA processing (GO:1905267)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035747	natural killer cell chemotaxis (GO:0035747)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905259	negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905259)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905258	regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905258)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035739	CD4-positive, alpha-beta T cell proliferation (GO:0035739)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0035735	intraciliary transport involved in cilium assembly (GO:0035735)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0035732	nitric oxide storage (GO:0035732)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905244	regulation of modification of synaptic structure (GO:1905244)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1905240	negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043335	protein unfolding (GO:0043335)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035723	interleukin-15-mediated signaling pathway (GO:0035723)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035722	interleukin-12-mediated signaling pathway (GO:0035722)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035720	intraciliary anterograde transport (GO:0035720)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0031365	N-terminal protein amino acid modification (GO:0031365)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:1905239	regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905232	cellular response to L-glutamate (GO:1905232)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0043328	protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0043324	pigment metabolic process involved in developmental pigmentation (GO:0043324)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043323	positive regulation of natural killer cell degranulation (GO:0043323)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0043322	negative regulation of natural killer cell degranulation (GO:0043322)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035713	response to nitrogen dioxide (GO:0035713)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043321	regulation of natural killer cell degranulation (GO:0043321)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035712	T-helper 2 cell activation (GO:0035712)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043320	natural killer cell degranulation (GO:0043320)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0035711	T-helper 1 cell activation (GO:0035711)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905229	cellular response to thyrotropin-releasing hormone (GO:1905229)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905226	regulation of adhesion of symbiont to host epithelial cell (GO:1905226)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905225	response to thyrotropin-releasing hormone (GO:1905225)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905224	clathrin-coated pit assembly (GO:1905224)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905223	epicardium morphogenesis (GO:1905223)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905222	atrioventricular canal morphogenesis (GO:1905222)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905221	positive regulation of platelet formation (GO:1905221)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035709	memory T cell activation (GO:0035709)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043316	cytotoxic T cell degranulation (GO:0043316)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043315	positive regulation of neutrophil degranulation (GO:0043315)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0043314	negative regulation of neutrophil degranulation (GO:0043314)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035705	T-helper 17 cell chemotaxis (GO:0035705)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043313	regulation of neutrophil degranulation (GO:0043313)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0043312	neutrophil degranulation (GO:0043312)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035702	monocyte homeostasis (GO:0035702)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043311	positive regulation of eosinophil degranulation (GO:0043311)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043310	negative regulation of eosinophil degranulation (GO:0043310)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905219	regulation of platelet formation (GO:1905219)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905217	response to astaxanthin (GO:1905217)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905216	positive regulation of RNA binding (GO:1905216)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1905215	negative regulation of RNA binding (GO:1905215)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905214	regulation of RNA binding (GO:1905214)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1905213	negative regulation of mitotic chromosome condensation (GO:1905213)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043309	regulation of eosinophil degranulation (GO:0043309)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043308	eosinophil degranulation (GO:0043308)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043307	eosinophil activation (GO:0043307)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0017062	respiratory chain complex III assembly (GO:0017062)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0009452	7-methylguanosine RNA capping (GO:0009452)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0009450	gamma-aminobutyric acid catabolic process (GO:0009450)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031339	negative regulation of vesicle fusion (GO:0031339)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0031335	regulation of sulfur amino acid metabolic process (GO:0031335)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905206	positive regulation of hydrogen peroxide-induced cell death (GO:1905206)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1905205	positive regulation of connective tissue replacement (GO:1905205)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009447	putrescine catabolic process (GO:0009447)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009443	pyridoxal 5'-phosphate salvage (GO:0009443)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009440	cyanate catabolic process (GO:0009440)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009439	cyanate metabolic process (GO:0009439)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009437	carnitine metabolic process (GO:0009437)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0009436	glyoxylate catabolic process (GO:0009436)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070094	positive regulation of glucagon secretion (GO:0070094)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070093	negative regulation of glucagon secretion (GO:0070093)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0070086	ubiquitin-dependent endocytosis (GO:0070086)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0070084	protein initiator methionine removal (GO:0070084)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048199	vesicle targeting, to, from or within Golgi (GO:0048199)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:0048194	Golgi vesicle budding (GO:0048194)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0070079	histone H4-R3 demethylation (GO:0070079)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070078	histone H3-R2 demethylation (GO:0070078)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904799	regulation of neuron remodeling (GO:1904799)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070077	histone arginine demethylation (GO:0070077)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070076	histone lysine demethylation (GO:0070076)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0009407	toxin catabolic process (GO:0009407)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0070075	tear secretion (GO:0070075)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904797	negative regulation of core promoter binding (GO:1904797)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0017014	protein nitrosylation (GO:0017014)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009404	toxin metabolic process (GO:0009404)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0070072	vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0009403	toxin biosynthetic process (GO:0009403)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070071	proton-transporting two-sector ATPase complex assembly (GO:0070071)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0070070	proton-transporting V-type ATPase complex assembly (GO:0070070)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1904792	positive regulation of shelterin complex assembly (GO:1904792)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904791	negative regulation of shelterin complex assembly (GO:1904791)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904790	regulation of shelterin complex assembly (GO:1904790)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042883	cysteine transport (GO:0042883)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0017006	protein-tetrapyrrole linkage (GO:0017006)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0017004	cytochrome complex assembly (GO:0017004)	39	0	2.29	-	 < 0.01	2.76E-01	8.80E-01
GO:0017003	protein-heme linkage (GO:0017003)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904784	NLRP1 inflammasome complex assembly (GO:1904784)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0070060	'de novo' actin filament nucleation (GO:0070060)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904781	positive regulation of protein localization to centrosome (GO:1904781)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1904780	negative regulation of protein localization to centrosome (GO:1904780)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042874	D-glucuronate transmembrane transport (GO:0042874)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048174	negative regulation of short-term neuronal synaptic plasticity (GO:0048174)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904779	regulation of protein localization to centrosome (GO:1904779)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1904778	positive regulation of protein localization to cell cortex (GO:1904778)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0070054	mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042868	antisense RNA metabolic process (GO:0042868)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042866	pyruvate biosynthetic process (GO:0042866)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0048162	multi-layer follicle stage (GO:0048162)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048160	primary follicle stage (GO:0048160)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904766	negative regulation of macroautophagy by TORC1 signaling (GO:1904766)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904764	chaperone-mediated autophagy translocation complex disassembly (GO:1904764)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904762	positive regulation of myofibroblast differentiation (GO:1904762)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904761	negative regulation of myofibroblast differentiation (GO:1904761)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904760	regulation of myofibroblast differentiation (GO:1904760)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0042853	L-alanine catabolic process (GO:0042853)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042851	L-alanine metabolic process (GO:0042851)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0030889	negative regulation of B cell proliferation (GO:0030889)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0030887	positive regulation of myeloid dendritic cell activation (GO:0030887)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030886	negative regulation of myeloid dendritic cell activation (GO:0030886)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0030885	regulation of myeloid dendritic cell activation (GO:0030885)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904750	negative regulation of protein localization to nucleolus (GO:1904750)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048149	behavioral response to ethanol (GO:0048149)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0042843	D-xylose catabolic process (GO:0042843)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042840	D-glucuronate catabolic process (GO:0042840)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048143	astrocyte activation (GO:0048143)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0036179	osteoclast maturation (GO:0036179)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904748	regulation of apoptotic process involved in development (GO:1904748)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1904747	positive regulation of apoptotic process involved in development (GO:1904747)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904746	negative regulation of apoptotic process involved in development (GO:1904746)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904744	positive regulation of telomeric DNA binding (GO:1904744)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904743	negative regulation of telomeric DNA binding (GO:1904743)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016598	protein arginylation (GO:0016598)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904742	regulation of telomeric DNA binding (GO:1904742)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042839	D-glucuronate metabolic process (GO:0042839)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900383	regulation of synaptic plasticity by receptor localization to synapse (GO:1900383)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048137	spermatocyte division (GO:0048137)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030862	positive regulation of polarized epithelial cell differentiation (GO:0030862)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030860	regulation of polarized epithelial cell differentiation (GO:0030860)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036166	phenotypic switching (GO:0036166)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036164	cell-abiotic substrate adhesion (GO:0036164)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904738	vascular associated smooth muscle cell migration (GO:1904738)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904736	negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904736)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904735	regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904735)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904734	positive regulation of electron transfer activity (GO:1904734)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904733	negative regulation of electron transfer activity (GO:1904733)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904732	regulation of electron transfer activity (GO:1904732)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904731	positive regulation of intestinal lipid absorption (GO:1904731)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904730	negative regulation of intestinal lipid absorption (GO:1904730)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900377	negative regulation of secondary metabolite biosynthetic process (GO:1900377)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0050435	amyloid-beta metabolic process (GO:0050435)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0050434	positive regulation of viral transcription (GO:0050434)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0050432	catecholamine secretion (GO:0050432)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042823	pyridoxal phosphate biosynthetic process (GO:0042823)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042822	pyridoxal phosphate metabolic process (GO:0042822)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042820	vitamin B6 catabolic process (GO:0042820)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030854	positive regulation of granulocyte differentiation (GO:0030854)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0036159	inner dynein arm assembly (GO:0036159)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0036158	outer dynein arm assembly (GO:0036158)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0036155	acylglycerol acyl-chain remodeling (GO:0036155)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904729	regulation of intestinal lipid absorption (GO:1904729)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0036153	triglyceride acyl-chain remodeling (GO:0036153)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016577	histone demethylation (GO:0016577)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0050428	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0042819	vitamin B6 biosynthetic process (GO:0042819)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042816	vitamin B6 metabolic process (GO:0042816)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1900365	positive regulation of mRNA polyadenylation (GO:1900365)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900364	negative regulation of mRNA polyadenylation (GO:1900364)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900363	regulation of mRNA polyadenylation (GO:1900363)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0030845	phospholipase C-inhibiting G protein-coupled receptor signaling pathway (GO:0030845)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036149	phosphatidylinositol acyl-chain remodeling (GO:0036149)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0036148	phosphatidylglycerol acyl-chain remodeling (GO:0036148)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0036146	cellular response to mycotoxin (GO:0036146)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904719	positive regulation of AMPA glutamate receptor clustering (GO:1904719)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904717	regulation of AMPA glutamate receptor clustering (GO:1904717)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1904716	positive regulation of chaperone-mediated autophagy (GO:1904716)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904710	positive regulation of granulosa cell apoptotic process (GO:1904710)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016561	protein import into peroxisome matrix, translocation (GO:0016561)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0016560	protein import into peroxisome matrix, docking (GO:0016560)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0048105	establishment of body hair planar orientation (GO:0048105)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048104	establishment of body hair or bristle planar orientation (GO:0048104)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0048102	autophagic cell death (GO:0048102)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0036138	peptidyl-histidine hydroxylation (GO:0036138)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904708	regulation of granulosa cell apoptotic process (GO:1904708)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0016559	peroxisome fission (GO:0016559)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0016558	protein import into peroxisome matrix (GO:0016558)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1904702	regulation of protein localization to adherens junction (GO:1904702)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016557	peroxisome membrane biogenesis (GO:0016557)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0016556	mRNA modification (GO:0016556)	31	0	1.82	-	 < 0.01	4.16E-01	1.00E00
GO:0016554	cytidine to uridine editing (GO:0016554)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0036123	histone H3-K9 dimethylation (GO:0036123)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0036116	long-chain fatty-acyl-CoA catabolic process (GO:0036116)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036115	fatty-acyl-CoA catabolic process (GO:0036115)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0036114	medium-chain fatty-acyl-CoA catabolic process (GO:0036114)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0036113	very long-chain fatty-acyl-CoA catabolic process (GO:0036113)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036112	medium-chain fatty-acyl-CoA metabolic process (GO:0036112)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0036111	very long-chain fatty-acyl-CoA metabolic process (GO:0036111)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016539	intein-mediated protein splicing (GO:0016539)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061987	negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0061987)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061986	negative regulation of transcription by glucose (GO:0061986)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036109	alpha-linolenic acid metabolic process (GO:0036109)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0036102	leukotriene B4 metabolic process (GO:0036102)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0036101	leukotriene B4 catabolic process (GO:0036101)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0036100	leukotriene catabolic process (GO:0036100)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0061974	perichondral bone morphogenesis (GO:0061974)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061973	membrane bone morphogenesis (GO:0061973)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061966	establishment of left/right asymmetry (GO:0061966)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0061960	regulation of heme oxygenase activity (GO:0061960)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000184	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	36	0	2.11	-	 < 0.01	2.65E-01	8.49E-01
GO:0000183	rDNA heterochromatin formation (GO:0000183)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0061956	penetration of cumulus oophorus (GO:0061956)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061951	establishment of protein localization to plasma membrane (GO:0061951)	49	0	2.88	-	 < 0.01	1.14E-01	5.63E-01
GO:0061945	regulation of protein K48-linked ubiquitination (GO:0061945)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061944	negative regulation of protein K48-linked ubiquitination (GO:0061944)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0000160	phosphorelay signal transduction system (GO:0000160)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035696	monocyte extravasation (GO:0035696)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035695	mitophagy by induced vacuole formation (GO:0035695)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061938	protein localization to somatodendritic compartment (GO:0061938)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035694	mitochondrial protein catabolic process (GO:0035694)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035691	macrophage migration inhibitory factor signaling pathway (GO:0035691)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061931	positive regulation of erythrocyte enucleation (GO:0061931)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061930	regulation of erythrocyte enucleation (GO:0061930)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000154	rRNA modification (GO:0000154)	38	0	2.23	-	 < 0.01	2.72E-01	8.68E-01
GO:0035685	helper T cell diapedesis (GO:0035685)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035683	memory T cell extravasation (GO:0035683)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061921	peptidyl-lysine propionylation (GO:0061921)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905199	manchette disassembly (GO:1905199)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905198	manchette assembly (GO:1905198)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035677	posterior lateral line neuromast hair cell development (GO:0035677)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035675	neuromast hair cell development (GO:0035675)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035674	tricarboxylic acid transmembrane transport (GO:0035674)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035672	oligopeptide transmembrane transport (GO:0035672)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0061912	selective autophagy (GO:0061912)	58	0	3.41	-	 < 0.01	7.70E-02	4.84E-01
GO:0061910	autophagosome-endosome fusion (GO:0061910)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905184	positive regulation of protein serine/threonine phosphatase activity (GO:1905184)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905183	negative regulation of protein serine/threonine phosphatase activity (GO:1905183)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035669	TRAM-dependent toll-like receptor 4 signaling pathway (GO:0035669)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035668	TRAM-dependent toll-like receptor signaling pathway (GO:0035668)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035666	TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0061909	autophagosome-lysosome fusion (GO:0061909)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0035665	TIRAP-dependent toll-like receptor 4 signaling pathway (GO:0035665)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035664	TIRAP-dependent toll-like receptor signaling pathway (GO:0035664)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061903	positive regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061903)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061901	regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061901)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905179	negative regulation of cardiac muscle tissue regeneration (GO:1905179)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905178	regulation of cardiac muscle tissue regeneration (GO:1905178)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905176	positive regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905176)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905174	regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905174)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035655	interleukin-18-mediated signaling pathway (GO:0035655)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035654	clathrin-coated vesicle cargo loading, AP-3-mediated (GO:0035654)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0035652	clathrin-coated vesicle cargo loading (GO:0035652)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0031296	B cell costimulation (GO:0031296)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0031293	membrane protein intracellular domain proteolysis (GO:0031293)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0031291	Ran protein signal transduction (GO:0031291)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905167	positive regulation of lysosomal protein catabolic process (GO:1905167)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905166	negative regulation of lysosomal protein catabolic process (GO:1905166)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905165	regulation of lysosomal protein catabolic process (GO:1905165)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0000117	regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905164	positive regulation of phagosome maturation (GO:1905164)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035646	endosome to melanosome transport (GO:0035646)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0035644	phosphoanandamide dephosphorylation (GO:0035644)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043252	sodium-independent organic anion transport (GO:0043252)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0043251	sodium-dependent organic anion transport (GO:0043251)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031283	negative regulation of guanylate cyclase activity (GO:0031283)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905154	negative regulation of membrane invagination (GO:1905154)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000105	histidine biosynthetic process (GO:0000105)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009398	FMN biosynthetic process (GO:0009398)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905151	negative regulation of voltage-gated sodium channel activity (GO:1905151)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000103	sulfate assimilation (GO:0000103)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009397	folic acid-containing compound catabolic process (GO:0009397)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0000101	sulfur amino acid transport (GO:0000101)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0043248	proteasome assembly (GO:0043248)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0043247	telomere maintenance in response to DNA damage (GO:0043247)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0035635	entry of bacterium into host cell (GO:0035635)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905146	lysosomal protein catabolic process (GO:1905146)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1905143	eukaryotic translation initiation factor 2 complex assembly (GO:1905143)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009386	translational attenuation (GO:0009386)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035623	renal glucose absorption (GO:0035623)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035622	intrahepatic bile duct development (GO:0035622)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031269	pseudopodium assembly (GO:0031269)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0031268	pseudopodium organization (GO:0031268)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035617	stress granule disassembly (GO:0035617)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035616	histone H2B conserved C-terminal lysine deubiquitination (GO:0035616)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035611	protein branching point deglutamylation (GO:0035611)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035610	protein side chain deglutamylation (GO:0035610)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1905128	positive regulation of axo-dendritic protein transport (GO:1905128)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905126	regulation of axo-dendritic protein transport (GO:1905126)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905123	regulation of glucosylceramidase activity (GO:1905123)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035609	C-terminal protein deglutamylation (GO:0035609)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035608	protein deglutamylation (GO:0035608)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0035607	fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035606	peptidyl-cysteine S-trans-nitrosylation (GO:0035606)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035604	fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035603	fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035602	fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell (GO:0035602)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035600	tRNA methylthiolation (GO:0035600)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031247	actin rod assembly (GO:0031247)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043201	response to leucine (GO:0043201)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0031204	post-translational protein targeting to membrane, translocation (GO:0031204)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0009313	oligosaccharide catabolic process (GO:0009313)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0042797	tRNA transcription by RNA polymerase III (GO:0042797)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0042796	snRNA transcription by RNA polymerase III (GO:0042796)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0042795	snRNA transcription by RNA polymerase II (GO:0042795)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0042791	5S class rRNA transcription by RNA polymerase III (GO:0042791)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0042790	nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904697	regulation of acinar cell proliferation (GO:1904697)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009304	tRNA transcription (GO:0009304)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904695	positive regulation of vascular associated smooth muscle contraction (GO:1904695)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009303	rRNA transcription (GO:0009303)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:1904694	negative regulation of vascular associated smooth muscle contraction (GO:1904694)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904693	midbrain morphogenesis (GO:1904693)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009301	snRNA transcription (GO:0009301)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1904692	positive regulation of type B pancreatic cell proliferation (GO:1904692)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042780	tRNA 3'-end processing (GO:0042780)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0048086	negative regulation of developmental pigmentation (GO:0048086)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904689	negative regulation of cytoplasmic translational initiation (GO:1904689)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904685	positive regulation of metalloendopeptidase activity (GO:1904685)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042779	tRNA 3'-trailer cleavage (GO:0042779)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042776	proton motive force-driven mitochondrial ATP synthesis (GO:0042776)	64	0	3.76	-	 < 0.01	5.04E-02	3.81E-01
GO:0042774	plasma membrane ATP synthesis coupled electron transport (GO:0042774)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048075	positive regulation of eye pigmentation (GO:0048075)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048074	negative regulation of eye pigmentation (GO:0048074)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0048073	regulation of eye pigmentation (GO:0048073)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904679	myo-inositol import across plasma membrane (GO:1904679)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904677	positive regulation of somatic stem cell division (GO:1904677)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904675	regulation of somatic stem cell division (GO:1904675)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904674	positive regulation of somatic stem cell population maintenance (GO:1904674)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904673	negative regulation of somatic stem cell population maintenance (GO:1904673)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0048069	eye pigmentation (GO:0048069)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042761	very long-chain fatty acid biosynthetic process (GO:0042761)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0042760	very long-chain fatty acid catabolic process (GO:0042760)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1904669	ATP export (GO:1904669)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036093	germ cell proliferation (GO:0036093)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0036091	positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036090	cleavage furrow ingression (GO:0036090)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042758	long-chain fatty acid catabolic process (GO:0042758)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0042753	positive regulation of circadian rhythm (GO:0042753)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0036088	D-serine catabolic process (GO:0036088)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036085	GDP-fucose import into Golgi lumen (GO:0036085)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904651	positive regulation of fat cell apoptotic process (GO:1904651)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042748	circadian sleep/wake cycle, non-REM sleep (GO:0042748)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042747	circadian sleep/wake cycle, REM sleep (GO:0042747)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042745	circadian sleep/wake cycle (GO:0042745)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0036076	ligamentous ossification (GO:0036076)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904649	regulation of fat cell apoptotic process (GO:1904649)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036071	N-glycan fucosylation (GO:0036071)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904640	response to methionine (GO:1904640)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042732	D-xylose metabolic process (GO:0042732)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900281	positive regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900281)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900280	negative regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900280)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036066	protein O-linked fucosylation (GO:0036066)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0036065	fucosylation (GO:0036065)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:1904637	cellular response to ionomycin (GO:1904637)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904636	response to ionomycin (GO:1904636)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0036060	slit diaphragm assembly (GO:0036060)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904635	positive regulation of podocyte apoptotic process (GO:1904635)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904633	regulation of podocyte apoptotic process (GO:1904633)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016488	farnesol catabolic process (GO:0016488)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016487	farnesol metabolic process (GO:0016487)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900279	regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900279)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042728	flavin-containing compound catabolic process (GO:0042728)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042727	flavin-containing compound biosynthetic process (GO:0042727)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900276	regulation of proteinase activated receptor activity (GO:1900276)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042726	flavin-containing compound metabolic process (GO:0042726)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1900275	negative regulation of phospholipase C activity (GO:1900275)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016480	negative regulation of transcription by RNA polymerase III (GO:0016480)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042724	thiamine-containing compound biosynthetic process (GO:0042724)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042723	thiamine-containing compound metabolic process (GO:0042723)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0048026	positive regulation of mRNA splicing, via spliceosome (GO:0048026)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0048025	negative regulation of mRNA splicing, via spliceosome (GO:0048025)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0048022	negative regulation of melanin biosynthetic process (GO:0048022)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0036058	filtration diaphragm assembly (GO:0036058)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016476	regulation of embryonic cell shape (GO:0016476)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042711	maternal behavior (GO:0042711)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1900260	negative regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900260)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036049	peptidyl-lysine desuccinylation (GO:0036049)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036048	protein desuccinylation (GO:0036048)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036047	peptidyl-lysine demalonylation (GO:0036047)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0036046	protein demalonylation (GO:0036046)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904618	positive regulation of actin binding (GO:1904618)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904617	negative regulation of actin binding (GO:1904617)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904616	regulation of actin binding (GO:1904616)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900259	regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900259)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042706	eye photoreceptor cell fate commitment (GO:0042706)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042704	uterine wall breakdown (GO:0042704)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042700	luteinizing hormone signaling pathway (GO:0042700)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036035	osteoclast development (GO:0036035)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0036031	recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex (GO:0036031)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900246	positive regulation of RIG-I signaling pathway (GO:1900246)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1900245	positive regulation of MDA-5 signaling pathway (GO:1900245)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900240	negative regulation of phenotypic switching (GO:1900240)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0036023	embryonic skeletal limb joint morphogenesis (GO:0036023)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0036022	limb joint morphogenesis (GO:0036022)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1900238	regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900235	negative regulation of Kit signaling pathway (GO:1900235)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900234	regulation of Kit signaling pathway (GO:1900234)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061890	positive regulation of astrocyte activation (GO:0061890)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030718	germ-line stem cell population maintenance (GO:0030718)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0036010	protein localization to endosome (GO:0036010)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0061889	negative regulation of astrocyte activation (GO:0061889)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900229	negative regulation of single-species biofilm formation in or on host organism (GO:1900229)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900228	regulation of single-species biofilm formation in or on host organism (GO:1900228)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900227	positive regulation of NLRP3 inflammasome complex assembly (GO:1900227)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1900226	negative regulation of NLRP3 inflammasome complex assembly (GO:1900226)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1900225	regulation of NLRP3 inflammasome complex assembly (GO:1900225)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:1900224	positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900224)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900223	positive regulation of amyloid-beta clearance (GO:1900223)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1900220	semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis (GO:1900220)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030704	vitelline membrane formation (GO:0030704)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900218	negative regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900218)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900217	regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900217)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900215	negative regulation of apoptotic process involved in metanephric collecting duct development (GO:1900215)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900214	regulation of apoptotic process involved in metanephric collecting duct development (GO:1900214)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900212	negative regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900212)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900211	regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900211)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900210	positive regulation of cardiolipin metabolic process (GO:1900210)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900208	regulation of cardiolipin metabolic process (GO:1900208)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900200	mesenchymal cell apoptotic process involved in metanephros development (GO:1900200)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000088	mitotic prophase (GO:0000088)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000085	mitotic G2 phase (GO:0000085)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000080	mitotic G1 phase (GO:0000080)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061857	endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061855	negative regulation of neuroblast migration (GO:0061855)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061853	regulation of neuroblast migration (GO:0061853)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061847	response to cholecystokinin (GO:0061847)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061837	neuropeptide processing (GO:0061837)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061833	protein localization to tricellular tight junction (GO:0061833)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000056	ribosomal small subunit export from nucleus (GO:0000056)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0000055	ribosomal large subunit export from nucleus (GO:0000055)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0000054	ribosomal subunit export from nucleus (GO:0000054)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0000053	argininosuccinate metabolic process (GO:0000053)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000052	citrulline metabolic process (GO:0000052)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0035582	sequestering of BMP in extracellular matrix (GO:0035582)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061824	cytosolic ciliogenesis (GO:0061824)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905099	positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905091	positive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905091)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905090	negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905090)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061819	telomeric DNA-containing double minutes formation (GO:0061819)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035574	histone H4-K20 demethylation (GO:0035574)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061817	endoplasmic reticulum-plasma membrane tethering (GO:0061817)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035573	N-terminal peptidyl-serine trimethylation (GO:0035573)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035572	N-terminal peptidyl-serine dimethylation (GO:0035572)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043181	vacuolar sequestering (GO:0043181)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035570	N-terminal peptidyl-serine methylation (GO:0035570)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015990	electron transport coupled proton transport (GO:0015990)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905089	regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905089)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043179	rhythmic excitation (GO:0043179)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035568	N-terminal peptidyl-proline methylation (GO:0035568)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035566	regulation of metanephros size (GO:0035566)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043174	nucleoside salvage (GO:0043174)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0035565	regulation of pronephros size (GO:0035565)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043173	nucleotide salvage (GO:0043173)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0015988	energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0015986	proton motive force-driven ATP synthesis (GO:0015986)	73	0	4.29	-	 < 0.01	3.47E-02	2.97E-01
GO:0000028	ribosomal small subunit assembly (GO:0000028)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0000027	ribosomal large subunit assembly (GO:0000027)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:1905075	positive regulation of tight junction disassembly (GO:1905075)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905073	regulation of tight junction disassembly (GO:1905073)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000025	maltose catabolic process (GO:0000025)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905072	cardiac jelly development (GO:1905072)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0000023	maltose metabolic process (GO:0000023)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0055130	D-alanine catabolic process (GO:0055130)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043163	cell envelope organization (GO:0043163)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	37	0	2.17	-	 < 0.01	2.68E-01	8.57E-01
GO:0035553	oxidative single-stranded RNA demethylation (GO:0035553)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035552	oxidative single-stranded DNA demethylation (GO:0035552)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035551	protein initiator methionine removal involved in protein maturation (GO:0035551)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905068	positive regulation of canonical Wnt signaling pathway involved in heart development (GO:1905068)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000019	regulation of mitotic recombination (GO:0000019)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0000017	alpha-glucoside transport (GO:0000017)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905064	negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1905062	positive regulation of cardioblast proliferation (GO:1905062)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0000012	single strand break repair (GO:0000012)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0043157	response to cation stress (GO:0043157)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035545	determination of left/right asymmetry in nervous system (GO:0035545)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035544	negative regulation of SNARE complex assembly (GO:0035544)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043152	induction of bacterial agglutination (GO:0043152)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0015966	diadenosine tetraphosphate biosynthetic process (GO:0015966)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015965	diadenosine tetraphosphate metabolic process (GO:0015965)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015964	diadenosine triphosphate catabolic process (GO:0015964)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015962	diadenosine triphosphate metabolic process (GO:0015962)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015961	diadenosine polyphosphate catabolic process (GO:0015961)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0015960	diadenosine polyphosphate biosynthetic process (GO:0015960)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905053	positive regulation of base-excision repair (GO:1905053)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0055113	epiboly involved in gastrulation with mouth forming second (GO:0055113)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009298	GDP-mannose biosynthetic process (GO:0009298)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905051	regulation of base-excision repair (GO:1905051)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0055111	ingression involved in gastrulation with mouth forming second (GO:0055111)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905050	positive regulation of metallopeptidase activity (GO:1905050)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0043144	sno(s)RNA processing (GO:0043144)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0043143	regulation of translation by machinery localization (GO:0043143)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031179	peptide modification (GO:0031179)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0015959	diadenosine polyphosphate metabolic process (GO:0015959)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0031173	otolith mineralization completed early in development (GO:0031173)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0055107	Golgi to secretory granule transport (GO:0055107)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905045	negative regulation of Schwann cell proliferation involved in axon regeneration (GO:1905045)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905044	regulation of Schwann cell proliferation involved in axon regeneration (GO:1905044)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905042	negative regulation of epithelium regeneration (GO:1905042)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905041	regulation of epithelium regeneration (GO:1905041)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905040	otic placode development (GO:1905040)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035526	retrograde transport, plasma membrane to Golgi (GO:0035526)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043134	regulation of hindgut contraction (GO:0043134)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035524	proline transmembrane transport (GO:0035524)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0043132	NAD transport (GO:0043132)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035523	protein K29-linked deubiquitination (GO:0035523)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035522	monoubiquitinated histone H2A deubiquitination (GO:0035522)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0035521	monoubiquitinated histone deubiquitination (GO:0035521)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0035520	monoubiquitinated protein deubiquitination (GO:0035520)	34	0	2.00	-	 < 0.01	2.61E-01	8.48E-01
GO:0031167	rRNA methylation (GO:0031167)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0031163	metallo-sulfur cluster assembly (GO:0031163)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0031161	phosphatidylinositol catabolic process (GO:0031161)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905038	regulation of membrane lipid metabolic process (GO:1905038)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1905036	positive regulation of antifungal innate immune response (GO:1905036)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905035	negative regulation of antifungal innate immune response (GO:1905035)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905034	regulation of antifungal innate immune response (GO:1905034)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1905033	positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905032	negative regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905032)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043128	positive regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043128)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043126	regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043126)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035513	oxidative RNA demethylation (GO:0035513)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035511	oxidative DNA demethylation (GO:0035511)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035510	DNA dealkylation (GO:0035510)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0015939	pantothenate metabolic process (GO:0015939)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0015938	coenzyme A catabolic process (GO:0015938)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015937	coenzyme A biosynthetic process (GO:0015937)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0015936	coenzyme A metabolic process (GO:0015936)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:1905026	positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905025	negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905025)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905024	regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009264	deoxyribonucleotide catabolic process (GO:0009264)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0035508	positive regulation of myosin-light-chain-phosphatase activity (GO:0035508)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035502	metanephric part of ureteric bud development (GO:0035502)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0031144	proteasome localization (GO:0031144)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015920	lipopolysaccharide transport (GO:0015920)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905012	regulation of 'de novo' NAD biosynthetic process from tryptophan (GO:1905012)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009258	10-formyltetrahydrofolate catabolic process (GO:0009258)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1905010	positive regulation of L-lysine import across plasma membrane (GO:1905010)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009253	peptidoglycan catabolic process (GO:0009253)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0043105	negative regulation of GTP cyclohydrolase I activity (GO:0043105)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043103	hypoxanthine salvage (GO:0043103)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043101	purine-containing compound salvage (GO:0043101)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0015919	peroxisomal membrane transport (GO:0015919)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0015917	aminophospholipid transport (GO:0015917)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0015916	fatty-acyl-CoA transport (GO:0015916)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0031134	sister chromatid biorientation (GO:0031134)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0031133	regulation of axon diameter (GO:0031133)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0015913	short-chain fatty acid import (GO:0015913)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015912	short-chain fatty acid transport (GO:0015912)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015911	long-chain fatty acid import across plasma membrane (GO:0015911)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0015910	long-chain fatty acid import into peroxisome (GO:0015910)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1905008	regulation of L-lysine import across plasma membrane (GO:1905008)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905006	negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905006)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1905004	picolinic acid biosynthetic process (GO:1905004)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1905003	picolinic acid metabolic process (GO:1905003)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009240	isopentenyl diphosphate biosynthetic process (GO:0009240)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0031129	inductive cell-cell signaling (GO:0031129)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031126	sno(s)RNA 3'-end processing (GO:0031126)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0031125	rRNA 3'-end processing (GO:0031125)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0015904	tetracycline transmembrane transport (GO:0015904)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031120	snRNA pseudouridine synthesis (GO:0031120)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009237	siderophore metabolic process (GO:0009237)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009235	cobalamin metabolic process (GO:0009235)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0009234	menaquinone biosynthetic process (GO:0009234)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009233	menaquinone metabolic process (GO:0009233)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0009231	riboflavin biosynthetic process (GO:0009231)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031119	tRNA pseudouridine synthesis (GO:0031119)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0031118	rRNA pseudouridine synthesis (GO:0031118)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0031117	positive regulation of microtubule depolymerization (GO:0031117)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0009229	thiamine diphosphate biosynthetic process (GO:0009229)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009227	nucleotide-sugar catabolic process (GO:0009227)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009226	nucleotide-sugar biosynthetic process (GO:0009226)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0009224	CMP biosynthetic process (GO:0009224)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009223	pyrimidine deoxyribonucleotide catabolic process (GO:0009223)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0009222	pyrimidine ribonucleotide catabolic process (GO:0009222)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0009220	pyrimidine ribonucleotide biosynthetic process (GO:0009220)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0031104	dendrite regeneration (GO:0031104)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009218	pyrimidine ribonucleotide metabolic process (GO:0009218)	33	0	1.94	-	 < 0.01	2.60E-01	8.47E-01
GO:0009217	purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0009216	purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009215	purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0009213	pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009210	pyrimidine ribonucleoside triphosphate catabolic process (GO:0009210)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042699	follicle-stimulating hormone signaling pathway (GO:0042699)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042694	muscle cell fate specification (GO:0042694)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009209	pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0009208	pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0009207	purine ribonucleoside triphosphate catabolic process (GO:0009207)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009204	deoxyribonucleoside triphosphate catabolic process (GO:0009204)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904595	positive regulation of termination of RNA polymerase II transcription (GO:1904595)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009203	ribonucleoside triphosphate catabolic process (GO:0009203)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904594	regulation of termination of RNA polymerase II transcription (GO:1904594)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009202	deoxyribonucleoside triphosphate biosynthetic process (GO:0009202)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009200	deoxyribonucleoside triphosphate metabolic process (GO:0009200)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1904591	positive regulation of protein import (GO:1904591)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042686	regulation of cardioblast cell fate specification (GO:0042686)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904589	regulation of protein import (GO:1904589)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904588	cellular response to glycoprotein (GO:1904588)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904587	response to glycoprotein (GO:1904587)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1904586	cellular response to putrescine (GO:1904586)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904585	response to putrescine (GO:1904585)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042670	retinal cone cell differentiation (GO:0042670)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1904574	negative regulation of selenocysteine insertion sequence binding (GO:1904574)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904573	regulation of selenocysteine insertion sequence binding (GO:1904573)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904572	negative regulation of mRNA binding (GO:1904572)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904570	negative regulation of selenocysteine incorporation (GO:1904570)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042669	regulation of inner ear auditory receptor cell fate specification (GO:0042669)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042668	auditory receptor cell fate determination (GO:0042668)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042667	auditory receptor cell fate specification (GO:0042667)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042664	negative regulation of endodermal cell fate specification (GO:0042664)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904569	regulation of selenocysteine incorporation (GO:1904569)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0062234	platelet activating factor catabolic process (GO:0062234)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0062232	prostanoid catabolic process (GO:0062232)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904562	phosphatidylinositol 5-phosphate metabolic process (GO:1904562)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904557	L-alanine transmembrane transport (GO:1904557)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904556	L-tryptophan transmembrane transport (GO:1904556)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904555	L-proline transmembrane transport (GO:1904555)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904550	response to arachidonic acid (GO:1904550)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097753	membrane bending (GO:0097753)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097752	regulation of DNA stability (GO:0097752)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900191	negative regulation of single-species biofilm formation (GO:1900191)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097750	endosome membrane tubulation (GO:0097750)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900190	regulation of single-species biofilm formation (GO:1900190)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904544	positive regulation of free ubiquitin chain polymerization (GO:1904544)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904542	regulation of free ubiquitin chain polymerization (GO:1904542)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097749	membrane tubulation (GO:0097749)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900186	negative regulation of clathrin-dependent endocytosis (GO:1900186)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0097745	mitochondrial tRNA 5'-end processing (GO:0097745)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042636	negative regulation of hair cycle (GO:0042636)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097744	renal urate salt excretion (GO:0097744)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042635	positive regulation of hair cycle (GO:0042635)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042631	cellular response to water deprivation (GO:0042631)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904539	negative regulation of glycolytic process through fructose-6-phosphate (GO:1904539)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904538	regulation of glycolytic process through fructose-6-phosphate (GO:1904538)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904535	positive regulation of telomeric loop disassembly (GO:1904535)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904534	negative regulation of telomeric loop disassembly (GO:1904534)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904533	regulation of telomeric loop disassembly (GO:1904533)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904531	positive regulation of actin filament binding (GO:1904531)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904530	negative regulation of actin filament binding (GO:1904530)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042628	mating plug formation (GO:0042628)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900176	negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900176)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900175	regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900175)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0030656	regulation of vitamin metabolic process (GO:0030656)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1904529	regulation of actin filament binding (GO:1904529)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904527	negative regulation of microtubule binding (GO:1904527)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900164)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900163	positive regulation of phospholipid scramblase activity (GO:1900163)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900161	regulation of phospholipid scramblase activity (GO:1900161)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030647	aminoglycoside antibiotic metabolic process (GO:0030647)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1904518	protein localization to cytoplasmic microtubule plus-end (GO:1904518)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904510	positive regulation of protein localization to basolateral plasma membrane (GO:1904510)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900159	positive regulation of bone mineralization involved in bone maturation (GO:1900159)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900158	negative regulation of bone mineralization involved in bone maturation (GO:1900158)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900157	regulation of bone mineralization involved in bone maturation (GO:1900157)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1900155	negative regulation of bone trabecula formation (GO:1900155)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900154	regulation of bone trabecula formation (GO:1900154)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097712	vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900152	negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900152)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0097711	ciliary basal body-plasma membrane docking (GO:0097711)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900150	regulation of defense response to fungus (GO:1900150)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0030638	polyketide metabolic process (GO:0030638)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1904508	regulation of protein localization to basolateral plasma membrane (GO:1904508)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904507	positive regulation of telomere maintenance in response to DNA damage (GO:1904507)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1904506	negative regulation of telomere maintenance in response to DNA damage (GO:1904506)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904505	regulation of telomere maintenance in response to DNA damage (GO:1904505)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0097709	connective tissue replacement (GO:0097709)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1900149	positive regulation of Schwann cell migration (GO:1900149)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900146	negative regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900146)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900145	regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1900139	negative regulation of arachidonic acid secretion (GO:1900139)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900138	negative regulation of phospholipase A2 activity (GO:1900138)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061795	Golgi lumen acidification (GO:0061795)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0016344	meiotic chromosome movement towards spindle pole (GO:0016344)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900135	positive regulation of renin secretion into blood stream (GO:1900135)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061792	secretory granule maturation (GO:0061792)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900134	negative regulation of renin secretion into blood stream (GO:1900134)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900133	regulation of renin secretion into blood stream (GO:1900133)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0016340	calcium-dependent cell-matrix adhesion (GO:0016340)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900131	negative regulation of lipid binding (GO:1900131)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900130	regulation of lipid binding (GO:1900130)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061789	dense core granule priming (GO:0061789)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900127	positive regulation of hyaluronan biosynthetic process (GO:1900127)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0016334	establishment or maintenance of polarity of follicular epithelium (GO:0016334)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900126	negative regulation of hyaluronan biosynthetic process (GO:1900126)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0016333	morphogenesis of follicular epithelium (GO:0016333)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016332	establishment or maintenance of polarity of embryonic epithelium (GO:0016332)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900125	regulation of hyaluronan biosynthetic process (GO:1900125)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0061780	mitotic cohesin loading (GO:0061780)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900118	negative regulation of execution phase of apoptosis (GO:1900118)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:1900114	positive regulation of histone H3-K9 trimethylation (GO:1900114)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061772	xenobiotic transport across blood-nerve barrier (GO:0061772)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900113	negative regulation of histone H3-K9 trimethylation (GO:1900113)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0016320	endoplasmic reticulum membrane fusion (GO:0016320)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061771	response to caloric restriction (GO:0061771)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900112	regulation of histone H3-K9 trimethylation (GO:1900112)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1900111	positive regulation of histone H3-K9 dimethylation (GO:1900111)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900110	negative regulation of histone H3-K9 dimethylation (GO:1900110)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900109	regulation of histone H3-K9 dimethylation (GO:1900109)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061767	negative regulation of lung blood pressure (GO:0061767)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900108	negative regulation of nodal signaling pathway (GO:1900108)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900107	regulation of nodal signaling pathway (GO:1900107)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0061764	late endosome to lysosome transport via multivesicular body sorting pathway (GO:0061764)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0100012	regulation of heart induction by canonical Wnt signaling pathway (GO:0100012)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061763	multivesicular body-lysosome fusion (GO:0061763)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0061762	CAMKK-AMPK signaling cascade (GO:0061762)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0061760	antifungal innate immune response (GO:0061760)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:1900102	negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:1900101	regulation of endoplasmic reticulum unfolded protein response (GO:1900101)	31	0	1.82	-	 < 0.01	4.16E-01	1.00E00
GO:1900100	positive regulation of plasma cell differentiation (GO:1900100)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0055096	low-density lipoprotein particle mediated signaling (GO:0055096)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0055095	lipoprotein particle mediated signaling (GO:0055095)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0055091	phospholipid homeostasis (GO:0055091)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0061757	leukocyte adhesion to arterial endothelial cell (GO:0061757)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0100002	negative regulation of protein kinase activity by protein phosphorylation (GO:0100002)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061753	substrate localization to autophagosome (GO:0061753)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0100001	regulation of skeletal muscle contraction by action potential (GO:0100001)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0055073	cadmium ion homeostasis (GO:0055073)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0055071	manganese ion homeostasis (GO:0055071)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035499	carnosine biosynthetic process (GO:0035499)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035498	carnosine metabolic process (GO:0035498)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061739	protein lipidation involved in autophagosome assembly (GO:0061739)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061738	late endosomal microautophagy (GO:0061738)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035494	SNARE complex disassembly (GO:0035494)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061737	leukotriene signaling pathway (GO:0061737)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061736	engulfment of target by autophagosome (GO:0061736)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035491	positive regulation of leukotriene production involved in inflammatory response (GO:0035491)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061734	parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035490	regulation of leukotriene production involved in inflammatory response (GO:0035490)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061732	mitochondrial acetyl-CoA biosynthetic process from pyruvate (GO:0061732)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0043097	pyrimidine nucleoside salvage (GO:0043097)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043096	purine nucleobase salvage (GO:0043096)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043095	regulation of GTP cyclohydrolase I activity (GO:0043095)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035483	gastric emptying (GO:0035483)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061726	mitochondrion disassembly (GO:0061726)	57	0	3.35	-	 < 0.01	7.59E-02	4.78E-01
GO:0035482	gastric motility (GO:0035482)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043090	amino acid import (GO:0043090)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061724	lipophagy (GO:0061724)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061723	glycophagy (GO:0061723)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0043084	penile erection (GO:0043084)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061718	glucose catabolic process to pyruvate (GO:0061718)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0061713	anterior neural tube closure (GO:0061713)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015891	siderophore transport (GO:0015891)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0055048	anastral spindle assembly (GO:0055048)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035469	determination of pancreatic left/right asymmetry (GO:0035469)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061709	reticulophagy (GO:0061709)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0015889	cobalamin transport (GO:0015889)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0015888	thiamine transport (GO:0015888)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0015886	heme transport (GO:0015886)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0015883	FAD transport (GO:0015883)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015882	L-ascorbic acid transmembrane transport (GO:0015882)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015881	creatine transmembrane transport (GO:0015881)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0015880	coenzyme A transport (GO:0015880)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035459	vesicle cargo loading (GO:0035459)	34	0	2.00	-	 < 0.01	2.61E-01	8.48E-01
GO:0035458	cellular response to interferon-beta (GO:0035458)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0035456	response to interferon-beta (GO:0035456)	33	0	1.94	-	 < 0.01	2.60E-01	8.46E-01
GO:0043063	intercellular bridge organization (GO:0043063)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043060	meiotic metaphase I plate congression (GO:0043060)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015879	carnitine transport (GO:0015879)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0015876	acetyl-CoA transport (GO:0015876)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015871	choline transport (GO:0015871)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0015870	acetylcholine transport (GO:0015870)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0055026	negative regulation of cardiac muscle tissue development (GO:0055026)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0055025	positive regulation of cardiac muscle tissue development (GO:0055025)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0055020	positive regulation of cardiac muscle fiber development (GO:0055020)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035445	borate transmembrane transport (GO:0035445)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035444	nickel cation transmembrane transport (GO:0035444)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035443	tripeptide transmembrane transport (GO:0035443)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0043052	thermotaxis (GO:0043052)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035442	dipeptide transmembrane transport (GO:0035442)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0031087	deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0015861	cytidine transport (GO:0015861)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0055018	regulation of cardiac muscle fiber development (GO:0055018)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0055014	atrial cardiac muscle cell development (GO:0055014)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0055011	atrial cardiac muscle cell differentiation (GO:0055011)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009197	pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009196	pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0043049	otic placode formation (GO:0043049)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009195	pyrimidine ribonucleoside diphosphate catabolic process (GO:0009195)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0043048	dolichyl monophosphate biosynthetic process (GO:0043048)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009194	pyrimidine ribonucleoside diphosphate biosynthetic process (GO:0009194)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0009193	pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0009192	deoxyribonucleoside diphosphate catabolic process (GO:0009192)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035434	copper ion transmembrane transport (GO:0035434)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0043041	amino acid activation for nonribosomal peptide biosynthetic process (GO:0043041)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0055005	ventricular cardiac myofibril assembly (GO:0055005)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009189	deoxyribonucleoside diphosphate biosynthetic process (GO:0009189)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0009186	deoxyribonucleoside diphosphate metabolic process (GO:0009186)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009184	purine deoxyribonucleoside diphosphate catabolic process (GO:0009184)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009183	purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035426	extracellular matrix-cell signaling (GO:0035426)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0009182	purine deoxyribonucleoside diphosphate metabolic process (GO:0009182)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0015847	putrescine transport (GO:0015847)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015846	polyamine transport (GO:0015846)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0031064	negative regulation of histone deacetylation (GO:0031064)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0015842	aminergic neurotransmitter loading into synaptic vesicle (GO:0015842)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0015840	urea transport (GO:0015840)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0009178	pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0009175	pyrimidine ribonucleoside monophosphate catabolic process (GO:0009175)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009174	pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0009173	pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0009172	purine deoxyribonucleoside monophosphate catabolic process (GO:0009172)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009171	purine deoxyribonucleoside monophosphate biosynthetic process (GO:0009171)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009170	purine deoxyribonucleoside monophosphate metabolic process (GO:0009170)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0015838	amino-acid betaine transport (GO:0015838)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0015837	amine transport (GO:0015837)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0031054	pre-miRNA processing (GO:0031054)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0031053	primary miRNA processing (GO:0031053)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0015835	peptidoglycan transport (GO:0015835)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009168	purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0009164	nucleoside catabolic process (GO:0009164)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0043012	regulation of fusion of sperm to egg plasma membrane (GO:0043012)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031048	small non-coding RNA-dependent heterochromatin formation (GO:0031048)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015829	valine transport (GO:0015829)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015828	tyrosine transport (GO:0015828)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015827	tryptophan transport (GO:0015827)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0015826	threonine transport (GO:0015826)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015825	L-serine transport (GO:0015825)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0015824	proline transport (GO:0015824)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0015823	phenylalanine transport (GO:0015823)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015822	ornithine transport (GO:0015822)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0015821	methionine transport (GO:0015821)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015820	leucine transport (GO:0015820)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009159	deoxyribonucleoside monophosphate catabolic process (GO:0009159)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0009156	ribonucleoside monophosphate biosynthetic process (GO:0009156)	35	0	2.06	-	 < 0.01	2.62E-01	8.51E-01
GO:0009155	purine deoxyribonucleotide catabolic process (GO:0009155)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0009153	purine deoxyribonucleotide biosynthetic process (GO:0009153)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0009151	purine deoxyribonucleotide metabolic process (GO:0009151)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0043004	cytoplasmic sequestering of CFTR protein (GO:0043004)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043002	negative regulation of Golgi to plasma membrane CFTR protein transport (GO:0043002)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0043001	Golgi to plasma membrane protein transport (GO:0043001)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:0043000	Golgi to plasma membrane CFTR protein transport (GO:0043000)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015819	lysine transport (GO:0015819)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015818	isoleucine transport (GO:0015818)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015817	histidine transport (GO:0015817)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015816	glycine transport (GO:0015816)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0015811	L-cystine transport (GO:0015811)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0015810	aspartate transmembrane transport (GO:0015810)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0009149	pyrimidine nucleoside triphosphate catabolic process (GO:0009149)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0009146	purine nucleoside triphosphate catabolic process (GO:0009146)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046986	negative regulation of hemoglobin biosynthetic process (GO:0046986)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009140	pyrimidine nucleoside diphosphate catabolic process (GO:0009140)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015808	L-alanine transport (GO:0015808)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0015805	S-adenosyl-L-methionine transport (GO:0015805)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0031022	nuclear migration along microfilament (GO:0031022)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015803	branched-chain amino acid transport (GO:0015803)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0015802	basic amino acid transport (GO:0015802)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0015801	aromatic amino acid transport (GO:0015801)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0009139	pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009138	pyrimidine nucleoside diphosphate metabolic process (GO:0009138)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0062196	regulation of lysosome size (GO:0062196)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0009131	pyrimidine nucleoside monophosphate catabolic process (GO:0009131)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0031017	exocrine pancreas development (GO:0031017)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0009127	purine nucleoside monophosphate biosynthetic process (GO:0009127)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0046968	peptide antigen transport (GO:0046968)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046963	3'-phosphoadenosine 5'-phosphosulfate transport (GO:0046963)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046960	sensitization (GO:0046960)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0062177	radial spoke assembly (GO:0062177)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0062176	R-loop disassembly (GO:0062176)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009115	xanthine catabolic process (GO:0009115)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009114	hypoxanthine catabolic process (GO:0009114)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009113	purine nucleobase biosynthetic process (GO:0009113)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0009111	vitamin catabolic process (GO:0009111)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0046952	ketone body catabolic process (GO:0046952)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042595	behavioral response to starvation (GO:0042595)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034982	mitochondrial protein processing (GO:0034982)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0046949	fatty-acyl-CoA biosynthetic process (GO:0046949)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0009107	lipoate biosynthetic process (GO:0009107)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009106	lipoate metabolic process (GO:0009106)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046947	hydroxylysine biosynthetic process (GO:0046947)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046946	hydroxylysine metabolic process (GO:0046946)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009104	lipopolysaccharide catabolic process (GO:0009104)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097699	vascular endothelial cell response to fluid shear stress (GO:0097699)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097698	telomere maintenance via base-excision repair (GO:0097698)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097695	establishment of protein-containing complex localization to telomere (GO:0097695)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097694	establishment of RNA localization to telomere (GO:0097694)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097692	histone H3-K4 monomethylation (GO:0097692)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0034975	protein folding in endoplasmic reticulum (GO:0034975)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0034972	histone H3-R26 methylation (GO:0034972)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034971	histone H3-R17 methylation (GO:0034971)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034970	histone H3-R2 methylation (GO:0034970)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904486	response to 17alpha-ethynylestradiol (GO:1904486)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904482	cellular response to tetrahydrofolate (GO:1904482)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904481	response to tetrahydrofolate (GO:1904481)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046931	pore complex assembly (GO:0046931)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:1904480	positive regulation of intestinal absorption (GO:1904480)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034969	histone arginine methylation (GO:0034969)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0034964	box H/ACA RNA processing (GO:0034964)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097680	double-strand break repair via classical nonhomologous end joining (GO:0097680)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034963	box C/D RNA processing (GO:0034963)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0150202	negative regulation of transport across blood-brain barrier (GO:0150202)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150201	positive regulation of transport across blood-brain barrier (GO:0150201)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150200	regulation of transport across blood-brain barrier (GO:0150200)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904479	negative regulation of intestinal absorption (GO:1904479)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904478	regulation of intestinal absorption (GO:1904478)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1904472	positive regulation of endothelin production (GO:1904472)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904470	regulation of endothelin production (GO:1904470)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097676	histone H3-K36 dimethylation (GO:0097676)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034959	endothelin maturation (GO:0034959)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042560	pteridine-containing compound catabolic process (GO:0042560)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0030592	DNA ADP-ribosylation (GO:0030592)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904466	positive regulation of matrix metallopeptidase secretion (GO:1904466)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042554	superoxide anion generation (GO:0042554)	24	0	1.41	-	 < 0.01	6.42E-01	1.00E00
GO:0030581	symbiont intracellular protein transport in host (GO:0030581)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904457	positive regulation of neuronal action potential (GO:1904457)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0062126	fatty acid primary amide metabolic process (GO:0062126)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0062125	regulation of mitochondrial gene expression (GO:0062125)	31	0	1.82	-	 < 0.01	4.16E-01	1.00E00
GO:1904456	negative regulation of neuronal action potential (GO:1904456)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046901	tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900099	negative regulation of plasma cell differentiation (GO:1900099)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904450	positive regulation of aspartate secretion (GO:1904450)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900098	regulation of plasma cell differentiation (GO:1900098)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1900095	regulation of dosage compensation by inactivation of X chromosome (GO:1900095)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0042543	protein N-linked glycosylation via arginine (GO:0042543)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030576	Cajal body organization (GO:0030576)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0030573	bile acid catabolic process (GO:0030573)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010999	regulation of eIF2 alpha phosphorylation by heme (GO:0010999)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010998	regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904448	regulation of aspartate secretion (GO:1904448)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904445	negative regulation of establishment of Sertoli cell barrier (GO:1904445)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904444	regulation of establishment of Sertoli cell barrier (GO:1904444)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0062112	fatty acid primary amide biosynthetic process (GO:0062112)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0062111	zinc ion import into organelle (GO:0062111)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010991	negative regulation of SMAD protein complex assembly (GO:0010991)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010990	regulation of SMAD protein complex assembly (GO:0010990)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904440	positive regulation of iron ion import across plasma membrane (GO:1904440)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042539	hypotonic salinity response (GO:0042539)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042538	hyperosmotic salinity response (GO:0042538)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1900086	positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0097640	L-ornithine import across plasma membrane (GO:0097640)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010989	negative regulation of low-density lipoprotein particle clearance (GO:0010989)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904439	negative regulation of iron ion import across plasma membrane (GO:1904439)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010988	regulation of low-density lipoprotein particle clearance (GO:0010988)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1904438	regulation of iron ion import across plasma membrane (GO:1904438)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904437	positive regulation of transferrin receptor binding (GO:1904437)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010987	negative regulation of high-density lipoprotein particle clearance (GO:0010987)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904435	regulation of transferrin receptor binding (GO:1904435)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904434	positive regulation of ferrous iron binding (GO:1904434)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010983	positive regulation of high-density lipoprotein particle clearance (GO:0010983)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010982	regulation of high-density lipoprotein particle clearance (GO:0010982)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904432	regulation of ferrous iron binding (GO:1904432)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904431	positive regulation of t-circle formation (GO:1904431)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0062100	positive regulation of programmed necrotic cell death (GO:0062100)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097639	L-lysine import across plasma membrane (GO:0097639)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010980	positive regulation of vitamin D 24-hydroxylase activity (GO:0010980)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900079	regulation of arginine biosynthetic process (GO:1900079)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097638	L-arginine import across plasma membrane (GO:0097638)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904430	negative regulation of t-circle formation (GO:1904430)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010979	regulation of vitamin D 24-hydroxylase activity (GO:0010979)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904429	regulation of t-circle formation (GO:1904429)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904426	positive regulation of GTP binding (GO:1904426)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900063	regulation of peroxisome organization (GO:1900063)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900060	negative regulation of ceramide biosynthetic process (GO:1900060)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010968	regulation of microtubule nucleation (GO:0010968)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1904417	positive regulation of xenophagy (GO:1904417)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0010967	regulation of polyamine biosynthetic process (GO:0010967)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904415	regulation of xenophagy (GO:1904415)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904414	positive regulation of cardiac ventricle development (GO:1904414)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016269	O-glycan processing, core 3 (GO:0016269)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016268	O-glycan processing, core 2 (GO:0016268)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904412	regulation of cardiac ventricle development (GO:1904412)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016267	O-glycan processing, core 1 (GO:0016267)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010961	cellular magnesium ion homeostasis (GO:0010961)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904411	positive regulation of secretory granule organization (GO:1904411)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010960	magnesium ion homeostasis (GO:0010960)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0016264	gap junction assembly (GO:0016264)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0008655	pyrimidine-containing compound salvage (GO:0008655)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0008653	lipopolysaccharide metabolic process (GO:0008653)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016261	selenocysteine catabolic process (GO:0016261)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900054	positive regulation of retinoic acid biosynthetic process (GO:1900054)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016260	selenocysteine biosynthetic process (GO:0016260)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900053	negative regulation of retinoic acid biosynthetic process (GO:1900053)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900052	regulation of retinoic acid biosynthetic process (GO:1900052)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900051	positive regulation of histone exchange (GO:1900051)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042501	serine phosphorylation of STAT protein (GO:0042501)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0030538	embryonic genitalia morphogenesis (GO:0030538)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904409	regulation of secretory granule organization (GO:1904409)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010957	negative regulation of vitamin D biosynthetic process (GO:0010957)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010956	negative regulation of calcidiol 1-monooxygenase activity (GO:0010956)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0016259	selenocysteine metabolic process (GO:0016259)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904401	cellular response to Thyroid stimulating hormone (GO:1904401)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904400	response to Thyroid stimulating hormone (GO:1904400)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0016256	N-glycan processing to lysosome (GO:0016256)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900049	regulation of histone exchange (GO:1900049)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0016255	attachment of GPI anchor to protein (GO:0016255)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0016254	preassembly of GPI anchor in ER membrane (GO:0016254)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1900045	negative regulation of protein K63-linked ubiquitination (GO:1900045)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1900044	regulation of protein K63-linked ubiquitination (GO:1900044)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0030521	androgen receptor signaling pathway (GO:0030521)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0010949	negative regulation of intestinal phytosterol absorption (GO:0010949)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010944	negative regulation of transcription by competitive promoter binding (GO:0010944)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0061698	protein deglutarylation (GO:0061698)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010940	positive regulation of necrotic cell death (GO:0010940)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:1900039	positive regulation of cellular response to hypoxia (GO:1900039)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0008635	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0016243	regulation of autophagosome size (GO:0016243)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1900036	positive regulation of cellular response to heat (GO:1900036)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061692	cellular detoxification of hydrogen peroxide (GO:0061692)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016240	autophagosome membrane docking (GO:0016240)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0061691	detoxification of hydrogen peroxide (GO:0061691)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010938	cytoplasmic microtubule depolymerization (GO:0010938)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016237	lysosomal microautophagy (GO:0016237)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0008628	hormone-mediated apoptotic signaling pathway (GO:0008628)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0008626	granzyme-mediated apoptotic signaling pathway (GO:0008626)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016233	telomere capping (GO:0016233)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:1900022	regulation of D-erythro-sphingosine kinase activity (GO:1900022)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010925	positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010924	regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016226	iron-sulfur cluster assembly (GO:0016226)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0008617	guanosine metabolic process (GO:0008617)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010920	negative regulation of inositol phosphate biosynthetic process (GO:0010920)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0008615	pyridoxine biosynthetic process (GO:0008615)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0008614	pyridoxine metabolic process (GO:0008614)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0008612	peptidyl-lysine modification to peptidyl-hypusine (GO:0008612)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061670	evoked neurotransmitter secretion (GO:0061670)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900011	negative regulation of corticotropin-releasing hormone receptor activity (GO:1900011)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1900010	regulation of corticotropin-releasing hormone receptor activity (GO:1900010)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010918	positive regulation of mitochondrial membrane potential (GO:0010918)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0061669	spontaneous neurotransmitter secretion (GO:0061669)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0061668	mitochondrial ribosome assembly (GO:0061668)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1903999	negative regulation of eating behavior (GO:1903999)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903998	regulation of eating behavior (GO:1903998)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1903997	positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903996	negative regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903996)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903995	regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1900005	positive regulation of serine-type endopeptidase activity (GO:1900005)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1900004	negative regulation of serine-type endopeptidase activity (GO:1900004)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1900003	regulation of serine-type endopeptidase activity (GO:1900003)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0010909	positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010908	regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010905	negative regulation of UDP-glucose catabolic process (GO:0010905)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010904	regulation of UDP-glucose catabolic process (GO:0010904)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010903	negative regulation of very-low-density lipoprotein particle remodeling (GO:0010903)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010902	positive regulation of very-low-density lipoprotein particle remodeling (GO:0010902)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010901	regulation of very-low-density lipoprotein particle remodeling (GO:0010901)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903988	iron ion export across plasma membrane (GO:1903988)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016203	muscle attachment (GO:0016203)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061646	positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903974	positive regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903974)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061642	chemoattraction of axon (GO:0061642)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903972	regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903972)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903971	positive regulation of response to macrophage colony-stimulating factor (GO:1903971)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035397	helper T cell enhancement of adaptive immune response (GO:0035397)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035395	negative regulation of chemokine (C-X-C motif) ligand 9 production (GO:0035395)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903969	regulation of response to macrophage colony-stimulating factor (GO:1903969)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0035394	regulation of chemokine (C-X-C motif) ligand 9 production (GO:0035394)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061635	regulation of protein complex stability (GO:0061635)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1903965	monounsaturated fatty acid catabolic process (GO:1903965)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035382	sterol transmembrane transport (GO:0035382)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061624	fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061623	glycolytic process from galactose (GO:0061623)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903954	positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903954)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061622	glycolytic process through glucose-1-phosphate (GO:0061622)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061621	canonical glycolysis (GO:0061621)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:1903952	regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903952)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061620	glycolytic process through glucose-6-phosphate (GO:0061620)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:1903949	positive regulation of atrial cardiac muscle cell action potential (GO:1903949)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061615	glycolytic process through fructose-6-phosphate (GO:0061615)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0061614	miRNA transcription (GO:0061614)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903945	positive regulation of hepatocyte apoptotic process (GO:1903945)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903944	negative regulation of hepatocyte apoptotic process (GO:1903944)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903943	regulation of hepatocyte apoptotic process (GO:1903943)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0061611	mannose to fructose-6-phosphate metabolic process (GO:0061611)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015798	myo-inositol transport (GO:0015798)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903942	positive regulation of respiratory gaseous exchange (GO:1903942)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903940	negative regulation of TORC2 signaling (GO:1903940)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015790	UDP-xylose transmembrane transport (GO:0015790)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903937	response to acrylamide (GO:1903937)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903936	cellular response to sodium arsenite (GO:1903936)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903935	response to sodium arsenite (GO:1903935)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0015789	UDP-N-acetylgalactosamine transmembrane transport (GO:0015789)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015787	UDP-glucuronic acid transmembrane transport (GO:0015787)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0015786	UDP-glucose transmembrane transport (GO:0015786)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015783	GDP-fucose transmembrane transport (GO:0015783)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015782	CMP-N-acetylneuraminate transmembrane transport (GO:0015782)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015780	nucleotide-sugar transmembrane transport (GO:0015780)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0035359	negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035357	peroxisome proliferator activated receptor signaling pathway (GO:0035357)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0035356	cellular triglyceride homeostasis (GO:0035356)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0035352	NAD transmembrane transport (GO:0035352)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035351	heme transmembrane transport (GO:0035351)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903926	cellular response to bisphenol A (GO:1903926)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903925	response to bisphenol A (GO:1903925)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035350	FAD transmembrane transport (GO:0035350)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015779	glucuronoside transport (GO:0015779)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903920	positive regulation of actin filament severing (GO:1903920)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015774	polysaccharide transport (GO:0015774)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015772	oligosaccharide transport (GO:0015772)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0015770	sucrose transport (GO:0015770)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0039702	viral budding via host ESCRT complex (GO:0039702)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0035349	coenzyme A transmembrane transport (GO:0035349)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903919	negative regulation of actin filament severing (GO:1903919)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903918	regulation of actin filament severing (GO:1903918)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903917	positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903917)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903916	regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903916)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035340	inosine transport (GO:0035340)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903912	negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903911	positive regulation of receptor clustering (GO:1903911)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0015766	disaccharide transport (GO:0015766)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903910	negative regulation of receptor clustering (GO:1903910)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015760	glucose-6-phosphate transport (GO:0015760)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009099	valine biosynthetic process (GO:0009099)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009098	leucine biosynthetic process (GO:0009098)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009097	isoleucine biosynthetic process (GO:0009097)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009095	aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035338	long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0035337	fatty-acyl-CoA metabolic process (GO:0035337)	39	0	2.29	-	 < 0.01	2.76E-01	8.80E-01
GO:0035336	long-chain fatty-acyl-CoA metabolic process (GO:0035336)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0009092	homoserine metabolic process (GO:0009092)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035332	positive regulation of hippo signaling (GO:0035332)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1903905	positive regulation of establishment of T cell polarity (GO:1903905)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903904	negative regulation of establishment of T cell polarity (GO:1903904)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015756	fucose transmembrane transport (GO:0015756)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015755	fructose transmembrane transport (GO:0015755)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0015750	pentose transmembrane transport (GO:0015750)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009087	methionine catabolic process (GO:0009087)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009085	lysine biosynthetic process (GO:0009085)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0009083	branched-chain amino acid catabolic process (GO:0009083)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0009082	branched-chain amino acid biosynthetic process (GO:0009082)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0009081	branched-chain amino acid metabolic process (GO:0009081)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0009080	pyruvate family amino acid catabolic process (GO:0009080)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0015747	urate transport (GO:0015747)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0086073	bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0015746	citrate transport (GO:0015746)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0086072	AV node cell-bundle of His cell adhesion involved in cell communication (GO:0086072)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015744	succinate transport (GO:0015744)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0015743	malate transport (GO:0015743)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0015742	alpha-ketoglutarate transport (GO:0015742)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0015741	fumarate transport (GO:0015741)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015740	C4-dicarboxylate transport (GO:0015740)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0009078	pyruvate family amino acid metabolic process (GO:0009078)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0098038	non-replicative transposition, DNA-mediated (GO:0098038)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0009073	aromatic amino acid family biosynthetic process (GO:0009073)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009070	serine family amino acid biosynthetic process (GO:0009070)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0015739	sialic acid transport (GO:0015739)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0015738	glucuronate transmembrane transport (GO:0015738)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015736	hexuronate transmembrane transport (GO:0015736)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015735	uronic acid transmembrane transport (GO:0015735)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015734	taurine transport (GO:0015734)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0015732	prostaglandin transport (GO:0015732)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0015730	propanoate transport (GO:0015730)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015729	oxaloacetate transport (GO:0015729)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0086055	Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling (GO:0086055)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015728	mevalonate transport (GO:0015728)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0086053	AV node cell to bundle of His cell communication by electrical coupling (GO:0086053)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015727	lactate transport (GO:0015727)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0086052	membrane repolarization during SA node cell action potential (GO:0086052)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0086050	membrane repolarization during bundle of His cell action potential (GO:0086050)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015723	bilirubin transport (GO:0015723)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015722	canalicular bile acid transport (GO:0015722)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0150178	regulation of phosphatidylserine metabolic process (GO:0150178)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015721	bile acid and bile salt transport (GO:0015721)	32	0	1.88	-	 < 0.01	2.60E-01	8.48E-01
GO:0150175	regulation of phosphatidylethanolamine metabolic process (GO:0150175)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150173	positive regulation of phosphatidylcholine metabolic process (GO:0150173)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0009052	pentose-phosphate shunt, non-oxidative branch (GO:0009052)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0009051	pentose-phosphate shunt, oxidative branch (GO:0009051)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0086044	atrial cardiac muscle cell to AV node cell communication by electrical coupling (GO:0086044)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0086042	cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0015712	hexose phosphate transport (GO:0015712)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0046884	follicle-stimulating hormone secretion (GO:0046884)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015709	thiosulfate transport (GO:0015709)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0015707	nitrite transport (GO:0015707)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015706	nitrate transmembrane transport (GO:0015706)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0086030	adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation (GO:0086030)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015700	arsenite transport (GO:0015700)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150153	positive regulation of interleukin-17A production (GO:0150153)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150151	regulation of interleukin-17A production (GO:0150151)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0062094	stomach development (GO:0062094)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0086021	SA node cell to atrial cardiac muscle cell communication by electrical coupling (GO:0086021)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0150147	cell-cell junction disassembly (GO:0150147)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046867	carotenoid transport (GO:0046867)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046866	tetraterpenoid transport (GO:0046866)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046856	phosphatidylinositol dephosphorylation (GO:0046856)	31	0	1.82	-	 < 0.01	4.16E-01	1.00E00
GO:0046855	inositol phosphate dephosphorylation (GO:0046855)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0042496	detection of diacyl bacterial lipopeptide (GO:0042496)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042495	detection of triacyl bacterial lipopeptide (GO:0042495)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042492	gamma-delta T cell differentiation (GO:0042492)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0150129	positive regulation of interleukin-33 production (GO:0150129)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150127	regulation of interleukin-33 production (GO:0150127)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904395	positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904394	negative regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904394)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904393	regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042489	negative regulation of odontogenesis of dentin-containing tooth (GO:0042489)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042483	negative regulation of odontogenesis (GO:0042483)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0150111	regulation of transepithelial transport (GO:0150111)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904387	cellular response to L-phenylalanine derivative (GO:1904387)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904386	response to L-phenylalanine derivative (GO:1904386)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0046836	glycolipid transport (GO:0046836)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1904382	mannose trimming involved in glycoprotein ERAD pathway (GO:1904382)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046833	positive regulation of RNA export from nucleus (GO:0046833)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904381	Golgi apparatus mannose trimming (GO:1904381)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046832	negative regulation of RNA export from nucleus (GO:0046832)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904380	endoplasmic reticulum mannose trimming (GO:1904380)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0046831	regulation of RNA export from nucleus (GO:0046831)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0042473	outer ear morphogenesis (GO:0042473)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0150107	positive regulation of protein localization to cell-cell junction (GO:0150107)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150106	regulation of protein localization to cell-cell junction (GO:0150106)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0150103	reactive gliosis (GO:0150103)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150102	negative regulation of monocyte activation (GO:0150102)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0150101	regulation of microtubule anchoring at centrosome (GO:0150101)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904379	protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904378	maintenance of unfolded protein involved in ERAD pathway (GO:1904378)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0062044	negative regulation of cardiac epithelial to mesenchymal transition (GO:0062044)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046826	negative regulation of protein export from nucleus (GO:0046826)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904372	positive regulation of protein localization to actin cortical patch (GO:1904372)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904370	regulation of protein localization to actin cortical patch (GO:1904370)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097577	sequestering of iron ion (GO:0097577)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097576	vacuole fusion (GO:0097576)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0030497	fatty acid elongation (GO:0030497)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0030490	maturation of SSU-rRNA (GO:0030490)	55	0	3.23	-	 < 0.01	7.47E-02	4.75E-01
GO:0046814	coreceptor-mediated virion attachment to host cell (GO:0046814)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0062030	negative regulation of stress granule assembly (GO:0062030)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042454	ribonucleoside catabolic process (GO:0042454)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0042453	deoxyguanosine metabolic process (GO:0042453)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042450	arginine biosynthetic process via ornithine (GO:0042450)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030488	tRNA methylation (GO:0030488)	43	0	2.52	-	 < 0.01	1.74E-01	7.00E-01
GO:0062029	positive regulation of stress granule assembly (GO:0062029)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0062026	negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process (GO:0062026)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0062025	regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0062025)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904354	negative regulation of telomere capping (GO:1904354)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904352	positive regulation of protein catabolic process in the vacuole (GO:1904352)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904351	negative regulation of protein catabolic process in the vacuole (GO:1904351)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904350	regulation of protein catabolic process in the vacuole (GO:1904350)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0042448	progesterone metabolic process (GO:0042448)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0008594	photoreceptor cell morphogenesis (GO:0008594)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0097552	mitochondrial double-strand break repair via homologous recombination (GO:0097552)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097551	mitochondrial double-strand break repair (GO:0097551)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042441	eye pigment metabolic process (GO:0042441)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0030473	nuclear migration along microtubule (GO:0030473)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010898	positive regulation of triglyceride catabolic process (GO:0010898)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0010897	negative regulation of triglyceride catabolic process (GO:0010897)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010896	regulation of triglyceride catabolic process (GO:0010896)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1904346	positive regulation of gastric mucosal blood circulation (GO:1904346)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904344	regulation of gastric mucosal blood circulation (GO:1904344)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016199	axon midline choice point recognition (GO:0016199)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010893	positive regulation of steroid biosynthetic process (GO:0010893)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0016198	axon choice point recognition (GO:0016198)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0010891	negative regulation of sequestering of triglyceride (GO:0010891)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010890	positive regulation of sequestering of triglyceride (GO:0010890)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0042439	ethanolamine-containing compound metabolic process (GO:0042439)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0042435	indole-containing compound biosynthetic process (GO:0042435)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0042431	indole metabolic process (GO:0042431)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010889	regulation of sequestering of triglyceride (GO:0010889)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1904339	negative regulation of dopaminergic neuron differentiation (GO:1904339)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010886	positive regulation of cholesterol storage (GO:0010886)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0062003	negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062003)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016189	synaptic vesicle to endosome fusion (GO:0016189)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904333	positive regulation of error-prone translesion synthesis (GO:1904333)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0062002	regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062002)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904331	regulation of error-prone translesion synthesis (GO:1904331)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016185	synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0097536	thymus epithelium morphogenesis (GO:0097536)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042427	serotonin biosynthetic process (GO:0042427)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0016183	synaptic vesicle coating (GO:0016183)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0097535	lymphoid lineage cell migration into thymus (GO:0097535)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016182	synaptic vesicle budding from endosome (GO:0016182)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097534	lymphoid lineage cell migration (GO:0097534)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016180	snRNA processing (GO:0016180)	37	0	2.17	-	 < 0.01	2.68E-01	8.57E-01
GO:0030450	regulation of complement activation, classical pathway (GO:0030450)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0010879	cholesterol transport involved in cholesterol storage (GO:0010879)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010878	cholesterol storage (GO:0010878)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904328	regulation of myofibroblast contraction (GO:1904328)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904327	protein localization to cytosolic proteasome complex (GO:1904327)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010877	lipid transport involved in lipid storage (GO:0010877)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904325	positive regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904325)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904323	regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904323)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097528	execution phase of necroptosis (GO:0097528)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097527	necroptotic signaling pathway (GO:0097527)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0042418	epinephrine biosynthetic process (GO:0042418)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042414	epinephrine metabolic process (GO:0042414)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042413	carnitine catabolic process (GO:0042413)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010868	negative regulation of triglyceride biosynthetic process (GO:0010868)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904317	cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904317)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904316	response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904316)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042407	cristae formation (GO:0042407)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0042404	thyroid hormone catabolic process (GO:0042404)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097510	base-excision repair, AP site formation via deaminated base removal (GO:0097510)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030433	ubiquitin-dependent ERAD pathway (GO:0030433)	81	0	4.76	-	 < 0.01	2.37E-02	2.34E-01
GO:0030432	peristalsis (GO:0030432)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1904303	positive regulation of maternal process involved in parturition (GO:1904303)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904301	regulation of maternal process involved in parturition (GO:1904301)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904300	positive regulation of transcytosis (GO:1904300)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030422	siRNA processing (GO:0030422)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0030421	defecation (GO:0030421)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010849	regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010842	retina layer formation (GO:0010842)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0010841	positive regulation of circadian sleep/wake cycle, wakefulness (GO:0010841)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010840	regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0008535	respiratory chain complex IV assembly (GO:0008535)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:0061591	calcium activated galactosylceramide scrambling (GO:0061591)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061590	calcium activated phosphatidylcholine scrambling (GO:0061590)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010836	negative regulation of protein ADP-ribosylation (GO:0010836)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010835	regulation of protein ADP-ribosylation (GO:0010835)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0016139	glycoside catabolic process (GO:0016139)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0061589	calcium activated phosphatidylserine scrambling (GO:0061589)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061588	calcium activated phospholipid scrambling (GO:0061588)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0016137	glycoside metabolic process (GO:0016137)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:0061586	positive regulation of transcription by transcription factor localization (GO:0061586)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061582	intestinal epithelial cell migration (GO:0061582)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061580	colon epithelial cell migration (GO:0061580)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0039695	DNA-templated viral transcription (GO:0039695)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0039694	viral RNA genome replication (GO:0039694)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0039692	single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010825	positive regulation of centrosome duplication (GO:0010825)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0016123	xanthophyll biosynthetic process (GO:0016123)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061573	actin filament bundle retrograde transport (GO:0061573)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061571	TDP phosphorylation (GO:0061571)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061570	dCDP phosphorylation (GO:0061570)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0039689	negative stranded viral RNA replication (GO:0039689)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010816	calcitonin catabolic process (GO:0010816)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010815	bradykinin catabolic process (GO:0010815)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0010814	substance P catabolic process (GO:0010814)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010813	neuropeptide catabolic process (GO:0010813)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061569	UDP phosphorylation (GO:0061569)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016117	carotenoid biosynthetic process (GO:0016117)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903899	positive regulation of PERK-mediated unfolded protein response (GO:1903899)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061568	GDP phosphorylation (GO:0061568)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903898	negative regulation of PERK-mediated unfolded protein response (GO:1903898)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0061567	dCMP phosphorylation (GO:0061567)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903897	regulation of PERK-mediated unfolded protein response (GO:1903897)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0061566	CMP phosphorylation (GO:0061566)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903896	positive regulation of IRE1-mediated unfolded protein response (GO:1903896)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0061565	dAMP phosphorylation (GO:0061565)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903895	negative regulation of IRE1-mediated unfolded protein response (GO:1903895)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903894	regulation of IRE1-mediated unfolded protein response (GO:1903894)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1903893	positive regulation of ATF6-mediated unfolded protein response (GO:1903893)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903892	negative regulation of ATF6-mediated unfolded protein response (GO:1903892)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903891	regulation of ATF6-mediated unfolded protein response (GO:1903891)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010808	positive regulation of synaptic vesicle priming (GO:0010808)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016109	tetraterpenoid biosynthetic process (GO:0016109)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010801	negative regulation of peptidyl-threonine phosphorylation (GO:0010801)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0016107	sesquiterpenoid catabolic process (GO:0016107)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016104	triterpenoid biosynthetic process (GO:0016104)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903886	positive regulation of chemokine (C-C motif) ligand 20 production (GO:1903886)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016103	diterpenoid catabolic process (GO:0016103)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903884	regulation of chemokine (C-C motif) ligand 20 production (GO:1903884)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061552	ganglion morphogenesis (GO:0061552)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903883	positive regulation of interleukin-17-mediated signaling pathway (GO:1903883)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903881	regulation of interleukin-17-mediated signaling pathway (GO:1903881)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061549	sympathetic ganglion development (GO:0061549)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0039654	fusion of virus membrane with host endosome membrane (GO:0039654)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061535	glutamate secretion, neurotransmission (GO:0061535)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035290	trunk segmentation (GO:0035290)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061534	gamma-aminobutyric acid secretion, neurotransmission (GO:0061534)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903860	negative regulation of dendrite extension (GO:1903860)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061526	acetylcholine secretion (GO:0061526)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061525	hindgut development (GO:0061525)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0035281	pre-miRNA export from nucleus (GO:0035281)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903852	positive regulation of cristae formation (GO:1903852)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903850	regulation of cristae formation (GO:1903850)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035279	miRNA-mediated gene silencing by mRNA destabilization (GO:0035279)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061519	macrophage homeostasis (GO:0061519)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903849	positive regulation of aorta morphogenesis (GO:1903849)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903847	regulation of aorta morphogenesis (GO:1903847)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061516	monocyte proliferation (GO:0061516)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903845	negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903843	cellular response to arsenite ion (GO:1903843)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903842	response to arsenite ion (GO:1903842)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061511	centriole elongation (GO:0061511)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903841	cellular response to arsenite(3-) (GO:1903841)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903840	response to arsenite(3-) (GO:1903840)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015693	magnesium ion transport (GO:0015693)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0015692	lead ion transport (GO:0015692)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015691	cadmium ion transport (GO:0015691)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0035269	protein O-linked mannosylation (GO:0035269)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:1903839	positive regulation of mRNA 3'-UTR binding (GO:1903839)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061508	CDP phosphorylation (GO:0061508)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035262	gonad morphogenesis (GO:0035262)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903837	regulation of mRNA 3'-UTR binding (GO:1903837)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035261	external genitalia morphogenesis (GO:0035261)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061502	early endosome to recycling endosome transport (GO:0061502)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0015689	molybdate ion transport (GO:0015689)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903830	magnesium ion transmembrane transport (GO:1903830)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0015680	protein maturation by copper ion transfer (GO:0015680)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903826	L-arginine transmembrane transport (GO:1903826)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1903824	negative regulation of telomere single strand break repair (GO:1903824)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015679	plasma membrane copper ion transport (GO:0015679)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015676	vanadium ion transport (GO:0015676)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0015675	nickel cation transport (GO:0015675)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035247	peptidyl-arginine omega-N-methylation (GO:0035247)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035246	peptidyl-arginine N-methylation (GO:0035246)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903812	L-serine import across plasma membrane (GO:1903812)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903811	L-asparagine import across plasma membrane (GO:1903811)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903810	L-histidine import across plasma membrane (GO:1903810)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035238	vitamin A biosynthetic process (GO:0035238)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903806	L-isoleucine import across plasma membrane (GO:1903806)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903804	glycine import across plasma membrane (GO:1903804)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903803	L-glutamine import across plasma membrane (GO:1903803)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903801	L-leucine import across plasma membrane (GO:1903801)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0035229	positive regulation of glutamate-cysteine ligase activity (GO:0035229)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035227	regulation of glutamate-cysteine ligase activity (GO:0035227)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150099	neuron-glial cell signaling (GO:0150099)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0150098	glial cell-neuron signaling (GO:0150098)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0150094	amyloid-beta clearance by cellular catabolic process (GO:0150094)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0150093	amyloid-beta clearance by transcytosis (GO:0150093)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0150090	multiple spine synapse organization, single dendrite (GO:0150090)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035212	cell competition in a multicellular organism (GO:0035212)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150089	multiple spine synapse organization (GO:0150089)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150066	negative regulation of deacetylase activity (GO:0150066)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046784	viral mRNA export from host cell nucleus (GO:0046784)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0046761	viral budding from plasma membrane (GO:0046761)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0150033	negative regulation of protein localization to lysosome (GO:0150033)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150032	positive regulation of protein localization to lysosome (GO:0150032)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0150031	regulation of protein localization to lysosome (GO:0150031)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046755	viral budding (GO:0046755)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0046754	viral exocytosis (GO:0046754)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046753	non-lytic viral release (GO:0046753)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0150024	oxidised low-density lipoprotein particle clearance (GO:0150024)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150020	basal dendrite arborization (GO:0150020)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904298	regulation of transcytosis (GO:1904298)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046745	viral capsid secondary envelopment (GO:0046745)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904293	negative regulation of ERAD pathway (GO:1904293)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904290	negative regulation of mitotic DNA damage checkpoint (GO:1904290)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097497	blood vessel endothelial cell delamination (GO:0097497)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097494	regulation of vesicle size (GO:0097494)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0034776	response to histamine (GO:0034776)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0034775	glutathione transmembrane transport (GO:0034775)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097491	sympathetic neuron projection guidance (GO:0097491)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0097490	sympathetic neuron projection extension (GO:0097490)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034772	histone H4-K20 dimethylation (GO:0034772)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034771	histone H4-K20 monomethylation (GO:0034771)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150019	basal dendrite morphogenesis (GO:0150019)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0150018	basal dendrite development (GO:0150018)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0150013	negative regulation of neuron projection arborization (GO:0150013)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0150012	positive regulation of neuron projection arborization (GO:0150012)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0150011	regulation of neuron projection arborization (GO:0150011)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1904283	negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904283)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904282	regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904282)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034769	basement membrane disassembly (GO:0034769)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042377	vitamin K catabolic process (GO:0042377)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042376	phylloquinone catabolic process (GO:0042376)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042374	phylloquinone metabolic process (GO:0042374)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042373	vitamin K metabolic process (GO:0042373)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0042371	vitamin K biosynthetic process (GO:0042371)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034761	positive regulation of iron ion transmembrane transport (GO:0034761)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034760	negative regulation of iron ion transmembrane transport (GO:0034760)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0150007	clathrin-dependent synaptic vesicle endocytosis (GO:0150007)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0150003	regulation of spontaneous synaptic transmission (GO:0150003)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0046726	positive regulation by virus of viral protein levels in host cell (GO:0046726)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904274	tricellular tight junction assembly (GO:1904274)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046725	negative regulation by virus of viral protein levels in host cell (GO:0046725)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904273	L-alanine import across plasma membrane (GO:1904273)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904271	L-proline import across plasma membrane (GO:1904271)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904270	pyroptosome complex assembly (GO:1904270)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042369	vitamin D catabolic process (GO:0042369)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046720	citric acid secretion (GO:0046720)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034759	regulation of iron ion transmembrane transport (GO:0034759)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034758	positive regulation of iron ion transport (GO:0034758)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097474	retinal cone cell apoptotic process (GO:0097474)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034757	negative regulation of iron ion transport (GO:0034757)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034756	regulation of iron ion transport (GO:0034756)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097473	retinal rod cell apoptotic process (GO:0097473)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042365	water-soluble vitamin catabolic process (GO:0042365)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042363	fat-soluble vitamin catabolic process (GO:0042363)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0042361	menaquinone catabolic process (GO:0042361)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042360	vitamin E metabolic process (GO:0042360)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0030393	fructoselysine metabolic process (GO:0030393)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030392	fructosamine catabolic process (GO:0030392)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046719	regulation by virus of viral protein levels in host cell (GO:0046719)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904263	positive regulation of TORC1 signaling (GO:1904263)	23	0	1.35	-	 < 0.01	6.36E-01	1.00E00
GO:1904262	negative regulation of TORC1 signaling (GO:1904262)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0046713	borate transport (GO:0046713)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046712	GDP catabolic process (GO:0046712)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904261	positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0097468	programmed cell death in response to reactive oxygen species (GO:0097468)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097466	ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0042357	thiamine diphosphate metabolic process (GO:0042357)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042355	L-fucose catabolic process (GO:0042355)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0042354	L-fucose metabolic process (GO:0042354)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0042352	GDP-L-fucose salvage (GO:0042352)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042351	'de novo' GDP-L-fucose biosynthetic process (GO:0042351)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042350	GDP-L-fucose biosynthetic process (GO:0042350)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0030389	fructosamine metabolic process (GO:0030389)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030388	fructose 1,6-bisphosphate metabolic process (GO:0030388)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0030382	sperm mitochondrion organization (GO:0030382)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904259	regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046709	IDP catabolic process (GO:0046709)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904257	zinc ion import into Golgi lumen (GO:1904257)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046707	IDP metabolic process (GO:0046707)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904255	negative regulation of iron ion transmembrane transporter activity (GO:1904255)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904254	regulation of iron ion transmembrane transporter activity (GO:1904254)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046705	CDP biosynthetic process (GO:0046705)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904253	positive regulation of bile acid metabolic process (GO:1904253)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046704	CDP metabolic process (GO:0046704)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904252	negative regulation of bile acid metabolic process (GO:1904252)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042340	keratan sulfate catabolic process (GO:0042340)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904247	positive regulation of polynucleotide adenylyltransferase activity (GO:1904247)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010796	regulation of multivesicular body size (GO:0010796)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010795	regulation of ubiquinone biosynthetic process (GO:0010795)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010793	regulation of mRNA export from nucleus (GO:0010793)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0016098	monoterpenoid metabolic process (GO:0016098)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010792	DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904240	negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904240)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042339	keratan sulfate metabolic process (GO:0042339)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0016095	polyprenol catabolic process (GO:0016095)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034729	histone H3-K79 methylation (GO:0034729)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016094	polyprenol biosynthetic process (GO:0016094)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0016093	polyprenol metabolic process (GO:0016093)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0034727	piecemeal microautophagy of the nucleus (GO:0034727)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0042335	cuticle development (GO:0042335)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034724	chromatin organization (GO:0034724)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034720	histone H3-K4 demethylation (GO:0034720)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0010789	meiotic sister chromatid cohesion involved in meiosis I (GO:0010789)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904239	regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904239)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904234	positive regulation of aconitate hydratase activity (GO:1904234)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904232	regulation of aconitate hydratase activity (GO:1904232)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904231	positive regulation of succinate dehydrogenase activity (GO:1904231)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010780	meiotic DNA double-strand break formation involved in reciprocal meiotic recombination (GO:0010780)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016081	synaptic vesicle docking (GO:0016081)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0016080	synaptic vesicle targeting (GO:0016080)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042323	negative regulation of circadian sleep/wake cycle, non-REM sleep (GO:0042323)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042322	negative regulation of circadian sleep/wake cycle, REM sleep (GO:0042322)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042321	negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042320	regulation of circadian sleep/wake cycle, REM sleep (GO:0042320)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904229	regulation of succinate dehydrogenase activity (GO:1904229)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904227	negative regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904227)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904226	regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904226)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904224	negative regulation of glucuronosyltransferase activity (GO:1904224)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0010774	meiotic strand invasion involved in reciprocal meiotic recombination (GO:0010774)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904223	regulation of glucuronosyltransferase activity (GO:1904223)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0016078	tRNA catabolic process (GO:0016078)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1904222	positive regulation of serine C-palmitoyltransferase activity (GO:1904222)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016077	sno(s)RNA catabolic process (GO:0016077)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904221	negative regulation of serine C-palmitoyltransferase activity (GO:1904221)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097428	protein maturation by iron-sulfur cluster transfer (GO:0097428)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0016076	snRNA catabolic process (GO:0016076)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904220	regulation of serine C-palmitoyltransferase activity (GO:1904220)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0016075	rRNA catabolic process (GO:0016075)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0016074	sno(s)RNA metabolic process (GO:0016074)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0016073	snRNA metabolic process (GO:0016073)	63	0	3.70	-	 < 0.01	4.99E-02	3.78E-01
GO:0016072	rRNA metabolic process (GO:0016072)	254	0	14.92	-	 < 0.01	1.11E-06	5.09E-05
GO:0042313	protein kinase C deactivation (GO:0042313)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904219	positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904219)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010768	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904217	regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904217)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904211	membrane protein proteolysis involved in retrograde protein transport, ER to cytosol (GO:1904211)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010760	negative regulation of macrophage chemotaxis (GO:0010760)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0042309	homoiothermy (GO:0042309)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0016062	adaptation of rhodopsin mediated signaling (GO:0016062)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097411	hypoxia-inducible factor-1alpha signaling pathway (GO:0097411)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010757	negative regulation of plasminogen activation (GO:0010757)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904206	positive regulation of skeletal muscle hypertrophy (GO:1904206)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016056	rhodopsin mediated signaling pathway (GO:0016056)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010750	positive regulation of nitric oxide mediated signal transduction (GO:0010750)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0097403	cellular response to raffinose (GO:0097403)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097401	synaptic vesicle lumen acidification (GO:0097401)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097400	interleukin-17-mediated signaling pathway (GO:0097400)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0030329	prenylcysteine metabolic process (GO:0030329)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030328	prenylcysteine catabolic process (GO:0030328)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030327	prenylated protein catabolic process (GO:0030327)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010748	negative regulation of long-chain fatty acid import across plasma membrane (GO:0010748)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010747	positive regulation of long-chain fatty acid import across plasma membrane (GO:0010747)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010746	regulation of long-chain fatty acid import across plasma membrane (GO:0010746)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010742	macrophage derived foam cell differentiation (GO:0010742)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0016046	detection of fungus (GO:0016046)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0030311	poly-N-acetyllactosamine biosynthetic process (GO:0030311)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0016038	absorption of visible light (GO:0016038)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016037	light absorption (GO:0016037)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016036	cellular response to phosphate starvation (GO:0016036)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061485	memory T cell proliferation (GO:0061485)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016031	tRNA import into mitochondrion (GO:0016031)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061481	response to TNF agonist (GO:0061481)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030309	poly-N-acetyllactosamine metabolic process (GO:0030309)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0030302	deoxynucleotide transport (GO:0030302)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030300	regulation of intestinal cholesterol absorption (GO:0030300)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0010729	positive regulation of hydrogen peroxide biosynthetic process (GO:0010729)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010725	regulation of primitive erythrocyte differentiation (GO:0010725)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010724	regulation of definitive erythrocyte differentiation (GO:0010724)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010722	regulation of ferrochelatase activity (GO:0010722)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061476	response to anticoagulant (GO:0061476)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0016024	CDP-diacylglycerol biosynthetic process (GO:0016024)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0010716	negative regulation of extracellular matrix disassembly (GO:0010716)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010711	negative regulation of collagen catabolic process (GO:0010711)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010710	regulation of collagen catabolic process (GO:0010710)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903797	positive regulation of inorganic anion transmembrane transport (GO:1903797)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903796	negative regulation of inorganic anion transmembrane transport (GO:1903796)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903795	regulation of inorganic anion transmembrane transport (GO:1903795)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0093001	glycolysis from storage polysaccharide through glucose-1-phosphate (GO:0093001)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010707	globoside biosynthetic process via lactosylceramide (GO:0010707)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010706	ganglioside biosynthetic process via lactosylceramide (GO:0010706)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010701	positive regulation of norepinephrine secretion (GO:0010701)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903788	positive regulation of glutathione biosynthetic process (GO:1903788)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903786	regulation of glutathione biosynthetic process (GO:1903786)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061452	retrotrapezoid nucleus neuron differentiation (GO:0061452)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061451	retrotrapezoid nucleus development (GO:0061451)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061450	trophoblast cell migration (GO:0061450)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903780	negative regulation of cardiac conduction (GO:1903780)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019988	charged-tRNA amino acid modification (GO:0019988)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903778	protein localization to vacuolar membrane (GO:1903778)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061445	endocardial cushion cell fate commitment (GO:0061445)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903775	regulation of DNA double-strand break processing (GO:1903775)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061444	endocardial cushion cell development (GO:0061444)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903774	positive regulation of viral budding via host ESCRT complex (GO:1903774)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061443	endocardial cushion cell differentiation (GO:0061443)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903772	regulation of viral budding via host ESCRT complex (GO:1903772)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061441	renal artery morphogenesis (GO:0061441)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903771	positive regulation of beta-galactosidase activity (GO:1903771)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903770	negative regulation of beta-galactosidase activity (GO:1903770)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035196	miRNA processing (GO:0035196)	34	0	2.00	-	 < 0.01	2.61E-01	8.48E-01
GO:1903766	positive regulation of potassium ion export across plasma membrane (GO:1903766)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061433	cellular response to caloric restriction (GO:0061433)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903762	positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061428	negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903755	positive regulation of SUMO transferase activity (GO:1903755)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903751	negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903750	regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0039536	negative regulation of RIG-I signaling pathway (GO:0039536)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0039534	negative regulation of MDA-5 signaling pathway (GO:0039534)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0039533	regulation of MDA-5 signaling pathway (GO:0039533)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0039532	negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0039530	MDA-5 signaling pathway (GO:0039530)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061419	positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903744	positive regulation of anterograde synaptic vesicle transport (GO:1903744)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903743	negative regulation of anterograde synaptic vesicle transport (GO:1903743)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903742	regulation of anterograde synaptic vesicle transport (GO:1903742)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903741	negative regulation of phosphatidate phosphatase activity (GO:1903741)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0039529	RIG-I signaling pathway (GO:0039529)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0039528	cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0039526	modulation by virus of host apoptotic process (GO:0039526)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061402	positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061400	positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903730	regulation of phosphatidate phosphatase activity (GO:1903730)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903727	positive regulation of phospholipid metabolic process (GO:1903727)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:1903724	positive regulation of centriole elongation (GO:1903724)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903723	negative regulation of centriole elongation (GO:1903723)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903722	regulation of centriole elongation (GO:1903722)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1903720	negative regulation of I-kappaB phosphorylation (GO:1903720)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903716	guanine transmembrane transport (GO:1903716)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903714	isoleucine transmembrane transport (GO:1903714)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903713	asparagine transmembrane transport (GO:1903713)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903712	cysteine transmembrane transport (GO:1903712)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903710	spermine transmembrane transport (GO:1903710)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019919	peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019918	peptidyl-arginine methylation, to symmetrical-dimethyl arginine (GO:0019918)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903709	uterine gland development (GO:1903709)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903704	negative regulation of siRNA production (GO:1903704)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903703	enterocyte differentiation (GO:1903703)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903701	substantia propria of cornea development (GO:1903701)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035128	post-embryonic forelimb morphogenesis (GO:0035128)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035127	post-embryonic limb morphogenesis (GO:0035127)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035120	post-embryonic appendage morphogenesis (GO:0035120)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060995	cell-cell signaling involved in kidney development (GO:0060995)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060992	response to fungicide (GO:0060992)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0035112	genitalia morphogenesis (GO:0035112)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0060989	lipid tube assembly involved in organelle fusion (GO:0060989)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060981	cell migration involved in coronary angiogenesis (GO:0060981)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060975	cardioblast migration to the midline involved in heart field formation (GO:0060975)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060974	cell migration involved in heart formation (GO:0060974)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046692	sperm competition (GO:0046692)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046687	response to chromate (GO:0046687)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046684	response to pyrethroid (GO:0046684)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060957	endocardial cell fate commitment (GO:0060957)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060948	cardiac vascular smooth muscle cell development (GO:0060948)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060945	cardiac neuron differentiation (GO:0060945)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034696	response to prostaglandin F (GO:0034696)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060930	sinoatrial node cell fate commitment (GO:0060930)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046657	folic acid catabolic process (GO:0046657)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904199	positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization (GO:1904199)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904197	positive regulation of granulosa cell proliferation (GO:1904197)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904195	regulation of granulosa cell proliferation (GO:1904195)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904193	negative regulation of cholangiocyte apoptotic process (GO:1904193)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904192	regulation of cholangiocyte apoptotic process (GO:1904192)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046642	negative regulation of alpha-beta T cell proliferation (GO:0046642)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0060916	mesenchymal cell proliferation involved in lung development (GO:0060916)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060915	mesenchymal cell differentiation involved in lung development (GO:0060915)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060912	cardiac cell fate specification (GO:0060912)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046639	negative regulation of alpha-beta T cell differentiation (GO:0046639)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0046636	negative regulation of alpha-beta T cell activation (GO:0046636)	45	0	2.64	-	 < 0.01	1.79E-01	7.16E-01
GO:1904184	positive regulation of pyruvate dehydrogenase activity (GO:1904184)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046633	alpha-beta T cell proliferation (GO:0046633)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1904182	regulation of pyruvate dehydrogenase activity (GO:1904182)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042275	error-free postreplication DNA repair (GO:0042275)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042274	ribosomal small subunit biogenesis (GO:0042274)	79	0	4.64	-	 < 0.01	2.27E-02	2.26E-01
GO:0042273	ribosomal large subunit biogenesis (GO:0042273)	76	0	4.46	-	 < 0.01	2.20E-02	2.22E-01
GO:0097380	dorsal spinal cord interneuron anterior axon guidance (GO:0097380)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060907	positive regulation of macrophage cytokine production (GO:0060907)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0042271	susceptibility to natural killer cell mediated cytotoxicity (GO:0042271)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034661	ncRNA catabolic process (GO:0034661)	38	0	2.23	-	 < 0.01	2.72E-01	8.68E-01
GO:0042270	protection from natural killer cell mediated cytotoxicity (GO:0042270)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060904	regulation of protein folding in endoplasmic reticulum (GO:0060904)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060903	positive regulation of meiosis I (GO:0060903)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060901	regulation of hair cycle by canonical Wnt signaling pathway (GO:0060901)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060900	embryonic camera-type eye formation (GO:0060900)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1904179	positive regulation of adipose tissue development (GO:1904179)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904178	negative regulation of adipose tissue development (GO:1904178)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904177	regulation of adipose tissue development (GO:1904177)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0097379	dorsal spinal cord interneuron posterior axon guidance (GO:0097379)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097378	dorsal spinal cord interneuron axon guidance (GO:0097378)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097377	spinal cord interneuron axon guidance (GO:0097377)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097376	interneuron axon guidance (GO:0097376)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042268	regulation of cytolysis (GO:0042268)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0097374	sensory neuron axon guidance (GO:0097374)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034656	nucleobase-containing small molecule catabolic process (GO:0034656)	30	0	1.76	-	 < 0.01	4.11E-01	1.00E00
GO:0042265	peptidyl-asparagine hydroxylation (GO:0042265)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042264	peptidyl-aspartic acid hydroxylation (GO:0042264)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097370	protein O-GlcNAcylation via threonine (GO:0097370)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042262	DNA protection (GO:0042262)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034653	retinoic acid catabolic process (GO:0034653)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0030299	intestinal cholesterol absorption (GO:0030299)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0046619	lens placode formation involved in camera-type eye formation (GO:0046619)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904161	DNA synthesis involved in UV-damage excision repair (GO:1904161)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042256	mature ribosome assembly (GO:0042256)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0042255	ribosome assembly (GO:0042255)	62	0	3.64	-	 < 0.01	4.96E-02	3.77E-01
GO:0034642	mitochondrion migration along actin filament (GO:0034642)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904158	axonemal central apparatus assembly (GO:1904158)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904157	DN4 thymocyte differentiation (GO:1904157)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904156	DN3 thymocyte differentiation (GO:1904156)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904155	DN2 thymocyte differentiation (GO:1904155)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904154	positive regulation of retrograde protein transport, ER to cytosol (GO:1904154)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046604	positive regulation of mitotic centrosome separation (GO:0046604)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904153	negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1904152	regulation of retrograde protein transport, ER to cytosol (GO:1904152)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0046603	negative regulation of mitotic centrosome separation (GO:0046603)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097359	UDP-glucosylation (GO:0097359)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904151	positive regulation of microglial cell mediated cytotoxicity (GO:1904151)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904150	negative regulation of microglial cell mediated cytotoxicity (GO:1904150)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097355	protein localization to heterochromatin (GO:0097355)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042247	establishment of planar polarity of follicular epithelium (GO:0042247)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097354	prenylation (GO:0097354)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0042245	RNA repair (GO:0042245)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097352	autophagosome maturation (GO:0097352)	45	0	2.64	-	 < 0.01	1.79E-01	7.16E-01
GO:0034635	glutathione transport (GO:0034635)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0034633	retinol transport (GO:0034633)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904149	regulation of microglial cell mediated cytotoxicity (GO:1904149)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010693	negative regulation of alkaline phosphatase activity (GO:0010693)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904140	negative regulation of microglial cell migration (GO:1904140)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097345	mitochondrial outer membrane permeabilization (GO:0097345)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0034626	fatty acid elongation, polyunsaturated fatty acid (GO:0034626)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097343	ripoptosome assembly (GO:0097343)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034625	fatty acid elongation, monounsaturated fatty acid (GO:0034625)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097341	zymogen inhibition (GO:0097341)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0097340	inhibition of cysteine-type endopeptidase activity (GO:0097340)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0030264	nuclear fragmentation involved in apoptotic nuclear change (GO:0030264)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030259	lipid glycosylation (GO:0030259)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0030252	growth hormone secretion (GO:0030252)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904120	positive regulation of otic vesicle morphogenesis (GO:1904120)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0089718	amino acid import across plasma membrane (GO:0089718)	35	0	2.06	-	 < 0.01	2.62E-01	8.51E-01
GO:0097327	response to antineoplastic agent (GO:0097327)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097325	melanocyte proliferation (GO:0097325)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0097323	B cell adhesion (GO:0097323)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030242	autophagy of peroxisome (GO:0030242)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1904118	regulation of otic vesicle morphogenesis (GO:1904118)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010668	ectodermal cell differentiation (GO:0010668)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0089709	L-histidine transmembrane transport (GO:0089709)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0089708	L-histidine transmembrane export from vacuole (GO:0089708)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0008355	olfactory learning (GO:0008355)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097310	cap2 mRNA methylation (GO:0097310)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0089700	protein kinase D signaling (GO:0089700)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0030237	female sex determination (GO:0030237)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904108	protein localization to ciliary inversin compartment (GO:1904108)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904106	protein localization to microvillus (GO:1904106)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904105	positive regulation of convergent extension involved in gastrulation (GO:1904105)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904103	regulation of convergent extension involved in gastrulation (GO:1904103)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010652	positive regulation of cell communication by chemical coupling (GO:0010652)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0008348	negative regulation of antimicrobial humoral response (GO:0008348)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097309	cap1 mRNA methylation (GO:0097309)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904100	positive regulation of protein O-linked glycosylation (GO:1904100)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0008343	adult feeding behavior (GO:0008343)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0097300	programmed necrotic cell death (GO:0097300)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0022615	protein to membrane docking (GO:0022615)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0030223	neutrophil differentiation (GO:0030223)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0022614	membrane to membrane docking (GO:0022614)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0030222	eosinophil differentiation (GO:0030222)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010645	regulation of cell communication by chemical coupling (GO:0010645)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010643	cell communication by chemical coupling (GO:0010643)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061395	positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061395)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0008334	histone mRNA metabolic process (GO:0008334)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0030211	heparin catabolic process (GO:0030211)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010636	positive regulation of mitochondrial fusion (GO:0010636)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061386	closure of optic fissure (GO:0061386)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061381	cell migration in diencephalon (GO:0061381)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030209	dermatan sulfate catabolic process (GO:0030209)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030208	dermatan sulfate biosynthetic process (GO:0030208)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0030205	dermatan sulfate metabolic process (GO:0030205)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0030200	heparan sulfate proteoglycan catabolic process (GO:0030200)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0010625	positive regulation of Schwann cell proliferation (GO:0010625)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061379	inferior colliculus development (GO:0061379)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061378	corpora quadrigemina development (GO:0061378)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010621	negative regulation of transcription by transcription factor localization (GO:0010621)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061374	mammillothalamic axonal tract development (GO:0061374)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061373	mammillary axonal complex development (GO:0061373)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061370	testosterone biosynthetic process (GO:0061370)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0010615	positive regulation of cardiac muscle adaptation (GO:0010615)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061369	negative regulation of testicular blood vessel morphogenesis (GO:0061369)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903699	tarsal gland development (GO:1903699)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061368	behavioral response to formalin induced pain (GO:0061368)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010610	regulation of mRNA stability involved in response to stress (GO:0010610)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061366	behavioral response to chemical pain (GO:0061366)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061360	optic chiasma development (GO:0061360)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903690	negative regulation of wound healing, spreading of epidermal cells (GO:1903690)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010609	mRNA localization resulting in post-transcriptional regulation of gene expression (GO:0010609)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010607	negative regulation of cytoplasmic mRNA processing body assembly (GO:0010607)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010606	positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0010603	regulation of cytoplasmic mRNA processing body assembly (GO:0010603)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0061358	negative regulation of Wnt protein secretion (GO:0061358)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061357	positive regulation of Wnt protein secretion (GO:0061357)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061356	regulation of Wnt protein secretion (GO:0061356)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061355	Wnt protein secretion (GO:0061355)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061354	planar cell polarity pathway involved in pericardium morphogenesis (GO:0061354)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061350	planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:0061350)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061349	planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:0061349)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903679	positive regulation of cap-independent translational initiation (GO:1903679)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061348	planar cell polarity pathway involved in ventricular septum morphogenesis (GO:0061348)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061347	planar cell polarity pathway involved in outflow tract morphogenesis (GO:0061347)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903677	regulation of cap-independent translational initiation (GO:1903677)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061346	planar cell polarity pathway involved in heart morphogenesis (GO:0061346)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903676	positive regulation of cap-dependent translational initiation (GO:1903676)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903674	regulation of cap-dependent translational initiation (GO:1903674)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903673	mitotic cleavage furrow formation (GO:1903673)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061341	non-canonical Wnt signaling pathway involved in heart development (GO:0061341)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019878	lysine biosynthetic process via aminoadipic acid (GO:0019878)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035095	behavioral response to nicotine (GO:0035095)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0035093	sperm DNA condensation (GO:0035093)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0035092	sperm DNA condensation (GO:0035092)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0035090	maintenance of apical/basal cell polarity (GO:0035090)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1903661	positive regulation of complement-dependent cytotoxicity (GO:1903661)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903660	negative regulation of complement-dependent cytotoxicity (GO:1903660)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903655	phosphorylation of RNA polymerase II C-terminal domain serine 2 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter (GO:1903655)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061324	canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation (GO:0061324)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903654	phosphorylation of RNA polymerase II C-terminal domain serine 5 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter (GO:1903654)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903651	positive regulation of cytoplasmic transport (GO:1903651)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1903650	negative regulation of cytoplasmic transport (GO:1903650)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019859	thymine metabolic process (GO:0019859)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019858	cytosine metabolic process (GO:0019858)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019857	5-methylcytosine metabolic process (GO:0019857)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019856	pyrimidine nucleobase biosynthetic process (GO:0019856)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0061317	canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:0061317)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061316	canonical Wnt signaling pathway involved in heart development (GO:0061316)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061314	Notch signaling involved in heart development (GO:0061314)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1903645	negative regulation of chaperone-mediated protein folding (GO:1903645)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903644	regulation of chaperone-mediated protein folding (GO:1903644)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903640	negative regulation of gastrin-induced gastric acid secretion (GO:1903640)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903639	regulation of gastrin-induced gastric acid secretion (GO:1903639)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035063	nuclear speck organization (GO:0035063)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903638	positive regulation of protein insertion into mitochondrial outer membrane (GO:1903638)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903636	regulation of protein insertion into mitochondrial outer membrane (GO:1903636)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061304	retinal blood vessel morphogenesis (GO:0061304)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0061302	smooth muscle cell-matrix adhesion (GO:0061302)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903632	positive regulation of aminoacyl-tRNA ligase activity (GO:1903632)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061301	cerebellum vasculature morphogenesis (GO:0061301)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061300	cerebellum vasculature development (GO:0061300)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035054	embryonic heart tube anterior/posterior pattern specification (GO:0035054)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903621	protein localization to photoreceptor connecting cilium (GO:1903621)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903620	positive regulation of transdifferentiation (GO:1903620)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903618	regulation of transdifferentiation (GO:1903618)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903615	positive regulation of protein tyrosine phosphatase activity (GO:1903615)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903614	negative regulation of protein tyrosine phosphatase activity (GO:1903614)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903613	regulation of protein tyrosine phosphatase activity (GO:1903613)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903612	positive regulation of calcium-dependent ATPase activity (GO:1903612)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035039	male pronucleus assembly (GO:0035039)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035038	female pronucleus assembly (GO:0035038)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035037	sperm entry (GO:0035037)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903608	protein localization to cytoplasmic stress granule (GO:1903608)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1903606	cytochrome c metabolic process (GO:1903606)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903604	cytochrome metabolic process (GO:1903604)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0035026	leading edge cell differentiation (GO:0035026)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0035022	positive regulation of Rac protein signal transduction (GO:0035022)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060897	neural plate regionalization (GO:0060897)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060896	neural plate pattern specification (GO:0060896)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060887	limb epidermis development (GO:0060887)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060879	semicircular canal fusion (GO:0060879)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060876	semicircular canal formation (GO:0060876)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060875	lateral semicircular canal development (GO:0060875)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060873	anterior semicircular canal development (GO:0060873)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046598	positive regulation of viral entry into host cell (GO:0046598)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0023021	termination of signal transduction (GO:0023021)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046588	negative regulation of calcium-dependent cell-cell adhesion (GO:0046588)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046587	positive regulation of calcium-dependent cell-cell adhesion (GO:0046587)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046586	regulation of calcium-dependent cell-cell adhesion (GO:0046586)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060854	branching involved in lymph vessel morphogenesis (GO:0060854)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060853	Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060847	endothelial cell fate specification (GO:0060847)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060846	blood vessel endothelial cell fate commitment (GO:0060846)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060844	arterial endothelial cell fate commitment (GO:0060844)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060843	venous endothelial cell differentiation (GO:0060843)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003429	growth plate cartilage chondrocyte morphogenesis (GO:0003429)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003420	regulation of growth plate cartilage chondrocyte proliferation (GO:0003420)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060839	endothelial cell fate commitment (GO:0060839)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0060838	lymphatic endothelial cell fate commitment (GO:0060838)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060836	lymphatic endothelial cell differentiation (GO:0060836)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0060831	smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060830	ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003419	growth plate cartilage chondrocyte proliferation (GO:0003419)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003414	chondrocyte morphogenesis involved in endochondral bone morphogenesis (GO:0003414)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003412	establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis (GO:0003412)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046552	photoreceptor cell fate commitment (GO:0046552)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034589	hydroxyproline transport (GO:0034589)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042197	halogenated hydrocarbon metabolic process (GO:0042197)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060829	negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060827	regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060825	fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060825)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003409	optic cup structural organization (GO:0003409)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060820	inactivation of X chromosome by heterochromatin formation (GO:0060820)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003408	optic cup formation involved in camera-type eye development (GO:0003408)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003406	retinal pigment epithelium development (GO:0003406)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0003404	optic vesicle morphogenesis (GO:0003404)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046549	retinal cone cell development (GO:0046549)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1904098	regulation of protein O-linked glycosylation (GO:1904098)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904094	positive regulation of autophagic cell death (GO:1904094)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904093	negative regulation of autophagic cell death (GO:1904093)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046544	development of secondary male sexual characteristics (GO:0046544)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904092	regulation of autophagic cell death (GO:1904092)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046541	saliva secretion (GO:0046541)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0097298	regulation of nucleus size (GO:0097298)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097296	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097294	'de novo' XMP biosynthetic process (GO:0097294)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097293	XMP biosynthetic process (GO:0097293)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097292	XMP metabolic process (GO:0097292)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060819	inactivation of X chromosome by genomic imprinting (GO:0060819)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097291	renal phosphate ion absorption (GO:0097291)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060817	inactivation of paternal X chromosome (GO:0060817)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060816	random inactivation of X chromosome (GO:0060816)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046533	negative regulation of photoreceptor cell differentiation (GO:0046533)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0046532	regulation of photoreceptor cell differentiation (GO:0046532)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0042178	xenobiotic catabolic process (GO:0042178)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0097283	keratinocyte apoptotic process (GO:0097283)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060809	mesodermal to mesenchymal transition involved in gastrulation (GO:0060809)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097281	immune complex formation (GO:0097281)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097280	histamine secretion mediated by immunoglobulin (GO:0097280)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060806	negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060804	positive regulation of Wnt signaling pathway by BMP signaling pathway (GO:0060804)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060803	BMP signaling pathway involved in mesodermal cell fate specification (GO:0060803)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060802	epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification (GO:0060802)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060800	regulation of cell differentiation involved in embryonic placenta development (GO:0060800)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0097279	histamine secretion mediated by IgE immunoglobulin (GO:0097279)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904071	presynaptic active zone assembly (GO:1904071)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046521	sphingoid catabolic process (GO:0046521)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046520	sphingoid biosynthetic process (GO:0046520)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0097277	cellular urea homeostasis (GO:0097277)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042168	heme metabolic process (GO:0042168)	41	0	2.41	-	 < 0.01	1.71E-01	6.95E-01
GO:0097276	cellular creatinine homeostasis (GO:0097276)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042167	heme catabolic process (GO:0042167)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0097275	cellular ammonium homeostasis (GO:0097275)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097273	creatinine homeostasis (GO:0097273)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097272	ammonium homeostasis (GO:0097272)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0034553	mitochondrial respiratory chain complex II assembly (GO:0034553)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034552	respiratory chain complex II assembly (GO:0034552)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042161	lipoprotein oxidation (GO:0042161)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034551	mitochondrial respiratory chain complex III assembly (GO:0034551)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0042160	lipoprotein modification (GO:0042160)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046514	ceramide catabolic process (GO:0046514)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0046512	sphingosine biosynthetic process (GO:0046512)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0046511	sphinganine biosynthetic process (GO:0046511)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042159	lipoprotein catabolic process (GO:0042159)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0097267	omega-hydroxylase P450 pathway (GO:0097267)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0097264	self proteolysis (GO:0097264)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0030187	melatonin biosynthetic process (GO:0030187)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030186	melatonin metabolic process (GO:0030186)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904059	regulation of locomotor rhythm (GO:1904059)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904058	positive regulation of sensory perception of pain (GO:1904058)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1904057	negative regulation of sensory perception of pain (GO:1904057)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904056	positive regulation of cholangiocyte proliferation (GO:1904056)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046502	uroporphyrinogen III metabolic process (GO:0046502)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0008298	intracellular mRNA localization (GO:0008298)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0046501	protoporphyrinogen IX metabolic process (GO:0046501)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1904050	positive regulation of spontaneous neurotransmitter secretion (GO:1904050)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0008295	spermidine biosynthetic process (GO:0008295)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0008292	acetylcholine biosynthetic process (GO:0008292)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0008291	acetylcholine metabolic process (GO:0008291)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0042144	vacuole fusion, non-autophagic (GO:0042144)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097252	oligodendrocyte apoptotic process (GO:0097252)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904049	negative regulation of spontaneous neurotransmitter secretion (GO:1904049)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904048	regulation of spontaneous neurotransmitter secretion (GO:1904048)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904046	negative regulation of vascular endothelial growth factor production (GO:1904046)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904045	cellular response to aldosterone (GO:1904045)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1904044	response to aldosterone (GO:1904044)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1904042	negative regulation of cystathionine beta-synthase activity (GO:1904042)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904041	regulation of cystathionine beta-synthase activity (GO:1904041)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042138	meiotic DNA double-strand break formation (GO:0042138)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0042137	sequestering of neurotransmitter (GO:0042137)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904039	negative regulation of iron export across plasma membrane (GO:1904039)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904038	regulation of iron export across plasma membrane (GO:1904038)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010587	miRNA catabolic process (GO:0010587)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0010586	miRNA metabolic process (GO:0010586)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0010585	glutamine secretion (GO:0010585)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904034	positive regulation of t-SNARE clustering (GO:1904034)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904032	regulation of t-SNARE clustering (GO:1904032)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097238	cellular response to methylglyoxal (GO:0097238)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042126	nitrate metabolic process (GO:0042126)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034516	response to vitamin B6 (GO:0034516)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034514	mitochondrial unfolded protein response (GO:0034514)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030150	protein import into mitochondrial matrix (GO:0030150)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0010578	regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway (GO:0010578)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904025	positive regulation of glucose catabolic process to lactate via pyruvate (GO:1904025)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904024	negative regulation of glucose catabolic process to lactate via pyruvate (GO:1904024)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904023	regulation of glucose catabolic process to lactate via pyruvate (GO:1904023)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1904022	positive regulation of G protein-coupled receptor internalization (GO:1904022)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904021	negative regulation of G protein-coupled receptor internalization (GO:1904021)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1904020	regulation of G protein-coupled receptor internalization (GO:1904020)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0042118	endothelial cell activation (GO:0042118)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0097222	mitochondrial mRNA polyadenylation (GO:0097222)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904015	cellular response to serotonin (GO:1904015)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904014	response to serotonin (GO:1904014)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1904010	response to Aroclor 1254 (GO:1904010)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097214	positive regulation of lysosomal membrane permeability (GO:0097214)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097213	regulation of lysosomal membrane permeability (GO:0097213)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097212	lysosomal membrane organization (GO:0097212)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0097211	cellular response to gonadotropin-releasing hormone (GO:0097211)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0097210	response to gonadotropin-releasing hormone (GO:0097210)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0014916	regulation of lung blood pressure (GO:0014916)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1904009	cellular response to monosodium glutamate (GO:1904009)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002949	tRNA threonylcarbamoyladenosine modification (GO:0002949)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904008	response to monosodium glutamate (GO:1904008)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002946	tRNA C5-cytosine methylation (GO:0002946)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002943	tRNA dihydrouridine synthesis (GO:0002943)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1904000	positive regulation of eating behavior (GO:1904000)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002940	tRNA N2-guanine methylation (GO:0002940)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0097202	activation of cysteine-type endopeptidase activity (GO:0097202)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0097201	negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0014908	myotube differentiation involved in skeletal muscle regeneration (GO:0014908)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0014906	myotube cell development involved in skeletal muscle regeneration (GO:0014906)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014905	myoblast fusion involved in skeletal muscle regeneration (GO:0014905)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0014901	satellite cell activation involved in skeletal muscle regeneration (GO:0014901)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014900	muscle hyperplasia (GO:0014900)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002939	tRNA N1-guanine methylation (GO:0002939)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002934	desmosome organization (GO:0002934)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0002933	lipid hydroxylation (GO:0002933)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002930	trabecular meshwork development (GO:0002930)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061296	negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061296)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061295	regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061295)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061290	canonical Wnt signaling pathway involved in metanephric kidney development (GO:0061290)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002926	tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002925	positive regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002925)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002924	negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0002923	regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0061289	Wnt signaling pathway involved in kidney development (GO:0061289)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030103	vasopressin secretion (GO:0030103)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010529	negative regulation of transposition (GO:0010529)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0010528	regulation of transposition (GO:0010528)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0010526	negative regulation of transposition, RNA-mediated (GO:0010526)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010525	regulation of transposition, RNA-mediated (GO:0010525)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002913	positive regulation of lymphocyte anergy (GO:0002913)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002911	regulation of lymphocyte anergy (GO:0002911)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0008216	spermidine metabolic process (GO:0008216)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0008215	spermine metabolic process (GO:0008215)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0008214	protein dealkylation (GO:0008214)	32	0	1.88	-	 < 0.01	2.60E-01	8.48E-01
GO:0002906	negative regulation of mature B cell apoptotic process (GO:0002906)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002905	regulation of mature B cell apoptotic process (GO:0002905)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002904	positive regulation of B cell apoptotic process (GO:0002904)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010513	positive regulation of phosphatidylinositol biosynthetic process (GO:0010513)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010512	negative regulation of phosphatidylinositol biosynthetic process (GO:0010512)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010511	regulation of phosphatidylinositol biosynthetic process (GO:0010511)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002901	mature B cell apoptotic process (GO:0002901)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903597	negative regulation of gap junction assembly (GO:1903597)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903595	positive regulation of histamine secretion by mast cell (GO:1903595)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903593	regulation of histamine secretion by mast cell (GO:1903593)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010509	polyamine homeostasis (GO:0010509)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010501	RNA secondary structure unwinding (GO:0010501)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1903586	positive regulation of histone deubiquitination (GO:1903586)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903584	regulation of histone deubiquitination (GO:1903584)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903577	cellular response to L-arginine (GO:1903577)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903576	response to L-arginine (GO:1903576)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903575	cornified envelope assembly (GO:1903575)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903572	positive regulation of protein kinase D signaling (GO:1903572)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903570	regulation of protein kinase D signaling (GO:1903570)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903569	positive regulation of protein localization to ciliary membrane (GO:1903569)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903568	negative regulation of protein localization to ciliary membrane (GO:1903568)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903567	regulation of protein localization to ciliary membrane (GO:1903567)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903566	positive regulation of protein localization to cilium (GO:1903566)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1903565	negative regulation of protein localization to cilium (GO:1903565)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903564	regulation of protein localization to cilium (GO:1903564)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0061227	pattern specification involved in mesonephros development (GO:0061227)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903553	positive regulation of extracellular exosome assembly (GO:1903553)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903551	regulation of extracellular exosome assembly (GO:1903551)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0061218	negative regulation of mesonephros development (GO:0061218)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903547	regulation of growth hormone activity (GO:1903547)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903545	cellular response to butyrate (GO:1903545)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903544	response to butyrate (GO:1903544)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903543	positive regulation of exosomal secretion (GO:1903543)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:1903542	negative regulation of exosomal secretion (GO:1903542)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903541	regulation of exosomal secretion (GO:1903541)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:1903540	establishment of protein localization to postsynaptic membrane (GO:1903540)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0019747	regulation of isoprenoid metabolic process (GO:0019747)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061209	cell proliferation involved in mesonephros development (GO:0061209)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903538	regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061205	paramesonephric duct development (GO:0061205)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019742	pentacyclic triterpenoid metabolic process (GO:0019742)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019740	nitrogen utilization (GO:0019740)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903527	positive regulation of membrane tubulation (GO:1903527)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903526	negative regulation of membrane tubulation (GO:1903526)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019732	antifungal humoral response (GO:0019732)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:1903525	regulation of membrane tubulation (GO:1903525)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903518	positive regulation of single strand break repair (GO:1903518)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903517	negative regulation of single strand break repair (GO:1903517)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903516	regulation of single strand break repair (GO:1903516)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903513	endoplasmic reticulum to cytosol transport (GO:1903513)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0019720	Mo-molybdopterin cofactor metabolic process (GO:0019720)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903512	phytanic acid metabolic process (GO:1903512)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003383	apical constriction (GO:0003383)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060792	sweat gland development (GO:0060792)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003374	dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003373	dynamin family protein polymerization involved in membrane fission (GO:0003373)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072755	cellular response to benomyl (GO:0072755)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072752	cellular response to rapamycin (GO:0072752)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072750	cellular response to leptomycin B (GO:0072750)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060789	hair follicle placode formation (GO:0060789)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060785	regulation of apoptosis involved in tissue homeostasis (GO:0060785)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060784	regulation of cell proliferation involved in tissue homeostasis (GO:0060784)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060783	mesenchymal smoothened signaling pathway involved in prostate gland development (GO:0060783)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060782	regulation of mesenchymal cell proliferation involved in prostate gland development (GO:0060782)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003366	cell-matrix adhesion involved in ameboidal cell migration (GO:0003366)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003363	lamellipodium assembly involved in ameboidal cell migration (GO:0003363)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003360	brainstem development (GO:0003360)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0072749	cellular response to cytochalasin B (GO:0072749)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072740	cellular response to anisomycin (GO:0072740)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060775	planar cell polarity pathway involved in gastrula mediolateral intercalation (GO:0060775)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003359	noradrenergic neuron fate commitment (GO:0003359)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003358	noradrenergic neuron development (GO:0003358)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0003356	regulation of cilium beat frequency (GO:0003356)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0046499	S-adenosylmethioninamine metabolic process (GO:0046499)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003351	epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	42	0	2.47	-	 < 0.01	1.72E-01	6.98E-01
GO:0046498	S-adenosylhomocysteine metabolic process (GO:0046498)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003350	pulmonary myocardium development (GO:0003350)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072739	response to anisomycin (GO:0072739)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046495	nicotinamide riboside metabolic process (GO:0046495)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072738	cellular response to diamide (GO:0072738)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072737	response to diamide (GO:0072737)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046491	L-methylmalonyl-CoA metabolic process (GO:0046491)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046490	isopentenyl diphosphate metabolic process (GO:0046490)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072734	cellular response to staurosporine (GO:0072734)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072733	response to staurosporine (GO:0072733)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060769	positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060764	cell-cell signaling involved in mammary gland development (GO:0060764)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060763	mammary duct terminal end bud growth (GO:0060763)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060762	regulation of branching involved in mammary gland duct morphogenesis (GO:0060762)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0003345	proepicardium cell migration involved in pericardium morphogenesis (GO:0003345)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003343	septum transversum development (GO:0003343)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003342	proepicardium development (GO:0003342)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046487	glyoxylate metabolic process (GO:0046487)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0072721	cellular response to dithiothreitol (GO:0072721)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072720	response to dithiothreitol (GO:0072720)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060755	negative regulation of mast cell chemotaxis (GO:0060755)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060754	positive regulation of mast cell chemotaxis (GO:0060754)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060753	regulation of mast cell chemotaxis (GO:0060753)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0003339	regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0003337	mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0003332	negative regulation of extracellular matrix constituent secretion (GO:0003332)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046479	glycosphingolipid catabolic process (GO:0046479)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0003331	positive regulation of extracellular matrix constituent secretion (GO:0003331)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0003330	regulation of extracellular matrix constituent secretion (GO:0003330)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0046478	lactosylceramide metabolic process (GO:0046478)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046477	glycosylceramide catabolic process (GO:0046477)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0046476	glycosylceramide biosynthetic process (GO:0046476)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0072717	cellular response to actinomycin D (GO:0072717)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0072716	response to actinomycin D (GO:0072716)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046471	phosphatidylglycerol metabolic process (GO:0046471)	34	0	2.00	-	 < 0.01	2.61E-01	8.48E-01
GO:0072715	cellular response to selenite ion (GO:0072715)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072714	response to selenite ion (GO:0072714)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060746	parental behavior (GO:0060746)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0060743	epithelial cell maturation involved in prostate gland development (GO:0060743)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060742	epithelial cell differentiation involved in prostate gland development (GO:0060742)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0003329	pancreatic PP cell fate commitment (GO:0003329)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003327	type B pancreatic cell fate commitment (GO:0003327)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003326	pancreatic A cell fate commitment (GO:0003326)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003322	pancreatic A cell development (GO:0003322)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046465	dolichyl diphosphate metabolic process (GO:0046465)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072709	cellular response to sorbitol (GO:0072709)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072707	cellular response to sodium dodecyl sulfate (GO:0072707)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046463	acylglycerol biosynthetic process (GO:0046463)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0072706	response to sodium dodecyl sulfate (GO:0072706)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046460	neutral lipid biosynthetic process (GO:0046460)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0072703	cellular response to methyl methanesulfonate (GO:0072703)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034499	late endosome to Golgi transport (GO:0034499)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034498	early endosome to Golgi transport (GO:0034498)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0072702	response to methyl methanesulfonate (GO:0072702)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034497	protein localization to phagophore assembly site (GO:0034497)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0060739	mesenchymal-epithelial cell signaling involved in prostate gland development (GO:0060739)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060738	epithelial-mesenchymal signaling involved in prostate gland development (GO:0060738)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060735	regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060734	regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060731	positive regulation of intestinal epithelial structure maintenance (GO:0060731)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060730	regulation of intestinal epithelial structure maintenance (GO:0060730)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003318	cell migration to the midline involved in heart development (GO:0003318)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003312	pancreatic PP cell differentiation (GO:0003312)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046459	short-chain fatty acid metabolic process (GO:0046459)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0003311	pancreatic D cell differentiation (GO:0003311)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046458	hexadecanal metabolic process (GO:0046458)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046452	dihydrofolate metabolic process (GO:0046452)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034486	vacuolar transmembrane transport (GO:0034486)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060729	intestinal epithelial structure maintenance (GO:0060729)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060723	regulation of cell proliferation involved in embryonic placenta development (GO:0060723)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060721	regulation of spongiotrophoblast cell proliferation (GO:0060721)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003306	Wnt signaling pathway involved in heart development (GO:0003306)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046449	creatinine metabolic process (GO:0046449)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046448	tropane alkaloid metabolic process (GO:0046448)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046444	FMN metabolic process (GO:0046444)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046443	FAD metabolic process (GO:0046443)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097198	histone H3-K36 trimethylation (GO:0097198)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046440	L-lysine metabolic process (GO:0046440)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0042088	T-helper 1 type immune response (GO:0042088)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0097195	pilomotor reflex (GO:0097195)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034478	phosphatidylglycerol catabolic process (GO:0034478)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034477	U6 snRNA 3'-end processing (GO:0034477)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034476	U5 snRNA 3'-end processing (GO:0034476)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034475	U4 snRNA 3'-end processing (GO:0034475)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0034474	U2 snRNA 3'-end processing (GO:0034474)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034473	U1 snRNA 3'-end processing (GO:0034473)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034472	snRNA 3'-end processing (GO:0034472)	32	0	1.88	-	 < 0.01	2.60E-01	8.47E-01
GO:0034471	ncRNA 5'-end processing (GO:0034471)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060715	syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034470	ncRNA processing (GO:0034470)	413	0	24.25	-	 < 0.01	1.14E-10	1.16E-08
GO:0060712	spongiotrophoblast layer development (GO:0060712)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014895	smooth muscle hypertrophy (GO:0014895)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046437	D-amino acid biosynthetic process (GO:0046437)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046436	D-alanine metabolic process (GO:0046436)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097188	dentin mineralization (GO:0097188)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097187	dentinogenesis (GO:0097187)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097185	cellular response to azide (GO:0097185)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097184	response to azide (GO:0097184)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034463	90S preribosome assembly (GO:0034463)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034462	small-subunit processome assembly (GO:0034462)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060702	negative regulation of endoribonuclease activity (GO:0060702)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060701	negative regulation of ribonuclease activity (GO:0060701)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060700	regulation of ribonuclease activity (GO:0060700)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0014886	transition between slow and fast fiber (GO:0014886)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014883	transition between fast and slow fiber (GO:0014883)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0034454	microtubule anchoring at centrosome (GO:0034454)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0034453	microtubule anchoring (GO:0034453)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation (GO:0014878)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014876	response to injury involved in regulation of muscle adaptation (GO:0014876)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014873	response to muscle activity involved in regulation of muscle adaptation (GO:0014873)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046416	D-amino acid metabolic process (GO:0046416)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046415	urate metabolic process (GO:0046415)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0097168	mesenchymal stem cell proliferation (GO:0097168)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)	27	0	1.59	-	 < 0.01	4.01E-01	1.00E00
GO:0034445	negative regulation of plasma lipoprotein oxidation (GO:0034445)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034444	regulation of plasma lipoprotein oxidation (GO:0034444)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034441	plasma lipoprotein particle oxidation (GO:0034441)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014862	regulation of skeletal muscle contraction by chemo-mechanical energy conversion (GO:0014862)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014861	regulation of skeletal muscle contraction via regulation of action potential (GO:0014861)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002897	positive regulation of central B cell tolerance induction (GO:0002897)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002895	regulation of central B cell tolerance induction (GO:0002895)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002893	negative regulation of type II hypersensitivity (GO:0002893)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002890	negative regulation of immunoglobulin mediated immune response (GO:0002890)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0042048	olfactory behavior (GO:0042048)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0034439	lipoprotein lipid oxidation (GO:0034439)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034436	glycoprotein transport (GO:0034436)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034435	cholesterol esterification (GO:0034435)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034434	sterol esterification (GO:0034434)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097151	positive regulation of inhibitory postsynaptic potential (GO:0097151)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034433	steroid esterification (GO:0034433)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0042040	metal incorporation into metallo-molybdopterin complex (GO:0042040)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014859	negative regulation of skeletal muscle cell proliferation (GO:0014859)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0014858	positive regulation of skeletal muscle cell proliferation (GO:0014858)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014853	regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010499	proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002884	negative regulation of hypersensitivity (GO:0002884)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002882	positive regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002882)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002880	regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002880)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0042038	peptidyl-histidine methylation, to form tele-methylhistidine (GO:0042038)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034427	nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0014849	ureter smooth muscle contraction (GO:0014849)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014846	esophagus smooth muscle contraction (GO:0014846)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014841	skeletal muscle satellite cell proliferation (GO:0014841)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002879	positive regulation of acute inflammatory response to non-antigenic stimulus (GO:0002879)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002877	regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002876	positive regulation of chronic inflammatory response to antigenic stimulus (GO:0002876)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002875	negative regulation of chronic inflammatory response to antigenic stimulus (GO:0002875)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002874	regulation of chronic inflammatory response to antigenic stimulus (GO:0002874)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010482	regulation of epidermal cell division (GO:0010482)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0010481	epidermal cell division (GO:0010481)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002870	T cell anergy (GO:0002870)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034418	urate biosynthetic process (GO:0034418)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034414	tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042023	DNA endoreduplication (GO:0042023)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014839	myoblast migration involved in skeletal muscle regeneration (GO:0014839)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0014835	myoblast differentiation involved in skeletal muscle regeneration (GO:0014835)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030050	vesicle transport along actin filament (GO:0030050)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0010476	gibberellin mediated signaling pathway (GO:0010476)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002865	negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002862	negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0010470	regulation of gastrulation (GO:0010470)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0002860	positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034402	recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0030047	actin modification (GO:0030047)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0030046	parallel actin filament bundle assembly (GO:0030046)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002859	negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002859)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002858	regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0002857	positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0002856	negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002855	regulation of natural killer cell mediated immune response to tumor cell (GO:0002855)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0002854	positive regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002854)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002852	regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002852)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002851	positive regulation of peripheral T cell tolerance induction (GO:0002851)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097115	neurexin clustering involved in presynaptic membrane assembly (GO:0097115)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045994	positive regulation of translational initiation by iron (GO:0045994)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045993	negative regulation of translational initiation by iron (GO:0045993)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097111	endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045992	negative regulation of embryonic development (GO:0045992)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0042000	translocation of peptides or proteins into host (GO:0042000)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030037	actin filament reorganization involved in cell cycle (GO:0030037)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0030035	microspike assembly (GO:0030035)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0030034	microvillar actin bundle assembly (GO:0030034)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014816	skeletal muscle satellite cell differentiation (GO:0014816)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0014810	positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014810)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002849	regulation of peripheral T cell tolerance induction (GO:0002849)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010457	centriole-centriole cohesion (GO:0010457)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:0002845	positive regulation of tolerance induction to tumor cell (GO:0002845)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010452	histone H3-K36 methylation (GO:0010452)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0002843	regulation of tolerance induction to tumor cell (GO:0002843)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002842	positive regulation of T cell mediated immune response to tumor cell (GO:0002842)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002841	negative regulation of T cell mediated immune response to tumor cell (GO:0002841)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002840	regulation of T cell mediated immune response to tumor cell (GO:0002840)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0097102	endothelial tip cell fate specification (GO:0097102)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097101	blood vessel endothelial cell fate specification (GO:0097101)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0022417	protein maturation by protein folding (GO:0022417)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0030026	cellular manganese ion homeostasis (GO:0030026)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014807	regulation of somitogenesis (GO:0014807)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0014806	smooth muscle hyperplasia (GO:0014806)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014805	smooth muscle adaptation (GO:0014805)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0022410	circadian sleep/wake cycle process (GO:0022410)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002839	positive regulation of immune response to tumor cell (GO:0002839)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0002838	negative regulation of immune response to tumor cell (GO:0002838)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002837	regulation of immune response to tumor cell (GO:0002837)	21	0	1.23	-	 < 0.01	6.28E-01	1.00E00
GO:0010446	response to alkaline pH (GO:0010446)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002836	positive regulation of response to tumor cell (GO:0002836)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0002835	negative regulation of response to tumor cell (GO:0002835)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002834	regulation of response to tumor cell (GO:0002834)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0061198	fungiform papilla formation (GO:0061198)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045977	positive regulation of mitotic cell cycle, embryonic (GO:0045977)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045976	negative regulation of mitotic cell cycle, embryonic (GO:0045976)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061193	taste bud development (GO:0061193)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061190	regulation of sclerotome development (GO:0061190)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0022400	regulation of rhodopsin mediated signaling pathway (GO:0022400)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0002829	negative regulation of type 2 immune response (GO:0002829)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0061189	positive regulation of sclerotome development (GO:0061189)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061188	negative regulation of ribosomal DNA heterochromatin formation (GO:0061188)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0010430	fatty acid omega-oxidation (GO:0010430)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0061187	regulation of rDNA heterochromatin formation (GO:0061187)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061185	negative regulation of dermatome development (GO:0061185)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045967	negative regulation of growth rate (GO:0045967)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061184	positive regulation of dermatome development (GO:0061184)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061183	regulation of dermatome development (GO:0061183)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061182	negative regulation of chondrocyte development (GO:0061182)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061181	regulation of chondrocyte development (GO:0061181)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045963	negative regulation of dopamine metabolic process (GO:0045963)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045960	positive regulation of complement activation, classical pathway (GO:0045960)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002816	regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0002816)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010424	DNA methylation on cytosine within a CG sequence (GO:0010424)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002815	biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0002815)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010421	hydrogen peroxide-mediated programmed cell death (GO:0010421)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002812	biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002812)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045959	negative regulation of complement activation, classical pathway (GO:0045959)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0045957	negative regulation of complement activation, alternative pathway (GO:0045957)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061172	regulation of establishment of bipolar cell polarity (GO:0061172)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045954	positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	26	0	1.53	-	 < 0.01	3.99E-01	1.00E00
GO:0061171	establishment of bipolar cell polarity (GO:0061171)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045953	negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)	19	0	1.12	-	 < 0.01	6.23E-01	1.00E00
GO:0061170	negative regulation of hair follicle placode formation (GO:0061170)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045951	positive regulation of mitotic recombination (GO:0045951)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045950	negative regulation of mitotic recombination (GO:0045950)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002808	regulation of antibacterial peptide biosynthetic process (GO:0002808)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002807	positive regulation of antimicrobial peptide biosynthetic process (GO:0002807)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002805	regulation of antimicrobial peptide biosynthetic process (GO:0002805)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002803	positive regulation of antibacterial peptide production (GO:0002803)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061168	regulation of hair follicle placode formation (GO:0061168)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903496	response to 11-deoxycorticosterone (GO:1903496)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903495	cellular response to dehydroepiandrosterone (GO:1903495)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903494	response to dehydroepiandrosterone (GO:1903494)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061163	endoplasmic reticulum polarization (GO:0061163)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033979	box H/ACA RNA metabolic process (GO:0033979)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061159	establishment of bipolar cell polarity involved in cell morphogenesis (GO:0061159)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903489	positive regulation of lactation (GO:1903489)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903487	regulation of lactation (GO:1903487)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0045938	positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061156	pulmonary artery morphogenesis (GO:0061156)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0061155	pulmonary artery endothelial tube morphogenesis (GO:0061155)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061153	trachea gland development (GO:0061153)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061152	trachea submucosa development (GO:0061152)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061151	BMP signaling pathway involved in renal system segmentation (GO:0061151)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061150	renal system segmentation (GO:0061150)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0033967	box C/D RNA metabolic process (GO:0033967)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0033962	P-body assembly (GO:0033962)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0021999	neural plate anterior/posterior regionalization (GO:0021999)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021998	neural plate mediolateral regionalization (GO:0021998)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021997	neural plate axis specification (GO:0021997)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021993	initiation of neural tube closure (GO:0021993)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061149	BMP signaling pathway involved in ureter morphogenesis (GO:0061149)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061146	Peyer's patch morphogenesis (GO:0061146)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019682	glyceraldehyde-3-phosphate metabolic process (GO:0019682)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0061144	alveolar secondary septum development (GO:0061144)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061143	alveolar primary septum development (GO:0061143)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021985	neurohypophysis development (GO:0021985)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019678	propionate metabolic process, methylmalonyl pathway (GO:0019678)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019677	NAD catabolic process (GO:0019677)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019676	ammonia assimilation cycle (GO:0019676)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045919	positive regulation of cytolysis (GO:0045919)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019674	NAD metabolic process (GO:0019674)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0045918	negative regulation of cytolysis (GO:0045918)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019673	GDP-mannose metabolic process (GO:0019673)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1903464	negative regulation of mitotic cell cycle DNA replication (GO:1903464)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045914	negative regulation of catecholamine metabolic process (GO:0045914)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903463	regulation of mitotic cell cycle DNA replication (GO:1903463)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903461	Okazaki fragment processing involved in mitotic DNA replication (GO:1903461)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021978	telencephalon regionalization (GO:0021978)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1903457	lactate catabolic process (GO:1903457)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045906	negative regulation of vasoconstriction (GO:0045906)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0045905	positive regulation of translational termination (GO:0045905)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019661	glucose catabolic process to lactate via pyruvate (GO:0019661)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019660	glycolytic fermentation (GO:0019660)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045903	positive regulation of translational fidelity (GO:0045903)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903451	negative regulation of G1 to G0 transition (GO:1903451)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045901	positive regulation of translational elongation (GO:0045901)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903450	regulation of G1 to G0 transition (GO:1903450)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019659	glucose catabolic process to lactate (GO:0019659)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061115	lung proximal/distal axis specification (GO:0061115)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903445	protein transport from ciliary membrane to plasma membrane (GO:1903445)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061114	branching involved in pancreas morphogenesis (GO:0061114)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061113	pancreas morphogenesis (GO:0061113)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903444	negative regulation of brown fat cell differentiation (GO:1903444)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903442	response to lipoic acid (GO:1903442)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021956	central nervous system interneuron axonogenesis (GO:0021956)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061108	seminal vesicle epithelium development (GO:0061108)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903438	positive regulation of mitotic cytokinetic process (GO:1903438)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061106	negative regulation of stomach neuroendocrine cell differentiation (GO:0061106)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903436	regulation of mitotic cytokinetic process (GO:1903436)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061105	regulation of stomach neuroendocrine cell differentiation (GO:0061105)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903435	positive regulation of constitutive secretory pathway (GO:1903435)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061104	adrenal chromaffin cell differentiation (GO:0061104)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903434	negative regulation of constitutive secretory pathway (GO:1903434)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061103	carotid body glomus cell differentiation (GO:0061103)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019640	glucuronate catabolic process to xylulose 5-phosphate (GO:0019640)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903433	regulation of constitutive secretory pathway (GO:1903433)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061102	stomach neuroendocrine cell differentiation (GO:0061102)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903432	regulation of TORC1 signaling (GO:1903432)	48	0	2.82	-	 < 0.01	1.13E-01	5.60E-01
GO:0061100	lung neuroendocrine cell differentiation (GO:0061100)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021943	formation of radial glial scaffolds (GO:0021943)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021942	radial glia guided migration of Purkinje cell (GO:0021942)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021941	negative regulation of cerebellar granule cell precursor proliferation (GO:0021941)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072697	protein localization to cell cortex (GO:0072697)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072695	regulation of DNA recombination at telomere (GO:0072695)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903422	negative regulation of synaptic vesicle recycling (GO:1903422)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903420	protein localization to endoplasmic reticulum tubular network (GO:1903420)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021935	cerebellar granule cell precursor tangential migration (GO:0021935)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021933	radial glia guided migration of cerebellar granule cell (GO:0021933)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019626	short-chain fatty acid catabolic process (GO:0019626)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0072684	mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003290	atrial septum secundum morphogenesis (GO:0003290)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072679	thymocyte migration (GO:0072679)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903408	positive regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903408)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072675	osteoclast fusion (GO:0072675)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0072674	multinuclear osteoclast differentiation (GO:0072674)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1903406	regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903406)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0072672	neutrophil extravasation (GO:0072672)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903405	protein localization to nuclear body (GO:1903405)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903401	L-lysine transmembrane transport (GO:1903401)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0003285	septum secundum development (GO:0003285)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021919	BMP signaling pathway involved in spinal cord dorsal/ventral patterning (GO:0021919)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021914	negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021910	smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019606	2-oxobutyrate catabolic process (GO:0019606)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019605	butyrate metabolic process (GO:0019605)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072663	establishment of protein localization to peroxisome (GO:0072663)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0072662	protein localization to peroxisome (GO:0072662)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0072660	maintenance of protein location in plasma membrane (GO:0072660)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060699	regulation of endoribonuclease activity (GO:0060699)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060697	positive regulation of phospholipid catabolic process (GO:0060697)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0007635	chemosensory behavior (GO:0007635)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0060695	negative regulation of cholesterol transporter activity (GO:0060695)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060694	regulation of cholesterol transporter activity (GO:0060694)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007634	optokinetic behavior (GO:0007634)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007630	jump response (GO:0007630)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003275	apoptotic process involved in outflow tract morphogenesis (GO:0003275)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003271	smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003271)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021905	forebrain-midbrain boundary formation (GO:0021905)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003270	Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021904	dorsal/ventral neural tube patterning (GO:0021904)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0021902	commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0072658	maintenance of protein location in membrane (GO:0072658)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072656	maintenance of protein location in mitochondrion (GO:0072656)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0072655	establishment of protein localization to mitochondrion (GO:0072655)	75	0	4.40	-	 < 0.01	2.20E-02	2.22E-01
GO:0060686	negative regulation of prostatic bud formation (GO:0060686)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0007625	grooming behavior (GO:0007625)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0060685	regulation of prostatic bud formation (GO:0060685)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060684	epithelial-mesenchymal cell signaling (GO:0060684)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0007624	ultradian rhythm (GO:0007624)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060683	regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060682	primary ureteric bud growth (GO:0060682)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060681	branch elongation involved in ureteric bud branching (GO:0060681)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003260	cardioblast migration (GO:0003260)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060678	dichotomous subdivision of terminal units involved in ureteric bud branching (GO:0060678)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007618	mating (GO:0007618)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060676	ureteric bud formation (GO:0060676)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060672	epithelial cell morphogenesis involved in placental branching (GO:0060672)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060671	epithelial cell differentiation involved in embryonic placenta development (GO:0060671)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003259	cardioblast anterior-lateral migration (GO:0003259)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003252	negative regulation of cell proliferation involved in heart valve morphogenesis (GO:0003252)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003251	positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003250	regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046391	5-phosphoribose 1-diphosphate metabolic process (GO:0046391)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060668	regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902999	negative regulation of phospholipid efflux (GO:1902999)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060667	branch elongation involved in salivary gland morphogenesis (GO:0060667)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060666	dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902997	negative regulation of neurofibrillary tangle assembly (GO:1902997)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060664	epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902995	positive regulation of phospholipid efflux (GO:1902995)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0007604	phototransduction, UV (GO:0007604)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007603	phototransduction, visible light (GO:0007603)	13	0	.76	-	 < 0.01	1.00E00	1.00E00
GO:1902994	regulation of phospholipid efflux (GO:1902994)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0007602	phototransduction (GO:0007602)	42	0	2.47	-	 < 0.01	1.72E-01	6.98E-01
GO:0060661	submandibular salivary gland formation (GO:0060661)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003242	cardiac chamber ballooning (GO:0003242)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046386	deoxyribose phosphate catabolic process (GO:0046386)	29	0	1.70	-	 < 0.01	4.07E-01	1.00E00
GO:0046380	N-acetylneuraminate biosynthetic process (GO:0046380)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060658	nipple morphogenesis (GO:0060658)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902988	neurofibrillary tangle assembly (GO:1902988)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003236	sinus venosus morphogenesis (GO:0003236)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003235	sinus venosus development (GO:0003235)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046379	extracellular polysaccharide metabolic process (GO:0046379)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046373	L-arabinose metabolic process (GO:0046373)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046370	fructose biosynthetic process (GO:0046370)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060648	mammary gland bud morphogenesis (GO:0060648)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902979	mitotic DNA replication termination (GO:1902979)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003226	right ventricular compact myocardium morphogenesis (GO:0003226)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003222	ventricular trabecula myocardium morphogenesis (GO:0003222)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0046368	GDP-L-fucose metabolic process (GO:0046368)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046365	monosaccharide catabolic process (GO:0046365)	43	0	2.52	-	 < 0.01	1.74E-01	7.00E-01
GO:0046361	2-oxobutyrate metabolic process (GO:0046361)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046360	2-oxobutyrate biosynthetic process (GO:0046360)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034398	telomere tethering at nuclear periphery (GO:0034398)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034397	telomere localization (GO:0034397)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0034395	regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034393	positive regulation of smooth muscle cell apoptotic process (GO:0034393)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1902966	positive regulation of protein localization to early endosome (GO:1902966)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0034390	smooth muscle cell apoptotic process (GO:0034390)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902965	regulation of protein localization to early endosome (GO:1902965)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1902963	negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902963)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060631	regulation of meiosis I (GO:0060631)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902962	regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902962)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003213	cardiac right atrium morphogenesis (GO:0003213)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046359	butyrate catabolic process (GO:0046359)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003210	cardiac atrium formation (GO:0003210)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046356	acetyl-CoA catabolic process (GO:0046356)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046352	disaccharide catabolic process (GO:0046352)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046351	disaccharide biosynthetic process (GO:0046351)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060629	regulation of homologous chromosome segregation (GO:0060629)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034384	high-density lipoprotein particle clearance (GO:0034384)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0034383	low-density lipoprotein particle clearance (GO:0034383)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1902958	positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034380	high-density lipoprotein particle assembly (GO:0034380)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:1902955	positive regulation of early endosome to recycling endosome transport (GO:1902955)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902954	regulation of early endosome to recycling endosome transport (GO:1902954)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902953	positive regulation of ER to Golgi vesicle-mediated transport (GO:1902953)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902952	positive regulation of dendritic spine maintenance (GO:1902952)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060621	negative regulation of cholesterol import (GO:0060621)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902951	negative regulation of dendritic spine maintenance (GO:1902951)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0060620	regulation of cholesterol import (GO:0060620)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902950	regulation of dendritic spine maintenance (GO:1902950)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0046349	amino sugar biosynthetic process (GO:0046349)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0046341	CDP-diacylglycerol metabolic process (GO:0046341)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:0046340	diacylglycerol catabolic process (GO:0046340)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0034378	chylomicron assembly (GO:0034378)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060618	nipple development (GO:0060618)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902948	negative regulation of tau-protein kinase activity (GO:1902948)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034373	intermediate-density lipoprotein particle remodeling (GO:0034373)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034372	very-low-density lipoprotein particle remodeling (GO:0034372)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0060615	mammary gland bud formation (GO:0060615)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034371	chylomicron remodeling (GO:0034371)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902946	protein localization to early endosome (GO:1902946)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034370	triglyceride-rich lipoprotein particle remodeling (GO:0034370)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0060613	fat pad development (GO:0060613)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1902943	positive regulation of voltage-gated chloride channel activity (GO:1902943)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060611	mammary gland fat development (GO:0060611)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902941	regulation of voltage-gated chloride channel activity (GO:1902941)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046338	phosphatidylethanolamine catabolic process (GO:0046338)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046333	octopamine metabolic process (GO:0046333)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097089	methyl-branched fatty acid metabolic process (GO:0097089)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0046331	lateral inhibition (GO:0046331)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902939	negative regulation of intracellular calcium activated chloride channel activity (GO:1902939)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902938	regulation of intracellular calcium activated chloride channel activity (GO:1902938)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097080	plasma membrane selenite transport (GO:0097080)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060601	lateral sprouting from an epithelium (GO:0060601)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0046327	glycerol biosynthetic process from pyruvate (GO:0046327)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034355	NAD salvage (GO:0034355)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046318	negative regulation of glucosylceramide biosynthetic process (GO:0046318)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046317	regulation of glucosylceramide biosynthetic process (GO:0046317)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097069	cellular response to thyroxine stimulus (GO:0097069)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097068	response to thyroxine (GO:0097068)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034349	glial cell apoptotic process (GO:0034349)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0097064	ncRNA export from nucleus (GO:0097064)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0034346	positive regulation of type III interferon production (GO:0034346)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0097062	dendritic spine maintenance (GO:0097062)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0034345	negative regulation of type III interferon production (GO:0034345)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034344	regulation of type III interferon production (GO:0034344)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034343	type III interferon production (GO:0034343)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034342	response to type III interferon (GO:0034342)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1902915	negative regulation of protein polyubiquitination (GO:1902915)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:1902910	positive regulation of melanosome transport (GO:1902910)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097056	selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0097055	agmatine biosynthetic process (GO:0097055)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034337	RNA folding (GO:0034337)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097053	L-kynurenine catabolic process (GO:0097053)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0097052	L-kynurenine metabolic process (GO:0097052)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0097051	establishment of protein localization to endoplasmic reticulum membrane (GO:0097051)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902908	regulation of melanosome transport (GO:1902908)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002787	negative regulation of antibacterial peptide production (GO:0002787)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002786	regulation of antibacterial peptide production (GO:0002786)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002785	negative regulation of antimicrobial peptide production (GO:0002785)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002784	regulation of antimicrobial peptide production (GO:0002784)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0002780	antibacterial peptide biosynthetic process (GO:0002780)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097045	phosphatidylserine exposure on blood platelet (GO:0097045)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097043	histone H3-K56 acetylation (GO:0097043)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014744	positive regulation of muscle adaptation (GO:0014744)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0014740	negative regulation of muscle hyperplasia (GO:0014740)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0010387	COP9 signalosome assembly (GO:0010387)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0002778	antibacterial peptide production (GO:0002778)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002777	antimicrobial peptide biosynthetic process (GO:0002777)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002775	antimicrobial peptide production (GO:0002775)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002774	Fc receptor mediated inhibitory signaling pathway (GO:0002774)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0008078	mesodermal cell migration (GO:0008078)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0097039	protein linear polyubiquitination (GO:0097039)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097037	heme export (GO:0097037)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097036	regulation of plasma membrane sterol distribution (GO:0097036)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034314	Arp2/3 complex-mediated actin nucleation (GO:0034314)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0034312	diol biosynthetic process (GO:0034312)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:0014739	positive regulation of muscle hyperplasia (GO:0014739)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014738	regulation of muscle hyperplasia (GO:0014738)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014737	positive regulation of muscle atrophy (GO:0014737)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014736	negative regulation of muscle atrophy (GO:0014736)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0014735	regulation of muscle atrophy (GO:0014735)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014734	skeletal muscle hypertrophy (GO:0014734)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002769	natural killer cell inhibitory signaling pathway (GO:0002769)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002767	immune response-inhibiting cell surface receptor signaling pathway (GO:0002767)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0002765	immune response-inhibiting signal transduction (GO:0002765)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0097029	mature conventional dendritic cell differentiation (GO:0097029)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002760	positive regulation of antimicrobial humoral response (GO:0002760)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0008063	Toll signaling pathway (GO:0008063)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0097022	lymphocyte migration into lymph node (GO:0097022)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0097021	lymphocyte migration into lymphoid organs (GO:0097021)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0014728	regulation of the force of skeletal muscle contraction (GO:0014728)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0014724	regulation of twitch skeletal muscle contraction (GO:0014724)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0002756	MyD88-independent toll-like receptor signaling pathway (GO:0002756)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0002753	cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	28	0	1.64	-	 < 0.01	4.03E-01	1.00E00
GO:0010360	negative regulation of anion channel activity (GO:0010360)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0008057	eye pigment granule organization (GO:0008057)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0008053	mitochondrial fusion (GO:0008053)	18	0	1.06	-	 < 0.01	6.21E-01	1.00E00
GO:0008052	sensory organ boundary specification (GO:0008052)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0097010	eukaryotic translation initiation factor 4F complex assembly (GO:0097010)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014719	skeletal muscle satellite cell activation (GO:0014719)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0014718	positive regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014718)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0014717	regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0002747	antigen processing and presentation following phagocytosis (GO:0002747)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0008049	male courtship behavior (GO:0008049)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002737	negative regulation of plasmacytoid dendritic cell cytokine production (GO:0002737)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002736	regulation of plasmacytoid dendritic cell cytokine production (GO:0002736)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002735	positive regulation of myeloid dendritic cell cytokine production (GO:0002735)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0002733	regulation of myeloid dendritic cell cytokine production (GO:0002733)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0008039	synaptic target recognition (GO:0008039)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002731	negative regulation of dendritic cell cytokine production (GO:0002731)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0008033	tRNA processing (GO:0008033)	135	0	7.93	-	 < 0.01	9.25E-04	1.89E-02
GO:0061090	positive regulation of sequestering of zinc ion (GO:0061090)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002729	positive regulation of natural killer cell cytokine production (GO:0002729)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0002728	negative regulation of natural killer cell cytokine production (GO:0002728)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0002727	regulation of natural killer cell cytokine production (GO:0002727)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0010335	response to non-ionic osmotic stress (GO:0010335)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002725	negative regulation of T cell cytokine production (GO:0002725)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0061088	regulation of sequestering of zinc ion (GO:0061088)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061087	positive regulation of histone H3-K27 methylation (GO:0061087)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869)	16	0	.94	-	 < 0.01	1.00E00	1.00E00
GO:0002721	regulation of B cell cytokine production (GO:0002721)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061086	negative regulation of histone H3-K27 methylation (GO:0061086)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061085	regulation of histone H3-K27 methylation (GO:0061085)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0061084	negative regulation of protein refolding (GO:0061084)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061083	regulation of protein refolding (GO:0061083)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0085017	entry into host cell by a symbiont-containing vacuole (GO:0085017)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002717	positive regulation of natural killer cell mediated immunity (GO:0002717)	31	0	1.82	-	 < 0.01	4.16E-01	1.00E00
GO:0002716	negative regulation of natural killer cell mediated immunity (GO:0002716)	20	0	1.17	-	 < 0.01	6.25E-01	1.00E00
GO:0002713	negative regulation of B cell mediated immunity (GO:0002713)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0061078	positive regulation of prostaglandin secretion involved in immune response (GO:0061078)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061074	regulation of neural retina development (GO:0061074)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0061073	ciliary body morphogenesis (GO:0061073)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0045852	pH elevation (GO:0045852)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045851	pH reduction (GO:0045851)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0010312	detoxification of zinc ion (GO:0010312)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045848	positive regulation of nitrogen utilization (GO:0045848)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045844	positive regulation of striated muscle tissue development (GO:0045844)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903393	positive regulation of adherens junction organization (GO:1903393)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0045843	negative regulation of striated muscle tissue development (GO:0045843)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1903392	negative regulation of adherens junction organization (GO:1903392)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903391	regulation of adherens junction organization (GO:1903391)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0045838	positive regulation of membrane potential (GO:0045838)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:1903387	positive regulation of homophilic cell adhesion (GO:1903387)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903385	regulation of homophilic cell adhesion (GO:1903385)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903384	negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903383	regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903382	negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903381	regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0033869	nucleoside bisphosphate catabolic process (GO:0033869)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0033861	negative regulation of NAD(P)H oxidase activity (GO:0033861)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021897	forebrain astrocyte development (GO:0021897)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021896	forebrain astrocyte differentiation (GO:0021896)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021893	cerebral cortex GABAergic interneuron fate commitment (GO:0021893)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061048	negative regulation of branching involved in lung morphogenesis (GO:0061048)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903379	regulation of mitotic chromosome condensation (GO:1903379)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019585	glucuronate metabolic process (GO:0019585)	25	0	1.47	-	 < 0.01	3.99E-01	1.00E00
GO:0045829	negative regulation of isotype switching (GO:0045829)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0061047	positive regulation of branching involved in lung morphogenesis (GO:0061047)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903378	positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0045828	positive regulation of isoprenoid metabolic process (GO:0045828)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045827	negative regulation of isoprenoid metabolic process (GO:0045827)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903376	regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:1903375	facioacoustic ganglion development (GO:1903375)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061044	negative regulation of vascular wound healing (GO:0061044)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1903373	positive regulation of endoplasmic reticulum tubular network organization (GO:1903373)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903371	regulation of endoplasmic reticulum tubular network organization (GO:1903371)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0061040	female gonad morphogenesis (GO:0061040)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061038	uterus morphogenesis (GO:0061038)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0045819	positive regulation of glycogen catabolic process (GO:0045819)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0045818	negative regulation of glycogen catabolic process (GO:0045818)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061034	olfactory bulb mitral cell layer development (GO:0061034)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021877	forebrain neuron fate commitment (GO:0021877)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0021874	Wnt signaling pathway involved in forebrain neuroblast division (GO:0021874)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021870	Cajal-Retzius cell differentiation (GO:0021870)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019566	arabinose metabolic process (GO:0019566)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903358	regulation of Golgi organization (GO:1903358)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0061027	umbilical cord development (GO:0061027)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061026	cardiac muscle tissue regeneration (GO:0061026)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019563	glycerol catabolic process (GO:0019563)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1903352	L-ornithine transmembrane transport (GO:1903352)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0007598	blood coagulation, extrinsic pathway (GO:0007598)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021861	forebrain radial glial cell differentiation (GO:0021861)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0019557	histidine catabolic process to glutamate and formate (GO:0019557)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0019556	histidine catabolic process to glutamate and formamide (GO:0019556)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061017	hepatoblast differentiation (GO:0061017)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903347	negative regulation of bicellular tight junction assembly (GO:1903347)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0061015	snRNA import into nucleus (GO:0061015)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019551	glutamate catabolic process to 2-oxoglutarate (GO:0019551)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903343	positive regulation of meiotic DNA double-strand break formation (GO:1903343)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019550	glutamate catabolic process to aspartate (GO:0019550)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903341	regulation of meiotic DNA double-strand break formation (GO:1903341)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021858	GABAergic neuron differentiation in basal ganglia (GO:0021858)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021853	cerebral cortex GABAergic interneuron migration (GO:0021853)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0021852	pyramidal neuron migration to cerebral cortex (GO:0021852)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0019547	arginine catabolic process to ornithine (GO:0019547)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019544	arginine catabolic process to glutamate (GO:0019544)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903337	positive regulation of vacuolar transport (GO:1903337)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0061006	regulation of cell proliferation involved in kidney morphogenesis (GO:0061006)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019543	propionate catabolic process (GO:0019543)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061004	pattern specification involved in kidney development (GO:0061004)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0019542	propionate biosynthetic process (GO:0019542)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019541	propionate metabolic process (GO:0019541)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903334	positive regulation of protein folding (GO:1903334)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0061002	negative regulation of dendritic spine morphogenesis (GO:0061002)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1903333	negative regulation of protein folding (GO:1903333)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1903332	regulation of protein folding (GO:1903332)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0061000	negative regulation of dendritic spine development (GO:0061000)	14	0	.82	-	 < 0.01	1.00E00	1.00E00
GO:1903331	positive regulation of iron-sulfur cluster assembly (GO:1903331)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021849	neuroblast division in subventricular zone (GO:0021849)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021847	ventricular zone neuroblast division (GO:0021847)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021843	substrate-independent telencephalic tangential interneuron migration (GO:0021843)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0021842	chemorepulsion involved in interneuron migration from the subpallium to the cortex (GO:0021842)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021840	directional guidance of interneurons involved in migration from the subpallium to the cortex (GO:0021840)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1903329	regulation of iron-sulfur cluster assembly (GO:1903329)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903327	negative regulation of tRNA metabolic process (GO:1903327)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903326	regulation of tRNA metabolic process (GO:1903326)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072592	oxygen metabolic process (GO:0072592)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0021831	embryonic olfactory bulb interneuron precursor migration (GO:0021831)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021830	interneuron migration from the subpallium to the cortex (GO:0021830)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0019527	pentitol catabolic process (GO:0019527)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019521	D-gluconate metabolic process (GO:0019521)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1903314	regulation of nitrogen cycle metabolic process (GO:1903314)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019520	aldonic acid metabolic process (GO:0019520)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003199	endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003195	tricuspid valve formation (GO:0003195)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003193	pulmonary valve formation (GO:0003193)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021826	substrate-independent telencephalic tangential migration (GO:0021826)	10	0	.59	-	 < 0.01	1.00E00	1.00E00
GO:0021822	negative regulation of cell motility involved in cerebral cortex radial glia guided migration (GO:0021822)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019519	pentitol metabolic process (GO:0019519)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072579	glycine receptor clustering (GO:0072579)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019518	L-threonine catabolic process to glycine (GO:0019518)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0019516	lactate oxidation (GO:0019516)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0080184	response to phenylpropanoid (GO:0080184)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0072573	tolerance induction to lipopolysaccharide (GO:0072573)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019511	peptidyl-proline hydroxylation (GO:0019511)	15	0	.88	-	 < 0.01	1.00E00	1.00E00
GO:0019510	S-adenosylhomocysteine catabolic process (GO:0019510)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903302	regulation of pyruvate kinase activity (GO:1903302)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1903301	positive regulation of hexokinase activity (GO:1903301)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1903300	negative regulation of hexokinase activity (GO:1903300)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0007542	primary sex determination, germ-line (GO:0007542)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003182	coronary sinus valve morphogenesis (GO:0003182)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021817	nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration (GO:0021817)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021816	extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0021815	modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0021814	cell motility involved in cerebral cortex radial glia guided migration (GO:0021814)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0021813	cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021812	neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0019509	L-methionine salvage from methylthioadenosine (GO:0019509)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0080170	hydrogen peroxide transmembrane transport (GO:0080170)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0072560	type B pancreatic cell maturation (GO:0072560)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060599	lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0007538	primary sex determination (GO:0007538)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060596	mammary placode formation (GO:0060596)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060595	fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060594	mammary gland specification (GO:0060594)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060592	mammary gland formation (GO:0060592)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0003178	coronary sinus valve development (GO:0003178)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021808	cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration (GO:0021808)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0021806	initiation of movement involved in cerebral cortex radial glia guided migration (GO:0021806)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0080163	regulation of protein serine/threonine phosphatase activity (GO:0080163)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072554	blood vessel lumenization (GO:0072554)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0072553	terminal button organization (GO:0072553)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0007529	establishment of synaptic specificity at neuromuscular junction (GO:0007529)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060586	multicellular organismal iron ion homeostasis (GO:0060586)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0060585	positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060584	regulation of prostaglandin-endoperoxide synthase activity (GO:0060584)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060582	cell fate determination involved in pattern specification (GO:0060582)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0007522	visceral muscle development (GO:0007522)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060581	cell fate commitment involved in pattern specification (GO:0060581)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0060580	ventral spinal cord interneuron fate determination (GO:0060580)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003169	coronary vein morphogenesis (GO:0003169)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0003168	Purkinje myocyte differentiation (GO:0003168)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003165	Purkinje myocyte development (GO:0003165)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0080154	regulation of fertilization (GO:0080154)	17	0	1.00	-	 < 0.01	1.00E00	1.00E00
GO:0060579	ventral spinal cord interneuron fate commitment (GO:0060579)	11	0	.65	-	 < 0.01	1.00E00	1.00E00
GO:0007518	myoblast fate determination (GO:0007518)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060577	pulmonary vein morphogenesis (GO:0060577)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060573	cell fate specification involved in pattern specification (GO:0060573)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060572	morphogenesis of an epithelial bud (GO:0060572)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0046296	glycolate catabolic process (GO:0046296)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046295	glycolate biosynthetic process (GO:0046295)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046294	formaldehyde catabolic process (GO:0046294)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0046293	formaldehyde biosynthetic process (GO:0046293)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046292	formaldehyde metabolic process (GO:0046292)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0080144	amino acid homeostasis (GO:0080144)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:0007509	mesoderm migration involved in gastrulation (GO:0007509)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060567	negative regulation of termination of DNA-templated transcription (GO:0060567)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902897	regulation of postsynaptic density protein 95 clustering (GO:1902897)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060566	positive regulation of termination of DNA-templated transcription (GO:0060566)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902896	terminal web assembly (GO:1902896)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0007501	mesodermal cell fate specification (GO:0007501)	9	0	.53	-	 < 0.01	1.00E00	1.00E00
GO:0003147	neural crest cell migration involved in heart formation (GO:0003147)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003144	embryonic heart tube formation (GO:0003144)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003140	determination of left/right asymmetry in lateral mesoderm (GO:0003140)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0072529	pyrimidine-containing compound catabolic process (GO:0072529)	39	0	2.29	-	 < 0.01	2.76E-01	8.80E-01
GO:0072526	pyridine-containing compound catabolic process (GO:0072526)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060559	positive regulation of calcidiol 1-monooxygenase activity (GO:0060559)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0060558	regulation of calcidiol 1-monooxygenase activity (GO:0060558)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:1902889	protein localization to spindle microtubule (GO:1902889)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060557	positive regulation of vitamin D biosynthetic process (GO:0060557)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902888	protein localization to astral microtubule (GO:1902888)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060556	regulation of vitamin D biosynthetic process (GO:0060556)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060552	positive regulation of fructose 1,6-bisphosphate metabolic process (GO:0060552)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060551	regulation of fructose 1,6-bisphosphate metabolic process (GO:0060551)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060550	positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060550)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003136	negative regulation of heart induction by canonical Wnt signaling pathway (GO:0003136)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003134	endodermal-mesodermal cell signaling involved in heart induction (GO:0003134)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003133	endodermal-mesodermal cell signaling (GO:0003133)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003131	mesodermal-endodermal cell signaling (GO:0003131)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003130	BMP signaling pathway involved in heart induction (GO:0003130)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0080129	proteasome core complex assembly (GO:0080129)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046275	flavonoid catabolic process (GO:0046275)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046271	phenylpropanoid catabolic process (GO:0046271)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0080121	AMP transport (GO:0080121)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0080120	CAAX-box protein maturation (GO:0080120)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0060549	regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060549)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060545	positive regulation of necroptotic process (GO:0060545)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0060542	regulation of strand invasion (GO:0060542)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902871	positive regulation of amacrine cell differentiation (GO:1902871)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003129	heart induction (GO:0003129)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902870	negative regulation of amacrine cell differentiation (GO:1902870)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0003127	detection of nodal flow (GO:0003127)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0080111	DNA demethylation (GO:0080111)	22	0	1.29	-	 < 0.01	6.32E-01	1.00E00
GO:1902869	regulation of amacrine cell differentiation (GO:1902869)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:1902866	regulation of retina development in camera-type eye (GO:1902866)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060535	trachea cartilage morphogenesis (GO:0060535)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902860	propionyl-CoA biosynthetic process (GO:1902860)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034287	detection of monosaccharide stimulus (GO:0034287)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:0034285	response to disaccharide (GO:0034285)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0060529	squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902859	propionyl-CoA catabolic process (GO:1902859)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060528	secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902858	propionyl-CoA metabolic process (GO:1902858)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:1902857	positive regulation of non-motile cilium assembly (GO:1902857)	8	0	.47	-	 < 0.01	1.00E00	1.00E00
GO:1902856	negative regulation of non-motile cilium assembly (GO:1902856)	3	0	.18	-	 < 0.01	1.00E00	1.00E00
GO:1902855	regulation of non-motile cilium assembly (GO:1902855)	12	0	.70	-	 < 0.01	1.00E00	1.00E00
GO:0060520	activation of prostate induction by androgen receptor signaling pathway (GO:0060520)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003108	negative regulation of the force of heart contraction by chemical signal (GO:0003108)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003106	negative regulation of glomerular filtration by angiotensin (GO:0003106)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0003105	negative regulation of glomerular filtration (GO:0003105)	4	0	.23	-	 < 0.01	1.00E00	1.00E00
GO:0003100	regulation of systemic arterial blood pressure by endothelin (GO:0003100)	6	0	.35	-	 < 0.01	1.00E00	1.00E00
GO:0034276	kynurenic acid biosynthetic process (GO:0034276)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034275	kynurenic acid metabolic process (GO:0034275)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060517	epithelial cell proliferation involved in prostatic bud elongation (GO:0060517)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060516	primary prostatic bud elongation (GO:0060516)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902846	positive regulation of mitotic spindle elongation (GO:1902846)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060513	prostatic bud formation (GO:0060513)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:1902838	regulation of nuclear migration along microtubule (GO:1902838)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034263	positive regulation of autophagy in response to ER overload (GO:0034263)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0060506	smoothened signaling pathway involved in lung development (GO:0060506)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902836	positive regulation of proline import across plasma membrane (GO:1902836)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0060503	bud dilation involved in lung branching (GO:0060503)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902834	regulation of proline import across plasma membrane (GO:1902834)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046226	coumarin catabolic process (GO:0046226)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046223	aflatoxin catabolic process (GO:0046223)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046222	aflatoxin metabolic process (GO:0046222)	7	0	.41	-	 < 0.01	1.00E00	1.00E00
GO:0034255	regulation of urea metabolic process (GO:0034255)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902824	positive regulation of late endosome to lysosome transport (GO:1902824)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046219	indolalkylamine biosynthetic process (GO:0046219)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046210	nitric oxide catabolic process (GO:0046210)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0034247	snoRNA splicing (GO:0034247)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034241	positive regulation of macrophage fusion (GO:0034241)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0046208	spermine catabolic process (GO:0046208)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0046204	nor-spermidine metabolic process (GO:0046204)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0046203	spermidine catabolic process (GO:0046203)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:0034239	regulation of macrophage fusion (GO:0034239)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034238	macrophage fusion (GO:0034238)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:1902805	positive regulation of synaptic vesicle transport (GO:1902805)	2	0	.12	-	 < 0.01	1.00E00	1.00E00
GO:1902804	negative regulation of synaptic vesicle transport (GO:1902804)	1	0	.06	-	 < 0.01	1.00E00	1.00E00
GO:0002681	somatic recombination of T cell receptor gene segments (GO:0002681)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
GO:0034227	tRNA thio-modification (GO:0034227)	5	0	.29	-	 < 0.01	1.00E00	1.00E00
